Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,PanglaoDB_Augmented_2021__T Cytotoxic Cells,-0.8322327697925329,-2.289542454671834,0.0,0.0,0.0,12/30,7.87%,THEMIS;ITK;NKG7;GRAP2;ZNF831;CST7;GNLY;BIN2;CD2;GZMB;CD96;RASAL3
prerank,PanglaoDB_Augmented_2021__Decidual Cells,-0.8812129341974269,-2.217207960396082,0.0,0.0,0.0,12/24,5.90%,TRGC2;NKG7;SKAP1;CCL5;GRAP2;CST7;GNLY;CD2;KLRC4-KLRK1;GZMB;HCST;CD96
prerank,PanglaoDB_Augmented_2021__T Cells Naive,-0.6362282087532624,-2.0414461831572424,0.0,0.015535909054632842,0.04,26/58,15.91%,NKG7;GRAP2;CD37;CST7;GNLY;BIN2;SELPLG;CD2;CEACAM21;GZMB;HCST;CD96;RASAL3;AOAH;ITGB2;CYTH4;LCP2;PRF1;CD53;SNX20;GIMAP4;GIMAP7;PIK3R5;CD247;PYHIN1;PSTPIP1
prerank,PanglaoDB_Augmented_2021__T Helper Cells,-0.695251982423093,-1.9410939407139314,0.0,0.04660772716389853,0.15,23/58,14.51%,THEMIS;ITK;NKG7;CCL5;CST7;GNLY;BIN2;CD2;HAVCR1;HPGDS;GZMB;CD96;RASAL3;CYTH4;LCP2;PRF1;CD53;IL18R1;SNX20;GIMAP4;GIMAP7;HAVCR2;CD247
prerank,PanglaoDB_Augmented_2021__Nuocytes,-0.7853837839388584,-1.9104833770293854,0.0,0.06525081802945794,0.21,9/29,5.90%,THEMIS;ITK;ZNF831;GNLY;GIMAP8;BCL11B;CD2;GZMB;CD96
prerank,PanglaoDB_Augmented_2021__NK Cells,-0.6063242764945632,-1.9050883799337168,0.0,0.06214363621853137,0.22,23/83,9.16%,TRGC2;THEMIS;ITK;NKG7;CCL5;GRAP2;ITGAM;SAMD3;CST7;GNLY;BIN2;SELPLG;CD2;KLRG1;GZMB;HCST;CD96;TGFB1;RASAL3;ITGAX;AOAH;SERPINB9;MYO1F
prerank,GO_Biological_Process_2021__regulation of interleukin-4 production (GO:0032673),-0.7414480796457343,-1.870811861339245,0.0,0.08156352253682242,0.32,5/15,13.95%,LGALS9;HLA-E;NLRP3;SYK;HAVCR2
prerank,GO_Biological_Process_2021__negative regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045869),-0.8666760644614306,-1.8263258277533487,0.0,0.1471056388610547,0.6,4/8,11.82%,INPP5K;SETDB1;APOBEC3G;TASOR
prerank,GO_Biological_Process_2021__regulation of monooxygenase activity (GO:0032768),-0.8160946502532482,-1.786407679518435,0.0,0.2433959085225812,0.75,8/16,15.72%,IL1B;IL1A;ZDHHC21;NOS1AP;EGFR;DDAH2;AKT1;LYPLA1
prerank,PanglaoDB_Augmented_2021__T Memory Cells,-0.6318958848879295,-1.747410254175441,0.0,0.392670101355845,0.9,28/75,13.92%,THEMIS;ITK;NKG7;SKAP1;GRAP2;CST7;GNLY;BIN2;SELPLG;CD2;CEACAM21;GZMB;ITGB5;HCST;CD96;RAPGEF6;ARHGEF1;RASAL3;ENPP1;CYTH4;APBB1IP;LCP2;PRF1;CD53;SNX20;GIMAP4;BCL2;GIMAP7
prerank,GO_Biological_Process_2021__mitochondrial calcium ion homeostasis (GO:0051560),-0.7993988406044965,-1.7275525685247752,0.0,0.4660772716389852,0.93,3/17,4.64%,SMDT1;MAIP1;MICU3
prerank,GO_Biological_Process_2021__regulation of integrin-mediated signaling pathway (GO:2001044),-0.8760363006822662,-1.696147423747562,0.0,0.6437692314513483,0.99,2/9,0.84%,FLNA;LOXL3
prerank,GO_Biological_Process_2021__cellular defense response (GO:0006968),-0.6658899538047395,-1.695344116272342,0.0,0.603211545794302,0.99,4/23,3.32%,ITK;CX3CR1;GNLY;KLRG1
prerank,GO_Biological_Process_2021__response to growth factor (GO:0070848),0.8822738264338503,1.6931474989112334,0.0,0.10452716002232733,0.09,5/26,4.63%,KLF4;LRP2;ACVR1B;ACVR2A;BMPR1B
prerank,GO_Biological_Process_2021__regulation of cell-cell adhesion mediated by integrin (GO:0033632),-0.9509725874860416,-1.6831934295760316,0.0,0.6491790569257294,0.99,2/5,0.45%,SKAP1;CCL5
prerank,PanglaoDB_Augmented_2021__T Follicular Helper Cells,-0.5492692943447794,-1.6752124895347031,0.0,0.6610529302746274,0.99,27/72,14.51%,NKG7;CD37;CST7;GNLY;GIMAP8;BIN2;SELPLG;CD2;CEACAM21;GZMB;HCST;RASAL3;AOAH;MYO1F;NCKAP1L;PLEK;ITGB2;CYTH4;LCP2;PRF1;CD53;SNX20;GIMAP4;GIMAP7;IL6R;PIK3R5;CD247
prerank,GO_Biological_Process_2021__positive regulation of integrin-mediated signaling pathway (GO:2001046),-0.9103641619513481,-1.669705837775067,0.0425531914893617,0.6590623919270026,0.99,2/6,0.84%,FLNA;LOXL3
prerank,GO_Biological_Process_2021__positive regulation of membrane invagination (GO:1905155),-0.8760660047475035,-1.6657357521421206,0.0,0.6518227725421691,0.99,4/6,10.32%,APPL2;C3;NCKAP1L;TREM2
prerank,GO_Biological_Process_2021__regulation of helicase activity (GO:0051095),-0.7909191489816498,-1.6637041690469307,0.0,0.6311463053444593,0.99,3/9,8.14%,TP53;CHTOP;SSBP1
prerank,GO_Biological_Process_2021__regulation of gastrulation (GO:0010470),-0.8804327672718681,-1.6601379620379069,0.0,0.6224584614652237,0.99,1/8,0.03%,PHLDB2
prerank,GO_Biological_Process_2021__calcium import into the mitochondrion (GO:0036444),-0.9107928468645878,-1.6576814728139542,0.0,0.6064830497202296,0.99,3/9,4.64%,SMDT1;MAIP1;MICU3
prerank,GO_Biological_Process_2021__positive regulation of immune effector process (GO:0002699),-0.776475123512512,-1.6432658881277553,0.0,0.671373212718062,0.99,3/18,4.51%,IL1B;LGALS9;APPL2
prerank,GO_Biological_Process_2021__positive regulation of interleukin-4 production (GO:0032753),-0.744337989608194,-1.6386827333099157,0.0,0.6673379116649107,0.99,5/12,13.95%,LGALS9;HLA-E;NLRP3;SYK;HAVCR2
prerank,GO_Biological_Process_2021__positive regulation of helicase activity (GO:0051096),-0.8162041436474057,-1.6375460788635519,0.0,0.6464289115340708,0.99,3/7,8.14%,GTF2H2;CHTOP;SSBP1
prerank,"GO_Biological_Process_2021__positive regulation of phagocytosis, engulfment (GO:0060100)",-0.8759308949063574,-1.6347054323779846,0.034482758620689655,0.6374577683979038,0.99,4/7,10.32%,APPL2;C3;NCKAP1L;TREM2
prerank,GO_Biological_Process_2021__mitochondrial calcium ion transmembrane transport (GO:0006851),-0.746478797356833,-1.6332865089596729,0.041666666666666664,0.6226792349096842,1.0,5/17,8.31%,SMDT1;MAIP1;MICU3;STOML2;PHB2
prerank,PanglaoDB_Augmented_2021__Chromaffin Cells,0.7757569823967281,1.632106797440855,0.0,0.42761110918224815,0.43,49/91,15.84%,PCSK1;FAM13C;PCDH17;LRP4;SULT4A1;GRIA4;PTPRD;KCTD16;BRINP1;MAPK4;PLPPR4;NRXN1;RAB3C;TTLL7;PHYHIPL;LIFR;ASXL3;KIF1B;CNTN1;SYT4;ANK2;SNAP25;CSRNP3;ARNT2;UNC13A;GRIA2;AKAP12;ERC2;FAIM2;MAP2;FAM171B;TAGLN3;MAP1B;UNC5D;CADPS;CRMP1;CACNA1B;KALRN;NFASC;STMN2;ITSN1;LSAMP;MAPK10;CHGB;NDRG4;CPE;ST8SIA3;ASIC2;SYNPR
prerank,GO_Biological_Process_2021__negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948),-0.8708892196807503,-1.6282817892850765,0.0,0.6350302826081173,1.0,3/7,3.78%,NEDD4;HHEX;DAB2IP
prerank,GO_Biological_Process_2021__sterol transport (GO:0015918),-0.7781950586071793,-1.624124850695514,0.0,0.646034884855149,1.0,3/13,2.97%,NPC2;ARV1;NPC1
prerank,"GO_Biological_Process_2021__negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515)",-0.8826729818315244,-1.6149648246632018,0.0,0.6791411672453784,1.0,4/8,7.43%,LGALS9;RUNX3;CD274;CBFB
prerank,GO_Biological_Process_2021__regulation of monocyte chemotaxis (GO:0090025),-0.6679577699596726,-1.6123935313701918,0.03571428571428571,0.6709905548595735,1.0,1/15,0.45%,CCL5
prerank,GO_Biological_Process_2021__regulation of lymphocyte activation (GO:0051249),-0.9386998058543242,-1.611042402229782,0.0,0.6583341461900666,1.0,2/8,0.45%,IKZF3;CCL5
prerank,GO_Biological_Process_2021__histone H3-K4 monomethylation (GO:0097692),-0.8339548434631888,-1.6072333939687946,0.0,0.6656635871553571,1.0,5/7,16.52%,KMT2B;SETD1B;SETD1A;KMT2D;KMT2A
prerank,GO_Biological_Process_2021__artery morphogenesis (GO:0048844),0.863904145476674,1.6053627176911798,0.014492753623188406,0.6525028777151343,0.72,3/14,5.04%,LRP2;TGFB2;VEGFA
prerank,"GO_Biological_Process_2021__wound healing, spreading of cells (GO:0044319)",-0.6945536550318657,-1.6040277245229884,0.06666666666666667,0.6637959892170859,1.0,6/18,10.04%,ITGA5;FLNA;DDR1;ARHGAP35;LCP1;COL5A1
prerank,GO_Biological_Process_2021__sensory perception of mechanical stimulus (GO:0050954),0.7847935309791699,1.6032997114536152,0.0,0.5083820964722283,0.74,9/41,7.65%,KCNE1;LRP2;COL11A1;LHFPL3;NDUFB9;PCDH15;CEMIP;SLC26A5;TIMM13
prerank,"GO_Biological_Process_2021__regulation of wound healing, spreading of epidermal cells (GO:1903689)",-0.886759038985287,-1.602549783206062,0.0,0.6542736245053331,1.0,1/7,0.03%,PHLDB2
prerank,GO_Biological_Process_2021__gliogenesis (GO:0042063),0.9500636692807553,1.5954801246071608,0.0,0.5036308619257589,0.84,6/12,4.08%,TGFB2;METRN;RELN;NFIB;ANXA1;CDH2
prerank,GO_Biological_Process_2021__sensory perception of sound (GO:0007605),0.7757925512454397,1.5907767851720205,0.024390243902439025,0.4862096685887044,0.91,9/41,7.65%,KCNE1;LRP2;COL11A1;LHFPL3;NDUFB9;PCDH15;CEMIP;SLC26A5;TIMM13
prerank,GO_Biological_Process_2021__tRNA aminoacylation for mitochondrial protein translation (GO:0070127),-0.8877815128781061,-1.5870835826796643,0.0,0.7440101152413506,1.0,2/7,3.88%,TARS2;DARS2
prerank,GO_Biological_Process_2021__regulation of lymphocyte differentiation (GO:0045619),-0.6888590896496566,-1.5864561167939004,0.0,0.7287451054412419,1.0,5/13,10.62%,IKZF3;CD2;IL4I1;NCKAP1L;ABL1
prerank,GO_Biological_Process_2021__CD40 signaling pathway (GO:0023035),-0.8672396561044857,-1.5864004675369772,0.0,0.7085021858456518,1.0,2/6,8.31%,ITGA5;PHB2
prerank,PanglaoDB_Augmented_2021__Purkinje Fiber Cells,0.7481398251883956,1.5811921845127777,0.0,0.5497857118057476,0.94,43/79,15.35%,PCDH17;DENND2A;SULT4A1;GRIA4;PTPRD;SCN3B;NCAN;BRINP1;GPM6B;MAPK4;NRXN1;RAB3C;ASXL3;CNTN1;ROBO2;RUNX1T1;ANK2;FMN2;SNAP25;CSRNP3;UNC13A;GRIA2;GABRB3;MAP1B;UNC5D;NTRK3;CADPS;CRMP1;NOVA1;CACNA1B;PNMA2;PLP1;MAGI2;GRID2;SH3GL2;TMEM132B;NFASC;STMN2;CTNNA2;LSAMP;NEFL;NDRG4;ST8SIA3
prerank,GO_Biological_Process_2021__interleukin-35-mediated signaling pathway (GO:0070757),-0.8718663718919968,-1.5806885736369922,0.0,0.7324971174542431,1.0,1/9,0.13%,STAT4
prerank,PanglaoDB_Augmented_2021__Gamma (PP) Cells,0.7348582978703622,1.5771713784183277,0.0,0.5345138864778103,0.94,40/81,15.35%,FAM13C;PCDH17;PTPRD;PPP1R9A;MAPK4;AGT;NFIB;PLPPR4;NRXN1;PHYHIPL;LIFR;ASXL3;SYBU;CNTN1;SYT4;ANK2;SNAP25;CSRNP3;PTPRT;GRIA2;MAP2;PXK;SHC2;THSD7A;NOVA1;UNC5C;PPFIA2;LMO3;FGF14;KALRN;NTRK2;ADGRL2;NFASC;PAK5;STMN2;LIMCH1;LONRF2;MAPK10;CPE;ST8SIA3
prerank,PanglaoDB_Augmented_2021__Trigeminal Neurons,0.7310149844625993,1.5767098218949842,0.0,0.4761792845461579,0.94,54/104,16.46%,FAM13C;SULT4A1;AMER2;GRIA4;PTPRD;SCN3B;NCAN;KCTD16;BRINP1;MAPK4;PLPPR4;NRXN1;RAB3C;CADM2;PHYHIPL;ASXL3;KIF1B;CA10;SYT4;ANK2;TCEAL2;SNAP25;CSRNP3;GRIA2;ERC2;FAIM2;MAP2;OLFM3;TAGLN3;MAP1B;CRMP1;NOVA1;CACNA1B;ADCY8;PPFIA2;PLP1;ZNF536;NKAIN2;MAGI2;SH3GL2;NFASC;PAK5;LY6H;STMN2;LSAMP;MAPK10;NDRG4;SCN2A;ST8SIA3;PIEZO2;KIF5A;ASIC2;SYNPR;CCDC92
prerank,PanglaoDB_Augmented_2021__Alpha Cells,0.7553352714666123,1.5744817072669823,0.0,0.45421802264247696,0.95,37/69,18.52%,PCSK1;DEPP1;FAM13C;PCDH17;KCNT2;PTPRD;AGT;PLPPR4;RAB3C;PHYHIPL;ASXL3;RUNX1T1;SYT4;CAMK2N1;SNAP25;CSRNP3;PTPRT;MAFB;SHC2;CADPS;GRIA3;FGF14;SH3GL2;NFASC;STMN2;ALDH1A1;MAPK10;CHGB;CPE;ST8SIA3;PEMT;LDB2;EDIL3;SORBS2;KCNB2;CNTN3;SCG5
prerank,GO_Biological_Process_2021__regulation of cation transmembrane transport (GO:1904062),0.8411866159713094,1.5740040147152425,0.0,0.4198363617425709,0.96,1/19,0.01%,KCNE1
prerank,GO_Biological_Process_2021__regulation of actin nucleation (GO:0051125),-0.855131282075156,-1.5717144047943694,0.0,0.7822125789151653,1.0,5/9,11.55%,CORO1B;WHAMM;ARFIP1;WASHC5;GSN
prerank,GO_Biological_Process_2021__amide biosynthetic process (GO:0043604),0.8766402190953883,1.570450553479607,0.0,0.4173167676648977,0.99,5/25,4.70%,PCSK1;FA2H;AANAT;NMRAL1;DMD
prerank,GO_Biological_Process_2021__negative regulation of cell migration involved in sprouting angiogenesis (GO:0090051),0.9457049804536339,1.5701806070485866,0.0,0.3874083553275069,0.99,2/9,0.30%,THBS1;KLF4
prerank,PanglaoDB_Augmented_2021__T Regulatory Cells,-0.5583745652125564,-1.5695870366955462,0.0,0.7809781974771202,1.0,26/64,14.51%,ITK;CCL5;GNLY;GIMAP8;BIN2;SELPLG;CD2;MAF;GZMB;HCST;CD96;RASAL3;AOAH;HLA-E;PLEK;ITGB2;CYTH4;LCP2;ENTPD1;PRF1;CD53;SNX20;GIMAP4;GIMAP7;HAVCR2;CD247
prerank,GO_Biological_Process_2021__positive regulation of wound healing (GO:0090303),0.8152951289820505,1.5694349392820734,0.0,0.36380881670108733,0.99,5/21,7.71%,THBS1;PLPP3;PRKCE;ANXA1;KANK1
prerank,GO_Biological_Process_2021__DNA ligation (GO:0006266),0.9599722241722719,1.5664519344762884,0.0,0.36996279668508586,0.99,1/7,0.08%,TOP2A
prerank,GO_Biological_Process_2021__membrane repolarization during cardiac muscle cell action potential (GO:0086013),0.955425933633494,1.5654002993426248,0.0,0.3533730693936634,0.99,1/11,0.01%,KCNE1
prerank,GO_Biological_Process_2021__plasma membrane tubulation (GO:0097320),-0.8847241059891437,-1.5649324471154002,0.0,0.796409537913116,1.0,3/7,9.33%,BIN2;WHAMM;BIN3
prerank,GO_Biological_Process_2021__regulation of cell migration involved in sprouting angiogenesis (GO:0090049),0.862394261329145,1.5641312302831574,0.0,0.34152991857562565,0.99,4/19,5.04%,THBS1;KLF4;ANXA1;VEGFA
prerank,GO_Biological_Process_2021__positive regulation of myeloid leukocyte mediated immunity (GO:0002888),-0.8309034896644288,-1.5607236836038498,0.0,0.8096671627435786,1.0,4/8,12.54%,ITGAM;TICAM1;ITGB2;TYROBP
prerank,GO_Biological_Process_2021__protein targeting to lysosome (GO:0006622),-0.6655357979310937,-1.5586450873214268,0.0,0.8095318325253327,1.0,4/20,12.50%,NCOA4;NEDD4;M6PR;SORL1
prerank,GO_Biological_Process_2021__regulation of megakaryocyte differentiation (GO:0045652),0.7749494941474783,1.5583924229337627,0.0,0.3764033590702999,0.99,5/41,2.92%,THBS1;RAB7B;HMGB2;WDR5;FAXDC2
prerank,PanglaoDB_Augmented_2021__Oligodendrocytes,0.7382738402731059,1.5577417725999447,0.0,0.36359447529297595,0.99,55/118,16.43%,FA2H;ST18;OPALIN;MOBP;AMER2;NFE2L3;ASPA;ENPP2;OMG;GFAP;TMEM163;NCAN;CREB5;ANLN;GPM6B;MAPK4;MYRF;NRXN1;SLC1A2;HEPACAM;PHYHIPL;KIF1B;CA10;MOG;GRM3;OLIG1;SRCIN1;PEX5L;TTYH1;PTPRT;GRIA2;MAG;ERMN;FAIM2;NDRG2;MPPED1;GPRC5B;ADCY8;TYRO3;PLP1;VSTM2B;NTRK2;GALC;SORBS1;ZDHHC9;TPPP;LY6H;FASN;BCAS1;PLLP;ST8SIA3;SYNPR;NINJ2;KLHL2;SLC39A12
prerank,GO_Biological_Process_2021__NAD biosynthetic process (GO:0009435),0.865738795586761,1.5576979494465788,0.0,0.3458898749829741,0.99,2/15,0.84%,NAMPT;NUDT12
prerank,PanglaoDB_Augmented_2021__Vascular Smooth Muscle Cells,0.7870800995008406,1.5572698329114631,0.0,0.330776424139919,0.99,9/37,5.92%,ASPN;SPARC;SVEP1;ADAMTS2;RBMS3;ECM2;DAAM2;LAMA2;RUNX1T1
prerank,GO_Biological_Process_2021__regulation of cation channel activity (GO:2001257),0.7705852141082078,1.5561064905453192,0.0,0.3235158795732362,0.99,26/57,17.45%,KCNE1;GRIA4;CACNB2;JPH1;RELN;NETO1;DMD;PRRT1;ANK3;ANK2;DAPK1;GRIN2A;GRIA2;NLGN1;CACNG2;CAMK2B;GRIA3;FGF14;LRRC7;AHNAK;GRIN2B;NEFL;SHISA9;CACNG8;GRIA1;APP
prerank,GO_Biological_Process_2021__peptidyl-methionine modification (GO:0018206),-0.8483188121412183,-1.5556554005719467,0.0625,0.8183449769475206,1.0,2/8,11.62%,METAP1D;NAA20
prerank,GO_Biological_Process_2021__actin filament polymerization (GO:0030041),0.810074178334932,1.5554236892246118,0.02631578947368421,0.3181261391983875,0.99,6/24,9.85%,DIAPH3;COBL;SPIRE2;MICALL2;PSTPIP2;WASF1
prerank,GO_Biological_Process_2021__negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),0.7978445468400253,1.5532741256900404,0.0,0.3211042680988919,0.99,4/37,5.04%,THBS1;KLF4;BEX3;VEGFA
prerank,PanglaoDB_Augmented_2021__Radial Glia Cells,0.7401972630450926,1.5530279618387555,0.0,0.3113008874846767,0.99,39/80,15.32%,FAM13C;PCDH17;LRP4;LRRC4C;GFAP;PTPRD;NCAN;BRINP1;GPM6B;MAPK4;PLPPR4;FBXL7;PHYHIPL;ASXL3;RUNX1T1;PTPRZ1;ANK2;CSRNP3;ARNT2;GRIA2;NLGN1;SPRY1;FAIM2;MAP2;PTN;MAP1B;CRMP1;GPRC5B;NOVA1;PPFIA2;PLP1;ZNF536;NTRK2;NFASC;LY6H;STMN2;MAPK10;NDRG4;CPE
prerank,GO_Biological_Process_2021__inositol lipid-mediated signaling (GO:0048017),-0.6265611775040132,-1.552708822735431,0.07692307692307693,0.8217260078953246,1.0,8/36,10.80%,TNFAIP8L3;PTAFR;CSF1R;PIK3C2B;ADAP2;IGF1;PLCL2;PI4KB
prerank,PanglaoDB_Augmented_2021__Bergmann Glia,0.725695098871343,1.5453782926331427,0.0,0.3504949176972444,0.99,50/100,17.39%,LRRC4C;OPALIN;VIM;AMER2;GRIA4;GFAP;METRN;NCAN;GPM6B;PLPPR4;GRIN3A;NRXN1;SLC1A2;CADM2;HEPACAM;PHYHIPL;RFTN2;KIF1B;CA10;GRM3;PTPRZ1;AKAP6;BAALC;GRIN2A;CDH20;GRIA2;NRXN3;SEPTIN4;CHL1;FAIM2;NTRK3;SCN1A;ADCY8;PPFIA2;PLP1;GRIA3;NTRK2;MAGI2;NFASC;CTNNA2;GRIN2B;LSAMP;MAPK10;SCN2A;ST8SIA3;SYNPR;SLC39A12;LRRTM2;DPP6;GRIA1
prerank,GO_Biological_Process_2021__positive regulation of vacuole organization (GO:0044090),-0.871787481359395,-1.5449803633228576,0.041666666666666664,0.8674215888836669,1.0,2/10,6.70%,RALB;PIP4K2B
prerank,GO_Biological_Process_2021__inorganic anion transport (GO:0015698),0.843499305256787,1.5444726519367151,0.0,0.3420888873457985,0.99,7/26,7.51%,GLRA1;ANO4;RACGAP1;SLC4A10;SLC11A1;SLC13A4;TTYH1
prerank,GO_Biological_Process_2021__regulation of type I interferon-mediated signaling pathway (GO:0060338),-0.6950393830730417,-1.5441583206128273,0.0,0.8551504723115294,1.0,1/20,0.09%,RNASEL
prerank,GO_Biological_Process_2021__regulation of nitric oxide metabolic process (GO:0080164),-0.8795902845038639,-1.5434536687764284,0.0,0.8446410981244802,1.0,4/8,6.94%,CX3CR1;TMEM106A;SIRPA;NOS1AP
prerank,GO_Biological_Process_2021__ventricular cardiac muscle cell membrane repolarization (GO:0099625),0.9704065278144802,1.5424374780745163,0.0,0.34650074799609154,0.99,1/5,0.01%,KCNE1
prerank,GO_Biological_Process_2021__termination of RNA polymerase II transcription (GO:0006369),-0.6504589328170064,-1.5422342251026029,0.0,0.8357833574234511,1.0,8/24,16.32%,CPSF1;LSM11;WDR33;SNRPB;CSTF1;CPSF2;CPSF4;TTF2
prerank,GO_Biological_Process_2021__action potential (GO:0001508),0.8098325139738405,1.5417836979157258,0.012987012987012988,0.34110587330170145,0.99,8/24,10.47%,KCNE1;SCN3B;GNA11;DMD;ANK3;AKAP6;SCN3A;SCN1A
prerank,GO_Biological_Process_2021__epithelial cell morphogenesis (GO:0003382),-0.9092784725553248,-1.5412539375816754,0.0,0.828000540738238,1.0,2/6,8.33%,COL18A1;CCDC88C
prerank,GO_Biological_Process_2021__positive regulation of dendritic cell cytokine production (GO:0002732),-0.8928633366340056,-1.5402855242691955,0.06666666666666667,0.8193638435413361,1.0,2/6,4.52%,TICAM1;SCIMP
prerank,GO_Biological_Process_2021__interleukin-23-mediated signaling pathway (GO:0038155),-0.8698635946586897,-1.5401029016686816,0.029411764705882353,0.8042117628280528,1.0,1/6,0.13%,STAT4
prerank,"GO_Biological_Process_2021__positive regulation of CD8-positive, alpha-beta T cell activation (GO:2001187)",-0.8715490899430314,-1.5392434816817806,0.0,0.7965887984022079,1.0,5/8,9.42%,LILRB4;RUNX3;CBFB;HLA-E;NCKAP1L
prerank,GO_Biological_Process_2021__negative regulation of stress fiber assembly (GO:0051497),-0.716190813600501,-1.5387348696132086,0.07692307692307693,0.7846366898488388,1.0,4/19,3.82%,PHLDB2;INPP5K;PFN1;ARAP1
prerank,PanglaoDB_Augmented_2021__Neuroendocrine Cells,0.7343410216173086,1.5378395020236837,0.0,0.3626775703804994,0.99,47/87,16.25%,LRRC4C;SULT4A1;AMER2;GRIA4;GFAP;PDE10A;SPOCK1;SCN3B;NCAN;BRINP1;PLPPR4;NRXN1;RAB3C;CADM2;PHYHIPL;GABRB1;CA10;GRM3;SYT4;TCEAL2;SNAP25;CSRNP3;GRIA2;FAIM2;OLFM3;TAGLN3;FXYD7;PPFIA2;PLP1;ZNF536;CLASP2;VSTM2B;GAD2;SH3GL2;NFASC;CCK;PAK5;LY6H;STMN2;NEGR1;LSAMP;SCN2A;ST8SIA3;ASIC2;SYNPR;CCDC85C;NRGN
prerank,GO_Biological_Process_2021__synapse pruning (GO:0098883),-0.7829754319670879,-1.537692364464693,0.0,0.7778743353048804,1.0,4/8,10.32%,ITGAM;CX3CR1;C3;TREM2
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell apoptotic process (GO:2000353),0.8885502965942544,1.5364711875243886,0.034482758620689655,0.3623199505759264,0.99,1/8,0.28%,THBS1
prerank,PanglaoDB_Augmented_2021__Tanycytes,0.7374413267101517,1.5361734398372588,0.0,0.3530761172345091,0.99,33/69,16.12%,PLPP3;FAM13C;LRP4;TGFB2;COL11A1;KCNT2;PTPRD;BRINP1;VCAN;MAPK4;PLPPR4;FBXL7;LIFR;ASXL3;COL23A1;RUNX1T1;ANK2;CSRNP3;MAP2;PTN;SHC2;MAP1B;CRMP1;GPRC5B;CCDC3;ADGRL2;NFASC;STMN2;MAPK10;CPE;THY1;LDB2;EDIL3
prerank,GO_Biological_Process_2021__negative regulation of chromosome organization (GO:2001251),0.9420289279458488,1.5358140080528437,0.0,0.34583228426119866,0.99,1/7,0.08%,TOP2A
prerank,PanglaoDB_Augmented_2021__Retinal Progenitor Cells,0.7363293605682503,1.535681568767597,0.0,0.3362197152589833,0.99,25/60,11.45%,LRP4;LRRC4C;SULT4A1;NCAN;MAPK4;CASKIN1;DPYSL5;CADM2;PHYHIPL;SRRM3;CTNND2;PTPRZ1;GALNT13;ANK2;LINGO1;CSRNP3;UNC13A;GRIA2;ERC2;TAGLN3;MAP1B;UNC5D;CSPG5;CACNA1B;ZNF536
prerank,"GO_Biological_Process_2021__regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370)",-0.7663887948215647,-1.5355937257758256,0.08,0.7775016304159436,1.0,3/9,9.42%,RUNX3;CBFB;NCKAP1L
prerank,GO_Biological_Process_2021__cardiac muscle cell membrane repolarization (GO:0099622),0.9594201858039646,1.5354150464520757,0.0,0.3290569297326253,0.99,1/10,0.01%,KCNE1
prerank,GO_Biological_Process_2021__melanosome assembly (GO:1903232),-0.9375886799186359,-1.533767040978218,0.0,0.7773503066264503,1.0,1/5,2.40%,HPS4
prerank,PanglaoDB_Augmented_2021__Astrocytes,0.7418523808512922,1.533732042989575,0.0,0.33047475845442886,0.99,41/100,14.20%,SOCS3;AANAT;FGF1;OPALIN;VIM;AMER2;GFAP;NCAN;BRINP1;GPM6B;MAPK4;AGT;PLPPR4;NRXN1;SLC1A2;CADM2;PHYHIPL;DAAM2;CA10;PTPRZ1;LUZP2;BAALC;GRIN2A;TCEAL2;SNAP25;CDH20;GRIA2;FAIM2;PTN;GPRC5B;ADCY8;SLC25A28;PLP1;GRIA3;VSTM2B;NTRK2;SORBS1;NFASC;LY6H;STMN2;PLXNB1
prerank,PanglaoDB_Augmented_2021__Cajal-Retzius Cells,0.7090352130018851,1.5333304786251638,0.0,0.3241112431159142,0.99,64/119,21.39%,SULT4A1;INSYN2A;TMEM163;NCAN;RELN;BRINP1;GPM6B;MAPK4;NRG1;DPYSL5;CADM2;KIF1B;SYT4;GALNT13;ANK2;CNR1;LINGO1;SNAP25;CSRNP3;CHN1;GRIA2;NLGN1;MAP9;ERC2;MAP2;FAM171B;OLFM3;TAGLN3;DNM3;MAP1B;SLITRK5;CRMP1;NOVA1;CACNA1B;PPFIA2;CNTNAP2;EPHA7;PNMA2;ZNF536;KCNH7;GRID2;SH3GL2;SYT1;LINGO2;PAK5;STMN2;NEFL;NDRG4;ST8SIA3;KIF5A;PREPL;EDIL3;APLP1;SMAD1;PTPN5;TMEM59L;SNAP91;DYNC1I1;CLSTN2;REEP2;CNTN2;RNF138;KIF5C;ELAVL3
prerank,GO_Biological_Process_2021__response to organonitrogen compound (GO:0010243),0.7882084004386459,1.5323015814333885,0.0,0.3228338841837909,0.99,1/26,0.04%,GLRA1
prerank,GO_Biological_Process_2021__kidney development (GO:0001822),0.8056227161622483,1.5320080193842562,0.01098901098901099,0.31553070449630277,0.99,10/30,7.86%,CENPF;LRP4;TGFB2;GREB1L;ZBTB16;AGT;VEGFA;SOX4;ROBO2;PAX8
prerank,GO_Biological_Process_2021__glycosaminoglycan biosynthetic process (GO:0006024),0.7573871264156121,1.5315470121650192,0.010869565217391304,0.30954293070248295,0.99,10/53,4.30%,HS3ST5;OMD;HS3ST2;OGN;CHST7;NCAN;VCAN;B4GAT1;GPC5;CEMIP
prerank,PanglaoDB_Augmented_2021__Adrenergic Neurons,0.7779391743698534,1.5313790478180875,0.0,0.30315194081863445,0.99,14/31,15.42%,RAP1GAP;FAAH;COL26A1;PHYHIPL;SYT4;LINGO1;SHC2;PTOV1;SYT1;STMN2;CALY;KLC4;ST8SIA3;CPLX1
prerank,PanglaoDB_Augmented_2021__Immature Neurons,0.7262875109759678,1.5313625156657082,0.0,0.2959340374658099,0.99,45/96,15.84%,LRRC4C;SULT4A1;AMER2;GRIA4;SCN3B;NCAN;GPM6B;MAPK4;NRXN1;DPYSL5;RAB3C;CADM2;PHYHIPL;KIF1B;CTNND2;ROBO2;GRM3;SYT4;ANK2;EPHA3;BSN;SNAP25;CSRNP3;UNC13A;GRIA2;ROBO1;ERC2;OLFM3;NTRK3;NOVA1;CACNA1B;PPFIA2;EPHA7;ZNF536;CLASP2;GAD2;PAK5;STMN2;CTNNA2;HIVEP2;LSAMP;NDRG4;ST8SIA3;KIF5A;SYNPR
prerank,GO_Biological_Process_2021__DNA topological change (GO:0006265),0.8522909473775888,1.5313496513431015,0.03076923076923077,0.2890518505480003,0.99,2/8,2.26%,TOP2A;HMGB2
prerank,GO_Biological_Process_2021__positive regulation of monocyte chemotaxis (GO:0090026),-0.8025827539791286,-1.5303815040014914,0.07407407407407407,0.7909004227944008,1.0,1/10,0.45%,CCL5
prerank,GO_Biological_Process_2021__glial cell differentiation (GO:0010001),0.8716439619214711,1.5303082135020698,0.012345679012345678,0.28744969006140014,0.99,8/14,6.68%,METRN;RELN;MYRF;NFIB;CDH2;SOX4;PTPRZ1;ADGRG6
prerank,GO_Biological_Process_2021__negative regulation of intracellular protein transport (GO:0090317),0.8427570709201093,1.5288350415321612,0.0,0.2911978862036149,0.99,1/19,0.01%,KCNE1
prerank,GO_Biological_Process_2021__macrophage activation involved in immune response (GO:0002281),-0.7799878393495727,-1.5288189871921873,0.0,0.786706291266494,1.0,7/10,19.63%,CX3CR1;NMI;TREM2;TYROBP;SYK;PLCG2;GRN
prerank,PanglaoDB_Augmented_2021__Enteric Neurons,0.7151303465477954,1.5255353787048278,0.0,0.3034592847288515,1.0,49/114,15.69%,FAM13C;TUB;PCDH17;LRRC4C;SULT4A1;NCAN;KCTD16;PPP2R5B;BRINP1;MAPK4;PLPPR4;NRXN1;CADM2;PHYHIPL;TTBK2;ASXL3;KIF1B;CNTN1;CA10;SYT4;ANK2;AKAP6;SNAP25;CSRNP3;GRIA2;FAIM2;MAP2;OLFM3;TAGLN3;SCN3A;MAP1B;CRMP1;NOVA1;CACNA1B;PPFIA2;ZNF536;KALRN;NTRK2;NFASC;CCK;PAK5;LY6H;STMN2;LSAMP;MAPK10;NDRG4;CPE;ST8SIA3;ASIC2
prerank,GO_Biological_Process_2021__regulation of mast cell activation (GO:0033003),-0.864825340838403,-1.525434647265037,0.037037037037037035,0.7952937173263532,1.0,4/8,10.73%,CD300LF;HAVCR1;MILR1;CD226
prerank,GO_Biological_Process_2021__NAD biosynthesis via nicotinamide riboside salvage pathway (GO:0034356),0.9655797297452671,1.524890285165326,0.0,0.3018550288459085,1.0,2/8,0.84%,NAMPT;NUDT12
prerank,PanglaoDB_Augmented_2021__Dopaminergic Neurons,0.74087280166395,1.5235273919198893,0.0,0.304276979080146,1.0,41/71,19.66%,SULT4A1;MAPT;NCAN;MAPK4;NR4A2;NRXN1;CASKIN1;DPYSL5;PHYHIPL;CTNND2;SYT4;SRCIN1;LINGO1;BSN;SYP;SNAP25;CSRNP3;UNC13A;GRIA2;ERC2;OLFM3;CACNA1B;HS6ST3;GAD2;PAK5;LY6H;STMN2;CALY;LONRF2;SCN2A;ST8SIA3;KIF5A;APLP1;KCNJ6;CHD5;KCNB2;GABRG2;PTPN5;TMEM59L;MAPK8IP2;SNAP91
prerank,PanglaoDB_Augmented_2021__Cholinergic Neurons,0.7578608368815282,1.5234948518032776,0.0,0.2982611727538765,1.0,22/36,20.46%,SULT4A1;GRM8;VGF;NCAN;CASKIN1;DPYSL5;SYT4;LINGO1;KLHL23;UNC13A;CSPG5;CRMP1;CACNA1B;PPM1E;BRCA1;STMN2;KIF5A;APLP1;KCNB2;TMEM59L;SNAP91;REEP2
prerank,GO_Biological_Process_2021__positive regulation of monocyte chemotactic protein-1 production (GO:0071639),-0.8494777729603202,-1.5233075026833278,0.03333333333333333,0.7989341231344939,1.0,3/6,13.23%,IL1B;LGALS9;SYK
prerank,GO_Biological_Process_2021__autophagosome-lysosome fusion (GO:0061909),-0.8979421118758034,-1.5229535623463142,0.043478260869565216,0.7877469951799897,1.0,3/7,8.37%,RUBCNL;PIP4K2B;PLEKHM1
prerank,PanglaoDB_Augmented_2021__Pericytes,0.7498853106971909,1.5228439941887568,0.012048192771084338,0.29590688755411576,1.0,14/47,6.89%,PLPP3;ASPN;SPARC;SVEP1;ADAMTS2;ECM2;PDE5A;VIM;TNS1;VEGFA;DAAM2;LAMA2;INPP4B;PDZD2
prerank,GO_Biological_Process_2021__positive regulation of leukocyte proliferation (GO:0070665),-0.8622203707224816,-1.521700956698169,0.034482758620689655,0.7825587738325542,1.0,1/6,4.25%,CSF1R
prerank,GO_Biological_Process_2021__membrane repolarization during action potential (GO:0086011),0.9702623470394781,1.521098952616587,0.0,0.29960726081266015,1.0,1/9,0.01%,KCNE1
prerank,GO_Biological_Process_2021__regulation of heart rate by cardiac conduction (GO:0086091),0.8600172399573323,1.5210559668239167,0.0,0.29439380209085547,1.0,5/23,7.48%,KCNE1;CACNB2;SCN3B;ANK2;PKP2
prerank,GO_Biological_Process_2021__cellular response to interferon-alpha (GO:0035457),-0.8398827621550026,-1.5207728820097601,0.03225806451612903,0.7753158423454866,1.0,1/7,0.82%,PDE12
prerank,GO_Biological_Process_2021__regulation of basement membrane assembly involved in embryonic body morphogenesis (GO:1904259),-0.9032451928532754,-1.520334332000442,0.023809523809523808,0.7541488776096964,1.0,1/5,0.03%,PHLDB2
prerank,GO_Biological_Process_2021__positive regulation of basement membrane assembly involved in embryonic body morphogenesis (GO:1904261),-0.9032451928532754,-1.520334332000442,0.023809523809523808,0.7541488776096964,1.0,1/5,0.03%,PHLDB2
prerank,PanglaoDB_Augmented_2021__Glutaminergic Neurons,0.7286081841003536,1.5188578214717652,0.0,0.3046168865830774,1.0,41/81,15.84%,AMER2;GRIA4;SCN3B;NCAN;KCTD16;MEIS2;NRXN1;SLC1A2;PHYHIPL;DIRAS2;CA10;GRM3;GRIN2A;BSN;FRRS1L;SNAP25;CSRNP3;UNC13A;GRIA2;GABRA2;OLFM3;NTRK3;CADPS;TMEM130;SCN1A;CACNA1B;PPFIA2;MAGI2;GAD2;TMEM132B;PAK5;STMN2;CTNNA2;GRIN2B;LSAMP;SLC17A7;NDRG4;SCN2A;ST8SIA3;ASIC2;SYNPR
prerank,GO_Biological_Process_2021__metal ion export (GO:0070839),0.8719041246186368,1.5183227944048312,0.0,0.30267123777508925,1.0,3/16,4.13%,KCNE1;KCNT2;SLC11A1
prerank,GO_Biological_Process_2021__granulocyte differentiation (GO:0030851),-0.7638956942389736,-1.5182527150531144,0.07692307692307693,0.7543743112550697,1.0,3/11,9.74%,TAL1;CEBPA;EP300
prerank,GO_Biological_Process_2021__regulation of potassium ion transport (GO:0043266),0.8570722577587292,1.5179909740030535,0.013333333333333334,0.2980319851876275,1.0,4/17,6.41%,KCNE1;FHL1;ANK3;ANK2
prerank,GO_Biological_Process_2021__tRNA metabolic process (GO:0006399),-0.7610089841778327,-1.5168236990413584,0.05714285714285714,0.7549408343973264,1.0,5/12,19.43%,KARS1;DARS2;SARS1;TRPT1;RPP30
prerank,GO_Biological_Process_2021__sphingoid metabolic process (GO:0046519),0.9039671599245419,1.5162899958193108,0.0125,0.3040790109740431,1.0,1/9,0.38%,PLPP3
prerank,GO_Biological_Process_2021__sensory organ development (GO:0007423),0.7756108669233404,1.5158755726383124,0.012048192771084338,0.3014116512286568,1.0,7/24,8.46%,TGFB2;SH3PXD2B;MEIS2;BMPR1B;SCO2;PAX8;MAFB
prerank,GO_Biological_Process_2021__positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),0.7262221168667558,1.5135264320295478,0.025,0.3114516163047716,1.0,5/41,4.63%,THBS1;ACVR1B;TGFB2;ACVR2A;BMPR1B
prerank,GO_Biological_Process_2021__histone H3-K4 dimethylation (GO:0044648),-0.8340959590466474,-1.512593957423507,0.027777777777777776,0.7707410175853513,1.0,5/6,16.52%,KMT2B;SETD1B;SETD1A;KMT2D;KMT2A
prerank,GO_Biological_Process_2021__protein polymerization (GO:0051258),0.7343059101991266,1.5120092471206117,0.021052631578947368,0.31583630324157763,1.0,11/41,13.36%,DIAPH3;COBL;MAPT;HDGFL3;SPIRE2;MICALL2;PSTPIP2;MID1IP1;WASF1;CKAP5;TPPP
prerank,GO_Biological_Process_2021__keratan sulfate metabolic process (GO:0042339),0.8123217921610032,1.5113842038381489,0.05128205128205128,0.31358148006698205,1.0,5/17,11.28%,OMD;OGN;B4GAT1;GNS;B4GALT5
prerank,GO_Biological_Process_2021__negative regulation of signaling (GO:0023057),0.8934991183342466,1.5100087979497376,0.0,0.31809904734067423,1.0,3/11,1.30%,GLRA1;HHIP;NLRP12
prerank,GO_Biological_Process_2021__positive regulation of mononuclear cell migration (GO:0071677),-0.6904922463083475,-1.5098492159217158,0.0,0.7779775327684075,1.0,2/17,3.60%,CCL5;LGALS9
prerank,GO_Biological_Process_2021__connective tissue development (GO:0061448),0.8230281640077062,1.5097203898693135,0.025,0.3143478082196383,1.0,10/20,13.96%,NAMPT;SH3PXD2B;ZBTB16;CHI3L1;ARID5B;ITGB8;SOX6;SULF2;SPTLC2;PKD1
prerank,GO_Biological_Process_2021__monoubiquitinated protein deubiquitination (GO:0035520),-0.8006996234378752,-1.509475541846369,0.10256410256410256,0.7688610420358832,1.0,1/6,4.68%,BAP1
prerank,GO_Biological_Process_2021__positive regulation of fibroblast migration (GO:0010763),0.9189792553112068,1.5094704413397417,0.014705882352941176,0.31162065311129616,1.0,2/8,2.53%,THBS1;PRKCE
prerank,GO_Biological_Process_2021__histone monoubiquitination (GO:0010390),-0.7138869203872193,-1.508588606679827,0.05263157894736842,0.7641041467433504,1.0,3/21,5.87%,RING1;DDB2;LEO1
prerank,GO_Biological_Process_2021__negative regulation of blood vessel endothelial cell migration (GO:0043537),0.7884903825968066,1.5038097071313596,0.02631578947368421,0.3460977414943821,1.0,2/22,0.30%,THBS1;KLF4
prerank,"GO_Biological_Process_2021__G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)",0.8504471619718084,1.5028899855112663,0.01282051282051282,0.34764417696936284,1.0,7/16,6.83%,HTR2B;TSHR;HTR7;CHRM5;AGT;ANXA1;CNR1
prerank,PanglaoDB_Augmented_2021__Anterior Pituitary Gland Cells,0.7351649068215503,1.5024756064430143,0.0,0.34410456260793704,1.0,39/86,15.39%,PCSK1;FAM13C;COL11A1;KCNT2;GNRHR;GRIA4;PTPRD;KCTD16;PLPPR4;NRXN1;RAB3C;CADM2;ASXL3;ROBO2;RUNX1T1;SYT4;FMN2;CSRNP3;GRIA2;OLFM3;SCN3A;UNC5D;CADPS;TMEM130;NOVA1;ZNF536;GRIA3;SGIP1;FGF14;MAGI2;NREP;GAD2;NFASC;STMN2;LSAMP;MAPK10;CHGB;ST8SIA3;THY1
prerank,GO_Biological_Process_2021__negative regulation of MyD88-independent toll-like receptor signaling pathway (GO:0034128),-0.8791046233894879,-1.502071857458271,0.08108108108108109,0.7992901543836625,1.0,2/5,8.55%,TICAM1;TLR3
prerank,GO_Biological_Process_2021__spindle assembly checkpoint signaling (GO:0071173),0.8836843252427338,1.5005495453970592,0.012048192771084338,0.33883089794250526,1.0,2/11,3.61%,CENPF;TEX14
prerank,GO_Biological_Process_2021__mitotic spindle assembly checkpoint signaling (GO:0007094),0.8836843252427338,1.5005495453970592,0.012048192771084338,0.33883089794250526,1.0,2/11,3.61%,CENPF;TEX14
prerank,GO_Biological_Process_2021__mitotic spindle checkpoint signaling (GO:0071174),0.8836843252427338,1.5005495453970592,0.012048192771084338,0.33883089794250526,1.0,2/11,3.61%,CENPF;TEX14
prerank,GO_Biological_Process_2021__negative regulation of mitotic metaphase/anaphase transition (GO:0045841),0.8836843252427338,1.5005495453970592,0.012048192771084338,0.33883089794250526,1.0,2/11,3.61%,CENPF;TEX14
prerank,GO_Biological_Process_2021__histone H2A ubiquitination (GO:0033522),-0.7389302581791035,-1.500346966688,0.0,0.7985563664417271,1.0,2/16,4.08%,RING1;DDB2
prerank,GO_Biological_Process_2021__cellular response to alcohol (GO:0097306),0.7663551831658132,1.5003141557075865,0.0,0.3356646828886004,1.0,4/30,4.57%,GLRA1;GRAMD1C;ADCY3;ADAM15
prerank,PanglaoDB_Augmented_2021__Beta Cells,0.7239850813924273,1.4985529565835212,0.0,0.3419569086083966,1.0,41/90,15.35%,PCSK1;PCDH17;LRRC4C;SULT4A1;GRIA4;SCN3B;MAPK4;NRXN1;RAB3C;CADM2;UBE2QL1;PHYHIPL;ASXL3;CNTN1;CTNND2;CA10;ROBO2;SYT4;TCEAL2;SYP;SNAP25;CSRNP3;PTPRT;GRIA2;MAFB;GABRB3;UNC5D;CADPS;NOVA1;CACNA1B;CAMK2B;GAD2;SH3GL2;NFASC;PAK5;LY6H;STMN2;LSAMP;MAPK10;CHGB;ST8SIA3
prerank,PanglaoDB_Augmented_2021__T Cells,-0.5445217760073863,-1.498446006742509,0.0,0.8024087082000907,1.0,15/85,5.90%,THEMIS;ITK;NKG7;SKAP1;CCL5;GRAP2;CST7;GNLY;CYTL1;BIN2;SELPLG;CD2;GZMB;HCST;CD96
prerank,GO_Biological_Process_2021__anterograde trans-synaptic signaling (GO:0098916),0.7063105755756733,1.498328684112082,0.0,0.3379234214420445,1.0,55/124,19.52%,GLRA1;HTR2B;HTR7;PRKAR2B;CHRM5;GRIA4;CACNB2;NRXN1;SLC1A2;NRXN2;GRIK2;GAD1;GABRB1;GRM3;GRIN2A;GRIK1;BSN;NLGN3;SNAP25;GRIA2;NLGN1;GABRB3;GABRA2;KCNMB1;NOVA1;CACNA1B;CHRM3;GABRB2;PLP1;RPS6KA2;GRIA3;PMP22;GAD2;SYT1;DLGAP1;GABRA4;UNC13C;GLRB;GRIN2B;SDCBP;HTR1F;CPLX1;KIF5A;ASIC2;NRGN;CACNA1A;GRIA1;AMPH;GABRD;SPG11;GRM7;GRIK4;GABRG2;DLG4;NLGN4X
prerank,GO_Biological_Process_2021__positive regulation of autophagosome assembly (GO:2000786),-0.9027154818083578,-1.4976581818169012,0.04,0.7955939026877478,1.0,2/8,6.70%,RALB;PIP4K2B
prerank,GO_Biological_Process_2021__chloride transmembrane transport (GO:1902476),0.7466219171413978,1.496167184115457,0.012195121951219513,0.34889470980425474,1.0,9/30,14.25%,GLRA1;ANO4;GABRB1;GABRB3;GABRA2;GABRB2;GABRA4;SLC12A8;GLRB
prerank,GO_Biological_Process_2021__negative regulation of interleukin-1 beta production (GO:0032691),-0.6931562185654674,-1.495534869443337,0.07407407407407407,0.7953976596260051,1.0,5/14,10.52%,CX3CR1;FFAR4;LILRB4;IGF1;NLRP3
prerank,GO_Biological_Process_2021__positive regulation of integrin activation (GO:0033625),-0.8817816844740485,-1.4946203687112924,0.03571428571428571,0.7894562097859046,1.0,4/7,10.03%,SKAP1;SRC;P2RY12;PLEK
prerank,GO_Biological_Process_2021__diol metabolic process (GO:0034311),0.8966084089559256,1.4940627622761153,0.013333333333333334,0.3576729366582182,1.0,1/12,0.38%,PLPP3
prerank,PanglaoDB_Augmented_2021__Purkinje Neurons,0.6995314018805107,1.4939780676470882,0.0,0.3537169087358421,1.0,57/104,19.66%,SULT4A1;PDE5A;AMER2;GRIA4;NCAN;BRINP1;PDE1A;NRXN1;RAB3C;CADM2;NRXN2;GAD1;SLC24A2;CTNND2;CA10;GRM3;SYT4;SHANK2;BSN;TCEAL2;SYP;SNAP25;GRIA2;SLC22A15;FAIM2;OLFM3;CACNG2;CADPS;CACNA1B;CNTNAP2;PLP1;GRIA3;VSTM2B;GAD2;GRID2;PPM1E;DLGAP1;PAK5;LY6H;STMN2;CALY;CTNNA2;HCN1;HIVEP2;ST8SIA3;CPLX1;KIF5A;ASIC2;SLC24A3;SYNPR;KCNMA1;PKP4;ATP1B2;GABRG2;PTPN5;DLG4;SNAP91
prerank,PanglaoDB_Augmented_2021__Delta Cells,0.7021310380967911,1.493270559067764,0.0,0.3541829389186298,1.0,34/77,15.69%,PCSK1;FAM13C;PCDH17;KCNT2;PTPRD;MAPK4;AGT;PLPPR4;NRXN1;RAB3C;PHYHIPL;ASXL3;CNTN1;SYT4;SNAP25;CSRNP3;PTPRT;GRIA2;GABRB3;SHC2;UNC5D;CADPS;GRIA3;KALRN;SORBS1;GAD2;NFASC;LY6H;STMN2;MAPK10;CHGB;CPE;ST8SIA3;ASIC2
prerank,"GO_Biological_Process_2021__DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator (GO:0006978)",-0.8259228221890804,-1.4930537635166383,0.0625,0.7771396026157636,1.0,3/8,6.50%,RPS6KA6;TFAP4;TP53
prerank,"GO_Biological_Process_2021__DNA damage response, signal transduction resulting in transcription (GO:0042772)",-0.8259228221890804,-1.4930537635166383,0.0625,0.7771396026157636,1.0,3/8,6.50%,RPS6KA6;TFAP4;TP53
prerank,PanglaoDB_Augmented_2021__Schwann Cells,0.70854705156072,1.4917589108557685,0.0,0.36036286637068093,1.0,34/82,15.46%,FAM13C;FGF1;LRP4;ASPA;GFAP;CLIP3;MAPK4;AGT;PLPPR4;PHYHIPL;DAAM2;NDRG1;SEMA3B;ANK2;OLIG1;ARNT2;GRIA2;MAG;FAIM2;PTN;SHC2;GPRC5B;CTHRC1;PLP1;NTRK2;PMP22;SORBS1;NFASC;RGS11;BCAS1;NDRG4;CPE;THY1;BAG3
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell migration (GO:0010595),0.7088839053988794,1.4911578948255075,0.0,0.3591692748293089,1.0,11/60,12.39%,THBS1;PLPP3;RHOB;SPARC;FGF1;AGT;VEGFA;HIF1A;SEMA5A;SASH1;GPI
prerank,GO_Biological_Process_2021__delamination (GO:0060232),-0.7854774639327349,-1.491021649312769,0.12121212121212122,0.7792229385214284,1.0,3/5,21.14%,AKNA;TRPV4;SPI1
prerank,PanglaoDB_Augmented_2021__Ionocytes,0.7543357063262168,1.4897554582421266,0.025,0.3663201835327926,1.0,9/21,16.77%,SHROOM3;ARFGEF3;EYA2;SHANK2;SLC9A7;MROH9;DNAH7;NEBL;KCNMA1
prerank,GO_Biological_Process_2021__positive regulation of megakaryocyte differentiation (GO:0045654),0.9595898034485513,1.4874829354788401,0.0,0.37669664515341533,1.0,3/8,2.92%,RAB7B;HMGB2;FAXDC2
prerank,GO_Biological_Process_2021__sister chromatid segregation (GO:0000819),0.8148843345781791,1.4863599416204938,0.0,0.37917169356214525,1.0,3/21,5.73%,TOP2A;KNSTRN;SMC4
prerank,MSigDB_Hallmark_2020__Pancreas Beta Cells,0.8098685849712783,1.4856000812087746,0.038461538461538464,0.3800987637175539,1.0,1/18,0.06%,PCSK1
prerank,GO_Biological_Process_2021__eosinophil chemotaxis (GO:0048245),-0.8660887223468166,-1.484877739616556,0.10714285714285714,0.7988678113275534,1.0,1/5,0.45%,CCL5
prerank,GO_Biological_Process_2021__eosinophil migration (GO:0072677),-0.8660887223468166,-1.484877739616556,0.10714285714285714,0.7988678113275534,1.0,1/5,0.45%,CCL5
prerank,GO_Biological_Process_2021__negative regulation of cell communication (GO:0010648),0.9087441255716446,1.4842590836952516,0.0,0.3855287460563761,1.0,3/9,1.30%,GLRA1;HHIP;NLRP12
prerank,GO_Biological_Process_2021__renal system development (GO:0072001),0.8171453684412837,1.4836146188334196,0.0,0.38501768889507526,1.0,7/23,7.86%,CENPF;LRP4;TGFB2;GREB1L;AGT;VEGFA;PAX8
prerank,GO_Biological_Process_2021__pharyngeal system development (GO:0060037),0.9104012482664106,1.4822276993405008,0.015625,0.3900432081171411,1.0,1/5,1.28%,TGFB2
prerank,GO_Biological_Process_2021__antigen processing and presentation of endogenous peptide antigen (GO:0002483),-0.7579577254349412,-1.4820726452503314,0.030303030303030304,0.8093179129514306,1.0,3/11,9.22%,IDE;ERAP2;HLA-E
prerank,GO_Biological_Process_2021__cellular response to acid chemical (GO:0071229),0.7702502949533225,1.4818482457638145,0.012658227848101266,0.38818132363568575,1.0,3/23,6.30%,GLRA1;VEGFA;NSMF
prerank,GO_Biological_Process_2021__rRNA methylation (GO:0031167),-0.7141113001404947,-1.4815378934835763,0.037037037037037035,0.8028735857876329,1.0,2/15,1.82%,BUD23;FBL
prerank,PanglaoDB_Augmented_2021__Enteroendocrine Cells,0.7436738767161132,1.4811700130880685,0.0,0.38733359814058693,1.0,38/72,15.69%,PCSK1;SULT4A1;ENPP2;GRIA4;NCAN;NRXN1;RAB3C;PHYHIPL;ASXL3;VEGFA;CTNND2;CA10;SYT4;SYP;SNAP25;CSRNP3;PTPRT;UNC13A;GRIA2;ALCAM;OLFM3;TAGLN3;SCN3A;UNC5D;CADPS;CACNA1B;GAD2;SH3GL2;NFASC;CCK;PAK5;LY6H;STMN2;CALY;CHGB;CPE;ST8SIA3;ASIC2
prerank,"GO_Biological_Process_2021__chemical synaptic transmission, postsynaptic (GO:0099565)",0.8099529751017641,1.4805770415677184,0.047058823529411764,0.3867184612879158,1.0,4/14,7.49%,GLRA1;INSYN2A;GRIN2A;NLGN3
prerank,GO_Biological_Process_2021__positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740),-0.6936444905101977,-1.4795410317730426,0.05263157894736842,0.7969379394710788,1.0,7/18,17.28%,GZMB;TP53;BID;PPP1R13B;PPP3CC;BCL2;CASP8
prerank,GO_Biological_Process_2021__regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739),-0.6936444905101977,-1.4795410317730426,0.05263157894736842,0.7969379394710788,1.0,7/18,17.28%,GZMB;TP53;BID;PPP1R13B;PPP3CC;BCL2;CASP8
prerank,GO_Biological_Process_2021__natural killer cell differentiation (GO:0001779),0.9071120664928116,1.4792909031322963,0.03076923076923077,0.390234730750022,1.0,1/8,0.50%,NFIL3
prerank,GO_Biological_Process_2021__negative regulation by host of viral transcription (GO:0043922),-0.8232881205076226,-1.477579466222592,0.09375,0.8022422003211269,1.0,3/11,2.39%,CCL5;INPP5K;TFAP4
prerank,GO_Biological_Process_2021__positive regulation of extracellular matrix assembly (GO:1901203),-0.8321019363499753,-1.477465486525529,0.10344827586206896,0.7941850782075662,1.0,1/8,0.03%,PHLDB2
prerank,GO_Biological_Process_2021__regulation of MyD88-independent toll-like receptor signaling pathway (GO:0034127),-0.8523064864549813,-1.4774630604200578,0.1111111111111111,0.7852616503625375,1.0,2/6,8.55%,TICAM1;TLR3
prerank,GO_Biological_Process_2021__cellular response to organonitrogen compound (GO:0071417),0.7080994213095052,1.477438613469887,0.0,0.3987904336915765,1.0,15/72,12.87%,KCNE1;GLRA1;AANAT;TSHR;EGR1;GABRB1;NSMF;AKAP6;RAPGEF3;GABRB3;PDE2A;IMPACT;GABRB2;RYR3;BRCA1
prerank,GO_Biological_Process_2021__positive regulation of epithelial cell migration (GO:0010634),0.725200148011071,1.4754827280892215,0.010869565217391304,0.41015548660934964,1.0,14/63,7.22%,THBS1;RHOB;SPARC;FGF1;TGFB2;ENPP2;PRKCE;DOCK1;GLIPR2;AGT;ARF6;DOCK5;VEGFA;HIF1A
prerank,GO_Biological_Process_2021__natural killer cell mediated immunity (GO:0002228),-0.750773601895063,-1.474806900995391,0.027777777777777776,0.7933670890565837,1.0,4/9,18.76%,GZMB;PLEKHM2;LYST;CEBPG
prerank,GO_Biological_Process_2021__membrane repolarization (GO:0086009),0.9184743326568154,1.47324023542713,0.0,0.4202543589167472,1.0,1/11,0.01%,KCNE1
prerank,GO_Biological_Process_2021__cardiac muscle cell action potential involved in contraction (GO:0086002),0.8351929586050909,1.4729692419878984,0.01282051282051282,0.4180075499925759,1.0,7/20,10.47%,KCNE1;SCN3B;ANK2;PKP2;CAV3;RYR2;SCN1A
prerank,PanglaoDB_Augmented_2021__Neuroblasts,0.7020675750010328,1.4729162484941793,0.0,0.4139075484903258,1.0,38/71,21.39%,SULT4A1;NCAN;MAPK4;CASKIN1;DPYSL5;B4GALNT4;SYT4;CNR1;LINGO1;CSRNP3;UNC13A;ERC2;ADGRB2;TAGLN3;MAP1B;UNC5D;CSPG5;CRMP1;CACNA1B;EPHA7;GRID2;EPHA4;PPM1E;PAK5;STMN2;DAB1;KIF5A;APLP1;EZH2;NTNG1;TMEM59L;SNAP91;NCAM1;POU6F2;REEP2;TACC3;KIF5C;ELAVL3
prerank,GO_Biological_Process_2021__regulation of hemoglobin biosynthetic process (GO:0046984),0.9335292309320706,1.4727543717760854,0.014492753623188406,0.41048686800434797,1.0,1/6,0.30%,KLF4
prerank,PanglaoDB_Augmented_2021__Follicular Cells,0.8200000568502601,1.4726268660560395,0.029850746268656716,0.40723468061182255,1.0,8/14,14.65%,PRLR;TSHR;CYP3A5;TG;SLC5A9;FMO5;SLC10A1;DIO1
prerank,"GO_Biological_Process_2021__regulation of synaptic transmission, glutamatergic (GO:0051966)",0.7407206542021543,1.4721463456787474,0.011627906976744186,0.40647296364897606,1.0,20/31,20.68%,GRM8;SHANK3;RELN;NRXN1;TSHZ3;CDH2;DGKI;GRM3;GRIK1;NLGN3;UNC13A;NLGN1;CACNG2;SYT1;CACNG8;GRM7;MAPK8IP2;TNF;ATP1A2;LRRK2
prerank,GO_Biological_Process_2021__skeletal system morphogenesis (GO:0048705),0.8485183542535957,1.4718665681404868,0.0,0.40419088232692413,1.0,2/15,0.90%,HHIP;FBN2
prerank,PanglaoDB_Augmented_2021__Enteric Glia Cells,0.7148460274186605,1.4715382578350764,0.011111111111111112,0.402619615467819,1.0,29/65,15.39%,PCDH17;GFAP;PTPRD;GPM6B;MAPK4;PLPPR4;NRXN1;PHYHIPL;DAAM2;CNTN1;PTPRZ1;ANK2;LINGO1;PTPRT;CHL1;FAIM2;NDRG2;PTN;SHC2;GPRC5B;CCDC3;PLP1;ZNF536;NTRK2;SORBS1;NFASC;STMN2;ALDH1A1;THY1
prerank,GO_Biological_Process_2021__lipid modification (GO:0030258),0.7804548559283718,1.470610794648985,0.023529411764705882,0.40531323616218373,1.0,8/25,9.47%,PLPP3;CYP3A5;PLPPR4;ALOX12;DGKI;ALOX15B;MBOAT2;DGKB
prerank,GO_Biological_Process_2021__eye development (GO:0001654),0.7683206061290584,1.4695112940213972,0.0125,0.4089788168431524,1.0,6/26,6.04%,FBN2;TGFB2;SH3PXD2B;MEIS2;BMPR1B;SCO2
prerank,GO_Biological_Process_2021__negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037),0.8682320928285105,1.469074939035117,0.06349206349206349,0.4086061709963705,1.0,3/7,12.26%,THBS1;SPRY1;SULF2
prerank,GO_Biological_Process_2021__histone H3-K4 trimethylation (GO:0080182),-0.6692140459032694,-1.4685194989477246,0.06666666666666667,0.8226776017254066,1.0,6/10,16.89%,SETD1B;SETD1A;KMT2D;TET2;KMT2A;ZNF335
prerank,GO_Biological_Process_2021__negative regulation of telomere capping (GO:1904354),-0.7860990924118013,-1.4685018480599474,0.06666666666666667,0.8137354538805652,1.0,4/6,18.72%,NBN;TERF2;SMG6;ERCC4
prerank,GO_Biological_Process_2021__negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736),-0.690893643232199,-1.4680021282329212,0.030303030303030304,0.8087442979649596,1.0,4/14,3.56%,CEBPA;TFAP4;HHEX;LATS2
prerank,"GO_Biological_Process_2021__wound healing, spreading of epidermal cells (GO:0035313)",-0.858094670736665,-1.4672208777305815,0.14285714285714285,0.8049749473466942,1.0,1/5,0.21%,ITGA5
prerank,PanglaoDB_Augmented_2021__Neurons,0.6691298753164922,1.466771409722742,0.0,0.42203754557965906,1.0,78/199,16.33%,SCRG1;MAP7D2;SULT4A1;AMER2;VGF;GRIA4;PPP1R9A;PNMA8A;SCN3B;NCAN;BRINP1;PDE1A;PQBP1;NRXN1;SLC11A1;RAB3C;CADM2;PHYHIPL;GAD1;CA10;GRM3;ENO2;SYT4;LUZP2;CAMK2N1;BSN;TCEAL2;FRRS1L;SYP;SNAP25;CSRNP3;UNC13A;CHN1;GRIA2;BEX2;ERC2;FAIM2;OLFM3;TAGLN3;DNM3;RYR2;DGKB;CACNG2;CADPS;TMEM130;SCN1A;CACNA1B;PPFIA2;CNTNAP2;GRIA3;SGIP1;VSTM2B;GAD2;SH3GL2;GNAI1;CCK;DLGAP1;PAK5;SPOCK3;NWD2;LY6H;STMN2;CALY;CTNNA2;RGS17;RASGRF1;SLC17A7;AIM2;SCN8A;RIMS3;NDRG4;SCN2A;ST8SIA3;CPLX1;KIF5A;SYNPR;NRGN;GPR162
prerank,GO_Biological_Process_2021__chloride transport (GO:0006821),0.7224067208787845,1.4664141161163708,0.0,0.42009963361354413,1.0,11/42,14.25%,GLRA1;ANO4;SLC4A10;GABRB1;TTYH1;GABRB3;GABRA2;GABRB2;GABRA4;SLC12A8;GLRB
prerank,GO_Biological_Process_2021__regulation of neurotransmitter receptor activity (GO:0099601),0.7475717613503485,1.4661108027018983,0.0,0.4181086400893093,1.0,23/42,19.42%,GRIA4;RELN;BEGAIN;NETO1;PRRT1;DAPK1;GRIN2A;GRIA2;NLGN1;CACNG2;CAMK2B;GRIA3;DLGAP1;LRRC7;GRIN2B;NEFL;SHISA9;CACNG8;DLGAP2;GRIA1;APP;DLG4;MAPK8IP2
prerank,GO_Biological_Process_2021__negative regulation of transcription regulatory region DNA binding (GO:2000678),-0.8498269628551895,-1.4660611229002785,0.07142857142857142,0.8020208629598222,1.0,1/7,3.98%,ZNF675
prerank,GO_Biological_Process_2021__regulation of ossification (GO:0030278),0.778213507022103,1.464881967510505,0.036585365853658534,0.42263785432986894,1.0,5/20,9.26%,LRP4;TGFB2;ZBTB16;PTN;RBPJ
prerank,PanglaoDB_Augmented_2021__Neural Stem/Precursor Cells,0.7112185835966284,1.4646898056100317,0.0,0.4204842573625441,1.0,27/69,13.71%,SULT4A1;GFAP;NCAN;GPM6B;MAPK4;DPYSL5;PHYHIPL;SRRM3;CTNND2;RBM3;PTPRZ1;LINGO1;RND3;CSRNP3;ARNT2;GRIA2;MAP2;PTN;TAGLN3;IGF1R;CSPG5;CRMP1;PLP1;ZNF536;PAK5;LY6H;STMN2
prerank,GO_Biological_Process_2021__B cell differentiation (GO:0030183),-0.5922808151280613,-1.4646404468615237,0.0625,0.8024054278138885,1.0,4/28,3.76%,TCF3;LYL1;HHEX;BLNK
prerank,GO_Biological_Process_2021__positive regulation of epithelial cell apoptotic process (GO:1904037),0.8401195696981003,1.4640416975549282,0.05172413793103448,0.421072713017382,1.0,2/10,4.44%,THBS1;PIAS4
prerank,GO_Biological_Process_2021__ventricular cardiac muscle cell action potential (GO:0086005),0.8735403423041481,1.4637013711877613,0.0,0.4195772034945817,1.0,6/11,9.36%,KCNE1;SCN3B;ANK2;PKP2;CAV3;RYR2
prerank,GO_Biological_Process_2021__negative regulation of glycogen metabolic process (GO:0070874),-0.8806955316969333,-1.4636994829382046,0.04878048780487805,0.7897156219964643,1.0,3/5,9.65%,INPP5K;PASK;ENPP1
prerank,GO_Biological_Process_2021__negative regulation of glycogen biosynthetic process (GO:0045719),-0.8806955316969333,-1.4636994829382046,0.04878048780487805,0.7897156219964643,1.0,3/5,9.65%,INPP5K;PASK;ENPP1
prerank,GO_Biological_Process_2021__folic acid transport (GO:0015884),-0.8672135484618433,-1.4618143324418977,0.03125,0.794920679962047,1.0,3/5,11.90%,FOLR2;SLC46A1;SLC19A1
prerank,GO_Biological_Process_2021__regulation of fibroblast growth factor receptor signaling pathway (GO:0040036),0.8525349554090992,1.4616791650017347,0.07575757575757576,0.42863840313824153,1.0,3/10,12.26%,THBS1;SPRY1;SULF2
prerank,GO_Biological_Process_2021__cellular response to cAMP (GO:0071320),0.7977347408030669,1.4615404742536384,0.03225806451612903,0.42616877012349846,1.0,5/20,9.87%,KCNE1;AANAT;AKAP6;RAPGEF3;PDE2A
prerank,GO_Biological_Process_2021__positive regulation of excitatory postsynaptic potential (GO:2000463),0.8059562912930347,1.4613924654718842,0.028169014084507043,0.4235746621339202,1.0,6/14,9.12%,SHANK3;RELN;NRXN1;NLGN3;NLGN1;RIMS2
prerank,GO_Biological_Process_2021__regulation of postsynaptic membrane potential (GO:0060078),0.7691064624489984,1.4611771635495339,0.023529411764705882,0.420859354826739,1.0,8/20,14.52%,GLRA1;INSYN2A;GRIN2A;NLGN3;GABRA2;GRID2;GABRA4;GRIN2B
prerank,GO_Biological_Process_2021__protein localization to lysosome (GO:0061462),-0.5820868810004522,-1.4608537909425396,0.0625,0.7909331299713579,1.0,4/24,12.50%,NCOA4;NEDD4;M6PR;SORL1
prerank,GO_Biological_Process_2021__anoikis (GO:0043276),0.8824293525465351,1.4601674495673609,0.0375,0.42455379303930263,1.0,1/9,0.36%,DAPK2
prerank,GO_Biological_Process_2021__organophosphate ester transport (GO:0015748),-0.6544833430185916,-1.4594534341947671,0.08333333333333333,0.791754533479791,1.0,2/21,1.31%,TNFAIP8L3;NPC2
prerank,PanglaoDB_Augmented_2021__Cardiomyocytes,0.7264068319623075,1.4584295504163736,0.011627906976744186,0.4340007004688795,1.0,18/49,17.60%,CORO6;HMGB2;CKMT2;LDB3;PDE1A;DMD;LAMA2;CAV3;RYR2;CKB;CPT1A;SORBS1;COL21A1;ATP2A2;IL11RA;HAMP;SLC25A4;SORBS2
prerank,PanglaoDB_Augmented_2021__Mller Cells,0.6819532248900361,1.4581155019241105,0.0,0.4328090409937703,1.0,31/79,16.54%,PLPP3;FAM13C;SPARC;PCDH17;LRP4;COL11A1;PTPRD;BRINP1;AGT;PLPPR4;FBXL7;LIFR;VEGFA;ANK2;CA2;PTN;GLUL;SEMA5A;GPRC5B;PLP1;NTRK2;ADGRL2;NFASC;MAPK10;TIMP3;CPE;THY1;SYNPR;LDB2;EDIL3;CRB1
prerank,GO_Biological_Process_2021__positive regulation of response to wounding (GO:1903036),0.8013831419888158,1.4575409841863114,0.027777777777777776,0.43244287312781027,1.0,4/15,8.95%,PRKCE;ANXA1;KANK1;PTN
prerank,GO_Biological_Process_2021__regulation of microtubule-based process (GO:0032886),-0.5834016009626057,-1.4570292307100816,0.13043478260869565,0.7986142661833691,1.0,1/29,0.03%,PHLDB2
prerank,GO_Biological_Process_2021__negative regulation of cysteine-type endopeptidase activity (GO:2000117),0.7499698745423594,1.4568296641325043,0.022727272727272728,0.4347978505130422,1.0,4/35,5.04%,THBS1;KLF4;BEX3;VEGFA
prerank,PanglaoDB_Augmented_2021__Adipocytes,0.6898049034679159,1.4562932024043327,0.011235955056179775,0.436084144123452,1.0,13/72,5.79%,PLPP3;ASPN;SVEP1;ADAMTS2;ECM2;ACSL1;METRN;ZBTB16;GULP1;TNS1;AGT;LAMA2;TRIP10
prerank,PanglaoDB_Augmented_2021__Retinal Ganglion Cells,0.6997912511581127,1.4562742547945602,0.0,0.4325586757347701,1.0,48/96,20.82%,PIANP;CDK14;SULT4A1;GALNTL6;TMEM163;NCAN;BRINP1;MAPK4;SYT16;SRRM3;CA10;SYT4;KCTD8;LINGO1;BSN;TCEAL2;SNAP25;GRIA2;ERC2;OLFM3;NARF;TAGLN3;CRMP1;CACNA1B;FXYD7;VSTM2B;SH3GL2;PAK5;LY6H;STMN2;CALY;ABLIM3;NEFL;NDRG4;ST8SIA3;KIF5A;ASIC2;APLP1;DCTN1;PTPN5;TMEM59L;LHFPL5;SNAP91;POU6F2;REEP2;CNTN2;NELL1;MTUS2
prerank,GO_Biological_Process_2021__regulation of protein autophosphorylation (GO:0031952),0.7460654549013254,1.4542792475795683,0.0,0.4429552600946166,1.0,10/31,11.11%,NLRP12;TOM1L1;PPP2R5B;VEGFA;GPNMB;PPP2R5A;CALM3;ERRFI1;IMPACT;EPHA7
prerank,GO_Biological_Process_2021__carbohydrate phosphorylation (GO:0046835),-0.7794165498186068,-1.453846408413413,0.06666666666666667,0.8078295623237849,1.0,2/7,9.39%,POMK;IPPK
prerank,GO_Biological_Process_2021__small GTPase mediated signal transduction (GO:0007264),-0.46108207411065577,-1.453462167779054,0.0,0.801854575269283,1.0,17/84,14.04%,RALB;GRAP2;SETDB1;BCR;TP53;RAPGEF6;KRAS;USP28;IGF1;CCDC88C;CRKL;PLD2;RASGRP2;RIN2;RIT2;ABR;RGS19
prerank,GO_Biological_Process_2021__postsynaptic membrane organization (GO:0001941),0.8187979561155745,1.453303146190593,0.012987012987012988,0.4472340941383983,1.0,6/15,7.94%,LRP4;SHANK3;NRXN1;NRXN2;NLGN3;NLGN1
prerank,GO_Biological_Process_2021__cellular response to fluid shear stress (GO:0071498),0.9325991514719486,1.4530413488181957,0.0,0.4457730864002039,1.0,1/9,0.30%,KLF4
prerank,PanglaoDB_Augmented_2021__Interneurons,0.6574184995521,1.4530148199919932,0.0,0.44235894121448927,1.0,84/199,19.66%,PIANP;SULT4A1;AMER2;VGF;GRIA4;TACR1;TMEM163;NCAN;RELN;BRINP1;MAPK4;PDE1A;NRXN1;RAB3C;CADM2;PHYHIPL;RORB;GAD1;CTNND2;CA10;SV2B;GRM3;SYT4;LINGO1;BSN;TCEAL2;FRRS1L;SYP;DNAJC6;SNAP25;CSRNP3;UNC13A;CHN1;GRIA2;RAB15;ERC2;SLC22A15;MAP2;OLFM3;TAGLN3;DEPTOR;DNM3;CACNG2;TRIM9;CACNA1B;FAM81A;ADCY8;PPFIA2;LMO3;VSTM2B;GAD2;ADGRL2;SH3GL2;SYT1;CCK;DLGAP1;PAK5;GABRA4;SPOCK3;LY6H;TMEM132D;STMN2;CTNNA2;RGS17;HIVEP2;SLC17A7;SCN8A;NDRG4;ST8SIA3;CPLX1;KIF5A;SYNPR;NRGN;SHISA9;KCNMA1;HSPA12A;SLC16A1;NTNG1;GABRG2;PARM1;PTPN5;TMEM59L;TIMELESS;SNAP91
prerank,GO_Biological_Process_2021__negative regulation of cell adhesion mediated by integrin (GO:0033629),-0.8556716053755855,-1.4520414708191234,0.10344827586206896,0.8034284396824412,1.0,2/6,5.66%,NEXMIF;ACER2
prerank,GO_Biological_Process_2021__endothelial cell development (GO:0001885),-0.6191393199785282,-1.4519506540022316,0.037037037037037035,0.7961786977549928,1.0,3/17,5.01%,COL18A1;PPP1R16B;ICAM1
prerank,GO_Biological_Process_2021__keratan sulfate biosynthetic process (GO:0018146),0.8254608165016815,1.4518812871874023,0.0273972602739726,0.44691771305361594,1.0,3/13,3.62%,OMD;OGN;B4GAT1
prerank,GO_Biological_Process_2021__negative regulation of wound healing (GO:0061045),-0.7096842044045466,-1.4516917037398611,0.07142857142857142,0.7901534306103918,1.0,1/15,0.03%,PHLDB2
prerank,GO_Biological_Process_2021__positive regulation of macromolecule biosynthetic process (GO:0010557),0.678304196324638,1.45168383601063,0.020833333333333332,0.4449699503599003,1.0,18/89,12.38%,THBS1;KLF4;NAMPT;PRR16;TGFB2;NLRP12;VIM;EIF4A3;SOX4;RBM3;INSR;DNA2;IRS2;NOD2;EIF3E;SORBS1;NMD3;UPF3A
prerank,GO_Biological_Process_2021__protein localization to ciliary membrane (GO:1903441),-0.7556137283605235,-1.4512002647064308,0.09375,0.7858580663468445,1.0,2/6,17.33%,RABEP1;RAB29
prerank,GO_Biological_Process_2021__regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092),-0.6612727826789522,-1.4509407933542873,0.045454545454545456,0.7800380392545128,1.0,6/19,9.02%,TGFBR3;ZNF703;LATS2;BCL9;TGFB1;ENG
prerank,PanglaoDB_Augmented_2021__Distal Tubule Cells,0.6886967308240322,1.4507699803051444,0.0,0.44772961796495464,1.0,20/52,20.52%,MACC1;COBL;CYP3A5;TFRC;LARP1B;INSR;PDZD2;ATP5MK;ITGB8;TRHDE;CLMN;MAP7;NEBL;ATP10B;FGD4;ESRRG;PPARA;TRPM7;PLD1;CPEB4
prerank,GO_Biological_Process_2021__actin polymerization or depolymerization (GO:0008154),0.7025254270774475,1.4487161792348906,0.022988505747126436,0.4589176934031707,1.0,8/43,9.85%,DIAPH3;COBL;ENAH;SPIRE2;MICALL2;SVIL;PSTPIP2;WASF1
prerank,GO_Biological_Process_2021__chemokine-mediated signaling pathway (GO:0070098),-0.7322444784840209,-1.448217798943265,0.05263157894736842,0.7879883690278207,1.0,2/13,3.04%,CCL5;SH2B3
prerank,GO_Biological_Process_2021__T cell proliferation (GO:0042098),0.8270056809050853,1.4476752288850205,0.0273972602739726,0.4636473958193163,1.0,2/11,4.13%,CADM1;SLC11A1
prerank,GO_Biological_Process_2021__protein secretion (GO:0009306),0.7058280276321878,1.446251537117403,0.011235955056179775,0.4709162545905267,1.0,6/40,9.12%,ANXA1;RAB3C;TVP23A;RAB15;ABCA1;RIMS2
prerank,GO_Biological_Process_2021__fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540),-0.7973011504592096,-1.446244880688811,0.1,0.7920164447108432,1.0,3/9,6.25%,EHHADH;ACOX1;ACAA1
prerank,GO_Biological_Process_2021__histone H2A monoubiquitination (GO:0035518),-0.5984027409965749,-1.4449949252295997,0.10344827586206896,0.7922273266809984,1.0,2/15,4.08%,RING1;DDB2
prerank,GO_Biological_Process_2021__activin receptor signaling pathway (GO:0032924),0.9037278027680017,1.444653829690216,0.013888888888888888,0.4787228747579041,1.0,2/7,4.25%,ACVR1B;ACVR2A
prerank,GO_Biological_Process_2021__dopamine metabolic process (GO:0042417),0.9516907996770463,1.4439375938570638,0.014925373134328358,0.481267908346136,1.0,1/6,1.28%,TGFB2
prerank,GO_Biological_Process_2021__regulation of endothelial cell chemotaxis (GO:2001026),0.866981881323089,1.4436362475132334,0.014705882352941176,0.48022925893568574,1.0,2/11,0.82%,THBS1;FGF1
prerank,GO_Biological_Process_2021__leukocyte aggregation (GO:0070486),-0.838517325562868,-1.443619788785518,0.06896551724137931,0.7935687350738121,1.0,2/5,10.29%,IL1B;SEMA4D
prerank,GO_Biological_Process_2021__adipose tissue development (GO:0060612),0.8703264696361912,1.442748480719003,0.014285714285714285,0.4850482556995674,1.0,3/7,4.94%,NAMPT;SH3PXD2B;ARID5B
prerank,GO_Biological_Process_2021__regulation of low-density lipoprotein particle clearance (GO:0010988),-0.8471756631191434,-1.442707892927485,0.027777777777777776,0.792331361786275,1.0,2/5,10.32%,KHSRP;TREM2
prerank,PanglaoDB_Augmented_2021__Oligodendrocyte Progenitor Cells,0.6841640252159066,1.4425622972310406,0.0,0.48266953304427623,1.0,45/83,20.69%,LRRC4C;GFAP;CLIP3;NCAN;LHFPL3;BRINP1;VCAN;MAPK4;PLPPR4;PCDH15;NRXN2;PHYHIPL;CTNND2;CA10;ANK2;OLIG1;LINGO1;SNAP25;ARNT2;GRIA2;FAIM2;MAP2;PTN;TAGLN3;CSPG5;CRMP1;GPRC5B;ADCY8;PLP1;ZNF536;VSTM2B;NFASC;LY6H;STMN2;NDRG4;ST8SIA3;APLP1;ATP1B2;NKX6-2;PTPN5;TMEM59L;SNAP91;TMEM178A;ATP1A2;CNTN2
prerank,GO_Biological_Process_2021__establishment of apical/basal cell polarity (GO:0035089),-0.7632062054752239,-1.4425027995611235,0.030303030303030304,0.7862520930257663,1.0,4/10,20.12%,FSCN1;OPHN1;CDC42;RAP2A
prerank,GO_Biological_Process_2021__regulation of exocytosis (GO:0017157),0.7158397017615414,1.442399495070132,0.0,0.48018681409062514,1.0,14/39,16.65%,IL1RAPL1;ANXA1;RAB3C;STXBP5L;SEPTIN4;RAB15;RIMS2;CADPS;CLASP2;SYT1;NSF;CPLX1;STXBP6;RAB2B
prerank,GO_Biological_Process_2021__kinetochore organization (GO:0051383),0.9434183575956193,1.4410670876884824,0.0,0.4873114041357118,1.0,2/7,1.81%,CENPF;CENPE
prerank,GO_Biological_Process_2021__oxidative RNA demethylation (GO:0035513),-0.8635233039592987,-1.440917410521608,0.12903225806451613,0.7869071866422004,1.0,1/5,6.81%,JMJD6
prerank,GO_Biological_Process_2021__regulation of water loss via skin (GO:0033561),0.9102245531828419,1.4406645483329723,0.05,0.4831326785967052,1.0,3/7,4.32%,FA2H;LSR;ALOX12
prerank,GO_Biological_Process_2021__establishment of skin barrier (GO:0061436),0.9102245531828419,1.4406645483329723,0.05,0.4831326785967052,1.0,3/7,4.32%,FA2H;LSR;ALOX12
prerank,PanglaoDB_Augmented_2021__Meningeal Cells,0.6777389595662072,1.4405409528527962,0.06741573033707865,0.48078450006401235,1.0,16/50,15.39%,PLPP3;FAM13C;SVEP1;LRP4;FBXL7;LIFR;LAMB1;RUNX1T1;ANK2;PTN;MAP1B;GPRC5B;ADGRL2;TIMP3;CPE;THY1
prerank,GO_Biological_Process_2021__chemical synaptic transmission (GO:0007268),0.668361195589153,1.4401692562075163,0.0,0.4804769583612742,1.0,65/166,19.52%,GLRA1;HTR2B;HTR7;PRKAR2B;CHRM5;GRIA4;CACNB2;NAPA;CDH8;NRXN1;SLC1A2;NRXN2;GRIK2;GAD1;KIF1B;GABRB1;GRM3;GRIN2A;GRIK1;BSN;NLGN3;SNAP25;UNC13A;GRIA2;NLGN1;ERC2;GABRB3;GABRA2;KCNMB1;NOVA1;CACNA1B;CHRM3;GABRB2;PLP1;RPS6KA2;GRIA3;PMP22;GAD2;GRID2;SYT1;DLGAP1;GABRA4;CBLN2;UNC13C;GLRB;GRIN2B;SLC17A7;SDCBP;HTR1F;CPLX1;KIF5A;ASIC2;NRGN;CACNA1A;DLGAP2;GRIA1;AMPH;GABRD;STXBP2;SPG11;GRM7;GRIK4;GABRG2;DLG4;NLGN4X
prerank,GO_Biological_Process_2021__regulation of endothelial cell differentiation (GO:0045601),0.9131375652165105,1.4397984093783958,0.0,0.4803066196067272,1.0,1/6,1.51%,APOLD1
prerank,GO_Biological_Process_2021__response to zinc ion (GO:0010043),0.8853017125373547,1.4395997775072056,0.0,0.4785549018193926,1.0,1/11,0.04%,GLRA1
prerank,GO_Biological_Process_2021__fat-soluble vitamin metabolic process (GO:0006775),0.9050202209190743,1.439584729028818,0.013888888888888888,0.4753855917253683,1.0,3/8,4.44%,LRP2;CBR1;PIAS4
prerank,GO_Biological_Process_2021__cellular response to interleukin-21 (GO:0098757),-0.8677203439862495,-1.439169521027251,0.03125,0.78344429516604,1.0,1/6,0.13%,STAT4
prerank,GO_Biological_Process_2021__interleukin-21-mediated signaling pathway (GO:0038114),-0.8677203439862495,-1.439169521027251,0.03125,0.78344429516604,1.0,1/6,0.13%,STAT4
prerank,GO_Biological_Process_2021__positive regulation of dendrite morphogenesis (GO:0050775),0.8275824978714471,1.4390768704892105,0.014285714285714285,0.47616482112288083,1.0,5/16,11.27%,PTPRD;RELN;IL1RAPL1;SS18L1;CAMK2B
prerank,GO_Biological_Process_2021__androgen metabolic process (GO:0008209),-0.7446627224170705,-1.4387830436767515,0.11428571428571428,0.7787211221312709,1.0,4/8,14.75%,CYP19A1;SRD5A1;DHRS9;MED1
prerank,GO_Biological_Process_2021__negative regulation of bone remodeling (GO:0046851),-0.7337164123718566,-1.4383649391052564,0.10344827586206896,0.7683534195056742,1.0,2/6,12.04%,TMEM119;UBASH3B
prerank,GO_Biological_Process_2021__negative regulation of bone resorption (GO:0045779),-0.7337164123718566,-1.4383649391052564,0.10344827586206896,0.7683534195056742,1.0,2/6,12.04%,TMEM119;UBASH3B
prerank,GO_Biological_Process_2021__regulation of potassium ion transmembrane transporter activity (GO:1901016),0.8185527205339533,1.438254159649285,0.025,0.478484872285261,1.0,5/19,8.38%,KCNE1;NETO1;FHL1;ANK2;CAV3
prerank,GO_Biological_Process_2021__response to cAMP (GO:0051591),0.7884817350637463,1.438186613644682,0.022222222222222223,0.4760865427306862,1.0,6/25,9.87%,KCNE1;AANAT;VGF;AKAP6;RAPGEF3;PDE2A
prerank,GO_Biological_Process_2021__interleukin-6-mediated signaling pathway (GO:0070102),0.8215960186639366,1.4381307352580333,0.0125,0.4734015307173494,1.0,2/16,0.94%,SOCS3;ST18
prerank,GO_Biological_Process_2021__response to ethanol (GO:0045471),0.8629609034586512,1.4380917647097362,0.029850746268656716,0.47056226948233176,1.0,3/9,6.66%,GLRA1;GRIN3A;GRIN2A
prerank,GO_Biological_Process_2021__necroptotic process (GO:0070266),-0.7339682048757848,-1.4372684974363406,0.09375,0.7684544523785399,1.0,3/11,8.55%,TICAM1;MLKL;TLR3
prerank,GO_Biological_Process_2021__neuromuscular process controlling balance (GO:0050885),0.9042513191793515,1.4358207850693914,0.030303030303030304,0.48569573814107303,1.0,2/6,4.18%,NRXN1;PCDH15
prerank,GO_Biological_Process_2021__negative regulation of viral genome replication (GO:0045071),-0.5562011958237282,-1.43500687111593,0.08333333333333333,0.7741429804540219,1.0,6/37,6.48%,RNASEL;CCL5;INPP5K;SETDB1;APOBEC3G;BANF1
prerank,GO_Biological_Process_2021__cellular response to zinc ion (GO:0071294),0.9773231842780402,1.4337786598058937,0.0,0.4961914288858924,1.0,1/6,0.04%,GLRA1
prerank,GO_Biological_Process_2021__regulation of cellular response to transforming growth factor beta stimulus (GO:1903844),-0.7255177942074357,-1.4337494923832095,0.0,0.7727861858788336,1.0,6/16,9.02%,TGFBR3;ZNF703;LATS2;BCL9;TGFB1;ENG
prerank,GO_Biological_Process_2021__response to glucose (GO:0009749),0.7264237781287609,1.4329112598357026,0.036585365853658534,0.498972788840985,1.0,9/30,18.04%,THBS1;SOX4;IRS2;IGF1R;ADCY8;EIF2B2;PDK3;SLC39A14;PRKAA2
prerank,GO_Biological_Process_2021__stem cell differentiation (GO:0048863),0.7641017820657381,1.4327544071776182,0.06172839506172839,0.49709020138126864,1.0,3/22,2.25%,HTR2B;TGFB2;GPM6A
prerank,MSigDB_Hallmark_2020__Estrogen Response Late,0.6634057990363946,1.4321932832342688,0.0,0.4984811367399083,1.0,28/112,15.70%,TOP2A;KLF4;TSPAN13;ALDH3B1;PRLR;PRKAR2B;LSR;GLA;FKBP5;MAPT;SEMA3B;PAPSS2;ETFB;OVOL2;CA2;ID2;BLVRB;CKB;ST14;CELSR2;RAPGEFL1;RPS6KA2;SNX10;XRCC3;PLXNB1;FDFT1;CPE;SLC24A3
prerank,GO_Biological_Process_2021__neuron migration (GO:0001764),0.7053943670859735,1.4315570691566983,0.0,0.5004633722281127,1.0,12/39,14.90%,DDIT4;SEMA3A;GPM6A;SPOCK1;RELN;NR4A2;VEGFA;MAP1B;NTRK2;ASTN2;CCK;TUBB2A
prerank,PanglaoDB_Augmented_2021__Chondrocytes,0.6859518800979195,1.430901947460806,0.03225806451612903,0.5018756287812034,1.0,11/59,5.30%,TNC;SCRG1;PLPP3;SPARC;ADAMTS2;COL11A1;GADD45B;FBXL7;VEGFA;DAAM2;LAMA2
prerank,GO_Biological_Process_2021__positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552),-0.610482273844519,-1.4306989637394973,0.07142857142857142,0.7827301699905118,1.0,1/16,0.05%,TNFAIP8L3
prerank,GO_Biological_Process_2021__antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885),-0.8493331281974087,-1.4306052778810743,0.058823529411764705,0.776795452731642,1.0,2/7,5.42%,IDE;ERAP2
prerank,GO_Biological_Process_2021__keratan sulfate catabolic process (GO:0042340),0.9320806291037429,1.430533855275947,0.0,0.5014056001761467,1.0,3/6,6.20%,OMD;OGN;GNS
prerank,GO_Biological_Process_2021__response to lead ion (GO:0010288),0.8916699361871503,1.4304949592546352,0.08333333333333333,0.49867045353133177,1.0,1/5,2.79%,MAPT
prerank,GO_Biological_Process_2021__L-serine metabolic process (GO:0006563),-0.795685907594988,-1.430153380301951,0.2,0.7733396304419303,1.0,2/6,5.35%,PSAT1;PSPH
prerank,"GO_Biological_Process_2021__regulation of CD8-positive, alpha-beta T cell differentiation (GO:0043376)",-0.8108052217209626,-1.4300976574537807,0.1,0.7672979145791028,1.0,4/6,9.42%,LILRB4;RUNX3;CBFB;NCKAP1L
prerank,GO_Biological_Process_2021__regulation of phosphatidylinositol 3-kinase activity (GO:0043551),-0.5799400483924987,-1.429849950912031,0.043478260869565216,0.7620724691507981,1.0,5/22,9.18%,TNFAIP8L3;WDR91;DAB2IP;TGFB1;P2RY12
prerank,GO_Biological_Process_2021__positive regulation of reproductive process (GO:2000243),0.856018491688495,1.4295273102633543,0.0,0.5033339097666046,1.0,6/16,8.42%,GLRA1;ACVR1B;TACR1;RNASE10;VEGFA;POMZP3
prerank,GO_Biological_Process_2021__B cell receptor signaling pathway (GO:0050853),-0.6431219275621493,-1.4293505097908714,0.0,0.7588096503260863,1.0,6/21,13.78%,ITK;BLNK;NCKAP1L;BTK;SYK;BCL2
prerank,GO_Biological_Process_2021__negative regulation of heterotypic cell-cell adhesion (GO:0034115),0.9811768560305002,1.4291697538236778,0.028169014084507043,0.5000527717117511,1.0,1/5,0.30%,KLF4
prerank,GO_Biological_Process_2021__regulation of cell-cell adhesion involved in gastrulation (GO:0070587),0.9811768560305002,1.4291697538236778,0.028169014084507043,0.5000527717117511,1.0,1/5,0.30%,KLF4
prerank,GO_Biological_Process_2021__glycerophospholipid catabolic process (GO:0046475),0.8126873205859401,1.428083060312105,0.0,0.504505322271735,1.0,3/17,3.60%,GDPD1;ENPP2;ABHD12B
prerank,GO_Biological_Process_2021__regulation of endoplasmic reticulum unfolded protein response (GO:1900101),0.9161180502758405,1.4280419462334397,0.015384615384615385,0.5015449540760895,1.0,2/7,7.07%,HSPA5;COPS5
prerank,GO_Biological_Process_2021__plasma membrane repair (GO:0001778),-0.7415139787449874,-1.4278095361113194,0.1111111111111111,0.7602218398279401,1.0,1/7,0.83%,MYH9
prerank,PanglaoDB_Augmented_2021__Principal Cells,0.8048089998855851,1.42780051899939,0.01282051282051282,0.5003481907845619,1.0,7/26,10.27%,KCNE1;FA2H;COBL;SLC2A9;OVOL2;CELSR2;GPRC5B
prerank,GO_Biological_Process_2021__chromatin-mediated maintenance of transcription (GO:0048096),-0.7419348654313611,-1.426842727440065,0.12121212121212122,0.7602885493610947,1.0,2/7,10.48%,SMARCD1;ZMIZ1
prerank,MSigDB_Hallmark_2020__Cholesterol Homeostasis,0.6780554271352369,1.4266358525388443,0.043010752688172046,0.5066647827807335,1.0,16/53,15.59%,NFIL3;TM7SF2;IDI1;SEMA3B;MVD;ABCA2;ALCAM;ERRFI1;GNAI1;ANTXR2;FASN;SCD;FDFT1;HMGCS1;CPEB2;PDK3
prerank,GO_Biological_Process_2021__glutamate receptor signaling pathway (GO:0007215),0.7140630712088513,1.426483556385061,0.02531645569620253,0.5047119811638777,1.0,18/28,20.52%,GRM8;GRIA4;GRIN3A;GRIK2;GRM3;GRIN2A;GRIK1;GRIA2;GRIA3;GRID2;GRIN2B;PLCB1;APP;GRM7;GNAQ;GRIK4;CDK5R1;CPEB4
prerank,GO_Biological_Process_2021__calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338),0.9107159184351711,1.426434413425875,0.05405405405405406,0.502499615605171,1.0,2/5,7.78%,CLDN18;CLDN20
prerank,GO_Biological_Process_2021__adrenergic receptor signaling pathway (GO:0071875),-0.7167032180122477,-1.426380592058367,0.0,0.7571127408842313,1.0,3/8,19.10%,ZDHHC21;PDE4D;ADRB2
prerank,PanglaoDB_Augmented_2021__Myocytes,0.7150468602367096,1.426217601754294,0.046511627906976744,0.501044391048391,1.0,8/42,8.38%,CKMT2;LDB3;DOCK1;DOCK5;DMD;LAMA2;LAMB1;CAV3
prerank,GO_Biological_Process_2021__cardiac muscle cell action potential (GO:0086001),0.8444132639467676,1.4258945788805149,0.013157894736842105,0.5005565336898081,1.0,5/20,7.48%,KCNE1;SCN3B;DMD;ANK2;PKP2
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, deadenylation-independent decay (GO:0031086)",-0.7789778989303033,-1.425284416626136,0.05714285714285714,0.7568538381242029,1.0,3/6,15.53%,DCP1B;EDC3;ZFP36
prerank,PanglaoDB_Augmented_2021__Glycinergic Neurons,0.7076186476793674,1.4237601196257836,0.0,0.5116885111566135,1.0,36/61,24.23%,PIANP;SULT4A1;CLIP3;NCAN;BRINP1;CASKIN1;B4GALNT4;GAD1;SRRM3;LINGO1;BSN;GRIA2;FAIM2;ADGRB2;TAGLN3;CSPG5;CKB;CELSR2;VSTM2B;LY6H;STMN2;NDRG4;KIF5A;ASIC2;APLP1;NCDN;TMEM59L;SNAP91;CNTN2;ELAVL3;KCNQ2;DNER;MAPK8IP1;BRSK1;PPFIA3;CLVS2
prerank,GO_Biological_Process_2021__negative regulation of natural killer cell mediated cytotoxicity (GO:0045953),-0.7543655576937123,-1.4235967368905853,0.125,0.7597059527715458,1.0,4/10,12.78%,LGALS9;SERPINB9;HLA-E;ARRB2
prerank,GO_Biological_Process_2021__monoacylglycerol metabolic process (GO:0046462),0.9085182980723733,1.423455500090989,0.0,0.5103157384388148,1.0,3/7,5.89%,FAAH;ABHD12B;DGAT1
prerank,GO_Biological_Process_2021__positive regulation of protein processing (GO:0010954),-0.7773380051367815,-1.4213576470541172,0.14814814814814814,0.7666285710708897,1.0,5/10,11.55%,MYH9;PLGRKT;HPN;KLKB1;GSN
prerank,GO_Biological_Process_2021__regulation of stress fiber assembly (GO:0051492),-0.526193340185514,-1.4206639590426104,0.06666666666666667,0.7647749683536049,1.0,8/54,6.02%,PHLDB2;INPP5K;SERPINF2;PFN1;EVL;ARAP1;LPAR1;NF2
prerank,PanglaoDB_Augmented_2021__Mesothelial Cells,0.7090277798800888,1.4205861260122097,0.02197802197802198,0.5278539189777013,1.0,17/43,16.59%,PLPP3;FGF1;SVEP1;FRAS1;NTN4;DOCK1;OSMR;RND3;PALLD;FN1;SH3D19;THBD;UACA;TIMP3;PCSK6;GBP2;EPAS1
prerank,PanglaoDB_Augmented_2021__Hepatic Stellate Cells,0.7101741827780232,1.4204868615986526,0.060240963855421686,0.525584842243928,1.0,11/46,8.46%,PLPP3;SPARC;SVEP1;ADAMTS2;GFAP;RELN;FBXL7;VEGFA;LAMA2;SYP;FN1
prerank,GO_Biological_Process_2021__neural tube closure (GO:0001843),0.7386074570697763,1.4204733773190916,0.013333333333333334,0.5226900999350249,1.0,3/27,1.28%,LRP2;COBL;TGFB2
prerank,PanglaoDB_Augmented_2021__Fibroblasts,0.6773441823257424,1.4204428893158307,0.0,0.5202601828384019,1.0,23/92,11.16%,KLF4;ASPN;HHIP;SPARC;SVEP1;ADAMTS2;VIM;EGR1;TNS1;NR4A2;NR4A1;VEGFA;LAMA2;CD55;LAMB1;HIF1A;PALLD;FOSL2;FN1;FGR;P4HA1;CKAP4;CTHRC1
prerank,GO_Biological_Process_2021__macromolecule catabolic process (GO:0009057),-0.5859085775053244,-1.420418136440694,0.14285714285714285,0.7604996350819456,1.0,5/20,8.92%,NEDD4;IDE;SNX25;TGFB1;SMURF1
prerank,GO_Biological_Process_2021__positive regulation of signaling receptor activity (GO:2000273),0.7904844557510777,1.4202470526525874,0.02666666666666667,0.5197367417442993,1.0,4/21,7.49%,SHANK3;RELN;HIF1A;NLGN3
prerank,GO_Biological_Process_2021__positive regulation of cation transmembrane transport (GO:1904064),0.7502187329140619,1.4198790553090732,0.011764705882352941,0.5188988740638517,1.0,4/23,6.56%,KCNE1;ANK3;ANK2;AKAP6
prerank,GO_Biological_Process_2021__positive regulation of alpha-beta T cell differentiation (GO:0046638),-0.7471046267438929,-1.4182179262558658,0.12903225806451613,0.7661773853921447,1.0,4/9,9.42%,LILRB4;RUNX3;CBFB;NCKAP1L
prerank,"GO_Biological_Process_2021__positive regulation of CD8-positive, alpha-beta T cell differentiation (GO:0043378)",-0.8725744453209459,-1.4172085884967915,0.03333333333333333,0.7638673569826083,1.0,4/5,9.42%,LILRB4;RUNX3;CBFB;NCKAP1L
prerank,GO_Biological_Process_2021__response to amino acid (GO:0043200),0.7362415465526325,1.4170049874630333,0.012658227848101266,0.5380839481901015,1.0,2/25,6.30%,GLRA1;NSMF
prerank,GO_Biological_Process_2021__regulation of AMPA receptor activity (GO:2000311),0.7683961574494034,1.416884687992415,0.075,0.5356225078719864,1.0,9/16,19.42%,SHANK3;RELN;PRRT1;NLGN3;NLGN1;CACNG2;SHISA9;CACNG8;MAPK8IP2
prerank,GO_Biological_Process_2021__positive regulation of hemoglobin biosynthetic process (GO:0046985),0.9336229195667147,1.4149856398442213,0.04225352112676056,0.5468382213925471,1.0,1/5,0.30%,KLF4
prerank,GO_Biological_Process_2021__potassium ion export across plasma membrane (GO:0097623),0.9590452372285445,1.4147847510624278,0.0,0.5456610136829885,1.0,2/6,1.92%,KCNE1;KCNT2
prerank,GO_Biological_Process_2021__regulation of presynapse organization (GO:0099174),0.8490011421858749,1.41346349790902,0.04838709677419355,0.5489225216785164,1.0,3/10,3.77%,IL1RAPL2;PTPRD;IL1RAPL1
prerank,GO_Biological_Process_2021__regulation of presynapse assembly (GO:1905606),0.8490011421858749,1.41346349790902,0.04838709677419355,0.5489225216785164,1.0,3/10,3.77%,IL1RAPL2;PTPRD;IL1RAPL1
prerank,PanglaoDB_Augmented_2021__Natural Killer T Cells,-0.45892940174579366,-1.4124138353572657,0.0,0.7834891156753935,1.0,27/70,14.74%,THEMIS;ITK;NKG7;GRAP2;ZNF831;CST7;GNLY;BIN2;SELPLG;CD2;GZMB;CD96;RASAL3;AOAH;MYO1F;IL17RA;ITGB2;CYTH4;LCP2;PRF1;CD53;SNX20;GIMAP4;GIMAP7;PIK3R5;CD247;IL12RB1
prerank,GO_Biological_Process_2021__cardiac muscle cell contraction (GO:0086003),0.8514007930501891,1.4122409186997005,0.038461538461538464,0.5540196304672347,1.0,2/14,2.89%,KCNE1;SCN3B
prerank,"GO_Biological_Process_2021__positive regulation of synaptic transmission, glutamatergic (GO:0051968)",0.8350448961682705,1.4121345741413134,0.0379746835443038,0.551603004282047,1.0,7/11,9.88%,SHANK3;RELN;NRXN1;TSHZ3;NLGN3;NLGN1;CACNG2
prerank,"GO_Biological_Process_2021__negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371)",-0.8260805564661236,-1.4120182298607835,0.125,0.7797768155607882,1.0,2/5,7.43%,RUNX3;CBFB
prerank,GO_Biological_Process_2021__response to alcohol (GO:0097305),0.7544225193645344,1.4114832905164851,0.05333333333333334,0.5542937586405184,1.0,4/18,7.02%,GLRA1;GRIN3A;GRIN2A;ABCA2
prerank,GO_Biological_Process_2021__membrane lipid biosynthetic process (GO:0046467),0.7292766391073638,1.4109251705875934,0.011111111111111112,0.5553889914532556,1.0,7/42,13.49%,FA2H;PLPP3;ALDH3B1;VAPB;ELOVL4;PPM1L;SPTLC2
prerank,GO_Biological_Process_2021__neural crest cell differentiation (GO:0014033),0.8443162353280347,1.4109031957560765,0.012345679012345678,0.5525509805894071,1.0,3/10,4.08%,HTR2B;NRG1;CDH2
prerank,GO_Biological_Process_2021__regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947),-0.665637697987084,-1.410746293778777,0.21428571428571427,0.7794571993878554,1.0,5/15,3.78%,ITGA5;NEDD4;IL1B;HHEX;DAB2IP
prerank,GO_Biological_Process_2021__TRIF-dependent toll-like receptor signaling pathway (GO:0035666),-0.5402359554882612,-1.4098051203740485,0.0,0.7740097035218458,1.0,6/25,11.56%,CD300LF;TICAM1;CHUK;TLR3;IKBKB;BIRC2
prerank,GO_Biological_Process_2021__MyD88-independent toll-like receptor signaling pathway (GO:0002756),-0.5402359554882612,-1.4098051203740485,0.0,0.7740097035218458,1.0,6/25,11.56%,CD300LF;TICAM1;CHUK;TLR3;IKBKB;BIRC2
prerank,GO_Biological_Process_2021__programmed necrotic cell death (GO:0097300),-0.7259425298207974,-1.409657602029635,0.0967741935483871,0.7696659602202695,1.0,3/12,8.55%,TICAM1;MLKL;TLR3
prerank,GO_Biological_Process_2021__embryonic axis specification (GO:0000578),0.8655962258698056,1.4091605180393236,0.07692307692307693,0.5645466901110195,1.0,1/6,0.98%,COBL
prerank,PanglaoDB_Augmented_2021__Gastric Chief Cells,0.7633871555595628,1.4089743097837153,0.060240963855421686,0.5627352246608969,1.0,8/26,13.57%,FA2H;FAAH;AATK;SLC5A9;OVOL2;ST14;CHRM3;MAP7
prerank,GO_Biological_Process_2021__tight junction assembly (GO:0120192),0.7807720650394112,1.4083352064497696,0.036585365853658534,0.5634172299688326,1.0,5/22,12.63%,CLDN18;LSR;CLDN20;MICALL2;PARD3
prerank,GO_Biological_Process_2021__kinetochore assembly (GO:0051382),0.9439799976864303,1.4076436761059703,0.0,0.5660615915104557,1.0,2/6,1.81%,CENPF;CENPE
prerank,PanglaoDB_Augmented_2021__Photoreceptor Cells,0.6758904560208625,1.4066938813762064,0.0,0.5697562911807458,1.0,55/97,21.44%,AMER2;GRIA4;SCN3B;NRXN1;SLC1A2;PCDH15;RAB3C;CADM2;AP3B2;KIF1B;SLC24A2;CA10;SV2B;SYT4;FRRS1L;SYP;SNAP25;CDH20;GRIA2;OLFM3;NTRK3;CADPS;TMEM130;SCN1A;CACNA1B;CACNA2D3;PPFIA2;CNTNAP2;ZNF536;SGIP1;VSTM2B;MAGI2;GAD2;PAK5;STMN2;CTNNA2;HCN1;LSAMP;FAM135B;SCN2A;ST8SIA3;SYNPR;KCNMA1;HSPA12A;GRIA1;AMPH;ATP1B2;NTNG1;GABRG2;PTPN5;SNAP91;NCAM1;CNTN2;ELAVL3;PAK3
prerank,GO_Biological_Process_2021__renal absorption (GO:0070293),-0.8113214698530327,-1.40603437937662,0.041666666666666664,0.7851975259958823,1.0,3/7,17.71%,MAGED2;GSN;KCNQ1
prerank,GO_Biological_Process_2021__ceramide metabolic process (GO:0006672),0.7569373801115261,1.4059144036808224,0.011363636363636364,0.573023251609579,1.0,2/27,0.38%,FA2H;PLPP3
prerank,GO_Biological_Process_2021__postsynaptic density assembly (GO:0097107),0.9171362631793873,1.4047637064611285,0.01639344262295082,0.5787294569510767,1.0,3/5,4.46%,SHANK3;NRXN1;NRXN2
prerank,PanglaoDB_Augmented_2021__Enterochromaffin Cells,0.7161369129591731,1.4044598013733671,0.02197802197802198,0.5780588305064931,1.0,26/44,18.16%,PCSK1;PLPP3;FAM13C;FGF1;DENND2A;ENPP2;PTPRD;AGT;PHYHIPL;GRIN2A;GABRA2;PDE1C;CADPS;SEMA5A;GRIA3;SGIP1;FGF14;KALRN;NFASC;LSAMP;THY1;PIEZO2;GIPC2;SORBS2;CNTN3;SGCD
prerank,GO_Biological_Process_2021__mitotic cytokinesis (GO:0000281),0.7151776194375956,1.4031484950972248,0.034482758620689655,0.5845938182883238,1.0,9/34,17.16%,RHOB;ANLN;CIT;RACGAP1;ANK3;SPAST;INCENP;SPTBN1;ROCK1
prerank,GO_Biological_Process_2021__SCF complex assembly (GO:0010265),0.8794628587712847,1.4027695256492403,0.02857142857142857,0.5848554846749499,1.0,2/6,11.07%,FBXL7;RBX1
prerank,GO_Biological_Process_2021__phospholipid catabolic process (GO:0009395),0.822618120731754,1.4018918517629775,0.0625,0.5893431331440674,1.0,2/13,2.08%,GDPD1;ENPP2
prerank,GO_Biological_Process_2021__response to hydroperoxide (GO:0033194),0.9324591840940927,1.4015612176128427,0.014492753623188406,0.5890112558652991,1.0,1/5,6.52%,DAPK1
prerank,GO_Biological_Process_2021__positive regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903800),-0.770911763519403,-1.4010175440352233,0.16,0.8061877131052717,1.0,4/7,17.87%,TP53;TGFB1;EGFR;DDX5
prerank,GO_Biological_Process_2021__membrane assembly (GO:0071709),0.7093071148700943,1.4009912510977207,0.05,0.590093922286262,1.0,15/31,19.52%,LRP4;PTPRD;IL1RAPL1;NRXN1;NRXN2;ANK3;NLGN3;NLGN1;SPAST;PICALM;UGCG;UBXN2B;SPTBN1;STX2;NLGN4X
prerank,PanglaoDB_Augmented_2021__Myofibroblasts,0.7019243497299331,1.4009607015820873,0.01282051282051282,0.5874679168294707,1.0,11/41,8.95%,PLPP3;SPARC;SVEP1;GFAP;TNS1;FBXL7;DAAM2;LAMA2;PALLD;FN1;PTN
prerank,GO_Biological_Process_2021__regulation of natural killer cell activation (GO:0032814),-0.7826988501492367,-1.4008100785060553,0.125,0.8015590661576508,1.0,1/6,0.93%,TICAM1
prerank,GO_Biological_Process_2021__protein localization to synapse (GO:0035418),0.8719776158312422,1.399834598643496,0.0,0.593205607345962,1.0,5/8,7.94%,ZDHHC15;NRXN1;NRXN2;BSN;NLGN1
prerank,PanglaoDB_Augmented_2021__Juxtaglomerular Cells,0.7242055149178546,1.3995868435312413,0.05952380952380952,0.5920733547517458,1.0,5/28,5.30%,ASPN;SVEP1;ADAMTS2;TNS1;LAMA2
prerank,GO_Biological_Process_2021__positive regulation of cation channel activity (GO:2001259),0.7845970576963038,1.3982739267872255,0.07058823529411765,0.5995319941792535,1.0,8/21,8.65%,SHANK3;RELN;ANTKMT;ANK3;ANK2;AKAP6;NLGN3;CALM3
prerank,PanglaoDB_Augmented_2021__Pyramidal Cells,0.6655169760591335,1.398263800112991,0.010526315789473684,0.5966816100000925,1.0,48/89,21.39%,AMER2;GRIA4;GFAP;NCAN;BRINP1;NR4A2;NRXN1;RAB3C;CADM2;CA10;GRM3;SYT4;GRIN2A;TCEAL2;SNAP25;CDH20;GRIA2;FAIM2;MAP2;OLFM3;TAGLN3;PDE2A;CACNA1B;ADCY8;GRIA3;VSTM2B;GAD2;CCK;PAK5;LY6H;STMN2;CALY;CTNNA2;GRIN2B;DAB1;ST8SIA3;ASIC2;SYNPR;NRGN;GRIA1;KCNB2;GABRG2;PTPN5;DLG4;SNAP91;CNTN2;SORCS3;ELAVL3
prerank,GO_Biological_Process_2021__regulation of NMDA receptor activity (GO:2000310),0.7558431211837185,1.398164245862904,0.03571428571428571,0.5943154828367379,1.0,15/26,19.42%,GRIA4;RELN;DAPK1;GRIN2A;GRIA2;NLGN1;CAMK2B;GRIA3;LRRC7;GRIN2B;NEFL;GRIA1;APP;DLG4;MAPK8IP2
prerank,GO_Biological_Process_2021__reelin-mediated signaling pathway (GO:0038026),0.915436368456286,1.3980396490291216,0.05714285714285714,0.592244796194361,1.0,1/5,3.07%,RELN
prerank,GO_Biological_Process_2021__regulation of axonogenesis (GO:0050770),0.6895908566458062,1.3980270552144236,0.0641025641025641,0.5895150825847968,1.0,24/44,24.85%,LRP4;LRRC4C;OMG;METRN;CDH2;ROBO2;LINGO1;SIPA1L1;CHN1;MAG;ROBO1;NTRK2;EPHA4;PLXNB1;THY1;ARHGDIA;PLXNC1;CHODL;PAK3;RTN4;GDI1;PTEN;BRSK1;RUFY3
prerank,GO_Biological_Process_2021__cellular response to decreased oxygen levels (GO:0036294),0.6933254106642034,1.3973571401033331,0.011363636363636364,0.5924857032545189,1.0,20/39,22.96%,VEGFA;SUV39H2;NDRG1;HIF1A;FMN2;BNIP3L;FAM162A;BNIP3;PINK1;CPEB2;SCN2A;HYOU1;EPAS1;EGLN3;RGCC;NOP53;PGK1;CPEB4;P4HB;RORA
prerank,PanglaoDB_Augmented_2021__Pancreatic Progenitor Cells,0.7217487111816153,1.3969292785763108,0.04819277108433735,0.5934112656670633,1.0,17/41,16.59%,SHROOM3;LRP4;COBL;JPH1;ENAH;MAPK4;MFNG;ARFGEF3;LINGO1;SHC2;RPL23A;CKB;NR2F1;PLXNB1;CPE;EPB41L4B;EPAS1
prerank,GO_Biological_Process_2021__regulation of MHC class I biosynthetic process (GO:0045343),0.8657597503908354,1.3967569845072954,0.058823529411764705,0.5921421233360439,1.0,1/5,1.30%,NLRP12
prerank,GO_Biological_Process_2021__postsynaptic density organization (GO:0097106),0.8484069884019421,1.396617461761571,0.04477611940298507,0.5901743771693936,1.0,5/8,11.82%,SHANK3;NRXN1;NRXN2;NLGN1;TMEM108
prerank,GO_Biological_Process_2021__negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665),-0.8134575532593366,-1.3966173654999432,0.16129032258064516,0.8168780980925948,1.0,3/5,18.50%,TRIB1;LILRA2;SIGIRR
prerank,GO_Biological_Process_2021__centromere complex assembly (GO:0034508),0.7380602724087502,1.3957807084247236,0.06666666666666667,0.5943683923806587,1.0,7/24,14.03%,CENPF;CENPE;OIP5;CENPP;CENPK;CENPV;CENPI
prerank,GO_Biological_Process_2021__aminoglycan biosynthetic process (GO:0006023),0.7681889434644117,1.3954601009440497,0.06172839506172839,0.5938163324837434,1.0,4/24,3.84%,HS3ST5;HS3ST2;B4GAT1;GPC5
prerank,GO_Biological_Process_2021__regulation of pattern recognition receptor signaling pathway (GO:0062207),-0.7733430367851412,-1.395409882955076,0.1111111111111111,0.8165612067026062,1.0,2/6,11.56%,ZDHHC5;BIRC2
prerank,GO_Biological_Process_2021__positive regulation of potassium ion transport (GO:0043268),0.7497345967676474,1.3951020094092137,0.011904761904761904,0.5939700035789057,1.0,4/24,6.56%,KCNE1;FHL1;ANK2;AKAP6
prerank,GO_Biological_Process_2021__regulation of transcription regulatory region DNA binding (GO:2000677),-0.6577778153758174,-1.3950455909898256,0.07142857142857142,0.812568927528494,1.0,3/12,7.51%,ZNF675;IGF1;TGFB1
prerank,GO_Biological_Process_2021__tube closure (GO:0060606),0.7400316020601954,1.3949820158542385,0.0684931506849315,0.5895002059208547,1.0,3/24,1.28%,LRP2;COBL;TGFB2
prerank,GO_Biological_Process_2021__primary neural tube formation (GO:0014020),0.7400316020601954,1.3949820158542385,0.0684931506849315,0.5895002059208547,1.0,3/24,1.28%,LRP2;COBL;TGFB2
prerank,GO_Biological_Process_2021__regulation of dendritic cell apoptotic process (GO:2000668),-0.8196577173541346,-1.3949743979143452,0.07142857142857142,0.8074864887562353,1.0,2/7,12.16%,LGALS9;CXCL12
prerank,GO_Biological_Process_2021__regulation of T cell activation (GO:0050863),-0.5484100104716128,-1.3941481754567402,0.058823529411764705,0.8067071217881266,1.0,8/27,10.62%,FGL1;CCL5;CD2;DUSP3;IL4I1;SIRPA;HLA-DPA1;ABL1
prerank,GO_Biological_Process_2021__neuron differentiation (GO:0030182),0.6602429826318286,1.3939032814095953,0.010526315789473684,0.5957184260446028,1.0,24/73,19.55%,DDIT4;TGFB2;PTPRD;SPOCK1;MANF;ERCC2;NR4A2;IL1RAPL1;RORB;VEGFA;SOX4;OLIG1;ID2;ALK;NTRK2;EPHA5;WNT5A;CASP3;UGCG;NRBP2;ERCC6;CDK5R1;NLGN4X;ACSL3
prerank,GO_Biological_Process_2021__chondroitin sulfate biosynthetic process (GO:0030206),0.8019452433502613,1.3938819170818015,0.06172839506172839,0.5931088627511243,1.0,4/14,9.58%,CHST7;NCAN;VCAN;CSPG5
prerank,GO_Biological_Process_2021__negative regulation of ossification (GO:0030279),0.7855963167187646,1.392993519322352,0.08108108108108109,0.5965153571134946,1.0,3/13,9.26%,LRP4;SRGN;RBPJ
prerank,GO_Biological_Process_2021__muscle contraction (GO:0006936),0.6936484363512093,1.392672142647653,0.02197802197802198,0.5960136107754963,1.0,8/54,8.38%,GLRA1;VIM;MYOT;CKMT2;GNAO1;DMD;LTB4R;CAV3
prerank,PanglaoDB_Augmented_2021__Taste Receptor Cells,0.6798486862815478,1.3919481618199454,0.010638297872340425,0.599249457173456,1.0,46/82,22.53%,ST18;MOBP;AMER2;ASPA;GRIA4;CACNB2;SCN3B;NRXN1;SLC1A2;SLC4A10;AP3B2;SLC24A2;SV2B;MOG;KCNT1;FRRS1L;SYP;GRIA2;UNC80;CACNG2;CADPS;SCN1A;GAD2;XKR4;CCK;RUNDC3A;UNC13C;CTNNA2;HCN1;FAM135B;ST8SIA3;SYNPR;CACNA1A;KCNJ6;DLGAP2;DPP6;RPH3A;ATP1B2;B3GAT1;CYP46A1;CNTN2;SLC24A4;SEZ6;CNDP1;MYT1L;PRKCB
prerank,GO_Biological_Process_2021__neural crest cell development (GO:0014032),0.7269828770031648,1.3917535380545751,0.03488372093023256,0.597599722955932,1.0,7/22,10.26%,HTR2B;SEMA3A;NRG1;CDH2;SEMA3B;SEMA6A;SEMA5A
prerank,GO_Biological_Process_2021__DNA conformation change (GO:0071103),0.7695312773927652,1.3915657741967973,0.07792207792207792,0.5966373293309835,1.0,3/13,6.03%,TOP2A;HMGB2;MTERF1
prerank,PanglaoDB_Augmented_2021__Mammary Epithelial Cells,0.7692095605512871,1.390110201977664,0.04938271604938271,0.6058556615951715,1.0,7/21,7.93%,PRLR;LSR;RARRES1;OVOL2;BAIAP2L1;KDM3A;PPP1R13L
prerank,GO_Biological_Process_2021__R-loop disassembly (GO:0062176),-0.8955158370173009,-1.3898041914362174,0.06896551724137931,0.8239795120056318,1.0,1/5,7.98%,DDX23
prerank,GO_Biological_Process_2021__potassium ion transport (GO:0006813),0.6785696000259465,1.389696297594219,0.010416666666666666,0.6065742770992631,1.0,25/56,22.34%,KCNE1;KCNJ13;SLC24A2;KCNH8;SLC9A7;KCNH5;KCNMB1;SLC24A1;SLC9A6;NALCN;KCNH7;HCN1;SLC24A3;ATP1B3;KCNJ6;KCNMA1;KCNB2;KCNJ3;TMEM175;ATP1A2;SLC24A4;SLC9A1;KCNQ5;CHP1;KCNQ2
prerank,GO_Biological_Process_2021__activation of protein kinase B activity (GO:0032148),0.7513850347192882,1.3896431238588058,0.04819277108433735,0.604257445115177,1.0,9/23,15.83%,FGF1;NRG1;INSR;TXN;NTRK3;PRR5;PINK1;WNT5A;IL18
prerank,GO_Biological_Process_2021__potassium ion transmembrane transport (GO:0071805),0.6739082537900681,1.3889187827139222,0.02197802197802198,0.6064641035445624,1.0,20/63,18.37%,KCNE1;KCNT2;KCNJ13;SLC24A2;KCNH8;SLC9A7;KCNH5;SLC24A1;SLC9A6;NALCN;KCNH7;SLC12A8;HCN1;SLC24A3;ATP1B3;KCNJ6;KCNB2;KCNJ3;ATP1B2;TMEM175
prerank,GO_Biological_Process_2021__postsynaptic membrane assembly (GO:0097104),0.8421600339579453,1.3881925605722367,0.04054054054054054,0.6098034711416688,1.0,5/8,7.94%,LRP4;NRXN1;NRXN2;NLGN3;NLGN1
prerank,GO_Biological_Process_2021__branching involved in ureteric bud morphogenesis (GO:0001658),0.9061135473140827,1.3881570884618217,0.06349206349206349,0.6074207614150134,1.0,2/5,7.86%,FGF1;PAX8
prerank,GO_Biological_Process_2021__bile acid and bile salt transport (GO:0015721),0.779090308560381,1.3879300419555793,0.1038961038961039,0.6066898292985334,1.0,5/13,13.75%,SLC51A;SLCO1A2;ATP8B1;SLC10A1;STARD5
prerank,GO_Biological_Process_2021__negative regulation of interleukin-12 production (GO:0032695),0.8969498038667958,1.3874686080099914,0.031746031746031744,0.6075488893139236,1.0,1/7,0.28%,THBS1
prerank,GO_Biological_Process_2021__growth hormone receptor signaling pathway (GO:0060396),0.7754162693454218,1.3870904465145157,0.0641025641025641,0.6077940975998462,1.0,2/13,9.54%,PRLR;GHR
prerank,GO_Biological_Process_2021__artery development (GO:0060840),0.7902466157012014,1.386468530942211,0.07792207792207792,0.6102920510240428,1.0,4/13,9.87%,VEGFA;ROBO2;ROBO1;PDE2A
prerank,GO_Biological_Process_2021__regulation of protein targeting to membrane (GO:0090313),0.7620887218589223,1.3863094449627462,0.07058823529411765,0.6087995388488754,1.0,4/22,6.39%,KCNE1;MTCL1;CEMIP;ANK3
prerank,PanglaoDB_Augmented_2021__Choroid Plexus Cells,0.6847306832507247,1.3856098718991452,0.03333333333333333,0.6118312452949366,1.0,17/62,17.30%,PLPP3;SHROOM3;COBL;PRLR;AGT;SLC4A10;PHYHIPL;CGNL1;SHANK2;SLC13A4;SHC2;GPRC5B;ADGRL2;PLXNB1;CPE;EPB41L4B;MPDZ
prerank,GO_Biological_Process_2021__actin filament bundle organization (GO:0061572),-0.5670161359157183,-1.3855403216397348,0.0,0.8395366239138131,1.0,5/18,9.24%,BAIAP2L2;FSCN1;CORO1B;LIMA1;LCP1
prerank,GO_Biological_Process_2021__autonomic nervous system development (GO:0048483),0.8794708819229251,1.385462228748234,0.045454545454545456,0.6106230976123633,1.0,3/6,8.46%,SEMA3A;SOX4;FN1
prerank,GO_Biological_Process_2021__protein acetylation (GO:0006473),0.7574722814839484,1.3854101498569245,0.03614457831325301,0.6085539581602921,1.0,2/23,2.79%,AANAT;MAPT
prerank,GO_Biological_Process_2021__striated muscle cell development (GO:0055002),-0.800586652898053,-1.3853813652410625,0.09375,0.8350798503952009,1.0,1/5,2.93%,FLII
prerank,PanglaoDB_Augmented_2021__Eosinophils,-0.4484254697539066,-1.3849257353730227,0.0,0.8318594341911002,1.0,24/86,13.61%,NKG7;CCL5;CD300LF;ITGAM;CST7;LY86;BIN2;SELPLG;PIK3R6;HCST;RASAL3;ITGAX;AOAH;MYO1F;NCKAP1L;PLEK;HCK;ITGB2;CYTH4;LCP2;LTC4S;TYROBP;CD53;SNX20
prerank,GO_Biological_Process_2021__sphingolipid biosynthetic process (GO:0030148),0.7007057382217577,1.3834487995223732,0.01098901098901099,0.6201051096458475,1.0,10/50,16.95%,FA2H;PLPP3;ALDH3B1;VAPB;ELOVL4;PPM1L;SPTLC2;ST6GALNAC5;ST8SIA3;PRKD3
prerank,GO_Biological_Process_2021__cyclic-nucleotide-mediated signaling (GO:0019935),0.7201344411022298,1.3833492503755704,0.05063291139240506,0.6182494870591825,1.0,9/23,14.46%,HTR2B;NUDT4;AKAP6;ADGRG6;RAPGEF3;RIMS2;PDE2A;GUCY1B1;EPHA5
prerank,PanglaoDB_Augmented_2021__Satellite Glial Cells,0.6578445826785159,1.3831118805834992,0.030927835051546393,0.6173085477412867,1.0,24/80,11.79%,OPALIN;CD163;ENPP2;GFAP;TNS1;CHI3L1;NRXN1;SLC1A2;RTN1;PDK4;CA10;BAALC;GRIN2A;PTPRT;CDH20;GRIA2;CHL1;FAIM2;NDRG2;GLUL;PLP1;GRIA3;KIAA0513;NTRK2
prerank,GO_Biological_Process_2021__neurogenesis (GO:0022008),0.707454134518956,1.38286843265183,0.06896551724137931,0.6168426555863049,1.0,5/23,3.87%,TGFB2;SPOCK1;MAPT;CIT;ANXA1
prerank,GO_Biological_Process_2021__inorganic anion transmembrane transport (GO:0098661),0.6710406072385278,1.382835258141505,0.06896551724137931,0.6145576439902696,1.0,9/43,14.25%,GLRA1;ANO4;GABRB1;GABRB3;GABRA2;GABRB2;GABRA4;SLC12A8;GLRB
prerank,GO_Biological_Process_2021__negative regulation of alpha-beta T cell differentiation (GO:0046639),-0.7522473288350133,-1.3828338433429495,0.17142857142857143,0.8400383277983786,1.0,2/5,7.43%,RUNX3;CBFB
prerank,GO_Biological_Process_2021__regulation of embryonic development (GO:0045995),-0.5572552485874367,-1.3827180895983702,0.14285714285714285,0.8355163339865747,1.0,3/24,1.70%,PHLDB2;RPS6KA6;RBM19
prerank,GO_Biological_Process_2021__regulation of calcium ion transmembrane transporter activity (GO:1901019),0.7856877106672675,1.3825141303988884,0.047058823529411764,0.614647513035947,1.0,6/16,14.09%,CACNB2;JPH1;DMD;ANK2;CAV3;AHNAK
prerank,PanglaoDB_Augmented_2021__Pinealocytes,0.7029868618253431,1.3816867747997261,0.011111111111111112,0.6189300516890696,1.0,17/39,16.85%,ZNF382;AANAT;PDE10A;SCN3B;AP3B2;TVP23A;SLC24A2;SV2B;MGAT4C;FRRS1L;XKR4;UNC13C;HCN1;CACNA1A;CRB1;KCNJ6;SV2C
prerank,GO_Biological_Process_2021__positive regulation of cilium assembly (GO:0045724),-0.6686797655518251,-1.3815576834111871,0.043478260869565216,0.8366955492885572,1.0,6/15,15.78%,TAPT1;WRAP73;ARHGAP35;MARK4;KCTD17;CROCC
prerank,GO_Biological_Process_2021__positive regulation of neutrophil chemotaxis (GO:0090023),0.8092959287710058,1.3807737728490301,0.1,0.6200265676826405,1.0,1/13,0.36%,DAPK2
prerank,GO_Biological_Process_2021__positive regulation of granulocyte chemotaxis (GO:0071624),0.8092959287710058,1.3807737728490301,0.1,0.6200265676826405,1.0,1/13,0.36%,DAPK2
prerank,GO_Biological_Process_2021__pentose metabolic process (GO:0019321),-0.8740782959884985,-1.3807646179231565,0.02857142857142857,0.8371409513281094,1.0,1/5,4.41%,RPIA
prerank,GO_Biological_Process_2021__positive regulation of cytokinesis (GO:0032467),0.7507253028741699,1.380361589242992,0.08641975308641975,0.620017103376074,1.0,9/18,19.88%,PRKCE;CIT;RACGAP1;SVIL;SPAST;CENPV;PKP4;CDC25B;ECT2
prerank,PanglaoDB_Augmented_2021__Myoepithelial Cells,0.7401056923401053,1.380009766474795,0.024691358024691357,0.6201212898101129,1.0,5/21,7.71%,TNC;NTN4;OSMR;RND3;PALLD
prerank,GO_Biological_Process_2021__megakaryocyte differentiation (GO:0030219),-0.8288365906185868,-1.3798296663334653,0.07692307692307693,0.8355793294767021,1.0,4/6,14.75%,TAL1;SH2B3;ZNF385A;MED1
prerank,GO_Biological_Process_2021__positive regulation of neutrophil migration (GO:1902624),0.7960178150790318,1.3789632197731545,0.12658227848101267,0.6253152578103369,1.0,1/14,0.36%,DAPK2
prerank,GO_Biological_Process_2021__apoptotic nuclear changes (GO:0030262),0.7874626242686369,1.3788101678493265,0.047619047619047616,0.624195785990319,1.0,2/16,2.26%,TOP2A;HMGB2
prerank,GO_Biological_Process_2021__regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307),0.8672529921498903,1.3782115984379566,0.02531645569620253,0.6258535647865118,1.0,3/10,8.38%,KCNE1;ANK2;CAV3
prerank,"GO_Biological_Process_2021__synaptic transmission, glutamatergic (GO:0035249)",0.7742381971973917,1.3777197115534678,0.06666666666666667,0.6268275788718601,1.0,9/16,14.60%,NAPA;CDH8;GRIK2;GRIK1;UNC13A;GRIA2;GRID2;UNC13C;SLC17A7
prerank,GO_Biological_Process_2021__establishment of protein localization to extracellular region (GO:0035592),0.6769778852959847,1.3774738018387227,0.036585365853658534,0.6264948177758667,1.0,4/30,9.03%,RAB3C;TVP23A;RAB15;ABCA1
prerank,GO_Biological_Process_2021__atrial septum development (GO:0003283),0.8472319033849945,1.3772116311725662,0.08695652173913043,0.6262755700241176,1.0,2/6,6.41%,TGFB2;ANK2
prerank,GO_Biological_Process_2021__microvillus organization (GO:0032528),-0.6648961543280181,-1.3765241033057887,0.06896551724137931,0.8438117149718537,1.0,4/13,14.14%,MAP4K4;RAPGEF6;STK26;RAP1A
prerank,GO_Biological_Process_2021__microvillus assembly (GO:0030033),-0.6648961543280181,-1.3765241033057887,0.06896551724137931,0.8438117149718537,1.0,4/13,14.14%,MAP4K4;RAPGEF6;STK26;RAP1A
prerank,GO_Biological_Process_2021__endocrine system development (GO:0035270),0.8611459990197214,1.376424463067543,0.056338028169014086,0.630035799627178,1.0,2/7,7.86%,TG;PAX8
prerank,PanglaoDB_Augmented_2021__Osteoblasts,0.6587543508249156,1.3761753185379901,0.03260869565217391,0.6298045731636612,1.0,15/64,8.46%,SOCS3;TNC;PLPP3;SPARC;SVEP1;LRP4;ADAMTS2;COL11A1;ITGA2;OSMR;LAMA2;INSR;HIF1A;PALLD;FN1
prerank,GO_Biological_Process_2021__negative regulation of receptor signaling pathway via JAK-STAT (GO:0046426),0.8284086866694305,1.3747557020852474,0.04225352112676056,0.6378349638844953,1.0,1/12,0.14%,SOCS3
prerank,GO_Biological_Process_2021__dopaminergic neuron differentiation (GO:0071542),0.8953730743001647,1.3743225675984572,0.03076923076923077,0.6383401938946238,1.0,3/6,5.04%,MANF;NR4A2;VEGFA
prerank,GO_Biological_Process_2021__negative regulation of protein targeting to membrane (GO:0090315),0.9231939458066842,1.3738343857619586,0.03125,0.6392767947791609,1.0,1/5,0.01%,KCNE1
prerank,GO_Biological_Process_2021__presynapse assembly (GO:0099054),0.7911037533778065,1.3730956774450858,0.08695652173913043,0.6430606270575119,1.0,6/14,7.94%,LRP4;PTPRD;IL1RAPL1;BSN;NLGN3;NLGN1
prerank,GO_Biological_Process_2021__cardiac right ventricle morphogenesis (GO:0003215),0.904857658549761,1.3730161163082741,0.10294117647058823,0.6413446753711529,1.0,2/5,5.16%,TGFB2;SOX4
prerank,GO_Biological_Process_2021__activation of protein kinase activity (GO:0032147),0.6659882562247731,1.3727900099787254,0.03125,0.6408250006034346,1.0,20/85,13.26%,FGF1;PRLR;TGFB2;TOM1L1;PRKAR2B;ADCY3;NRG1;CHI3L1;CLSPN;SLC11A1;VEGFA;TRAF2;INSR;TXN;GHR;NTRK3;PRR5;ADCY8;PAK5;PINK1
prerank,GO_Biological_Process_2021__negative regulation of T cell migration (GO:2000405),-0.8358315524240612,-1.3724883034883009,0.20512820512820512,0.8594352581246589,1.0,3/5,15.04%,CD200R1;RIPOR2;LRCH1
prerank,GO_Biological_Process_2021__cellular response to heat (GO:0034605),0.7249607111421974,1.3713815578417072,0.047619047619047616,0.6494901901455684,1.0,4/31,5.23%,THBS1;FGF1;MAPT;IER5
prerank,GO_Biological_Process_2021__negative regulation of hippo signaling (GO:0035331),0.7590201347789934,1.3712915685275169,0.14285714285714285,0.647627078967072,1.0,3/10,9.23%,CIT;SHANK2;LIMD1
prerank,PanglaoDB_Augmented_2021__Melanocytes,0.6458983011586373,1.3711902245125194,0.08791208791208792,0.6458133285775679,1.0,24/71,18.07%,TNC;PLPP3;SH3PXD2B;DOCK1;OSMR;FILIP1L;SYNC;GPNMB;LAMB1;RND3;BMI1;PALLD;FN1;PPFIBP1;PTN;MLANA;SASH1;PMP22;UACA;TIMP3;ITGAV;EPAS1;HSPB1;STARD13
prerank,GO_Biological_Process_2021__positive regulation of synaptic transmission (GO:0050806),0.6811661916042672,1.3708582440112131,0.056818181818181816,0.6460972479920131,1.0,23/48,20.39%,SHANK3;RELN;NRXN1;TSHZ3;GRIK2;SLC24A2;SHANK2;GRIN2A;NLGN3;NLGN1;RIMS2;PLK2;CACNG2;SLC24A1;ADCY8;SYT1;GRIN2B;RIMS3;CACNG8;APP;DLG4;TNF;CLSTN2
prerank,MSigDB_Hallmark_2020__Apical Surface,0.7228672321153176,1.3706150017147773,0.0875,0.6457103720301816,1.0,13/24,22.04%,MAL;ATP8B1;SULF2;BRCA1;THY1;HSPB1;APP;NTNG1;CRYBG1;CX3CL1;FLOT2;RTN4RL1;GSTM3
prerank,GO_Biological_Process_2021__regulation of delayed rectifier potassium channel activity (GO:1902259),0.9070124640858349,1.3698156184696202,0.0273972602739726,0.6493938287868173,1.0,3/6,6.56%,KCNE1;ANK3;AKAP6
prerank,GO_Biological_Process_2021__positive regulation of potassium ion transmembrane transport (GO:1901381),0.7037303480753757,1.3696851442576605,0.011904761904761904,0.6485435155930763,1.0,3/30,6.56%,KCNE1;ANK2;AKAP6
prerank,GO_Biological_Process_2021__extracellular structure organization (GO:0043062),0.6362310889249766,1.3691590467627082,0.010309278350515464,0.6504144229694334,1.0,19/93,6.19%,TNC;THBS1;SPARC;FBN2;ADAMTS2;ECM2;THSD4;COL11A1;NCAN;ITGA2;MMP21;COL4A5;VCAN;TEX14;ADAM15;COL23A1;LAMA2;LAMB1;COL24A1
prerank,GO_Biological_Process_2021__lysosome localization (GO:0032418),-0.5459288025889764,-1.3682861075928148,0.10526315789473684,0.876546222095894,1.0,6/25,12.77%,MYH9;PLEKHM2;PLEKHM1;LAMTOR1;MILR1;DEF8
prerank,GO_Biological_Process_2021__modulation of excitatory postsynaptic potential (GO:0098815),0.7291308232187441,1.3680216850714508,0.06493506493506493,0.656155895030668,1.0,14/20,25.86%,SHANK3;RELN;NRXN1;NLGN3;NLGN1;RIMS2;TMEM108;APP;DLG4;NLGN4X;LRRK2;PTEN;RIMS1;PTK2B
prerank,GO_Biological_Process_2021__regulation of response to interferon-gamma (GO:0060330),0.8621644996215491,1.367617895978672,0.02564102564102564,0.6571562080345855,1.0,1/12,0.14%,SOCS3
prerank,GO_Biological_Process_2021__positive regulation of protein autophosphorylation (GO:0031954),0.7659960450692789,1.3675066962116096,0.013888888888888888,0.6554637919977166,1.0,4/17,8.65%,TOM1L1;VEGFA;GPNMB;CALM3
prerank,GO_Biological_Process_2021__vocal learning (GO:0042297),0.8888759882965982,1.3669435074900032,0.07017543859649122,0.6550209180862846,1.0,4/5,11.01%,SHANK3;NRXN1;NRXN2;CNTNAP2
prerank,GO_Biological_Process_2021__imitative learning (GO:0098596),0.8888759882965982,1.3669435074900032,0.07017543859649122,0.6550209180862846,1.0,4/5,11.01%,SHANK3;NRXN1;NRXN2;CNTNAP2
prerank,GO_Biological_Process_2021__positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846),0.779340766642715,1.366216012767114,0.057971014492753624,0.6562133656466628,1.0,1/16,0.28%,THBS1
prerank,GO_Biological_Process_2021__positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511),0.779340766642715,1.366216012767114,0.057971014492753624,0.6562133656466628,1.0,1/16,0.28%,THBS1
prerank,GO_Biological_Process_2021__presynaptic membrane assembly (GO:0097105),0.8255914578429657,1.3661546525190797,0.058823529411764705,0.6543515193892054,1.0,5/9,7.94%,LRP4;PTPRD;IL1RAPL1;NLGN3;NLGN1
prerank,PanglaoDB_Augmented_2021__Trophoblast Stem Cells,0.7965153953520109,1.366019106592614,0.0273972602739726,0.6530757215966235,1.0,7/14,7.17%,SHROOM3;TOM1L1;SH2D4A;ENAH;OVOL2;BAIAP2L1;RND3
prerank,GO_Biological_Process_2021__negative regulation of blood vessel morphogenesis (GO:2000181),0.7057854291887463,1.365482735549806,0.01098901098901099,0.6547637714215814,1.0,4/36,1.28%,THBS1;KLF4;SPARC;TGFB2
prerank,GO_Biological_Process_2021__ion homeostasis (GO:0050801),0.7896158316426919,1.3652431825384488,0.0684931506849315,0.6541981538913393,1.0,3/16,8.05%,SLC4A10;FHL1;UNC80
prerank,GO_Biological_Process_2021__TRAIL-activated apoptotic signaling pathway (GO:0036462),-0.7825910805972569,-1.3649172884665708,0.16216216216216217,0.8876968749564541,1.0,3/5,21.14%,ZDHHC3;CASP8;SPI1
prerank,GO_Biological_Process_2021__atrioventricular valve development (GO:0003171),0.8063254262557715,1.3647493721025463,0.1111111111111111,0.6560037873809539,1.0,1/9,1.28%,TGFB2
prerank,GO_Biological_Process_2021__positive regulation of calcium ion import (GO:0090280),-0.8061496997402717,-1.3636067315437113,0.07317073170731707,0.8892009722378688,1.0,2/5,12.16%,CALCR;CXCL12
prerank,GO_Biological_Process_2021__negative regulation of angiogenesis (GO:0016525),0.6854682969260881,1.3631004074809123,0.031578947368421054,0.6648738077580395,1.0,4/43,1.28%,THBS1;KLF4;SPARC;TGFB2
prerank,GO_Biological_Process_2021__regulation of transforming growth factor beta2 production (GO:0032909),0.9017768168132517,1.3629158238979255,0.047619047619047616,0.6641464374050883,1.0,2/5,7.22%,TGFB2;HIF1A
prerank,GO_Biological_Process_2021__presynaptic active zone organization (GO:1990709),0.8519202458370427,1.3626044519265132,0.09230769230769231,0.6640180225534525,1.0,2/6,8.25%,BSN;ERC2
prerank,GO_Biological_Process_2021__N-terminal protein amino acid modification (GO:0031365),0.7970484097017227,1.361914836328553,0.06578947368421052,0.6663565350778501,1.0,1/10,0.75%,AANAT
prerank,GO_Biological_Process_2021__negative regulation of protein secretion (GO:0050709),-0.5513548610455979,-1.3618209321862824,0.09090909090909091,0.8922638120876927,1.0,4/18,12.06%,SERGEF;IL1B;NR1H3;REST
prerank,GO_Biological_Process_2021__response to hexose (GO:0009746),0.7624245724832568,1.361604373421668,0.04,0.6670077960547007,1.0,3/13,14.41%,THBS1;IRS2;EIF2B2
prerank,GO_Biological_Process_2021__positive chemotaxis (GO:0050918),0.7909879763766211,1.3615944931755695,0.12162162162162163,0.6647809821101343,1.0,3/10,10.26%,VEGFA;GPNMB;SEMA5A
prerank,GO_Biological_Process_2021__negative regulation of protein localization to membrane (GO:1905476),0.7605693758945363,1.3614446366814794,0.05063291139240506,0.663773500303677,1.0,1/19,0.01%,KCNE1
prerank,GO_Biological_Process_2021__tRNA aminoacylation for protein translation (GO:0006418),-0.5501278053626426,-1.361311875330209,0.13333333333333333,0.8895670732817181,1.0,10/38,16.05%,KARS1;TARS2;DARS2;CARS2;FARSA;YARS1;TARS1;LARS2;SARS1;WARS1
prerank,GO_Biological_Process_2021__positive regulation of MHC class II biosynthetic process (GO:0045348),-0.8115767254362012,-1.35918755136012,0.13333333333333333,0.8950309466416094,1.0,1/5,5.75%,TMEM106A
prerank,GO_Biological_Process_2021__aorta development (GO:0035904),0.8412504637936372,1.358989739056067,0.06756756756756757,0.6799940937598936,1.0,3/7,9.87%,ROBO2;ROBO1;PDE2A
prerank,GO_Biological_Process_2021__cytoplasmic sequestering of protein (GO:0051220),-0.6578810124813336,-1.358450969501507,0.16,0.8942352508021397,1.0,3/10,11.00%,FLNA;NFKBIE;NFKBIA
prerank,GO_Biological_Process_2021__pulmonary valve morphogenesis (GO:0003184),0.8237262763372767,1.358179297319471,0.08955223880597014,0.6838222401336981,1.0,3/9,8.14%,TGFB2;ROBO2;ROBO1
prerank,MSigDB_Hallmark_2020__TNF-alpha Signaling via NF-kB,0.6355330362220935,1.358107011387226,0.0,0.682148433834461,1.0,41/133,16.67%,SOCS3;TNC;KLF4;PLPP3;NAMPT;NFIL3;RHOB;EGR1;TGIF1;GADD45B;SLC2A3;NR4A2;NR4A1;MAP3K8;VEGFA;IER5;TRIP10;BHLHE40;FOSL2;ID2;ABCA1;IRS2;MCL1;MXD1;PLK2;PER1;PDE4B;B4GALT5;ETS2;RIPK2;IFIT2;NR4A3;SOD2;PPP1R15A;TUBB2A;GPR183;IL18;CEBPD;DENND5A;LITAF;KLF9
prerank,GO_Biological_Process_2021__negative regulation of endothelial cell proliferation (GO:0001937),0.7163900384915655,1.3573845931955013,0.09302325581395349,0.685429789200464,1.0,2/19,0.68%,THBS1;SPARC
prerank,GO_Biological_Process_2021__synapse organization (GO:0050808),0.6306392207266641,1.3570840819042762,0.011363636363636364,0.6861614551083048,1.0,35/82,21.44%,LRP4;LRRC4C;SHANK3;MYOT;GPM6A;PTPRD;CACNB2;MAPT;NRXN1;CDH2;NRXN2;CTNND2;SHANK2;ANK3;NLGN3;UNC13A;NLGN1;PPFIBP1;DNM3;C5AR1;PPFIA2;CBLN2;UNC13C;APP;APBB2;DCTN1;PPFIA4;NTNG1;LRFN5;NLGN4X;PTPRS;LRRK2;CNTN2;CX3CL1;PAK3
prerank,GO_Biological_Process_2021__cellular response to amino acid stimulus (GO:0071230),0.7014382428245896,1.3564514660987104,0.08433734939759036,0.6889608967182441,1.0,1/28,0.04%,GLRA1
prerank,GO_Biological_Process_2021__pyrimidine nucleobase metabolic process (GO:0006206),0.8066379554966745,1.3564227642273885,0.07352941176470588,0.6868155838377975,1.0,4/9,11.64%,DPYD;DPYSL5;CRMP1;ALDH6A1
prerank,GO_Biological_Process_2021__regulation of endothelial cell apoptotic process (GO:2000351),0.6987829131128038,1.3560208146354076,0.10810810810810811,0.6869651656255258,1.0,1/19,0.28%,THBS1
prerank,GO_Biological_Process_2021__cellular response to laminar fluid shear stress (GO:0071499),0.9575395337090917,1.3554282462632508,0.015873015873015872,0.6895130480361374,1.0,1/5,0.30%,KLF4
prerank,GO_Biological_Process_2021__rRNA base methylation (GO:0070475),-0.8332523520790429,-1.3552398840776707,0.08333333333333333,0.9055024234342468,1.0,2/5,9.94%,BUD23;METTL16
prerank,GO_Biological_Process_2021__dicarboxylic acid catabolic process (GO:0043649),0.8074140346000888,1.3548828646051876,0.06666666666666667,0.6916350103704928,1.0,3/10,9.72%,ASPA;GAD1;GLUL
prerank,GO_Biological_Process_2021__regulation of synapse assembly (GO:0051963),0.715075245286886,1.3546864849547693,0.060240963855421686,0.6908577282123759,1.0,7/33,7.94%,IL1RAPL2;PTPRD;IL1RAPL1;NRXN1;ROBO2;NLGN3;NLGN1
prerank,GO_Biological_Process_2021__negative regulation of microtubule polymerization or depolymerization (GO:0031111),0.7562308906760238,1.3535603454065501,0.03896103896103896,0.696993604718258,1.0,10/26,16.42%,CLIP3;TUBB4A;TTBK2;HDGFL3;MAP2;MID1IP1;CLASP2;STMN2;APC2;EML2
prerank,GO_Biological_Process_2021__apical junction assembly (GO:0043297),0.7412479942868532,1.3529833377509684,0.047619047619047616,0.6990701688765963,1.0,4/25,12.63%,CLDN18;CLDN20;MICALL2;PARD3
prerank,PanglaoDB_Augmented_2021__Thymocytes,-0.45940784893219505,-1.352913695760972,0.0,0.9115805608584782,1.0,26/75,14.51%,NKG7;CD37;CST7;GNLY;BIN2;SELPLG;CD2;CEACAM21;GZMB;UCP2;HCST;RASAL3;AOAH;MYO1F;NCKAP1L;PLEK;ITGB2;CYTH4;LCP2;PRF1;CD53;SNX20;GIMAP4;GIMAP7;PIK3R5;CD247
prerank,GO_Biological_Process_2021__regulation of cardiac muscle contraction (GO:0055117),0.6924403351726093,1.3527381743002689,0.047619047619047616,0.6989283394600478,1.0,7/22,15.68%,RGS2;ANK2;CAV3;CALM3;RYR2;PDE4B;ATP2A2
prerank,GO_Biological_Process_2021__external encapsulating structure organization (GO:0045229),0.629620353898369,1.3526396357455983,0.020618556701030927,0.6976421852955984,1.0,21/91,9.79%,TNC;THBS1;SPARC;FBN2;ADAMTS2;ECM2;THSD4;COL11A1;NCAN;ITGA2;MMP21;COL4A5;VCAN;ADAM15;COL23A1;LAMA2;LAMB1;COL24A1;FN1;ITGAE;ITGB8
prerank,GO_Biological_Process_2021__protein kinase C signaling (GO:0070528),0.8667865960536898,1.3521732304705036,0.1,0.6987708522271817,1.0,1/7,0.27%,HTR2B
prerank,GO_Biological_Process_2021__skin development (GO:0043588),0.6965653448974408,1.3516076231711103,0.06976744186046512,0.7005380127415759,1.0,13/30,16.10%,FA2H;LSR;ANXA1;ALOX12;ST14;TXNIP;ERRFI1;PKD1;WNT5A;COL5A3;CASP3;UGCG;CLIC4
prerank,GO_Biological_Process_2021__sodium ion transmembrane transport (GO:0035725),0.6987150698665984,1.3512925542817051,0.023255813953488372,0.7008837284195057,1.0,19/38,21.02%,SCN3B;SLC6A15;SLC24A2;SLC9A7;SCN3A;SCN1A;SLC24A1;SLC9A6;NALCN;HCN1;SCN8A;SCN2A;ASIC2;SLC24A3;ATP1B3;ATP1B2;ATP1A2;SLC24A4;SLC9A1
prerank,GO_Biological_Process_2021__PERK-mediated unfolded protein response (GO:0036499),0.8497956841902011,1.3511704347227076,0.04411764705882353,0.6994856107544986,1.0,3/8,7.35%,HSPA5;EIF2AK3;HERPUD1
prerank,GO_Biological_Process_2021__synapse assembly (GO:0007416),0.6790176277618472,1.3510902634751643,0.04878048780487805,0.6980355421187996,1.0,15/39,15.06%,SHANK3;GPM6A;NRXN1;CDH2;NRXN2;SHANK2;NLGN3;NLGN1;GABRB3;GABRA2;DNM3;GABRB2;GRID2;PLXNB1;WNT5A
prerank,GO_Biological_Process_2021__regulation of dendritic spine development (GO:0060998),0.6950004894829915,1.3508301784758514,0.09210526315789473,0.6977483934920561,1.0,6/19,11.27%,SHANK3;ARF6;GRIN3A;NLGN1;PPFIA2;CAMK2B
prerank,GO_Biological_Process_2021__response to misfolded protein (GO:0051788),-0.7556561870538607,-1.3506472595599857,0.15,0.9165303620127999,1.0,2/7,11.93%,DNAJB12;DNAJB14
prerank,GO_Biological_Process_2021__response to progesterone (GO:0032570),0.8171222040664456,1.3504508374214061,0.04285714285714286,0.6986735794543923,1.0,2/11,1.28%,THBS1;TGFB2
prerank,GO_Biological_Process_2021__folic acid metabolic process (GO:0046655),-0.693231465456856,-1.3503545836737965,0.10526315789473684,0.9130638075752436,1.0,5/14,11.90%,FOLR2;SLC46A1;MTHFD2L;MTHFD1L;SLC19A1
prerank,GO_Biological_Process_2021__long-term synaptic depression (GO:0060292),0.8880032219067314,1.3499405090826007,0.05970149253731343,0.7005582214137107,1.0,5/7,10.68%,SLC24A2;PRRT1;SHANK2;PLK2;SLC24A1
prerank,GO_Biological_Process_2021__ventricular trabecula myocardium morphogenesis (GO:0003222),0.829572465335545,1.3498654322658372,0.11428571428571428,0.6990629715302197,1.0,3/7,9.26%,TGFB2;NRG1;RBPJ
prerank,GO_Biological_Process_2021__ribonucleoprotein complex biogenesis (GO:0022613),0.6418042505010919,1.3495767800894605,0.13186813186813187,0.6988061813709476,1.0,15/50,16.75%,RIOK2;WDR12;WDR74;PES1;RPL38;XPO1;RPS6;GLUL;RPS25;RRP36;HEATR3;RPL14;SHQ1;RPL11;RPS24
prerank,GO_Biological_Process_2021__myelination (GO:0042552),0.708128898707861,1.3492317828213398,0.09195402298850575,0.6995669935056332,1.0,14/31,15.12%,MAL;MYRF;ADGRG6;B4GALT5;PLP1;PMP22;PARD3;NFASC;TPPP;BCAS1;EIF2B2;SCN8A;PLLP;SCN2A
prerank,GO_Biological_Process_2021__translational readthrough (GO:0006451),0.8484935636038438,1.3489889936808908,0.1076923076923077,0.6971248888307262,1.0,2/7,5.71%,SEPSECS;TRNAU1AP
prerank,GO_Biological_Process_2021__selenocysteine incorporation (GO:0001514),0.8484935636038438,1.3489889936808908,0.1076923076923077,0.6971248888307262,1.0,2/7,5.71%,SEPSECS;TRNAU1AP
prerank,GO_Biological_Process_2021__canonical glycolysis (GO:0061621),0.772679214615225,1.3488015077074127,0.06944444444444445,0.694270459256147,1.0,7/15,20.23%,PFKM;ENO2;PGAM1;GPI;PKM;PGK1;ENO1
prerank,GO_Biological_Process_2021__glucose catabolic process to pyruvate (GO:0061718),0.772679214615225,1.3488015077074127,0.06944444444444445,0.694270459256147,1.0,7/15,20.23%,PFKM;ENO2;PGAM1;GPI;PKM;PGK1;ENO1
prerank,GO_Biological_Process_2021__bicellular tight junction assembly (GO:0070830),0.7520346575911243,1.3484567376508052,0.08536585365853659,0.6946805036890558,1.0,4/20,12.63%,CLDN18;CLDN20;MICALL2;PARD3
prerank,GO_Biological_Process_2021__negative regulation of sodium ion transport (GO:0010766),-0.7969326519153067,-1.3484394380814364,0.04,0.9178841998485745,1.0,3/7,13.85%,NEDD4;COMMD1;WNK3
prerank,GO_Biological_Process_2021__regulation of endothelial cell migration (GO:0010594),0.6733193379701881,1.3472646933614967,0.0,0.7010417244707323,1.0,10/52,12.39%,THBS1;RHOB;SPARC;FGF1;AGT;VEGFA;PTN;GLUL;SASH1;GPI
prerank,GO_Biological_Process_2021__response to prostaglandin E (GO:0034695),-0.863856529625115,-1.3470083889176785,0.07317073170731707,0.920893179033062,1.0,1/5,0.57%,TGFBR3
prerank,MSigDB_Hallmark_2020__Spermatogenesis,0.6311501066623268,1.3467599131173598,0.043010752688172046,0.7028903292130767,1.0,20/65,19.66%,TULP2;ZPBP;GRM8;DCC;CLVS1;TALDO1;GAD1;SEPTIN4;NPHP1;MEP1B;MAP7;PEBP1;AGFG1;RFC4;SCG5;EZH2;DBF4;HSPA2;SPATA6;SNAP91
prerank,GO_Biological_Process_2021__regulation of dendritic spine morphogenesis (GO:0061001),0.7107399704617468,1.3462631919358337,0.07228915662650602,0.7043778086836419,1.0,11/27,15.33%,SHANK3;ZDHHC15;RELN;SRCIN1;SIPA1L1;NGEF;NLGN1;PPFIA2;CAMK2B;EPHA4;CFL1
prerank,GO_Biological_Process_2021__glycosaminoglycan catabolic process (GO:0006027),0.6818648319714384,1.3460889025578915,0.09195402298850575,0.7033280105700274,1.0,8/31,9.58%,OMD;OGN;NCAN;VCAN;GPC5;CEMIP;GNS;CSPG5
prerank,GO_Biological_Process_2021__positive regulation of chromatin organization (GO:1905269),-0.7195990089711981,-1.3458585150129676,0.1111111111111111,0.9210204751221502,1.0,1/11,1.65%,TAL1
prerank,GO_Biological_Process_2021__negative regulation of neuron projection development (GO:0010977),0.6642536910898758,1.3457357326994694,0.05747126436781609,0.7039938992634573,1.0,23/45,22.84%,LRP4;SEMA3A;OMG;DCC;SPOCK1;LINGO1;NGEF;KANK1;PAQR3;NLGN1;MAG;CRMP1;EPHA4;STMN2;THY1;DENND5A;ARHGDIA;PTPN9;PTPRS;BCL11A;RTN4RL1;RTN4;GDI1
prerank,GO_Biological_Process_2021__long-term synaptic potentiation (GO:0060291),0.8184604642301149,1.3455948461555993,0.04225352112676056,0.702922766914446,1.0,7/12,14.52%,TSHZ3;SLC24A2;SHANK2;GRIN2A;PLK2;SLC24A1;GRIN2B
prerank,GO_Biological_Process_2021__positive regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061419),0.8926470668396375,1.3453503770040034,0.0967741935483871,0.7024628288552824,1.0,3/5,9.26%,VEGFA;HIF1A;RBPJ
prerank,GO_Biological_Process_2021__antigen receptor-mediated signaling pathway (GO:0050851),-0.46942056782919217,-1.3449630404569297,0.16666666666666666,0.9213394905659056,1.0,31/138,15.36%,THEMIS;ITK;SKAP1;GRAP2;BTN3A2;PSMB3;CD276;PSME3;CHUK;BLNK;PSMC4;PSMD12;SPG21;FYN;STOML2;PSME4;NCKAP1L;INPP5D;BTK;IKBKB;HLA-DPA1;LCP2;NCK1;SYK;PSMA1;BCL2;BCL10;CD247;CARD11;PSMA7;BTN3A1
prerank,GO_Biological_Process_2021__integrated stress response signaling (GO:0140467),0.7851679825240521,1.3448202268350882,0.056338028169014086,0.703814296925948,1.0,4/11,10.79%,HSPA5;EIF2AK3;HERPUD1;IMPACT
prerank,GO_Biological_Process_2021__snoRNA localization (GO:0048254),-0.8386935220295162,-1.3447708591635796,0.0625,0.9170454449116516,1.0,3/6,12.41%,FBL;PIH1D1;ZNHIT6
prerank,PanglaoDB_Augmented_2021__Glomus Cells,0.6496421217434399,1.3445125257700972,0.042105263157894736,0.703898260248931,1.0,31/70,19.39%,PLPP3;FAM13C;LRP4;VIM;PLPPR4;FBXL7;LIFR;SRRM3;ANK2;RBFOX2;ARNT2;PTN;SHC2;MAP1B;CRMP1;GPRC5B;FIGN;NR2F1;ADGRL2;NFASC;LIMCH1;NDRG4;CPE;THY1;EDIL3;EPAS1;HSPA12A;MPDZ;TNFRSF1A;TMEM59L;GUCY1A2
prerank,GO_Biological_Process_2021__toll-like receptor 3 signaling pathway (GO:0034138),-0.7296651296032821,-1.3442266110555547,0.1,0.9154088708133457,1.0,3/10,8.55%,TICAM1;SCIMP;TLR3
prerank,GO_Biological_Process_2021__positive regulation of T cell chemotaxis (GO:0010820),-0.709471377093012,-1.343792374493702,0.09523809523809523,0.9084097957904168,1.0,1/7,0.45%,CCL5
prerank,GO_Biological_Process_2021__regulation of T cell chemotaxis (GO:0010819),-0.709471377093012,-1.343792374493702,0.09523809523809523,0.9084097957904168,1.0,1/7,0.45%,CCL5
prerank,GO_Biological_Process_2021__negative regulation of neuron differentiation (GO:0045665),-0.8106910591851666,-1.343393212930656,0.10526315789473684,0.9052799264052387,1.0,4/7,18.05%,REST;EIF2AK4;MED1;CNTN4
prerank,GO_Biological_Process_2021__heterochromatin organization (GO:0070828),-0.6352590506968532,-1.3432149548711352,0.125,0.9007504062584452,1.0,3/10,10.21%,SETDB1;BAHD1;POLE3
prerank,GO_Biological_Process_2021__UDP-N-acetylglucosamine metabolic process (GO:0006047),0.7791158243899748,1.3431664987739462,0.1232876712328767,0.7076644744198162,1.0,1/10,0.21%,UAP1L1
prerank,GO_Biological_Process_2021__amino sugar biosynthetic process (GO:0046349),0.7791158243899748,1.3431664987739462,0.1232876712328767,0.7076644744198162,1.0,1/10,0.21%,UAP1L1
prerank,GO_Biological_Process_2021__UDP-N-acetylglucosamine biosynthetic process (GO:0006048),0.7791158243899748,1.3431664987739462,0.1232876712328767,0.7076644744198162,1.0,1/10,0.21%,UAP1L1
prerank,MSigDB_Hallmark_2020__E2F Targets,0.619853887966616,1.3430359527903994,0.0,0.706746138787327,1.0,34/132,21.07%,TOP2A;DIAPH3;CKS2;CENPE;TBRG4;HMGB2;NAA38;CIT;RACGAP1;TFRC;RPA2;SMC4;XPO1;PAICS;ATAD2;LMNB1;GINS1;DONSON;PRPS1;BRCA1;UBR7;DCK;ORC6;PRDX4;EZH2;CDC25B;MLH1;TIMELESS;RFC1;CTPS1;HELLS;CDKN1B;CBX5;TACC3
prerank,GO_Biological_Process_2021__retinoic acid receptor signaling pathway (GO:0048384),0.848050235314142,1.3423793080352289,0.11940298507462686,0.7100628388676145,1.0,1/6,5.33%,RXRB
prerank,GO_Biological_Process_2021__regulation of microtubule cytoskeleton organization (GO:0070507),-0.5262479297201784,-1.3420541514126434,0.05263157894736842,0.9032726272428949,1.0,1/28,0.03%,PHLDB2
prerank,GO_Biological_Process_2021__regulation of histone deacetylase activity (GO:1901725),0.8250813203602282,1.3420325774482804,0.08955223880597014,0.7111108083928852,1.0,1/7,5.04%,VEGFA
prerank,GO_Biological_Process_2021__folic acid-containing compound metabolic process (GO:0006760),-0.7134353695293919,-1.3420206020370689,0.13043478260869565,0.898678358291202,1.0,5/13,11.90%,FOLR2;SLC46A1;MTHFD2L;MTHFD1L;SLC19A1
prerank,GO_Biological_Process_2021__glycolytic process through glucose-6-phosphate (GO:0061620),0.759382532636583,1.3417950529989566,0.08450704225352113,0.7105268040348494,1.0,7/16,20.23%,PFKM;ENO2;PGAM1;GPI;PKM;PGK1;ENO1
prerank,GO_Biological_Process_2021__sulfur compound catabolic process (GO:0044273),0.7356137269495544,1.3416909683211966,0.15853658536585366,0.7089959880872726,1.0,7/17,9.58%,OMD;OGN;NCAN;VCAN;GNS;ACAT1;CSPG5
prerank,PanglaoDB_Augmented_2021__Motor Neurons,0.7741271087273255,1.3410699121939889,0.03896103896103896,0.7122114518396806,1.0,11/20,10.80%,FGF1;VGF;ENAH;SRRM3;RBFOX2;LINGO1;ADGRB2;CSPG5;CKB;TMEM132A;NR2F1
prerank,GO_Biological_Process_2021__negative regulation of axonogenesis (GO:0050771),0.7163524329594254,1.3410015716136467,0.1,0.7106013071693307,1.0,6/22,8.44%,LRP4;OMG;DCC;LINGO1;MAG;MAP2
prerank,GO_Biological_Process_2021__positive regulation of cell division (GO:0051781),0.7231801420768479,1.3406673424936733,0.0963855421686747,0.7114939103348558,1.0,5/23,3.33%,HTR2B;FGF1;PRKCE;CIT;RACGAP1
prerank,GO_Biological_Process_2021__glutamine family amino acid catabolic process (GO:0009065),0.8880322575315331,1.3406352186711952,0.05,0.709674225193872,1.0,2/5,9.72%,GAD1;GLUL
prerank,GO_Biological_Process_2021__monoacylglycerol catabolic process (GO:0052651),0.9392183046052305,1.340588465661465,0.0,0.707837545563581,1.0,2/5,3.60%,FAAH;ABHD12B
prerank,GO_Biological_Process_2021__cellular response to chemokine (GO:1990869),-0.6562451109638459,-1.3403878157984088,0.21052631578947367,0.9030860397573285,1.0,5/17,15.04%,CCL5;SH2B3;RIPOR2;CXCL12;LRCH1
prerank,GO_Biological_Process_2021__epiboly involved in wound healing (GO:0090505),-0.59811849769619,-1.3403803425196796,0.13636363636363635,0.8985408552317556,1.0,4/13,9.24%,FLNA;DDR1;ARHGAP35;LCP1
prerank,GO_Biological_Process_2021__sulfate transport (GO:0008272),0.84962291698636,1.340276598831312,0.04285714285714286,0.7076593095888881,1.0,2/8,6.27%,RACGAP1;SLC13A4
prerank,GO_Biological_Process_2021__rRNA modification (GO:0000154),-0.6172503869316158,-1.3401166564195575,0.07692307692307693,0.8956208821416853,1.0,3/17,5.85%,BUD23;FBL;THUMPD1
prerank,GO_Biological_Process_2021__positive regulation of viral entry into host cell (GO:0046598),-0.6568767511845438,-1.339722156298244,0.09523809523809523,0.8881895222934681,1.0,3/8,12.19%,TRIM38;LGALS9;TRIM11
prerank,GO_Biological_Process_2021__positive regulation by symbiont of entry into host (GO:0075294),-0.6568767511845438,-1.339722156298244,0.09523809523809523,0.8881895222934681,1.0,3/8,12.19%,TRIM38;LGALS9;TRIM11
prerank,GO_Biological_Process_2021__negative regulation of actin filament bundle assembly (GO:0032232),-0.5966426015249643,-1.3396488123797703,0.16,0.8838737182158807,1.0,4/21,3.82%,PHLDB2;INPP5K;PFN1;ARAP1
prerank,GO_Biological_Process_2021__positive regulation of cellular protein metabolic process (GO:0032270),0.6539084468015182,1.3396223611793332,0.0,0.7106587188209108,1.0,9/76,7.42%,THBS1;KLF4;PRR16;VIM;EIF4A3;AGT;SOX4;RBM3;VPS11
prerank,GO_Biological_Process_2021__short-chain fatty acid catabolic process (GO:0019626),-0.7109548054484647,-1.3394796285633566,0.1111111111111111,0.8801369906396909,1.0,3/7,17.68%,MMAA;MCEE;PCCB
prerank,GO_Biological_Process_2021__negative regulation of tyrosine phosphorylation of STAT protein (GO:0042532),0.8588165641321722,1.3392232081588684,0.06153846153846154,0.7119206154916713,1.0,1/8,0.14%,SOCS3
prerank,GO_Biological_Process_2021__positive regulation of heart contraction (GO:0045823),0.7875366627644416,1.3389526918672128,0.0759493670886076,0.7121950832779411,1.0,4/10,9.36%,TGFB2;SCN3B;RGS2;RYR2
prerank,GO_Biological_Process_2021__regulation of long-chain fatty acid import across plasma membrane (GO:0010746),0.8783873392870456,1.3389100108841692,0.05714285714285714,0.7102959897413319,1.0,3/6,9.28%,THBS1;ACSL1;IRS2
prerank,GO_Biological_Process_2021__negative regulation of muscle hypertrophy (GO:0014741),0.8042188629687903,1.3388538269066859,0.10606060606060606,0.7085972251811435,1.0,2/7,8.38%,RGS2;CAV3
prerank,GO_Biological_Process_2021__epithelial cell development (GO:0002064),-0.7253153419773569,-1.3385751310943597,0.2,0.8798687173732925,1.0,1/8,2.54%,ACTA2
prerank,GO_Biological_Process_2021__canonical Wnt signaling pathway (GO:0060070),0.6624092615877238,1.338511832279939,0.05952380952380952,0.7096886647280379,1.0,5/30,7.98%,PLPP3;FZD6;NR4A2;TCF7;TCF7L1
prerank,GO_Biological_Process_2021__protein kinase C-activating G protein-coupled receptor signaling pathway (GO:0007205),0.8229187775813492,1.3383193281232382,0.13432835820895522,0.7090510932238223,1.0,1/8,0.27%,HTR2B
prerank,GO_Biological_Process_2021__late endosome to Golgi transport (GO:0034499),0.9128113054871717,1.337926011693437,0.09230769230769231,0.7101082411994472,1.0,1/5,0.81%,RAB7B
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial membrane potential (GO:0010918),-0.8355856675521023,-1.3379139684675336,0.2,0.8783084948499816,1.0,3/5,14.21%,MTLN;STOML2;AKT1
prerank,GO_Biological_Process_2021__cellular response to brain-derived neurotrophic factor stimulus (GO:1990416),0.8761398176291791,1.3378693611504493,0.1323529411764706,0.7083756114803766,1.0,5/5,12.42%,MAPT;WASF1;NTRK2;TMEM108;SH3GL2
prerank,GO_Biological_Process_2021__cytoskeleton-dependent cytokinesis (GO:0061640),0.6794087038240012,1.3375741008917323,0.07777777777777778,0.7082275630419844,1.0,12/49,17.16%,RHOB;ANLN;CIT;RACGAP1;ANK3;SPIRE2;SEPTIN4;SEPTIN8;SPAST;INCENP;SPTBN1;ROCK1
prerank,PanglaoDB_Augmented_2021__Endothelial Cells (Blood Brain Barrier),0.6505270809085352,1.3369937071756184,0.031578947368421054,0.710129896163909,1.0,30/74,17.45%,LRP4;SH3PXD2B;GFAP;DOCK1;DZIP1;MTCL1;GNA11;LIFR;SRRM3;SEMA3B;SLC13A4;RBFOX2;CAMK2N1;KAZN;NGEF;ARNT2;ALCAM;ADGRB2;MAP1B;GPRC5B;TMEM132A;NR2F1;TYRO3;PLXNB1;NDRG4;CPE;APLP1;HSPA12A;MPDZ;APP
prerank,GO_Biological_Process_2021__cellular response to nerve growth factor stimulus (GO:1990090),0.7618945458400813,1.3367183343793694,0.07317073170731707,0.7100839474142461,1.0,8/16,13.71%,MAPT;NTRK3;WASF1;NTRK2;TMEM108;MAGI2;SH3GL2;STMN2
prerank,GO_Biological_Process_2021__cellular response to interleukin-6 (GO:0071354),0.7198216561790769,1.3366097066162606,0.13095238095238096,0.7088736066239423,1.0,2/23,0.94%,SOCS3;ST18
prerank,GO_Biological_Process_2021__generation of neurons (GO:0048699),0.619138645804428,1.3364931642715896,0.030303030303030304,0.7078283644340226,1.0,22/95,15.15%,DDIT4;TGFB2;SEMA3A;GPM6A;HMGB2;PTPRD;SPOCK1;MAPT;RELN;CIT;RACGAP1;NR4A2;IL1RAPL1;OLIG1;BHLHE40;MAP1B;NTRK2;ASTN2;CCK;TUBB2A;WNT5A;CASP3
prerank,GO_Biological_Process_2021__positive regulation of heterotypic cell-cell adhesion (GO:0034116),-0.7191629923200132,-1.3364322943871367,0.08823529411764706,0.8806284127450172,1.0,2/8,2.23%,SKAP1;IL1B
prerank,GO_Biological_Process_2021__regulation of chaperone-mediated autophagy (GO:1904714),0.8533672193492936,1.3359388238079228,0.058823529411764705,0.7104477584997771,1.0,2/8,2.24%,EEF1A2;GFAP
prerank,GO_Biological_Process_2021__neuron projection morphogenesis (GO:0048812),0.6058778987346195,1.3358996209930571,0.020618556701030927,0.7087476947772069,1.0,42/106,24.09%,LRP2;LRP4;FLRT1;SHANK3;GPM6A;DCC;PLPPR4;CTNND2;NYAP2;ANK3;NLGN1;ALCAM;MAP2;MAP1B;CELSR2;SLITRK5;IMPACT;CNTNAP2;SLC9A6;PARD3;CCK;CTNNA2;PLXNB1;IQGAP1;ROCK1;APP;KLF7;NTNG1;UBB;SPTBN4;DLG4;MAPK8IP2;CNTNAP1;LRRK2;FGFR2;PAK3;CTTN;DCLK1;MAP1A;TMEM106B;PTEN;BRSK1
prerank,GO_Biological_Process_2021__negative regulation of natural killer cell mediated immunity (GO:0002716),-0.7576112172643956,-1.3355512822488804,0.25,0.8805947451029077,1.0,3/6,12.78%,LGALS9;HLA-E;ARRB2
prerank,GO_Biological_Process_2021__positive regulation of extrinsic apoptotic signaling pathway (GO:2001238),0.7584252043750772,1.3354349692078358,0.14864864864864866,0.7099103562848722,1.0,3/17,5.44%,THBS1;AGT;TRAF2
prerank,GO_Biological_Process_2021__synaptic membrane adhesion (GO:0099560),0.803516471419073,1.3353491502369164,0.11940298507462686,0.7084821667946907,1.0,2/8,2.68%,LRRC4C;PTPRD
prerank,GO_Biological_Process_2021__negative regulation of biomineral tissue development (GO:0070168),0.773335976348404,1.3352551429128996,0.07692307692307693,0.707191973809838,1.0,2/13,4.57%,ASPN;SRGN
prerank,GO_Biological_Process_2021__DNA geometric change (GO:0032392),0.7061978745340718,1.33503933986763,0.08,0.7067915740903669,1.0,5/21,12.48%,HMGB2;ANXA1;MTERF1;DNA2;DDX1
prerank,GO_Biological_Process_2021__positive regulation of trophoblast cell migration (GO:1901165),0.9021347710863508,1.3349425748700248,0.07692307692307693,0.7057460492267962,1.0,2/5,5.04%,ACVR1B;VEGFA
prerank,GO_Biological_Process_2021__negative regulation of execution phase of apoptosis (GO:1900118),-0.8516591455181723,-1.3347843809250883,0.11904761904761904,0.879865774743348,1.0,1/6,1.84%,BCL2L1
prerank,GO_Biological_Process_2021__negative regulation of microtubule depolymerization (GO:0007026),0.7723121116535367,1.334542453813757,0.1,0.7065137414453799,1.0,6/16,13.90%,TTBK2;HDGFL3;MID1IP1;CLASP2;STMN2;APC2
prerank,GO_Biological_Process_2021__regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091),0.7927055925565597,1.3342842832697952,0.08450704225352113,0.7063759545238825,1.0,1/10,0.08%,TOP2A
prerank,GO_Biological_Process_2021__natural killer cell mediated cytotoxicity (GO:0042267),-0.6895451402749057,-1.3338782877255864,0.14705882352941177,0.8796631673879363,1.0,4/10,18.76%,GZMB;PLEKHM2;LYST;CEBPG
prerank,GO_Biological_Process_2021__regulation of interleukin-18 production (GO:0032661),0.8836939285848211,1.333575135051683,0.05970149253731343,0.7096546648002332,1.0,1/5,1.30%,NLRP12
prerank,GO_Biological_Process_2021__muscle filament sliding (GO:0030049),0.7842600405987401,1.3334075450629748,0.10256410256410256,0.7067844551949597,1.0,2/13,4.70%,VIM;DMD
prerank,GO_Biological_Process_2021__actin-myosin filament sliding (GO:0033275),0.7842600405987401,1.3334075450629748,0.10256410256410256,0.7067844551949597,1.0,2/13,4.70%,VIM;DMD
prerank,GO_Biological_Process_2021__regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000341),0.8066292261704947,1.3328976415389098,0.13924050632911392,0.7080485884719823,1.0,1/11,0.30%,KLF4
prerank,PanglaoDB_Augmented_2021__Spermatozoa,0.6379705826234983,1.3328776654248815,0.042105263157894736,0.70633326412754,1.0,13/72,13.19%,KCNE1;CD163;CCPG1;OMG;ANKUB1;CHL1;ABCA1;CPM;FGL2;FAM20A;FMO5;SOD2;CLMN
prerank,GO_Biological_Process_2021__positive regulation of alcohol biosynthetic process (GO:1902932),0.9186229751071485,1.332373345980014,0.04918032786885246,0.7080986568882218,1.0,1/5,0.82%,FGF1
prerank,MSigDB_Hallmark_2020__Epithelial Mesenchymal Transition,0.6152814327342124,1.3320191406965416,0.020833333333333332,0.708869030818728,1.0,34/103,16.47%,TNC;THBS1;RHOB;SPARC;FBN2;ECM2;COL11A1;VIM;CADM1;SPOCK1;GADD45B;ITGA2;IL15;VCAN;CDH2;VEGFA;LAMA2;ENO2;FN1;ID2;TNFRSF11B;CTHRC1;PMP22;CRLF1;SERPINE2;TGFBI;TIMP3;WNT5A;COL5A3;THY1;PLOD1;EDIL3;ITGAV;APLP1
prerank,GO_Biological_Process_2021__glial cell development (GO:0021782),0.7359772123573944,1.3319697749675,0.14285714285714285,0.7072660019837244,1.0,6/16,17.45%,MYRF;SOX4;CSPG5;TPPP;EIF2B2;APP
prerank,GO_Biological_Process_2021__regulation of homotypic cell-cell adhesion (GO:0034110),-0.6584888132321444,-1.331838233524803,0.14814814814814814,0.8846284372536996,1.0,2/10,0.95%,CCL5;ZNF703
prerank,GO_Biological_Process_2021__neural crest cell migration (GO:0001755),0.7478821472317485,1.331808349742381,0.0273972602739726,0.7067524234891078,1.0,6/18,10.26%,HTR2B;SEMA3A;SEMA3B;SEMA6A;FN1;SEMA5A
prerank,GO_Biological_Process_2021__sympathetic nervous system development (GO:0048485),0.8583890253631445,1.3308717652529984,0.07575757575757576,0.7114817030351601,1.0,2/7,5.16%,SEMA3A;SOX4
prerank,GO_Biological_Process_2021__dendrite morphogenesis (GO:0048813),0.6675962085283647,1.3301955845611029,0.10126582278481013,0.7147107082770663,1.0,14/29,23.76%,LRP4;SHANK3;CTNND2;MAP2;PTN;CELSR2;CTNNA2;PHACTR1;KLF7;DLG4;MAPK8IP2;PAK3;TMEM106B;PTEN
prerank,GO_Biological_Process_2021__regulation of wound healing (GO:0061041),0.690061262997449,1.3297145511421025,0.06756756756756757,0.7163514889432798,1.0,3/21,7.71%,PRKCE;ANXA1;KANK1
prerank,GO_Biological_Process_2021__lipid import into cell (GO:0140354),0.8440446035963568,1.3295182172701168,0.06349206349206349,0.7157448775160458,1.0,1/6,2.03%,ACSL1
prerank,GO_Biological_Process_2021__regulation of lysosomal protein catabolic process (GO:1905165),0.8787387641370767,1.3292832753152142,0.14754098360655737,0.7154887825121946,1.0,1/5,0.62%,LRP2
prerank,GO_Biological_Process_2021__central nervous system neuron differentiation (GO:0021953),0.7505490681692373,1.3289145093560986,0.0375,0.7160011477476371,1.0,10/22,12.37%,SPOCK1;MAPT;NR4A2;SOX4;MDGA2;AGTPBP1;FAIM2;MAP2;NTRK2;GRID2
prerank,"GO_Biological_Process_2021__regulation of CD4-positive, alpha-beta T cell activation (GO:2000514)",0.8410212482984504,1.3288027664699877,0.1044776119402985,0.7147584479543275,1.0,1/6,5.63%,CD55
prerank,GO_Biological_Process_2021__mammary gland development (GO:0030879),0.8113081328733396,1.328318662840741,0.13043478260869565,0.7160824377601172,1.0,3/8,5.04%,PRLR;NRG1;VEGFA
prerank,GO_Biological_Process_2021__cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),0.6272114786816785,1.3276828741055375,0.010638297872340425,0.7182098733035176,1.0,23/86,9.89%,CLDN18;LRRC4C;TGFB2;MYOT;CADM1;PTPRD;IL1RAPL1;CDH8;CDH2;IGSF11;CDH9;ROBO2;PTPRT;PALLD;CLDN20;CDH20;NLGN1;ALCAM;MAG;ROBO1;CDH12;UNC5D;CELSR2
prerank,GO_Biological_Process_2021__regulation of oligodendrocyte differentiation (GO:0048713),0.7976366344224672,1.3276799243007285,0.07352941176470588,0.7163588169290239,1.0,5/10,12.72%,OPALIN;DAAM2;PTPRZ1;PTN;TNFRSF1B
prerank,GO_Biological_Process_2021__prostanoid metabolic process (GO:0006692),-0.731641546917325,-1.3267277684668206,0.125,0.9032531830513374,1.0,4/7,10.10%,CYP2S1;HPGDS;ACOX1;PTGS1
prerank,GO_Biological_Process_2021__regulation of endothelial cell proliferation (GO:0001936),0.6606729114434633,1.3266433953883696,0.07865168539325842,0.7213571010655121,1.0,7/46,7.22%,HTR2B;THBS1;SPARC;HMGB2;NR4A1;VEGFA;HIF1A
prerank,PanglaoDB_Augmented_2021__Embryonic Stem Cells,0.6438184138314272,1.3266364966660629,0.0425531914893617,0.7195805633891359,1.0,24/83,13.05%,KLF4;SHROOM3;LRP4;FRAS1;SH3PXD2B;GULP1;ENAH;COL4A5;DOCK1;ADGRA3;PTPRG;KITLG;LIFR;LAMB1;RBFOX2;RND3;MYO10;PTK7;POU5F1;SH3D19;ADGRL2;PARD3;UACA;BNIP3
prerank,GO_Biological_Process_2021__postsynaptic density protein 95 clustering (GO:0097119),0.9143510169526026,1.3261712757266477,0.031746031746031744,0.7208995925929541,1.0,3/5,7.94%,NRXN1;NRXN2;NLGN1
prerank,GO_Biological_Process_2021__intracellular sterol transport (GO:0032366),-0.6762056559220846,-1.3260572944959053,0.18181818181818182,0.9015753271631199,1.0,3/11,2.97%,NPC2;ARV1;NPC1
prerank,GO_Biological_Process_2021__protein kinase B signaling (GO:0043491),-0.6112338305572736,-1.3251518876998323,0.08,0.9020065838382157,1.0,6/17,14.21%,CCL5;IL1B;IGF1;TGFB1;PLK3;AKT1
prerank,GO_Biological_Process_2021__regulation of respiratory burst (GO:0060263),0.8256388803748395,1.3251371530345053,0.13846153846153847,0.726890403624654,1.0,1/6,6.48%,INSR
prerank,GO_Biological_Process_2021__N-terminal protein amino acid acetylation (GO:0006474),0.7861289116952056,1.325118473896747,0.08695652173913043,0.7250891683436391,1.0,1/12,0.75%,AANAT
prerank,GO_Biological_Process_2021__glial cell migration (GO:0008347),0.8866526135386283,1.3249698821892657,0.06451612903225806,0.7245994452493776,1.0,1/5,1.28%,TGFB2
prerank,GO_Biological_Process_2021__nucleotide-sugar biosynthetic process (GO:0009226),0.7535418106191059,1.3249501924949285,0.09210526315789473,0.7230777557631974,1.0,1/16,0.21%,UAP1L1
prerank,GO_Biological_Process_2021__presynaptic membrane organization (GO:0097090),0.7998902377872541,1.324921367957023,0.08695652173913043,0.7213957786389409,1.0,5/10,7.94%,LRP4;PTPRD;IL1RAPL1;NLGN3;NLGN1
prerank,GO_Biological_Process_2021__phosphatidylinositol phosphate biosynthetic process (GO:0046854),0.7147917168023171,1.3248049234066739,0.0989010989010989,0.7204403456633914,1.0,2/28,3.76%,SOCS3;ITPKC
prerank,GO_Biological_Process_2021__peptide cross-linking (GO:0018149),0.8168402616135655,1.3245611803933188,0.0684931506849315,0.7205163625294185,1.0,4/8,8.46%,THBS1;ANXA1;F13A1;FN1
prerank,GO_Biological_Process_2021__positive regulation of cholesterol metabolic process (GO:0090205),0.9177821875696466,1.3245544128523372,0.028985507246376812,0.7187105571095452,1.0,1/5,0.82%,FGF1
prerank,GO_Biological_Process_2021__cellular response to hexose stimulus (GO:0071331),0.7087908978133225,1.3242708405678252,0.10714285714285714,0.7185767128080357,1.0,6/19,18.04%,SOX4;IGF1R;ADCY8;PDK3;SLC39A14;PRKAA2
prerank,GO_Biological_Process_2021__negative regulation of cell cycle G1/S phase transition (GO:1902807),0.7184599860261199,1.3242043885065204,0.08974358974358974,0.7172823864692419,1.0,3/21,6.00%,KLF4;GPNMB;FHL1
prerank,GO_Biological_Process_2021__regulation of neuronal synaptic plasticity (GO:0048168),0.7063246738980121,1.324074011608841,0.08536585365853659,0.7164908972041528,1.0,13/22,22.05%,SLC4A10;NETO1;GRIK2;NSMF;SYP;CAMK2B;MCTP1;SHISA9;APP;NCDN;DLG4;SYNGR1;RAB5A
prerank,GO_Biological_Process_2021__actin filament bundle assembly (GO:0051017),-0.5325255366734483,-1.3238740910901754,0.041666666666666664,0.9033343061911153,1.0,5/19,9.24%,BAIAP2L2;FSCN1;CORO1B;LIMA1;LCP1
prerank,GO_Biological_Process_2021__malate metabolic process (GO:0006108),0.8643690419331204,1.3237126602047833,0.09090909090909091,0.7173067302141258,1.0,1/6,0.72%,MDH1
prerank,GO_Biological_Process_2021__IRE1-mediated unfolded protein response (GO:0036498),0.6384015059173335,1.3227294407243735,0.047058823529411764,0.7227521541777845,1.0,12/42,19.69%,PPP2R5B;HSPA5;VAPB;ARFGAP1;SERP1;DNAJB9;HYOU1;SYVN1;GFPT1;CXXC1;DCTN1;SRPRA
prerank,GO_Biological_Process_2021__axonal transport (GO:0098930),0.6966562441693441,1.3220615044098618,0.10843373493975904,0.7260355644738264,1.0,13/26,19.12%,MAPT;AP3B2;SYBU;KIF1B;HIF1A;TMEM108;DYNC1H1;SPAST;NEFL;KIF3A;DCTN1;SOD1;RAB21
prerank,GO_Biological_Process_2021__DNA packaging (GO:0006323),-0.6735632199216287,-1.3217801573082162,0.1111111111111111,0.9084025284732914,1.0,5/15,14.80%,BANF1;TP53;CDAN1;M1AP;RBBP4
prerank,GO_Biological_Process_2021__DNA alkylation (GO:0006305),-0.6092259088450054,-1.321696539916544,0.20833333333333334,0.8999730173790882,1.0,1/14,1.05%,DNMT3A
prerank,GO_Biological_Process_2021__DNA methylation or demethylation (GO:0044728),-0.6092259088450054,-1.321696539916544,0.20833333333333334,0.8999730173790882,1.0,1/14,1.05%,DNMT3A
prerank,GO_Biological_Process_2021__positive regulation of stem cell differentiation (GO:2000738),0.8638926611962041,1.3213609909611017,0.11940298507462686,0.7294666360089288,1.0,3/7,11.78%,TGFB2;PTN;SOX6
prerank,GO_Biological_Process_2021__membrane raft organization (GO:0031579),0.7783159901257398,1.3210841188699676,0.07792207792207792,0.7295888370644866,1.0,2/13,8.38%,FA2H;CAV3
prerank,GO_Biological_Process_2021__regulation of monocyte chemotactic protein-1 production (GO:0071637),-0.6884337663873648,-1.3209192205904345,0.16666666666666666,0.8996837570547805,1.0,2/8,3.60%,IL1B;LGALS9
prerank,GO_Biological_Process_2021__L-serine biosynthetic process (GO:0006564),-0.7973645298540848,-1.3204522764876154,0.19444444444444445,0.8975285195595082,1.0,2/5,5.35%,PSAT1;PSPH
prerank,GO_Biological_Process_2021__glycerolipid catabolic process (GO:0046503),0.8010012289764175,1.3204213591512215,0.08860759493670886,0.7327614769657893,1.0,1/12,0.34%,GDPD1
prerank,GO_Biological_Process_2021__brain development (GO:0007420),0.6089831803649405,1.3200525249207953,0.061224489795918366,0.7337578946043881,1.0,22/93,15.09%,DDIT4;CENPF;SHANK3;RELN;NFIB;MEIS2;CDH2;AATK;CA10;ROBO2;GRIN2A;ARNT2;POU6F1;MFSD2A;CNTNAP2;EPHA7;SOX6;ADGRL2;SHROOM4;CTNNA2;GRIN2B;NDRG4
prerank,PanglaoDB_Augmented_2021__Pulmonary Alveolar Type I Cells,0.6949348335646719,1.3200115207650878,0.10465116279069768,0.7322463622495364,1.0,12/39,12.31%,CLDN18;SHROOM3;THSD4;NTN4;DOCK1;OSMR;VEGFA;SEMA3B;RND3;PALLD;SH3D19;CRLF1
prerank,GO_Biological_Process_2021__forebrain neuron differentiation (GO:0021879),0.9000633561874466,1.3198660796550332,0.06349206349206349,0.7316669997935348,1.0,1/5,1.63%,SHANK3
prerank,GO_Biological_Process_2021__cardiac muscle hypertrophy (GO:0003300),0.8603996761841272,1.3195665388289255,0.1,0.7318515698738898,1.0,2/6,9.36%,HTR2B;RYR2
prerank,GO_Biological_Process_2021__regulation of immunoglobulin production (GO:0002637),0.7344803421015426,1.3194313162888405,0.14102564102564102,0.7307927925664012,1.0,5/15,14.62%,CR1;CD22;FCGR2B;GPI;DNAJB9
prerank,GO_Biological_Process_2021__axon extension (GO:0048675),0.7208709649743563,1.3194263593489555,0.08974358974358974,0.7290505454082528,1.0,6/21,11.53%,SEMA3A;NLGN3;ALCAM;MAP1B;SEMA5A;SLC9A6
prerank,GO_Biological_Process_2021__response to laminar fluid shear stress (GO:0034616),0.8513054548637324,1.319189002704452,0.08695652173913043,0.7287363406069199,1.0,2/8,9.03%,KLF4;ABCA1
prerank,GO_Biological_Process_2021__somatic recombination of immunoglobulin gene segments (GO:0016447),-0.77972240841946,-1.3180783946246122,0.22727272727272727,0.9034349930889485,1.0,1/7,1.60%,TCF3
prerank,GO_Biological_Process_2021__regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),-0.49501192834903385,-1.3180584348399431,0.0,0.8992677825221356,1.0,18/49,21.93%,CCND1;CSF1R;TP53;CBFB;MED12;MED24;AGO1;MECP2;MED4;MED1;MED27;PAXIP1;MED30;MED10;CDKN1A;ZNF45;MOV10;MED23
prerank,GO_Biological_Process_2021__regulation of interferon-gamma-mediated signaling pathway (GO:0060334),0.7811553475131696,1.3170926869920165,0.07058823529411765,0.7421976580955987,1.0,1/18,0.14%,SOCS3
prerank,GO_Biological_Process_2021__regulation of double-strand break repair (GO:2000779),0.7101090632299298,1.316972497559676,0.056818181818181816,0.7414204662058954,1.0,7/30,13.31%,SLF1;RPA2;FIGNL1;SPIRE2;FMN2;KDM1A;ZCWPW1
prerank,GO_Biological_Process_2021__sequestering of extracellular ligand from receptor (GO:0035581),0.8390118846369105,1.3169181028499932,0.13559322033898305,0.7400104639075249,1.0,2/5,10.41%,FBN2;LTBP1
prerank,GO_Biological_Process_2021__organic acid transport (GO:0015849),0.6424125168290105,1.3163838554832235,0.054945054945054944,0.7420543883555111,1.0,9/54,9.91%,SLC51A;SLC38A4;SLC16A10;ACSL1;SLCO1A2;SLC6A15;SLC13A3;ATP8B1;MFSD2A
prerank,GO_Biological_Process_2021__negative regulation of production of molecular mediator of immune response (GO:0002701),0.8925971256451668,1.316246742281846,0.05555555555555555,0.7410794646171714,1.0,3/5,5.61%,CR1;CD22;FCGR2B
prerank,GO_Biological_Process_2021__dephosphorylation of RNA polymerase II C-terminal domain (GO:0070940),-0.8134835569165522,-1.315510079772231,0.22580645161290322,0.9068454635273417,1.0,4/5,14.22%,CTDP1;RPRD1B;RPAP2;RPRD1A
prerank,GO_Biological_Process_2021__ISG15-protein conjugation (GO:0032020),-0.7957360686009262,-1.3153413052964313,0.15789473684210525,0.9032944344438435,1.0,2/5,14.53%,UBA7;UBE2E2
prerank,GO_Biological_Process_2021__long-chain fatty acid import into cell (GO:0044539),0.796539652303456,1.3145012152896467,0.10606060606060606,0.751485049834456,1.0,1/8,2.03%,ACSL1
prerank,GO_Biological_Process_2021__regulation of long-term neuronal synaptic plasticity (GO:0048169),0.7800487898102766,1.314078934303766,0.1388888888888889,0.752721651276682,1.0,9/10,22.05%,SHANK3;NETO1;SYP;CAMK2B;NEURL1;APP;DLG4;SYNGR1;RAB5A
prerank,GO_Biological_Process_2021__regulation of release of sequestered calcium ion into cytosol (GO:0051279),0.6815557904488534,1.3138226355358777,0.10714285714285714,0.7527842536746592,1.0,6/23,8.65%,JPH1;CEMIP;DMD;ANK2;AKAP6;CALM3
prerank,GO_Biological_Process_2021__positive regulation of amyloid-beta formation (GO:1902004),0.7275916728323326,1.3136582261515428,0.1,0.7519949243973352,1.0,6/14,22.91%,ABCA2;EPHA4;PICALM;CASP3;TNF;ABCG1
prerank,GO_Biological_Process_2021__positive regulation of neurogenesis (GO:0050769),0.6297563301127792,1.312719445829818,0.03571428571428571,0.7565530510535807,1.0,16/52,17.93%,LRP2;SHANK3;METRN;PTPRD;IL1RAPL1;VEGFA;ROBO2;ROBO1;SS18L1;KDM1A;NTRK2;PLXNB1;SMARCD3;NEURL1;ARHGDIA;PLXNC1
prerank,GO_Biological_Process_2021__ncRNA transcription (GO:0098781),-0.677053378387958,-1.3127117296623094,0.11764705882352941,0.9121798030648711,1.0,3/11,10.59%,SPIN1;NIFK;RPAP2
prerank,GO_Biological_Process_2021__positive regulation of Rho protein signal transduction (GO:0035025),0.7629189467644715,1.312537969735132,0.09411764705882353,0.7558478056672134,1.0,3/15,11.42%,GPR18;ROBO1;GPR65
prerank,PanglaoDB_Augmented_2021__Trophoblast Cells,0.7129101910607718,1.3124287069905327,0.075,0.7548565612002007,1.0,7/26,12.23%,KLF4;CD55;BHLHE40;PPP1R13L;FOSL2;MLANA;NFKBIZ
prerank,PanglaoDB_Augmented_2021__Peritubular Myoid Cells,0.6540784649749617,1.3122835198392313,0.07228915662650602,0.7540253629308158,1.0,9/42,12.78%,PLPP3;ASPN;SVEP1;TNS1;LAMA2;KCNMB1;SH3D19;PMP22;UACA
prerank,GO_Biological_Process_2021__neuronal action potential (GO:0019228),0.7932286410061806,1.3119790746155824,0.1323529411764706,0.7543498541471455,1.0,5/9,15.12%,ANK3;SCN3A;SCN1A;SCN8A;SCN2A
prerank,"GO_Biological_Process_2021__regulation of DNA-templated transcription, initiation (GO:2000142)",-0.4381639864924061,-1.3116114663902507,0.07142857142857142,0.9132335164247365,1.0,17/49,21.93%,CCND1;CSF1R;TP53;CBFB;MED12;MED24;AGO1;MECP2;MED4;MED1;MED27;MED30;MED10;CDKN1A;ZNF45;MOV10;MED23
prerank,GO_Biological_Process_2021__regulation of leukocyte cell-cell adhesion (GO:1903037),-0.7259628070683251,-1.31122487841317,0.2777777777777778,0.9106064502398667,1.0,1/6,0.41%,SKAP1
prerank,GO_Biological_Process_2021__sympathetic ganglion development (GO:0061549),0.8746190826075999,1.311186209109696,0.06349206349206349,0.757766663248542,1.0,1/5,1.64%,SEMA3A
prerank,GO_Biological_Process_2021__chromosome condensation (GO:0030261),0.7004078089218784,1.310102525980844,0.07228915662650602,0.7635266987414507,1.0,3/29,6.47%,TOP2A;SMC4;NCAPH2
prerank,GO_Biological_Process_2021__defense response to tumor cell (GO:0002357),0.8517447616893778,1.309646733031109,0.07228915662650602,0.7649267655253437,1.0,3/8,6.52%,KLF4;RBMS3;DAPK1
prerank,GO_Biological_Process_2021__genetic imprinting (GO:0071514),-0.8332140208130288,-1.309214905255275,0.16216216216216217,0.9154710954863478,1.0,4/5,16.71%,DNMT3A;KDM1B;MECP2;CTCF
prerank,PanglaoDB_Augmented_2021__Satellite Cells,0.6463538940635595,1.3091349681894617,0.1,0.7666276046735168,1.0,20/60,14.87%,PLPP3;NTN4;SH3PXD2B;ENAH;DOCK1;GNA11;KITLG;LIFR;DMD;LAMB1;RBFOX2;RND3;BMI1;PALLD;SPRY1;ERRFI1;SH3D19;UACA;LIMCH1;TIMP3
prerank,GO_Biological_Process_2021__chromatin organization involved in regulation of transcription (GO:0034401),-0.6683010643350192,-1.3085694056535329,0.23333333333333334,0.9141757706955164,1.0,2/8,10.48%,SMARCD1;ZMIZ1
prerank,GO_Biological_Process_2021__postsynapse assembly (GO:0099068),0.7968670234992827,1.308454517705153,0.09333333333333334,0.7698313670685022,1.0,5/9,7.94%,LRP4;NRXN1;NRXN2;NLGN3;NLGN1
prerank,GO_Biological_Process_2021__negative regulation of peptidyl-serine phosphorylation (GO:0033137),0.6740539721979216,1.3083120550483731,0.136986301369863,0.7685640691882011,1.0,3/15,7.82%,DDIT4;DMD;PAQR3
prerank,GO_Biological_Process_2021__organonitrogen compound biosynthetic process (GO:1901566),0.6260912246659096,1.3082939198852506,0.010416666666666666,0.76693207548492,1.0,14/101,13.49%,PCSK1;FA2H;PLPP3;ALDH3B1;NMRAL1;DMD;VAPB;MFSD2A;ELOVL4;B4GALT5;ARG2;SLC44A5;PPM1L;SPTLC2
prerank,GO_Biological_Process_2021__regulation of epithelial cell migration (GO:0010632),0.6609727384022995,1.3082148445133188,0.07142857142857142,0.7657859360320993,1.0,12/39,11.93%,TGFB2;ENPP2;PRKCE;DOCK1;GLIPR2;PTPRG;DOCK5;HIF1A;PTN;GLUL;CLASP2;SASH1
prerank,PanglaoDB_Augmented_2021__Trichocytes,0.8636963403299062,1.3081882278748536,0.11666666666666667,0.7641894322595387,1.0,4/5,13.64%,ADGRG6;BAIAP2L1;PPP1R13L;TRIM16
prerank,GO_Biological_Process_2021__dendritic cell migration (GO:0036336),-0.701695883491826,-1.3076486648279322,0.2,0.913889352902929,1.0,2/10,8.65%,CCL5;ALOX5
prerank,GO_Biological_Process_2021__nuclear body organization (GO:0030575),-0.7255559141294563,-1.3073590289096204,0.20689655172413793,0.9111497155650924,1.0,4/8,15.48%,ZPR1;ETS1;SERBP1;HABP4
prerank,GO_Biological_Process_2021__regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882),0.7299367459845324,1.307295472713665,0.15384615384615385,0.7681631507294164,1.0,8/15,21.02%,DMD;ANK2;CALM3;RYR2;ATP2A2;CLIC2;ATP1A2;SLC9A1
prerank,GO_Biological_Process_2021__positive regulation of blood vessel endothelial cell migration (GO:0043536),0.6475984254734527,1.307257416312702,0.11904761904761904,0.7665685010315101,1.0,4/36,7.22%,THBS1;ANXA1;VEGFA;HIF1A
prerank,GO_Biological_Process_2021__regulation of microglial cell migration (GO:1904139),-0.7599046354143317,-1.3068994080131737,0.2,0.909578925432957,1.0,3/6,10.32%,CX3CR1;P2RY12;TREM2
prerank,GO_Biological_Process_2021__protein maturation (GO:0051604),0.6455936193835468,1.306539947465723,0.08045977011494253,0.7698292818218282,1.0,5/63,10.66%,PCSK1;AANAT;SRGN;CPM;TYSND1
prerank,GO_Biological_Process_2021__pulmonary valve development (GO:0003177),0.7616110030268866,1.3062390467467595,0.11267605633802817,0.7703664592924836,1.0,6/12,20.17%,TGFB2;ROBO2;ROBO1;TNFRSF1B;TNFRSF1A;NOTCH2
prerank,GO_Biological_Process_2021__response to steroid hormone (GO:0048545),0.7145730953047504,1.3061175458656005,0.1411764705882353,0.7694854938397185,1.0,3/17,7.02%,THBS1;TGFB2;ABCA2
prerank,GO_Biological_Process_2021__cellular lipid catabolic process (GO:0044242),0.7543525464327265,1.306100092922502,0.12048192771084337,0.7679236340624748,1.0,2/18,2.08%,FAAH;ENPP2
prerank,GO_Biological_Process_2021__cell junction disassembly (GO:0150146),-0.7349194982872198,-1.3059749502098112,0.14285714285714285,0.9099899796933609,1.0,1/5,1.00%,CX3CR1
prerank,GO_Biological_Process_2021__negative regulation of cell volume (GO:0045794),0.8331335966908363,1.3059694688348737,0.19696969696969696,0.7670094097736415,1.0,1/5,1.63%,SHANK3
prerank,GO_Biological_Process_2021__aromatic amino acid family catabolic process (GO:0009074),0.7787352616760728,1.3057904899882407,0.1791044776119403,0.7666958527116692,1.0,2/6,3.98%,KMO;FAH
prerank,PanglaoDB_Augmented_2021__Mesangial Cells,0.626038094559676,1.3055777907991353,0.06976744186046512,0.7660435654676765,1.0,15/71,8.95%,PLPP3;SPARC;FGF1;SVEP1;TNS1;NR4A2;FBXL7;FILIP1L;ARID5B;LAMA2;NOCT;PALLD;AKAP12;FN1;PTN
prerank,GO_Biological_Process_2021__regulation of dendritic cell antigen processing and presentation (GO:0002604),0.8915896934739476,1.305106865842522,0.07462686567164178,0.7677910183620544,1.0,4/5,10.87%,THBS1;SLC11A1;FCGR2B;NOD2
prerank,GO_Biological_Process_2021__dendritic cell differentiation (GO:0097028),-0.6836229314353055,-1.303589265957974,0.19230769230769232,0.9181309793525497,1.0,3/12,18.44%,LGALS9;TREM2;BATF3
prerank,GO_Biological_Process_2021__glycolytic process (GO:0006096),0.7599108625325849,1.3033989583278094,0.11267605633802817,0.7785252295163663,1.0,9/16,20.23%,PFKM;ENO2;PGAM1;GPI;PKM;ENO4;PGK1;PGM1;ENO1
prerank,GO_Biological_Process_2021__monocarboxylic acid biosynthetic process (GO:0072330),-0.48087974532100575,-1.3031736459942886,0.07142857142857142,0.9162422135193707,1.0,9/36,13.97%,ACSM5;ALOX5;CH25H;LPL;MLYCD;LIPG;NDUFAB1;OSBPL6;ABCD3
prerank,GO_Biological_Process_2021__oligodendrocyte differentiation (GO:0048709),0.8018268160246382,1.303119758419489,0.12121212121212122,0.7790546494350954,1.0,5/10,14.41%,MYRF;PTPRZ1;SOX6;TPPP;EIF2B2
prerank,GO_Biological_Process_2021__negative regulation of alpha-beta T cell proliferation (GO:0046642),-0.7975447051166149,-1.3030684099948115,0.2413793103448276,0.9125302371036973,1.0,2/6,5.98%,LGALS9;CD274
prerank,GO_Biological_Process_2021__endothelial tube morphogenesis (GO:0061154),0.7991343344369206,1.3029646010530231,0.0958904109589041,0.778422883899392,1.0,2/7,9.26%,RHOB;RBPJ
prerank,GO_Biological_Process_2021__negative regulation of monooxygenase activity (GO:0032769),0.8349946178963659,1.30279855614067,0.140625,0.777878006433253,1.0,2/6,8.38%,GLA;CAV3
prerank,GO_Biological_Process_2021__regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314),0.7675471172613917,1.3025485873120122,0.11688311688311688,0.7780906977138647,1.0,4/13,8.65%,JPH1;DMD;AKAP6;CALM3
prerank,GO_Biological_Process_2021__positive regulation of cell junction assembly (GO:1901890),0.6561291355559861,1.302519366738906,0.14285714285714285,0.7767535914274307,1.0,12/37,17.16%,PTPRD;AGT;IL1RAPL1;NRXN1;VEGFA;NLGN3;NLGN1;NPHP1;CNTNAP2;GRID2;THY1;ROCK1
prerank,GO_Biological_Process_2021__sulfur compound biosynthetic process (GO:0044272),0.6295842852908015,1.3024831413772193,0.07608695652173914,0.775380593436353,1.0,10/60,11.28%,OMD;OGN;CHST7;NCAN;VCAN;B4GAT1;PAPSS2;MAT2A;CSPG5;B4GALT5
prerank,GO_Biological_Process_2021__pyrimidine nucleobase catabolic process (GO:0006208),0.8628787465028942,1.3024284938534585,0.10606060606060606,0.7739927786182779,1.0,4/6,11.64%,DPYD;DPYSL5;CRMP1;ALDH6A1
prerank,GO_Biological_Process_2021__methylguanosine-cap decapping (GO:0110156),-0.6454126216452684,-1.3023053600088519,0.16129032258064516,0.9115982967995697,1.0,2/9,11.60%,DCP1B;EDC3
prerank,GO_Biological_Process_2021__negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),0.6856811599670464,1.3023052208309984,0.12195121951219512,0.773068486666025,1.0,3/23,6.00%,KLF4;GPNMB;FHL1
prerank,GO_Biological_Process_2021__actin filament organization (GO:0007015),0.6100562624492532,1.3022226025776618,0.06315789473684211,0.77179551918828,1.0,16/98,9.76%,RHOBTB3;RHOB;SHROOM3;COBL;GAS2L3;CORO6;PPP1R9A;ENAH;CGNL1;MARCKSL1;BAIAP2L1;SPIRE2;RND3;ERMN;SVIL;CARMIL1
prerank,PanglaoDB_Augmented_2021__Podocytes,0.6151086764478135,1.3020823847172922,0.07526881720430108,0.7709214468036095,1.0,34/105,18.07%,PLPP3;SH2D4A;THSD4;NTN4;MAPT;ENAH;COL4A5;DOCK1;NFIB;PTPRG;KITLG;DOCK5;LIFR;VEGFA;LAMB1;RBFOX2;EMC7;RND3;PALLD;KANK1;MAFB;THSD7A;SH3D19;MAGI2;ADGRL2;UACA;LIMCH1;CPE;NEBL;HSPA12A;MPDZ;APBB2;EPB41L5;STARD13
prerank,GO_Biological_Process_2021__regulation of potassium ion transmembrane transport (GO:1901379),0.6579527630994699,1.3019651425776528,0.08888888888888889,0.769823941777085,1.0,5/37,10.16%,KCNE1;FHL1;AKAP6;CAV3;KCNMB1
prerank,PanglaoDB_Augmented_2021__Stromal Cells,0.6366463209437673,1.3015111953680019,0.10843373493975904,0.7707100203578818,1.0,6/44,5.30%,TNC;SPARC;SVEP1;ADAMTS2;TNS1;LAMA2
prerank,GO_Biological_Process_2021__response to magnesium ion (GO:0032026),0.8606485107709473,1.3014415149908718,0.05,0.7694120429191698,1.0,4/7,12.53%,THBS1;ANK3;RYR3;FBP1
prerank,PanglaoDB_Augmented_2021__Pulmonary Vascular Smooth Muscle Cells,0.6584677015935881,1.3012656130407736,0.1282051282051282,0.7688585251828837,1.0,7/35,8.95%,SPARC;SVEP1;ADAMTS2;TNS1;DAAM2;LAMA2;PTN
prerank,PanglaoDB_Augmented_2021__Parietal Cells,0.639980168598033,1.3011562161743846,0.04395604395604396,0.7679592424916248,1.0,25/70,17.60%,RAP1GAP;COBL;FAAH;PPP1R9A;MAPK4;PHYHIPL;SYBU;ARFGEF3;MYRIP;SHANK2;ANK3;SRCIN1;BMI1;PTPRT;NDRG2;SHC2;KALRN;SORBS1;TPPP;PLXNB1;NEBL;EPB41L4B;MTUS1;HAMP;SORBS2
prerank,GO_Biological_Process_2021__skeletal system development (GO:0001501),0.6601869014630204,1.301116381159552,0.06521739130434782,0.7664712005781879,1.0,21/72,15.06%,HHIP;TGFB2;SH3PXD2B;ZBTB16;NCAN;VCAN;CHI3L1;BMPR1B;SOX4;EIF2AK3;PAPSS2;TRPS1;TNFRSF11B;ITGB8;DEAF1;SOX6;ETS2;SULF2;COL10A1;PKD1;WNT5A
prerank,GO_Biological_Process_2021__positive regulation of dendrite development (GO:1900006),0.8005672303686209,1.3008692935546404,0.18571428571428572,0.766233430549936,1.0,4/8,10.17%,COBL;ZDHHC15;PTN;ALK
prerank,GO_Biological_Process_2021__body fluid secretion (GO:0007589),0.8572656695748256,1.3008139898983404,0.1724137931034483,0.7631822773425053,1.0,2/5,5.04%,PRLR;VEGFA
prerank,GO_Biological_Process_2021__lactation (GO:0007595),0.8572656695748256,1.3008139898983404,0.1724137931034483,0.7631822773425053,1.0,2/5,5.04%,PRLR;VEGFA
prerank,GO_Biological_Process_2021__positive regulation of cellular component organization (GO:0051130),0.6223456960407832,1.3006282004358618,0.08045977011494253,0.7628922574763891,1.0,19/78,13.89%,LRP4;TGFB2;SHANK3;CLIP3;RELN;TFRC;NRG1;NRXN1;SLF1;VEGFA;FRMPD4;INSR;RAPGEF3;IGF1R;CAMK2B;BNIP3;TPPP;PPP1R15A;CALY
prerank,GO_Biological_Process_2021__atrial cardiac muscle cell action potential (GO:0086014),0.7877876192161534,1.3003949525589038,0.14705882352941177,0.7628460879695228,1.0,3/9,6.41%,CACNB2;SCN3B;ANK2
prerank,GO_Biological_Process_2021__positive regulation of T cell receptor signaling pathway (GO:0050862),-0.6441046791871454,-1.299100547535367,0.16,0.9231876218562205,1.0,8/11,25.20%,CD226;BCL10;CARD11;RAB29;CD81;PRKD2;RELA;IKBKG
prerank,GO_Biological_Process_2021__neurotransmitter transport (GO:0006836),0.6154777297923504,1.29873304215142,0.1111111111111111,0.7720806575746854,1.0,23/47,25.50%,SLC6A15;NRXN1;SLC1A2;NRXN2;GAD1;SNAP25;UNC13A;GABRA2;GLUL;PPFIA2;GAD2;SYT1;SLC17A7;CPLX1;STXBP2;PPFIA4;ATP1A2;TSPOAP1;SYN2;BRSK1;PPFIA3;RIMS1;PTPRN2
prerank,GO_Biological_Process_2021__negative regulation of reproductive process (GO:2000242),-0.7441509986688255,-1.2986885774745973,0.21052631578947367,0.9213096716976261,1.0,2/6,7.34%,ARHGDIB;IGF1
prerank,GO_Biological_Process_2021__potassium ion import across plasma membrane (GO:1990573),0.702124918489071,1.2986224004501845,0.11267605633802817,0.7711092610121689,1.0,7/18,20.66%,KCNJ13;SLC12A8;ATP1B3;KCNJ6;KCNJ3;ATP1B2;ATP1A2
prerank,GO_Biological_Process_2021__negative regulation of sprouting angiogenesis (GO:1903671),0.8530918833601892,1.2982337070799899,0.0547945205479452,0.7724322075146,1.0,2/7,6.68%,THBS1;SEMA6A
prerank,GO_Biological_Process_2021__positive regulation of axonogenesis (GO:0050772),0.6476952265696434,1.2979938386318373,0.10126582278481013,0.7727872966130944,1.0,10/31,19.47%,METRN;MAPT;ROBO2;ROBO1;NTRK2;PLXNB1;ARHGDIA;MAP3K13;PLXNC1;CHODL
prerank,PanglaoDB_Augmented_2021__Osteoclast Precursor Cells,-0.4531304441777273,-1.2976176258867749,0.0,0.9234658182786661,1.0,25/93,11.22%,CYSLTR1;ITGAM;LY86;TRIM38;PTAFR;IL1B;MPEG1;LGALS9;CSF1R;LILRB4;TMEM106A;ITGAX;MILR1;HLA-E;CSF2RA;WDFY4;APOL6;IGSF6;PLEK;HCK;TREM2;NLRP3;ITGB2;CYTH4;TLR7
prerank,GO_Biological_Process_2021__nucleobase catabolic process (GO:0046113),0.8741827125713295,1.2971937191664076,0.109375,0.7773019718023978,1.0,3/5,10.22%,DPYD;DPYSL5;CRMP1
prerank,GO_Biological_Process_2021__regulation of microtubule polymerization (GO:0031113),0.6907512336302799,1.2970858317565621,0.05813953488372093,0.7761880268961246,1.0,11/34,19.33%,CLIP3;MAPT;TUBB4A;CAV3;MAP2;STMN2;TOGARAM1;EML2;DCTN1;FES;CDK5R1
prerank,GO_Biological_Process_2021__unsaturated fatty acid biosynthetic process (GO:0006636),0.8231582219226021,1.2968673416304524,0.20634920634920634,0.7762142677930174,1.0,4/7,13.55%,ALOX12;ALOX15B;SCD5;SCD
prerank,GO_Biological_Process_2021__membrane depolarization during cardiac muscle cell action potential (GO:0086012),0.792026430000778,1.2966467396943375,0.11392405063291139,0.7758428060462853,1.0,3/11,6.41%,CACNB2;SCN3B;ANK2
prerank,GO_Biological_Process_2021__regulation of viral life cycle (GO:1903900),0.733068627797797,1.2963721623062239,0.1506849315068493,0.7761275539103268,1.0,4/16,11.25%,HS3ST5;TRIM5;TRIM25;TYRO3
prerank,GO_Biological_Process_2021__regulation of telomere capping (GO:1904353),-0.6572118048721891,-1.2961387922898504,0.18181818181818182,0.9258534986184734,1.0,5/17,15.06%,PKIB;MAP3K4;NBN;TERF2;SMG6
prerank,GO_Biological_Process_2021__regulation of dendrite development (GO:0050773),0.6630285991066528,1.296018643626279,0.10843373493975904,0.7770644100750744,1.0,8/31,10.17%,COBL;DCC;ZDHHC15;CSMD3;NSMF;PTN;MFSD2A;ALK
prerank,GO_Biological_Process_2021__regulation of DNA biosynthetic process (GO:2000278),0.7126269807776976,1.2959373559878296,0.13513513513513514,0.7761600950590052,1.0,1/18,1.31%,TOM1L1
prerank,GO_Biological_Process_2021__negative regulation of interleukin-8 production (GO:0032717),0.7772242004552075,1.2958499013375284,0.14473684210526316,0.7750821003918896,1.0,2/11,3.87%,KLF4;ANXA1
prerank,GO_Biological_Process_2021__chondroitin sulfate proteoglycan biosynthetic process (GO:0050650),0.7184646593407413,1.2956881188539244,0.09090909090909091,0.7744413941499892,1.0,4/19,9.58%,CHST7;NCAN;VCAN;CSPG5
prerank,GO_Biological_Process_2021__phosphatidylinositol 3-kinase signaling (GO:0014065),0.6963622929239184,1.2954430524233191,0.12790697674418605,0.7745297638769371,1.0,4/21,11.25%,HTR2B;NYAP2;IGF1R;TYRO3
prerank,GO_Biological_Process_2021__negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),0.6853017231220624,1.294789857271416,0.14864864864864866,0.7775174917199695,1.0,2/23,0.62%,SOCS3;SH3BP5
prerank,GO_Biological_Process_2021__negative regulation of telomerase activity (GO:0051974),-0.7694586033573242,-1.2944839505730654,0.15625,0.9288183063976487,1.0,3/5,18.72%,TP53;SRC;ERCC4
prerank,GO_Biological_Process_2021__RNA methylation (GO:0001510),-0.47589252010741767,-1.2940306542142037,0.15384615384615385,0.9268491956114415,1.0,4/47,5.91%,BUD23;ALKBH8;FBL;METTL8
prerank,PanglaoDB_Augmented_2021__His Bundle Cells,0.6254854168529542,1.2939464435057781,0.07368421052631578,0.7813532302304985,1.0,25/64,18.04%,DENND2A;RBMS3;PDE10A;ENAH;DZIP1;FBXL7;PTPRG;LIFR;LAMB1;RUNX1T1;ANK2;AKAP12;PPFIBP1;MAP1B;FIGN;TYRO3;ADGRL2;NFASC;LIMCH1;ITSN1;THY1;MPDZ;APBB2;FLRT2;PRKAA2
prerank,GO_Biological_Process_2021__regulation of smooth muscle cell migration (GO:0014910),-0.6439658071302949,-1.2935774424843078,0.14285714285714285,0.9251436351664518,1.0,3/13,7.34%,CCL5;TRIB1;IGF1
prerank,GO_Biological_Process_2021__cytoplasmic translation (GO:0002181),0.6224307485188602,1.2929244420624493,0.07692307692307693,0.7860902922941013,1.0,45/84,31.36%,RPL23;RPL37A;FTSJ1;RPL38;RPS6;RPS27A;RPL23A;RPS25;RPS27;RPS11;RPS20;RPL9;DRG2;RPS18;RPL37;RPL14;RPS4X;RPL11;RPS24;RPS9;RPL36;UBA52;RPS3A;RPL35;RPL4;RPL32;RPL24;RPL27A;RPL3;RPS16;EIF4A2;RPL30;RPL21;RPL7;RPL12;RPL10A;RPS12;DRG1;RPL6;RPLP0;RPL8;RWDD1;RPL18A;RPL15;RPS23
prerank,GO_Biological_Process_2021__growth hormone receptor signaling pathway via JAK-STAT (GO:0060397),0.7784273280222993,1.2928920683554075,0.1111111111111111,0.7847325910767122,1.0,2/10,9.54%,PRLR;GHR
prerank,GO_Biological_Process_2021__positive regulation of morphogenesis of an epithelium (GO:1905332),0.7891537778402836,1.2927647986811321,0.12307692307692308,0.783905119037123,1.0,3/9,7.86%,AGT;VEGFA;PAX8
prerank,GO_Biological_Process_2021__regulation of cell communication by electrical coupling (GO:0010649),0.8020626959932267,1.2927159560328105,0.17142857142857143,0.7826737757590183,1.0,2/7,8.65%,ANK3;CALM3
prerank,GO_Biological_Process_2021__regulation of activin receptor signaling pathway (GO:0032925),0.7946696095663197,1.2924355730168144,0.14285714285714285,0.7829957119391445,1.0,3/8,11.99%,ACVR1B;ACVR2A;MAGI2
prerank,GO_Biological_Process_2021__regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),0.6391660171318985,1.2921856766518385,0.08602150537634409,0.7833163394356116,1.0,10/58,14.63%,THBS1;KLF4;NLRP12;BEX3;VEGFA;DAPK1;EPHA7;CYCS;UACA;PYCARD
prerank,GO_Biological_Process_2021__positive regulation of amyloid precursor protein catabolic process (GO:1902993),0.6910664033643548,1.2920567965451515,0.11688311688311688,0.7824406295309525,1.0,6/17,22.91%,ABCA2;EPHA4;PICALM;CASP3;TNF;ABCG1
prerank,GO_Biological_Process_2021__neuron projection extension (GO:1990138),0.715045583411702,1.2916711360823472,0.11688311688311688,0.7837228709587196,1.0,10/27,12.42%,FLRT1;SEMA3A;NLGN3;ALCAM;MAP1B;SEMA5A;IMPACT;SLC9A6;TMEM108;SH3GL2
prerank,GO_Biological_Process_2021__rRNA transcription (GO:0009303),-0.6263706790801167,-1.29156095174689,0.13043478260869565,0.9284672230909531,1.0,3/15,11.96%,SPIN1;NIFK;GTF3C2
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",0.6010962063752405,1.291216903888867,0.06315789473684211,0.7852494914074012,1.0,37/102,25.39%,RPL23;EIF4A3;RPL37A;RPL38;RPS6;RPS27A;RPL23A;RPS25;RPS27;RPS11;RPS20;EIF3E;RPL9;UPF3A;RPLP2;RPS18;RPL37;RPL14;RPS4X;RPL11;RPS24;RPS9;RPL36;PYM1;UBA52;RPS3A;RPL35;RPL4;RPL32;RPL24;RPL27A;RPL3;RPS16;RPL30;RPL21;RPL7;RPL12
prerank,GO_Biological_Process_2021__regulation of mitochondrial fusion (GO:0010635),0.8202880548337089,1.2911470084886778,0.13333333333333333,0.7841069657979863,1.0,2/7,13.05%,TFRC;BNIP3
prerank,GO_Biological_Process_2021__T-tubule organization (GO:0033292),0.7938262263929561,1.2910398259226126,0.19402985074626866,0.7832175934067345,1.0,2/5,8.38%,ANK2;CAV3
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte chemotaxis (GO:0140131),-0.6621297144076118,-1.2910115773672062,0.2222222222222222,0.9272587736178971,1.0,1/10,0.45%,CCL5
prerank,GO_Biological_Process_2021__peptide biosynthetic process (GO:0043043),0.6040040840141004,1.2906043981819144,0.021739130434782608,0.7844688942749035,1.0,41/128,22.94%,PCSK1;EEF1A2;RPL23;CARNS1;DMD;RPL37A;RPS6KB2;RPL38;COPS5;RPS6;RPS27A;RPL23A;RPS25;DARS1;RPS27;RPS11;RPS20;RPL9;RPLP2;RPS18;MRPL43;RPL37;RPL14;MRPL55;MRPL27;RPS4X;RPL11;RPS24;RPS9;RPL36;MRPL3;RPS3A;MRPS14;RPL35;RPL4;RPL32;TNIP1;EEF1A1;RPL24;RPL27A;RPL3
prerank,GO_Biological_Process_2021__positive regulation of adaptive immune response (GO:0002821),-0.6805268363741043,-1.290574989193165,0.25,0.9251828853444585,1.0,1/7,0.41%,SKAP1
prerank,GO_Biological_Process_2021__atrial septum morphogenesis (GO:0060413),0.8318452892672905,1.2905470821530125,0.15384615384615385,0.7832015007101982,1.0,2/6,5.16%,TGFB2;SOX4
prerank,PanglaoDB_Augmented_2021__Crypt Cells,0.6268213976779754,1.2903889027185222,0.07777777777777778,0.7828324088144881,1.0,12/46,11.69%,SPON1;COBL;PPP1R9A;ASXL3;LRRN1;ANK3;SEMA6A;BMI1;PTPRT;NDRG2;SHC2;KALRN
prerank,"GO_Biological_Process_2021__regulation of phagocytosis, engulfment (GO:0060099)",-0.6522105379994964,-1.2902527325956148,0.13333333333333333,0.9225416995504163,1.0,4/7,10.32%,APPL2;C3;NCKAP1L;TREM2
prerank,GO_Biological_Process_2021__regulation of epithelial to mesenchymal transition (GO:0010717),-0.4720517341384863,-1.2896519715752974,0.21428571428571427,0.9220014076924739,1.0,7/45,4.79%,PHLDB2;IL17RD;ZNF703;IL1B;BCL9L;DAB2IP;WWTR1
prerank,GO_Biological_Process_2021__cellular biogenic amine biosynthetic process (GO:0042401),0.8537615454398526,1.2895441026177177,0.10294117647058823,0.7869410033254148,1.0,1/5,0.75%,AANAT
prerank,PanglaoDB_Augmented_2021__Peri-islet Schwann Cells,0.6440947709666918,1.2895438127564034,0.07368421052631578,0.7853733917650056,1.0,29/65,17.30%,FAM13C;LRP4;DENND2A;GULP1;ENAH;DZIP1;FBXL7;PTPRG;LIFR;SEMA3B;RUNX1T1;ANK2;RBFOX2;CSRNP3;ARNT2;TUSC3;PTN;MAP1B;GPRC5B;FIGN;PLP1;ADGRL2;NFASC;ITSN1;CPE;THY1;EDIL3;HSPA12A;MPDZ
prerank,GO_Biological_Process_2021__positive regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901838),-0.6678802397406258,-1.2893663141155756,0.15384615384615385,0.9197322358313942,1.0,3/10,20.16%,IPPK;PIH1D1;NOL11
prerank,GO_Biological_Process_2021__regulation of viral genome replication (GO:0045069),-0.4625508714344244,-1.2892368035446948,0.18181818181818182,0.9166186342233377,1.0,6/50,6.48%,RNASEL;CCL5;PDE12;ADARB1;APOBEC3G;BANF1
prerank,GO_Biological_Process_2021__protein peptidyl-prolyl isomerization (GO:0000413),0.7122820312996438,1.2892026293935972,0.18181818181818182,0.7861923534229486,1.0,2/16,11.73%,FKBP5;PPID
prerank,GO_Biological_Process_2021__development of primary male sexual characteristics (GO:0046546),0.766786492289752,1.288322320287987,0.15714285714285714,0.7910994060925022,1.0,3/10,4.14%,LRP2;TGFB2;KITLG
prerank,GO_Biological_Process_2021__cell-cell adhesion mediated by cadherin (GO:0044331),0.84661900502645,1.2881176866125554,0.13333333333333333,0.7908876800897282,1.0,1/5,4.08%,CDH2
prerank,GO_Biological_Process_2021__glycosphingolipid catabolic process (GO:0046479),0.7930727866101807,1.2879220345710831,0.12307692307692308,0.7906392317822498,1.0,1/7,2.27%,GLA
prerank,GO_Biological_Process_2021__negative regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002924),0.8687798876926962,1.2875721776897526,0.15,0.7915912862727263,1.0,4/5,13.15%,CR1;FCGR2B;CD55;SUSD4
prerank,PanglaoDB_Augmented_2021__Oxyphil Cells,0.6696353682640581,1.2874550498068702,0.11235955056179775,0.7907625559742065,1.0,14/38,14.56%,SYCP2L;PREX2;CKMT2;CACNB2;MAPT;LDB3;ZNF483;CADM2;RYR2;HIF3A;SORBS1;L2HGDH;LRP1B;TMEM266
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell membrane repolarization (GO:0099623),0.7916165382258356,1.2874123792687275,0.08860759493670886,0.7894703595328055,1.0,3/12,8.38%,KCNE1;ANK2;CAV3
prerank,GO_Biological_Process_2021__neurotrophin TRK receptor signaling pathway (GO:0048011),0.7991587456268429,1.28678536806291,0.136986301369863,0.7918910567039098,1.0,3/8,15.15%,DDIT4;NTRK2;CASP3
prerank,GO_Biological_Process_2021__positive regulation of immune system process (GO:0002684),0.7760985224987467,1.286181383620037,0.0759493670886076,0.7944882378213686,1.0,4/12,5.04%,TGFB2;IL15;ANXA1;VEGFA
prerank,GO_Biological_Process_2021__dendritic cell chemotaxis (GO:0002407),-0.7853821794569258,-1.286039192609908,0.11764705882352941,0.927140392302346,1.0,1/8,0.45%,CCL5
prerank,GO_Biological_Process_2021__positive regulation of cellular amide metabolic process (GO:0034250),0.6199709960802001,1.2855025665958382,0.052083333333333336,0.7977619755681318,1.0,19/66,20.20%,THBS1;PRR16;VIM;EIF4A3;SOX4;RBM3;ABCA2;EIF3E;UPF3A;EPHA4;PICALM;CASP3;RPS4X;TNFRSF1A;PYM1;SIRT3;PLD1;SAMD4A;TNF
prerank,GO_Biological_Process_2021__regulation of attachment of spindle microtubules to kinetochore (GO:0051988),0.8638985850290424,1.2852860195313769,0.11290322580645161,0.7977443205177337,1.0,2/7,3.33%,KNSTRN;RACGAP1
prerank,GO_Biological_Process_2021__negative regulation of exocytosis (GO:0045920),0.7390922038768855,1.2850761874194445,0.19718309859154928,0.7978746325156709,1.0,2/9,3.87%,IL1RAPL1;ANXA1
prerank,GO_Biological_Process_2021__cardiocyte differentiation (GO:0035051),0.896416782529529,1.2849039481434599,0.0684931506849315,0.7974508965586876,1.0,2/5,3.66%,TGFB2;NRG1
prerank,GO_Biological_Process_2021__regulation of reactive oxygen species metabolic process (GO:2000377),0.6515478776542527,1.2847383385308484,0.08641975308641975,0.7971761280913505,1.0,7/35,15.59%,THBS1;CBR1;AGT;SIRT5;BRCA1;PINK1;PDK3
prerank,GO_Biological_Process_2021__negative regulation of transcription by competitive promoter binding (GO:0010944),-0.771647095502395,-1.2846290884501756,0.20930232558139536,0.9293010089618134,1.0,2/6,10.19%,HHEX;BHLHE41
prerank,GO_Biological_Process_2021__negative regulation of response to stimulus (GO:0048585),0.6478276358094286,1.2841513431489688,0.05813953488372093,0.7998799854073612,1.0,4/38,5.61%,KLF4;HHIP;NLRP12;FCGR2B
prerank,GO_Biological_Process_2021__positive regulation of BMP signaling pathway (GO:0030513),0.7311237762799823,1.284142341839625,0.09210526315789473,0.7984091936910762,1.0,3/14,9.26%,ACVR2A;BMPR1B;RBPJ
prerank,GO_Biological_Process_2021__phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200),0.6617202867501789,1.284037485316845,0.10588235294117647,0.7975116546247213,1.0,6/34,6.22%,GPR18;HTR2B;TACR1;AGT;GNA11;LTB4R
prerank,GO_Biological_Process_2021__regulation of axon extension (GO:0030516),0.6339569230451155,1.2839187758402335,0.11764705882352941,0.7967272115058478,1.0,10/28,24.85%,SEMA3A;MAPT;MAG;MAP2;MAP3K13;OLFM1;PTPRS;CTTN;RTN4;RUFY3
prerank,GO_Biological_Process_2021__positive regulation of calcium-mediated signaling (GO:0050850),-0.6742217199410078,-1.2836096961666157,0.21875,0.9304020169516857,1.0,4/7,28.13%,TREM2;PLCG2;CDH13;P2RX4
prerank,GO_Biological_Process_2021__regulation of toll-like receptor 9 signaling pathway (GO:0034163),0.7838962026616684,1.2833796156049,0.10144927536231885,0.7982074038068632,1.0,1/8,0.81%,RAB7B
prerank,GO_Biological_Process_2021__positive regulation of dendritic spine development (GO:0060999),0.6961874434015892,1.2831071710392108,0.0821917808219178,0.7985714830824547,1.0,4/18,11.27%,SHANK3;RELN;NLGN1;CAMK2B
prerank,GO_Biological_Process_2021__neuron projection arborization (GO:0140058),0.8287740628166159,1.2828041368837277,0.16393442622950818,0.7995519214223077,1.0,5/5,17.16%,LRP2;NLGN1;PTN;PHACTR1;ROCK1
prerank,GO_Biological_Process_2021__regulation of trophoblast cell migration (GO:1901163),0.8041054137185304,1.2822961406321514,0.11764705882352941,0.8010907866041481,1.0,2/9,5.04%,ACVR1B;VEGFA
prerank,GO_Biological_Process_2021__regulation of fibroblast migration (GO:0010762),0.7325847032159827,1.2819468855529503,0.11764705882352941,0.8015558929158036,1.0,2/18,2.53%,THBS1;PRKCE
prerank,GO_Biological_Process_2021__positive regulation of tau-protein kinase activity (GO:1902949),0.8411685884016528,1.2816058547091502,0.09230769230769231,0.8023444103131048,1.0,1/5,2.02%,EGR1
prerank,GO_Biological_Process_2021__positive regulation of myeloid cell differentiation (GO:0045639),0.689609622113587,1.2814133720091758,0.12345679012345678,0.8023004977045807,1.0,6/30,7.22%,ACVR1B;RAB7B;HMGB2;FAXDC2;ACVR2A;HIF1A
prerank,GO_Biological_Process_2021__phagosome-lysosome fusion (GO:0090385),0.8302845199669656,1.2811809560206728,0.08823529411764706,0.8022927456328047,1.0,2/6,6.59%,RAB7B;RAB20
prerank,GO_Biological_Process_2021__positive regulation of ossification (GO:0045778),0.6601221185590803,1.2809445967804736,0.14457831325301204,0.8025185429038487,1.0,7/25,8.95%,FBN2;TGFB2;ZBTB16;GPM6B;ACVR2A;BMPR1B;PTN
prerank,GO_Biological_Process_2021__cardiac atrium morphogenesis (GO:0003209),0.7815412371004589,1.280135037932441,0.1527777777777778,0.8063651838772165,1.0,1/7,1.28%,TGFB2
prerank,GO_Biological_Process_2021__modulation by symbiont of entry into host (GO:0052372),0.7331331891293307,1.2797870047031419,0.1375,0.8072624873492872,1.0,3/12,9.61%,HS3ST5;TRIM5;TRIM25
prerank,GO_Biological_Process_2021__regulation of cholesterol biosynthetic process (GO:0045540),0.7204334593782432,1.2796638753245633,0.13580246913580246,0.8066560276432545,1.0,4/16,18.25%,FGF1;ABCA2;ERLIN1;SOD1
prerank,GO_Biological_Process_2021__sphingolipid catabolic process (GO:0030149),0.7715120416370433,1.2796523239653335,0.15853658536585366,0.8052139147890864,1.0,2/10,2.27%,ENPP2;GLA
prerank,GO_Biological_Process_2021__monocarboxylic acid transport (GO:0015718),0.6894654942386246,1.2790622552890534,0.11842105263157894,0.8075319240403838,1.0,7/25,13.75%,SLC51A;SLC16A4;SLCO1A2;ATP8B1;SLCO3A1;SLC10A1;STARD5
prerank,GO_Biological_Process_2021__long-chain fatty acid transport (GO:0015909),0.71164576126193,1.2784271758910914,0.11392405063291139,0.8104274014441378,1.0,8/19,20.77%,ACSL1;MID1IP1;MFSD2A;CPT1A;PRKAG2;PRKAA2;ACSL3;ACACB
prerank,GO_Biological_Process_2021__regulation of podosome assembly (GO:0071801),-0.7053620282741883,-1.2784058997719245,0.16666666666666666,0.949608854057973,1.0,5/7,15.15%,FSCN1;LCP1;HCK;GSN;CAPG
prerank,GO_Biological_Process_2021__desensitization of G protein-coupled receptor signaling pathway (GO:0002029),-0.7659277972998184,-1.278328014843462,0.22580645161290322,0.9460147040777185,1.0,3/6,12.78%,GTF2H2;GRK2;ARRB2
prerank,GO_Biological_Process_2021__striated muscle tissue development (GO:0014706),0.7415386019563966,1.2781361872036794,0.11538461538461539,0.8108655436060392,1.0,6/12,22.29%,SVIL;SGCZ;IGSF8;ZBTB18;SGCD;MYL6
prerank,GO_Biological_Process_2021__positive regulation of vasculature development (GO:1904018),0.6196509870146328,1.2780163966105742,0.11235955056179775,0.8100279798852305,1.0,13/54,13.23%,THBS1;RHOB;FGF1;CHI3L1;VEGFA;HIF1A;RAPGEF3;ITGB8;SEMA5A;FLT1;SASH1;BRCA1;GAB1
prerank,GO_Biological_Process_2021__ventricular cardiac muscle tissue morphogenesis (GO:0055010),0.6891429849010289,1.2775710714538733,0.18666666666666668,0.8113836899468861,1.0,6/19,9.36%,LRP2;TGFB2;NRG1;PKP2;RBPJ;RYR2
prerank,GO_Biological_Process_2021__positive regulation of Notch signaling pathway (GO:0045747),0.6648588498557162,1.2775383335383843,0.14606741573033707,0.8100898976262338,1.0,5/29,10.87%,TGFB2;ROBO2;ROBO1;RBPJ;NOD2
prerank,GO_Biological_Process_2021__receptor recycling (GO:0001881),-0.8106928253912331,-1.2775106980018691,0.16666666666666666,0.9453975018998413,1.0,2/5,12.50%,PLEKHJ1;SORL1
prerank,GO_Biological_Process_2021__regulation of hippocampal neuron apoptotic process (GO:0110089),-0.7992202885315709,-1.277324571594442,0.19444444444444445,0.9426412818898476,1.0,4/5,12.54%,ITGAM;CX3CR1;TREM2;TYROBP
prerank,GO_Biological_Process_2021__ceramide biosynthetic process (GO:0046513),0.706413045614923,1.2772848121519476,0.1095890410958904,0.8100678930080499,1.0,1/22,0.15%,FA2H
prerank,GO_Biological_Process_2021__protein localization to cell junction (GO:1902414),0.7458797327335116,1.2765181207435656,0.12857142857142856,0.8140331425365082,1.0,7/14,24.36%,CGNL1;BSN;NLGN1;KIF3A;DLG4;TJP1;JAM3
prerank,GO_Biological_Process_2021__resolution of meiotic recombination intermediates (GO:0000712),0.7420285094201583,1.2763260372965541,0.13114754098360656,0.8139513470641678,1.0,4/11,10.95%,TOP2A;FANCM;EME2;SHOC1
prerank,GO_Biological_Process_2021__cellular glucose homeostasis (GO:0001678),0.6536261493779437,1.2759327199164776,0.1411764705882353,0.8150773489368689,1.0,10/31,25.32%,SOX4;HIF1A;IGF1R;ADCY8;PDK3;SLC39A14;PRKAA2;NR1D1;KCNB1;PPARGC1A
prerank,GO_Biological_Process_2021__nuclear migration (GO:0007097),0.7548341038125971,1.2756812986813364,0.14084507042253522,0.8153083546193395,1.0,6/12,19.70%,SYNE3;DYNC1H1;CLMN;HOOK3;DCTN1;SUN2
prerank,GO_Biological_Process_2021__regulation of leukocyte adhesion to vascular endothelial cell (GO:1904994),-0.6361800755550373,-1.2755200071589883,0.23076923076923078,0.945570512551244,1.0,3/10,10.89%,ZDHHC21;ETS1;ITGB2
prerank,GO_Biological_Process_2021__protein localization to endosome (GO:0036010),0.7914318367075337,1.2750379752823273,0.15492957746478872,0.8178748994707806,1.0,1/9,3.86%,ARF6
prerank,GO_Biological_Process_2021__erythrocyte development (GO:0048821),-0.700659078465988,-1.2748580978012103,0.21621621621621623,0.9444538046128882,1.0,3/8,14.75%,SH2B3;NCKAP1L;MED1
prerank,GO_Biological_Process_2021__rRNA-containing ribonucleoprotein complex export from nucleus (GO:0071428),0.8326512601022659,1.2745328490740808,0.16923076923076924,0.8197532952666771,1.0,1/6,8.25%,XPO1
prerank,GO_Biological_Process_2021__cell morphogenesis involved in differentiation (GO:0000904),0.6252681368625228,1.2734904747273765,0.17857142857142858,0.8253250532658716,1.0,9/48,11.25%,NTN4;RELN;LAMB1;SRCIN1;TMEFF2;FN1;MICALL2;MEGF9;TYRO3
prerank,GO_Biological_Process_2021__positive regulation of leukocyte adhesion to vascular endothelial cell (GO:1904996),-0.6395103911863971,-1.2733519501241675,0.18518518518518517,0.9470763847810367,1.0,3/9,10.89%,ETS1;ALOX5;ITGB2
prerank,GO_Biological_Process_2021__regulation of tumor necrosis factor superfamily cytokine production (GO:1903555),-0.7027530060765255,-1.273177161338817,0.19047619047619047,0.9438982225633622,1.0,5/8,15.53%,CX3CR1;CD274;SIRPA;MAPKAPK2;ZFP36
prerank,GO_Biological_Process_2021__autophagosome membrane docking (GO:0016240),0.8113321482313101,1.2730685691162642,0.1527777777777778,0.8266107694532754,1.0,3/7,15.68%,SNAP29;VMP1;ATP2A2
prerank,GO_Biological_Process_2021__cellular response to growth hormone stimulus (GO:0071378),0.8043033965087211,1.2729149512898816,0.18333333333333332,0.8261609331057633,1.0,1/6,9.54%,GHR
prerank,GO_Biological_Process_2021__regulation of synapse structural plasticity (GO:0051823),0.85862915304521,1.2726039083862228,0.14285714285714285,0.8266457022195494,1.0,4/5,13.99%,SHANK3;FRMPD4;CAMK2B;CTNNA2
prerank,GO_Biological_Process_2021__positive regulation of myeloid cell apoptotic process (GO:0033034),0.839315742581942,1.2725844854683026,0.125,0.8252661588101683,1.0,1/6,3.87%,ANXA1
prerank,GO_Biological_Process_2021__response to chemokine (GO:1990868),-0.6654274391474924,-1.2721950765656895,0.27586206896551724,0.9446289643718374,1.0,4/11,15.04%,SH2B3;RIPOR2;CXCL12;LRCH1
prerank,"GO_Biological_Process_2021__endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000479)",-0.7260727618657781,-1.2721720846840847,0.24242424242424243,0.9410300381968769,1.0,1/8,5.38%,KRI1
prerank,GO_Biological_Process_2021__positive regulation of pri-miRNA transcription by RNA polymerase II (GO:1902895),0.7164869041777123,1.2721653415178547,0.14666666666666667,0.82637051872724,1.0,4/23,7.22%,KLF4;TGFB2;EGR1;HIF1A
prerank,GO_Biological_Process_2021__neurotrophin signaling pathway (GO:0038179),0.7553026037334725,1.2720892859201982,0.17333333333333334,0.8253401320125603,1.0,4/13,15.15%,DDIT4;NTRK2;MAGI2;CASP3
prerank,GO_Biological_Process_2021__regulation of cellular catabolic process (GO:0031329),0.619143680554098,1.2720598683972035,0.07777777777777778,0.8239875681510639,1.0,7/52,10.66%,DEPP1;DAPK2;MAPT;FBXL2;DAPK1;BOK;TYSND1
prerank,GO_Biological_Process_2021__atrioventricular valve morphogenesis (GO:0003181),0.7395895818691502,1.27193435250097,0.1518987341772152,0.8233418625968348,1.0,2/13,5.16%,TGFB2;SOX4
prerank,GO_Biological_Process_2021__N-terminal peptidyl-methionine acetylation (GO:0017196),-0.7991243804324133,-1.2714549769419106,0.2702702702702703,0.9407234736612163,1.0,1/5,11.62%,NAA20
prerank,GO_Biological_Process_2021__receptor catabolic process (GO:0032801),-0.5593141328095633,-1.2713699475155156,0.058823529411764705,0.9372127462259905,1.0,7/21,16.04%,NEDD4;CLTA;SNX25;TGFB1;SMURF1;ZNRF3;BECN1
prerank,GO_Biological_Process_2021__positive regulation of regulated secretory pathway (GO:1903307),0.7500274276121317,1.2710901614944374,0.16176470588235295,0.8275693496731743,1.0,3/11,8.20%,SYT4;NLGN1;RAB15
prerank,GO_Biological_Process_2021__positive regulation of MAP kinase activity (GO:0043406),0.6339794134613461,1.2709910450582433,0.13793103448275862,0.8264589097636078,1.0,9/43,11.93%,HTR2B;FGF1;DIRAS2;VEGFA;TRAF2;ROBO1;NOD2;FLT1;SASH1
prerank,GO_Biological_Process_2021__muscle tissue morphogenesis (GO:0060415),-0.7688578504254318,-1.2706110303556897,0.3125,0.9369232875630799,1.0,1/6,0.57%,TGFBR3
prerank,GO_Biological_Process_2021__sodium ion transport (GO:0006814),0.637701441405813,1.2704838745304345,0.12048192771084337,0.8285199396230482,1.0,18/37,21.00%,SCN3B;SLC6A15;SLC5A9;SLC24A2;SLC9B2;SCN3A;SCN1A;SLC24A1;NALCN;HCN1;SCN8A;SCN2A;ASIC2;SLC24A3;ATP1B3;ATP1A2;SLC24A4;SLC5A6
prerank,GO_Biological_Process_2021__phagolysosome assembly (GO:0001845),0.8199867343160832,1.270365168660397,0.109375,0.8280407370056249,1.0,2/8,6.59%,RAB7B;RAB20
prerank,PanglaoDB_Augmented_2021__Germ Cells,0.658103284792636,1.2703499520081691,0.05813953488372093,0.8267826858649152,1.0,12/42,19.51%,TULP2;WDR5;CREB5;SMC1B;POU5F1;GGNBP1;BRCA1;MRPL14;OSBP2;AQP11;SPAG6;SORD
prerank,GO_Biological_Process_2021__cAMP biosynthetic process (GO:0006171),0.8001411221120096,1.2702177125143979,0.18181818181818182,0.8261727807630879,1.0,3/8,10.81%,ADCY3;ADCY10;ADCY8
prerank,GO_Biological_Process_2021__regulation of peptidyl-threonine phosphorylation (GO:0010799),0.6677363815358953,1.26991824288648,0.16666666666666666,0.8269177107816144,1.0,7/27,12.63%,DDIT4;CHI3L1;CEMIP;CALM3;PRKAG2;RIPK2;PARD3
prerank,GO_Biological_Process_2021__3'-phosphoadenosine 5'-phosphosulfate metabolic process (GO:0050427),0.7582455077986384,1.2698393835889812,0.15714285714285714,0.8258877755873602,1.0,2/10,5.87%,SULT4A1;PAPSS2
prerank,GO_Biological_Process_2021__ribosomal subunit export from nucleus (GO:0000054),0.7651689166830045,1.2698330807791756,0.14666666666666667,0.8244402839091785,1.0,2/10,12.11%,XPO1;NMD3
prerank,GO_Biological_Process_2021__cotranslational protein targeting to membrane (GO:0006613),0.6115693701878094,1.2697477800478807,0.0851063829787234,0.82372111285817,1.0,38/87,26.86%,RPL23;RPL37A;RPL38;RPS6;RPS27A;RPL23A;RPS25;RPS27;RPS11;RPS20;RPL9;RPLP2;RPS18;RPL37;RPL14;RPS4X;RPL11;RPS24;RPS9;RPL36;UBA52;SRPRA;RPS3A;RPL35;RPL4;RPL32;SRP19;RPL24;RPL27A;RPL3;RPS16;RPL30;RPL21;RPL7;RPL12;SRP54;RPL10A;RPS12
prerank,GO_Biological_Process_2021__axon extension involved in axon guidance (GO:0048846),0.8420804220731686,1.2692270784939381,0.0847457627118644,0.8244858368540027,1.0,2/7,7.99%,SEMA3A;ALCAM
prerank,GO_Biological_Process_2021__neuron projection extension involved in neuron projection guidance (GO:1902284),0.8420804220731686,1.2692270784939381,0.0847457627118644,0.8244858368540027,1.0,2/7,7.99%,SEMA3A;ALCAM
prerank,GO_Biological_Process_2021__regulation of sodium ion transmembrane transporter activity (GO:2000649),0.6677336749024506,1.2691282075135937,0.13636363636363635,0.8237536543436901,1.0,8/26,11.60%,PRKCE;SCN3B;NETO1;DMD;ANK3;CAV3;FXYD7;FGF14
prerank,GO_Biological_Process_2021__positive regulation of dendritic spine morphogenesis (GO:0061003),0.794217510499593,1.269083232033263,0.17142857142857143,0.8226566388719995,1.0,2/8,11.27%,RELN;CAMK2B
prerank,GO_Biological_Process_2021__regulation of dephosphorylation (GO:0035303),-0.6670495169087577,-1.2688858917659753,0.08823529411764706,0.9409831223657473,1.0,5/12,15.60%,PPP1R16B;INPP5K;SRC;SMG6;MTMR1
prerank,GO_Biological_Process_2021__positive regulation of organelle assembly (GO:1902117),-0.5202362069422519,-1.2688292747233096,0.125,0.9376010401304568,1.0,11/36,15.78%,RALB;FSCN1;TAPT1;ARHGAP35;PIP4K2B;LCP1;CNOT6L;CAPG;MARK4;KCTD17;CROCC
prerank,GO_Biological_Process_2021__negative regulation of osteoblast differentiation (GO:0045668),0.6973238791314784,1.2683608574109309,0.1282051282051282,0.8259479451588813,1.0,4/18,9.23%,RORB;NOCT;RANBP3L;LIMD1
prerank,GO_Biological_Process_2021__regulation of chondrocyte differentiation (GO:0032330),0.7763004339874404,1.268295106929515,0.1643835616438356,0.8249341382433955,1.0,5/11,11.78%,ZBTB16;BMPR1B;MBOAT2;TRPS1;SOX6
prerank,GO_Biological_Process_2021__positive regulation of kinase activity (GO:0033674),0.6103719243558416,1.2677326129984652,0.07526881720430108,0.8270969033743819,1.0,18/71,14.46%,EEF1A2;CENPE;MAPT;RELN;SPDYA;INSR;EPHA3;IGF1R;NTRK3;ALK;EPHA7;TYRO3;PRKAG2;FLT1;NTRK2;EPHA4;EPHA6;EPHA5
prerank,GO_Biological_Process_2021__positive regulation of oligodendrocyte differentiation (GO:0048714),0.8309129673896815,1.26733482736271,0.14516129032258066,0.8281410106354052,1.0,3/5,12.72%,PTPRZ1;PTN;TNFRSF1B
prerank,GO_Biological_Process_2021__sphingosine metabolic process (GO:0006670),0.7183209051576216,1.2671001831541064,0.11392405063291139,0.828519286923886,1.0,3/13,13.49%,PLPP3;ABCA2;SPTLC2
prerank,GO_Biological_Process_2021__superoxide metabolic process (GO:0006801),0.72212202276833,1.2669644060938172,0.07894736842105263,0.828102997874909,1.0,4/16,18.25%,SH3PXD2B;ALOX12;SOD2;SOD1
prerank,GO_Biological_Process_2021__regulation of leukocyte activation (GO:0002694),-0.6740722513013637,-1.2669481177147814,0.16666666666666666,0.9413604588532825,1.0,1/10,4.46%,LILRB4
prerank,GO_Biological_Process_2021__T cell differentiation (GO:0030217),0.6947196488998124,1.266905674826638,0.11904761904761904,0.8270282605870095,1.0,3/23,5.53%,ANXA1;SOX4;TCF7
prerank,GO_Biological_Process_2021__gland development (GO:0048732),0.6630339196873243,1.2668775371467,0.1724137931034483,0.8258090298029908,1.0,8/30,7.86%,COBL;LSR;TG;NRG1;ANXA1;ARID5B;ALOX15B;PAX8
prerank,GO_Biological_Process_2021__Fc receptor signaling pathway (GO:0038093),-0.4524768065537101,-1.2667777519630028,0.14285714285714285,0.938401396443474,1.0,17/96,15.17%,ITK;GRAP2;PSMB3;PSME3;CHUK;PSMC4;PSMD12;PSME4;NFATC3;BTK;IKBKB;LCP2;SYK;PSMA1;BCL10;CARD11;PSMA7
prerank,GO_Biological_Process_2021__purine ribonucleoside bisphosphate metabolic process (GO:0034035),0.7698495838695634,1.2667131314955198,0.1917808219178082,0.8253995904499789,1.0,1/6,1.43%,SULT4A1
prerank,GO_Biological_Process_2021__regulation of long-term synaptic depression (GO:1900452),0.7830305361983575,1.2666957162964572,0.19444444444444445,0.8240232654358665,1.0,4/8,12.37%,SHANK3;MAPT;ADCY8;GRID2
prerank,GO_Biological_Process_2021__male gonad development (GO:0008584),0.769064873635261,1.2663129130886919,0.15492957746478872,0.8252402900195341,1.0,3/9,4.14%,LRP2;TGFB2;KITLG
prerank,GO_Biological_Process_2021__histone phosphorylation (GO:0016572),0.8081493566910298,1.2660781539911532,0.1388888888888889,0.8254881584488978,1.0,1/7,1.25%,NEK11
prerank,PanglaoDB_Augmented_2021__Pluripotent Stem Cells,0.6370154180995155,1.266054560626025,0.0989010989010989,0.8242167393138248,1.0,20/52,24.41%,CENPF;SUV39H2;WDHD1;DNA2;PAICS;FANCI;KDM1A;POU5F1;GINS1;RFC4;KIF11;PFAS;ZGRF1;SMARCC1;KNTC1;HELLS;HNRNPU;ATAD5;MCM3;NASP
prerank,GO_Biological_Process_2021__ribosomal small subunit export from nucleus (GO:0000056),0.8371199307110977,1.2658237613205254,0.13636363636363635,0.8242210241710664,1.0,1/6,8.25%,XPO1
prerank,GO_Biological_Process_2021__SRP-dependent cotranslational protein targeting to membrane (GO:0006614),0.5991821149976484,1.265751291630436,0.11956521739130435,0.8233629127412527,1.0,38/84,26.86%,RPL23;RPL37A;SEC61B;RPL38;RPS6;RPS27A;RPL23A;RPS25;RPS27;RPS11;RPS20;RPL9;RPLP2;RPS18;RPL37;RPL14;RPS4X;RPL11;RPS24;RPS9;RPL36;UBA52;RPS3A;RPL35;RPL4;RPL32;SRP19;RPL24;RPL27A;RPL3;RPS16;RPL30;RPL21;RPL7;RPL12;SRP54;RPL10A;RPS12
prerank,GO_Biological_Process_2021__regulation of cell-substrate adhesion (GO:0010810),0.6376399317431206,1.2654619088605144,0.09876543209876543,0.8237909744416986,1.0,2/30,2.71%,ECM2;SPOCK1
prerank,GO_Biological_Process_2021__secretory granule organization (GO:0033363),0.8363666924545635,1.265168566354275,0.140625,0.8244770282617454,1.0,2/5,9.03%,SRGN;ABCA1
prerank,GO_Biological_Process_2021__glucosamine-containing compound metabolic process (GO:1901071),0.7640000590112952,1.2648563981852272,0.19444444444444445,0.8248693571221448,1.0,2/8,10.25%,CHST7;OGA
prerank,GO_Biological_Process_2021__response to dsRNA (GO:0043331),-0.7354637504960666,-1.2641643401249174,0.17142857142857143,0.9460574164376561,1.0,3/7,8.55%,PDE12;TICAM1;TLR3
prerank,GO_Biological_Process_2021__membrane lipid catabolic process (GO:0046466),0.84264399764216,1.2641192082960278,0.11594202898550725,0.8284763232134525,1.0,1/7,2.08%,ENPP2
prerank,GO_Biological_Process_2021__morphogenesis of an epithelial sheet (GO:0002011),-0.7564534806574941,-1.264058709648596,0.3055555555555556,0.9429270839903809,1.0,4/5,24.37%,ARHGAP12;LRP6;PHACTR4;NOTCH1
prerank,GO_Biological_Process_2021__positive regulation of reactive oxygen species metabolic process (GO:2000379),0.6503521539506844,1.2637316573303372,0.13095238095238096,0.8292799937440452,1.0,4/29,3.59%,THBS1;CBR1;MAPT;AGT
prerank,GO_Biological_Process_2021__nervous system development (GO:0007399),0.5823456538137267,1.263446761278019,0.01,0.8298876694099323,1.0,77/254,18.00%,SCRG1;ACVR1B;IL1RAPL2;MOBP;SHANK3;MAL;GPM6A;ZBTB16;SPOCK1;NCAN;RELN;GPM6B;VCAN;NRG1;NRXN1;CDH2;DPYSL5;NRXN2;VEGFA;ROBO2;MOG;SH3GL3;SHANK2;PTPRZ1;MARCKSL1;RBFOX2;SEMA6A;ADGRG6;GRIK1;STMN3;NLGN3;ARNT2;PAX8;NLGN1;ROBO1;FN1;SCD5;ADGRB2;PTN;TAGLN3;ADAM23;DNM3;CSPG5;CRMP1;RAPGEFL1;SEMA5A;BTBD2;CHRM3;TYRO3;KALRN;SOX6;PMP22;IGSF8;SH3GL2;PRPS1;NFASC;LY6H;UGT8;APC2;PKD1;GLRB;EIF2B2;LSAMP;DPF3;SCN8A;SCN2A;ASIC2;NINJ2;NR2C2;LDB2;NRGN;APLP1;NEURL1;GMFB;GSTP1;ERCC6;DCTN1
prerank,GO_Biological_Process_2021__regulation of myeloid cell differentiation (GO:0045637),0.5926404624304429,1.2632034493847093,0.12631578947368421,0.8302360305972765,1.0,5/48,8.46%,THBS1;WDR5;ZBTB16;MEIS2;MAFB
prerank,GO_Biological_Process_2021__visual system development (GO:0150063),0.6684302658869195,1.2630472843379785,0.1839080459770115,0.8297324870814105,1.0,5/20,6.04%,TGFB2;SH3PXD2B;MEIS2;BMPR1B;SCO2
prerank,PanglaoDB_Augmented_2021__GABAergic Neurons,0.6043428660184481,1.2625338662459267,0.05263157894736842,0.8320188874259206,1.0,44/80,19.66%,SULT4A1;GFAP;NCAN;KCTD16;GADD45B;BRINP1;MAPK4;PLPPR4;CADM2;UBE2QL1;PHYHIPL;GAD1;CTNND2;CA10;ANK2;SNAP25;PTPRT;GRIA2;FAIM2;MAP2;OLFM3;PPFIA2;CAMK2B;ZNF536;HS6ST3;VSTM2B;NTRK2;NKAIN2;GAD2;SH3GL2;PAK5;LY6H;STMN2;NDRG4;ST8SIA3;ASIC2;SYNPR;GABRG2;SPTBN4;PARM1;LRFN5;PTPN5;TMEM59L;SNAP91
prerank,GO_Biological_Process_2021__positive regulation of steroid metabolic process (GO:0045940),0.8569379401965,1.2625095097431966,0.12307692307692308,0.8308421461462491,1.0,1/5,3.59%,AGT
prerank,GO_Biological_Process_2021__negative regulation of smoothened signaling pathway (GO:0045879),0.6522149863788269,1.2624547858068682,0.13953488372093023,0.8297332424446132,1.0,1/20,0.41%,HHIP
prerank,GO_Biological_Process_2021__mitochondrion transport along microtubule (GO:0047497),0.7444791472196981,1.262330972722244,0.19444444444444445,0.8294571343809575,1.0,7/12,18.81%,MAPT;SYBU;HIF1A;SPAST;NEFL;UXT;UBB
prerank,GO_Biological_Process_2021__extracellular matrix organization (GO:0030198),0.5885276471188013,1.2618875540483578,0.030303030303030304,0.8308691568700299,1.0,24/139,6.19%,TNC;THBS1;P4HA3;SPARC;FBN2;ADAMTS2;TGFB2;ECM2;THSD4;COL11A1;SH3PXD2B;NCAN;ITGA2;MMP21;COL4A5;GPM6B;VCAN;COL26A1;ADAM15;COL23A1;LAMA2;COLGALT2;LAMB1;COL24A1
prerank,GO_Biological_Process_2021__positive regulation of vesicle fusion (GO:0031340),0.8809327072525532,1.261789223238711,0.078125,0.8303060452244827,1.0,1/5,3.87%,ANXA1
prerank,GO_Biological_Process_2021__regulation of neuron apoptotic process (GO:0043523),0.6333142513092627,1.2615257267557285,0.14444444444444443,0.8308394220442175,1.0,19/57,20.52%,TGFB2;PTPRZ1;NSMF;MAG;FAIM2;RETREG1;EPHA7;TYRO3;NTRK2;CRLF1;GRID2;SOD2;PINK1;NRBP2;EGLN3;SOD1;CDK5R1;TNF;CPEB4
prerank,GO_Biological_Process_2021__regulation of response to endoplasmic reticulum stress (GO:1905897),0.721740298631554,1.2612686713259773,0.2125,0.8311809715593611,1.0,3/12,5.64%,MANF;FCGR2B;EIF2AK3
prerank,GO_Biological_Process_2021__I-kappaB phosphorylation (GO:0007252),-0.6672046658069858,-1.2605936825089317,0.17142857142857143,0.9551517770759467,1.0,4/8,11.22%,CHUK;DAB2IP;TLR3;TLR7
prerank,GO_Biological_Process_2021__synaptic vesicle endocytosis (GO:0048488),0.6590432692159247,1.260284271787135,0.1125,0.8365335021118279,1.0,12/29,19.66%,DNAJC6;NLGN3;FCHO2;NLGN1;DNM3;DNM1;SYT1;ITSN1;PICALM;AMPH;NLGN4X;SNAP91
prerank,GO_Biological_Process_2021__monocarboxylic acid catabolic process (GO:0072329),0.7387240577577894,1.2602139823449752,0.1506849315068493,0.8355385323862659,1.0,2/11,3.98%,FAAH;FAH
prerank,GO_Biological_Process_2021__RNA catabolic process (GO:0006401),0.6396022523507093,1.260177344676024,0.1728395061728395,0.8343262415531582,1.0,5/39,8.41%,NUDT12;NUDT16;RIDA;RNASEH2C;DNA2
prerank,GO_Biological_Process_2021__cell-cell junction organization (GO:0045216),0.6424034674828957,1.2596441545880297,0.1111111111111111,0.8362172801786187,1.0,10/40,9.37%,TGFB2;CADM1;CDH8;CDH2;CADM2;CDH9;CTNND2;PKP2;CDH20;CDH12
prerank,GO_Biological_Process_2021__pyrimidine deoxyribonucleotide biosynthetic process (GO:0009221),-0.7450822779110471,-1.2594018790288497,0.2926829268292683,0.956549411709262,1.0,2/5,20.96%,TYMS;DCTD
prerank,GO_Biological_Process_2021__lymphocyte migration (GO:0072676),-0.7776096451761815,-1.2591915452006643,0.2727272727272727,0.9542410408519074,1.0,1/6,0.45%,CCL5
prerank,MSigDB_Hallmark_2020__PI3K/AKT/mTOR  Signaling,-0.40905371906516086,-1.2591190438501383,0.0,0.9511701494349885,1.0,11/85,7.62%,RALB;MKNK1;PFN1;IRAK4;DUSP3;GRK2;ITPR2;TRIB3;DAPP1;MAP2K3;PLA2G12A
prerank,GO_Biological_Process_2021__amino acid transport (GO:0006865),0.6650569258864529,1.2585696292983453,0.13580246913580246,0.8419972944368029,1.0,3/27,3.24%,SLC38A4;SLC16A10;SLC6A15
prerank,GO_Biological_Process_2021__regulation of osteoblast proliferation (GO:0033688),-0.6187484166957717,-1.258482153468274,0.1891891891891892,0.9504092364171641,1.0,3/8,9.11%,ATRAID;HPSE;TMEM119
prerank,GO_Biological_Process_2021__negative regulation of glial cell apoptotic process (GO:0034351),-0.7894154058541912,-1.2584673823176842,0.2222222222222222,0.9469021912643332,1.0,2/6,16.68%,TREM2;PRKCA
prerank,GO_Biological_Process_2021__regulation of postsynapse organization (GO:0099175),0.7025042562439502,1.258405977886221,0.16666666666666666,0.8415330178395201,1.0,10/25,15.33%,SHANK3;ZDHHC15;IL1RAPL1;FCGR2B;SRCIN1;SIPA1L1;PPFIA2;EPHA4;WNT5A;CFL1
prerank,GO_Biological_Process_2021__negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway (GO:1903377),0.8149795472817809,1.257874770812399,0.21739130434782608,0.8437002789041949,1.0,2/5,13.26%,HIF1A;PINK1
prerank,GO_Biological_Process_2021__regulation of mRNA export from nucleus (GO:0010793),-0.7152142449029327,-1.257609921566239,0.1891891891891892,0.9435077075871252,1.0,3/6,22.94%,AKAP8L;NSUN2;SUPT6H
prerank,GO_Biological_Process_2021__regulation of ribonucleoprotein complex localization (GO:2000197),-0.7152142449029327,-1.257609921566239,0.1891891891891892,0.9435077075871252,1.0,3/6,22.94%,AKAP8L;NSUN2;SUPT6H
prerank,GO_Biological_Process_2021__negative regulation of lymphocyte activation (GO:0051250),-0.6261632198020854,-1.257551831504858,0.13636363636363635,0.9403194005913542,1.0,5/14,4.42%,FGL1;SAMSN1;BANK1;DUSP3;IL4I1
prerank,GO_Biological_Process_2021__modulation of chemical synaptic transmission (GO:0050804),0.6080571427260913,1.257464432147362,0.043478260869565216,0.8449695543431675,1.0,36/81,20.68%,LRRC4C;GRM8;RELN;CDH2;BEGAIN;DGKI;GRIK2;GRM3;IQSEC2;GRIK1;NLGN3;UNC13A;NLGN1;PXK;RIMS2;CACNA1B;NRG3;TMEM108;GRID2;SYT1;DLGAP1;RIMS3;CPLX1;MCTP1;CACNA1A;DLGAP2;APP;GRM7;GRIK4;DLG4;MAPK8IP2;NLGN4X;TNF;CLSTN2;ATP1A2;LRRK2
prerank,GO_Biological_Process_2021__organic hydroxy compound transport (GO:0015850),0.6659598824683921,1.2572318422029245,0.18072289156626506,0.8453140609358983,1.0,5/18,13.75%,SLC51A;SLCO1A2;ATP8B1;SLC10A1;STARD5
prerank,GO_Biological_Process_2021__mesoderm formation (GO:0001707),0.795579864870631,1.257200406264715,0.11428571428571428,0.8441308118166727,1.0,3/6,19.88%,ITGA2;TBX19;KDM6B
prerank,GO_Biological_Process_2021__regulation of protein metabolic process (GO:0051246),0.6735689741157117,1.2564703982257033,0.14606741573033707,0.8476015803030559,1.0,1/34,0.30%,KLF4
prerank,GO_Biological_Process_2021__odontogenesis of dentin-containing tooth (GO:0042475),-0.7236718909644685,-1.2563900282805047,0.21875,0.9421963899487377,1.0,2/5,20.26%,EDA;LRP6
prerank,GO_Biological_Process_2021__dendrite arborization (GO:0140059),0.8251264332290607,1.2562393464787782,0.19047619047619047,0.8478779898008361,1.0,3/5,15.66%,SEMA3A;PTN;PHACTR1
prerank,GO_Biological_Process_2021__regulation of cell cycle G2/M phase transition (GO:1902749),0.6209134923548565,1.2562057267753084,0.10989010989010989,0.8467583551919928,1.0,10/64,12.75%,CENPF;TUBA4A;PRKAR2B;HAUS6;TUBB4A;CEP152;TUBA1A;KCNH5;DYNC1H1;CKAP5
prerank,GO_Biological_Process_2021__positive regulation of synapse assembly (GO:0051965),0.7010577606739676,1.2561218530489802,0.14473684210526316,0.8459518942819714,1.0,6/20,12.37%,PTPRD;IL1RAPL1;NRXN1;NLGN3;NLGN1;GRID2
prerank,GO_Biological_Process_2021__peptidyl-threonine modification (GO:0018210),0.6120647624937758,1.2559913087495933,0.12941176470588237,0.8455652375789895,1.0,4/52,6.35%,ACVR1B;GALNTL6;CIT;GALNT13
prerank,GO_Biological_Process_2021__negative regulation of supramolecular fiber organization (GO:1902904),0.618716314209632,1.255574077571181,0.14606741573033707,0.8469075579081748,1.0,15/56,16.42%,SHANK3;CLIP3;TUBB4A;VBP1;TTBK2;HDGFL3;KANK1;CAV3;MAP2;MID1IP1;CLASP2;STMN2;APC2;PFDN4;EML2
prerank,GO_Biological_Process_2021__neuromuscular process (GO:0050905),0.7861179644225615,1.2552350933061516,0.20833333333333334,0.8478450989228145,1.0,3/8,18.00%,NRXN1;AGTPBP1;DCTN1
prerank,GO_Biological_Process_2021__intermediate filament organization (GO:0045109),0.8208078141754972,1.2545570437864784,0.11290322580645161,0.850932268725451,1.0,4/7,14.68%,VIM;GFAP;PKP2;NEFL
prerank,GO_Biological_Process_2021__acylglycerol catabolic process (GO:0046464),0.7823535130822318,1.254552214814133,0.16455696202531644,0.8496036340542934,1.0,3/11,10.84%,FAAH;ABHD12B;LIPE
prerank,"GO_Biological_Process_2021__regulation of complement activation, classical pathway (GO:0030450)",0.8136950388241657,1.2542162110311854,0.16666666666666666,0.8503790244397083,1.0,3/5,13.15%,CR1;CD55;SUSD4
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell contraction (GO:0086004),0.707343492591076,1.253921735446816,0.16455696202531644,0.8505398422897149,1.0,6/18,15.68%,ANK2;PKP2;CAV3;RYR2;PDE4B;ATP2A2
prerank,GO_Biological_Process_2021__calcium ion transmembrane import into cytosol (GO:0097553),0.674477215534587,1.25348714562844,0.1566265060240964,0.8516473344935195,1.0,8/24,14.52%,HTR2B;SLC24A2;GRIN2A;RYR2;SLC24A1;IBTK;RYR3;GRIN2B
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell proliferation (GO:0001938),0.6301942024745728,1.253451460886928,0.18292682926829268,0.8504786101977162,1.0,6/41,10.26%,HTR2B;HMGB2;NR4A1;VEGFA;HIF1A;SEMA5A
prerank,GO_Biological_Process_2021__endocardial cushion development (GO:0003197),0.7763473374287202,1.2532905525195344,0.11864406779661017,0.8502121024485078,1.0,1/7,1.28%,TGFB2
prerank,MSigDB_Hallmark_2020__Estrogen Response Early,0.5848295730344313,1.2528266400278956,0.07368421052631578,0.8518773492437819,1.0,29/116,14.37%,RHOBTB3;KLF4;SH3BP5;ALDH3B1;THSD4;GLA;FKBP5;MAPT;SYBU;SEMA3B;PAPSS2;MINDY1;OVOL2;SLC19A2;KAZN;BHLHE40;ENDOD1;RETREG1;SVIL;BLVRB;DEPTOR;IGF1R;CELSR2;RAPGEFL1;RPS6KA2;ASB13;FASN;KDM4B;FDFT1
prerank,GO_Biological_Process_2021__regulation of epithelial cell differentiation (GO:0030856),0.7621021284738249,1.252715434282544,0.17647058823529413,0.8512906856247662,1.0,2/8,5.56%,APOLD1;ALOX15B
prerank,GO_Biological_Process_2021__positive regulation of metabolic process (GO:0009893),0.586105729450067,1.2525946422649235,0.1276595744680851,0.8508271369658484,1.0,22/72,21.14%,PRLR;TSHR;ACSL1;PLAC8;VEGFA;INSR;GRB10;KDM3A;IGF1R;KDM1A;DYNC1H1;FASN;SCD;PEMT;IL18;EPAS1;ESRRG;KDM6B;TNF;ACACB;LEPR;MFN2
prerank,GO_Biological_Process_2021__heparan sulfate proteoglycan biosynthetic process (GO:0015012),0.7429283356602563,1.2525274789971295,0.09333333333333334,0.8500170442116762,1.0,4/15,15.66%,HS3ST5;HS6ST3;HS2ST1;NDST3
prerank,GO_Biological_Process_2021__protein import into peroxisome membrane (GO:0045046),-0.5774859854568474,-1.2524813285220708,0.2857142857142857,0.9549095839857071,1.0,7/15,20.48%,PEX13;PEX16;ABCD3;FIS1;ACBD5;PEX2;SLC25A17
prerank,GO_Biological_Process_2021__response to cholesterol (GO:0070723),0.7229820959677279,1.252412357941947,0.16666666666666666,0.8494814580221803,1.0,2/13,7.02%,GRAMD1C;ABCA2
prerank,GO_Biological_Process_2021__regulation of nuclease activity (GO:0032069),0.8233946971648032,1.251785451968713,0.14705882352941177,0.8521904782253206,1.0,2/5,9.68%,HMGB2;NEIL1
prerank,GO_Biological_Process_2021__regulation of multicellular organismal development (GO:2000026),0.6822119745328725,1.251757593399973,0.19736842105263158,0.8509754730646409,1.0,5/17,8.95%,RACGAP1;TDG;ALOX15B;INSR;PTN
prerank,GO_Biological_Process_2021__protein targeting to ER (GO:0045047),0.5973099588763358,1.2516333057185431,0.06593406593406594,0.8501251661136953,1.0,40/95,26.86%,RPL23;RPL37A;RPL38;RPS6;RPS27A;RPL23A;RPS25;RPS27;RPS11;RPS20;RPL9;RPLP2;RPS18;RPL37;RPL14;RPS4X;RPL11;RPS24;RPS9;RPL36;UBA52;SRPRA;RPS3A;RPL35;RPL4;RPL32;SRP19;SPCS3;RPL24;RPL27A;RPL3;RPS16;RPL30;MAN1A1;RPL21;RPL7;RPL12;SRP54;RPL10A;RPS12
prerank,GO_Biological_Process_2021__excitatory synapse assembly (GO:1904861),0.7985603954385836,1.2514530192306723,0.16923076923076924,0.850193265527001,1.0,4/7,15.06%,SHANK3;NLGN1;GRID2;WNT5A
prerank,GO_Biological_Process_2021__fructose 6-phosphate metabolic process (GO:0006002),0.7972203612624169,1.2512196722786393,0.21739130434782608,0.8503360907236476,1.0,3/7,16.64%,PFKM;FBP1;GFPT1
prerank,GO_Biological_Process_2021__commissural neuron axon guidance (GO:0071679),0.8280224847141198,1.250760288607555,0.203125,0.8519749179028148,1.0,2/6,5.04%,NFIB;VEGFA
prerank,GO_Biological_Process_2021__regulation of microtubule polymerization or depolymerization (GO:0031110),0.6811247913767677,1.2506902376333797,0.2222222222222222,0.8509939184379213,1.0,6/21,13.71%,MAPT;STMN3;MAP2;MAP1B;CLASP2;STMN2
prerank,GO_Biological_Process_2021__aromatic amino acid transport (GO:0015801),0.8172033949198474,1.2506776235467967,0.16393442622950818,0.8497624009578785,1.0,1/5,1.06%,SLC16A10
prerank,PanglaoDB_Augmented_2021__Pancreatic Stellate Cells,0.6306415180769926,1.250636022284745,0.1566265060240964,0.848728368012582,1.0,6/36,8.46%,TNC;SPARC;ADAMTS2;FBXL7;LAMA2;FN1
prerank,GO_Biological_Process_2021__photoreceptor cell development (GO:0042461),0.8366703622609963,1.250143102385738,0.1111111111111111,0.8504486775525504,1.0,3/7,9.91%,RORB;VEGFA;MFSD2A
prerank,GO_Biological_Process_2021__prostaglandin metabolic process (GO:0006693),-0.6363201177203004,-1.2500785520217967,0.16666666666666666,0.9614736640660908,1.0,5/13,10.10%,CYP2S1;HPGDS;ACOX1;DAGLB;PTGS1
prerank,GO_Biological_Process_2021__regulation of neuron projection development (GO:0010975),0.5806537193458585,1.2499903507480377,0.05102040816326531,0.8502334220907034,1.0,46/128,21.81%,LRRC4C;SHANK3;SEMA3A;DCC;SPOCK1;ZDHHC15;RELN;IL1RAPL1;CDH2;CSMD3;ZNF804A;EPHA3;SRCIN1;SIPA1L1;KANK1;CHN1;PTK7;PAQR3;MAG;PTN;NTRK3;MFSD2A;CRMP1;PPFIA2;CAMK2B;NTRK2;MAGI2;EPHA4;LRRC7;STMN2;CTNNA2;WNT5A;NDRG4;CFL1;DENND5A;PTPN9;ATP1B2;FES;NTNG1;CDK5R1;FBXO7;PTPRS;LRRK2;CX3CL1;PAK3;RTN4RL1
prerank,GO_Biological_Process_2021__activation of protein kinase A activity (GO:0034199),0.7205522368721312,1.2499662151381654,0.17073170731707318,0.8489959515641308,1.0,3/14,10.81%,PRKAR2B;ADCY3;ADCY8
prerank,GO_Biological_Process_2021__serine family amino acid biosynthetic process (GO:0009070),-0.7015137668077895,-1.2499610473434561,0.26666666666666666,0.9586438270617689,1.0,2/7,5.35%,PSAT1;PSPH
prerank,GO_Biological_Process_2021__central nervous system projection neuron axonogenesis (GO:0021952),0.7723228994442293,1.2498779951900814,0.17391304347826086,0.8482803834663838,1.0,3/9,18.98%,NFIB;EPHA4;SPTBN4
prerank,GO_Biological_Process_2021__outflow tract septum morphogenesis (GO:0003148),0.7398107359787414,1.2498243982935098,0.1044776119402985,0.8472862527301135,1.0,4/16,8.14%,LRP2;TGFB2;ROBO2;ROBO1
prerank,GO_Biological_Process_2021__negative regulation of receptor signaling pathway via STAT (GO:1904893),0.7733323138312931,1.2494722628025452,0.16666666666666666,0.8483904742805978,1.0,2/8,7.69%,SOCS3;PTPRT
prerank,GO_Biological_Process_2021__organophosphate catabolic process (GO:0046434),0.875348860751684,1.2492752404927157,0.15151515151515152,0.8484599961727771,1.0,1/5,2.08%,ENPP2
prerank,GO_Biological_Process_2021__neuron cell-cell adhesion (GO:0007158),0.7383763690837507,1.249246155009413,0.21739130434782608,0.8473231070596849,1.0,10/14,19.52%,NCAM2;NRXN1;NRXN2;NLGN3;NLGN1;NRXN3;ASTN2;NINJ2;CDK5R1;NLGN4X
prerank,GO_Biological_Process_2021__response to histamine (GO:0034776),0.7743152978638542,1.2490195063117677,0.19444444444444445,0.8459983710505171,1.0,4/6,18.88%,GABRB1;GABRB3;GABRB2;GABRG2
prerank,GO_Biological_Process_2021__cellular response to histamine (GO:0071420),0.7743152978638542,1.2490195063117677,0.19444444444444445,0.8459983710505171,1.0,4/6,18.88%,GABRB1;GABRB3;GABRB2;GABRG2
prerank,GO_Biological_Process_2021__negative regulation of microtubule polymerization (GO:0031115),0.7703770787125337,1.2489841582744525,0.17391304347826086,0.8449290969895564,1.0,5/11,16.42%,CLIP3;TUBB4A;MAP2;STMN2;EML2
prerank,GO_Biological_Process_2021__activation of Janus kinase activity (GO:0042976),0.8464615498247581,1.2489625882759179,0.171875,0.8436876828039905,1.0,2/5,9.54%,PRLR;GHR
prerank,"GO_Biological_Process_2021__Wnt signaling pathway, calcium modulating pathway (GO:0007223)",0.6272917937553502,1.2487500946678003,0.2222222222222222,0.8437783846181613,1.0,4/28,16.96%,FZD6;GNAO1;WNT5A;PLCB1
prerank,GO_Biological_Process_2021__modified amino acid transport (GO:0072337),-0.64932304250923,-1.248280565836637,0.1875,0.9616393599246661,1.0,3/8,11.90%,FOLR2;SLC46A1;SLC19A1
prerank,GO_Biological_Process_2021__cleavage furrow formation (GO:0036089),0.8377131229628991,1.248085524360512,0.23809523809523808,0.8463755945310395,1.0,1/5,6.84%,SPIRE2
prerank,GO_Biological_Process_2021__regulation of glutamate receptor signaling pathway (GO:1900449),0.7552592417433585,1.2480353581636476,0.2835820895522388,0.8453268447301955,1.0,2/5,7.29%,SHANK3;FRRS1L
prerank,GO_Biological_Process_2021__axon guidance (GO:0007411),0.5725222491519187,1.247945600508739,0.05154639175257732,0.844513778423371,1.0,45/133,20.17%,RAP1GAP;SHANK3;SEMA3A;NTN4;DCC;RELN;ENAH;NFIB;NRXN1;DOK6;VEGFA;LAMA2;SEMA3B;ROBO2;SEMA6A;EPHA3;GRB10;PALLD;CHN1;ALCAM;NRXN3;ROBO1;IRS2;UNC5D;SEMA5A;SPTAN1;UNC5C;EPHA7;EPHA4;GAB1;EPHA6;PLXNB1;EPHA5;WNT5A;SPTBN5;DAB1;KIF5A;SPTBN1;KLF7;PLXNC1;RHOH;SPTBN4;CDK5R1;NCAM1;NOTCH2
prerank,GO_Biological_Process_2021__cellular response to glucagon stimulus (GO:0071377),0.7260550115046,1.2478200958638372,0.1875,0.8440223616625898,1.0,3/13,10.81%,PRKAR2B;ADCY3;ADCY8
prerank,GO_Biological_Process_2021__regulation of angiogenesis (GO:0045765),0.5714191538444408,1.247716622000384,0.08247422680412371,0.843358617469501,1.0,19/103,13.23%,THBS1;KLF4;RHOB;SPARC;FGF1;TGFB2;CHI3L1;VEGFA;GPNMB;SEMA6A;HIF1A;RAPGEF3;GLUL;ITGB8;SEMA5A;FLT1;SASH1;BRCA1;GAB1
prerank,GO_Biological_Process_2021__calcium ion-regulated exocytosis of neurotransmitter (GO:0048791),0.7943006616097334,1.2475382301686833,0.171875,0.8430729428118805,1.0,5/7,15.01%,UNC13A;RIMS2;SYT1;UNC13C;RIMS3
prerank,GO_Biological_Process_2021__protein-DNA complex subunit organization (GO:0071824),0.8184392689418423,1.2475310921273568,0.19117647058823528,0.8418783255956886,1.0,1/5,1.97%,RPL23
prerank,GO_Biological_Process_2021__cellular response to peptide hormone stimulus (GO:0071375),0.5921029260122834,1.2473510617028176,0.11827956989247312,0.841509247033108,1.0,14/74,15.02%,TSHR;PRKAR2B;ADCY3;NR4A2;NR4A1;INSR;RAB15;IRS2;ADCY8;SORBS1;NR4A3;PKM;INSIG1;CPEB2
prerank,GO_Biological_Process_2021__response to glucagon (GO:0033762),0.7212290626754612,1.2470599593983853,0.18292682926829268,0.8418755685930505,1.0,3/15,10.81%,PRKAR2B;ADCY3;ADCY8
prerank,GO_Biological_Process_2021__negative regulation of response to cytokine stimulus (GO:0060761),0.8117271926958703,1.247011736257715,0.11764705882352941,0.8409181990793616,1.0,1/7,0.30%,KLF4
prerank,GO_Biological_Process_2021__regulation of maintenance of mitotic sister chromatid cohesion (GO:0034182),0.8253041017128616,1.246656696408713,0.11428571428571428,0.8390937806118727,1.0,1/5,3.94%,SLF1
prerank,GO_Biological_Process_2021__positive regulation of maintenance of sister chromatid cohesion (GO:0034093),0.8253041017128616,1.246656696408713,0.11428571428571428,0.8390937806118727,1.0,1/5,3.94%,SLF1
prerank,GO_Biological_Process_2021__positive regulation of maintenance of mitotic sister chromatid cohesion (GO:0034184),0.8253041017128616,1.246656696408713,0.11428571428571428,0.8390937806118727,1.0,1/5,3.94%,SLF1
prerank,GO_Biological_Process_2021__cellular response to cholesterol (GO:0071397),0.8257651973974405,1.2466125072509313,0.16129032258064516,0.8381606422788287,1.0,1/6,2.49%,GRAMD1C
prerank,GO_Biological_Process_2021__cellular response to dsRNA (GO:0071359),-0.56032557774488,-1.2463528127333354,0.13636363636363635,0.967151952693005,1.0,2/14,0.82%,RALB;PDE12
prerank,GO_Biological_Process_2021__negative regulation of chemotaxis (GO:0050922),0.6853454486517773,1.2460684126316646,0.16883116883116883,0.8403407239742032,1.0,7/21,10.26%,THBS1;SEMA3A;SEMA3B;ROBO2;SEMA6A;ROBO1;SEMA5A
prerank,GO_Biological_Process_2021__regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO:0010881),0.734083730262008,1.2459529399729732,0.18181818181818182,0.8399071444890702,1.0,6/12,20.66%,DMD;ANK2;CALM3;RYR2;CLIC2;ATP1A2
prerank,GO_Biological_Process_2021__regulation of neutrophil chemotaxis (GO:0090022),0.6971429402764144,1.245914134864586,0.17073170731707318,0.8389769792864482,1.0,1/17,0.36%,DAPK2
prerank,GO_Biological_Process_2021__cytoskeleton organization (GO:0007010),0.5682732773022184,1.2455083579175894,0.12371134020618557,0.840222805267122,1.0,10/88,10.63%,DIAPH3;RHOBTB3;RHOB;SYNE3;SEMA6A;RND3;PALLD;LIMD1;CSPG5;SH3D19
prerank,GO_Biological_Process_2021__neurotransmitter secretion (GO:0007269),0.6342685868941531,1.2454494776290377,0.19230769230769232,0.8393374939106284,1.0,15/32,25.50%,NRXN1;NRXN2;GAD1;SNAP25;UNC13A;RIMS2;GAD2;SYT1;CPLX1;STXBP2;SYN2;BRSK1;PPFIA3;RIMS1;PTPRN2
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",-0.4075563700012178,-1.2454150409806148,0.07142857142857142,0.9685201809316528,1.0,6/45,11.60%,PDE12;NT5C3B;DCP1B;LSM6;CNOT6L;EDC3
prerank,GO_Biological_Process_2021__cellular response to leptin stimulus (GO:0044320),0.7759549162082016,1.2454023917924955,0.19718309859154928,0.8383415281129567,1.0,3/7,20.93%,NR4A3;UGCG;LEPR
prerank,GO_Biological_Process_2021__negative regulation of receptor-mediated endocytosis (GO:0048261),0.6601947277438386,1.2453389148892196,0.189873417721519,0.8376737598163756,1.0,7/18,19.39%,ARF6;ABCA2;SDCBP;PICALM;ITGAV;APP;DLG4
prerank,GO_Biological_Process_2021__lymphocyte chemotaxis (GO:0048247),-0.6247969921524703,-1.2450897472523106,0.23076923076923078,0.9659947281602691,1.0,2/12,9.50%,CCL5;CH25H
prerank,MSigDB_Hallmark_2020__IL-6/JAK/STAT3 Signaling,0.6028937335908244,1.2450565993574492,0.17045454545454544,0.8381375413920505,1.0,5/55,5.77%,SOCS3;ACVR1B;OSMR;MAP3K8;IL7
prerank,GO_Biological_Process_2021__positive regulation of cardiac epithelial to mesenchymal transition (GO:0062043),0.8070454831721728,1.2450265039378385,0.13043478260869565,0.8370631973085537,1.0,1/7,1.28%,TGFB2
prerank,GO_Biological_Process_2021__regulation of skeletal muscle cell differentiation (GO:2001014),-0.7038792382782638,-1.244786619043639,0.25,0.9638576792463467,1.0,4/6,22.31%,UQCC2;DDX5;NR1D2;MEF2C
prerank,GO_Biological_Process_2021__regulation of microtubule depolymerization (GO:0031114),0.6995156051566653,1.2446966390924834,0.1875,0.8377517529654784,1.0,7/20,13.90%,TTBK2;HDGFL3;MID1IP1;MAP1B;CLASP2;STMN2;APC2
prerank,GO_Biological_Process_2021__regulation of T cell migration (GO:2000404),-0.6124313003345805,-1.244674242389959,0.25,0.9607099817516266,1.0,5/13,15.04%,CCL5;CD200R1;RIPOR2;CXCL12;LRCH1
prerank,GO_Biological_Process_2021__nitrogen compound transport (GO:0071705),0.5978117323336418,1.2442947721295305,0.08888888888888889,0.8387194096143333,1.0,13/76,13.82%,CENPF;LRP2;SLC38A4;SLC16A10;ARRDC3;SLC6A15;SLC11A1;SLC19A2;FLVCR1;TXNIP;SLC35F3;LRP1B;SCAMP3
prerank,GO_Biological_Process_2021__peripheral nervous system development (GO:0007422),0.7355492902199696,1.244096685294773,0.18571428571428572,0.8388420389974954,1.0,9/12,24.37%,ADGRG6;ADGRB2;PMP22;NFASC;UGT8;SCN8A;ASIC2;GSTM3;SERPINI1
prerank,GO_Biological_Process_2021__positive regulation of cell migration (GO:0030335),0.5641365856431169,1.2440806342277504,0.06060606060606061,0.8376468551749015,1.0,30/166,13.23%,THBS1;ACVR1B;FGF1;TGFB2;SEMA3A;ENPP2;PRKCE;DOCK1;GLIPR2;CEMIP;DOCK5;VEGFA;HSPA5;GPNMB;SEMA3B;LAMB1;NSMF;INSR;SEMA6A;HIF1A;FN1;IGF1R;FGR;CARMIL1;NTRK3;SEMA5A;CLASP2;FLT1;SOD2;GAB1
prerank,GO_Biological_Process_2021__positive regulation of RNA metabolic process (GO:0051254),-0.47048089367394264,-1.2439358737217485,0.0,0.9604462513458808,1.0,11/35,15.48%,BUD23;IL1B;ZPR1;TP53;RIOK1;TGFB1;ZC3H18;EGFR;HSPA1A;GRSF1;HABP4
prerank,GO_Biological_Process_2021__ganglion development (GO:0061548),0.8037441506948256,1.2438072298610752,0.15714285714285714,0.8379806249587515,1.0,2/6,10.75%,SEMA3A;UNC5C
prerank,GO_Biological_Process_2021__urogenital system development (GO:0001655),0.8344020227739837,1.2437247070386,0.19672131147540983,0.8371675270879124,1.0,3/5,7.86%,ANXA1;ALOX15B;PAX8
prerank,GO_Biological_Process_2021__attachment of GPI anchor to protein (GO:0016255),0.8851366571871059,1.2434146602942848,0.11864406779661017,0.8376963722841274,1.0,1/5,3.16%,PIGU
prerank,GO_Biological_Process_2021__regulation of nucleocytoplasmic transport (GO:0046822),-0.620726509559217,-1.2432031124010445,0.21212121212121213,0.9594102858239915,1.0,3/11,10.83%,NEDD4;TGFB1;NUP214
prerank,GO_Biological_Process_2021__chromatin remodeling at centromere (GO:0031055),0.6649761505480452,1.2431331558353846,0.2028985507246377,0.8380843342232724,1.0,10/20,26.06%,OIP5;CENPP;CENPK;CENPV;CENPI;HELLS;CENPT;ITGB3BP;NASP;SMARCA5
prerank,GO_Biological_Process_2021__regulation of striated muscle tissue development (GO:0016202),0.8734436045205403,1.2431300939010415,0.15873015873015872,0.8368572707763862,1.0,1/6,0.31%,CENPF
prerank,GO_Biological_Process_2021__negative regulation of coagulation (GO:0050819),0.8376441084283185,1.2429418278899789,0.10714285714285714,0.8368702276162914,1.0,3/6,14.10%,HS3ST5;THBD;SERPINE2
prerank,PanglaoDB_Augmented_2021__Erythroblasts,-0.44041836825431885,-1.2429260781416727,0.0,0.9575695582645563,1.0,16/71,10.31%,GRAP2;TAL1;LYL1;RHOG;P2RX1;SH2B3;HHEX;RPIA;ETS1;ARHGDIB;FAM78A;SIPA1;EPOR;ENG;NMI;BTK
prerank,GO_Biological_Process_2021__regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893),0.64523227974331,1.2427368403299393,0.24096385542168675,0.8372715687203169,1.0,6/31,9.56%,KLF4;TGFB2;EGR1;NFIB;HIF1A;POU5F1
prerank,GO_Biological_Process_2021__positive regulation of angiogenesis (GO:0045766),0.5899454845968854,1.2422337200351066,0.13333333333333333,0.8390707913056527,1.0,15/62,13.35%,THBS1;KLF4;RHOB;FGF1;CHI3L1;VEGFA;HIF1A;RAPGEF3;ITGB8;SEMA5A;FLT1;SASH1;BRCA1;GAB1;PKM
prerank,PanglaoDB_Augmented_2021__Olfactory Epithelial Cells,0.5919250835108414,1.2419661372585407,0.0625,0.839523088203673,1.0,33/113,16.87%,FLRT1;METRN;GRAMD1C;SPOCK1;CARNS1;B4GAT1;NRG1;CASKIN1;SYBU;SRRM3;ARFGEF3;SRCIN1;LINGO1;ENDOD1;KCTD1;MAP2;RETREG1;PDE1C;ADGRB2;CSPG5;CKB;CELSR2;FAM81A;TTC5;IFT74;OSCP1;GNAL;NDRG4;CPE;EPB41L4B;EML2;APLP1;HSPA12A
prerank,GO_Biological_Process_2021__positive regulation of telomere capping (GO:1904355),-0.65205788015704,-1.2417942120813108,0.25,0.9592210098340886,1.0,2/12,9.48%,PKIB;MAP3K4
prerank,GO_Biological_Process_2021__regulation of store-operated calcium entry (GO:2001256),-0.7657378202262481,-1.2412339227128404,0.24242424242424243,0.9579984473541461,1.0,1/6,4.59%,STIM1
prerank,GO_Biological_Process_2021__positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261),-0.5218694586652654,-1.2407231166655854,0.12,0.956462883738452,1.0,8/18,18.30%,PSMC4;TP53;MED12;MED24;MED4;MED1;PAXIP1;MED30
prerank,MSigDB_Hallmark_2020__Hypoxia,0.5897555890615966,1.2405120055832914,0.10526315789473684,0.8467556288965145,1.0,32/129,15.59%,DDIT4;NFIL3;SAP30;PLIN2;PLAC8;NCAN;SLC2A3;VEGFA;HSPA5;NOCT;NDRG1;ENO2;KDM3A;BHLHE40;FOSL2;AKAP12;BNIP3L;RBPJ;IRS2;P4HA1;FAM162A;ERRFI1;MXI1;GPI;FBP1;PPP1R15A;PHKG1;HDLBP;TGFBI;ZNF292;KIF5A;PDK3
prerank,PanglaoDB_Augmented_2021__Epsilon Cells,0.6466930172024301,1.240435483562098,0.18518518518518517,0.8460783330109137,1.0,10/33,12.09%,PLPP3;THSD4;ACSL1;FAXDC2;AGT;CGNL1;ACSS3;FAM124A;KALRN;SORBS1
prerank,GO_Biological_Process_2021__regulation of stem cell proliferation (GO:0072091),0.7905931550451943,1.2403287655586128,0.1917808219178082,0.845430543690468,1.0,2/8,9.50%,HMGB2;KDM1A
prerank,GO_Biological_Process_2021__humoral immune response mediated by circulating immunoglobulin (GO:0002455),-0.7161967256277402,-1.240151510380988,0.2857142857142857,0.9562191859115641,1.0,3/6,23.15%,C1QC;CD81;C1QB
prerank,GO_Biological_Process_2021__substrate adhesion-dependent cell spreading (GO:0034446),0.6353515412396341,1.240122725185636,0.1875,0.8455959833933571,1.0,8/31,11.25%,NTN4;LAMB1;SRCIN1;TMEFF2;FN1;MICALL2;MEGF9;TYRO3
prerank,GO_Biological_Process_2021__negative regulation of leukocyte cell-cell adhesion (GO:1903038),-0.6012462380575248,-1.2400816754873725,0.12,0.9533435014321058,1.0,3/12,4.42%,FGL1;DUSP3;IL4I1
prerank,GO_Biological_Process_2021__cellular response to oxygen-containing compound (GO:1901701),0.568038307611459,1.2400068027022986,0.04040404040404041,0.8449782271169062,1.0,34/188,15.59%,KCNE1;GLRA1;AANAT;TSHR;VIM;EGR1;HMGB2;MAPT;BRINP1;RORB;PTPRK;PDK4;NSMF;DAPK1;AKAP6;EPHA3;RUVBL2;PTK7;RAPGEF3;PDE2A;PDE4B;PDCD1LG2;IMPACT;NOD2;RYR3;TNFRSF1B;NR4A3;GUCY1B1;INSIG1;HCN1;PYCARD;WNT5A;ESR1;PDK3
prerank,GO_Biological_Process_2021__glycosyl compound catabolic process (GO:1901658),0.793545635532745,1.2398850210683254,0.19672131147540983,0.8433646704761895,1.0,1/6,2.27%,GLA
prerank,GO_Biological_Process_2021__glycoside metabolic process (GO:0016137),0.793545635532745,1.2398850210683254,0.19672131147540983,0.8433646704761895,1.0,1/6,2.27%,GLA
prerank,GO_Biological_Process_2021__surfactant homeostasis (GO:0043129),0.8030403578704568,1.2394831899352312,0.16417910447761194,0.8432076022699759,1.0,1/5,5.04%,VEGFA
prerank,GO_Biological_Process_2021__chemical homeostasis within a tissue (GO:0048875),0.8030403578704568,1.2394831899352312,0.16417910447761194,0.8432076022699759,1.0,1/5,5.04%,VEGFA
prerank,GO_Biological_Process_2021__negative regulation of multicellular organismal process (GO:0051241),0.5560569812085331,1.239463674150719,0.10309278350515463,0.8421069023423913,1.0,20/116,10.44%,HS3ST5;LRP4;NLRP12;ARRDC3;IL15;NFIB;PTPRG;SLC11A1;SRGN;VASN;GPNMB;FCGR2B;RGS2;SFMBT1;OVOL2;ACOT13;ROBO1;SPRY1;RBPJ;NOVA1
prerank,GO_Biological_Process_2021__endosome to lysosome transport via multivesicular body sorting pathway (GO:0032510),-0.6755641844664543,-1.2392979148772756,0.17857142857142858,0.9535893256511285,1.0,3/6,21.06%,CHMP2B;LYST;VPS4B
prerank,GO_Biological_Process_2021__positive regulation of cell projection organization (GO:0031346),0.5752472173664096,1.2391487995848545,0.1326530612244898,0.8429016817898406,1.0,28/88,19.47%,METRN;PTPRD;RELN;IL1RAPL1;ROBO2;ZNF804A;EPHA3;PTK7;ROBO1;PTN;SS18L1;CARMIL1;NTRK3;CAMK2B;NTRK2;MAGI2;LRRC7;STMN2;PLXNB1;WNT5A;NDRG4;ARHGDIA;MAP3K13;PLXNC1;ATP1B2;FES;DLG4;CHODL
prerank,GO_Biological_Process_2021__regulation of blood coagulation (GO:0030193),0.7491453958131801,1.2380802401851116,0.21875,0.8485065964304308,1.0,4/9,14.33%,THBS1;THBD;SERPINE2;ENPP4
prerank,GO_Biological_Process_2021__cation transport (GO:0006812),0.5686359045856815,1.2380202157045328,0.14444444444444443,0.8477695676044629,1.0,21/71,21.98%,LRP2;KCNJ13;SCN3B;SLC5A9;SLC9B2;SCN3A;KCNMB1;SCN1A;SCN8A;SCN2A;PIEZO2;KCNJ6;KCNMA1;KCNB2;KCNJ3;TAF7;TRPM7;SLC3A2;ATP1A2;SLC5A6;CHP1
prerank,GO_Biological_Process_2021__regulation of cAMP-dependent protein kinase activity (GO:2000479),0.744818342968268,1.2379113257717056,0.17721518987341772,0.8473464201576525,1.0,2/12,1.97%,PKIA;PRKAR2B
prerank,GO_Biological_Process_2021__protein localization to cilium (GO:0061512),0.6752011248353751,1.2377215471523946,0.1282051282051282,0.8471816675935481,1.0,5/24,12.80%,TULP2;TUB;FSIP2;TULP3;SNX10
prerank,GO_Biological_Process_2021__negative regulation of histone methylation (GO:0031061),0.7348390172871884,1.2371378736075505,0.2702702702702703,0.8496532037609532,1.0,3/11,12.87%,WDR5;KDM1A;BRCA1
prerank,GO_Biological_Process_2021__attachment of mitotic spindle microtubules to kinetochore (GO:0051315),0.8189969652490674,1.2364559482713315,0.21428571428571427,0.8524011728525301,1.0,2/8,15.76%,CENPE;SEH1L
prerank,GO_Biological_Process_2021__response to tumor necrosis factor (GO:0034612),-0.4117409083468482,-1.2364482031704365,0.16666666666666666,0.961284372755407,1.0,5/56,3.78%,CCL5;GBP3;INPP5K;CHUK;DAB2IP
prerank,GO_Biological_Process_2021__axonogenesis (GO:0007409),0.5718015785302208,1.236143927404199,0.061855670103092786,0.8530251935954906,1.0,55/162,21.44%,RAP1GAP;SHANK3;SEMA3A;NTN4;DCC;RELN;ENAH;PLPPR4;NRXN1;DOK6;LAMA2;SEMA3B;ROBO2;ANK3;SEMA6A;EPHA3;GRB10;NLGN3;PALLD;NRXN3;ROBO1;IRS2;MAP1B;UNC5D;SLITRK5;SEMA5A;SPTAN1;UNC5C;EPHA7;B4GALT5;SLC9A6;EPHA4;PARD3;CCK;GAB1;CTNNA2;EPHA6;EPHA5;WNT5A;SPTBN5;DAB1;KIF5A;SPTBN1;APP;KLF7;SPG11;NTNG1;SPTBN4;CDK5R1;NCAM1;NOTCH2;CNTN2;FGFR2;KIF5C;PAK3
prerank,PanglaoDB_Augmented_2021__Spermatocytes,0.7928963804637942,1.2358825290840747,0.2318840579710145,0.8534724719309524,1.0,1/6,7.03%,SYCP3
prerank,PanglaoDB_Augmented_2021__Parathyroid Chief Cells,0.5950744890565933,1.2358744417629843,0.16470588235294117,0.8523862622419927,1.0,15/41,18.98%,LRP2;VEGFA;CTNND2;ANK2;LINGO1;ARNT2;GALNT18;CRMP1;NTRK2;SH3GL2;CPE;APP;STARD13;SCG5;SPTBN4
prerank,GO_Biological_Process_2021__protein oxidation (GO:0018158),-0.7603387838332473,-1.2354471842754393,0.28125,0.9621335813435629,1.0,1/5,0.84%,LOXL3
prerank,GO_Biological_Process_2021__inositol phosphate catabolic process (GO:0071545),-0.5986067127463939,-1.2351432891265477,0.19444444444444445,0.9599066105503932,1.0,2/11,10.33%,INPP5K;OCRL
prerank,GO_Biological_Process_2021__protein deglutamylation (GO:0035608),0.8576546237685501,1.2349850744150146,0.14516129032258066,0.8563093652522478,1.0,3/6,7.57%,FOLH1;AGBL3;AGTPBP1
prerank,GO_Biological_Process_2021__regulation of vesicle fusion (GO:0031338),0.8121379295436599,1.2349433808739303,0.17647058823529413,0.8552892315456878,1.0,1/7,3.87%,ANXA1
prerank,GO_Biological_Process_2021__cellular response to interleukin-15 (GO:0071350),0.746078776887932,1.2348063597115415,0.21621621621621623,0.8538189001440202,1.0,2/10,16.96%,IL15;PLCB1
prerank,GO_Biological_Process_2021__interleukin-15-mediated signaling pathway (GO:0035723),0.746078776887932,1.2348063597115415,0.21621621621621623,0.8538189001440202,1.0,2/10,16.96%,IL15;PLCB1
prerank,GO_Biological_Process_2021__regulation of cytoplasmic mRNA processing body assembly (GO:0010603),-0.6998025474773071,-1.234646325940326,0.3684210526315789,0.958832366907138,1.0,2/6,11.08%,NBDY;CNOT6L
prerank,GO_Biological_Process_2021__positive regulation of homotypic cell-cell adhesion (GO:0034112),-0.6281141441990554,-1.2345779026197747,0.20689655172413793,0.9558494112824356,1.0,1/7,0.45%,CCL5
prerank,GO_Biological_Process_2021__dosage compensation by inactivation of X chromosome (GO:0009048),0.6956392883929143,1.2345746731560947,0.25333333333333335,0.8540877943857045,1.0,6/11,27.38%,BRCA1;RLIM;LRIF1;PCGF5;HNRNPU;PCGF3
prerank,GO_Biological_Process_2021__activation of cysteine-type endopeptidase activity (GO:0097202),0.73984305729319,1.2345465575464605,0.1780821917808219,0.8530498446447922,1.0,4/10,15.86%,GRIN2A;RIPK2;ASPH;CIDEB
prerank,GO_Biological_Process_2021__mitochondrial RNA processing (GO:0000963),0.8181407353383768,1.234421336022777,0.17142857142857143,0.8525471535358118,1.0,1/6,1.87%,TBRG4
prerank,GO_Biological_Process_2021__negative regulation of protein kinase activity by regulation of protein phosphorylation (GO:0044387),-0.7704380816148997,-1.2342072472583594,0.25,0.9537047716405422,1.0,2/5,12.15%,ADARB1;PPM1F
prerank,GO_Biological_Process_2021__negative regulation of mitochondrial fusion (GO:0010637),0.8381462672423161,1.234118000387351,0.20270270270270271,0.8534147557118534,1.0,2/5,13.05%,TFRC;BNIP3
prerank,GO_Biological_Process_2021__positive regulation of sodium ion transport (GO:0010765),0.8085589091260099,1.2338180380559023,0.1935483870967742,0.8541074035547103,1.0,3/7,7.48%,SCN3B;ANK3;PKP2
prerank,GO_Biological_Process_2021__alpha-amino acid metabolic process (GO:1901605),0.6549171949493149,1.2335431731049082,0.17647058823529413,0.8546523352808194,1.0,3/25,1.94%,KMO;FOLH1;ASPA
prerank,GO_Biological_Process_2021__cell junction assembly (GO:0034329),0.5974273537515103,1.2330574572903779,0.11494252873563218,0.8560692351081566,1.0,16/56,9.37%,SHANK3;GPM6A;CDH8;NRXN1;CDH2;NRXN2;CDH9;CTNND2;SHANK2;PKP2;NLGN3;CDH20;NLGN1;FN1;DNM3;CDH12
prerank,GO_Biological_Process_2021__negative regulation of transcription by RNA polymerase I (GO:0016479),-0.7112561193725286,-1.2329713596198517,0.2857142857142857,0.9555360864051929,1.0,1/5,0.68%,FLNA
prerank,GO_Biological_Process_2021__positive regulation of locomotion (GO:0040017),0.7057300163024873,1.2328851370903793,0.22857142857142856,0.8558830298452292,1.0,1/15,0.28%,THBS1
prerank,GO_Biological_Process_2021__cAMP metabolic process (GO:0046058),0.7707019222780147,1.2326909511171413,0.23684210526315788,0.8559612992939472,1.0,3/9,10.81%,ADCY3;ADCY10;ADCY8
prerank,GO_Biological_Process_2021__myelin maintenance (GO:0043217),0.7483155900302173,1.2326673465284133,0.24615384615384617,0.8549454474200417,1.0,4/7,24.75%,MYRF;SOD1;PTEN;EPB41L3
prerank,GO_Biological_Process_2021__positive regulation of chemotaxis (GO:0050921),0.6386687323794671,1.2321186143431535,0.16883116883116883,0.8571042863427376,1.0,5/26,10.26%,THBS1;VEGFA;PTN;NTRK3;SEMA5A
prerank,GO_Biological_Process_2021__negative regulation of T-helper cell differentiation (GO:0045623),0.852289702716283,1.2317295618132522,0.15151515151515152,0.8582977062866924,1.0,1/5,3.87%,ANXA1
prerank,GO_Biological_Process_2021__AMP metabolic process (GO:0046033),-0.7004925774844247,-1.2311417997156526,0.3,0.959368191281476,1.0,3/6,17.23%,AMPD3;NUDT2;AK9
prerank,GO_Biological_Process_2021__positive regulation of microtubule polymerization or depolymerization (GO:0031112),0.6849118634183005,1.2307454816985997,0.1951219512195122,0.863254692238638,1.0,7/21,19.33%,MAPT;CAV3;STMN2;TOGARAM1;DCTN1;FES;CDK5R1
prerank,GO_Biological_Process_2021__actin filament reorganization (GO:0090527),-0.7155199095490455,-1.2306596650326733,0.21875,0.958236350863066,1.0,2/6,11.55%,WHAMM;GSN
prerank,GO_Biological_Process_2021__positive regulation of T cell apoptotic process (GO:0070234),-0.8053278939158486,-1.2305319453724965,0.14814814814814814,0.955496862080352,1.0,4/6,6.50%,CCL5;LGALS9;CD274;TP53
prerank,GO_Biological_Process_2021__chromatin organization involved in negative regulation of transcription (GO:0097549),-0.7399001340768316,-1.2302778173057174,0.30303030303030304,0.9533119983721086,1.0,2/5,10.21%,BAHD1;POLE3
prerank,GO_Biological_Process_2021__negative regulation of immune effector process (GO:0002698),0.7019144717009911,1.2296926155858607,0.16,0.8677261570054117,1.0,5/13,21.87%,CR1;CD55;CD300A;SLAMF8;APPL1
prerank,GO_Biological_Process_2021__negative regulation of membrane potential (GO:0045837),0.7897633565917344,1.2296312339006361,0.16666666666666666,0.8668974283244156,1.0,3/7,13.42%,MAPT;BNIP3;PRELID1
prerank,GO_Biological_Process_2021__neuropeptide signaling pathway (GO:0007218),0.6973664656261878,1.2294924447449316,0.1643835616438356,0.8665284573815418,1.0,3/15,6.22%,GLRA1;MCHR2;LTB4R
prerank,GO_Biological_Process_2021__ion transport (GO:0006811),0.6010372540214268,1.2291717833589466,0.18681318681318682,0.8672308331522762,1.0,11/59,15.70%,GLRA1;SLC1A2;SLC24A2;GABRB1;SLC9A7;SLC24A1;SLC9A6;GLRB;SLC17A7;PIEZO2;SLC24A3
prerank,GO_Biological_Process_2021__dermatan sulfate biosynthetic process (GO:0030208),0.8112955864909781,1.2283788267868434,0.19444444444444445,0.8703688151902783,1.0,3/7,9.58%,NCAN;VCAN;CSPG5
prerank,GO_Biological_Process_2021__phosphatidylcholine catabolic process (GO:0034638),0.7875743964263071,1.2281746694289046,0.30666666666666664,0.8705042713988937,1.0,2/7,16.37%,ENPP2;PNPLA8
prerank,GO_Biological_Process_2021__positive regulation of cellular metabolic process (GO:0031325),0.5791629009746427,1.2280890195475704,0.16129032258064516,0.8699243969474154,1.0,12/64,13.49%,THBS1;KLF4;CBR1;AGT;VEGFA;INSR;PAX8;IFNLR1;MAGI2;NSF;PRELID1;FASN
prerank,GO_Biological_Process_2021__embryonic appendage morphogenesis (GO:0035113),0.8101098620209275,1.2280675877051663,0.08695652173913043,0.8688787723068074,1.0,1/7,1.28%,TGFB2
prerank,GO_Biological_Process_2021__regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880),0.7232901034611474,1.227876425085837,0.20270270270270271,0.86861382896887,1.0,5/15,9.36%,DMD;ANK2;AKAP6;CALM3;RYR2
prerank,GO_Biological_Process_2021__regulation of response to cytokine stimulus (GO:0060759),0.7023687411257888,1.227363138754447,0.22666666666666666,0.8702526905946081,1.0,2/15,4.53%,KLF4;LIFR
prerank,GO_Biological_Process_2021__regulation of ketone biosynthetic process (GO:0010566),0.83665114759938,1.2271656878819606,0.16666666666666666,0.8704132403838203,1.0,2/5,9.10%,EGR1;SIRT5
prerank,GO_Biological_Process_2021__peptide metabolic process (GO:0006518),0.6094949034450964,1.2270044142420238,0.14444444444444443,0.8702634907738357,1.0,11/45,18.25%,PCSK1;DMD;GLRX2;CPM;BACE2;TRHDE;CPE;LTA4H;CARNMT1;GSTP1;SOD1
prerank,GO_Biological_Process_2021__dermatan sulfate proteoglycan biosynthetic process (GO:0050651),0.7468066516094845,1.2269815534595985,0.19444444444444445,0.8692244998230195,1.0,3/10,9.58%,NCAN;VCAN;CSPG5
prerank,GO_Biological_Process_2021__positive regulation of vasculogenesis (GO:2001214),-0.7318617577797752,-1.2269586668384167,0.3548387096774194,0.9626405812097664,1.0,2/5,14.14%,RIN2;RAP1A
prerank,MSigDB_Hallmark_2020__Myogenesis,0.5899498849186258,1.2268247640972294,0.13978494623655913,0.8689480070542969,1.0,20/97,12.09%,DAPK2;SPARC;PKIA;ACSL1;PFKM;CKMT2;LDB3;GADD45B;GNAO1;DMD;LAMA2;FHL1;BHLHE40;CAV3;SVIL;CKB;SPTAN1;CAMK2B;PDE4DIP;SORBS1
prerank,GO_Biological_Process_2021__glycosaminoglycan metabolic process (GO:0030203),0.6375049980570379,1.2264521375513802,0.2125,0.86985524925457,1.0,4/31,6.20%,HS3ST5;HS3ST2;GPC5;GNS
prerank,GO_Biological_Process_2021__membrane lipid metabolic process (GO:0006643),-0.6148595899312468,-1.2264465720268336,0.16666666666666666,0.9613224509638743,1.0,2/12,5.51%,ARV1;TECR
prerank,GO_Biological_Process_2021__positive regulation of cellular carbohydrate metabolic process (GO:0010676),0.8431699059536659,1.2261863894397702,0.23076923076923078,0.8702207101219999,1.0,2/5,9.28%,PRKCE;IRS2
prerank,GO_Biological_Process_2021__regulation of peptidyl-serine phosphorylation (GO:0033135),0.5887901299083738,1.2261829788559568,0.1348314606741573,0.8690591470436879,1.0,13/66,13.26%,DDIT4;ARAF;TFRC;MTCP1;DMD;VEGFA;PAQR3;RAPGEF3;TXN;NTRK3;HCLS1;RIPK2;PINK1
prerank,GO_Biological_Process_2021__mucosal immune response (GO:0002385),0.8390181180800386,1.2261749042654002,0.15625,0.867926327987401,1.0,3/5,12.22%,H2BC11;IFNLR1;OTUD7B
prerank,GO_Biological_Process_2021__neuron projection regeneration (GO:0031102),0.767080984369663,1.2261634461157125,0.22388059701492538,0.8668605048713259,1.0,3/8,12.06%,OMG;PTN;NREP
prerank,GO_Biological_Process_2021__positive regulation of sodium ion transmembrane transport (GO:1902307),0.7320790076291398,1.225856016151554,0.2571428571428571,0.8673046589047116,1.0,4/9,18.33%,DMD;ANK3;ATP1B3;ATP1B2
prerank,GO_Biological_Process_2021__cellular response to hydrogen peroxide (GO:0070301),0.6394568181692059,1.2258085996152235,0.19047619047619047,0.8663318164583886,1.0,3/24,10.79%,RHOB;ANXA1;IMPACT
prerank,GO_Biological_Process_2021__regulation of cell size (GO:0008361),0.6696007312570816,1.2252100854724306,0.15294117647058825,0.8686352209849583,1.0,3/20,9.06%,PRR16;CAV3;DEPTOR
prerank,GO_Biological_Process_2021__macrophage differentiation (GO:0030225),0.7202463503026013,1.2250355575251206,0.21052631578947367,0.8685791026316795,1.0,2/9,5.04%,IL15;VEGFA
prerank,GO_Biological_Process_2021__regulation of hippo signaling (GO:0035330),0.6683863385646756,1.2247700841412763,0.203125,0.869209141454504,1.0,5/13,15.05%,CIT;SHANK2;MOB3B;LIMD1;IQCJ-SCHIP1
prerank,GO_Biological_Process_2021__p38MAPK cascade (GO:0038066),-0.7627487858698305,-1.2247153120435745,0.275,0.9653644465910088,1.0,3/5,15.53%,LGALS9;MAP2K3;ZFP36
prerank,GO_Biological_Process_2021__positive regulation of bone resorption (GO:0045780),-0.7071032120256766,-1.2246189422587896,0.2,0.9624193011766058,1.0,5/7,22.20%,PLEKHM1;DEF8;SYK;PRKCA;ATP6AP1
prerank,GO_Biological_Process_2021__regulation of TOR signaling (GO:0032006),0.5948994334062794,1.224297709560818,0.15853658536585366,0.8707128922796876,1.0,2/51,1.00%,DDIT4;ARAF
prerank,GO_Biological_Process_2021__positive regulation of nervous system development (GO:0051962),0.6283241094188494,1.2242610955781383,0.21428571428571427,0.8698053409324599,1.0,6/31,7.94%,LRP2;PTPRD;IL1RAPL1;NRXN1;NLGN3;NLGN1
prerank,GO_Biological_Process_2021__response to retinoic acid (GO:0032526),0.63806809481538,1.2239882500601562,0.13095238095238096,0.8702161276522894,1.0,8/27,15.06%,BRINP1;TMEM161A;RORB;RXRB;EPHA3;PTK7;TRIM16;WNT5A
prerank,GO_Biological_Process_2021__ATP transport (GO:0015867),0.7811926825167205,1.2239596712575154,0.2,0.8691979242378878,1.0,1/8,1.54%,CR1
prerank,GO_Biological_Process_2021__negative regulation of pathway-restricted SMAD protein phosphorylation (GO:0060394),-0.7599767066041939,-1.223715559113756,0.29411764705882354,0.9630755273187446,1.0,2/5,5.78%,PMEPA1;SNX25
prerank,GO_Biological_Process_2021__histone H2B ubiquitination (GO:0033523),-0.610292415306233,-1.2235275182250738,0.2702702702702703,0.9604950483437603,1.0,4/9,22.80%,LEO1;RNF8;RNF20;CDC73
prerank,GO_Biological_Process_2021__negative regulation of cellular metabolic process (GO:0031324),0.6586098856554342,1.2232354602780051,0.1566265060240964,0.8726371019611172,1.0,11/24,26.37%,ABCA2;SIRT5;BRCA1;PINK1;SDCBP;ITGAV;AP1AR;DLG4;TRAP1;BTN2A2;LRPAP1
prerank,GO_Biological_Process_2021__membrane depolarization (GO:0051899),0.6942325482933814,1.2232135839549196,0.26136363636363635,0.8716183885102701,1.0,8/18,16.34%,SCN3B;SCN3A;CACNG2;SCN1A;CACNA1B;SCN8A;SCN2A;CACNA1A
prerank,GO_Biological_Process_2021__positive regulation of phosphoprotein phosphatase activity (GO:0032516),0.7339294547031405,1.222765236311523,0.225,0.8730692397867312,1.0,4/12,13.87%,CALM3;MAGI2;CD300A;PPP1R15A
prerank,GO_Biological_Process_2021__negative regulation of phosphatase activity (GO:0010923),0.7094371156984546,1.222531090510645,0.17567567567567569,0.8731838960547207,1.0,5/19,13.87%,TGFB2;SH2D4A;MASTL;PPP4R4;PPP1R15A
prerank,GO_Biological_Process_2021__linoleic acid metabolic process (GO:0043651),0.734841717200729,1.222221103873633,0.2328767123287671,0.8737124917778372,1.0,5/10,17.54%,ACSL1;ALOX12;ALOX15B;PNPLA8;GSTP1
prerank,GO_Biological_Process_2021__positive regulation of cell migration involved in sprouting angiogenesis (GO:0090050),0.745883404428193,1.2221410499905543,0.18666666666666668,0.8731239675263917,1.0,2/10,5.04%,ANXA1;VEGFA
prerank,GO_Biological_Process_2021__mesenchyme morphogenesis (GO:0072132),0.7765205927489338,1.2216266387905927,0.16393442622950818,0.8748781821008784,1.0,1/7,1.28%,TGFB2
prerank,GO_Biological_Process_2021__negative regulation of myeloid leukocyte mediated immunity (GO:0002887),-0.7304464451545517,-1.221531780976975,0.2727272727272727,0.96527450373849,1.0,2/5,3.60%,CX3CR1;LGALS9
prerank,GO_Biological_Process_2021__embryo development ending in birth or egg hatching (GO:0009792),0.7456090034233958,1.2210120117782604,0.19444444444444445,0.8770778972782557,1.0,2/9,12.87%,TGFB2;BRCA1
prerank,GO_Biological_Process_2021__cellular response to granulocyte macrophage colony-stimulating factor stimulus (GO:0097011),-0.8009645177056068,-1.220514763739812,0.27586206896551724,0.9628665040688781,1.0,3/5,15.53%,NPR2;PDE1B;ZFP36
prerank,GO_Biological_Process_2021__response to granulocyte macrophage colony-stimulating factor (GO:0097012),-0.8009645177056068,-1.220514763739812,0.27586206896551724,0.9628665040688781,1.0,3/5,15.53%,NPR2;PDE1B;ZFP36
prerank,GO_Biological_Process_2021__positive regulation of tissue remodeling (GO:0034105),0.8152029654329738,1.2201112113344026,0.13846153846153847,0.8810324727864471,1.0,3/5,17.16%,IL15;IL18;ROCK1
prerank,GO_Biological_Process_2021__regulation of cysteine-type endopeptidase activity (GO:2000116),0.7058567350038648,1.2198752572803429,0.2375,0.8809611897658426,1.0,6/14,14.69%,NLRP12;BEX3;EPHA7;GRIN2B;PYCARD;AIM2
prerank,GO_Biological_Process_2021__activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c (GO:0008635),0.8586111233531197,1.21987406402547,0.1780821917808219,0.8798065879443931,1.0,2/5,12.41%,BOK;CYCS
prerank,PanglaoDB_Augmented_2021__Loop Of Henle Cells,0.6051359858974167,1.2196576212651555,0.13953488372093023,0.8799361006781998,1.0,17/58,18.26%,THBS1;PLPP3;TNS1;DOCK1;ENC1;CGNL1;LAMA2;KCNT1;SASH1;SHROOM4;TIMP3;SMARCD3;LDB2;NRGN;EPAS1;SORBS2;IGFBP7
prerank,GO_Biological_Process_2021__negative regulation of cAMP-dependent protein kinase activity (GO:2000480),0.7832000211451363,1.2193198137784345,0.18666666666666668,0.8808726741513182,1.0,2/8,1.97%,PKIA;PRKAR2B
prerank,GO_Biological_Process_2021__protein processing (GO:0016485),0.5915728311635973,1.2192246873665011,0.14736842105263157,0.8802809488706798,1.0,5/57,10.66%,PCSK1;MYRF;SRGN;CPM;TYSND1
prerank,GO_Biological_Process_2021__sphingolipid metabolic process (GO:0006665),0.5984271386619834,1.2191682743918653,0.10752688172043011,0.879368648953985,1.0,17/78,17.64%,FA2H;PLPP3;ALDH3B1;ENPP2;GLA;VAPB;ABCA2;ELOVL4;ARSA;GALC;PPM1L;UGT8;SPTLC2;UGCG;SUMF2;PRKD3;SUMF1
prerank,GO_Biological_Process_2021__cellular response to interleukin-7 (GO:0098761),0.7356978439066483,1.2189991574129693,0.2191780821917808,0.8781195853725791,1.0,4/10,21.59%,IL7;IRS2;IL7R;BRWD1
prerank,GO_Biological_Process_2021__interleukin-7-mediated signaling pathway (GO:0038111),0.7356978439066483,1.2189991574129693,0.2191780821917808,0.8781195853725791,1.0,4/10,21.59%,IL7;IRS2;IL7R;BRWD1
prerank,GO_Biological_Process_2021__regulation of nitric oxide mediated signal transduction (GO:0010749),0.8434014423469466,1.2187359545342973,0.20967741935483872,0.878262620697635,1.0,2/5,5.04%,THBS1;VEGFA
prerank,GO_Biological_Process_2021__regulation of membrane depolarization (GO:0003254),0.7568514452370024,1.218454180921999,0.25,0.8788366551765208,1.0,3/9,8.38%,SCN3B;FHL1;CAV3
prerank,PanglaoDB_Augmented_2021__Ependymal Cells,0.6237079961106516,1.21830411873313,0.2073170731707317,0.8785968152653912,1.0,11/32,19.28%,GFAP;RFX2;TMEM232;PTPRT;CELSR2;CFAP54;PLTP;DNAH7;ENKUR;HSPA2;SPAG6
prerank,GO_Biological_Process_2021__release of sequestered calcium ion into cytosol (GO:0051209),0.7048003388210293,1.21814653919292,0.2,0.8785051115883336,1.0,4/15,12.36%,HTR2B;RYR2;IBTK;RYR3
prerank,GO_Biological_Process_2021__neuron development (GO:0048666),0.5661504608730641,1.217931694899672,0.13402061855670103,0.8783768135961277,1.0,28/96,17.73%,TGFB2;GPM6A;PPP1R9A;MAPT;MANF;GPM6B;PQBP1;LAMB1;HDGFL3;STMN3;NLGN1;MAP2;MICALL2;ALK;CNTNAP2;B4GALT5;PLP1;NTRK2;TMEM108;SH3GL2;STMN2;EPHA5;RASGRF1;UGCG;ROCK1;APP;ERCC6;NCDN
prerank,GO_Biological_Process_2021__positive regulation of ligase activity (GO:0051351),0.7831035690970658,1.2177984951669723,0.19230769230769232,0.877966837935337,1.0,2/8,9.13%,ANTKMT;MID1IP1
prerank,GO_Biological_Process_2021__Fc-epsilon receptor signaling pathway (GO:0038095),-0.43280702910070423,-1.2168979226982748,0.14285714285714285,0.971748846529467,1.0,17/97,15.17%,ITK;GRAP2;PSMB3;PSME3;CHUK;PSMC4;PSMD12;PSME4;NFATC3;BTK;IKBKB;LCP2;SYK;PSMA1;BCL10;CARD11;PSMA7
prerank,GO_Biological_Process_2021__response to muscle stretch (GO:0035994),0.7322173291772168,1.2166277049430085,0.20512820512820512,0.8842684254372424,1.0,4/11,9.36%,CDH2;DMD;CAV3;RYR2
prerank,GO_Biological_Process_2021__regulation of striated muscle contraction (GO:0006942),0.7040862099665426,1.216394291137852,0.18055555555555555,0.8844022585906895,1.0,5/14,9.36%,DMD;ANK2;CAV3;CALM3;RYR2
prerank,GO_Biological_Process_2021__cardiac left ventricle morphogenesis (GO:0003214),0.8242166518476469,1.2163855563599597,0.2222222222222222,0.8833265646149491,1.0,3/6,15.32%,RBPJ;RYR2;CPE
prerank,GO_Biological_Process_2021__T cell activation (GO:0042110),-0.44600481851304974,-1.2159060527245091,0.06666666666666667,0.9721410139638231,1.0,3/39,2.67%,ITK;CD276;CD2
prerank,GO_Biological_Process_2021__heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),0.650958371307819,1.2157038103421383,0.20512820512820512,0.8856935505777971,1.0,6/20,12.37%,CADM1;PTPRD;IL1RAPL1;NLGN1;ALCAM;GRID2
prerank,GO_Biological_Process_2021__protein O-linked mannosylation (GO:0035269),0.6972566407859851,1.2156794748581805,0.1891891891891892,0.8846798725526067,1.0,3/14,8.68%,B4GAT1;SDF2L1;TMTC2
prerank,GO_Biological_Process_2021__positive regulation of B cell differentiation (GO:0045579),-0.7643450113929322,-1.2156247800199078,0.34375,0.9697652091855468,1.0,4/6,21.44%,NCKAP1L;BTK;SYK;PPP2R3C
prerank,GO_Biological_Process_2021__negative regulation of tubulin deacetylation (GO:1904428),0.8129332928901666,1.2154210129371341,0.16176470588235295,0.8850315004102072,1.0,3/5,18.04%,MAPT;TPPP;PRKAA2
prerank,GO_Biological_Process_2021__inclusion body assembly (GO:0070841),0.816187340757252,1.2153973545167505,0.140625,0.8839848070383918,1.0,2/5,15.46%,MAPT;BAG3
prerank,GO_Biological_Process_2021__positive regulation of transforming growth factor beta production (GO:0071636),0.7478158832127659,1.2153433112807435,0.3230769230769231,0.8830985548989542,1.0,1/7,0.28%,THBS1
prerank,GO_Biological_Process_2021__hexose transmembrane transport (GO:0008645),0.7642912752993003,1.215328892432024,0.26865671641791045,0.882093358643891,1.0,3/8,4.98%,SLC2A3;SLC2A9;SLC5A9
prerank,GO_Biological_Process_2021__positive regulation of nucleocytoplasmic transport (GO:0046824),-0.5131704431618004,-1.214448008132638,0.2222222222222222,0.9717049489785657,1.0,6/38,7.51%,FLNA;NEDD4;IL1B;ZPR1;TP53;TGFB1
prerank,GO_Biological_Process_2021__adherens junction assembly (GO:0034333),-0.7130393390293785,-1.2144117785132789,0.2608695652173913,0.9687958382181422,1.0,2/9,3.45%,ZNF703;ACTB
prerank,GO_Biological_Process_2021__central nervous system development (GO:0007417),0.576722131130319,1.2142925664366737,0.0707070707070707,0.8866953644048035,1.0,42/160,15.09%,DDIT4;IL1RAPL2;LSR;MAL;ZBTB16;SPOCK1;NCAN;RELN;VCAN;MYRF;NR4A2;NFIB;MEIS2;CDH2;AATK;SOX4;CA10;ROBO2;MOG;SH3GL3;PTPRZ1;MARCKSL1;GRIN2A;GRIK1;ARNT2;POU6F1;PAX8;TAGLN3;ADAM23;MFSD2A;CNTNAP2;EPHA7;SOX6;ADGRL2;SH3GL2;SHROOM4;TPPP;UGT8;PKD1;EIF2B2;GRIN2B;NDRG4
prerank,GO_Biological_Process_2021__cellular copper ion homeostasis (GO:0006878),0.7218442203189017,1.2141490898997258,0.2602739726027397,0.8862442739528946,1.0,3/8,17.45%,ATOX1;SLC31A2;APP
prerank,GO_Biological_Process_2021__intracellular cholesterol transport (GO:0032367),-0.5659638281522021,-1.2141336569861807,0.17857142857142858,0.966854653627268,1.0,2/13,2.97%,NPC2;NPC1
prerank,GO_Biological_Process_2021__heart morphogenesis (GO:0003007),0.6482477505580051,1.214050921077313,0.22077922077922077,0.8856494383317212,1.0,5/23,9.36%,HTR2B;TGFB2;VEGFA;INSR;RYR2
prerank,PanglaoDB_Augmented_2021__Foveolar Cells,0.8084480785899251,1.213879498827502,0.203125,0.885478176428181,1.0,2/6,7.63%,CLDN18;ATP8B1
prerank,GO_Biological_Process_2021__negative regulation of dendritic spine development (GO:0061000),0.7427565293393282,1.2137703000448499,0.234375,0.8849219506625791,1.0,3/6,7.94%,GRIN3A;NGEF;NLGN1
prerank,GO_Biological_Process_2021__negative regulation of neuron projection regeneration (GO:0070571),0.7633125128196161,1.2137127263124028,0.2,0.8841867064351251,1.0,4/6,21.81%,EPHA4;THY1;PTPRS;RTN4RL1
prerank,GO_Biological_Process_2021__mitochondrion-endoplasmic reticulum membrane tethering (GO:1990456),0.7646370786812916,1.213676477469605,0.23529411764705882,0.8834292947617408,1.0,2/6,15.68%,VMP1;ATP2A2
prerank,GO_Biological_Process_2021__positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway (GO:0051482),0.7438951326070924,1.2135535494028926,0.24,0.8830457358222301,1.0,1/10,0.17%,GPR18
prerank,GO_Biological_Process_2021__store-operated calcium entry (GO:0002115),-0.8009714155204966,-1.2134467057652818,0.2,0.966636978921886,1.0,3/5,15.80%,STIM1;STIM2;CRACR2A
prerank,GO_Biological_Process_2021__heparan sulfate proteoglycan metabolic process (GO:0030201),0.7046067969073976,1.2128938711158335,0.1891891891891892,0.8861501789305432,1.0,5/17,15.66%,HS3ST5;HS6ST3;SULF2;HS2ST1;NDST3
prerank,GO_Biological_Process_2021__cellular response to oxidised low-density lipoprotein particle stimulus (GO:0140052),-0.7358173468620828,-1.2128576669719915,0.36363636363636365,0.9660213730629528,1.0,3/6,14.21%,TICAM1;TREM2;AKT1
prerank,GO_Biological_Process_2021__cellular response to metal ion (GO:0071248),0.5840660109701996,1.2127781539200715,0.1595744680851064,0.8857761271734043,1.0,24/79,22.86%,GLRA1;SYT4;ANK3;NLGN1;ADCY8;RYR3;SYT1;FBP1;BNIP3;WNT5A;CLIC4;IQGAP1;PRKAA2;DLG4;FOS;ECT2;CPNE8;CPNE2;LRRK2;CDKN1B;HFE;SYT11;CPNE3;JUN
prerank,GO_Biological_Process_2021__regulation of calcium-mediated signaling (GO:0050848),0.6904521770439673,1.2115197059768736,0.18292682926829268,0.8916543262830846,1.0,2/16,3.05%,MAPT;CD22
prerank,GO_Biological_Process_2021__signal release from synapse (GO:0099643),0.6256772611044842,1.2114251207272306,0.23076923076923078,0.8910116685411681,1.0,14/31,25.50%,NRXN1;NRXN2;GAD1;SNAP25;UNC13A;GAD2;SYT1;CPLX1;STXBP2;SYN2;BRSK1;PPFIA3;RIMS1;PTPRN2
prerank,GO_Biological_Process_2021__positive regulation of coagulation (GO:0050820),0.8097354956099247,1.2111754552694867,0.21875,0.890040789326593,1.0,1/5,0.28%,THBS1
prerank,GO_Biological_Process_2021__positive regulation of hemostasis (GO:1900048),0.8097354956099247,1.2111754552694867,0.21875,0.890040789326593,1.0,1/5,0.28%,THBS1
prerank,GO_Biological_Process_2021__positive regulation of nitric-oxide synthase activity (GO:0051000),0.7488215087405601,1.210362265902176,0.16901408450704225,0.8936245621706284,1.0,2/12,7.22%,HTR2B;HIF1A
prerank,GO_Biological_Process_2021__cellular response to angiotensin (GO:1904385),0.780311524406379,1.2100702736938669,0.2112676056338028,0.8941942197319118,1.0,1/7,6.90%,CA2
prerank,GO_Biological_Process_2021__regulation of amyloid-beta formation (GO:1902003),0.6067020383493041,1.2098348351640835,0.16279069767441862,0.8944302837230018,1.0,12/29,22.91%,RTN1;ABCA2;NTRK2;EPHA4;PICALM;CASP3;TMED10;ROCK1;RTN3;TNF;RTN4;ABCG1
prerank,PanglaoDB_Augmented_2021__Megakaryocytes,-0.40769595870561404,-1.2097881543035072,0.16666666666666666,0.9743837494893598,1.0,26/91,12.54%,MATK;NKG7;CD300LF;ITGAM;CST7;GNLY;BIN2;SELPLG;P2RX1;PIK3R6;MPEG1;HCST;TGFB1;EPOR;ITGAX;AOAH;MAFG;MYO1F;PLEK;HCK;ITGB2;CYTH4;TREML1;LCP2;PLK3;TYROBP
prerank,GO_Biological_Process_2021__second-messenger-mediated signaling (GO:0019932),0.6003079852563754,1.2097076586518054,0.1590909090909091,0.8941562750220987,1.0,8/44,12.93%,HTR2B;PPP1R9A;NUDT4;AGT;EIF2AK3;RYR2;CHRM3;GUCY1B1
prerank,GO_Biological_Process_2021__cellular response to growth factor stimulus (GO:0071363),0.5738704788332741,1.209380465299069,0.14893617021276595,0.8947823107402056,1.0,18/101,11.99%,KLF4;LRP2;ACVR1B;KNSTRN;MAPT;NR4A1;ANXA1;ACVR2A;BMPR1B;VEGFA;SEMA6A;OVOL2;NTRK3;PDE2A;FLT1;SOX6;NTRK2;MAGI2
prerank,PanglaoDB_Augmented_2021__Langerhans Cells,-0.4227814626232381,-1.2093145626676134,0.2,0.9733150825148189,1.0,31/91,14.46%,CD300LF;ITGAM;LY86;PTAFR;BIN2;PIK3R6;MPEG1;LGALS9;CSF1R;LILRB4;ITGAX;AOAH;ALOX5;MYO1F;NCKAP1L;WDFY4;IGSF6;PLEK;HCK;HLA-DPA1;HLA-DRB6;FCGR1A;ITGB2;CYTH4;TLR7;LCP2;TYROBP;CD53;SNX20;HAVCR2;PIK3R5
prerank,GO_Biological_Process_2021__vascular transport (GO:0010232),0.5862390239353429,1.2092291097810652,0.20987654320987653,0.894461269842801,1.0,16/50,21.00%,LRP2;SLC2A3;TFRC;SLC1A2;INSR;SLC13A3;ABCA2;SLCO3A1;MFSD2A;SLC24A3;SLC16A1;ATP1B2;SLC44A1;ATP1A2;LEPR;SLC5A6
prerank,GO_Biological_Process_2021__inositol metabolic process (GO:0006020),-0.7261892529975228,-1.209090024433982,0.34210526315789475,0.9712820179340828,1.0,2/7,16.01%,IPPK;ISYNA1
prerank,GO_Biological_Process_2021__regulation of adaptive immune response (GO:0002819),-0.5594003067601948,-1.209052222945914,0.23076923076923078,0.9685444225636296,1.0,3/13,4.42%,SKAP1;SAMSN1;IL4I1
prerank,GO_Biological_Process_2021__negative regulation of mitochondrial membrane potential (GO:0010917),0.7740340051698384,1.2089653885157379,0.208955223880597,0.8949083066756274,1.0,2/6,13.42%,MAPT;PRELID1
prerank,GO_Biological_Process_2021__motile cilium assembly (GO:0044458),0.8052899032281909,1.208615248395077,0.25396825396825395,0.8958611897830574,1.0,2/5,19.38%,CCDC39;SPATA6
prerank,GO_Biological_Process_2021__endocardial cushion morphogenesis (GO:0003203),0.7766236977567339,1.2085561457520895,0.19672131147540983,0.8950336780958796,1.0,1/7,1.28%,TGFB2
prerank,GO_Biological_Process_2021__negative regulation of establishment of protein localization to mitochondrion (GO:1903748),0.7869798458126501,1.208502901128848,0.22580645161290322,0.8941964542234063,1.0,1/5,2.79%,MAPT
prerank,GO_Biological_Process_2021__glycoside catabolic process (GO:0016139),0.7284293355244382,1.208163516184524,0.28125,0.8951819215217002,1.0,1/8,2.27%,GLA
prerank,"GO_Biological_Process_2021__retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)",0.598614956736861,1.20781734715332,0.22826086956521738,0.8960476411341595,1.0,11/66,17.12%,PLPP3;CENPE;RACGAP1;NAPA;KIF15;ARFGAP1;NSF;KIF11;TMED10;KIF5A;KIF3A
prerank,GO_Biological_Process_2021__cellular response to superoxide (GO:0071451),0.7974014236745126,1.2075477297906156,0.19718309859154928,0.8964894145979496,1.0,3/6,18.25%,SOD2;ADPRS;SOD1
prerank,GO_Biological_Process_2021__regulation of sprouting angiogenesis (GO:1903670),0.6360395297822661,1.2074787654104964,0.25301204819277107,0.8958534655205107,1.0,6/22,9.72%,THBS1;KLF4;FGF1;VEGFA;SEMA6A;GLUL
prerank,GO_Biological_Process_2021__limb development (GO:0060173),0.6966930414820295,1.207370847301567,0.2125,0.8952541453550443,1.0,2/17,4.63%,LRP4;BMPR1B
prerank,GO_Biological_Process_2021__positive regulation of hormone metabolic process (GO:0032352),0.8427295218417693,1.2071974232721652,0.1774193548387097,0.8952866826482385,1.0,3/5,7.86%,EGR1;HIF1A;PAX8
prerank,PanglaoDB_Augmented_2021__Leydig Cells,0.5871595709151551,1.2070663872955567,0.19540229885057472,0.895004334370763,1.0,14/47,16.59%,PLPP3;SVEP1;PRLR;LIFR;LAMA2;MAFB;SH3D19;MLANA;SASH1;COL21A1;ALDH1A1;TIMP3;CPE;EPAS1
prerank,GO_Biological_Process_2021__positive regulation of peptidyl-threonine phosphorylation (GO:0010800),0.7056061108076861,1.2067362753164244,0.1794871794871795,0.8957358090193177,1.0,6/15,17.45%,CHI3L1;CEMIP;CALM3;PRKAG2;RIPK2;APP
prerank,GO_Biological_Process_2021__negative regulation of cellular protein catabolic process (GO:1903363),-0.6535824919017139,-1.2066369641991825,0.2222222222222222,0.9756884479448634,1.0,2/7,3.78%,ATRAID;DAB2IP
prerank,GO_Biological_Process_2021__heart development (GO:0007507),0.5730657475598345,1.2062759436057802,0.13829787234042554,0.8974657529367778,1.0,20/83,18.16%,HTR2B;TGFB2;SH3PXD2B;LDB3;MMP21;VEGFA;SOX4;INSR;PKP2;POU6F1;FN1;ID2;NTRK3;SGCZ;PKD1;NDRG4;TBX19;CACYBP;FLRT2;SGCD
prerank,GO_Biological_Process_2021__divalent inorganic cation homeostasis (GO:0072507),0.6965282058749762,1.2060107977144767,0.25757575757575757,0.8978903955996607,1.0,5/14,25.31%,ANK3;TMTC2;FAM20A;TRPM7;CNNM2
prerank,GO_Biological_Process_2021__positive regulation of toll-like receptor 4 signaling pathway (GO:0034145),-0.7703460194362866,-1.2058699639450376,0.4,0.9753771526432677,1.0,3/5,17.46%,NR1H3;TIRAP;NINJ1
prerank,GO_Biological_Process_2021__positive regulation of protein ubiquitination (GO:0031398),0.5891866582606221,1.2055577129939554,0.23404255319148937,0.8993002160251493,1.0,11/56,13.26%,ARRDC3;BMI1;SEPTIN4;FANCM;FANCI;KDM1A;RBX1;PRICKLE1;RIPK2;BRCA1;PINK1
prerank,GO_Biological_Process_2021__positive regulation of cold-induced thermogenesis (GO:0120162),0.584073570958752,1.2053544789622574,0.17582417582417584,0.8994898182852603,1.0,18/62,21.14%,PRLR;TSHR;ACSL1;PLAC8;VEGFA;GRB10;KDM3A;IGF1R;KDM1A;DYNC1H1;SCD;PEMT;IL18;EPAS1;ESRRG;KDM6B;LEPR;MFN2
prerank,GO_Biological_Process_2021__regulation of cartilage development (GO:0061035),0.7307592422571596,1.205323538595626,0.23684210526315788,0.898475235417252,1.0,5/11,11.78%,ZBTB16;BMPR1B;MBOAT2;TRPS1;SOX6
prerank,GO_Biological_Process_2021__protein O-linked glycosylation via threonine (GO:0018243),0.7512612258947253,1.2051373541754336,0.18666666666666668,0.8983994958123389,1.0,2/7,6.35%,GALNTL6;GALNT13
prerank,GO_Biological_Process_2021__ribosomal large subunit export from nucleus (GO:0000055),0.7884781370741405,1.2043607821578204,0.2,0.9017877807603923,1.0,2/6,12.11%,XPO1;NMD3
prerank,GO_Biological_Process_2021__maintenance of blood-brain barrier (GO:0035633),0.6716900610619616,1.2043575389420147,0.20987654320987653,0.9007164423592097,1.0,4/17,9.91%,LSR;DMD;LAMA2;MFSD2A
prerank,GO_Biological_Process_2021__negative regulation of developmental process (GO:0051093),0.6235024249655907,1.2042483273827531,0.19101123595505617,0.900281199081559,1.0,16/40,20.74%,DCC;MAPT;TFRC;NFIB;GRIN3A;SFMBT1;KANK1;RAPGEF3;BNIP3;PINK1;THY1;ROCK1;KLF7;SUZ12;PTPRS;BCL11A
prerank,GO_Biological_Process_2021__regulation of short-term neuronal synaptic plasticity (GO:0048172),0.7338619604589873,1.2038743094329192,0.24,0.9014115808440961,1.0,5/10,19.63%,SLC4A10;GRIK2;SYP;SHISA9;SYNGR1
prerank,GO_Biological_Process_2021__pyruvate metabolic process (GO:0006090),0.627439905987328,1.2036375305154103,0.2073170731707317,0.9018613018569254,1.0,13/34,21.03%,PFKM;ENO2;PGAM1;GPI;NR4A3;PKM;ENO4;SLC16A3;SLC16A1;PGK1;PGM1;ENO1;PDHB
prerank,GO_Biological_Process_2021__diacylglycerol metabolic process (GO:0046339),0.698611635599156,1.2034651306844544,0.25316455696202533,0.9017590688136111,1.0,5/16,13.21%,DGKI;DGAT1;DGKB;LIPE;DGKG
prerank,GO_Biological_Process_2021__negative regulation of interleukin-2 production (GO:0032703),0.6539566427481662,1.2034344196270916,0.21621621621621623,0.900843240065216,1.0,1/15,1.54%,CR1
prerank,GO_Biological_Process_2021__purine nucleobase biosynthetic process (GO:0009113),0.8168606691083904,1.2033281562422005,0.27419354838709675,0.9003532221769843,1.0,2/5,12.55%,PAICS;PRPS1
prerank,GO_Biological_Process_2021__negative regulation of cellular response to growth factor stimulus (GO:0090288),0.5900953134947593,1.203170136051323,0.25882352941176473,0.9001388231744407,1.0,6/48,8.27%,THBS1;LRP2;AGT;ACVR2A;BMPR1B;SPRY1
prerank,"GO_Biological_Process_2021__positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517)",-0.6672135937737459,-1.2031632474496956,0.2702702702702703,0.9819949710302186,1.0,4/7,17.87%,ZNF385A;SPRED2;PYHIN1;DDX5
prerank,GO_Biological_Process_2021__positive regulation of telomerase RNA localization to Cajal body (GO:1904874),0.674518359263755,1.2031631477178408,0.3108108108108108,0.8990911892611047,1.0,6/15,27.75%,RUVBL2;NHP2;SHQ1;TCP1;CCT8;DKC1
prerank,GO_Biological_Process_2021__neuron projection development (GO:0031175),0.5407738723153172,1.2026455407530998,0.18556701030927836,0.9010006198890625,1.0,39/120,22.37%,SHANK3;OMG;GPM6A;PPP1R9A;MAPT;MANF;GPM6B;PQBP1;CTNND2;NYAP2;LAMB1;HDGFL3;STMN3;NLGN1;MAP2;MICALL2;CNTNAP2;PLP1;SLC9A6;TMEM108;SH3GL2;EPHA4;STMN2;PLXNB1;RASGRF1;ROCK1;APP;ERCC6;NCDN;GRM7;UBB;CDK5R1;DLG4;CNTNAP1;UHMK1;LRRK2;PAK3;CTTN;DCLK1
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell chemotaxis (GO:2001028),0.7366256789797989,1.20217999042155,0.2647058823529412,0.9024383237855258,1.0,3/10,17.22%,VEGFA;SEMA5A;HSPB1
prerank,GO_Biological_Process_2021__negative regulation of B cell receptor signaling pathway (GO:0050859),0.8007846163400083,1.2020672931623984,0.2857142857142857,0.9020176110712802,1.0,3/5,13.83%,CD22;FCGR2B;CD300A
prerank,GO_Biological_Process_2021__3'-UTR-mediated mRNA destabilization (GO:0061158),-0.6232826118001183,-1.2017047029360044,0.22727272727272727,0.9851017713251042,1.0,5/11,21.82%,KHSRP;ZFP36;UPF1;MOV10;ZC3H12D
prerank,GO_Biological_Process_2021__regulation of trans-synaptic signaling (GO:0099177),0.6382722558117223,1.2015522708377366,0.29545454545454547,0.9035302251168769,1.0,11/28,12.37%,LRRC4C;RELN;GRIK2;IQSEC2;GRIK1;NLGN3;NLGN1;PXK;CACNA1B;NRG3;GRID2
prerank,GO_Biological_Process_2021__regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903587),0.7457422137686542,1.2015317223611799,0.21212121212121213,0.9026210337325007,1.0,2/6,5.04%,THBS1;VEGFA
prerank,GO_Biological_Process_2021__regulation of mitotic sister chromatid separation (GO:0010965),0.7218480306293487,1.2013344904164314,0.2911392405063291,0.902666527057642,1.0,2/11,3.26%,CENPE;RIOK2
prerank,PanglaoDB_Augmented_2021__Cardiac Stem And Precursor Cells,0.5915428612447825,1.2012533042613083,0.18681318681318682,0.902009703254759,1.0,16/51,12.78%,LRP4;ENAH;DOCK1;GNA11;PTPRG;KITLG;LIFR;LAMB1;RBFOX2;RND3;FN1;ERRFI1;FIGN;SH3D19;ADGRL2;UACA
prerank,GO_Biological_Process_2021__negative regulation of TORC1 signaling (GO:1904262),-0.6687660928528086,-1.201068381166444,0.24242424242424243,0.9841998386109905,1.0,2/8,7.12%,SESN2;SESN3
prerank,GO_Biological_Process_2021__enzyme linked receptor protein signaling pathway (GO:0007167),0.566453326503129,1.2010450792903817,0.13541666666666666,0.9021010658896613,1.0,22/76,14.46%,ACVR1B;PTPRD;PTPRG;ACVR2A;LIFR;INSR;EPHA3;PTPRT;PTN;SHC2;IGF1R;FGR;NTRK3;GP6;ALK;EPHA7;TYRO3;FLT1;NTRK2;EPHA4;EPHA6;EPHA5
prerank,GO_Biological_Process_2021__sprouting angiogenesis (GO:0002040),0.6521993012306846,1.2009756634187672,0.19753086419753085,0.9014238784370612,1.0,5/25,10.26%,THBS1;NR4A1;VEGFA;ROBO1;SEMA5A
prerank,GO_Biological_Process_2021__protein exit from endoplasmic reticulum (GO:0032527),0.6006739767646263,1.2009352414720966,0.2638888888888889,0.9006015868000155,1.0,7/22,21.46%,SEC61B;HERPUD1;AUP1;SYVN1;TECPR2;SURF4;HSP90B1
prerank,GO_Biological_Process_2021__nucleobase biosynthetic process (GO:0046112),0.7738639846384161,1.2006107026969182,0.22580645161290322,0.9012691771363293,1.0,2/6,20.16%,PAICS;CTPS1
prerank,GO_Biological_Process_2021__mRNA cleavage involved in mRNA processing (GO:0098787),-0.5634905753398047,-1.200367941945639,0.16,0.9841834109125942,1.0,3/10,16.26%,CPSF1;CPSF2;CPSF4
prerank,GO_Biological_Process_2021__limb morphogenesis (GO:0035108),0.7276210074970328,1.2003661534700203,0.17721518987341772,0.9016649731137532,1.0,2/12,4.63%,TGFB2;BMPR1B
prerank,GO_Biological_Process_2021__digestive tract development (GO:0048565),0.6764461792529606,1.200358104702146,0.17333333333333334,0.9007103692295113,1.0,5/17,13.96%,COBL;TGFB2;CLMP;CCDC39;PKD1
prerank,GO_Biological_Process_2021__negative regulation of T cell mediated immunity (GO:0002710),-0.6592659056992123,-1.200348860458055,0.2222222222222222,0.9812891954085863,1.0,2/9,4.46%,IL4I1;LILRB4
prerank,GO_Biological_Process_2021__detection of muscle stretch (GO:0035995),0.7952070753298213,1.2002646396897463,0.18055555555555555,0.9001848469449151,1.0,2/5,8.38%,CDH2;CAV3
prerank,GO_Biological_Process_2021__negative regulation of cyclin-dependent protein kinase activity (GO:1904030),-0.5484735427454679,-1.2002441837112914,0.20689655172413793,0.9789022335865052,1.0,4/16,3.56%,CEBPA;TFAP4;HHEX;LATS2
prerank,GO_Biological_Process_2021__negative regulation of protein processing (GO:0010955),0.6970979949311086,1.2002135573130561,0.27419354838709675,0.8993913102404117,1.0,1/9,0.28%,THBS1
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell action potential (GO:0098901),0.6825758129049433,1.2000387562352122,0.2625,0.8992047551449031,1.0,6/18,15.68%,ANK2;PKP2;CAV3;CALM3;RYR2;ATP2A2
prerank,GO_Biological_Process_2021__cardiac muscle tissue development (GO:0048738),0.6602744017433544,1.2000149172581658,0.2236842105263158,0.8983582794766122,1.0,7/17,20.17%,NRG1;SGCZ;SMAD1;SGCD;SMAD5;KDM6B;NOTCH2
prerank,GO_Biological_Process_2021__PML body organization (GO:0030578),-0.7865183198415168,-1.1999827574398072,0.3611111111111111,0.9768784251822503,1.0,3/5,15.48%,ETS1;SERBP1;HABP4
prerank,"GO_Biological_Process_2021__negative regulation of retrograde protein transport, ER to cytosol (GO:1904153)",-0.6409130397523568,-1.1998705923568513,0.2962962962962963,0.9742406252692519,1.0,5/8,25.35%,SVIP;DERL2;OS9;YOD1;ERLEC1
prerank,GO_Biological_Process_2021__supramolecular fiber organization (GO:0097435),0.5531876685736827,1.199712977209702,0.09090909090909091,0.8989894730690323,1.0,42/201,15.60%,RHOBTB3;P4HA3;RHOB;SHROOM3;ADAMTS2;TGFB2;COL11A1;VIM;CORO6;GFAP;CLIP3;PPP1R9A;MAPT;COL4A5;COL26A1;FIGNL1;COL23A1;CGNL1;COLGALT2;COL24A1;HDGFL3;MARCKSL1;STMN3;RND3;ERMN;RPS27A;CARMIL1;P4HA1;FIGN;DYNC1H1;COL21A1;SPAST;CKAP5;SHROOM4;TPPP;COL10A1;STMN2;HOOK3;NEFL;TGFBI;COL5A3;PLOD1
prerank,GO_Biological_Process_2021__positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation (GO:1905007),0.8245192873810151,1.1995862626447154,0.15625,0.8986812191984775,1.0,1/5,1.28%,TGFB2
prerank,GO_Biological_Process_2021__extracellular matrix assembly (GO:0085029),0.7200074596530579,1.199486268803037,0.2857142857142857,0.8983290763976052,1.0,3/10,5.86%,NTN4;GPM6B;LAMB1
prerank,GO_Biological_Process_2021__regulation of T cell apoptotic process (GO:0070232),-0.7461545439146664,-1.1994203522658955,0.41935483870967744,0.9725548424937009,1.0,2/5,5.98%,CCL5;CD274
prerank,GO_Biological_Process_2021__UV protection (GO:0009650),0.804040166883287,1.1993515137181532,0.23880597014925373,0.8980891598294771,1.0,1/5,3.08%,ERCC2
prerank,GO_Biological_Process_2021__regulation of mitochondrial fission (GO:0090140),0.6760904272580397,1.198732161759008,0.1951219512195122,0.9003311290234823,1.0,7/20,22.85%,MAPT;INF2;BNIP3;PINK1;DDHD1;LRRK2;STAT2
prerank,GO_Biological_Process_2021__pyrimidine nucleotide metabolic process (GO:0006220),0.748122068198934,1.198672271743685,0.2807017543859649,0.899633758125179,1.0,2/5,15.28%,PRPS1;DCK
prerank,GO_Biological_Process_2021__positive regulation of fibroblast proliferation (GO:0048146),0.6703135860409363,1.1985537117642246,0.25316455696202533,0.899160036904043,1.0,4/18,15.06%,AGT;BMI1;FN1;WNT5A
prerank,GO_Biological_Process_2021__regulation of ion transport (GO:0043269),0.5820747385454056,1.1981036110811827,0.18888888888888888,0.9006943604300066,1.0,13/39,22.61%,KCNJ13;SYT4;ANK3;CA2;PXK;PER1;NKAIN2;SYT1;KCNJ6;KCNJ3;SPTBN4;HFE;SYT11
prerank,GO_Biological_Process_2021__platelet degranulation (GO:0002576),0.5531407997383653,1.19778954830454,0.1368421052631579,0.901283720646003,1.0,10/81,8.46%,THBS1;SPARC;TGFB2;TUBA4A;MANF;SRGN;F13A1;VEGFA;ENDOD1;FN1
prerank,GO_Biological_Process_2021__toll-like receptor signaling pathway (GO:0002224),-0.40710986197599813,-1.197553879847955,0.0,0.9762382614782452,1.0,13/67,11.56%,ITGAM;TICAM1;CHUK;LGALS9;IRAK4;SCIMP;TLR3;NMI;BTK;IKBKB;ITGB2;TLR7;BIRC2
prerank,GO_Biological_Process_2021__positive regulation of striated muscle contraction (GO:0045989),0.8017504787043671,1.197452907320736,0.22857142857142856,0.9021925137878005,1.0,1/5,6.34%,RGS2
prerank,GO_Biological_Process_2021__regulation of ubiquitin-dependent protein catabolic process (GO:2000058),0.5855876023516057,1.1972293430559116,0.2,0.9021378971652153,1.0,6/37,16.50%,ARAF;RPL23;XPO1;CAV3;RNF139;RPL11
prerank,GO_Biological_Process_2021__transport across blood-brain barrier (GO:0150104),0.5848749881052698,1.1970593828153497,0.25,0.9021606632567947,1.0,16/51,21.00%,LRP2;SLC2A3;TFRC;SLC1A2;INSR;SLC13A3;ABCA2;SLCO3A1;MFSD2A;SLC24A3;SLC16A1;ATP1B2;SLC44A1;ATP1A2;LEPR;SLC5A6
prerank,GO_Biological_Process_2021__ameboidal-type cell migration (GO:0001667),0.6187207024635882,1.1969954196830237,0.18181818181818182,0.9014999042718714,1.0,6/28,13.44%,HTR2B;SEMA3A;SEMA3B;SEMA6A;SEMA5A;CENPV
prerank,GO_Biological_Process_2021__actin filament network formation (GO:0051639),0.7494673989955977,1.1969373790013729,0.2,0.9007525888155997,1.0,3/10,9.76%,COBL;SPIRE2;CARMIL1
prerank,GO_Biological_Process_2021__regulation of Rac protein signal transduction (GO:0035020),0.6897067922772266,1.1969236391488263,0.2625,0.8997760404657641,1.0,3/13,14.50%,ARF6;STMN3;RASGRF1
prerank,GO_Biological_Process_2021__natural killer cell activation (GO:0030101),0.6870223975376243,1.1969190662559832,0.2236842105263158,0.8987578079775792,1.0,1/16,0.50%,NFIL3
prerank,GO_Biological_Process_2021__regulation of receptor signaling pathway via STAT (GO:1904892),0.7434811516565698,1.196250823722959,0.26153846153846155,0.9013410146666002,1.0,2/8,7.69%,PIGU;PTPRT
prerank,PanglaoDB_Augmented_2021__Granulosa Cells,0.6001465300434271,1.196240644207776,0.24719101123595505,0.9003452463410007,1.0,11/45,10.30%,LRP4;ENAH;COL4A5;MTCL1;GNA11;LAMB1;FHL1;RBFOX2;RND3;BOK;FIGN
prerank,GO_Biological_Process_2021__positive regulation of sodium ion transmembrane transporter activity (GO:2000651),0.6835461648920133,1.1961227421296863,0.3076923076923077,0.8998663070292482,1.0,4/11,21.98%,DMD;ANK3;SLC9A1;CHP1
prerank,GO_Biological_Process_2021__morphogenesis of a polarized epithelium (GO:0001738),-0.6778598765206008,-1.1960291076209493,0.30303030303030304,0.9782796460481599,1.0,1/7,3.45%,ACTB
prerank,GO_Biological_Process_2021__odontogenesis (GO:0042476),0.7292842548219842,1.1957480961070959,0.2602739726027397,0.9009193625985487,1.0,2/10,5.86%,TGFB2;LAMB1
prerank,GO_Biological_Process_2021__regulation of cGMP-mediated signaling (GO:0010752),0.8218151342754271,1.1956307488712046,0.2112676056338028,0.9005282434191059,1.0,4/5,13.76%,THBS1;PDE10A;PDE2A;RUNDC3A
prerank,GO_Biological_Process_2021__cartilage development (GO:0051216),0.6350485575459018,1.1956181176292155,0.2,0.8995598009060617,1.0,8/25,17.63%,ZBTB16;NFIB;CHI3L1;ITGB8;SOX6;SULF2;PKD1;SLC39A14
prerank,GO_Biological_Process_2021__negative regulation of cell size (GO:0045792),0.7626636507689237,1.1954025134201902,0.2222222222222222,0.8998794641705323,1.0,4/5,23.76%,CAV3;DEPTOR;RDX;PTEN
prerank,GO_Biological_Process_2021__gland morphogenesis (GO:0022612),0.803677414516613,1.1953809931314006,0.22058823529411764,0.8990119470711321,1.0,1/5,1.28%,TGFB2
prerank,"GO_Biological_Process_2021__RNA phosphodiester bond hydrolysis, endonucleolytic (GO:0090502)",0.7215586681208481,1.1951609120276963,0.32098765432098764,0.8990596959191067,1.0,2/10,14.47%,NUDT16;ZC3H12B
prerank,GO_Biological_Process_2021__cellular amino acid catabolic process (GO:0009063),0.5718613261391108,1.1951473403178634,0.17647058823529413,0.8981299388058693,1.0,11/50,16.61%,KMO;ASPA;CARNS1;FAH;GAD1;ACAT1;GLUL;ALDH6A1;BLMH;SLC25A21;CARNMT1
prerank,GO_Biological_Process_2021__positive regulation of deacetylase activity (GO:0090045),0.8129398882828198,1.195070172350965,0.19047619047619047,0.8974517984772942,1.0,1/6,5.04%,VEGFA
prerank,GO_Biological_Process_2021__fibroblast growth factor receptor signaling pathway (GO:0008543),0.591675211824431,1.1949788154195848,0.15555555555555556,0.8968835566339944,1.0,9/44,21.28%,FGF1;FLRT1;RBFOX2;HNRNPH1;POLR2D;FLRT2;FIBP;FGFR2;POLR2G
prerank,GO_Biological_Process_2021__regulation of protein tyrosine kinase activity (GO:0061097),0.6251664816957253,1.1947411929780223,0.24175824175824176,0.897085032090564,1.0,10/26,20.64%,SH3BP5;RELN;AGT;SRCIN1;GPRC5B;EPHA4;THY1;APP;DLG4;SH3BP5L
prerank,GO_Biological_Process_2021__regulation of interleukin-1 production (GO:0032652),0.7441851337782245,1.1942397610244722,0.25,0.898669798892962,1.0,4/8,17.56%,NLRP12;ANXA1;TMED10;FOXP1
prerank,GO_Biological_Process_2021__regulation of nitric-oxide synthase biosynthetic process (GO:0051769),0.7781983294115733,1.1942201512500366,0.3,0.8977565658157307,1.0,2/6,10.87%,NAMPT;NOD2
prerank,GO_Biological_Process_2021__regulation of cell-cell adhesion mediated by cadherin (GO:2000047),-0.6143770498478883,-1.193986754797576,0.2777777777777778,0.983471163230552,1.0,2/10,1.86%,NEXMIF;SERPINF2
prerank,GO_Biological_Process_2021__fatty-acyl-CoA metabolic process (GO:0035337),0.6914921710714661,1.1938627713343641,0.2191780821917808,0.8986143104880979,1.0,5/15,19.55%,DGAT1;SCD5;FASN;SCD;ACSL3
prerank,GO_Biological_Process_2021__regulation of non-motile cilium assembly (GO:1902855),-0.708053487751223,-1.1938460413526895,0.26666666666666666,0.9809898456372024,1.0,1/5,3.85%,WRAP73
prerank,GO_Biological_Process_2021__microtubule polymerization or depolymerization (GO:0031109),0.7139313075248823,1.1936797229524467,0.2361111111111111,0.8984681491344017,1.0,6/15,13.71%,MAPT;HDGFL3;STMN3;CKAP5;TPPP;STMN2
prerank,GO_Biological_Process_2021__Golgi to plasma membrane protein transport (GO:0043001),0.620190235098434,1.193544976847672,0.2236842105263158,0.898193179959179,1.0,4/23,16.92%,ANK3;NSF;PREPL;SPTBN1
prerank,GO_Biological_Process_2021__maturation of 5.8S rRNA (GO:0000460),0.7072797063596832,1.1934433200533765,0.17142857142857143,0.8977468424953404,1.0,3/15,5.83%,WDR12;MAK16;PES1
prerank,GO_Biological_Process_2021__regulation of mitotic metaphase/anaphase transition (GO:0030071),0.6856531696995487,1.1933346716328561,0.2597402597402597,0.8972800391973116,1.0,2/17,3.26%,CENPE;RIOK2
prerank,"GO_Biological_Process_2021__DNA-templated transcription, elongation (GO:0006354)",-0.4062414794177394,-1.1931862586535624,0.15384615384615385,0.9805391046152726,1.0,11/58,12.38%,GTF2H5;ELOA;GTF2F1;CTDP1;GTF2H2;ELOC;LEO1;SUPT16H;TCEA1;ADRM1;POLR2C
prerank,GO_Biological_Process_2021__positive regulation of cell communication (GO:0010647),0.6682927574628693,1.1929807099357381,0.25882352941176473,0.8982943581807971,1.0,9/18,20.39%,GRIK2;CDKN2AIP;ANK3;RIMS2;SYT1;RIMS3;DLG4;TNF;CLSTN2
prerank,GO_Biological_Process_2021__regulation of secretion by cell (GO:1903530),0.6021463149692832,1.1929237112779585,0.2,0.897581590172253,1.0,13/41,19.12%,ANXA1;RAB3C;STXBP5L;SEPTIN4;RAB15;RIMS2;SYT1;NSF;DISP1;CPLX1;MCTP1;SCG5;RAB21
prerank,GO_Biological_Process_2021__membrane fusion (GO:0061025),0.6180848654712271,1.1927454033509814,0.23809523809523808,0.8975445891556824,1.0,16/28,30.45%,NAPA;DNM3;DNM1;NSF;SNAP29;UBXN2B;NAPG;CHP1;HACE1;RIMS1;VAPA;OPA1;GCA;NSFL1C;MX2;MX1
prerank,GO_Biological_Process_2021__response to peptide hormone (GO:0043434),-0.47476037910964214,-1.1923955022824673,0.07692307692307693,0.980942748905677,1.0,2/32,0.57%,STAT4;TGFBR3
prerank,GO_Biological_Process_2021__positive regulation of developmental growth (GO:0048639),0.6191823643768316,1.1921959877235024,0.2222222222222222,0.8996561486449764,1.0,9/30,17.40%,MAPT;SYT4;INSR;UNC13A;RIMS2;GHR;SYT1;PLCB1;MAP3K13
prerank,GO_Biological_Process_2021__cellular response to organic substance (GO:0071310),0.5727752670500967,1.192177428605992,0.12903225806451613,0.8987307144922781,1.0,9/81,6.56%,KLF4;LRP2;ACVR1B;NLRP12;IL1RAPL1;ACVR2A;BMPR1B;ROBO2;AKAP6
prerank,GO_Biological_Process_2021__T cell receptor signaling pathway (GO:0050852),-0.45773442577392137,-1.1920795532947175,0.2,0.979101976908078,1.0,17/123,10.55%,THEMIS;ITK;SKAP1;GRAP2;BTN3A2;PSMB3;CD276;PSME3;CHUK;PSMC4;PSMD12;FYN;STOML2;PSME4;INPP5D;IKBKB;HLA-DPA1
prerank,GO_Biological_Process_2021__positive regulation of glial cell migration (GO:1903977),-0.6375259208496832,-1.1918140104934718,0.3170731707317073,0.9769670600205851,1.0,3/6,10.32%,CRKL;P2RY12;TREM2
prerank,GO_Biological_Process_2021__positive regulation of hormone secretion (GO:0046887),-0.6858316906572006,-1.1908628715622596,0.22857142857142856,0.9773437743977503,1.0,1/6,2.28%,CYP19A1
prerank,GO_Biological_Process_2021__glycosylceramide catabolic process (GO:0046477),0.78635880852545,1.1908343949770055,0.23214285714285715,0.9052408267212676,1.0,3/5,18.79%,GLA;GALC;GBA3
prerank,GO_Biological_Process_2021__progesterone receptor signaling pathway (GO:0050847),-0.7368254770379896,-1.1907101823248154,0.3055555555555556,0.9750915751666774,1.0,2/6,8.79%,NEDD4;SRC
prerank,GO_Biological_Process_2021__negative regulation of circadian rhythm (GO:0042754),0.7488100374309559,1.1906568939315283,0.24,0.9052060580327354,1.0,1/6,5.25%,SUV39H2
prerank,GO_Biological_Process_2021__regulation of axon guidance (GO:1902667),0.7428014136088901,1.1903526453235775,0.22388059701492538,0.9057140614171222,1.0,2/8,11.44%,VEGFA;ZSWIM4
prerank,GO_Biological_Process_2021__neuromuscular junction development (GO:0007528),0.6619315856214653,1.1903108522372305,0.2625,0.9048391375209154,1.0,5/20,8.58%,LRP4;CACNB2;ANK3;UNC13A;PPFIBP1
prerank,GO_Biological_Process_2021__embryonic limb morphogenesis (GO:0030326),0.6697311055111657,1.1896355180727431,0.21176470588235294,0.9073636996107788,1.0,1/19,1.28%,TGFB2
prerank,"GO_Biological_Process_2021__mitochondrial electron transport, NADH to ubiquinone (GO:0006120)",0.6114710251361883,1.1891495427585663,0.2247191011235955,0.9088751102631321,1.0,5/30,14.80%,NDUFA2;NDUFB9;NDUFA3;NDUFS8;NDUFB6
prerank,GO_Biological_Process_2021__secondary alcohol biosynthetic process (GO:1902653),0.6507588920520335,1.189030456706231,0.22666666666666666,0.9085186754509793,1.0,6/19,14.89%,TM7SF2;IDI1;MVD;INSIG1;FDFT1;HMGCS1
prerank,GO_Biological_Process_2021__negative regulation of cell growth (GO:0030308),0.5524792687155756,1.1889444709699122,0.21052631578947367,0.9078879073127776,1.0,13/79,12.53%,ACVR1B;TGFB2;DCC;ADAM15;TP53TG5;CDKN2AIP;FHL1;MAG;MAP2;TCHP;ING1;DNAJB2;FBP1
prerank,GO_Biological_Process_2021__negative regulation of protein tyrosine kinase activity (GO:0061099),0.680318389348971,1.1887080964373051,0.24285714285714285,0.9078610349193744,1.0,4/16,15.39%,SH3BP5;SRCIN1;ERRFI1;THY1
prerank,GO_Biological_Process_2021__inositol phosphate dephosphorylation (GO:0046855),-0.6122474251559857,-1.1886782908662474,0.21212121212121213,0.9762845608081561,1.0,2/10,10.33%,INPP5K;OCRL
prerank,GO_Biological_Process_2021__phosphorylated carbohydrate dephosphorylation (GO:0046838),-0.6122474251559857,-1.1886782908662474,0.21212121212121213,0.9762845608081561,1.0,2/10,10.33%,INPP5K;OCRL
prerank,GO_Biological_Process_2021__negative regulation of cellular component organization (GO:0051129),0.558969168109126,1.1885503711822687,0.2,0.9077075226544952,1.0,18/57,22.61%,VEGFA;HSPA5;EPHA3;TMEFF2;RAPGEF3;TFIP11;CARMIL1;IMPACT;DNAJB2;MCTP1;AIDA;HSPA1B;HSPA2;NOP53;TNF;IRAK3;RDX;SYT11
prerank,GO_Biological_Process_2021__positive regulation of microtubule polymerization (GO:0031116),0.6390610745833483,1.1883841761822018,0.2235294117647059,0.907469978504806,1.0,8/24,19.33%,MAPT;CAV3;CKAP5;TOGARAM1;HSPA1B;DCTN1;FES;CDK5R1
prerank,GO_Biological_Process_2021__response to exogenous dsRNA (GO:0043330),-0.5190098372713826,-1.187878314647953,0.1,0.9767590729992944,1.0,4/16,8.55%,RALB;TICAM1;CGAS;TLR3
prerank,GO_Biological_Process_2021__positive regulation of ion transmembrane transporter activity (GO:0032414),0.6696882048862058,1.1876859755058409,0.20481927710843373,0.9102459390656267,1.0,5/18,18.33%,DMD;ANK3;ANK2;ATP1B3;ATP1B2
prerank,GO_Biological_Process_2021__nucleus localization (GO:0051647),0.7492281863321172,1.1875717320164212,0.21739130434782608,0.9097325061844557,1.0,5/9,19.70%,SYNE3;DYNC1H1;CLMN;DCTN1;SUN2
prerank,GO_Biological_Process_2021__cardiac muscle cell-cardiac muscle cell adhesion (GO:0086042),0.824920285917523,1.187012096112478,0.2413793103448276,0.9116273612325383,1.0,1/5,7.48%,PKP2
prerank,GO_Biological_Process_2021__cell migration involved in sprouting angiogenesis (GO:0002042),0.6998812223524714,1.186873818260867,0.208955223880597,0.9111555364397287,1.0,3/9,8.14%,NR4A1;VEGFA;ROBO1
prerank,GO_Biological_Process_2021__acute-phase response (GO:0006953),-0.7498510382878538,-1.186294342842148,0.39285714285714285,0.9805267058273595,1.0,3/5,18.50%,IL6R;APOL2;SIGIRR
prerank,GO_Biological_Process_2021__sensory perception (GO:0007600),0.6681791984412377,1.186273971095468,0.24050632911392406,0.913600521864825,1.0,6/18,14.14%,OR3A2;PCDH15;NIPSNAP1;RETREG1;C5AR1;GNAL
prerank,GO_Biological_Process_2021__embryonic organ morphogenesis (GO:0048562),0.7320071142206951,1.1860276770137144,0.18055555555555555,0.91383998526085,1.0,3/10,9.36%,FBN2;ID2;RYR2
prerank,GO_Biological_Process_2021__regulation of hematopoietic stem cell differentiation (GO:1902036),-0.43843418670687084,-1.1843208019875566,0.14285714285714285,0.9851359767206926,1.0,11/55,12.03%,TCF3;TAL1;PSMB3;PSME3;LMO1;PSMC4;PSMD12;CBFB;PSME4;ABL1;SETD1A
prerank,GO_Biological_Process_2021__regulation of smoothened signaling pathway (GO:0008589),0.5752096394214324,1.1839979554673083,0.21428571428571427,0.9233616195364399,1.0,9/32,24.95%,HHIP;PDCL;TULP3;TXNDC15;FGFR2;IFT122;RORA;IFT81;GPC3
prerank,GO_Biological_Process_2021__fatty-acyl-CoA biosynthetic process (GO:0046949),0.6673166297733479,1.1838765289778082,0.2375,0.923088037232878,1.0,5/20,14.11%,ACSL1;SCD5;FASN;SCD;HSD17B12
prerank,GO_Biological_Process_2021__regulation of ceramide biosynthetic process (GO:2000303),-0.5254612380534684,-1.1836476803991698,0.18181818181818182,0.9848861550479209,1.0,1/12,0.87%,SMPD3
prerank,GO_Biological_Process_2021__peptidyl-threonine phosphorylation (GO:0018107),0.5840237756714532,1.1834639865332914,0.23255813953488372,0.9243709549946513,1.0,2/47,3.13%,ACVR1B;CIT
prerank,GO_Biological_Process_2021__cellular response to muramyl dipeptide (GO:0071225),0.7516443085627635,1.1833681244909164,0.22727272727272727,0.9238256642747694,1.0,3/8,12.29%,VIM;NOD2;RIPK2
prerank,GO_Biological_Process_2021__regulation of integrin activation (GO:0033623),-0.7119555736697621,-1.1833291168468747,0.3333333333333333,0.9828883086114775,1.0,3/9,10.03%,SKAP1;SRC;PLEK
prerank,GO_Biological_Process_2021__regulation of actin filament-based movement (GO:1903115),0.7519589686055157,1.183274436328304,0.24242424242424243,0.9232503112458534,1.0,2/7,10.68%,ANK2;PDE4B
prerank,PanglaoDB_Augmented_2021__Mast Cells,0.5715347908376675,1.182524476679746,0.1134020618556701,0.9263294131541548,1.0,31/124,15.99%,PLPP3;SPARC;COBL;ENPP2;GPM6A;ENAH;TNS1;RIOK2;MEIS2;DGKI;RGS1;GRIK2;CDH9;LAMA2;PDK4;CD55;ENO2;PAPSS2;TCF7L1;PDE1C;ABCA1;DNM3;SGCE;NCEH1;GNAI1;SHROOM4;LSAMP;ALDH1A1;HS2ST1;SLC31A2;LDB2
prerank,GO_Biological_Process_2021__negative regulation of plasminogen activation (GO:0010757),0.7527287141096249,1.1824800034591056,0.2711864406779661,0.9256382174525433,1.0,1/5,0.28%,THBS1
prerank,GO_Biological_Process_2021__regulation of calcium ion transmembrane transport via high voltage-gated calcium channel (GO:1902514),0.7510584395253475,1.1823600760446704,0.25316455696202533,0.9251770072279238,1.0,2/7,4.91%,CACNB2;SESTD1
prerank,GO_Biological_Process_2021__receptor clustering (GO:0043113),0.6571651097719292,1.1822377898606358,0.23076923076923078,0.924810168883529,1.0,9/22,15.39%,LRP4;NRXN1;NRXN2;NLGN1;SAV1;PTN;MAGI2;LRRC7;THY1
prerank,GO_Biological_Process_2021__cell morphogenesis involved in neuron differentiation (GO:0048667),0.5893880543121163,1.1821189229458693,0.2247191011235955,0.9244234054993336,1.0,22/57,24.09%,LRP4;DCC;PLPPR4;ANK3;MAP2;MAP1B;CELSR2;MFSD2A;SLITRK5;PARD3;CCK;CTNNA2;APP;KLF7;NTNG1;SPTBN4;MAPK8IP2;FGFR2;PAK3;MAP1A;TMEM106B;BRSK1
prerank,GO_Biological_Process_2021__receptor signaling pathway via STAT (GO:0097696),-0.5413989706055629,-1.1820827678896515,0.21052631578947367,0.9850819622607028,1.0,1/17,0.13%,STAT4
prerank,GO_Biological_Process_2021__positive regulation of cell population proliferation (GO:0008284),0.5451603581937322,1.18206021694735,0.05,0.9236751901636298,1.0,44/236,12.31%,HTR2B;THBS1;NAMPT;FGF1;PRLR;TSHR;TGFB2;CR1;TBRG4;RPL23;CCPG1;TBC1D8;IL15;AGT;OSMR;NRG1;MEIS2;KITLG;LIFR;VEGFA;SPDYA;SOX4;IL7;LAMB1;SHANK2;MVD;INSR;BMI1;FN1;ID2;RPS6;PTN;RBPJ;IRS2;IGF1R;KDM1A;NTRK3;C5AR1;NOD2;SAAL1;FLT1;NTRK2;HCLS1;CRLF1
prerank,GO_Biological_Process_2021__aggrephagy (GO:0035973),0.6333669022773519,1.182024818052148,0.20224719101123595,0.9227941830242954,1.0,9/26,25.73%,VIM;RPS27A;DYNC1H1;UBA52;UBB;DYNC1I1;ATG5;CFTR;DYNLL1
prerank,GO_Biological_Process_2021__negative regulation of sequestering of calcium ion (GO:0051283),0.6952614020697956,1.181378518396022,0.25675675675675674,0.9255301608814905,1.0,4/14,12.36%,HTR2B;RYR2;IBTK;RYR3
prerank,GO_Biological_Process_2021__purine ribonucleotide catabolic process (GO:0009154),0.6688500044068512,1.1813509076278175,0.2619047619047619,0.9246490528122547,1.0,5/15,9.87%,NUDT16;NUDT4;HINT1;ACAT1;PDE2A
prerank,PanglaoDB_Augmented_2021__Epiblast Cells,0.6211093949130674,1.1812829278276025,0.25842696629213485,0.9241099661054977,1.0,13/31,12.37%,FRAS1;DPYSL5;COL26A1;SEMA6A;LINGO1;GABRB3;UNC5D;POU5F1;CRMP1;CACNA1B;CNTNAP2;EPHA7;GRID2
prerank,"GO_Biological_Process_2021__Notch receptor processing, ligand-dependent (GO:0035333)",-0.6780319897211051,-1.1812698219052824,0.3548387096774194,0.9845390028227464,1.0,3/5,21.84%,APH1A;ADAM10;PSEN1
prerank,GO_Biological_Process_2021__G2/M transition of mitotic cell cycle (GO:0000086),0.5662506945119299,1.18097939367086,0.16494845360824742,0.9246118626617963,1.0,9/98,5.22%,CDK14;TUBA4A;PRKAR2B;HAUS6;TUBB4A;FBXL7;CEP152;MASTL;TUBA1A
prerank,GO_Biological_Process_2021__energy reserve metabolic process (GO:0006112),0.7002198892171435,1.1807642329253332,0.3287671232876712,0.9247630149082762,1.0,3/11,20.93%,PRKAG2;GFPT1;LEPR
prerank,GO_Biological_Process_2021__negative regulation of toll-like receptor 4 signaling pathway (GO:0034144),0.7213450363169044,1.1806446600044909,0.2571428571428571,0.9244926498171305,1.0,1/8,0.81%,RAB7B
prerank,GO_Biological_Process_2021__self proteolysis (GO:0097264),-0.6923622978092838,-1.180350414731472,0.37142857142857144,0.9846536966283168,1.0,1/6,3.62%,NLRP1
prerank,GO_Biological_Process_2021__regulation of actin filament-based process (GO:0032970),0.5694595933155207,1.1801264776229974,0.25263157894736843,0.926264975956738,1.0,5/47,7.17%,RHOBTB3;RHOB;GPM6B;EPHA3;RND3
prerank,GO_Biological_Process_2021__isocitrate metabolic process (GO:0006102),-0.7166323566426078,-1.18006999346333,0.3157894736842105,0.9829399938851315,1.0,3/5,26.08%,IDH3B;IDH3G;IDH3A
prerank,GO_Biological_Process_2021__negative regulation of oxidative stress-induced neuron death (GO:1903204),0.6788933415722377,1.1799259635634218,0.2328767123287671,0.9262703448835462,1.0,4/10,20.22%,HIF1A;NR4A3;PINK1;FBXO7
prerank,GO_Biological_Process_2021__positive regulation of release of sequestered calcium ion into cytosol (GO:0051281),0.6741616477543663,1.1797768544336515,0.3026315789473684,0.9260299487283673,1.0,6/14,22.92%,CEMIP;AKAP6;CALM3;THY1;CX3CL1;TRPC1
prerank,GO_Biological_Process_2021__inorganic cation transmembrane transport (GO:0098662),0.5545481701898978,1.179767298201855,0.17708333333333334,0.9250638318915,1.0,46/128,25.81%,KCNE1;SCN3B;SLC6A15;SLC11A1;SLC24A2;KCNH8;SLC9A7;SCN3A;KCNH5;TRPC4;SCN1A;SLC24A1;SLC9A6;NALCN;KCNH7;RYR3;PKD1;HCN1;SCN8A;SCN2A;ATP2A2;ASIC2;SLC24A3;ATP1B3;CACNA1A;ITGAV;KCNB2;SLC39A14;TMEM175;TRPM7;ATP1A2;SLC24A4;SLC9A1;KCNQ5;KCNQ2;TRPC1;KCNK10;ATP6V0E2;KCNB1;SLC6A1;CACNA1C;KCNC2;ATP2B4;SLC11A2;SLC39A6;ABCC8
prerank,GO_Biological_Process_2021__transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),0.5364350003243337,1.1796089431269383,0.06,0.9248456854605019,1.0,57/256,19.36%,DDIT4;NAMPT;FGF1;FLRT1;PRLR;DOCK1;NRG1;PTPRG;VEGFA;PDK4;EIF2AK3;INSR;RBFOX2;EPHA3;SIPA1L1;GRB10;NGEF;PTPRT;CHN1;SHC2;IRS2;IGF1R;GHR;FGR;NTRK3;ALK;DNM1;EPHA7;TYRO3;FLT1;KALRN;NTRK2;SORBS1;SULF2;EPHA4;NR4A3;GAB1;ANKS1B;EPHA6;ITSN1;EPHA5;GRIN2B;SDCBP;CASP3;ANGPT2;HNRNPH1;RASGRP4;ITGAV;POLR2D;PLCB1;ROCK1;SLC39A14;FLRT2;FES;FIBP;CDK5R1;AP2A2
prerank,GO_Biological_Process_2021__copper ion transport (GO:0006825),0.7160971613457836,1.1795688261414525,0.2835820895522388,0.924138084439172,1.0,3/8,15.49%,STEAP2;ATOX1;SLC31A2
prerank,MSigDB_Hallmark_2020__G2-M Checkpoint,0.5624153925625264,1.179220855616091,0.1958762886597938,0.9250531312588506,1.0,13/140,8.25%,TOP2A;CENPF;SAP30;CKS2;CENPE;RACGAP1;MEIS2;RPA2;KIF15;DMD;SMC4;HIF1A;XPO1
prerank,GO_Biological_Process_2021__positive regulation of long-term synaptic potentiation (GO:1900273),0.705195243536248,1.1792009994664852,0.25333333333333335,0.9241023882203864,1.0,3/10,10.81%,SHANK3;RELN;ADCY8
prerank,GO_Biological_Process_2021__chemokine (C-X-C motif) ligand 12 signaling pathway (GO:0038146),-0.6731549133587144,-1.1790917805131755,0.34375,0.9841651214957846,1.0,2/5,12.16%,TREM2;CXCL12
prerank,GO_Biological_Process_2021__cortical cytoskeleton organization (GO:0030865),0.6263910889046536,1.1790715504710958,0.2,0.923784465920508,1.0,5/33,7.94%,RHOBTB3;RHOB;ARF6;RND3;NLGN1
prerank,GO_Biological_Process_2021__positive regulation of cellular biosynthetic process (GO:0031328),0.5578208137104168,1.1790274118594117,0.15463917525773196,0.923009885583643,1.0,18/119,12.38%,THBS1;KLF4;PRR16;VIM;EGR1;EIF4A3;SOX4;RBM3;INSR;HIF1A;DNA2;MID1IP1;IRS2;MFSD2A;EIF3E;SORBS1;NMD3;UPF3A
prerank,GO_Biological_Process_2021__negative regulation of cell projection organization (GO:0031345),0.5983174016069012,1.17890543523973,0.2235294117647059,0.9227547230720062,1.0,12/39,17.74%,SEMA3A;DCC;SPOCK1;KANK1;PAQR3;MAG;CRMP1;EPHA4;STMN2;GRIN2B;DENND5A;PTPN9
prerank,GO_Biological_Process_2021__negative regulation of cell-matrix adhesion (GO:0001953),-0.5165074882391346,-1.1781017283039088,0.3157894736842105,0.985415880517495,1.0,5/26,6.02%,PHLDB2;NEXMIF;MAP4K4;ACER2;NF2
prerank,GO_Biological_Process_2021__regulation of myoblast fusion (GO:1901739),-0.7014164108687415,-1.1779293016371741,0.36363636363636365,0.9830993783862872,1.0,2/5,13.10%,RIPOR2;CD53
prerank,GO_Biological_Process_2021__positive regulation of protein kinase C signaling (GO:0090037),0.76191511793768,1.1776253309981728,0.30434782608695654,0.9282198411296766,1.0,2/6,15.06%,VEGFA;WNT5A
prerank,GO_Biological_Process_2021__negative regulation of chemokine production (GO:0032682),0.6986239520552975,1.1775895576624702,0.24324324324324326,0.927341703942995,1.0,1/10,0.30%,KLF4
prerank,GO_Biological_Process_2021__immunoglobulin mediated immune response (GO:0016064),0.7580866190531811,1.1775190194204113,0.2463768115942029,0.9267690303848134,1.0,1/7,5.61%,FCGR2B
prerank,GO_Biological_Process_2021__positive regulation of protein exit from endoplasmic reticulum (GO:0070863),-0.575584470183323,-1.1770230972627729,0.25,0.9834101324305125,1.0,3/10,20.36%,SORL1;EDEM2;CD81
prerank,GO_Biological_Process_2021__ventricular septum development (GO:0003281),0.6257498195201749,1.176933421921277,0.25301204819277107,0.9287046096799991,1.0,5/23,9.87%,TGFB2;SOX4;ROBO2;ROBO1;PDE2A
prerank,GO_Biological_Process_2021__negative regulation of cardiac muscle hypertrophy (GO:0010614),0.6914832799433313,1.1768073165803203,0.27941176470588236,0.9285154390622116,1.0,2/9,8.38%,RGS2;CAV3
prerank,GO_Biological_Process_2021__muscle cell development (GO:0055001),0.6489654706381832,1.1766485438945964,0.2727272727272727,0.9282964074401322,1.0,7/19,15.57%,DMD;VEGFA;ANK2;CAV3;KDM1A;SGCZ;NEBL
prerank,GO_Biological_Process_2021__negative regulation of protein transport (GO:0051224),-0.5651431876484773,-1.1766447938270614,0.2608695652173913,0.9822385373850328,1.0,8/14,23.60%,SERGEF;PKDCC;PPM1F;SNX3;CSK;HMGCR;WWP2;RHBDF2
prerank,GO_Biological_Process_2021__regulation of hyaluronan biosynthetic process (GO:1900125),-0.740396259697143,-1.1763414898890385,0.34375,0.9807845065378231,1.0,1/5,7.51%,TGFB1
prerank,GO_Biological_Process_2021__regulation of amyloid precursor protein catabolic process (GO:1902991),0.7065557986101645,1.1763313498274683,0.273972602739726,0.9289343725690008,1.0,5/10,21.58%,ABCA2;PICALM;TMED10;ROCK1;FLOT2
prerank,GO_Biological_Process_2021__positive regulation of peptidyl-serine phosphorylation (GO:0033138),0.584763303945309,1.1761667201006478,0.2111111111111111,0.9288059567854529,1.0,10/49,13.26%,ARAF;TFRC;MTCP1;VEGFA;RAPGEF3;TXN;NTRK3;HCLS1;RIPK2;PINK1
prerank,GO_Biological_Process_2021__purine-containing compound metabolic process (GO:0072521),0.7460020499197018,1.176072287435865,0.22972972972972974,0.9283057584359032,1.0,3/6,21.05%,PRPS1;GUK1;MACROD1
prerank,GO_Biological_Process_2021__response to ketone (GO:1901654),0.6990984045395809,1.176032276656213,0.2638888888888889,0.927525360574828,1.0,2/13,1.28%,THBS1;TGFB2
prerank,GO_Biological_Process_2021__positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213),-0.6219273894063333,-1.1757341987262397,0.15789473684210525,0.980202756514929,1.0,1/13,1.27%,BTG2
prerank,GO_Biological_Process_2021__regulation of glial cell apoptotic process (GO:0034350),-0.7896403749553156,-1.1755126737097639,0.3170731707317073,0.978443039433897,1.0,2/5,16.68%,TREM2;PRKCA
prerank,GO_Biological_Process_2021__CENP-A containing nucleosome assembly (GO:0034080),0.652442097526475,1.1753775415773273,0.2835820895522388,0.9289966619552452,1.0,8/18,26.06%,OIP5;CENPP;CENPK;CENPI;CENPT;ITGB3BP;NASP;SMARCA5
prerank,GO_Biological_Process_2021__CENP-A containing chromatin organization (GO:0061641),0.652442097526475,1.1753775415773273,0.2835820895522388,0.9289966619552452,1.0,8/18,26.06%,OIP5;CENPP;CENPK;CENPI;CENPT;ITGB3BP;NASP;SMARCA5
prerank,GO_Biological_Process_2021__regulation of protein glycosylation (GO:0060049),0.748838274867107,1.1753700876736675,0.3287671232876712,0.9280477797058496,1.0,2/7,7.02%,ALG10B;ABCA2
prerank,GO_Biological_Process_2021__negative regulation of DNA binding (GO:0043392),-0.4884314992979474,-1.1751579345866818,0.32,0.9769794612060914,1.0,5/17,15.48%,TFAP4;ZNF675;NFKBIA;ILRUN;HABP4
prerank,GO_Biological_Process_2021__regulation of protein sumoylation (GO:0033233),0.7368158453437337,1.1751448539233218,0.2361111111111111,0.9281911783992216,1.0,2/11,4.44%,EGR1;PIAS4
prerank,GO_Biological_Process_2021__camera-type eye development (GO:0043010),0.6983044092019932,1.1750938309191863,0.28169014084507044,0.9275548931949741,1.0,2/10,5.04%,FBN2;VEGFA
prerank,GO_Biological_Process_2021__sterol biosynthetic process (GO:0016126),0.6400270192394703,1.175074600488427,0.25316455696202533,0.9266903682651708,1.0,8/23,14.89%,TM7SF2;IDI1;FAXDC2;MVD;PRKAG2;INSIG1;FDFT1;HMGCS1
prerank,GO_Biological_Process_2021__sodium ion export across plasma membrane (GO:0036376),0.7505331520531031,1.1750740471768975,0.2753623188405797,0.9257179754338327,1.0,4/7,21.02%,ATP1B3;ATP1B2;ATP1A2;SLC9A1
prerank,GO_Biological_Process_2021__negative regulation of lyase activity (GO:0051350),0.7393286898241792,1.1741979084109355,0.2753623188405797,0.9292000359255621,1.0,1/7,5.76%,GRM3
prerank,GO_Biological_Process_2021__organic substance transport (GO:0071702),0.5704052925360185,1.174012164410175,0.20430107526881722,0.9293414772894193,1.0,19/71,17.28%,CENPF;LRP2;ARRDC3;SLCO1A2;SLC19A2;ABCA2;FLVCR1;ABCA1;TXNIP;MFSD2A;PLTP;SLC35F3;LRP1B;SCAMP3;ABCA5;DISP1;PEX3;KIF3A;ARRDC2
prerank,PanglaoDB_Augmented_2021__Smooth Muscle Cells,0.5768269869750771,1.1737574823584738,0.23863636363636365,0.9297311182815148,1.0,8/63,5.30%,HHIP;SVEP1;OGN;TNS1;FBXL7;VASN;DAAM2;LAMA2
prerank,"GO_Biological_Process_2021__maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000463)",0.6349717344738589,1.1733392707476122,0.2564102564102564,0.9309639469339192,1.0,3/13,8.88%,WDR12;PES1;RPL7L1
prerank,GO_Biological_Process_2021__phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092),-0.5795482683351267,-1.1732043853109546,0.2631578947368421,0.9809212114821584,1.0,1/7,5.04%,PIK3C2B
prerank,GO_Biological_Process_2021__regulation of B cell differentiation (GO:0045577),-0.6277832556480052,-1.1729933808237705,0.25,0.9789522475906349,1.0,5/12,13.23%,IKZF3;IL4I1;NCKAP1L;BTK;SYK
prerank,MSigDB_Hallmark_2020__UV Response Dn,0.5544637696528517,1.1728813149700916,0.15625,0.9324322595121332,1.0,27/111,17.55%,PLPP3;COL11A1;PRKAR2B;PRKCE;NFIB;ACVR2A;INPP4B;SFMBT1;RND3;SIPA1L1;BHLHE40;IGF1R;MAP1B;CELF2;LTBP1;KALRN;MAGI2;PMP22;ADGRL2;INSIG1;SCN8A;TOGARAM1;GCNT1;CACNA1A;KCNMA1;APBB2;AMPH
prerank,GO_Biological_Process_2021__regulation of respiratory system process (GO:0044065),0.790954298309943,1.172726134439611,0.26153846153846155,0.9322130263437819,1.0,2/6,7.49%,TSHZ3;NLGN3
prerank,GO_Biological_Process_2021__iron ion transport (GO:0006826),0.5958393606906655,1.1725356545317007,0.27380952380952384,0.9322714052597422,1.0,13/36,26.87%,TFRC;SLC11A1;TTYH1;SLC39A14;FTH1;ATP6V0B;ATP6V1B2;HFE;ATP6V0E2;ATP6V1D;TF;SLC11A2;ATP6V1E2
prerank,GO_Biological_Process_2021__cellular response to interferon-gamma (GO:0071346),-0.4516734649515736,-1.171919804309292,0.2,0.9791727721038817,1.0,15/75,11.78%,CCL5;PDE12;GBP3;TRIM38;PTAFR;LGALS9;ICAM1;SIRPA;DAPK3;HLA-E;IRF5;HCK;HLA-DPA1;FCGR1A;OAS2
prerank,GO_Biological_Process_2021__positive regulation of neuron projection development (GO:0010976),0.5701168322335542,1.1718320296027365,0.18085106382978725,0.9347621365576285,1.0,16/64,15.09%,COBL;ZDHHC15;RELN;ZNF804A;EPHA3;PTK7;PTN;NTRK3;ALK;CAMK2B;NTRK2;MAGI2;LRRC7;STMN2;WNT5A;NDRG4
prerank,GO_Biological_Process_2021__apical protein localization (GO:0045176),0.7996808389475216,1.1718061170119647,0.2638888888888889,0.9339484955689897,1.0,3/6,7.63%,SHROOM3;MAL;ATP8B1
prerank,GO_Biological_Process_2021__negative regulation of collateral sprouting (GO:0048671),0.7649682559958181,1.1715358104666793,0.35185185185185186,0.9342022418534709,1.0,1/5,2.44%,DCC
prerank,GO_Biological_Process_2021__regulation of vasculogenesis (GO:2001212),-0.7417911476964099,-1.1714197604007677,0.25925925925925924,0.9779434860457463,1.0,3/6,16.02%,RIN2;RAP1A;EMP2
prerank,GO_Biological_Process_2021__regulation of protein autoubiquitination (GO:1902498),0.7590897166013426,1.1706943499775817,0.3448275862068966,0.9377280962772536,1.0,3/6,20.68%,RBX1;SASH1;LRRK2
prerank,GO_Biological_Process_2021__cell junction organization (GO:0034330),0.5678957092980514,1.170299237807496,0.26666666666666666,0.9389325704464374,1.0,14/47,19.52%,LRP4;TGFB2;MYOT;MAPT;CTNND2;NLGN3;PPFIBP1;PPFIA2;CBLN2;VMP1;APP;APBB2;PPFIA4;NLGN4X
prerank,GO_Biological_Process_2021__cell cycle G2/M phase transition (GO:0044839),0.5579093297429754,1.1701007024140937,0.21428571428571427,0.9390328153332737,1.0,9/99,5.22%,CDK14;TUBA4A;PRKAR2B;HAUS6;TUBB4A;FBXL7;CEP152;MASTL;TUBA1A
prerank,"GO_Biological_Process_2021__positive regulation of DNA-templated transcription, initiation (GO:2000144)",-0.5321933951806501,-1.1700964156363087,0.13333333333333333,0.979641661520433,1.0,6/15,18.30%,MED12;MED24;MED4;MED1;PAXIP1;MED30
prerank,GO_Biological_Process_2021__transcription elongation from RNA polymerase II promoter (GO:0006368),-0.410389556799027,-1.1697807351694265,0.16666666666666666,0.9779165657151047,1.0,11/57,12.38%,GTF2H5;ELOA;GTF2F1;CTDP1;GTF2H2;ELOC;LEO1;SUPT16H;TCEA1;ADRM1;POLR2C
prerank,GO_Biological_Process_2021__positive regulation of response to endoplasmic reticulum stress (GO:1905898),0.6648487791983262,1.1697545179444269,0.2631578947368421,0.9399484732965736,1.0,2/14,8.90%,FCGR2B;BOK
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte migration (GO:2000403),-0.6278803571458742,-1.1695246007823172,0.2894736842105263,0.9761382429071721,1.0,1/9,0.45%,CCL5
prerank,GO_Biological_Process_2021__mesonephric tubule development (GO:0072164),0.7665142578057255,1.1689285504893834,0.3333333333333333,0.943188773676299,1.0,3/6,20.85%,ROBO2;PKD1;FGFR2
prerank,GO_Biological_Process_2021__regulation of receptor signaling pathway via JAK-STAT (GO:0046425),0.6048583296223218,1.1686562620429004,0.27058823529411763,0.9435294775821581,1.0,2/21,3.16%,SOCS3;PIGU
prerank,GO_Biological_Process_2021__renal water homeostasis (GO:0003091),0.6749892303895251,1.1686157662835428,0.2682926829268293,0.942772286698099,1.0,3/17,10.81%,PRKAR2B;ADCY3;ADCY8
prerank,GO_Biological_Process_2021__cellular response to virus (GO:0098586),-0.4763404431920473,-1.1682140303110047,0.2777777777777778,0.9782949469743165,1.0,3/22,3.60%,CCL5;CHUK;LGALS9
prerank,GO_Biological_Process_2021__modulation by host of symbiont process (GO:0051851),-0.4616195547953402,-1.1678286244304796,0.23333333333333334,0.9768358177190943,1.0,5/27,3.15%,CCL5;CX3CR1;INPP5K;TFAP4;CTDP1
prerank,GO_Biological_Process_2021__substantia nigra development (GO:0021762),0.5719808496512494,1.167485174083909,0.24096385542168675,0.9476633337629519,1.0,12/34,25.73%,HSPA5;NDRG2;CALM3;CASP5;CKB;PLP1;BASP1;ATP5PB;SYNGR3;COX6B1;SUDS3;DYNLL1
prerank,GO_Biological_Process_2021__positive regulation of heart rate (GO:0010460),0.7561216975760839,1.1669331463512698,0.23943661971830985,0.9497874277636708,1.0,3/8,15.68%,SCN3B;RYR2;ATP2A2
prerank,GO_Biological_Process_2021__response to light stimulus (GO:0009416),0.5993549487242621,1.1668770356836808,0.3058823529411765,0.9491433337466064,1.0,3/34,3.08%,AANAT;DTL;ERCC2
prerank,GO_Biological_Process_2021__positive regulation of mRNA 3'-end processing (GO:0031442),-0.5861348473859693,-1.166156611145429,0.24242424242424243,0.9802497510960358,1.0,1/8,5.87%,LEO1
prerank,GO_Biological_Process_2021__sensory perception of chemical stimulus (GO:0007606),0.7083966699891577,1.1661006326762406,0.25925925925925924,0.9524225259342599,1.0,4/10,14.14%,OR3A2;ADCY3;C5AR1;GNAL
prerank,GO_Biological_Process_2021__oligodendrocyte development (GO:0014003),0.7024068405596383,1.1660706730110932,0.2602739726027397,0.9516016202722628,1.0,6/12,20.25%,MYRF;B4GALT5;PLP1;TPPP;EIF2B2;CNTNAP1
prerank,GO_Biological_Process_2021__ERK1 and ERK2 cascade (GO:0070371),0.6691384215770835,1.1660424073724798,0.2894736842105263,0.9507239799758048,1.0,1/14,0.27%,HTR2B
prerank,GO_Biological_Process_2021__negative regulation of small GTPase mediated signal transduction (GO:0051058),0.6456112561208472,1.1659589865642155,0.3373493975903614,0.9502371831228581,1.0,4/19,12.53%,TGFB2;CGNL1;SPRY1;FBP1
prerank,GO_Biological_Process_2021__negative regulation of endocytosis (GO:0045806),0.6493821497857877,1.165811509381007,0.30120481927710846,0.9501011659028888,1.0,5/17,15.47%,ARF6;EPHA3;CD300A;PICALM;MCTP1
prerank,GO_Biological_Process_2021__protein hexamerization (GO:0034214),0.7510067174000845,1.1657929516950063,0.3225806451612903,0.9491986287402204,1.0,2/7,12.66%,MAT2A;SPAST
prerank,GO_Biological_Process_2021__G protein-coupled glutamate receptor signaling pathway (GO:0007216),0.699092930678939,1.165684492771113,0.3125,0.9488118425329104,1.0,2/9,5.76%,GRM8;GRM3
prerank,GO_Biological_Process_2021__establishment of epithelial cell apical/basal polarity (GO:0045198),-0.7385105937687766,-1.1654120716727026,0.21621621621621623,0.9798749217534738,1.0,3/7,20.12%,OPHN1;CDC42;RAP2A
prerank,GO_Biological_Process_2021__response to corticosteroid (GO:0031960),-0.7442356593669099,-1.1651975569920519,0.34210526315789475,0.9782998921961953,1.0,1/5,0.98%,CALCR
prerank,GO_Biological_Process_2021__central nervous system myelination (GO:0022010),0.727174539174271,1.1651359488593749,0.2777777777777778,0.9507312349357268,1.0,7/9,25.11%,MYRF;ABCA2;B4GALT5;PLP1;CNTNAP1;PTEN;B4GALT6
prerank,GO_Biological_Process_2021__positive regulation of cell morphogenesis involved in differentiation (GO:0010770),0.5876955325245186,1.165045068392033,0.22988505747126436,0.9501694961037183,1.0,7/37,9.76%,PTPRD;DOCK1;IL1RAPL1;DOCK5;SS18L1;CSPG5;CARMIL1
prerank,PanglaoDB_Augmented_2021__Enterocytes,0.6007675569548835,1.164963952986071,0.2903225806451613,0.9495508993501497,1.0,7/43,5.89%,SLC51A;ASPN;PLIN2;CBR1;GULP1;CD55;DGAT1
prerank,GO_Biological_Process_2021__ovarian follicle development (GO:0001541),0.7420513901074575,1.1649164621850143,0.2857142857142857,0.9487693912337023,1.0,3/7,18.25%,VEGFA;EIF2B2;SOD1
prerank,GO_Biological_Process_2021__Wnt signaling pathway (GO:0016055),0.5696289250880827,1.1648040953939487,0.20224719101123595,0.948520064656691,1.0,10/55,15.32%,PLPP3;FZD6;NR4A2;TCF7;TCF7L1;RPS27A;CELSR2;RBX1;WNT5A;CPE
prerank,"GO_Biological_Process_2021__retrograde transport, endosome to Golgi (GO:0042147)",0.574804883617658,1.1648027449832878,0.21505376344086022,0.9475677141540907,1.0,3/77,1.16%,RHOBTB3;RAB7B;DENND2A
prerank,GO_Biological_Process_2021__regulation of tau-protein kinase activity (GO:1902947),0.7326652062185038,1.1646349946257941,0.2714285714285714,0.9475800562657754,1.0,2/8,10.42%,EGR1;C5AR1
prerank,GO_Biological_Process_2021__membrane depolarization during action potential (GO:0086010),0.6940746592300856,1.1645743735257343,0.30434782608695654,0.9469479751857086,1.0,8/13,27.12%,SCN3B;SCN3A;SCN1A;SCN8A;SCN2A;ATP1A2;CACNA1C;SCN9A
prerank,GO_Biological_Process_2021__acetylcholine receptor signaling pathway (GO:0095500),0.6888717677744048,1.1642403582664398,0.25316455696202533,0.9476046656128351,1.0,7/11,19.33%,CHRM5;GNA11;CHRM3;LY6H;PLCB1;GNAQ;CDK5R1
prerank,GO_Biological_Process_2021__regulation of glucocorticoid receptor signaling pathway (GO:2000322),0.7843170563318789,1.1641827829416855,0.3013698630136986,0.9468778520700246,1.0,2/5,11.08%,PER1;LMO3
prerank,GO_Biological_Process_2021__regulation of microtubule binding (GO:1904526),0.8101409777751025,1.163871360429134,0.27419354838709675,0.9475141104124646,1.0,2/5,8.44%,TTBK2;MAP2
prerank,GO_Biological_Process_2021__positive regulation of cell migration by vascular endothelial growth factor signaling pathway (GO:0038089),0.7789638701837442,1.163265445532609,0.25,0.950017010848088,1.0,3/7,17.22%,VEGFA;GAB1;HSPB1
prerank,GO_Biological_Process_2021__cGMP-mediated signaling (GO:0019934),0.7330947499950897,1.1630374641526757,0.2835820895522388,0.9502469092938849,1.0,3/8,12.93%,HTR2B;PDE2A;GUCY1B1
prerank,GO_Biological_Process_2021__negative regulation of axon regeneration (GO:0048681),0.7558864429746043,1.1630263603898239,0.2222222222222222,0.9493196059719382,1.0,3/5,21.81%,EPHA4;PTPRS;RTN4RL1
prerank,GO_Biological_Process_2021__axonal transport of mitochondrion (GO:0019896),0.6829200731217921,1.163014502395223,0.2857142857142857,0.9484419176772362,1.0,5/9,14.68%,MAPT;SYBU;HIF1A;SPAST;NEFL
prerank,GO_Biological_Process_2021__ionotropic glutamate receptor signaling pathway (GO:0035235),0.7385009588089179,1.16299524021375,0.25806451612903225,0.9475755324404482,1.0,5/7,20.52%,GRIN3A;GRIA2;APP;CDK5R1;CPEB4
prerank,GO_Biological_Process_2021__positive regulation of protein-containing complex disassembly (GO:0043243),0.7448779765223235,1.1629349239263524,0.25,0.946930099620522,1.0,6/10,21.66%,INSR;IGF1R;BNIP3;CALCOCO2;TNF;FYCO1
prerank,GO_Biological_Process_2021__chondrocyte differentiation (GO:0002062),0.6388808404230093,1.1628908537023859,0.25,0.9462193096683206,1.0,5/18,12.26%,NFIB;BMPR1B;EIF2AK3;SOX6;SULF2
prerank,GO_Biological_Process_2021__positive regulation of cell cycle process (GO:0090068),0.5819314594074223,1.1627675832194078,0.21505376344086022,0.945976029791653,1.0,19/55,21.19%,PRKCE;NUDT16;CIT;RACGAP1;INSR;SVIL;DYNC1H1;SPAST;XRCC3;CENPV;E2F7;UBXN2B;RGCC;PKP4;GPSM2;DBF4;CDC25B;ECT2;WIZ
prerank,GO_Biological_Process_2021__ventricular septum morphogenesis (GO:0060412),0.6323495998410145,1.1626675887504028,0.2891566265060241,0.9456762216601812,1.0,4/19,8.14%,TGFB2;SOX4;ROBO2;ROBO1
prerank,GO_Biological_Process_2021__negative regulation of macromolecule metabolic process (GO:0010605),0.5360683305190519,1.162580082075972,0.17346938775510204,0.9450922232624505,1.0,30/127,21.77%,KLF4;RBMS3;TGFB2;MAPT;VEGFA;NOCT;OVOL2;HIF1A;ROBO1;ID2;ITGB8;CCDC3;HINFP;SH3GL2;PINK1;SDCBP;PICALM;ESR1;SLC24A3;APP;FOXP1;OLFM1;PRKAA2;AP1AR;DLG4;NOTCH2;TNF;RBL2;FLOT2;MSR1
prerank,GO_Biological_Process_2021__regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001267),0.7089985660241723,1.162497104190428,0.2727272727272727,0.9445662915427168,1.0,1/9,0.94%,ST18
prerank,GO_Biological_Process_2021__tetrapyrrole metabolic process (GO:0033013),-0.5959615174645018,-1.1624150530052875,0.3448275862068966,0.9839443137910129,1.0,2/9,16.86%,MMAA;MMAB
prerank,GO_Biological_Process_2021__cobalamin metabolic process (GO:0009235),-0.5959615174645018,-1.1624150530052875,0.3448275862068966,0.9839443137910129,1.0,2/9,16.86%,MMAA;MMAB
prerank,GO_Biological_Process_2021__inorganic cation import across plasma membrane (GO:0098659),0.6015737704903604,1.1621547970553314,0.2716049382716049,0.9452825086909935,1.0,17/39,25.67%,KCNJ13;SLC24A2;SLC9A7;SLC24A1;SLC9A6;SLC12A8;ATP1B3;SLC39A12;KCNJ6;SLC39A14;KCNJ3;ATP1B2;ATP1A2;SLC9A1;SLC6A1;ATP2B4;SLC39A6
prerank,GO_Biological_Process_2021__mitochondrial outer membrane permeabilization (GO:0097345),0.6877192665363892,1.161960270867325,0.3625,0.9451738779853041,1.0,2/10,13.05%,BNIP3L;BNIP3
prerank,GO_Biological_Process_2021__N-acetylglucosamine metabolic process (GO:0006044),0.7012387783499767,1.1617898154355704,0.25333333333333335,0.9451221946188869,1.0,3/10,12.51%,CHST7;OGA;AMDHD2
prerank,GO_Biological_Process_2021__positive regulation of natural killer cell activation (GO:0032816),-0.6092595494937671,-1.1617851194171034,0.2727272727272727,0.9835943051478374,1.0,3/10,12.54%,TICAM1;HLA-E;TYROBP
prerank,GO_Biological_Process_2021__mitochondrial ATP synthesis coupled electron transport (GO:0042775),0.5856475110159584,1.1616875047693287,0.25,0.9447211196126034,1.0,20/51,28.92%,NDUFA2;NDUFB9;NDUFA3;NDUFS8;COX7C;CYCS;NDUFB6;UQCRFS1;UQCRC1;CYC1;COX4I1;COX6C;COX6B1;NDUFS5;NDUFV1;NDUFS7;NDUFAF1;COA6;UQCRC2;NDUFA1
prerank,GO_Biological_Process_2021__insulin secretion (GO:0030073),0.7108562968271857,1.1615504151154399,0.3108108108108108,0.9443302775945078,1.0,2/11,9.12%,ANXA1;RIMS2
prerank,GO_Biological_Process_2021__removal of superoxide radicals (GO:0019430),0.7894547756882755,1.160909249652157,0.2676056338028169,0.9465986399099886,1.0,2/5,18.25%,SOD2;SOD1
prerank,GO_Biological_Process_2021__negative regulation of intracellular signal transduction (GO:1902532),0.5085622038881141,1.1601994548135095,0.21875,0.9490131893224527,1.0,26/142,13.70%,THBS1;DDIT4;NLRP12;TLE1;PDE10A;PPP2R5B;CD22;CIT;CGNL1;PHLPP1;SHANK2;HERPUD1;CAV3;DEPTOR;LIMD1;MCL1;PDE2A;PER1;PIK3IP1;MAGI2;OTUD7B;UACA;DGKG;PINK1;BCL2L2;PEBP1
prerank,GO_Biological_Process_2021__late endosome to lysosome transport (GO:1902774),-0.6935843687416817,-1.1600016479821436,0.22580645161290322,0.986753909523637,1.0,1/5,8.37%,PLEKHM1
prerank,GO_Biological_Process_2021__positive regulation of voltage-gated potassium channel activity (GO:1903818),0.8056160995725292,1.1598994040761572,0.24615384615384617,0.9494848300894017,1.0,2/5,6.56%,ALG10B;AKAP6
prerank,GO_Biological_Process_2021__positive regulation of receptor internalization (GO:0002092),0.6634201197372835,1.1598626762569753,0.2753623188405797,0.9487242584600014,1.0,3/12,11.99%,VEGFA;INSR;MAGI2
prerank,GO_Biological_Process_2021__negative regulation of hydrogen peroxide-induced cell death (GO:1903206),0.6808207438281709,1.15941841122796,0.3880597014925373,0.9499839951292581,1.0,3/9,20.68%,TXN;NR4A3;LRRK2
prerank,GO_Biological_Process_2021__positive regulation of protein glycosylation (GO:0060050),0.7867160264680634,1.159383515364908,0.2923076923076923,0.9492619544520697,1.0,1/5,0.57%,ALG10B
prerank,GO_Biological_Process_2021__regulation of Golgi to plasma membrane protein transport (GO:0042996),-0.6841997635322606,-1.1593598259933688,0.35135135135135137,0.9869764260125299,1.0,2/6,4.83%,PKDCC;ATP2C1
prerank,GO_Biological_Process_2021__regulation of intrinsic apoptotic signaling pathway (GO:2001242),0.5928277616538455,1.1593296418232868,0.34831460674157305,0.9485694517321136,1.0,9/37,14.63%,DAPK2;EIF2AK3;HERPUD1;SEPTIN4;BOK;MCL1;PINK1;BCL2L2;PYCARD
prerank,GO_Biological_Process_2021__vascular endothelial growth factor signaling pathway (GO:0038084),0.6887519510016444,1.1593074806008181,0.2923076923076923,0.9477472450103237,1.0,2/8,13.23%,VEGFA;GAB1
prerank,GO_Biological_Process_2021__homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),0.5956203615389362,1.159286224093804,0.2619047619047619,0.9469640681013439,1.0,9/36,9.89%,MYOT;CADM1;CDH2;IGSF11;ROBO2;PTPRT;PALLD;ROBO1;CELSR2
prerank,GO_Biological_Process_2021__positive regulation of epithelial cell proliferation (GO:0050679),0.569218464499517,1.15909830164813,0.29545454545454547,0.9471821994979321,1.0,11/53,10.87%,HTR2B;FGF1;HMGB2;NR4A1;VEGFA;LAMB1;HIF1A;PTN;SEMA5A;C5AR1;NOD2
prerank,GO_Biological_Process_2021__insulin receptor signaling pathway (GO:0008286),0.5848259457026223,1.1587872400388204,0.2261904761904762,0.9477826147550481,1.0,17/48,26.87%,NAMPT;PDK4;INSR;GRB10;IRS2;IGF1R;SORBS1;GAB1;SLC39A14;ATP6V0B;ATP6V1B2;APPL1;ATP6V0E2;ATP6V1D;AP3S1;PHIP;ATP6V1E2
prerank,GO_Biological_Process_2021__pexophagy (GO:0000425),-0.597015434043831,-1.1586462839602996,0.36666666666666664,0.9866819428310472,1.0,1/7,9.87%,PJVK
prerank,GO_Biological_Process_2021__regulation of phosphatase activity (GO:0010921),0.6578142301172831,1.158251720746643,0.35802469135802467,0.949687391977323,1.0,5/16,21.98%,SH2D4A;MTMR9;ZCCHC9;HSP90B1;CHP1
prerank,GO_Biological_Process_2021__cellular response to reactive oxygen species (GO:0034614),0.5639127826116199,1.1582354993999324,0.27472527472527475,0.948858803514622,1.0,4/47,4.93%,RHOB;MAPT;ANXA1;PTPRK
prerank,GO_Biological_Process_2021__regulation of mesenchymal cell proliferation (GO:0010464),0.7498333228772827,1.1580528788973734,0.2898550724637681,0.9489997683943218,1.0,4/6,22.07%,WNT5A;FGFR2;STAT1;CTNNBIP1
prerank,GO_Biological_Process_2021__regulation of cellular senescence (GO:2000772),-0.509025783349387,-1.1579083518703772,0.2631578947368421,0.9863587246744263,1.0,8/22,16.60%,ABI3;NEK6;CGAS;ZKSCAN3;RSL1D1;TERF2;NUAK1;HMGA1
prerank,GO_Biological_Process_2021__negative regulation of gene expression (GO:0010629),0.5207274407411613,1.1575930905582623,0.14,0.9504793571679782,1.0,45/236,18.65%,KLF4;NUDT12;RBMS3;TGFB2;NLRP12;EIF4A3;NUDT16;MAPT;RIDA;SLC11A1;ENC1;SRGN;VEGFA;NOCT;GPNMB;FCGR2B;EIF2AK3;DAPK1;OVOL2;PUS7;HIF1A;BMI1;ZNF540;ROBO1;ID2;ITGB8;CCDC3;SMYD5;HINFP;SH3GL2;PINK1;RNF139;CENPV;PICALM;ESR1;SLC24A3;SHQ1;HSPA1B;APP;FOXP1;RGCC;OLFM1;PRKAA2;SUZ12;EZH2
prerank,GO_Biological_Process_2021__regulation of glycogen metabolic process (GO:0070873),-0.6665265112993431,-1.1574916541583176,0.39473684210526316,0.9850410316142076,1.0,5/6,14.21%,INPP5K;RUBCNL;PPP1R3F;PPP1R3E;AKT1
prerank,GO_Biological_Process_2021__protein mannosylation (GO:0035268),0.646111393334281,1.1570617070597156,0.24324324324324326,0.9525876934692716,1.0,4/18,8.68%,B4GAT1;DPY19L2;SDF2L1;TMTC2
prerank,GO_Biological_Process_2021__negative regulation of peptidyl-threonine phosphorylation (GO:0010801),0.667824165783401,1.1570305831055157,0.4057971014492754,0.9518615866592866,1.0,3/14,12.63%,DDIT4;CALM3;PARD3
prerank,GO_Biological_Process_2021__cytoplasmic microtubule organization (GO:0031122),0.5699492546620472,1.1569690987890724,0.2087912087912088,0.9512666864648344,1.0,9/48,13.85%,CLIP3;MAPT;FIGNL1;STMN3;FIGN;DYNC1H1;SPAST;TPPP;HOOK3
prerank,GO_Biological_Process_2021__nuclear export (GO:0051168),-0.3321493840094369,-1.1569185417720735,0.0,0.9845731821619157,1.0,13/65,11.25%,NUP42;CCHCR1;PHAX;DHX38;TGFB1;NUP155;CHTOP;THOC5;SMURF1;NUP188;NUP214;DDX39A;RAE1
prerank,GO_Biological_Process_2021__regulation of lipid kinase activity (GO:0043550),0.7189729284257483,1.1568190697790126,0.25,0.9511638142063614,1.0,2/8,5.43%,EEF1A2;PPP2R5A
prerank,GO_Biological_Process_2021__inhibitory synapse assembly (GO:1904862),0.7438316178665159,1.1565755044617985,0.27631578947368424,0.9513202164163589,1.0,6/8,18.88%,GABRB3;GABRA2;GABRB2;PLXNB1;WNT5A;GABRG2
prerank,GO_Biological_Process_2021__regulation of signal transduction (GO:0009966),0.5308308135373773,1.156570189805921,0.18556701030927836,0.9504040512925034,1.0,33/127,21.28%,HHIP;NLRP12;RGS20;MFNG;LIFR;CDKN2AIP;CD55;KCTD8;RGS2;OVOL2;FRRS1L;GLRX2;TCF7L1;TRIM5;CAV3;GSKIP;SEMA5A;TULP3;TMEM108;RGS11;ESR1;UGCG;RASGRP4;PLCB1;GRK4;APP;IGFBP7;MAPK8IP2;NCAM1;LRRK2;FGFR2;CX3CL1;MTCH1
prerank,GO_Biological_Process_2021__regulation of high voltage-gated calcium channel activity (GO:1901841),0.7147792792768963,1.1563610339123596,0.30666666666666664,0.9507086424859617,1.0,3/9,10.68%,CACNB2;CALM3;PDE4B
prerank,GO_Biological_Process_2021__digestive system development (GO:0055123),0.7656067530852158,1.1563274937850456,0.3013698630136986,0.9499332355568364,1.0,3/7,13.96%,COBL;CLMP;PKD1
prerank,GO_Biological_Process_2021__protein localization to cell-cell junction (GO:0150105),0.7291566881834713,1.156045398947416,0.36764705882352944,0.9504404610406857,1.0,2/11,5.29%,LSR;CGNL1
prerank,GO_Biological_Process_2021__regulation of amyloid precursor protein biosynthetic process (GO:0042984),0.7333972070102637,1.1560396594455475,0.32432432432432434,0.9495286994205813,1.0,3/8,17.34%,ABCA2;BACE2;NECAB1
prerank,GO_Biological_Process_2021__aerobic electron transport chain (GO:0019646),0.58405641272412,1.1559929465176684,0.2604166666666667,0.9488578746055656,1.0,19/50,28.92%,NDUFA2;NDUFB9;NDUFA3;NDUFS8;COX7C;CYCS;NDUFB6;UQCRFS1;UQCRC1;CYC1;COX4I1;COX6C;COX6B1;NDUFS5;NDUFV1;NDUFS7;NDUFAF1;UQCRC2;NDUFA1
prerank,GO_Biological_Process_2021__microtubule cytoskeleton organization involved in mitosis (GO:1902850),0.5390435347934935,1.1558494181837273,0.2708333333333333,0.9487397478516778,1.0,23/85,21.07%,CENPF;CENPE;NUP133;RCC1;XPO1;CENPP;SBDS;PLK2;RPS27;CLASP2;DYNC1H1;CKAP5;CENPK;CENPI;INCENP;KIF11;SEH1L;GPSM2;SUN2;KNTC1;DYNC1I1;CENPT;TACC3
prerank,GO_Biological_Process_2021__regulation of cellular protein catabolic process (GO:1903362),-0.5677963809090958,-1.1556158939923278,0.28,0.9862098969474404,1.0,3/15,3.78%,ATRAID;WDR91;DAB2IP
prerank,GO_Biological_Process_2021__gonad development (GO:0008406),0.6540024362398463,1.155509392551936,0.2597402597402597,0.9494206076336292,1.0,3/14,4.14%,LRP2;TGFB2;KITLG
prerank,GO_Biological_Process_2021__C-terminal protein amino acid modification (GO:0018410),0.7125958143624063,1.1551480326937544,0.32857142857142857,0.9503844933058483,1.0,2/9,7.57%,FOLH1;AGTPBP1
prerank,GO_Biological_Process_2021__nucleosome assembly (GO:0006334),0.6046499493088027,1.1551304459721765,0.2823529411764706,0.9495321623418606,1.0,2/30,2.98%,HMGB2;H2BC11
prerank,"GO_Biological_Process_2021__regulation of retrograde protein transport, ER to cytosol (GO:1904152)",-0.6210490069747934,-1.1549988161651386,0.23529411764705882,0.9855317732304556,1.0,6/12,25.35%,SVIP;DERL2;EDEM2;OS9;YOD1;ERLEC1
prerank,GO_Biological_Process_2021__regulation of extracellular matrix constituent secretion (GO:0003330),0.7449887366285168,1.1546941875843542,0.3582089552238806,0.9509060400980193,1.0,3/5,17.86%,TNFRSF1B;RGCC;TNFRSF1A
prerank,GO_Biological_Process_2021__purine nucleobase metabolic process (GO:0006144),0.7650598759590854,1.1546483441326703,0.31746031746031744,0.9502194719432797,1.0,4/7,18.34%,DPYD;PAICS;PRPS1;HPRT1
prerank,GO_Biological_Process_2021__negative regulation of ubiquitin protein ligase activity (GO:1904667),0.8111507625348596,1.1542972243545742,0.2463768115942029,0.9511514712556165,1.0,1/5,1.97%,RPL23
prerank,GO_Biological_Process_2021__positive regulation of glial cell differentiation (GO:0045687),0.6641081873821387,1.1540145088057854,0.2898550724637681,0.951680038638353,1.0,5/11,14.10%,PTPRZ1;ID2;PTN;TNFRSF1B;SERPINE2
prerank,GO_Biological_Process_2021__regulation of B cell receptor signaling pathway (GO:0050855),0.6150276893807254,1.153964361652543,0.2823529411764706,0.9511041377917121,1.0,6/17,23.75%,CD22;FCGR2B;CD300A;FOXP1;PRKCB;GPS2
prerank,GO_Biological_Process_2021__regulation of immune effector process (GO:0002697),0.643719068702955,1.1539297998597127,0.3411764705882353,0.9503926806318397,1.0,5/22,13.15%,CR1;FCGR2B;CD55;C5AR1;SUSD4
prerank,GO_Biological_Process_2021__cellular protein-containing complex assembly (GO:0034622),0.546405527104778,1.1533818488027905,0.21052631578947367,0.9517305323419202,1.0,33/118,22.89%,CENPF;PRLR;CENPE;MAPT;ANLN;NRG1;VBP1;DMD;TRAF2;HIGD1C;RPL38;FCHO2;MID1IP1;COX7A2;CCDC39;PDE4DIP;SGIP1;NSG2;CALY;PICALM;STXBP6;SHQ1;TCP1;SMAD1;HSPD1;MAPK8IP2;HIP1R;CENPT;TCF4;SRP19;DNAAF2;RTN4;NDC1
prerank,GO_Biological_Process_2021__alpha-amino acid catabolic process (GO:1901606),0.6821578131574918,1.1533056676074398,0.29411764705882354,0.951119863392375,1.0,4/10,13.22%,KMO;FAH;ACAT1;BLMH
prerank,GO_Biological_Process_2021__regulation of DNA recombination (GO:0000018),0.5935157361621973,1.1529763546297245,0.2682926829268293,0.9519275563131905,1.0,9/28,29.84%,RPA2;FIGNL1;KDM1A;ZCWPW1;IL7R;H1-0;SPIDR;SMARCAD1;BLM
prerank,GO_Biological_Process_2021__regulation of blood vessel endothelial cell migration (GO:0043535),0.5584281467223581,1.1528913893513197,0.26744186046511625,0.951472156025066,1.0,7/41,17.58%,THBS1;VEGFA;HIF1A;ANGPT2;ATP5F1A;HSPB1;RGCC
prerank,GO_Biological_Process_2021__regulation of protein deacetylation (GO:0090311),-0.7713656448220896,-1.1528476574141264,0.2857142857142857,0.9909519837001193,1.0,2/5,13.15%,EP300;SPRED2
prerank,GO_Biological_Process_2021__metal ion homeostasis (GO:0055065),0.6131632556957356,1.1526791789581734,0.32432432432432434,0.9516341972435219,1.0,4/20,13.16%,ANK3;TMTC2;FAM20A;SLC12A8
prerank,GO_Biological_Process_2021__positive regulation of viral process (GO:0048524),-0.43166225586916107,-1.1525455163304592,0.07692307692307693,0.9894605914468814,1.0,5/52,3.43%,CCL5;PDE12;GTF2F1;CTDP1;ADARB1
prerank,GO_Biological_Process_2021__regulation of viral entry into host cell (GO:0046596),0.6140355811363132,1.1523118121670795,0.29411764705882354,0.9526564963088722,1.0,4/22,9.69%,HS3ST5;TRIM5;TRIM25;IFITM3
prerank,GO_Biological_Process_2021__endoplasmic reticulum membrane organization (GO:0090158),0.6692474051847999,1.1512102980939125,0.38028169014084506,0.956871487747248,1.0,4/9,22.83%,VAPB;VCPIP1;BNIP1;RTN4
prerank,MSigDB_Hallmark_2020__KRAS Signaling Up,0.5235669713027056,1.1510553834526527,0.23958333333333334,0.9566572333537267,1.0,20/116,15.32%,KLF4;SPON1;TSPAN13;ITGA2;RELN;F13A1;GPNMB;SEMA3B;CA2;SNAP25;AKAP12;MAFB;ID2;GPRC5B;PDCD1LG2;TNFRSF1B;MAP7;PPP1R15A;CDADC1;CPE
prerank,GO_Biological_Process_2021__chondroitin sulfate metabolic process (GO:0030204),0.6652881786338126,1.1509614736402853,0.3076923076923077,0.9562085343902154,1.0,4/18,9.58%,CHST7;NCAN;VCAN;CSPG5
prerank,GO_Biological_Process_2021__positive regulation of endopeptidase activity (GO:0010950),0.6203995474373681,1.1507804492499283,0.32926829268292684,0.9560765342075016,1.0,7/21,15.03%,CR1;EPHA4;PRELID1;GRIN2B;PYCARD;AIM2;PICALM
prerank,GO_Biological_Process_2021__negative regulation of fibrinolysis (GO:0051918),0.7362579030564181,1.1507200632058772,0.3,0.9554218782306465,1.0,1/5,0.28%,THBS1
prerank,GO_Biological_Process_2021__negative regulation of BMP signaling pathway (GO:0030514),0.5954156258008936,1.1502192827014959,0.32894736842105265,0.9567680350031623,1.0,3/31,4.63%,LRP2;ACVR2A;BMPR1B
prerank,GO_Biological_Process_2021__presynapse organization (GO:0099172),0.6886689391172479,1.1502137055749553,0.27631578947368424,0.9559159959686495,1.0,5/9,19.52%,NLGN3;NLGN1;C5AR1;WNT5A;NLGN4X
prerank,GO_Biological_Process_2021__negative regulation of adenylate cyclase activity (GO:0007194),0.7690985002749323,1.1497132888606687,0.3,0.9567854702576462,1.0,1/5,5.76%,GRM3
prerank,GO_Biological_Process_2021__negative regulation of cyclase activity (GO:0031280),0.7690985002749323,1.1497132888606687,0.3,0.9567854702576462,1.0,1/5,5.76%,GRM3
prerank,GO_Biological_Process_2021__negative regulation of NIK/NF-kappaB signaling (GO:1901223),0.6169055013940724,1.1494667645496235,0.26666666666666666,0.9571920566762594,1.0,2/15,12.78%,NLRP12;UACA
prerank,GO_Biological_Process_2021__positive regulation of neuron migration (GO:2001224),0.7248803728112668,1.1493058131823877,0.2625,0.9571586108699752,1.0,3/12,6.68%,SEMA3A;NSMF;SEMA6A
prerank,GO_Biological_Process_2021__regulation of cellular biosynthetic process (GO:0031326),-0.4604424424428923,-1.149226744403027,0.16666666666666666,0.9982316972864821,1.0,5/22,6.94%,CCL5;CX3CR1;C3;SIRPA;NOS1AP
prerank,GO_Biological_Process_2021__positive regulation of toll-like receptor 9 signaling pathway (GO:0034165),0.7104230116624778,1.1489366546275397,0.3333333333333333,0.9581910092801589,1.0,2/5,24.96%,RTN4;RSAD2
prerank,GO_Biological_Process_2021__regulation of Wnt signaling pathway (GO:0030111),0.5405941062241931,1.1488785076375927,0.25263157894736843,0.9575303460562693,1.0,10/62,8.75%,CDK14;AMER2;TLE1;DAAM2;CTNND2;GRB10;KANK1;PTK7;TCF7L1;GSKIP
prerank,GO_Biological_Process_2021__protein localization to Golgi apparatus (GO:0034067),0.6011122294746128,1.148655557496627,0.325,0.9577916730892192,1.0,3/26,15.33%,ZDHHC15;PAQR3;TMED10
prerank,GO_Biological_Process_2021__positive regulation of DNA repair (GO:0045739),0.5785808058280018,1.1485333089438363,0.3146067415730337,0.9575345171696725,1.0,10/36,20.52%,TMEM161A;SLF1;EYA2;SPIRE2;FMN2;BRCA1;ZCWPW1;ERCC6;TIMELESS;NPAS2
prerank,GO_Biological_Process_2021__cellular monovalent inorganic cation homeostasis (GO:0030004),0.6598714913495947,1.1480627724908279,0.3333333333333333,0.9589909653606266,1.0,5/12,21.02%,ATP1B3;KCNMA1;ATP1B2;ATP1A2;SLC9A1
prerank,GO_Biological_Process_2021__regulation of establishment of protein localization to mitochondrion (GO:1903747),0.7517948398422056,1.1480377241842752,0.24675324675324675,0.9582607176565039,1.0,3/7,21.55%,MAPT;PINK1;ATP5IF1
prerank,GO_Biological_Process_2021__chromatin maintenance (GO:0070827),-0.6863302714058807,-1.1477718720430892,0.34375,1.0,1.0,4/5,31.15%,SUPT6H;MTHFR;SUPV3L1;HDAC2
prerank,GO_Biological_Process_2021__eye morphogenesis (GO:0048592),0.661178135366466,1.147673443352889,0.3026315789473684,0.9592417488289066,1.0,3/13,7.57%,FBN2;VEGFA;AGTPBP1
prerank,GO_Biological_Process_2021__positive regulation of leukocyte cell-cell adhesion (GO:1903039),-0.49145314633781834,-1.1476356514093393,0.1875,0.9978962802610584,1.0,5/21,10.89%,SKAP1;ETS1;SIRPA;HLA-DPA1;ITGB2
prerank,GO_Biological_Process_2021__negative regulation of axon extension (GO:0030517),0.6390212855327362,1.1472007733729552,0.2894736842105263,0.9609683280738391,1.0,6/19,10.26%,SEMA3A;SEMA3B;SEMA6A;MAG;MAP2;SEMA5A
prerank,GO_Biological_Process_2021__ether lipid metabolic process (GO:0046485),0.7046351958869198,1.1471943792070083,0.30985915492957744,0.9600960540599992,1.0,3/11,11.82%,LIPE;AGPS;NCEH1
prerank,GO_Biological_Process_2021__peroxisomal membrane transport (GO:0015919),-0.49279465115997007,-1.1471589492649152,0.23809523809523808,0.9968448886390017,1.0,7/20,20.48%,PEX13;PEX16;ABCD3;FIS1;ACBD5;PEX2;SLC25A17
prerank,GO_Biological_Process_2021__DNA methylation (GO:0006306),-0.5338046022257038,-1.146813490743049,0.2857142857142857,0.9952985978825956,1.0,1/16,1.05%,DNMT3A
prerank,GO_Biological_Process_2021__regulation of chromatin assembly or disassembly (GO:0001672),-0.6519486192437972,-1.1466226876670595,0.2702702702702703,0.9934665974627209,1.0,3/7,15.77%,TAL1;MAP1S;TLK2
prerank,GO_Biological_Process_2021__positive regulation of interferon-gamma production (GO:0032729),-0.4372452903956119,-1.1466167970603942,0.25,0.9909704502329152,1.0,13/36,16.50%,BTN3A2;IL1B;CD276;CD2;LGALS9;TLR3;HLA-DPA1;CD226;TLR7;IL18R1;IL12RB1;BTN3A1;PDE4D
prerank,GO_Biological_Process_2021__regulation of cell cycle (GO:0051726),0.5283316459074643,1.1465127570748241,0.23232323232323232,0.9626089999269417,1.0,33/190,14.72%,THBS1;CENPF;RHOB;TGFB2;DTL;CKS2;TBRG4;RPL23;SPATA22;CCPG1;PPP2R3B;GADD45B;BRINP1;NR4A1;WDR12;MASTL;FIGNL1;PTPRK;ALOX15B;PES1;CAMK2N1;HCFC1;BEX2;ID2;SRA1;RPS6KA2;MAGI2;BRCA1;PPP1R15A;PKD1;PRR11;UHRF2;SDCBP
prerank,GO_Biological_Process_2021__positive regulation of telomerase activity (GO:0051973),0.620984598124829,1.1464492749748136,0.32142857142857145,0.9620473611086456,1.0,1/26,0.30%,KLF4
prerank,GO_Biological_Process_2021__superoxide anion generation (GO:0042554),0.7477135232115882,1.1459733709317321,0.2676056338028169,0.9633216685402326,1.0,1/7,4.32%,ALOX12
prerank,GO_Biological_Process_2021__cellular response to leucine (GO:0071233),-0.6039140161909569,-1.1458496997772503,0.391304347826087,0.9880838158746488,1.0,2/10,7.12%,SESN2;SESN3
prerank,GO_Biological_Process_2021__response to leucine (GO:0043201),-0.6039140161909569,-1.1458496997772503,0.391304347826087,0.9880838158746488,1.0,2/10,7.12%,SESN2;SESN3
prerank,GO_Biological_Process_2021__regulation of chemotaxis (GO:0050920),0.5719909464369298,1.1457845713755463,0.25316455696202533,0.9633006273209044,1.0,1/23,0.28%,THBS1
prerank,GO_Biological_Process_2021__calcium-mediated signaling (GO:0019722),0.5481885837911827,1.1454551445324515,0.26666666666666666,0.9641024647869408,1.0,7/54,11.06%,HTR2B;PPP1R9A;NUDT4;EIF2AK3;ANK2;RYR2;CHRM3
prerank,GO_Biological_Process_2021__positive regulation by host of viral transcription (GO:0043923),-0.5355605217073264,-1.145260509516201,0.21212121212121213,0.9874794263952165,1.0,4/15,9.74%,TFAP4;CTDP1;HPN;EP300
prerank,GO_Biological_Process_2021__response to hydrogen peroxide (GO:0042542),0.5686449779274072,1.144130244170972,0.28735632183908044,0.9697910573538735,1.0,4/37,10.79%,RHOB;ANXA1;GLRX2;IMPACT
prerank,GO_Biological_Process_2021__cardiac cell development (GO:0055006),0.7042919418917093,1.1440762288454611,0.3287671232876712,0.969181197151934,1.0,1/8,5.04%,VEGFA
prerank,GO_Biological_Process_2021__cytoskeleton-dependent intracellular transport (GO:0030705),0.6252094852486231,1.1439845758487217,0.2911392405063291,0.9686783465595759,1.0,9/21,22.75%,KIF1B;TUBA1A;MYO10;HOOK3;KIF5A;TUBA1C;DYNC1I1;KIF5C;TUBA1B
prerank,GO_Biological_Process_2021__positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001269),0.7184538868600531,1.1438631744461463,0.3448275862068966,0.9684937655298619,1.0,1/7,0.94%,ST18
prerank,"GO_Biological_Process_2021__maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000466)",0.6270928532757859,1.1436250091507785,0.3055555555555556,0.9687410567407537,1.0,3/17,10.65%,WDR12;PES1;ERI2
prerank,GO_Biological_Process_2021__cellular response to forskolin (GO:1904322),0.7284255746707297,1.1432831852809946,0.34285714285714286,0.9686277260129738,1.0,3/7,12.76%,ADCY3;ADCY8;GNAI1
prerank,GO_Biological_Process_2021__response to forskolin (GO:1904321),0.7284255746707297,1.1432831852809946,0.34285714285714286,0.9686277260129738,1.0,3/7,12.76%,ADCY3;ADCY8;GNAI1
prerank,GO_Biological_Process_2021__negative regulation of double-strand break repair via nonhomologous end joining (GO:2001033),0.7622369646978396,1.1432796385662036,0.36507936507936506,0.9678027648546841,1.0,3/5,17.68%,CYREN;TFIP11;ERCC6
prerank,GO_Biological_Process_2021__sensory perception of light stimulus (GO:0050953),0.5871190047695387,1.1432528284849541,0.325,0.9670319724285035,1.0,7/38,10.68%,TULP2;GRM8;COL11A1;SLC4A10;PCDH15;RP2;SLC24A1
prerank,GO_Biological_Process_2021__axo-dendritic transport (GO:0008088),0.7429097472317998,1.1428971368031806,0.3898305084745763,0.9679193979390552,1.0,4/6,18.48%,MAPT;APP;DCTN1;SPG11
prerank,GO_Biological_Process_2021__regulation of interleukin-23 production (GO:0032667),-0.7864705099780804,-1.1428510970079757,0.3333333333333333,0.993399647442969,1.0,3/5,19.81%,IL17RA;PLCG2;MYD88
prerank,GO_Biological_Process_2021__epithelial tube morphogenesis (GO:0060562),0.6560233205590339,1.1427696620490493,0.345679012345679,0.9675615465259034,1.0,3/16,13.96%,RHOB;RYR2;PKD1
prerank,GO_Biological_Process_2021__complement receptor mediated signaling pathway (GO:0002430),0.7216921427480902,1.142704792836621,0.2714285714285714,0.966898105135379,1.0,2/7,10.42%,CR1;C5AR1
prerank,GO_Biological_Process_2021__regulation of dendrite morphogenesis (GO:0048814),0.5762399826391602,1.1426571156748744,0.30952380952380953,0.9662621101938516,1.0,4/27,9.08%,PTPRD;IL1RAPL1;NSMF;SS18L1
prerank,GO_Biological_Process_2021__negative regulation of epithelial cell migration (GO:0010633),0.6178302499408164,1.142654423854749,0.3246753246753247,0.965382735523722,1.0,2/18,4.06%,THBS1;PTPRG
prerank,GO_Biological_Process_2021__calcium ion transport into cytosol (GO:0060402),0.6682586523103138,1.1426113195052847,0.32,0.9647493001409595,1.0,8/14,28.15%,JPH1;GRIN2A;RYR2;GRIN2B;JPH4;CACNA1C;ATP2B4;CACNA2D1
prerank,"GO_Biological_Process_2021__nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872)",0.6204022849623123,1.1423109890925234,0.3170731707317073,0.965346245503949,1.0,5/23,18.81%,RPS27A;NOD2;RIPK2;UBA52;UBB
prerank,GO_Biological_Process_2021__regulation of bone mineralization (GO:0030500),0.5913209017152175,1.1422643214194905,0.2976190476190476,0.964731424510711,1.0,6/33,8.95%,FBN2;GPM6B;ACVR2A;SRGN;BMPR1B;PTN
prerank,GO_Biological_Process_2021__regulation of innate immune response (GO:0045088),-0.41964770252106676,-1.142261267906614,0.2222222222222222,0.9926983278196599,1.0,2/48,0.45%,RNASEL;CCL5
prerank,GO_Biological_Process_2021__positive regulation of lipid kinase activity (GO:0090218),-0.4623354010486316,-1.1420847780678585,0.2608695652173913,0.9908179820473823,1.0,1/18,0.05%,TNFAIP8L3
prerank,PanglaoDB_Augmented_2021__Kidney Progenitor Cells,0.573455914730334,1.1420711321525912,0.31521739130434784,0.9647790735660532,1.0,17/45,18.04%,LRP4;ENAH;DZIP1;PTPRG;CDH2;LIFR;RBFOX2;TUSC3;MAP1B;FIGN;NR2F1;KIAA1549;ADGRL2;GLRB;HSPA12A;MPDZ;PRKAA2
prerank,MSigDB_Hallmark_2020__KRAS Signaling Dn,0.5782493753472047,1.141988788732193,0.2553191489361702,0.9642528358343464,1.0,15/64,14.46%,TGFB2;MYOT;DCC;ZBTB16;TG;NR4A2;BMPR1B;ARPP21;TCF7L1;RYR2;CELSR2;KCNMB1;GRID2;RGS11;EPHA5
prerank,GO_Biological_Process_2021__positive regulation of exosomal secretion (GO:1903543),-0.5196076754059956,-1.1418856545835248,0.2903225806451613,0.9891483133469104,1.0,1/12,0.87%,SMPD3
prerank,GO_Biological_Process_2021__carbohydrate catabolic process (GO:0016052),0.624704140260864,1.1418843885857541,0.3026315789473684,0.963849163955258,1.0,10/25,20.23%,PFKM;ENO2;PGAM1;GPI;PKM;ENO4;ENOSF1;PGK1;PGM1;ENO1
prerank,GO_Biological_Process_2021__mitotic G2 DNA damage checkpoint signaling (GO:0007095),0.5850837378718816,1.1418455314342186,0.35714285714285715,0.9630904291637932,1.0,4/24,12.87%,DTL;CLSPN;DONSON;BRCA1
prerank,PanglaoDB_Augmented_2021__Urothelial Cells,-0.41796376851723865,-1.1416698067079007,0.23076923076923078,0.9876303663123398,1.0,9/41,11.67%,CARD14;LRP10;DENND1C;ABHD11;SSH3;LLGL2;NBEAL2;BCL3;ARHGAP27
prerank,GO_Biological_Process_2021__associative learning (GO:0008306),0.7357768320858363,1.1414964943243595,0.3448275862068966,0.9638416825947318,1.0,4/5,24.45%,ADCY3;MAP1A;BRSK1;SLC6A1
prerank,GO_Biological_Process_2021__endoplasmic reticulum tubular network organization (GO:0071786),0.6471434271336162,1.1413808024076806,0.36363636363636365,0.963465476145138,1.0,7/13,32.66%,REEP3;RTN3;REEP2;RTN4;TMEM33;REEP1;LNPK
prerank,GO_Biological_Process_2021__phospholipid dephosphorylation (GO:0046839),0.6003661877632009,1.1412776512934264,0.33766233766233766,0.9630726462663214,1.0,3/28,6.92%,PLPP3;PLPPR4;MTMR7
prerank,GO_Biological_Process_2021__heart trabecula morphogenesis (GO:0061384),0.6607938132353082,1.1410354025340588,0.34285714285714286,0.9633030770193968,1.0,4/9,9.26%,TGFB2;NRG1;ADGRG6;RBPJ
prerank,GO_Biological_Process_2021__protein N-linked glycosylation (GO:0006487),0.5433889912077946,1.1409546301834053,0.25,0.9627901684965641,1.0,8/48,16.64%,ALG10B;MGAT4C;TUSC3;MGAT1;STT3B;MCFD2;MAGT1;GFPT1
prerank,GO_Biological_Process_2021__regulation of pH (GO:0006885),0.7599025486547666,1.1409004749018326,0.3157894736842105,0.9621228379695287,1.0,2/5,9.19%,PDK4;SLC9A7
prerank,GO_Biological_Process_2021__histone H4-K5 acetylation (GO:0043981),0.6199374495992365,1.1408632611802323,0.2948717948717949,0.9604988931747527,1.0,2/15,7.60%,WDR5;HCFC1
prerank,GO_Biological_Process_2021__histone H4-K8 acetylation (GO:0043982),0.6199374495992365,1.1408632611802323,0.2948717948717949,0.9604988931747527,1.0,2/15,7.60%,WDR5;HCFC1
prerank,GO_Biological_Process_2021__positive regulation of DNA-directed DNA polymerase activity (GO:1900264),0.7888240112018762,1.1404750228296652,0.3050847457627119,0.9604373399501135,1.0,2/5,14.36%,POLG2;RFC4
prerank,GO_Biological_Process_2021__regulation of DNA-directed DNA polymerase activity (GO:1900262),0.7888240112018762,1.1404750228296652,0.3050847457627119,0.9604373399501135,1.0,2/5,14.36%,POLG2;RFC4
prerank,GO_Biological_Process_2021__positive regulation of signaling (GO:0023056),0.6233144464937408,1.1403947342186478,0.30120481927710846,0.9599469885035847,1.0,9/25,20.39%,GRIK2;CDKN2AIP;RIMS2;SYT1;NSF;RIMS3;DLG4;TNF;CLSTN2
prerank,GO_Biological_Process_2021__defense response to Gram-negative bacterium (GO:0050829),0.6484730939251706,1.1402828088220944,0.2602739726027397,0.9595862827113353,1.0,5/17,14.63%,HMGB2;H2BC11;SLC11A1;GSDMD;PYCARD
prerank,GO_Biological_Process_2021__negative regulation of protein depolymerization (GO:1901880),0.6685984519126531,1.1400060987664924,0.3157894736842105,0.960101004048205,1.0,6/19,13.90%,TTBK2;HDGFL3;MID1IP1;CLASP2;STMN2;APC2
prerank,GO_Biological_Process_2021__regulation of phagocytosis (GO:0050764),0.5758734669223705,1.139849284731391,0.3103448275862069,0.9599892964522903,1.0,5/37,9.71%,TUB;IL15;SLC11A1;FCGR2B;FGR
prerank,GO_Biological_Process_2021__myoblast migration (GO:0051451),0.7200597966627977,1.1393009700952612,0.323943661971831,0.9614700957631125,1.0,4/6,23.45%,ANXA1;AKIRIN1;ROCK1;MEGF10
prerank,GO_Biological_Process_2021__tetrahydrofolate interconversion (GO:0035999),-0.6623264319422576,-1.1390664181020593,0.3939393939393939,0.993105311786533,1.0,3/7,11.72%,MTHFD2L;MTHFD1L;TYMS
prerank,GO_Biological_Process_2021__embryonic skeletal system morphogenesis (GO:0048704),0.7326196172814561,1.1390302118925346,0.3283582089552239,0.9618363292947237,1.0,1/7,2.61%,EIF4A3
prerank,GO_Biological_Process_2021__regulation of protein modification by small protein conjugation or removal (GO:1903320),0.6334256067550006,1.138996950348124,0.32894736842105265,0.961082458583315,1.0,6/19,17.43%,EGR1;HIF1A;DNAJB2;PINK1;EPAS1;HSPA1B
prerank,GO_Biological_Process_2021__lipopolysaccharide-mediated signaling pathway (GO:0031663),-0.5144018816354496,-1.138891170257843,0.2222222222222222,0.9911852859543051,1.0,5/15,10.06%,CCL5;TICAM1;IL1B;TGFB1;HCK
prerank,GO_Biological_Process_2021__regulation of sterol biosynthetic process (GO:0106118),0.7244075871025906,1.138787070627745,0.2972972972972973,0.9612093264684881,1.0,1/8,7.02%,ABCA2
prerank,GO_Biological_Process_2021__short-chain fatty acid metabolic process (GO:0046459),-0.7162996414232867,-1.1387601405691292,0.36666666666666664,0.9891322048475284,1.0,3/5,17.68%,MMAA;MCEE;PCCB
prerank,GO_Biological_Process_2021__positive regulation of signal transduction by p53 class mediator (GO:1901798),0.6507666657287444,1.1385888240521311,0.3108108108108108,0.9613956768921532,1.0,6/14,21.36%,RPL23;RPS20;RPL37;CHD5;UBB;HEXIM1
prerank,GO_Biological_Process_2021__regulation of dendrite extension (GO:1903859),0.666663079662683,1.1384086834020553,0.26666666666666666,0.9605327360539836,1.0,4/12,12.47%,SYT4;UNC13A;RIMS2;SYT1
prerank,GO_Biological_Process_2021__positive regulation of dendrite extension (GO:1903861),0.666663079662683,1.1384086834020553,0.26666666666666666,0.9605327360539836,1.0,4/12,12.47%,SYT4;UNC13A;RIMS2;SYT1
prerank,GO_Biological_Process_2021__determination of bilateral symmetry (GO:0009855),0.663190961702883,1.1379666375272695,0.30864197530864196,0.9615869194110626,1.0,2/11,3.14%,DNAH11;MMP21
prerank,GO_Biological_Process_2021__phosphatidylinositol acyl-chain remodeling (GO:0036149),-0.6397626763122506,-1.1378295174539357,0.2222222222222222,0.9895332025120627,1.0,2/8,7.62%,PLA2G4C;PLA2G12A
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell apoptotic process (GO:0010665),-0.67501352727034,-1.1378070778829439,0.30303030303030304,0.9872389799443055,1.0,1/5,9.02%,ENG
prerank,GO_Biological_Process_2021__positive regulation of gene expression (GO:0010628),0.5198201343131083,1.1377826025445672,0.09,0.9616447724903348,1.0,58/291,18.25%,HTR2B;THBS1;KLF4;FGF1;RBMS3;PRR16;VIM;RPL23;EGR1;TLE1;CADM1;EIF4A3;IL15;TFRC;AGT;SLC11A1;VEGFA;SOX4;EIF2AK3;RBM3;ZNF804A;ANK3;ANK2;OVOL2;CAMK2N1;HIF1A;HCFC1;ROBO1;FN1;ID2;RIMS2;RBPJ;FGR;NTRK3;ITGB8;PDE2A;POLR1C;TENT4B;NTRK2;HINFP;EIF3E;UPF3A;BRCA1;WNT5A;SLC24A3;RPS4X;EPB41L4B;RPL11;TXK;SMAD1;ROCK1;HSPA1B;APP;RGCC;ERCC6;OLFM1;PYM1;SOD1
prerank,GO_Biological_Process_2021__negative regulation of cytokine production (GO:0001818),0.5253237625325904,1.1377824926197735,0.24210526315789474,0.9607853937839091,1.0,12/117,10.74%,THBS1;KLF4;NLRP12;CR1;ANXA1;SLC11A1;SRGN;GPNMB;FCGR2B;FN1;TRIM25;PDCD1LG2
prerank,GO_Biological_Process_2021__regulation of sensory perception of pain (GO:0051930),0.7381939333236647,1.137682092985304,0.36363636363636365,0.9604281261791765,1.0,1/5,13.43%,ACP3
prerank,GO_Biological_Process_2021__positive regulation of nitrogen compound metabolic process (GO:0051173),0.6917870311654494,1.1374102690459509,0.32098765432098764,0.9608004989644546,1.0,2/13,7.86%,KLF4;PAX8
prerank,GO_Biological_Process_2021__plasma membrane bounded cell projection organization (GO:0120036),0.5279884013604356,1.137368074087159,0.21428571428571427,0.960113555009815,1.0,24/83,18.33%,GPM6A;PPP1R9A;MAPT;MANF;GPM6B;PQBP1;LAMB1;HDGFL3;STMN3;NLGN1;MAP2;MICALL2;CARMIL1;CNTNAP2;PLP1;TMEM108;SH3GL2;STMN2;RASGRF1;ROCK1;APP;ERCC6;NCDN;ATP1B2
prerank,GO_Biological_Process_2021__regulation of glial cell proliferation (GO:0060251),-0.6949106824532634,-1.1370658277694214,0.42424242424242425,0.9870769984674673,1.0,1/5,2.23%,IL1B
prerank,GO_Biological_Process_2021__cellular response to peptide (GO:1901653),0.5357072361863093,1.1369643362328041,0.2823529411764706,0.9613655596840199,1.0,10/43,17.45%,VIM;RPL23;FCGR2B;GRIN2A;IGF1R;NOD2;RIPK2;EPHA4;CACNA1A;APP
prerank,GO_Biological_Process_2021__meiosis I (GO:0007127),0.6978994070903777,1.1368738918282157,0.2875,0.9609752307164288,1.0,3/10,13.31%,MEI1;SYCP3;ZCWPW1
prerank,"GO_Biological_Process_2021__mitochondrial electron transport, cytochrome c to oxygen (GO:0006123)",0.6957142981634137,1.1365887046159437,0.2875,0.9617174453189612,1.0,5/11,24.57%,COX7C;CYCS;COX4I1;COX6C;COX6B1
prerank,"GO_Biological_Process_2021__regulation of DNA-templated transcription, elongation (GO:0032784)",-0.49826055193413027,-1.1364304979359487,0.2857142857142857,0.9866336723055056,1.0,9/22,21.35%,ZMYND11;SUPT16H;THOC5;HTATSF1;KAT7;TCEA2;THOC1;SUPT5H;WDR43
prerank,GO_Biological_Process_2021__acylglycerol metabolic process (GO:0006639),0.6290795456541511,1.135942697462536,0.3176470588235294,0.963926751567112,1.0,6/25,14.15%,DGKI;DGAT1;CAV3;DGKB;DGKG;GK
prerank,GO_Biological_Process_2021__regulation of lamellipodium assembly (GO:0010591),-0.46990073181829023,-1.1358371248722516,0.2916666666666667,0.9864457906808449,1.0,10/25,22.08%,FSCN1;ABI3;CYFIP1;ARPC2;CDC42;CAPZB;ACTR3;WASF2;ACTR2;FER
prerank,GO_Biological_Process_2021__stem cell development (GO:0048864),0.7426024389543083,1.1354261486406652,0.3,0.965617806504557,1.0,2/7,4.08%,NRG1;CDH2
prerank,GO_Biological_Process_2021__blood vessel diameter maintenance (GO:0097746),0.6706307109563545,1.1352204599293434,0.325,0.9657642391424606,1.0,2/14,3.59%,HTR2B;AGT
prerank,GO_Biological_Process_2021__regulation of mitochondrial translation (GO:0070129),-0.5113454007412567,-1.1351770474213851,0.3793103448275862,0.9862026606216479,1.0,4/15,14.28%,RPUSD3;UQCC2;FASTKD2;RPUSD4
prerank,GO_Biological_Process_2021__excitatory postsynaptic potential (GO:0060079),0.6485154571376307,1.1351343923573047,0.275,0.9654054095918325,1.0,5/11,20.68%,GRIN2A;GRID2;GRIN2B;MAPK8IP2;LRRK2
prerank,GO_Biological_Process_2021__regulation of kinase activity (GO:0043549),0.5457085684931865,1.1349861564814188,0.27472527472527475,0.9652994930782748,1.0,25/65,21.88%,MAPT;INSR;EPHA3;IRS2;IGF1R;FGR;NTRK3;ALK;EPHA7;TYRO3;FLT1;NTRK2;EPHA4;EPHA6;EPHA5;LDB2;NPRL2;SOD1;ECT2;RBL2;CDKN1B;FGFR2;SLAMF8;HNRNPU;EEF1A1
prerank,GO_Biological_Process_2021__glucose import (GO:0046323),0.7627360917049837,1.1349806709522625,0.3684210526315789,0.9644628047008279,1.0,1/6,3.11%,SLC2A3
prerank,GO_Biological_Process_2021__mammary gland epithelium development (GO:0061180),-0.595644595057226,-1.1349571322390886,0.3448275862068966,0.9846442552401975,1.0,2/9,4.25%,ZNF703;CSF1R
prerank,GO_Biological_Process_2021__coronary vasculature morphogenesis (GO:0060977),0.6987855249525653,1.1349363795347003,0.3230769230769231,0.9637786939032641,1.0,2/7,5.04%,LRP2;VEGFA
prerank,GO_Biological_Process_2021__positive regulation of neuron death (GO:1901216),0.5962736193835171,1.1348052100979984,0.32558139534883723,0.9636661066007711,1.0,9/38,15.06%,DDIT4;TGFB2;EGR1;MAPT;FCGR2B;EPHA7;GRIN2B;PICALM;WNT5A
prerank,GO_Biological_Process_2021__transferrin transport (GO:0033572),0.5922629146588767,1.1347302801834878,0.3625,0.9632017745652105,1.0,10/27,30.92%,TFRC;ATP6V0B;ATP6V1B2;HFE;ATP6V0E2;ATP6V1D;TF;ATP6V1E2;ATP6V0A1;MCOLN1
prerank,GO_Biological_Process_2021__negative regulation of endopeptidase activity (GO:0010951),0.5552862367899152,1.134175119878053,0.3493975903614458,0.9649903877720041,1.0,6/26,14.87%,CR1;SPOCK1;AGT;SPOCK3;SERPINE2;TIMP3
prerank,GO_Biological_Process_2021__cellular glucan metabolic process (GO:0006073),0.7239240389616449,1.1341401059394853,0.2835820895522388,0.9643082213935593,1.0,1/7,11.39%,PRKAG2
prerank,GO_Biological_Process_2021__cell part morphogenesis (GO:0032990),0.6826363056071568,1.133924616645647,0.3333333333333333,0.964513149172202,1.0,3/13,12.68%,CSPG5;WASF1;SLIRP
prerank,GO_Biological_Process_2021__negative regulation of lymphocyte migration (GO:2000402),-0.6436686359882865,-1.133750377611499,0.3448275862068966,0.9859154947547933,1.0,4/9,15.04%,CD200R1;RIPOR2;AKT1;LRCH1
prerank,GO_Biological_Process_2021__regulation of receptor binding (GO:1900120),0.6928962869494085,1.1336462099083133,0.39705882352941174,0.9641293575560888,1.0,3/5,22.43%,ADAM15;ATP2A2;HFE
prerank,GO_Biological_Process_2021__negative regulation of receptor binding (GO:1900121),0.6928962869494085,1.1336462099083133,0.39705882352941174,0.9641293575560888,1.0,3/5,22.43%,ADAM15;ATP2A2;HFE
prerank,GO_Biological_Process_2021__positive regulation of translation (GO:0045727),0.5291072651738477,1.1335960487344243,0.2631578947368421,0.9635253595263863,1.0,20/75,21.82%,THBS1;PRR16;VIM;EIF4A3;SOX4;RBM3;RPS6KB2;EIF3E;UPF3A;PKM;RPS4X;RCC1L;POLR2D;RPS9;PYM1;PLD1;SAMD4A;UHMK1;POLR2G;TRMT10C
prerank,GO_Biological_Process_2021__protein localization to axon (GO:0099612),0.7527862208713272,1.1328335058355887,0.29577464788732394,0.9660788056529354,1.0,5/5,24.75%,ANK3;CNTNAP2;CNTNAP1;CNTN2;EPB41L3
prerank,GO_Biological_Process_2021__ribonucleoprotein complex disassembly (GO:0032988),0.7531891568615,1.1324385436234448,0.2698412698412698,0.9670468086797375,1.0,1/6,9.71%,TFIP11
prerank,MSigDB_Hallmark_2020__IL-2/STAT5 Signaling,0.5174434417222713,1.1323547902478517,0.25,0.9665416069510676,1.0,36/128,20.69%,NFIL3;RHOB;PLIN2;GADD45B;SLC2A3;GLIPR2;FAH;MAP3K8;NDRG1;CA2;BHLHE40;ALCAM;ITGAE;IGF1R;MXD1;IFITM3;P4HA1;CKAP4;FGL2;GPR65;NFKBIZ;TNFRSF1B;GUCY1B1;AHNAK;CASP3;CCND3;DENND5A;ITGAV;APLP1;PLEC;RHOH;TNFRSF21;UCK2;SELL;EEF1AKMT1;AHCY
prerank,GO_Biological_Process_2021__wound healing (GO:0042060),0.5828246811504447,1.1322722943616657,0.27586206896551724,0.9660871265668168,1.0,4/36,4.13%,FGF1;TGFB2;NRG1;SLC11A1
prerank,GO_Biological_Process_2021__cristae formation (GO:0042407),0.5941260935633739,1.1321548952907974,0.35294117647058826,0.965757926529433,1.0,8/24,21.98%,ATP5ME;ATP5F1A;ATP5F1D;CHCHD3;ATP5MC1;IMMT;ATP5PB;ATP5F1E
prerank,GO_Biological_Process_2021__negative chemotaxis (GO:0050919),0.6353792131769844,1.1321119219351703,0.32098765432098764,0.9651059185561416,1.0,6/19,11.11%,SEMA3A;SEMA3B;SEMA6A;ROBO1;UNC5C;EPHA7
prerank,GO_Biological_Process_2021__positive regulation of response to stimulus (GO:0048584),0.6269474784923961,1.1318192107522616,0.3888888888888889,0.9655734723470121,1.0,8/28,15.06%,TGFB2;IL15;IER5;CDKN2AIP;FCGR2B;ARG2;NSMCE1;WNT5A
prerank,GO_Biological_Process_2021__aspartate family amino acid metabolic process (GO:0009066),0.673764126923446,1.1316942610466496,0.27906976744186046,0.9652538574345626,1.0,2/14,1.94%,FOLH1;ASPA
prerank,GO_Biological_Process_2021__mitochondrial respiratory chain complex I assembly (GO:0032981),0.5625883201469203,1.1316141186234252,0.2826086956521739,0.963889149704704,1.0,16/48,28.92%,NDUFA2;NDUFB9;NDUFA3;NDUFS8;ACAD9;NDUFB6;TIMMDC1;NDUFAF4;DMAC1;ECSIT;NDUFS5;NDUFV1;NDUFS7;TMEM126A;NDUFAF1;NDUFA1
prerank,GO_Biological_Process_2021__NADH dehydrogenase complex assembly (GO:0010257),0.5625883201469203,1.1316141186234252,0.2826086956521739,0.963889149704704,1.0,16/48,28.92%,NDUFA2;NDUFB9;NDUFA3;NDUFS8;ACAD9;NDUFB6;TIMMDC1;NDUFAF4;DMAC1;ECSIT;NDUFS5;NDUFV1;NDUFS7;TMEM126A;NDUFAF1;NDUFA1
prerank,GO_Biological_Process_2021__regulation of gene expression by genetic imprinting (GO:0006349),-0.6899480586577948,-1.131457451139228,0.35135135135135137,0.9910553372356963,1.0,3/6,11.50%,DNMT3A;KDM1B;MECP2
prerank,GO_Biological_Process_2021__cellular response to retinoic acid (GO:0071300),0.6314135737372422,1.131308656463651,0.2564102564102564,0.9644469499888064,1.0,4/19,7.79%,BRINP1;RORB;EPHA3;PTK7
prerank,GO_Biological_Process_2021__carboxylic acid transport (GO:0046942),0.5970629531925027,1.131273455300891,0.32142857142857145,0.9638407192462836,1.0,3/27,6.67%,SLC16A4;SLC6A15;SLC13A3
prerank,GO_Biological_Process_2021__positive regulation of cell-cell adhesion mediated by cadherin (GO:2000049),-0.7269137722365002,-1.1310897672763633,0.4594594594594595,0.9897467884787067,1.0,1/5,1.86%,SERPINF2
prerank,GO_Biological_Process_2021__regulation of fibrinolysis (GO:0051917),0.7073687397127628,1.1309968244298028,0.31746031746031744,0.9643975939708805,1.0,1/6,0.28%,THBS1
prerank,GO_Biological_Process_2021__cellular response to glucose stimulus (GO:0071333),0.6066378152779086,1.130601573132509,0.2823529411764706,0.9653981598406851,1.0,8/25,25.50%,SOX4;IGF1R;ADCY8;PDK3;SLC39A14;PRKAA2;KCNB1;PTPRN2
prerank,GO_Biological_Process_2021__regulation of long-term synaptic potentiation (GO:1900271),0.6144007299308946,1.1305706464712963,0.2911392405063291,0.964693953213539,1.0,7/20,20.00%,SHANK3;RELN;PTN;ADCY8;EPHA4;APP;CYP46A1
prerank,GO_Biological_Process_2021__regulation of extracellular matrix disassembly (GO:0010715),-0.640918841109678,-1.130472048406725,0.38235294117647056,0.9890548101905633,1.0,3/9,7.51%,FSCN1;DDR1;TGFB1
prerank,GO_Biological_Process_2021__aortic valve development (GO:0003176),0.626783760057459,1.1302650348048549,0.35,0.9653637264754718,1.0,5/15,17.86%,ROBO2;ROBO1;TNFRSF1B;ROCK1;TNFRSF1A
prerank,GO_Biological_Process_2021__tRNA aminoacylation (GO:0043039),-0.4625783708695895,-1.1301370266408914,0.19047619047619047,0.9877295528653268,1.0,8/35,16.05%,KARS1;DARS2;FARSA;YARS1;TARS1;LARS2;SARS1;WARS1
prerank,"GO_Biological_Process_2021__positive regulation of DNA-templated transcription, elongation (GO:0032786)",-0.48718316513799975,-1.1300534796524777,0.3076923076923077,0.9857479072738987,1.0,9/20,22.94%,LEO1;SUPT16H;THOC5;BRD4;KAT7;THOC1;SUPT5H;CDC73;SUPT6H
prerank,GO_Biological_Process_2021__pyrimidine-containing compound catabolic process (GO:0072529),0.7034431151759933,1.1297364056290706,0.34177215189873417,0.966935774632564,1.0,3/12,10.22%,DPYD;DPYSL5;CRMP1
prerank,GO_Biological_Process_2021__positive regulation of cardiocyte differentiation (GO:1905209),0.7166331186497656,1.1296908809145938,0.352112676056338,0.9663469476016103,1.0,1/5,1.28%,TGFB2
prerank,GO_Biological_Process_2021__positive regulation of T-helper cell differentiation (GO:0045624),0.6856426248165917,1.1296592528699032,0.3472222222222222,0.9656607504455027,1.0,3/8,15.83%,ANXA1;NFKBIZ;IL18
prerank,GO_Biological_Process_2021__bile acid metabolic process (GO:0008206),-0.5325103202168289,-1.129595328902862,0.2857142857142857,0.9849050146248176,1.0,4/18,11.79%,NPC1;ACAA1;CH25H;OSBPL6
prerank,GO_Biological_Process_2021__myeloid cell activation involved in immune response (GO:0002275),-0.4961723315941499,-1.129558645357751,0.2916666666666667,0.9826920493242024,1.0,5/14,15.26%,KARS1;NMI;TYROBP;SYK;LILRA2
prerank,"GO_Biological_Process_2021__alternative mRNA splicing, via spliceosome (GO:0000380)",-0.507125370948889,-1.129462050088201,0.2727272727272727,0.9807636610789069,1.0,1/14,0.24%,SCNM1
prerank,GO_Biological_Process_2021__positive regulation of histone H3-K4 methylation (GO:0051571),0.6797245194137822,1.1294246156405905,0.37681159420289856,0.9658686408113283,1.0,2/11,12.87%,WDR5;BRCA1
prerank,GO_Biological_Process_2021__cellular potassium ion homeostasis (GO:0030007),0.7051790219917662,1.1293092708487686,0.31666666666666665,0.9654868726453509,1.0,4/8,20.66%,ATP1B3;KCNMA1;ATP1B2;ATP1A2
prerank,GO_Biological_Process_2021__cardiac muscle cell differentiation (GO:0055007),0.6906906898424519,1.129203822053158,0.33766233766233766,0.9652611375680981,1.0,2/12,5.04%,NRG1;VEGFA
prerank,GO_Biological_Process_2021__regulation of peroxisome proliferator activated receptor signaling pathway (GO:0035358),0.7203977202493483,1.1287214287021876,0.36231884057971014,0.9666862625311962,1.0,2/6,23.75%,LMO3;GPS2
prerank,GO_Biological_Process_2021__regulation of PERK-mediated unfolded protein response (GO:1903897),0.6898796081600648,1.1285820519655716,0.3424657534246575,0.9665741757765977,1.0,3/8,13.87%,HSPA5;BOK;PPP1R15A
prerank,GO_Biological_Process_2021__engulfment of apoptotic cell (GO:0043652),0.6558963456971036,1.1284658146605435,0.3815789473684211,0.9662583657998411,1.0,1/10,0.28%,THBS1
prerank,GO_Biological_Process_2021__tryptophan catabolic process (GO:0006569),0.7304656976720635,1.1282361891190136,0.3157894736842105,0.9666765642607498,1.0,2/5,7.85%,KMO;AFMID
prerank,GO_Biological_Process_2021__dendritic spine organization (GO:0097061),0.5825170351357223,1.1280940703981732,0.26666666666666666,0.9666136298395636,1.0,4/21,9.30%,SHANK3;CTNND2;INSR;IGF1R
prerank,GO_Biological_Process_2021__negative regulation of cell division (GO:0051782),0.7311446682415291,1.1279617520037488,0.3472222222222222,0.9663880896709316,1.0,3/6,16.49%,TXNIP;E2F7;ORC6
prerank,GO_Biological_Process_2021__mature B cell differentiation involved in immune response (GO:0002313),0.7113717757763464,1.1273779660927814,0.30158730158730157,0.968203243105948,1.0,4/7,20.17%,MFNG;FCGR2B;GPR183;NOTCH2
prerank,GO_Biological_Process_2021__macromolecule biosynthetic process (GO:0009059),0.704115917142007,1.1270583485858636,0.4262295081967213,0.9690000726576419,1.0,1/5,4.13%,SLC11A1
prerank,GO_Biological_Process_2021__negative regulation of myeloid cell differentiation (GO:0045638),0.6260806778261433,1.1268737296363565,0.36,0.9689840580006276,1.0,3/15,8.46%,ZBTB16;MEIS2;MAFB
prerank,GO_Biological_Process_2021__carnitine shuttle (GO:0006853),0.7396407530745363,1.1268584435108366,0.38961038961038963,0.9682221430644014,1.0,5/8,20.77%,MID1IP1;CPT1A;PRKAG2;PRKAA2;ACACB
prerank,GO_Biological_Process_2021__triglyceride biosynthetic process (GO:0019432),0.6801079370122978,1.1265492795025875,0.3424657534246575,0.9689278076129956,1.0,4/9,27.54%,DGAT1;GK;GPAT4;LPGAT1
prerank,GO_Biological_Process_2021__negative regulation by symbiont of host apoptotic process (GO:0033668),-0.6812634574808426,-1.1264227477112687,0.4583333333333333,0.9881713421228437,1.0,2/7,8.88%,BCL2L1;SERPINB9
prerank,GO_Biological_Process_2021__regulation of humoral immune response (GO:0002920),0.643633742982788,1.1263388552265523,0.35714285714285715,0.9690090245898237,1.0,5/21,13.15%,CR1;FCGR2B;CD55;C5AR1;SUSD4
prerank,GO_Biological_Process_2021__synaptic vesicle transport (GO:0048489),0.6794515940931584,1.1261864084818851,0.3561643835616438,0.9688555743005677,1.0,3/9,21.23%,KIF5A;SPG11;KIF5C
prerank,GO_Biological_Process_2021__regulation of epithelial to mesenchymal transition involved in endocardial cushion formation (GO:1905005),0.7457245187905908,1.1260931690382705,0.34328358208955223,0.968484216047935,1.0,1/6,1.28%,TGFB2
prerank,GO_Biological_Process_2021__regulation of sequestering of triglyceride (GO:0010889),0.6455084196704903,1.1260266661367655,0.3835616438356164,0.9679681664383203,1.0,1/10,1.11%,PLIN2
prerank,"GO_Biological_Process_2021__positive regulation of mRNA splicing, via spliceosome (GO:0048026)",0.6506966923018511,1.1258709616939235,0.3142857142857143,0.9677272577865829,1.0,1/13,5.92%,RBM3
prerank,GO_Biological_Process_2021__regulation of G2/M transition of mitotic cell cycle (GO:0010389),0.5263791690776689,1.125584049999768,0.23958333333333334,0.9682363164316622,1.0,15/115,12.75%,CENPF;TUBA4A;DTL;PRKAR2B;HAUS6;TUBB4A;FBXL7;CEP152;TUBA1A;FHL1;KCNH5;PSMB4;RBX1;DYNC1H1;CKAP5
prerank,GO_Biological_Process_2021__axon ensheathment in central nervous system (GO:0032291),0.7492401215805474,1.1254671677457808,0.4,0.9679794829740977,1.0,5/5,25.11%,MYRF;B4GALT5;PLP1;CNTNAP1;B4GALT6
prerank,GO_Biological_Process_2021__positive regulation of cellular process (GO:0048522),0.515976998812552,1.1252403477485573,0.13,0.9680771137900342,1.0,66/336,16.36%,HTR2B;THBS1;NAMPT;TUB;FGF1;PRLR;TSHR;TGFB2;CR1;TBRG4;RPL23;CCPG1;MAPT;TBC1D8;IL15;MYRF;OSMR;NRG1;MEIS2;FRMD5;SLC11A1;KITLG;LIFR;BMPR1B;VEGFA;SPDYA;SOX4;IER5;CDKN2AIP;FCGR2B;IL7;SHANK2;MVD;INSR;AKAP6;HCFC1;PPP1R13L;FN1;RPS6;PTN;IRS2;IGF1R;RYR2;NTRK3;MFSD2A;FLT1;NTRK2;HCLS1;DYNC1H1;RIPK2;CRLF1;EPHA4;PARD3;TNFRSF1B;TPPP;FASN;NSMCE1;PYCARD;SDCBP;WNT5A;COPS9;CIDEB;RPS4X;IL11RA;EPB41L4B;ITGAV
prerank,GO_Biological_Process_2021__platelet aggregation (GO:0070527),-0.5136255990796909,-1.1251644643654044,0.2,0.9902231869575816,1.0,9/27,12.04%,FLNA;MYH9;ACTB;TLN1;ILK;GNAS;P2RY12;PLEK;UBASH3B
prerank,GO_Biological_Process_2021__phospholipid efflux (GO:0033700),0.7208103793059208,1.1250422190351583,0.4090909090909091,0.9681665400960512,1.0,2/5,22.91%,ABCA1;ABCG1
prerank,GO_Biological_Process_2021__stress granule assembly (GO:0034063),0.6074254833527157,1.1250142267995031,0.3,0.9675409210919383,1.0,2/19,11.90%,MAPT;DYNC1H1
prerank,GO_Biological_Process_2021__tetrahydrofolate metabolic process (GO:0046653),-0.6299759278232361,-1.1248843255064744,0.40625,0.9887807538509312,1.0,3/8,11.72%,MTHFD2L;MTHFD1L;TYMS
prerank,GO_Biological_Process_2021__positive regulation of calcium ion-dependent exocytosis (GO:0045956),0.7292887599165535,1.124831767532281,0.3333333333333333,0.9675824948012733,1.0,4/6,26.29%,SYT4;SYT1;KCNB1;SCAMP5
prerank,GO_Biological_Process_2021__fatty acid transport (GO:0015908),0.7059659048137926,1.1247777750068162,0.3188405797101449,0.9670065383270007,1.0,2/10,9.91%,ACSL1;MFSD2A
prerank,GO_Biological_Process_2021__branching morphogenesis of an epithelial tube (GO:0048754),0.6622825430850853,1.12447585796016,0.31343283582089554,0.967585309898539,1.0,3/13,13.96%,VEGFA;PAX8;PKD1
prerank,GO_Biological_Process_2021__very-low-density lipoprotein particle assembly (GO:0034379),0.7626093502061874,1.1243975637429753,0.38461538461538464,0.9672664958916845,1.0,4/7,21.29%,DGAT1;MFSD2A;ACSL3;P4HB
prerank,GO_Biological_Process_2021__negative regulation of protein catabolic process (GO:0042177),-0.4863565281890629,-1.1241675506021196,0.2857142857142857,0.988594436661759,1.0,4/27,5.22%,ATRAID;FLNA;DAB2IP;AZIN2
prerank,GO_Biological_Process_2021__sodium ion homeostasis (GO:0055078),0.6646429068736214,1.1239147788179955,0.37142857142857144,0.9678692342307478,1.0,4/9,21.02%,ATP1B3;ATP1B2;ATP1A2;SLC9A1
prerank,GO_Biological_Process_2021__cellular sodium ion homeostasis (GO:0006883),0.6646429068736214,1.1239147788179955,0.37142857142857144,0.9678692342307478,1.0,4/9,21.02%,ATP1B3;ATP1B2;ATP1A2;SLC9A1
prerank,GO_Biological_Process_2021__regulation of histone H3-K4 methylation (GO:0051569),0.6376064565988235,1.1237126721299757,0.323943661971831,0.9679342782357835,1.0,3/15,12.87%,WDR5;KDM1A;BRCA1
prerank,GO_Biological_Process_2021__glutamine metabolic process (GO:0006541),0.6961778478133728,1.1237030207916063,0.38235294117647056,0.9671455067236451,1.0,2/7,9.72%,GLYATL1;GLUL
prerank,GO_Biological_Process_2021__epidermal cell differentiation (GO:0009913),0.6312551643676074,1.1235625912448892,0.27848101265822783,0.9669878363871495,1.0,9/21,16.10%,ERCC2;ANXA1;OVOL2;ST14;TXNIP;WNT5A;CASP3;UGCG;CLIC4
prerank,GO_Biological_Process_2021__muscle organ development (GO:0007517),0.6045260746811738,1.1233377182524626,0.33707865168539325,0.9672844460833201,1.0,10/26,20.90%,DMD;LAMA2;FHL1;POU6F1;CAV3;SGCE;SOX6;SGCD;CHODL;UTRN
prerank,GO_Biological_Process_2021__negative regulation of establishment of protein localization (GO:1904950),0.6756721218918595,1.1232513568526512,0.3561643835616438,0.9668404168808006,1.0,1/10,2.79%,MAPT
prerank,GO_Biological_Process_2021__G1/S transition of mitotic cell cycle (GO:0000082),0.5345245374154522,1.1230442359101733,0.2967032967032967,0.9671605090936178,1.0,6/55,12.03%,ACVR1B;CDK14;SPDYA;RCC1;PLK2;HINFP
prerank,GO_Biological_Process_2021__regulation of tissue remodeling (GO:0034103),0.6437909886944817,1.1228438902828966,0.3287671232876712,0.9673211618697424,1.0,4/11,20.93%,IL15;GPNMB;IL18;LEPR
prerank,GO_Biological_Process_2021__Roundabout signaling pathway (GO:0035385),0.7314944637727218,1.1224445278723243,0.390625,0.9683627275646338,1.0,1/5,8.14%,ROBO1
prerank,GO_Biological_Process_2021__regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway (GO:1903376),0.7348098125480733,1.1223989416208942,0.34328358208955223,0.967720982258613,1.0,2/7,9.52%,HIF1A;MCL1
prerank,GO_Biological_Process_2021__regulation of actin filament length (GO:0030832),-0.6690196765934708,-1.1222443506912954,0.375,0.9917690780224918,1.0,2/6,12.16%,ARHGAP35;CXCL12
prerank,MSigDB_Hallmark_2020__Adipogenesis,0.5206342945508274,1.1221326748453435,0.2222222222222222,0.9681423014639066,1.0,34/149,22.69%,OMD;ARAF;PLIN2;ENPP2;TALDO1;FAH;LIFR;DGAT1;ETFB;ABCA1;LIPE;SORBS1;CMPK1;NKIRAS1;ITSN1;DNAJB9;GRPEL1;PEMT;ATP1B3;UQCRC1;BCL6;SOD1;SLC66A3;CD151;RTN3;CYC1;PGM1;GPAT4;SLC5A6;IMMT;RMDN3;GPD2;PDCD4;SPARCL1
prerank,GO_Biological_Process_2021__negative regulation of vascular permeability (GO:0043116),0.6890746031949201,1.122067021129091,0.3939393939393939,0.9676601839066953,1.0,3/9,12.42%,VEGFA;PDE2A;SH3GL2
prerank,GO_Biological_Process_2021__positive regulation of T cell migration (GO:2000406),-0.5012590303163983,-1.1218200320022564,0.2857142857142857,0.9909548951233761,1.0,1/14,0.45%,CCL5
prerank,GO_Biological_Process_2021__T-helper cell differentiation (GO:0042093),0.6976046020935729,1.1216821981506895,0.3384615384615385,0.9684527222687825,1.0,3/6,22.53%,GPR183;FOXP1;PTGER4
prerank,GO_Biological_Process_2021__ribosomal large subunit biogenesis (GO:0042273),0.560953343331334,1.1216513497038905,0.2808988764044944,0.9677497932970184,1.0,18/45,26.42%,WDR12;WDR74;MAK16;PES1;RPL23A;HEATR3;NHP2;MRPL20;RPL14;RPL11;NOP53;MRTO4;RPL24;RPL3;PAK1IP1;RPL7;TRAF7;RPL10A
prerank,GO_Biological_Process_2021__regulation of hydrolase activity (GO:0051336),0.5557734506329934,1.1215687060290356,0.3076923076923077,0.9672297094184222,1.0,16/55,18.25%,RAP1GAP;TDG;EPHA3;STMN3;SIPA1L1;NGEF;CHN1;TBC1D15;NTRK2;EPHA4;PLXNB1;EPHA5;FGD6;PLXNC1;FGD4;SOD1
prerank,GO_Biological_Process_2021__postsynaptic neurotransmitter receptor internalization (GO:0098884),0.751571829662129,1.1210462618251087,0.3382352941176471,0.9680926251090887,1.0,2/5,10.71%,DNM3;DNM1
prerank,GO_Biological_Process_2021__postsynaptic endocytosis (GO:0140239),0.751571829662129,1.1210462618251087,0.3382352941176471,0.9680926251090887,1.0,2/5,10.71%,DNM3;DNM1
prerank,GO_Biological_Process_2021__neuron projection organization (GO:0106027),0.6349458855367928,1.120840698005995,0.36764705882352944,0.9682117762357594,1.0,4/11,22.60%,INSR;APP;DCTN1;MAP1A
prerank,GO_Biological_Process_2021__epithelial structure maintenance (GO:0010669),0.7278348419626623,1.1206992961833822,0.36231884057971014,0.9679764539478188,1.0,1/6,10.87%,NOD2
prerank,GO_Biological_Process_2021__mitochondrial DNA repair (GO:0043504),0.7639323392604467,1.1206045425280518,0.2835820895522388,0.9675763293367196,1.0,1/5,8.41%,DNA2
prerank,GO_Biological_Process_2021__regulation of metaphase/anaphase transition of cell cycle (GO:1902099),0.7891010917048464,1.1200089130839876,0.328125,0.9692125486001391,1.0,2/5,3.26%,CENPE;RIOK2
prerank,GO_Biological_Process_2021__positive regulation of response to biotic stimulus (GO:0002833),-0.464318879959953,-1.1197598998581195,0.23529411764705882,0.9957816430347046,1.0,3/30,4.52%,CCL5;LY86;SCIMP
prerank,GO_Biological_Process_2021__inositol phosphate biosynthetic process (GO:0032958),0.6895969281156542,1.1195738596384461,0.3384615384615385,0.9703827198346248,1.0,1/9,3.76%,ITPKC
prerank,GO_Biological_Process_2021__regulation of MAP kinase activity (GO:0043405),0.5302758417513799,1.1195623261159195,0.3,0.9696284936535535,1.0,12/61,11.67%,HTR2B;FGF1;AGT;DIRAS2;VEGFA;RGS2;PAQR3;ROBO1;SPRY1;CAV3;NOD2;FLT1
prerank,GO_Biological_Process_2021__positive regulation of nitric oxide biosynthetic process (GO:0045429),0.6626199223802827,1.1194407579869983,0.3157894736842105,0.9693067297269988,1.0,2/17,6.48%,KLF4;INSR
prerank,GO_Biological_Process_2021__positive regulation of glycolytic process (GO:0045821),0.6181132940657786,1.119340956594512,0.325,0.9681638382508346,1.0,5/17,18.04%,INSR;HIF1A;PFKFB4;APP;PRKAA2
prerank,GO_Biological_Process_2021__positive regulation of purine nucleotide metabolic process (GO:1900544),0.6181132940657786,1.119340956594512,0.325,0.9681638382508346,1.0,5/17,18.04%,INSR;HIF1A;PFKFB4;APP;PRKAA2
prerank,GO_Biological_Process_2021__pyrimidine nucleobase biosynthetic process (GO:0019856),-0.6108754973704271,-1.1192308914541995,0.3076923076923077,0.9953117809532993,1.0,1/5,2.11%,DHODH
prerank,PanglaoDB_Augmented_2021__Sertoli Cells,0.5337361819865193,1.1191933038207809,0.23655913978494625,0.9680708821850845,1.0,13/69,9.21%,PLPP3;PRLR;NTN4;TNS1;AGT;KITLG;VASN;RXRB;SEMA3B;CD55;MAFB;BOK;SHC2
prerank,GO_Biological_Process_2021__regulation of fertilization (GO:0080154),0.7390143181578139,1.1191721882481667,0.3620689655172414,0.9673529165672755,1.0,2/5,16.96%,RNASE10;PLCB1
prerank,GO_Biological_Process_2021__positive regulation of protein secretion (GO:0050714),0.5474737666059026,1.1190964250084972,0.3563218390804598,0.9670031119836522,1.0,7/45,11.73%,TGFB2;ARF6;SOX4;MYRIP;APBB3;IRS2;PPID
prerank,GO_Biological_Process_2021__positive regulation of natural killer cell mediated immunity (GO:0002717),0.6934693502621666,1.118822804334663,0.3783783783783784,0.9666716036161345,1.0,1/10,2.51%,CADM1
prerank,GO_Biological_Process_2021__positive regulation of natural killer cell mediated cytotoxicity (GO:0045954),0.6934693502621666,1.118822804334663,0.3783783783783784,0.9666716036161345,1.0,1/10,2.51%,CADM1
prerank,GO_Biological_Process_2021__negative regulation of secretion (GO:0051048),0.7774123790842438,1.1188046341573585,0.4225352112676056,0.9659727167517895,1.0,1/5,3.66%,NRG1
prerank,GO_Biological_Process_2021__positive regulation of cellular respiration (GO:1901857),0.7351771215858098,1.118514786494704,0.35714285714285715,0.9664112240408416,1.0,4/7,22.98%,IFNLR1;PINK1;PRELID1;ISCU
prerank,GO_Biological_Process_2021__positive regulation of cellular protein catabolic process (GO:1903364),0.6222711009531378,1.1184975562363857,0.35443037974683544,0.9656903656102321,1.0,4/14,21.55%,ABCA2;VPS11;RDX;ATP5IF1
prerank,GO_Biological_Process_2021__nucleoside salvage (GO:0043174),0.7113662464893687,1.1183213947096806,0.35526315789473684,0.9656777380907585,1.0,5/9,19.80%,UCKL1;DCK;UPP2;HPRT1;UCK2
prerank,GO_Biological_Process_2021__negative regulation of protein autophosphorylation (GO:0031953),0.7315097510255351,1.1181205710884732,0.3283582089552239,0.9656651312044865,1.0,3/7,10.79%,NLRP12;ERRFI1;IMPACT
prerank,GO_Biological_Process_2021__positive regulation of transmembrane transport (GO:0034764),0.6758578986394571,1.1180977307629758,0.3333333333333333,0.9650087041378542,1.0,4/12,12.83%,ACSL1;CLIP3;CA2;NR4A3
prerank,GO_Biological_Process_2021__regulation of telomerase RNA localization to Cajal body (GO:1904872),0.6262235322799654,1.1180972467110615,0.3684210526315789,0.9642293352675076,1.0,6/18,27.75%,RUVBL2;NHP2;SHQ1;TCP1;CCT8;DKC1
prerank,GO_Biological_Process_2021__lipid phosphorylation (GO:0046834),0.6736439798378551,1.118088354202258,0.375,0.9634977036035983,1.0,5/9,25.23%,DGKI;DGKB;DGKG;DGKE;DGKZ
prerank,MSigDB_Hallmark_2020__UV Response Up,0.5287574798339095,1.1180838966359166,0.23958333333333334,0.9627363108541481,1.0,32/105,21.86%,RHOB;TUBA4A;HTR7;PTPRD;TFRC;NR4A1;RXRB;ENO2;DGAT1;GRINA;CA2;NTRK3;MGAT1;TYRO3;POLG2;CCK;SOD2;RFC4;NXF1;GRPEL1;CASP3;CCND3;SLC25A4;OLFM1;HSPA2;DLG4;MAPK8IP2;FOS;ATF3;WIZ;SELENOW;HNRNPU
prerank,GO_Biological_Process_2021__negative regulation of autophagy (GO:0010507),0.5603899453053176,1.1180124089013446,0.325,0.9623163594599365,1.0,8/47,21.39%,HTR2B;MCL1;PINK1;NRBP2;MTMR9;LRRK2;LEPR;TBC1D14
prerank,GO_Biological_Process_2021__negative regulation of viral process (GO:0048525),-0.40958991345878704,-1.117893521662935,0.3,0.9974483177379941,1.0,4/48,6.48%,RNASEL;CCL5;APOBEC3G;BANF1
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771),0.6209633652161395,1.1172721836714898,0.34146341463414637,0.9645855943642055,1.0,1/19,0.30%,DDIT4
prerank,GO_Biological_Process_2021__regulation of nervous system process (GO:0031644),0.68724321357382,1.1169029024132318,0.3037974683544304,0.9655620178888407,1.0,5/12,17.45%,BEGAIN;TMEM108;DLGAP1;DLGAP2;APP
prerank,GO_Biological_Process_2021__positive regulation of sprouting angiogenesis (GO:1903672),0.6733600661238764,1.1167568331442643,0.2878787878787879,0.965457030277063,1.0,3/11,5.04%,KLF4;FGF1;VEGFA
prerank,GO_Biological_Process_2021__establishment of protein localization to plasma membrane (GO:0061951),0.5565714623995484,1.1166959936545167,0.30120481927710846,0.9649360464318745,1.0,4/29,16.92%,ANK3;NSF;PREPL;SPTBN1
prerank,PanglaoDB_Augmented_2021__Plasmacytoid Dendritic Cells,-0.36351255014528605,-1.1164773435230146,0.16666666666666666,0.9992268127138336,1.0,29/111,13.61%,NKG7;CD300LF;ITGAM;CD37;LY86;BIN2;PIK3R6;MPEG1;BLNK;GZMB;RASAL3;ITGAX;AOAH;MYO1F;NCKAP1L;IRF5;WDFY4;PLEK;HCK;BTK;MCTP2;ITGB2;CYTH4;TLR7;LCP2;CD83;TYROBP;CD53;SNX20
prerank,GO_Biological_Process_2021__immune response-regulating cell surface receptor signaling pathway (GO:0002768),0.7170133228741915,1.116405852879409,0.2698412698412698,0.9654631807101305,1.0,4/7,26.55%,FGR;MICB;LILRB2;BAG6
prerank,GO_Biological_Process_2021__negative regulation of protein maturation (GO:1903318),0.696866747768193,1.1160578460284927,0.421875,0.9659817670226784,1.0,4/5,29.19%,SERPINE2;LRRK2;SNX12;PRNP
prerank,GO_Biological_Process_2021__positive regulation of ion transport (GO:0043270),0.6045685586624204,1.115993818031461,0.3058823529411765,0.9654616231570935,1.0,6/32,7.48%,CACNB2;SCN3B;FHL1;ANK3;ANK2;PKP2
prerank,GO_Biological_Process_2021__negative regulation of lipid biosynthetic process (GO:0051055),0.6874329824501084,1.115953457449275,0.4,0.9649039109344081,1.0,4/13,17.10%,ASXL3;ABCA2;BRCA1;ERLIN1
prerank,GO_Biological_Process_2021__mesenchymal cell development (GO:0014031),0.7341426755340368,1.1159018569773735,0.3188405797101449,0.9643624510240257,1.0,2/7,4.08%,NRG1;CDH2
prerank,"GO_Biological_Process_2021__mRNA cis splicing, via spliceosome (GO:0045292)",0.6575185868259442,1.1156807867377987,0.3253012048192771,0.9644814392668425,1.0,3/14,8.84%,WBP11;SRSF12;WBP4
prerank,GO_Biological_Process_2021__negative regulation of growth (GO:0045926),0.5257070132750254,1.1155175840830733,0.29896907216494845,0.9643856637103946,1.0,11/77,12.53%,ACVR1B;TGFB2;ADAM15;TP53TG5;ALOX15B;CDKN2AIP;FHL1;TCHP;ING1;DNAJB2;FBP1
prerank,GO_Biological_Process_2021__positive regulation of protein kinase activity (GO:0045860),0.5257575740977066,1.1153872507040932,0.19791666666666666,0.9641445574837995,1.0,18/107,13.01%,TGFB2;TOM1L1;CENPE;EGR1;RELN;AGT;CLSPN;SLC11A1;MTCP1;VEGFA;SPDYA;INSR;SRCIN1;CALM3;GPRC5B;PRKAG2;EPHA4;PAK5
prerank,GO_Biological_Process_2021__regulation of histone H3-K9 methylation (GO:0051570),0.6829027687095965,1.1153444113305278,0.3037974683544304,0.9635365943296618,1.0,5/8,30.64%,KDM1A;BRCA1;JARID2;RIF1;ZNF274
prerank,GO_Biological_Process_2021__peptidyl-serine autophosphorylation (GO:0036289),0.6845574403384279,1.1151293947742875,0.410958904109589,0.9637399567186935,1.0,1/8,13.26%,PINK1
prerank,GO_Biological_Process_2021__anterograde synaptic vesicle transport (GO:0048490),0.6826500709360788,1.115114014936612,0.3466666666666667,0.9622833701449407,1.0,4/8,27.05%,AP3B2;AP3B1;AP3S1;AP3M2
prerank,GO_Biological_Process_2021__synaptic vesicle transport along microtubule (GO:0099517),0.6826500709360788,1.115114014936612,0.3466666666666667,0.9622833701449407,1.0,4/8,27.05%,AP3B2;AP3B1;AP3S1;AP3M2
prerank,GO_Biological_Process_2021__negative regulation of Notch signaling pathway (GO:0045746),-0.5005027131852705,-1.1148515295648755,0.38095238095238093,1.0,1.0,3/14,14.21%,EGFL7;EGFR;AKT1
prerank,GO_Biological_Process_2021__RNA processing (GO:0006396),-0.35762891597267404,-1.114777375224959,0.0,0.9997197495899377,1.0,21/151,13.14%,RNASEL;SCNM1;NUFIP1;ELAVL4;RP9;SNRNP35;ADARB1;SF3A1;KHSRP;MTPAP;SMU1;DDX23;AKAP8L;HNRNPUL1;IVNS1ABP;LSM6;M1AP;AURKAIP1;SON;FASTKD2;PPP1R9B
prerank,GO_Biological_Process_2021__cellular response to inorganic substance (GO:0071241),0.648576568551641,1.1147228765168067,0.35443037974683544,0.963005842514179,1.0,7/14,29.84%,ADCY10;GUCY1B1;TIMELESS;KCNC2;SPIDR;FOXO1;BLM
prerank,GO_Biological_Process_2021__cellular response to nitrogen compound (GO:1901699),-0.5351043911541304,-1.1145742085317336,0.32,0.998022541256174,1.0,1/15,0.82%,PDE12
prerank,GO_Biological_Process_2021__thyroid hormone generation (GO:0006590),0.72643794701617,1.1142235045843887,0.44642857142857145,0.9643977393705387,1.0,2/6,14.65%,TG;DIO1
prerank,MSigDB_Hallmark_2020__Fatty Acid Metabolism,0.517490490166303,1.1142036971387401,0.2857142857142857,0.9636858980351004,1.0,16/106,14.89%,MDH1;CBR1;ACSL1;IDI1;PTPRG;BMPR1B;ENO2;NCAPH2;CA2;GLUL;RDH11;CPT1A;GAD2;FASN;ALDH1A1;HMGCS1
prerank,GO_Biological_Process_2021__positive regulation of reactive oxygen species biosynthetic process (GO:1903428),-0.6403696393188287,-1.1140633230329047,0.3055555555555556,0.9972089506120907,1.0,4/5,26.54%,PLCG2;RAB27A;CYBA;CD36
prerank,GO_Biological_Process_2021__negative regulation of cell motility (GO:2000146),0.5437287686833276,1.1139029176027189,0.24210526315789474,0.9642913912358906,1.0,19/72,18.31%,RHOB;FRMD5;ADAM15;PTPRK;ALOX15B;PTPRT;KANK1;TMEFF2;ROBO1;MAGI2;EPHA4;SPOCK3;LIMCH1;DUSP10;THY1;MCTP1;CLIC4;SPINT2;GTPBP4
prerank,GO_Biological_Process_2021__regulation of toll-like receptor 2 signaling pathway (GO:0034135),-0.5901057649349688,-1.1138634595135601,0.28205128205128205,0.9955251632229757,1.0,2/8,15.45%,TREM2;TIRAP
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell action potential involved in regulation of contraction (GO:0098909),0.7135721787769685,1.1136588081193473,0.4027777777777778,0.9645994386118596,1.0,3/5,26.68%,CAV3;ATP2A2;FGF13
prerank,GO_Biological_Process_2021__positive regulation of carbohydrate metabolic process (GO:0045913),0.6064445032785486,1.1133686530307383,0.33766233766233766,0.9651196786655669,1.0,5/19,18.04%,INSR;HIF1A;PFKFB4;APP;PRKAA2
prerank,GO_Biological_Process_2021__regulation of macrophage cytokine production (GO:0010935),0.6542221220458232,1.113206707382485,0.4155844155844156,0.9649711824890137,1.0,3/12,15.06%,TGFB2;GPRC5B;WNT5A
prerank,GO_Biological_Process_2021__glycoprotein catabolic process (GO:0006516),0.6441400347465633,1.1127087429012652,0.3108108108108108,0.9664155159228918,1.0,3/9,13.11%,OGA;STT3B;FBXO27
prerank,GO_Biological_Process_2021__defense response to fungus (GO:0050832),0.7179590607406329,1.1126150553385366,0.359375,0.9659024923449309,1.0,1/8,0.35%,CLEC4E
prerank,GO_Biological_Process_2021__phospholipid transport (GO:0015914),-0.43178364354595034,-1.1125076932544682,0.25,0.9976537244793902,1.0,2/44,1.31%,TNFAIP8L3;NPC2
prerank,GO_Biological_Process_2021__protein modification by small protein conjugation or removal (GO:0070647),-0.5647142876572793,-1.1123491101417908,0.42857142857142855,0.9958711024154947,1.0,3/13,18.48%,UBA7;SENP6;DESI2
prerank,GO_Biological_Process_2021__negative regulation of synaptic transmission (GO:0050805),0.6018699376551699,1.1123175479456742,0.34210526315789475,0.9665260396124654,1.0,10/18,23.76%,SLC24A2;PRRT1;SHANK2;PLK2;SLC24A1;PNKD;NLGN4X;LRRK2;SYT11;PTEN
prerank,GO_Biological_Process_2021__positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0035774),0.6875602400134658,1.1119523371639846,0.3333333333333333,0.9673604324533017,1.0,3/9,24.25%,ADCY8;C2CD2L;CFTR
prerank,GO_Biological_Process_2021__mitochondrial RNA metabolic process (GO:0000959),0.6451316155986663,1.1119093401894315,0.36486486486486486,0.9667874044214505,1.0,5/12,24.08%,MTERF1;TFAM;POLRMT;TEFM;FOXO3
prerank,GO_Biological_Process_2021__DNA damage induced protein phosphorylation (GO:0006975),-0.6940940918348917,-1.1118762092468117,0.4642857142857143,0.9953064354453068,1.0,3/6,23.59%,ABL1;CHEK2;MAP2K6
prerank,GO_Biological_Process_2021__negative regulation of neurogenesis (GO:0050768),0.5761792687961244,1.1117615469033446,0.35443037974683544,0.9666458444296322,1.0,13/27,24.85%,LRP4;OMG;LINGO1;MAG;PTN;HOOK3;THY1;ARHGDIA;TNF;RTN4;GDI1;PTEN;RUFY3
prerank,GO_Biological_Process_2021__positive regulation of behavior (GO:0048520),0.7688936299540673,1.111728781025338,0.3582089552238806,0.9659988179491377,1.0,4/5,20.52%,NLGN1;SGIP1;NR4A3;NPAS2
prerank,GO_Biological_Process_2021__antifungal innate immune response (GO:0061760),0.738816685136356,1.1114466679175807,0.3492063492063492,0.9664388149625671,1.0,1/6,0.35%,CLEC4E
prerank,GO_Biological_Process_2021__unsaturated fatty acid metabolic process (GO:0033559),0.5727084462399913,1.1113463524904348,0.3218390804597701,0.9661396192994424,1.0,6/30,8.63%,FAAH;ACSL1;FAAH2;ALOX12;ALOX15B;SCD5
prerank,GO_Biological_Process_2021__negative regulation of kinase activity (GO:0033673),0.5215727214462255,1.111207967625783,0.32222222222222224,0.9658860759389197,1.0,18/51,21.98%,MAPT;PPP2R5A;CAMK2N1;CAV3;GSKIP;DEPTOR;IRS2;PRKAG2;PPM1E;THY1;HSPB1;NPRL2;GSTP1;GNAQ;TAF7;CDKN1B;HNRNPU;CHP1
prerank,GO_Biological_Process_2021__isoprenoid biosynthetic process (GO:0008299),0.7399510183205076,1.1110284073600503,0.28169014084507044,0.9659113120266629,1.0,2/6,6.40%,IDI1;MVD
prerank,GO_Biological_Process_2021__negative regulation of epithelial cell proliferation (GO:0050680),0.5696998520723957,1.1101648902625139,0.2413793103448276,0.9688082986850763,1.0,6/42,8.14%,THBS1;SPARC;TGFB2;NFIB;PTPRK;ROBO1
prerank,GO_Biological_Process_2021__vacuolar acidification (GO:0007035),0.6234398839784773,1.1101545207540575,0.3291139240506329,0.9680800014888548,1.0,3/14,23.41%,SLC11A1;DMXL2;ATP6V0E2
prerank,GO_Biological_Process_2021__B cell mediated immunity (GO:0019724),0.7761711700190802,1.1100230247340437,0.35,0.9678707619243907,1.0,1/5,5.61%,FCGR2B
prerank,GO_Biological_Process_2021__liver development (GO:0001889),0.6235891578470367,1.1099460849947276,0.35714285714285715,0.967414353456266,1.0,5/19,9.57%,COBL;LSR;ANXA1;ARID5B;CCDC39
prerank,GO_Biological_Process_2021__cilium movement (GO:0003341),0.6300973075090538,1.109908784040862,0.36363636363636365,0.9667937955377404,1.0,9/16,22.26%,DNAH11;ADCY10;CCDC39;CFAP54;DNAH17;DNAH7;DNHD1;DNAAF2;DNAAF5
prerank,GO_Biological_Process_2021__positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process (GO:1902961),0.7319085412695816,1.1099021856155855,0.38181818181818183,0.9660768696268026,1.0,2/5,15.03%,EPHA4;PICALM
prerank,GO_Biological_Process_2021__positive regulation of interleukin-1 production (GO:0032732),0.5470448246947851,1.1097876680461736,0.3373493975903614,0.9657576324668472,1.0,12/41,17.45%,NLRP12;EGR1;GSDMD;NOD2;RIPK2;TRIM16;PYCARD;AIM2;WNT5A;TMED10;HSPB1;APP
prerank,GO_Biological_Process_2021__cardiac muscle cell development (GO:0055013),0.6848384699184383,1.109766718803236,0.38961038961038963,0.9650576026637604,1.0,5/10,27.96%,VEGFA;SORBS2;FHOD3;TTN;MYH11
prerank,GO_Biological_Process_2021__negative regulation of T cell receptor signaling pathway (GO:0050860),-0.5142295526552267,-1.1096071423396339,0.38461538461538464,1.0,1.0,2/12,4.46%,DUSP3;LILRB4
prerank,GO_Biological_Process_2021__negative regulation of glucose transmembrane transport (GO:0010829),-0.5912653256809929,-1.1092536795065988,0.2631578947368421,0.9994739065017811,1.0,4/9,9.65%,INPP5K;IL1B;APPL2;ENPP1
prerank,GO_Biological_Process_2021__inositol phosphate metabolic process (GO:0043647),0.5579133571447881,1.1092244732249712,0.3333333333333333,0.9666371743802903,1.0,3/36,5.87%,NUDT4;ITPKC;INPP4B
prerank,GO_Biological_Process_2021__positive regulation of bone mineralization (GO:0030501),0.5919768796531795,1.1091218151225424,0.3670886075949367,0.9663481079061937,1.0,5/21,8.95%,FBN2;GPM6B;ACVR2A;BMPR1B;PTN
prerank,GO_Biological_Process_2021__positive regulation of erythrocyte differentiation (GO:0045648),0.6105354494165044,1.1089102519954368,0.3670886075949367,0.9666338202806876,1.0,4/23,7.22%,ACVR1B;HMGB2;ACVR2A;HIF1A
prerank,GO_Biological_Process_2021__regulation of erythrocyte differentiation (GO:0045646),0.5949327085104356,1.1087416878762513,0.3333333333333333,0.9665091740474476,1.0,5/32,8.46%,ACVR1B;HMGB2;ACVR2A;HIF1A;MAFB
prerank,GO_Biological_Process_2021__regulation of translation (GO:0006417),0.5039490839264991,1.1077019914072836,0.27835051546391754,0.9701678378390348,1.0,26/151,19.98%,THBS1;PRR16;VIM;EIF4A3;RIDA;ENC1;SOX4;EIF2AK3;RBM3;DAPK1;PUS7;ZNF540;IMPACT;EIF3E;UPF3A;DDX1;RBM4B;RNF139;EIF2B2;RPS4X;HSPB1;APP;PYM1;MIF4GD;PLD1;SAMD4A
prerank,GO_Biological_Process_2021__T cell homeostasis (GO:0043029),-0.7109651197798679,-1.107691858340486,0.4838709677419355,1.0,1.0,4/6,21.44%,NCKAP1L;AKT1;FAS;PPP2R3C
prerank,GO_Biological_Process_2021__positive regulation of chondrocyte differentiation (GO:0032332),0.7402744375792846,1.1076869686945117,0.3333333333333333,0.9694676435672296,1.0,3/6,11.78%,ZBTB16;BMPR1B;SOX6
prerank,GO_Biological_Process_2021__heterotypic cell-cell adhesion (GO:0034113),-0.44924168075038834,-1.1076678509127915,0.25,0.9994855048352129,1.0,5/20,10.89%,ITGA5;CD2;CD200R1;ITGAX;ITGB2
prerank,GO_Biological_Process_2021__polyol metabolic process (GO:0019751),0.5605949684781075,1.1076392436584552,0.3372093023255814,0.9688652055448385,1.0,3/35,5.87%,NUDT4;ITPKC;INPP4B
prerank,GO_Biological_Process_2021__negative regulation of binding (GO:0051100),-0.3892883886736287,-1.10714048107912,0.2222222222222222,0.999049115970798,1.0,12/62,15.48%,RALB;TFAP4;GTF2F1;ACTB;NFKBIA;ILRUN;SORL1;CTSZ;DAB2;DISC1;AKT1;HABP4
prerank,GO_Biological_Process_2021__mitochondrial protein catabolic process (GO:0035694),0.769093746383579,1.106885840440657,0.36486486486486486,0.9715030188129606,1.0,2/5,13.05%,BNIP3L;BNIP3
prerank,GO_Biological_Process_2021__regulated exocytosis (GO:0045055),0.4963748567960217,1.1065887160893106,0.2857142857142857,0.9719689597360246,1.0,14/119,9.12%,THBS1;SPARC;TGFB2;TUBA4A;MANF;SRGN;F13A1;VEGFA;SYT4;STEAP2;SNAP25;ENDOD1;FN1;RIMS2
prerank,GO_Biological_Process_2021__cellular response to sterol (GO:0036315),0.6755518185895439,1.106537703740312,0.375,0.9713437259217678,1.0,2/9,13.53%,GRAMD1C;INSIG1
prerank,GO_Biological_Process_2021__regulation of collateral sprouting (GO:0048670),0.6920543354775553,1.1065341334349519,0.4032258064516129,0.9705934597307936,1.0,1/6,2.44%,DCC
prerank,GO_Biological_Process_2021__DNA replication-independent nucleosome assembly (GO:0006336),0.5910702201851368,1.1063042387549666,0.3783783783783784,0.9708738589617217,1.0,8/25,26.06%,OIP5;CENPP;CENPK;CENPI;CENPT;ITGB3BP;NASP;SMARCA5
prerank,GO_Biological_Process_2021__midbrain dopaminergic neuron differentiation (GO:1904948),0.7341886403187383,1.1062135353831188,0.34328358208955223,0.970502561869721,1.0,2/5,15.06%,NR4A2;WNT5A
prerank,GO_Biological_Process_2021__axon development (GO:0061564),0.5365643120892953,1.106146168339484,0.30851063829787234,0.970006129073132,1.0,23/58,22.83%,DCC;MAPT;PLPPR4;ANK3;MAP1B;SLITRK5;SEMA5A;PLP1;NREP;PARD3;CCK;CTNNA2;APP;KLF7;GRM7;NTNG1;SPTBN4;CDK5R1;FGFR2;PAK3;RTN4RL1;MAP1A;RTN4
prerank,GO_Biological_Process_2021__positive regulation of biomineral tissue development (GO:0070169),0.5915771233530535,1.1060785567386542,0.379746835443038,0.9695252466682841,1.0,5/22,8.95%,FBN2;GPM6B;ACVR2A;BMPR1B;PTN
prerank,GO_Biological_Process_2021__central nervous system neuron development (GO:0021954),0.658717580821355,1.1060598661060446,0.29411764705882354,0.9688826761863306,1.0,4/11,11.79%,MAPT;MAP2;B4GALT5;NTRK2
prerank,GO_Biological_Process_2021__cellular amino acid biosynthetic process (GO:0008652),0.8057796725680992,1.1057682948659504,0.2857142857142857,0.9693330021071092,1.0,3/5,14.58%,GAD1;GAD2;ALDH1A1
prerank,GO_Biological_Process_2021__regulation of ERAD pathway (GO:1904292),0.657002672540798,1.1056175328509887,0.35135135135135137,0.9692371035401304,1.0,5/10,27.56%,HERPUD1;AQP11;RNFT1;BAG6;USP25
prerank,GO_Biological_Process_2021__positive regulation of monooxygenase activity (GO:0032770),0.6624902736302113,1.1055261708542305,0.3466666666666667,0.9688909009793331,1.0,2/15,7.22%,HTR2B;HIF1A
prerank,GO_Biological_Process_2021__regulation of astrocyte differentiation (GO:0048710),0.7241277122507979,1.1053018296284942,0.4,0.9691119970438479,1.0,3/5,14.10%,ID2;EPHA4;SERPINE2
prerank,GO_Biological_Process_2021__regulation of chromosome segregation (GO:0051983),0.6952294899607433,1.1051873288330494,0.391304347826087,0.9688179111976546,1.0,1/10,5.06%,IHO1
prerank,GO_Biological_Process_2021__cholesterol biosynthetic process (GO:0006695),0.6075049007141354,1.1048359822996352,0.27631578947368424,0.9696046073532822,1.0,6/20,14.89%,TM7SF2;IDI1;MVD;INSIG1;FDFT1;HMGCS1
prerank,GO_Biological_Process_2021__cyclic nucleotide transport (GO:0070729),-0.6526918991995005,-1.1044448728762648,0.38461538461538464,1.0,1.0,3/5,19.06%,ABCC4;SLC19A1;LRRC8D
prerank,GO_Biological_Process_2021__internal protein amino acid acetylation (GO:0006475),0.6898372535988123,1.1040076011945381,0.3116883116883117,0.972622506918448,1.0,1/7,2.79%,MAPT
prerank,GO_Biological_Process_2021__regulation of phosphoprotein phosphatase activity (GO:0043666),0.6151251135028182,1.1039094426953378,0.3333333333333333,0.9722970402778858,1.0,6/27,13.87%,MASTL;CALM3;MAGI2;PPP4R4;CD300A;PPP1R15A
prerank,GO_Biological_Process_2021__negative regulation of Wnt signaling pathway (GO:0030178),0.5014107372988339,1.103780625026045,0.32989690721649484,0.9719354151402684,1.0,13/118,11.23%,LRP4;RBMS3;DKK2;FZD6;AMER2;TLE1;LZTS2;GRB10;RUVBL2;LIMD1;PSMB4;RBX1;PRICKLE1
prerank,GO_Biological_Process_2021__negative regulation of secretion by cell (GO:1903531),0.5939211518505275,1.1037419305864553,0.379746835443038,0.9713765321651536,1.0,8/22,18.62%,IL1RAPL1;ANXA1;SYT4;TNFRSF1B;STXBP6;TNFRSF1A;PNKD;GRM7
prerank,GO_Biological_Process_2021__negative regulation of cold-induced thermogenesis (GO:0120163),0.5537227215049152,1.1027474978639675,0.4117647058823529,0.9745814295288069,1.0,6/31,14.58%,ARRDC3;IL15;ACOT13;RBPJ;NOVA1;ALDH1A1
prerank,GO_Biological_Process_2021__negative regulation of protein phosphorylation (GO:0001933),0.5013126007109201,1.1024931628023809,0.2916666666666667,0.9749504028480453,1.0,18/112,12.68%,DDIT4;PLPP3;NLRP12;DMD;CAMK2N1;PAQR3;CAV3;CALM3;GSKIP;DEPTOR;NTRK3;ERRFI1;IMPACT;IBTK;PRKAG2;SH3GL2;PARD3;PPM1E
prerank,GO_Biological_Process_2021__cellular response to vascular endothelial growth factor stimulus (GO:0035924),0.6107899700800523,1.102154281918741,0.38961038961038963,0.9755965729972018,1.0,7/23,17.22%,NR4A1;ANXA1;VEGFA;SEMA6A;FLT1;GAB1;HSPB1
prerank,"GO_Biological_Process_2021__posttranslational protein targeting to membrane, translocation (GO:0031204)",0.7096388592272576,1.1020724289552355,0.36619718309859156,0.9751899776662032,1.0,2/7,5.78%,HSPA5;SEC61B
prerank,GO_Biological_Process_2021__negative regulation of protein localization to plasma membrane (GO:1903077),-0.4774606868922332,-1.1017625809547842,0.25,1.0,1.0,6/16,13.53%,BCL2L1;PKDCC;ABI3;TGFB1;DAB2;PPFIA1
prerank,GO_Biological_Process_2021__death-inducing signaling complex assembly (GO:0071550),0.7027896185561799,1.10169819280333,0.4,0.9759590434063452,1.0,4/6,23.60%,TRAF2;TNFRSF1A;TNF;TRADD
prerank,GO_Biological_Process_2021__positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862),0.616821032177319,1.1015854266477227,0.35294117647058826,0.9756621854173629,1.0,2/15,4.25%,TGFB2;ACVR2A
prerank,GO_Biological_Process_2021__positive regulation of macroautophagy (GO:0016239),-0.3542837466272437,-1.1015686652356713,0.3333333333333333,1.0,1.0,4/44,7.12%,RALB;SESN2;PIP4K2B;SESN3
prerank,GO_Biological_Process_2021__skeletal muscle organ development (GO:0060538),0.679293605843306,1.1013888721285905,0.3125,0.9758030129050325,1.0,6/12,22.29%,SVIL;IGSF8;DISP1;ZBTB18;BASP1;MYL6
prerank,GO_Biological_Process_2021__cholesterol metabolic process (GO:0008203),0.5699877228090864,1.101067607900813,0.34523809523809523,0.9763513933537973,1.0,12/42,20.18%,TM7SF2;IDI1;MVD;ABCA1;INSIG1;FDFT1;ABCA5;HMGCS1;SNX17;MSMO1;CYP46A1;OSBPL5
prerank,GO_Biological_Process_2021__regulation of lipid storage (GO:0010883),-0.5194769130714515,-1.1008459035911078,0.36,1.0,1.0,4/12,11.00%,C3;MEST;LPL;NFKBIA
prerank,GO_Biological_Process_2021__regulation of nitric-oxide synthase activity (GO:0050999),0.5921044712779556,1.1001150347901532,0.37349397590361444,0.9798166140363836,1.0,4/27,8.38%,HTR2B;GLA;HIF1A;CAV3
prerank,PanglaoDB_Augmented_2021__Undefined Placental Cells,0.5468825428589155,1.099718251711267,0.27848101265822783,0.9807391475309051,1.0,11/35,23.47%,WDR5;TFRC;PES1;BAIAP2L1;RCC1;FASN;PRDX4;TUBA1C;AHCY;DNAAF5;TRAP1
prerank,GO_Biological_Process_2021__G protein-coupled acetylcholine receptor signaling pathway (GO:0007213),0.6472927794123499,1.0996630592441954,0.3875,0.9801927637289719,1.0,6/12,19.33%,CHRM5;GNA11;CHRM3;PLCB1;GNAQ;CDK5R1
prerank,GO_Biological_Process_2021__protein O-linked glycosylation (GO:0006493),0.5606065805335666,1.0994447091525852,0.3176470588235294,0.9804167042138648,1.0,11/55,15.93%,GALNTL6;GALNT8;B4GAT1;GALNT13;SDF2L1;TMTC2;GALNT18;OGA;B4GALT5;PLOD1;GCNT1
prerank,GO_Biological_Process_2021__placenta development (GO:0001890),0.7136096365653228,1.0993827166261025,0.38095238095238093,0.9799076696916154,1.0,2/5,18.25%,E2F7;SOD1
prerank,GO_Biological_Process_2021__long-chain fatty-acyl-CoA metabolic process (GO:0035336),0.6497827928268962,1.0993073020829223,0.4024390243902439,0.9795298804117132,1.0,4/15,19.55%,ACSL1;DGAT1;HSD17B12;ACSL3
prerank,GO_Biological_Process_2021__regulation of protein processing (GO:0070613),0.6618617887354638,1.0988762814730426,0.34328358208955223,0.9805287867920381,1.0,5/10,29.19%,RNF139;SERPINE2;LRRK2;SNX12;PRNP
prerank,GO_Biological_Process_2021__DNA synthesis involved in DNA repair (GO:0000731),0.5742670646046203,1.0988367675312178,0.32954545454545453,0.9799484577763075,1.0,9/32,20.01%,DTL;RPA2;RPS27A;TRIM25;RFC4;USP43;UBA52;UBB;RFC1
prerank,GO_Biological_Process_2021__negative regulation of lipid metabolic process (GO:0045833),0.6427633863761537,1.098693979146579,0.3670886075949367,0.9797233659322552,1.0,4/12,10.85%,ASXL3;PPP2R5A;ALK;CCDC3
prerank,GO_Biological_Process_2021__actin-mediated cell contraction (GO:0070252),-0.6229242992132645,-1.0985961343653687,0.3333333333333333,1.0,1.0,3/7,16.02%,CCDC88C;GSN;EMP2
prerank,GO_Biological_Process_2021__sulfur amino acid metabolic process (GO:0000096),-0.5451535862794484,-1.09847263328867,0.3225806451612903,1.0,1.0,2/12,3.33%,TXN2;GCLC
prerank,GO_Biological_Process_2021__regulation of cell growth (GO:0001558),0.5059084071562975,1.0982703782540795,0.26804123711340205,0.9805536434199574,1.0,25/142,18.11%,ACVR1B;TGFB2;PAPPA2;SPOCK1;TFRC;AGT;ATAD3A;ADAM15;TP53TG5;CDKN2AIP;FHL1;AKAP6;TCHP;MFSD2A;ING1;NRG3;DNAJB2;FBP1;PAK5;SDCBP;BCL6;HSPA1B;APBB2;CHPT1;TAF9B
prerank,GO_Biological_Process_2021__positive regulation of blood coagulation (GO:0030194),0.6328471913277108,1.0982443631603604,0.3968253968253968,0.9799024112427448,1.0,1/9,0.28%,THBS1
prerank,GO_Biological_Process_2021__negative regulation of canonical Wnt signaling pathway (GO:0090090),0.5125361373927533,1.0982290433278288,0.3191489361702128,0.979230522313122,1.0,12/104,11.23%,LRP4;RBMS3;DKK2;FZD6;AMER2;TLE1;LZTS2;RUVBL2;LIMD1;PSMB4;RBX1;PRICKLE1
prerank,GO_Biological_Process_2021__spermatid development (GO:0007286),0.6291559765827592,1.0980519905394726,0.4189189189189189,0.9793455172294699,1.0,3/14,7.27%,RFX2;SYCP3;DPY19L2
prerank,GO_Biological_Process_2021__peptidyl-lysine methylation (GO:0018022),0.5881811855095569,1.097975489543299,0.35802469135802467,0.9789128111292175,1.0,3/17,8.08%,SUV39H2;ANTKMT;CSKMT
prerank,GO_Biological_Process_2021__nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423),0.5998559965175857,1.0978755253031764,0.3333333333333333,0.9785527490464876,1.0,5/24,18.81%,RPS27A;NOD2;RIPK2;UBA52;UBB
prerank,GO_Biological_Process_2021__magnesium ion transport (GO:0015693),0.6833421473066333,1.0978218351776474,0.36619718309859156,0.9780421708950323,1.0,2/10,14.24%,TUSC3;MAGT1
prerank,GO_Biological_Process_2021__positive regulation of ATP metabolic process (GO:1903580),0.5712329784167874,1.0977953604653108,0.3764705882352941,0.9774461097838096,1.0,8/25,20.23%,INSR;HIF1A;PFKFB4;PINK1;APP;PRKAA2;PPARA;ENO1
prerank,GO_Biological_Process_2021__regulation of ion transmembrane transporter activity (GO:0032412),0.57847810192514,1.0977044589076526,0.3707865168539326,0.9770376951719361,1.0,6/26,11.06%,SCN3B;FHL1;ANK2;CAV3;FXYD7;CHRM3
prerank,GO_Biological_Process_2021__negative regulation of actin filament depolymerization (GO:0030835),-0.6595833426579658,-1.097532121984928,0.3870967741935484,1.0,1.0,3/5,19.47%,LIMA1;GSN;PLEKHH2
prerank,GO_Biological_Process_2021__melanosome organization (GO:0032438),-0.5231622456752429,-1.0974746021077528,0.25806451612903225,1.0,1.0,1/15,2.40%,HPS4
prerank,GO_Biological_Process_2021__regulation of tubulin deacetylation (GO:0090043),0.6966429997183545,1.097440019953599,0.36619718309859156,0.9774480859269952,1.0,3/7,18.04%,MAPT;TPPP;PRKAA2
prerank,GO_Biological_Process_2021__regulation of transforming growth factor beta production (GO:0071634),0.6433139940718291,1.0974335987935935,0.3875,0.976760590981881,1.0,5/13,10.41%,TGFB2;HIF1A;FN1;ITGB8;LTBP1
prerank,MSigDB_Hallmark_2020__Mitotic Spindle,0.5097166324898099,1.0972759021509295,0.24489795918367346,0.976790759610812,1.0,35/163,20.28%,TOP2A;CENPF;TUBA4A;CENPE;ANLN;RACGAP1;ARF6;KIF15;KIF1B;SMC4;PALLD;MID1IP1;WASF1;LMNB1;SPTAN1;DYNC1H1;CKAP5;HOOK3;ITSN1;INCENP;KIF11;UXT;FGD6;SPTBN1;ROCK1;ARHGDIA;SORBS2;FGD4;SUN2;ECT2;RFC1;PCGF5;KNTC1;NOTCH2;SSH2
prerank,GO_Biological_Process_2021__TORC1 signaling (GO:0038202),-0.6549269561923843,-1.097134970147848,0.48,1.0,1.0,2/7,15.14%,CLEC16A;CARD11
prerank,GO_Biological_Process_2021__positive regulation of podosome assembly (GO:0071803),-0.6595839059920133,-1.0970983575773177,0.42105263157894735,1.0,1.0,3/5,15.15%,FSCN1;LCP1;CAPG
prerank,GO_Biological_Process_2021__regulation of cholesterol esterification (GO:0010872),0.709640191037537,1.0970524566830229,0.41935483870967744,0.9771073174081377,1.0,2/7,7.02%,AGT;ABCA2
prerank,GO_Biological_Process_2021__regulation of cytokinesis (GO:0032465),0.5319241872198257,1.0969656965037147,0.32558139534883723,0.9766148299320472,1.0,14/50,19.88%,PRKCE;CIT;RACGAP1;MAP9;CALM3;SVIL;PLK2;SPAST;CENPV;E2F7;PIK3R4;PKP4;CDC25B;ECT2
prerank,GO_Biological_Process_2021__microtubule anchoring at centrosome (GO:0034454),0.6870339982247491,1.096433902847088,0.4027777777777778,0.978089358238884,1.0,4/7,21.37%,HOOK3;KIF3A;DCTN1;NIN
prerank,GO_Biological_Process_2021__cilium-dependent cell motility (GO:0060285),0.6547031020754903,1.0961735197678604,0.34615384615384615,0.978489962169364,1.0,4/9,12.41%,CCDC39;CFAP54;DNAH17;DNAH7
prerank,GO_Biological_Process_2021__membrane biogenesis (GO:0044091),0.7514642572436616,1.0960704078360832,0.30357142857142855,0.978076078733611,1.0,2/5,6.39%,CLIP3;ANK3
prerank,GO_Biological_Process_2021__positive regulation of transcription elongation from RNA polymerase II promoter (GO:0032968),-0.5742168366087863,-1.0960577431075544,0.35714285714285715,1.0,1.0,3/10,12.55%,LEO1;SUPT16H;BRD4
prerank,GO_Biological_Process_2021__adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193),0.5758243291897635,1.0960372150192588,0.3372093023255814,0.9775415389857648,1.0,11/30,15.17%,GRM8;CHRM5;ADCY3;RGS1;AKAP12;PDE2A;ADCY8;CHRM3;GNAI1;GNAL;HTR1F
prerank,GO_Biological_Process_2021__deadenylation-dependent decapping of nuclear-transcribed mRNA (GO:0000290),-0.5928372621217493,-1.095902746337038,0.39285714285714285,1.0,1.0,1/7,7.65%,DCP1B
prerank,GO_Biological_Process_2021__negative regulation of neuron death (GO:1901215),0.5443759071646826,1.0958798792954316,0.3595505617977528,0.9773927474828655,1.0,16/59,20.68%,GPNMB;TRAF2;PTPRZ1;MAG;RETREG1;TYRO3;NTRK2;CRLF1;TNFRSF1B;SOD2;PINK1;NRBP2;SOD1;FBXO7;CPEB4;LRRK2
prerank,GO_Biological_Process_2021__negative regulation of protein localization to cell surface (GO:2000009),0.696097057777076,1.095694650457833,0.3888888888888889,0.9775718504037151,1.0,3/8,15.03%,GPM6B;CAV3;PICALM
prerank,GO_Biological_Process_2021__postreplication repair (GO:0006301),0.5620487484700047,1.0956172623441809,0.36666666666666664,0.9771456588835595,1.0,11/36,20.01%,DTL;RPA2;RPS27A;TRIM25;BRCA1;NSMCE1;RFC4;USP43;UBA52;UBB;RFC1
prerank,GO_Biological_Process_2021__positive regulation of transporter activity (GO:0032411),-0.5177751904122553,-1.0950690491830493,0.34285714285714286,1.0,1.0,3/7,16.52%,NR1H3;WNK3;KMT2A
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332),0.5650412044260084,1.0948834320709884,0.33707865168539325,0.9793162140714604,1.0,5/30,14.63%,DDIT4;HINT1;BOK;ZNF385B;PYCARD
prerank,GO_Biological_Process_2021__positive regulation of telomere maintenance (GO:0032206),-0.46251737902982026,-1.0948575104574696,0.21428571428571427,1.0,1.0,3/25,12.30%,PKIB;MAP3K4;NBN
prerank,GO_Biological_Process_2021__ATF6-mediated unfolded protein response (GO:0036500),0.6298240187312597,1.094822193966647,0.3194444444444444,0.9788324969466897,1.0,1/9,5.27%,HSPA5
prerank,GO_Biological_Process_2021__negative regulation of cholesterol metabolic process (GO:0090206),0.7276378617751804,1.0947204049562342,0.34328358208955223,0.9771587527324691,1.0,2/5,18.25%,ERLIN1;SOD1
prerank,GO_Biological_Process_2021__negative regulation of cholesterol biosynthetic process (GO:0045541),0.7276378617751804,1.0947204049562342,0.34328358208955223,0.9771587527324691,1.0,2/5,18.25%,ERLIN1;SOD1
prerank,GO_Biological_Process_2021__negative regulation of sterol biosynthetic process (GO:0106119),0.7276378617751804,1.0947204049562342,0.34328358208955223,0.9771587527324691,1.0,2/5,18.25%,ERLIN1;SOD1
prerank,GO_Biological_Process_2021__protein localization to organelle (GO:0033365),0.5136327733481046,1.0944236290239788,0.32653061224489793,0.9776276256064246,1.0,20/106,18.19%,TULP2;TUB;ARF6;RPA2;SEC61B;ANK2;FSIP2;PAQR3;TULP3;DDX1;SNX10;SERP1;AUP1;PPP1R15A;CNEP1R1;GBP2;RPL11;UBE2J2;APP;CEP68
prerank,GO_Biological_Process_2021__arachidonic acid metabolic process (GO:0019369),0.5993610988480199,1.094408174042608,0.36486486486486486,0.9769416250020663,1.0,5/21,5.56%,FAAH;CBR1;FAAH2;ALOX12;ALOX15B
prerank,GO_Biological_Process_2021__pantothenate metabolic process (GO:0015939),0.7106797399174051,1.0944061979679467,0.4166666666666667,0.9762212682217914,1.0,1/5,21.00%,SLC5A6
prerank,GO_Biological_Process_2021__circulatory system development (GO:0072359),0.5361989461296041,1.0943823343222663,0.31868131868131866,0.9756009674540624,1.0,9/67,9.77%,TGFB2;SH3PXD2B;LDB3;SOX4;PKP2;POU6F1;FN1;ID2;NTRK3
prerank,GO_Biological_Process_2021__maintenance of protein location in nucleus (GO:0051457),-0.4914333272450272,-1.0941594221593045,0.34615384615384615,1.0,1.0,6/18,17.71%,ARL2BP;BCL3;CHCHD10;SYNE1;TAF8;TAF3
prerank,GO_Biological_Process_2021__ciliary basal body-plasma membrane docking (GO:0097711),0.5298439989379322,1.094051181075071,0.34408602150537637,0.9762744900659196,1.0,10/76,12.75%,TUBA4A;PRKAR2B;HAUS6;TUBB4A;TTBK2;CEP152;TUBA1A;NPHP1;DYNC1H1;CKAP5
prerank,GO_Biological_Process_2021__positive regulation of Ras protein signal transduction (GO:0046579),0.582941992680338,1.0934400774629667,0.3655913978494624,0.9781189360241394,1.0,6/38,15.95%,GPR18;ROBO1;IRS2;GPR65;RASGRF1;RASGRP4
prerank,GO_Biological_Process_2021__lipoxin biosynthetic process (GO:2001301),0.7520080780372731,1.0932704290893112,0.3090909090909091,0.9781052986391078,1.0,2/5,5.56%,ALOX12;ALOX15B
prerank,GO_Biological_Process_2021__hexose biosynthetic process (GO:0019319),0.5685933822297077,1.0932247019415284,0.3218390804597701,0.977570032590792,1.0,11/30,20.23%,MDH1;ENO2;PGAM1;AKR1B1;GPI;FBP1;SLC39A14;SORD;PGK1;PGM1;ENO1
prerank,GO_Biological_Process_2021__response to peptide (GO:1901652),-0.427543194223417,-1.0931899777628795,0.2222222222222222,1.0,1.0,3/26,3.62%,STAT4;CALCR;NLRP1
prerank,GO_Biological_Process_2021__regulation of plasminogen activation (GO:0010755),0.6511987526501386,1.0929446367279223,0.3181818181818182,0.9779512910155516,1.0,1/9,0.28%,THBS1
prerank,GO_Biological_Process_2021__cellular response to sterol depletion (GO:0071501),0.7187429394183864,1.0929336765952375,0.39473684210526316,0.9766090515295138,1.0,2/8,17.10%,INSIG1;ERLIN1
prerank,GO_Biological_Process_2021__SREBP signaling pathway (GO:0032933),0.7187429394183864,1.0929336765952375,0.39473684210526316,0.9766090515295138,1.0,2/8,17.10%,INSIG1;ERLIN1
prerank,GO_Biological_Process_2021__endoplasmic reticulum to cytosol transport (GO:1903513),0.602043897077261,1.0927741469060799,0.3880597014925373,0.9764419553807065,1.0,5/15,21.46%,SEC61B;HERPUD1;AUP1;SYVN1;HSP90B1
prerank,GO_Biological_Process_2021__positive regulation of transferase activity (GO:0051347),0.5207688288071634,1.0926839964038302,0.3157894736842105,0.9761697573515621,1.0,18/97,14.46%,KLF4;ARRDC3;INSR;EPHA3;BMI1;IGF1R;NTRK3;ALK;EPHA7;TYRO3;FLT1;NTRK2;EPHA4;POLG2;PINK1;EPHA6;RFC4;EPHA5
prerank,GO_Biological_Process_2021__maintenance of DNA methylation (GO:0010216),0.7084748074066588,1.0926236274990748,0.44594594594594594,0.9757926903118297,1.0,4/6,27.86%,UHRF2;HELLS;UHRF1;ZNF445
prerank,GO_Biological_Process_2021__peptide antigen assembly with MHC protein complex (GO:0002501),0.7026681667215096,1.0925994266452328,0.36666666666666664,0.9751567028127917,1.0,2/5,28.80%,TAPBPL;HLA-DMB
prerank,GO_Biological_Process_2021__oligosaccharide catabolic process (GO:0009313),-0.566099177753054,-1.092420686875208,0.38461538461538464,1.0,1.0,3/7,16.14%,MAN2B2;MAN2B1;MANBA
prerank,GO_Biological_Process_2021__semaphorin-plexin signaling pathway involved in neuron projection guidance (GO:1902285),0.6403461326921192,1.0923403207482805,0.4142857142857143,0.9753625798168147,1.0,3/11,17.93%,SEMA3A;PLXNB1;PLXNC1
prerank,GO_Biological_Process_2021__positive regulation of aspartic-type peptidase activity (GO:1905247),0.670624734471345,1.0922110313911306,0.390625,0.9751970178997367,1.0,2/6,15.03%,EPHA4;PICALM
prerank,GO_Biological_Process_2021__monovalent inorganic cation homeostasis (GO:0055067),0.6682780758839068,1.0921523383768936,0.36231884057971014,0.9747028220183482,1.0,4/11,21.02%,PDK4;SLC9A7;SLC12A8;SLC9A1
prerank,GO_Biological_Process_2021__regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell (GO:2001188),-0.6536557942678803,-1.0919888502057407,0.40625,1.0,1.0,3/5,20.36%,LGALS9;HAVCR2;CD81
prerank,GO_Biological_Process_2021__phosphatidylcholine biosynthetic process (GO:0006656),0.5708026703556034,1.0918494475915452,0.379746835443038,0.9751113538078586,1.0,8/21,27.58%,MFSD2A;SLC44A5;PEMT;CHPT1;SLC44A1;GPAT4;PCTP;LPCAT1
prerank,GO_Biological_Process_2021__phosphatidylserine metabolic process (GO:0006658),0.6028886134622928,1.0917032021282524,0.375,0.9750162129221702,1.0,6/19,22.97%,ABHD12B;MBOAT2;OSBPL10;OSBPL5;SERINC5;LPCAT4
prerank,MSigDB_Hallmark_2020__Pperoxisome,0.5307992518439556,1.0916262680645439,0.3763440860215054,0.9746209868864267,1.0,16/77,20.27%,TOP2A;ACSL1;IDI1;CADM1;CACNA1B;RDH11;SOD2;ALDH1A1;DIO1;CTBP1;SLC25A4;SOD1;SMARCC1;DLG4;CTPS1;STS
prerank,GO_Biological_Process_2021__regulation of cell killing (GO:0031341),0.7196519004311981,1.0916007300699646,0.37142857142857144,0.9740449431235577,1.0,2/9,5.63%,TGFB2;CD55
prerank,GO_Biological_Process_2021__negative regulation of peptidyl-lysine acetylation (GO:2000757),0.7086006651041803,1.0915491475182388,0.43478260869565216,0.9735394619274202,1.0,3/7,19.08%,BRCA1;CTBP1;TAF7
prerank,GO_Biological_Process_2021__positive regulation of stress-activated protein kinase signaling cascade (GO:0070304),0.5731384907799849,1.0911159245716366,0.4444444444444444,0.9746161445483571,1.0,3/16,16.40%,TGFB2;NOD2;RNF13
prerank,GO_Biological_Process_2021__positive regulation of macromolecule metabolic process (GO:0010604),0.5081513745372696,1.0908305565705578,0.26262626262626265,0.9750438286411729,1.0,41/215,17.71%,KLF4;FGF1;RBMS3;RPL23;EGR1;TLE1;TFRC;SLC11A1;VEGFA;EIF2AK3;ZNF804A;ANK3;ANK2;INSR;OVOL2;CAMK2N1;HIF1A;HCFC1;ROBO1;FN1;ID2;RIMS2;RBPJ;NTRK3;ITGB8;PDE2A;NTRK2;MAGI2;HINFP;BRCA1;NSF;WNT5A;SLC24A3;EPB41L4B;RPL11;SMAD1;ROCK1;HSPA1B;APP;RGCC;OLFM1
prerank,GO_Biological_Process_2021__cAMP-mediated signaling (GO:0019933),0.6045542380082981,1.090754909221218,0.4225352112676056,0.9745943776872128,1.0,6/17,14.46%,AKAP6;ADGRG6;RAPGEF3;RIMS2;PDE2A;EPHA5
prerank,GO_Biological_Process_2021__positive regulation of apoptotic process (GO:0043065),0.4974742638908729,1.090711462994486,0.27,0.9740343630144678,1.0,46/217,20.53%,TOP2A;DAPK2;RHOB;TGFB2;CLIP3;GADD45B;PNMA1;SOX4;DAPK1;NGEF;CSRNP3;SEPTIN4;BNIP3L;RPS6;BOK;RRP1B;RPS27A;FAM162A;ARHGEF4;EPHA7;PNMA2;RPS6KA2;KALRN;PPID;RBM5;IFIT2;BNIP3;C3ORF38;ITSN1;PYCARD;CASP3;SHQ1;KCNMA1;NEURL1;BCL6;OLFM1;FGD4;SOD1;UBA52;HSPD1;UBB;CDK5R1;ECT2;HIP1R;TNF;DUSP6
prerank,PanglaoDB_Augmented_2021__Adipocyte Progenitor Cells,0.5508715581892654,1.0906226548619673,0.34146341463414637,0.9736557695593849,1.0,9/31,15.36%,SVEP1;ENAH;LAMB1;RND3;TCF7L1;SH3D19;UACA;TIMP3;NRG4
prerank,GO_Biological_Process_2021__collagen fibril organization (GO:0030199),0.5492097432750986,1.0904108714260292,0.3404255319148936,0.9737497291249227,1.0,9/44,6.19%,P4HA3;ADAMTS2;TGFB2;COL11A1;COL4A5;COL26A1;COL23A1;COLGALT2;COL24A1
prerank,PanglaoDB_Augmented_2021__Luteal Cells,0.5413544609457985,1.0903028053836905,0.358695652173913,0.9734967460818637,1.0,18/65,17.63%,PRLR;FKBP5;GNA11;PGAM1;RBFOX2;RND3;BOK;GALNT18;ERRFI1;SH3D19;ADGRL2;ZDHHC9;PEBP1;PLXNB1;CPE;EPB41L4B;MPDZ;SLC39A14
prerank,GO_Biological_Process_2021__establishment of vesicle localization (GO:0051650),0.6349949969742518,1.0901306166222506,0.3875,0.973458994627402,1.0,6/14,26.51%,KIF5A;SPG11;KIF5C;SYT11;LIMK2;RAB11A
prerank,GO_Biological_Process_2021__negative regulation of endothelial cell migration (GO:0010596),0.5713118487759079,1.0900940276226545,0.4166666666666667,0.9729087743610101,1.0,1/21,0.28%,THBS1
prerank,GO_Biological_Process_2021__nuclear polyadenylation-dependent tRNA catabolic process (GO:0071038),-0.6719229055042538,-1.0894814877154386,0.4358974358974359,1.0,1.0,4/5,25.96%,EXOSC10;EXOSC9;EXOSC8;EXOSC2
prerank,GO_Biological_Process_2021__tRNA surveillance (GO:0106354),-0.6719229055042538,-1.0894814877154386,0.4358974358974359,1.0,1.0,4/5,25.96%,EXOSC10;EXOSC9;EXOSC8;EXOSC2
prerank,GO_Biological_Process_2021__nuclear polyadenylation-dependent ncRNA catabolic process (GO:0071046),-0.6719229055042538,-1.0894814877154386,0.4358974358974359,1.0,1.0,4/5,25.96%,EXOSC10;EXOSC9;EXOSC8;EXOSC2
prerank,GO_Biological_Process_2021__nuclear polyadenylation-dependent rRNA catabolic process (GO:0071035),-0.6719229055042538,-1.0894814877154386,0.4358974358974359,1.0,1.0,4/5,25.96%,EXOSC10;EXOSC9;EXOSC8;EXOSC2
prerank,GO_Biological_Process_2021__activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),0.5267142186253079,1.0891852702092126,0.29347826086956524,0.975882120889111,1.0,17/59,21.28%,NLRP12;MAPT;BEX3;KHDC1;TRAF2;EIF2AK3;ROBO1;BOK;CASP5;FAM162A;CYCS;PYCARD;EGLN3;HSPD1;HIP1R;TNF;MTCH1
prerank,GO_Biological_Process_2021__regulation of cell division (GO:0051302),0.5464966520537262,1.0888516711577456,0.38636363636363635,0.9766864575779497,1.0,7/47,10.93%,HTR2B;FGF1;CALM3;POU5F1;PLK2;TXNIP;SMYD5
prerank,GO_Biological_Process_2021__peptidyl-proline hydroxylation to 4-hydroxy-L-proline (GO:0018401),0.782849381696079,1.0881612712346667,0.4492753623188406,0.9788372472120579,1.0,2/5,9.86%,P4HA3;P4HA1
prerank,GO_Biological_Process_2021__positive regulation of viral life cycle (GO:1903902),-0.47860174804215977,-1.088155009481016,0.29411764705882354,1.0,1.0,6/19,12.19%,TRIM38;LGALS9;VPS37B;CHMP2B;KPNA6;TRIM11
prerank,GO_Biological_Process_2021__positive regulation of phagocytosis (GO:0050766),0.5443393045833089,1.087885750577896,0.40217391304347827,0.9792860681135127,1.0,4/32,5.61%,TUB;IL15;SLC11A1;FCGR2B
prerank,GO_Biological_Process_2021__negative regulation of response to reactive oxygen species (GO:1901032),0.6788569395762747,1.087700987985473,0.43283582089552236,0.9792649793997729,1.0,2/6,20.68%,TXN;LRRK2
prerank,GO_Biological_Process_2021__positive regulation of gliogenesis (GO:0014015),0.7629004289860222,1.087652001089884,0.4032258064516129,0.97874742073156,1.0,1/5,0.62%,LRP2
prerank,GO_Biological_Process_2021__Rap protein signal transduction (GO:0032486),0.6471835544191264,1.087613262794201,0.4189189189189189,0.9782099401707128,1.0,2/9,9.63%,RAPGEF3;PLK2
prerank,GO_Biological_Process_2021__glutamine transport (GO:0006868),-0.6121523608423757,-1.0872892615112175,0.4482758620689655,1.0,1.0,1/5,6.84%,SLC38A1
prerank,GO_Biological_Process_2021__pteridine-containing compound metabolic process (GO:0042558),-0.6213082277479673,-1.0871727973868361,0.3793103448275862,1.0,1.0,3/8,19.85%,MTHFD1L;AKT1;FPGS
prerank,GO_Biological_Process_2021__G-quadruplex DNA unwinding (GO:0044806),0.674661926445077,1.087057482967393,0.4166666666666667,0.979814737036696,1.0,1/7,8.41%,DNA2
prerank,GO_Biological_Process_2021__histone exchange (GO:0043486),0.5832960557914277,1.0866449499597217,0.42105263157894735,0.9806121490528559,1.0,9/25,26.06%,OIP5;CENPP;CENPK;CENPI;ACTR6;CENPT;ITGB3BP;NASP;SMARCA5
prerank,GO_Biological_Process_2021__positive regulation of interleukin-1 beta production (GO:0032731),0.5442894140229481,1.0865781963466865,0.3780487804878049,0.9801845000541277,1.0,11/38,17.45%,NLRP12;EGR1;GSDMD;NOD2;RIPK2;TRIM16;PYCARD;AIM2;WNT5A;HSPB1;APP
prerank,PanglaoDB_Augmented_2021__Airway Goblet Cells,0.6738158133273799,1.0864255961446514,0.4,0.980155982295738,1.0,1/8,6.69%,OVOL2
prerank,GO_Biological_Process_2021__histone H2A-K119 monoubiquitination (GO:0036353),0.7170830044496828,1.0863643856333347,0.4032258064516129,0.9796812192660155,1.0,4/6,27.38%,BMI1;PCGF5;PCGF6;PCGF3
prerank,GO_Biological_Process_2021__hepaticobiliary system development (GO:0061008),0.6386151298854916,1.0863164639832992,0.37662337662337664,0.9791728368721015,1.0,3/14,4.94%,COBL;LSR;ARID5B
prerank,GO_Biological_Process_2021__negative regulation of complement activation (GO:0045916),0.6783126960977276,1.086196329293614,0.3492063492063492,0.9789462856452861,1.0,3/7,13.15%,CR1;CD55;SUSD4
prerank,GO_Biological_Process_2021__regulation of transcription by RNA polymerase I (GO:0006356),-0.5367843669239213,-1.0855150006984111,0.3125,1.0,1.0,3/12,5.92%,FLNA;UBTF;PHF8
prerank,GO_Biological_Process_2021__positive regulation of lamellipodium assembly (GO:0010592),-0.46740702535790074,-1.0849796733700994,0.34375,1.0,1.0,7/18,21.97%,FSCN1;CYFIP1;ARPC2;CDC42;ACTR3;WASF2;ACTR2
prerank,PanglaoDB_Augmented_2021__Sebocytes,0.586955329229403,1.084905981613392,0.3655913978494624,0.9834473168096611,1.0,8/32,15.94%,KLF4;ANKRD22;RAB20;ST14;FBP1;LTA4H;IL18;CEBPD
prerank,GO_Biological_Process_2021__Notch receptor processing (GO:0007220),-0.6063026943268919,-1.0847419476229356,0.4444444444444444,1.0,1.0,4/7,21.84%,APH1A;GALNT11;ADAM10;PSEN1
prerank,GO_Biological_Process_2021__intracellular pH reduction (GO:0051452),0.5648477614622197,1.0841393299810274,0.358974358974359,0.9858811683924056,1.0,10/28,26.87%,SLC11A1;RAB20;DMXL2;ATP6V0B;SLAMF8;ATP6V1B2;ATP6V0E2;ATP6V1D;GPR89B;ATP6V1E2
prerank,GO_Biological_Process_2021__negative regulation of axon extension involved in axon guidance (GO:0048843),0.6618212901205092,1.0840435171787346,0.43243243243243246,0.9854997697949028,1.0,4/11,10.26%,SEMA3A;SEMA3B;SEMA6A;SEMA5A
prerank,GO_Biological_Process_2021__maturation of LSU-rRNA (GO:0000470),0.5855812790584898,1.0839670939180235,0.3448275862068966,0.9850505568853609,1.0,5/23,11.74%,WDR12;MAK16;PES1;RPL7L1;NHP2
prerank,GO_Biological_Process_2021__regulation of neuron death (GO:1901214),0.5144520551978001,1.0839650137714667,0.35106382978723405,0.9843423968876,1.0,14/66,15.06%,DDIT4;EGR1;DCC;MAPT;GPNMB;TRAF2;FCGR2B;NSMF;FAIM2;GRID2;TNFRSF1B;GRIN2B;PICALM;WNT5A
prerank,GO_Biological_Process_2021__mesoderm development (GO:0007498),-0.5819194989170413,-1.0839616853370995,0.43333333333333335,1.0,1.0,5/9,10.31%,IKZF3;MEST;MESD;HCK;BTK
prerank,GO_Biological_Process_2021__regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),0.6155880050758921,1.0839336948122373,0.3037974683544304,0.9837239986845256,1.0,4/18,14.23%,CDK14;ID2;HINFP;E2F7
prerank,GO_Biological_Process_2021__respiratory tube development (GO:0030323),0.595772709812883,1.083725068246625,0.36585365853658536,0.9838295764471784,1.0,4/15,9.57%,FGF1;CHI3L1;VEGFA;CCDC39
prerank,GO_Biological_Process_2021__regulation of amyloid fibril formation (GO:1905906),0.6311930690588943,1.0837219583180309,0.4,0.9831578998108925,1.0,3/12,17.45%,VBP1;PFDN4;APP
prerank,GO_Biological_Process_2021__mitochondrial transcription (GO:0006390),0.6608036262865845,1.0837028925467027,0.42028985507246375,0.9825280569866713,1.0,5/9,24.08%,MTERF1;TFAM;POLRMT;TEFM;FOXO3
prerank,GO_Biological_Process_2021__synaptic vesicle budding (GO:0070142),0.7045570541507282,1.083546242415987,0.4626865671641791,0.9823075320931268,1.0,4/8,19.66%,DNM3;DNM1;PICALM;SNAP91
prerank,GO_Biological_Process_2021__nucleoside catabolic process (GO:0009164),0.6906761655445404,1.0835259747728305,0.42857142857142855,0.9816587935252318,1.0,1/9,1.95%,DPYD
prerank,GO_Biological_Process_2021__neuron projection maintenance (GO:1990535),0.6835344044796606,1.083524333474419,0.359375,0.9809701999234153,1.0,4/6,22.60%,INSR;APP;DCTN1;MAP1A
prerank,GO_Biological_Process_2021__regulation of smooth muscle cell apoptotic process (GO:0034391),-0.6979438675016942,-1.083415868862608,0.3783783783783784,1.0,1.0,2/5,20.26%,IGF1;LRP6
prerank,GO_Biological_Process_2021__regulation of cellular pH (GO:0030641),0.6184854838048743,1.0833911273220123,0.4444444444444444,0.9807172998234943,1.0,4/17,11.53%,SLC4A10;CA2;SLC9A7;SLC9A6
prerank,GO_Biological_Process_2021__positive regulation of heterochromatin assembly (GO:0031453),-0.49396999436095523,-1.0832440495466398,0.34375,1.0,1.0,2/12,11.82%,SETDB1;TASOR
prerank,MSigDB_Hallmark_2020__Interferon Alpha Response,0.4967863465308534,1.0829878366260801,0.41304347826086957,0.9816322072122773,1.0,16/78,20.74%,TMEM140;IL15;IL7;TRIM5;TENT5A;TRIM25;IFITM3;TXNIP;SLC25A28;RIPK2;IFIT2;TRIM26;GBP2;PSMA3;SELL;TRIM14
prerank,GO_Biological_Process_2021__regulation of ERK1 and ERK2 cascade (GO:0070372),-0.33490875068354165,-1.0829785814861905,0.4,1.0,1.0,21/136,8.91%,TNFAIP8L3;CCL5;TGFBR3;CALCR;RPS6KA6;SERPINF2;IL1B;FFAR4;LGALS9;DAB2IP;DUSP3;CSF1R;SCIMP;ICAM1;SIRPA;P2RY6;TGFB1;PDGFD;PHB2;ROR2;CRKL
prerank,GO_Biological_Process_2021__ureteric bud development (GO:0001657),0.7211445376559642,1.08250650247502,0.3442622950819672,0.9828171138508388,1.0,3/6,24.95%,ROBO2;FGFR2;GPC3
prerank,GO_Biological_Process_2021__negative regulation of ubiquitin-protein transferase activity (GO:0051444),0.6612387446036188,1.0816889223961925,0.4533333333333333,0.9851389998006246,1.0,1/11,1.97%,RPL23
prerank,GO_Biological_Process_2021__ncRNA 3'-end processing (GO:0043628),0.6434784314676402,1.0816475458219708,0.38666666666666666,0.9845790659810602,1.0,4/11,22.06%,INTS12;TRNT1;INTS8;INTS6
prerank,GO_Biological_Process_2021__primary alcohol metabolic process (GO:0034308),0.6471822832699857,1.081612742649674,0.37681159420289856,0.9840470023495376,1.0,1/13,0.34%,GDPD1
prerank,GO_Biological_Process_2021__embryonic digestive tract development (GO:0048566),0.6581038046828745,1.0810963100691637,0.4533333333333333,0.9852132902266206,1.0,2/9,8.86%,TGFB2;ID2
prerank,GO_Biological_Process_2021__apoptotic cell clearance (GO:0043277),0.5619472344065667,1.0809263764116142,0.41025641025641024,0.9852086963620019,1.0,4/20,12.52%,THBS1;ANXA1;TYRO3;XKR4
prerank,GO_Biological_Process_2021__galactose metabolic process (GO:0006012),-0.6385648292636724,-1.0805259892115202,0.42424242424242425,1.0,1.0,1/6,1.12%,PGM2
prerank,GO_Biological_Process_2021__microtubule bundle formation (GO:0001578),0.58305333903333,1.0803542197115095,0.4111111111111111,0.9868520141152982,1.0,5/23,15.04%,LRGUK;MTCL1;SPAST;TPPP;TOGARAM1
prerank,GO_Biological_Process_2021__positive regulation of positive chemotaxis (GO:0050927),0.6796300807341088,1.0801722827278475,0.38666666666666666,0.9869542455129859,1.0,2/7,9.77%,VEGFA;NTRK3
prerank,GO_Biological_Process_2021__cell-cell junction maintenance (GO:0045217),-0.6620679767825334,-1.0800513160280434,0.42424242424242425,1.0,1.0,1/5,4.25%,CSF1R
prerank,GO_Biological_Process_2021__metanephros development (GO:0001656),0.6860008768922812,1.0798941961697568,0.38028169014084506,0.9874946997838077,1.0,4/9,20.40%,ROBO2;PAX8;PKD1;BASP1
prerank,GO_Biological_Process_2021__positive regulation of nitric oxide metabolic process (GO:1904407),0.6245032754011519,1.0798771676987855,0.4050632911392405,0.9868684816705017,1.0,2/18,6.48%,KLF4;INSR
prerank,GO_Biological_Process_2021__synaptic vesicle budding from presynaptic endocytic zone membrane (GO:0016185),0.7063289482882258,1.079815258201143,0.46153846153846156,0.9864384535217043,1.0,4/7,19.66%,DNM3;DNM1;PICALM;SNAP91
prerank,GO_Biological_Process_2021__negative regulation of calcineurin-NFAT signaling cascade (GO:0070885),0.6920502174492444,1.0798005678685807,0.484375,0.9851229211240199,1.0,3/6,29.19%,CHP1;ATP2B4;PRNP
prerank,GO_Biological_Process_2021__negative regulation of calcineurin-mediated signaling (GO:0106057),0.6920502174492444,1.0798005678685807,0.484375,0.9851229211240199,1.0,3/6,29.19%,CHP1;ATP2B4;PRNP
prerank,GO_Biological_Process_2021__ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162),0.5918950185506324,1.0797394096928445,0.46511627906976744,0.9847286412004401,1.0,3/20,11.87%,TOM1L1;VPS37C;RNF126
prerank,GO_Biological_Process_2021__response to interferon-alpha (GO:0035455),-0.5285752303311944,-1.0796799886694568,0.4166666666666667,1.0,1.0,1/13,0.82%,PDE12
prerank,GO_Biological_Process_2021__regulation of ubiquitin protein ligase activity (GO:1904666),0.6278974886628822,1.0796532390968616,0.41333333333333333,0.984348349614693,1.0,1/13,1.97%,RPL23
prerank,GO_Biological_Process_2021__regulation of TORC1 signaling (GO:1903432),-0.4523495686649463,-1.0796337176236188,0.3157894736842105,1.0,1.0,5/26,12.21%,SESN2;SESN3;TELO2;CLEC16A;PIH1D1
prerank,GO_Biological_Process_2021__negative regulation of amyloid fibril formation (GO:1905907),0.6405052289057295,1.079008715047823,0.44,0.9862368399050649,1.0,2/10,15.74%,VBP1;PFDN4
prerank,GO_Biological_Process_2021__regulation of cholesterol transport (GO:0032374),-0.457568189270865,-1.079002874783645,0.25,1.0,1.0,6/18,11.79%,TTC39B;ARV1;LAMTOR1;NR1H3;LIPG;OSBPL6
prerank,GO_Biological_Process_2021__dendritic spine morphogenesis (GO:0060997),0.6214799246471063,1.0789215284195488,0.3333333333333333,0.9858627267621968,1.0,2/12,5.38%,SHANK3;CTNND2
prerank,GO_Biological_Process_2021__negative regulation of signal transduction (GO:0009968),0.4907677415618469,1.0787182175255472,0.40816326530612246,0.9859247269601799,1.0,14/144,8.27%,THBS1;DDIT4;HHIP;NLRP12;TLE1;DCC;NR4A2;AGT;RGS2;SEMA6A;GRB10;PTPRT;KANK1;SPRY1
prerank,GO_Biological_Process_2021__defense response to Gram-positive bacterium (GO:0050830),0.5827764269612986,1.0787181892880358,0.43037974683544306,0.9852299244746547,1.0,4/21,9.71%,HMGB2;H2BC11;GSDMD;FGR
prerank,GO_Biological_Process_2021__positive regulation of glycogen metabolic process (GO:0070875),0.6279240209027395,1.07823073378894,0.373134328358209,0.9864098268841959,1.0,3/10,12.09%,INSR;IRS2;SORBS1
prerank,GO_Biological_Process_2021__mRNA metabolic process (GO:0016071),0.512849611328344,1.078138783139087,0.3763440860215054,0.9861436398293498,1.0,5/78,5.88%,NUDT12;TBRG4;NUDT16;RIDA;GEMIN2
prerank,GO_Biological_Process_2021__positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),0.5035973126762394,1.077887894585199,0.30851063829787234,0.986419107043588,1.0,14/83,12.78%,ST18;NLRP12;MAPT;BEX3;KHDC1;TRAF2;EIF2AK3;DAPK1;ROBO1;BOK;CASP5;FAM162A;CYCS;UACA
prerank,GO_Biological_Process_2021__glycerolipid metabolic process (GO:0046486),0.6769299257707121,1.0770697988721722,0.46153846153846156,0.9891048626683129,1.0,5/8,29.48%,DGKB;DGKG;DGKZ;PIP5K1A;DGKQ
prerank,GO_Biological_Process_2021__extrinsic apoptotic signaling pathway (GO:0097191),0.5422187742460917,1.0767239507687163,0.3409090909090909,0.9897048445091569,1.0,17/52,22.52%,ACVR1B;TGFB2;DCC;TRAF2;BOK;MCL1;SIVA1;TNFRSF1B;BCL2L2;CASP3;BAG3;ITGAV;TNFRSF1A;TNF;DEDD;APPL1;SORT1
prerank,GO_Biological_Process_2021__regulation of cellular component biogenesis (GO:0044087),0.5621327027128737,1.0766356268465775,0.3291139240506329,0.989357071560612,1.0,5/31,7.60%,GFAP;AGT;TRAF2;VPS11;HCFC1
prerank,GO_Biological_Process_2021__cellular protein catabolic process (GO:0044257),-0.36373768577615395,-1.0766351640448022,0.3,1.0,1.0,13/46,21.23%,IDE;DAB2IP;CLTA;GZMB;RSPRY1;CAPN2;CTSZ;PISD;CASP8;RAB7A;CTSH;CTSC;CHEK2
prerank,GO_Biological_Process_2021__negative regulation of B cell proliferation (GO:0030889),0.6954270273610904,1.0764952437749598,0.46774193548387094,0.9891630520026947,1.0,3/8,19.50%,FCGR2B;CD300A;TNFRSF21
prerank,GO_Biological_Process_2021__hormone transport (GO:0009914),0.724856447826978,1.076347717742123,0.44776119402985076,0.9890159177445434,1.0,1/5,1.06%,SLC16A10
prerank,GO_Biological_Process_2021__bone cell development (GO:0098751),-0.6606459865794244,-1.0762971073231498,0.4,1.0,1.0,4/6,14.75%,SH2B3;ZNF385A;SRC;MED1
prerank,GO_Biological_Process_2021__regulation of mitotic cell cycle phase transition (GO:1901990),0.5057189461977261,1.0762831105886734,0.30612244897959184,0.9885761963914532,1.0,18/144,12.75%,CENPF;NEK11;TUBA4A;CENPE;PRKAR2B;HAUS6;ERCC2;ANLN;RIOK2;TUBB4A;CEP152;TUBA1A;ID2;RPS27A;KCNH5;PSMB4;DYNC1H1;CKAP5
prerank,GO_Biological_Process_2021__DNA integrity checkpoint signaling (GO:0031570),0.5735068423692533,1.0759259917632094,0.40476190476190477,0.9894138392850744,1.0,5/26,12.03%,BRIP1;CLSPN;DNA2;DONSON;HINFP
prerank,GO_Biological_Process_2021__positive regulation of cell cycle (GO:0045787),0.5416992132861405,1.0758713741075896,0.3488372093023256,0.9889545194102266,1.0,13/47,20.85%,TGFB2;CCPG1;NUDT16;MEIS2;SPDYA;HCFC1;PKD1;CCND3;APP;RGCC;CDC25B;CDKN1B;FGFR2
prerank,GO_Biological_Process_2021__antibacterial humoral response (GO:0019731),0.6772207194282821,1.0756659481679034,0.4090909090909091,0.9890270766612942,1.0,1/8,2.98%,H2BC11
prerank,GO_Biological_Process_2021__negative regulation of stress-activated protein kinase signaling cascade (GO:0070303),0.6708242174503414,1.0754028107382128,0.4375,0.9894313226973792,1.0,2/5,29.72%,GSTP1;FOXO1
prerank,GO_Biological_Process_2021__cell communication by electrical coupling involved in cardiac conduction (GO:0086064),0.6674159274328676,1.0751701583417357,0.463768115942029,0.9895233394665832,1.0,5/10,25.14%,PKP2;RYR2;ATP1B2;ATP1A2;CACNA1C
prerank,GO_Biological_Process_2021__protein retention in ER lumen (GO:0006621),0.7084054141543036,1.075103011785996,0.39655172413793105,0.9891182368386404,1.0,1/6,5.49%,PDIA2
prerank,GO_Biological_Process_2021__positive regulation of cell motility (GO:2000147),0.48715556438190166,1.075077678283631,0.3684210526315789,0.9885415286419443,1.0,17/124,11.67%,THBS1;FGF1;SEMA3A;CEMIP;VEGFA;HSPA5;GPNMB;SEMA3B;LAMB1;INSR;SEMA6A;IGF1R;FGR;CARMIL1;NTRK3;SEMA5A;FLT1
prerank,GO_Biological_Process_2021__regulation of BMP signaling pathway (GO:0030510),0.5505529935349298,1.074949335679533,0.41025641025641024,0.9883428108036681,1.0,7/40,16.98%,LRP2;ACVR2A;BMPR1B;RBPJ;VWC2;PCSK6;SMAD1
prerank,GO_Biological_Process_2021__mitochondrial gene expression (GO:0140053),-0.4312487474438158,-1.0745648005621504,0.2857142857142857,1.0,1.0,5/28,12.63%,MRPL57;MRPS11;SLC25A33;LARS2;FASTKD2
prerank,GO_Biological_Process_2021__positive regulation by host of viral genome replication (GO:0044829),0.6949980791913815,1.0745108296973354,0.4714285714285714,0.9891032129752408,1.0,2/5,25.61%,PPIB;VAPA
prerank,GO_Biological_Process_2021__modulation by symbiont of host process (GO:0044003),0.6822891190142787,1.0742452596218317,0.45714285714285713,0.9894925031346107,1.0,7/10,26.10%,RPS27A;UBA52;UBB;PGK1;ENO1;MRC1;TLR2
prerank,GO_Biological_Process_2021__pinocytosis (GO:0006907),0.6924195906476098,1.073893598501326,0.44285714285714284,0.990019926213114,1.0,2/7,14.63%,CARMIL1;PYCARD
prerank,GO_Biological_Process_2021__oligosaccharide metabolic process (GO:0009311),-0.430232885061194,-1.0734588158251537,0.25,1.0,1.0,4/25,3.73%,GAL3ST4;IDUA;ST6GALNAC3;MAN2B2
prerank,GO_Biological_Process_2021__DNA catabolic process (GO:0006308),-0.5762409606607074,-1.0734162275844878,0.35714285714285715,1.0,1.0,3/9,16.73%,DFFB;FBH1;REXO4
prerank,GO_Biological_Process_2021__regulation of protein import into nucleus (GO:0042306),-0.41379627806140296,-1.073251551367175,0.2857142857142857,1.0,1.0,3/27,7.51%,FLNA;ZPR1;TGFB1
prerank,GO_Biological_Process_2021__regulation of mitotic centrosome separation (GO:0046602),0.677236602810132,1.0732282075325366,0.5217391304347826,0.992004981807855,1.0,3/6,16.88%,MAP9;KIF11;UBXN2B
prerank,GO_Biological_Process_2021__positive regulation of multicellular organismal process (GO:0051240),0.48502129882617806,1.072798445608316,0.32653061224489793,0.9929387794588301,1.0,47/190,18.65%,HTR2B;ACVR1B;PRLR;TSHR;TGFB2;ACSL1;PLAC8;CADM1;ZBTB16;IL15;GLIPR2;TFRC;AGT;SLC11A1;BMPR1B;VEGFA;GRB10;KDM3A;PAX8;NLGN1;PTN;ABCA1;IGF1R;KDM1A;GHR;FGR;B4GALT5;SOX6;DYNC1H1;SCD;TRIM16;SDCBP;WNT5A;CFL1;PEMT;IL18;NR2C2;EPAS1;TXK;PLCB1;ROCK1;MAP3K13;RGCC;OLFM1;SOD1;ESRRG;EZH2
prerank,GO_Biological_Process_2021__negative regulation of calcium ion transmembrane transporter activity (GO:1901020),0.641048594954225,1.072608463796332,0.4444444444444444,0.9929948406433261,1.0,4/13,22.47%,CALM3;CLIC2;ATP1A2;GNB5
prerank,GO_Biological_Process_2021__regulation of protein kinase C signaling (GO:0090036),0.6093222923804498,1.0719942440799686,0.44155844155844154,0.9946905433259321,1.0,3/11,15.06%,VEGFA;DGKG;WNT5A
prerank,GO_Biological_Process_2021__response to interleukin-1 (GO:0070555),-0.39598795248032786,-1.0719515305190885,0.36363636363636365,1.0,1.0,7/40,6.41%,CCL5;GBP3;IL1B;LGALS9;DAB2IP;MAPK13;SIRPA
prerank,GO_Biological_Process_2021__negative regulation of smooth muscle cell proliferation (GO:0048662),0.5856863303837395,1.0717129620166006,0.3972602739726027,0.9951467338237475,1.0,8/18,26.11%,OGN;SOD2;NDRG4;CDKN1B;MFN2;PDCD4;PTEN;PRKG1
prerank,GO_Biological_Process_2021__dosage compensation (GO:0007549),0.6681952793490676,1.0715098383654764,0.4,0.9952471833443904,1.0,5/9,29.65%,BRCA1;LRIF1;HNRNPU;MACROH2A2;MACROH2A1
prerank,GO_Biological_Process_2021__regulation of Fc-gamma receptor signaling pathway involved in phagocytosis (GO:1905449),-0.6139075563537987,-1.0714518307383045,0.4444444444444444,1.0,1.0,1/5,4.51%,APPL2
prerank,GO_Biological_Process_2021__acyl-CoA biosynthetic process (GO:0071616),0.6036593525648226,1.0714400836153077,0.4,0.9948677703872838,1.0,4/14,13.55%,ACAT1;SCD5;FASN;SCD
prerank,GO_Biological_Process_2021__fatty acid biosynthetic process (GO:0006633),-0.36687121100492603,-1.0713177119033876,0.3,1.0,1.0,12/36,13.97%,ACSM5;TECR;GPX4;HACD4;ALOX5;GSTM4;LPL;MLYCD;LIPG;NDUFAB1;LTC4S;ABCD3
prerank,GO_Biological_Process_2021__calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339),0.6417021784867888,1.0712898930684467,0.4722222222222222,0.9947384283710518,1.0,6/14,14.45%,CDH8;CDH9;CDH20;NLGN1;CDH12;CDH10
prerank,GO_Biological_Process_2021__positive regulation of sphingolipid biosynthetic process (GO:0090154),-0.533331475511742,-1.0711317448507158,0.3333333333333333,1.0,1.0,1/9,0.87%,SMPD3
prerank,GO_Biological_Process_2021__positive regulation of ceramide biosynthetic process (GO:2000304),-0.533331475511742,-1.0711317448507158,0.3333333333333333,1.0,1.0,1/9,0.87%,SMPD3
prerank,GO_Biological_Process_2021__regulation of macrophage derived foam cell differentiation (GO:0010743),0.607730167232641,1.0710280586447634,0.42857142857142855,0.9950817634671985,1.0,9/18,22.91%,AGT;ALOX15B;ABCA1;ABCA5;IL18;ITGAV;PPARA;MSR1;ABCG1
prerank,GO_Biological_Process_2021__cell-matrix adhesion (GO:0007160),0.5130187524007376,1.070813019170416,0.41935483870967744,0.99516230668349,1.0,13/53,16.36%,ECM2;ITGA2;ADAM15;PTPRK;OTOA;FN1;ITGB8;PPFIA2;SGCE;SORBS1;PKD1;THY1;ITGAV
prerank,GO_Biological_Process_2021__protein insertion into membrane (GO:0051205),-0.4355280381875286,-1.0705864272415373,0.18181818181818182,1.0,1.0,2/22,0.88%,CYB5A;MAIP1
prerank,GO_Biological_Process_2021__peptidyl-glutamic acid modification (GO:0018200),0.6570126550381418,1.070576059605491,0.3972602739726027,0.9954655553223524,1.0,5/14,27.77%,TTLL7;AGTPBP1;TPGS1;GGCX;TTLL4
prerank,GO_Biological_Process_2021__negative regulation of defense response (GO:0031348),0.5114087040501971,1.0705184612560217,0.4175824175824176,0.9949301254352506,1.0,2/48,1.30%,KLF4;NLRP12
prerank,GO_Biological_Process_2021__positive regulation of glucose transmembrane transport (GO:0010828),0.5797336260870688,1.0704739870869138,0.3855421686746988,0.9943954330548803,1.0,5/21,12.83%,CLIP3;INSR;IRS2;SORBS1;NR4A3
prerank,GO_Biological_Process_2021__DNA damage checkpoint signaling (GO:0000077),0.5749665839043903,1.0704618814691447,0.38095238095238093,0.9937437585279773,1.0,4/23,12.03%,BRIP1;CLSPN;DONSON;HINFP
prerank,MSigDB_Hallmark_2020__Glycolysis,0.4948379674943151,1.0703527666932966,0.37373737373737376,0.9934981750827908,1.0,33/127,20.23%,DDIT4;MDH1;SAP30;VCAN;TALDO1;VEGFA;HSPA5;ENO2;PGAM1;PKP2;TXN;IRS2;P4HA1;FAM162A;MXI1;PRPS1;PKM;HDLBP;TGFBI;HS2ST1;ZNF292;PDK3;PLOD1;NDST3;GFPT1;EGLN3;SLC16A3;SOD1;PPFIA4;ERO1A;B3GAT1;PGK1;ENO1
prerank,GO_Biological_Process_2021__negative regulation of apoptotic process (GO:0043066),0.4892255389459304,1.0703407797655236,0.29,0.9928871984401376,1.0,57/294,18.46%,HTR2B;THBS1;KLF4;LRP2;ARAF;PRLR;TLE1;NAA38;NR4A2;TFRC;ATAD3A;ANXA1;BEX3;ALOX12;RNF144B;FIGNL1;VEGFA;HSPA5;PDK4;IL7;PTPRZ1;COPS5;FMN2;MAG;BNIP3L;FAIM2;RETREG1;IGF1R;RPS27A;MCL1;PLK2;TYRO3;NTRK2;HCLS1;RIPK2;CRLF1;SOD2;BNIP3;PINK1;PRELID1;BCL2L2;TMEM14A;WNT5A;CASP3;CFL1;BAG3;NUAK2;NRBP2;ARHGDIA;HSPB1;HSPA1B;GSTP1;PRKAA2;TAF9B;SOD1;UBA52;HSPD1
prerank,GO_Biological_Process_2021__monosaccharide transmembrane transport (GO:0015749),0.7358548770106176,1.070098947936614,0.3870967741935484,0.9930732844229129,1.0,2/5,4.98%,SLC2A9;SLC5A9
prerank,GO_Biological_Process_2021__negative regulation of T cell mediated cytotoxicity (GO:0001915),0.7226081604550089,1.069875423258562,0.45588235294117646,0.9931221541922927,1.0,1/6,5.61%,FCGR2B
prerank,GO_Biological_Process_2021__transport along microtubule (GO:0010970),0.644899294270437,1.0696011707418152,0.3770491803278688,0.9933729984488755,1.0,5/12,20.29%,CLIP3;BAG3;APP;SPG11;DYNC1I1
prerank,GO_Biological_Process_2021__plasma membrane organization (GO:0007009),0.5508910955720792,1.0695132062550676,0.4444444444444444,0.9930698937257374,1.0,9/36,16.92%,FA2H;CR1;ANK3;ANK2;CAV3;NSF;SERP1;UGCG;SPTBN1
prerank,GO_Biological_Process_2021__negative regulation of histone H3-K9 methylation (GO:0051573),0.7237878607568327,1.0694899480991567,0.43333333333333335,0.9924678113527166,1.0,2/5,12.87%,KDM1A;BRCA1
prerank,GO_Biological_Process_2021__pre-mRNA cleavage required for polyadenylation (GO:0098789),-0.5638350305801212,-1.0693499855213673,0.3333333333333333,1.0,1.0,3/9,16.26%,CPSF1;CPSF2;CPSF4
prerank,GO_Biological_Process_2021__detection of mechanical stimulus (GO:0050982),0.6160525871329687,1.0693345191989156,0.4936708860759494,0.9923803759496397,1.0,6/14,20.37%,CDH2;CAV3;PKD1;PIEZO2;LHFPL5;PKD2L2
prerank,GO_Biological_Process_2021__regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),0.525641960878717,1.0692426904213768,0.4024390243902439,0.992000576498426,1.0,3/31,8.43%,THBS1;TRAF2;FAIM2
prerank,GO_Biological_Process_2021__positive regulation of leukocyte differentiation (GO:1902107),-0.6131795795576008,-1.0692247839159683,0.3333333333333333,1.0,1.0,2/7,9.42%,LGALS9;NCKAP1L
prerank,GO_Biological_Process_2021__positive regulation of macrophage derived foam cell differentiation (GO:0010744),0.681233783712418,1.069214744264339,0.39655172413793105,0.9914069548454594,1.0,4/9,21.77%,AGT;ALOX15B;IL18;MSR1
prerank,GO_Biological_Process_2021__positive regulation of DNA recombination (GO:0045911),0.5899377842045815,1.0689633618053322,0.4146341463414634,0.9917488132421437,1.0,7/22,20.15%,ERCC2;TFRC;FANCB;ZCWPW1;ERCC6;TIMELESS;KMT5C
prerank,MSigDB_Hallmark_2020__mTORC1 Signaling,0.4876587634072755,1.0686237926772033,0.3469387755102041,0.992356144346007,1.0,38/162,20.23%,DDIT4;NAMPT;NFIL3;TUBA4A;TM7SF2;GLA;IDI1;SLC2A3;TFRC;HSPA5;COPS5;SDF2L1;BHLHE40;P4HA1;RDH11;FGL2;GPI;PPA1;SERP1;INSIG1;SCD;PPP1R15A;HMGCS1;LTA4H;ATP2A2;EGLN3;CACYBP;HPRT1;HSPD1;ERO1A;PSMC2;PSMA3;SORD;ACSL3;ATP5MC1;PGK1;PGM1;ENO1
prerank,GO_Biological_Process_2021__regulation of chromosome organization (GO:0033044),0.5964106120803603,1.0681036111539697,0.4225352112676056,0.9937534390018014,1.0,2/15,13.44%,MAPT;CENPV
prerank,GO_Biological_Process_2021__positive regulation of transcription regulatory region DNA binding (GO:2000679),-0.5285385497844491,-1.0679816102461863,0.41935483870967744,1.0,1.0,4/10,16.94%,IGF1;TGFB1;EP300;GTF2B
prerank,GO_Biological_Process_2021__regulation of glucan biosynthetic process (GO:0010962),-0.6286145210683232,-1.0679570579089293,0.43243243243243246,1.0,1.0,4/5,14.21%,INPP5K;PPP1R3F;PPP1R3E;AKT1
prerank,GO_Biological_Process_2021__regulation of cellular amide metabolic process (GO:0034248),0.5918443070527695,1.067803166085376,0.4,0.9943326656991622,1.0,7/25,17.45%,RBM3;PGAM1;RBM4B;PICALM;TMED10;ROCK1;APP
prerank,GO_Biological_Process_2021__chaperone-mediated protein complex assembly (GO:0051131),-0.5122480267516174,-1.0676673361346818,0.2857142857142857,1.0,1.0,3/16,12.08%,BBS10;MKKS;HSPA1A
prerank,GO_Biological_Process_2021__negative regulation of microglial cell activation (GO:1903979),-0.5487461478003872,-1.0675129631006652,0.38235294117647056,1.0,1.0,1/7,1.38%,CST7
prerank,"GO_Biological_Process_2021__synaptic transmission, GABAergic (GO:0051932)",0.675413176300047,1.067479969361272,0.5454545454545454,0.994736330326425,1.0,4/7,18.88%,GABRA2;GABRB2;GABRA4;GABRG2
prerank,GO_Biological_Process_2021__cellular response to organic cyclic compound (GO:0071407),0.5143585266130585,1.0674057692394008,0.35789473684210527,0.9944084862152556,1.0,22/99,15.83%,KCNE1;AANAT;EGR1;ADCY3;GABRB1;AKAP6;RUVBL2;RAPGEF3;GABRB3;PDE2A;IMPACT;ADCY8;GABRB2;RYR3;GNAI1;NR4A3;BRCA1;INSIG1;HCN1;CASP3;ESR1;IL18
prerank,GO_Biological_Process_2021__positive regulation of viral genome replication (GO:0045070),0.564756539562229,1.067195224550664,0.41975308641975306,0.9945659080021765,1.0,4/25,12.70%,TOP2A;VAPB;PPID;TMEM39A
prerank,GO_Biological_Process_2021__myeloid leukocyte mediated immunity (GO:0002444),-0.6990636172039277,-1.067050228084835,0.43243243243243246,1.0,1.0,2/5,8.88%,IRAK4;SERPINB9
prerank,"GO_Biological_Process_2021__neurotransmitter receptor transport, endosome to plasma membrane (GO:0099639)",0.6947899938933207,1.067042179008249,0.410958904109589,0.994425961725298,1.0,4/6,29.78%,GRIPAP1;RAB11A;GRIP1;ARHGAP44
prerank,GO_Biological_Process_2021__pancreas development (GO:0031016),0.6953017891943197,1.0667131621597525,0.4266666666666667,0.9949769421369372,1.0,3/6,29.10%,CCDC39;SRP54;PROX1
prerank,MSigDB_Hallmark_2020__Bile Acid Metabolism,0.5266572115381198,1.066702479216249,0.4111111111111111,0.9943788787879748,1.0,16/62,20.57%,NUDT12;ACSL1;PFKM;IDI1;SLCO1A2;ABCA2;ABCA1;LIPE;ABCA5;ALDH1A1;DIO1;PNPLA8;SOD1;HACL1;CYP46A1;PIPOX
prerank,GO_Biological_Process_2021__platelet activating factor metabolic process (GO:0046469),-0.6068496997968644,-1.0665402643113258,0.40625,1.0,1.0,1/7,2.58%,PLA2G4C
prerank,GO_Biological_Process_2021__regulation of axon extension involved in axon guidance (GO:0048841),0.6108473850993078,1.0664393569791226,0.4520547945205479,0.9947744222008921,1.0,5/15,10.26%,SEMA3A;VEGFA;SEMA3B;SEMA6A;SEMA5A
prerank,GO_Biological_Process_2021__mononuclear cell differentiation (GO:1903131),-0.4847437990756997,-1.0662106040255792,0.36,1.0,1.0,4/18,10.32%,MYH9;CSF1R;THOC5;TREM2
prerank,GO_Biological_Process_2021__cellular response to hypoxia (GO:0071456),0.4973518037998703,1.066008804165035,0.3473684210526316,0.9957170291975881,1.0,33/90,24.06%,VEGFA;SUV39H2;NDRG1;HIF1A;FMN2;BNIP3L;LIMD1;RPS27A;FAM162A;PSMB4;RBX1;HIF3A;BNIP3;PINK1;CPEB2;SCN2A;HYOU1;EPAS1;EGLN3;RGCC;UBA52;UBB;PSMC2;PSMA3;NOP53;PGK1;PSMB2;P4HB;PSMD5;PSMD7;RORA;PSMD14;PSMA5
prerank,GO_Biological_Process_2021__mitotic cell cycle phase transition (GO:0044772),0.4966989659253107,1.065898299392139,0.30303030303030304,0.9955059592419607,1.0,18/152,12.75%,ACVR1B;CDK14;TUBA4A;PRKAR2B;HAUS6;TUBB4A;FBXL7;CEP152;MASTL;SPDYA;TUBA1A;RCC1;PLK2;CLASP2;DYNC1H1;HINFP;SPAST;CKAP5
prerank,GO_Biological_Process_2021__extrinsic apoptotic signaling pathway in absence of ligand (GO:0097192),0.5726674490295934,1.0658798802597813,0.425,0.9948898565084432,1.0,6/16,16.36%,DCC;BOK;MCL1;BCL2L2;CASP3;ITGAV
prerank,GO_Biological_Process_2021__positive regulation of CREB transcription factor activity (GO:0032793),0.6152462945497562,1.0658675312344366,0.3924050632911392,0.9942552996465008,1.0,5/16,14.46%,RELN;VEGFA;CRTC3;ADCY8;EPHA5
prerank,GO_Biological_Process_2021__protein localization to presynapse (GO:1905383),0.6742916562406479,1.0658010313864876,0.4262295081967213,0.9924465981691439,1.0,5/8,26.57%,KIF5A;HSPB1;KIF5C;MAP1A;RAB27B
prerank,GO_Biological_Process_2021__axo-dendritic protein transport (GO:0099640),0.6742916562406479,1.0658010313864876,0.4262295081967213,0.9924465981691439,1.0,5/8,26.57%,KIF5A;HSPB1;KIF5C;MAP1A;RAB27B
prerank,GO_Biological_Process_2021__anterograde axonal protein transport (GO:0099641),0.6742916562406479,1.0658010313864876,0.4262295081967213,0.9924465981691439,1.0,5/8,26.57%,KIF5A;HSPB1;KIF5C;MAP1A;RAB27B
prerank,GO_Biological_Process_2021__regulation of canonical Wnt signaling pathway (GO:0060828),0.4913415147147033,1.0657036118121737,0.41836734693877553,0.992142410679352,1.0,22/171,11.23%,LRP4;CDK14;RBMS3;DKK2;FZD6;AMER2;TLE1;GPC5;DAAM2;SOX4;LZTS2;CTNND2;KANK1;RUVBL2;PTK7;GSKIP;LIMD1;SEMA5A;GPRC5B;PSMB4;RBX1;PRICKLE1
prerank,GO_Biological_Process_2021__positive regulation by host of viral process (GO:0044794),0.632180148339916,1.0654645821942499,0.44285714285714284,0.9922807577427578,1.0,4/9,26.37%,CFL1;PPIB;VAPA;IGF2R
prerank,GO_Biological_Process_2021__ncRNA catabolic process (GO:0034661),0.5966609233047179,1.065380253919849,0.425,0.9918362197781421,1.0,3/21,16.76%,NUDT16;TENT4B;SND1
prerank,GO_Biological_Process_2021__regulation of interleukin-5 production (GO:0032674),-0.6876211566360318,-1.0652649094975217,0.43902439024390244,1.0,1.0,2/5,4.46%,LGALS9;LILRB4
prerank,GO_Biological_Process_2021__steroid catabolic process (GO:0006706),-0.6626372537782358,-1.0651038901341283,0.5,0.9994054566857217,1.0,1/6,2.28%,CYP19A1
prerank,GO_Biological_Process_2021__positive regulation of B cell proliferation (GO:0030890),0.6050486430782994,1.065011135018597,0.4230769230769231,0.9925248980461049,1.0,4/18,14.98%,TFRC;IL7;IRS2;GPR183
prerank,GO_Biological_Process_2021__adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),0.5109617091437643,1.0647798750975097,0.3655913978494624,0.9927074710550652,1.0,20/67,15.17%,TSHR;GRM8;ADCY3;GNA11;GNAO1;RGS1;ADGRE1;ADGRG6;CNR1;AKAP12;ADGRB2;ABCA1;PDE2A;ADCY8;RXFP1;GPR65;ADGRL2;GNAI1;GNAL;HTR1F
prerank,GO_Biological_Process_2021__chondroitin sulfate catabolic process (GO:0030207),0.6716108175787585,1.0646982279734847,0.3918918918918919,0.9923466176895008,1.0,3/7,9.58%,NCAN;VCAN;CSPG5
prerank,GO_Biological_Process_2021__fatty acid metabolic process (GO:0006631),0.5247737405845266,1.064663074656628,0.3617021276595745,0.9918074394396147,1.0,14/69,19.55%,FA2H;FAAH;ACSL1;ALOX12;ALOX15B;ELOVL4;CPT1A;ACAD9;FASN;PNPLA8;HACL1;PPARA;MSMO1;ACSL3
prerank,GO_Biological_Process_2021__positive regulation of early endosome to late endosome transport (GO:2000643),0.6320889009511685,1.0643200790048435,0.46153846153846156,0.9923730331907884,1.0,3/8,21.38%,VPS11;RAB21;RDX
prerank,GO_Biological_Process_2021__phosphatidylethanolamine metabolic process (GO:0046337),0.6078438855608579,1.0641801064348375,0.4358974358974359,0.992229965695775,1.0,4/15,16.96%,SELENOI;PNPLA8;NAPEPLD;ETNPPL
prerank,GO_Biological_Process_2021__glucose transmembrane transport (GO:1904659),0.690837495432125,1.0641409465833505,0.40625,0.9916983237677107,1.0,2/7,4.58%,SLC2A3;SLC2A9
prerank,GO_Biological_Process_2021__GPI anchor metabolic process (GO:0006505),0.569307708793732,1.0641258621060508,0.40789473684210525,0.9910718602896877,1.0,5/18,19.17%,PIGU;PIGQ;PIGF;PIGL;PIGG
prerank,GO_Biological_Process_2021__regulation of cell motility (GO:2000145),0.5106602366217754,1.0640968323285465,0.3956043956043956,0.9905035181437428,1.0,22/80,22.26%,RHOB;FGF1;ENPP2;NRG1;FRMD5;TTBK2;SRCIN1;SPOCK3;SERPINE2;PLXNB1;NRG4;LDB2;ROCK1;SPINT2;PLXNC1;FES;NRG2;TMSB10;TBCCD1;CCDC125;HACE1;AMOT
prerank,GO_Biological_Process_2021__negative regulation of developmental growth (GO:0048640),0.5725606931945831,1.0636150252334917,0.38461538461538464,0.9915832858902768,1.0,8/22,23.76%,DCC;MAG;MAP2;DUSP10;PTPRS;CDKN1B;RTN4;PTEN
prerank,GO_Biological_Process_2021__mesenchymal cell differentiation (GO:0048762),0.5359085698682914,1.0635895854270416,0.38636363636363635,0.9910344304774223,1.0,5/32,9.26%,HTR2B;TGFB2;HIF1A;RANBP3L;RBPJ
prerank,GO_Biological_Process_2021__negative regulation of release of sequestered calcium ion into cytosol (GO:0051280),0.7236665550328678,1.0635764058271804,0.38095238095238093,0.9897611845801536,1.0,2/6,18.69%,CALM3;CLIC2
prerank,GO_Biological_Process_2021__negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315),0.7236665550328678,1.0635764058271804,0.38095238095238093,0.9897611845801536,1.0,2/6,18.69%,CALM3;CLIC2
prerank,GO_Biological_Process_2021__pyrimidine-containing compound salvage (GO:0008655),0.6952292252732166,1.063544737067609,0.410958904109589,0.9885230322979974,1.0,4/8,19.80%,UCKL1;DCK;UPP2;UCK2
prerank,GO_Biological_Process_2021__pyrimidine nucleoside salvage (GO:0043097),0.6952292252732166,1.063544737067609,0.410958904109589,0.9885230322979974,1.0,4/8,19.80%,UCKL1;DCK;UPP2;UCK2
prerank,GO_Biological_Process_2021__gluconeogenesis (GO:0006094),0.548244801364386,1.0635361546565663,0.39080459770114945,0.9879020268195038,1.0,9/27,20.23%,MDH1;ENO2;PGAM1;GPI;FBP1;SLC39A14;PGK1;PGM1;ENO1
prerank,GO_Biological_Process_2021__negative regulation of B cell apoptotic process (GO:0002903),0.723520070318288,1.0633695144765671,0.417910447761194,0.9878516170967208,1.0,3/5,17.56%,IRS2;BCL6;FOXP1
prerank,GO_Biological_Process_2021__error-prone translesion synthesis (GO:0042276),0.621725255887288,1.0629285129166164,0.43902439024390244,0.988864133889956,1.0,9/18,25.89%,RPA2;RPS27A;RFC4;POLE2;UBA52;UBB;RFC1;RPA3;REV3L
prerank,GO_Biological_Process_2021__regulation of vesicle size (GO:0097494),-0.6659884488242489,-1.062878659026853,0.4594594594594595,1.0,1.0,1/6,0.76%,RAB22A
prerank,GO_Biological_Process_2021__regulation of axon regeneration (GO:0048679),0.6493157280491804,1.062593355832259,0.4,0.9894580292635501,1.0,4/9,21.81%,PTN;EPHA4;PTPRS;RTN4RL1
prerank,GO_Biological_Process_2021__regulation of postsynaptic neurotransmitter receptor activity (GO:0098962),0.6996264174772429,1.062581677033244,0.43661971830985913,0.9888633262460406,1.0,3/7,17.18%,BEGAIN;DLGAP1;DLGAP2
prerank,GO_Biological_Process_2021__negative regulation of RNA metabolic process (GO:0051253),0.5956551703647537,1.062128755889953,0.41975308641975306,0.9898226410377656,1.0,4/15,20.20%,NUDT16;ESR1;SHQ1;TNF
prerank,GO_Biological_Process_2021__pyrimidine nucleoside catabolic process (GO:0046135),0.7010139876968432,1.0621222078202353,0.4342105263157895,0.9891780077689396,1.0,1/8,1.95%,DPYD
prerank,GO_Biological_Process_2021__adherens junction organization (GO:0034332),0.5758980975405338,1.0620373904683007,0.37349397590361444,0.9888053688183182,1.0,7/32,9.37%,CADM1;CDH8;CDH2;CADM2;CDH9;CDH20;CDH12
prerank,GO_Biological_Process_2021__positive regulation of small molecule metabolic process (GO:0062013),0.6617965392286514,1.061960783410937,0.44594594594594594,0.9883765117351136,1.0,2/9,9.28%,PRKCE;IRS2
prerank,GO_Biological_Process_2021__positive regulation of programmed cell death (GO:0043068),0.482391093102634,1.0617611532119497,0.38,0.9885527538878855,1.0,44/204,20.68%,TOP2A;DAPK2;RHOB;CLIP3;GADD45B;PNMA1;SOX4;DAPK1;NGEF;CSRNP3;SEPTIN4;BNIP3L;RPS6;BOK;RRP1B;RPS27A;FAM162A;ARHGEF4;PNMA2;RPS6KA2;KALRN;PPID;RBM5;IFIT2;BNIP3;C3ORF38;ITSN1;PYCARD;CASP3;SHQ1;KCNMA1;NEURL1;BCL6;OLFM1;FGD4;SOD1;UBA52;HSPD1;UBB;ECT2;HIP1R;TNF;DUSP6;LRRK2
prerank,GO_Biological_Process_2021__regulation of receptor internalization (GO:0002090),0.5598962069330793,1.0616105161554368,0.41333333333333333,0.9884204043387637,1.0,5/23,19.39%,VEGFA;INSR;MAGI2;SDCBP;DLG4
prerank,GO_Biological_Process_2021__regulation of lamellipodium morphogenesis (GO:2000392),0.6364778831695453,1.0615712064195821,0.4024390243902439,0.9879108983062017,1.0,2/9,7.71%,ENPP2;KANK1
prerank,GO_Biological_Process_2021__translesion synthesis (GO:0019985),0.5502034392004131,1.0615529950650282,0.40425531914893614,0.9873203651002647,1.0,10/33,20.01%,DTL;RPA2;RPS27A;TRIM25;RFC4;POLE2;USP43;UBA52;UBB;RFC1
prerank,GO_Biological_Process_2021__cellular polysaccharide biosynthetic process (GO:0033692),0.6319298359628023,1.0614748997274708,0.42028985507246375,0.9869315900419721,1.0,8/11,32.00%,B4GAT1;HS2ST1;NDST3;CSGALNACT2;CSGALNACT1;EXT1;B3GNT2;FUT9
prerank,GO_Biological_Process_2021__regulation of blood circulation (GO:1903522),0.6018068158857857,1.0613723548874545,0.40789473684210525,0.9866939621490342,1.0,3/15,9.92%,AGT;CAV3;CELF2
prerank,GO_Biological_Process_2021__fat cell differentiation (GO:0045444),0.5414234762543693,1.0613569265588405,0.3373493975903614,0.9860928570603175,1.0,7/41,13.91%,KLF4;CLIP3;NR4A2;NR4A1;MAFB;NR4A3;TMEM120B
prerank,GO_Biological_Process_2021__gamma-delta T cell activation (GO:0046629),-0.6426537943048146,-1.061285803102617,0.43902439024390244,1.0,1.0,1/5,0.24%,ITK
prerank,GO_Biological_Process_2021__myelin assembly (GO:0032288),0.671049974694759,1.0612588718551357,0.40540540540540543,0.9857683422422254,1.0,7/10,28.85%,ABCA2;PMP22;TPPP;CNTNAP1;EPB41L3;NCMAP;DICER1
prerank,GO_Biological_Process_2021__dense core granule cytoskeletal transport (GO:0099519),0.6334804605380031,1.0611568716597786,0.4520547945205479,0.9854630472243411,1.0,3/7,15.54%,SYT4;PPFIA2;KIF5A
prerank,GO_Biological_Process_2021__diterpenoid metabolic process (GO:0016101),0.5838560084206463,1.0609944349552385,0.4084507042253521,0.9853584699936832,1.0,6/22,16.55%,LRP2;GPC5;AKR1B1;RDH11;ALDH1A1;NAPEPLD
prerank,PanglaoDB_Augmented_2021__Intercalated Cells,0.5578991496318543,1.060349275021343,0.4268292682926829,0.9872496115221491,1.0,9/29,24.16%,PDZD2;PTPRT;NPHP1;ITGB8;DNAH7;MAP3K13;ESRRG;CX3CL1;TCTN1
prerank,GO_Biological_Process_2021__regulation of macrophage migration (GO:1905521),-0.6592364477859649,-1.0600894728102221,0.3939393939393939,1.0,1.0,3/7,9.18%,CX3CR1;CD200R1;P2RY12
prerank,GO_Biological_Process_2021__ceramide transport (GO:0035627),0.6221533712639414,1.0594618629817991,0.4057971014492754,0.9896508979075649,1.0,6/10,28.04%,ABCA2;PLTP;ABCB4;PLEKHA3;CERT1;PLEKHA8
prerank,GO_Biological_Process_2021__positive regulation of interleukin-17 production (GO:0032740),0.6236185979942891,1.0594531803531237,0.3880597014925373,0.9890189823976182,1.0,3/12,15.83%,IL15;NOD2;IL18
prerank,GO_Biological_Process_2021__cellular response to fibroblast growth factor stimulus (GO:0044344),0.5204359060788315,1.0594436651224053,0.3804347826086957,0.9884191143098034,1.0,4/52,6.62%,FGF1;FLRT1;NR4A1;RBFOX2
prerank,GO_Biological_Process_2021__positive regulation of lipid storage (GO:0010884),0.6157634792192083,1.0593813064834992,0.42857142857142855,0.9880134525765893,1.0,1/10,1.11%,PLIN2
prerank,GO_Biological_Process_2021__glucuronate catabolic process (GO:0006064),0.7064979901441618,1.0592951958991028,0.41379310344827586,0.9863886724756783,1.0,2/5,19.51%,CRYL1;SORD
prerank,GO_Biological_Process_2021__xylulose 5-phosphate biosynthetic process (GO:1901159),0.7064979901441618,1.0592951958991028,0.41379310344827586,0.9863886724756783,1.0,2/5,19.51%,CRYL1;SORD
prerank,GO_Biological_Process_2021__glucuronate catabolic process to xylulose 5-phosphate (GO:0019640),0.7064979901441618,1.0592951958991028,0.41379310344827586,0.9863886724756783,1.0,2/5,19.51%,CRYL1;SORD
prerank,GO_Biological_Process_2021__presynaptic endocytosis (GO:0140238),0.6014387394769013,1.0590895062677952,0.4266666666666667,0.9865019092516201,1.0,6/18,19.52%,NLGN3;FCHO2;NLGN1;SYT1;AMPH;NLGN4X
prerank,GO_Biological_Process_2021__regulation of cell morphogenesis (GO:0022604),0.541318889481051,1.0587640864097072,0.39759036144578314,0.9869508180546996,1.0,5/25,18.70%,SPARC;MFSD2A;SH3D19;CFL1;NTNG1
prerank,GO_Biological_Process_2021__regulation of cell communication (GO:0010646),0.5939771851931188,1.0584850435559527,0.45,0.9875110065347359,1.0,9/25,21.28%,ANXA1;ANK2;GLRX2;RYR2;UGCG;GRK4;IGFBP7;SCG5;MTCH1
prerank,GO_Biological_Process_2021__embryonic organ development (GO:0048568),0.54849749016457,1.0580469687024106,0.4177215189873418,0.9885362700507266,1.0,5/30,9.91%,COBL;TGFB2;KITLG;RBPJ;MFSD2A
prerank,GO_Biological_Process_2021__lung development (GO:0030324),0.5888937793799812,1.0578617695320158,0.3974358974358974,0.9885174673781832,1.0,6/16,13.96%,FGF1;CHI3L1;VEGFA;CCDC39;ERRFI1;PKD1
prerank,GO_Biological_Process_2021__negative regulation of leukocyte proliferation (GO:0070664),0.7242481485218688,1.0578150080274173,0.42857142857142855,0.9880024767669389,1.0,1/5,17.54%,GSTP1
prerank,GO_Biological_Process_2021__posttranslational protein targeting to endoplasmic reticulum membrane (GO:0006620),0.6490851475712639,1.057774532203642,0.40540540540540543,0.9875625413483479,1.0,2/10,5.78%,HSPA5;SEC61B
prerank,GO_Biological_Process_2021__positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949),-0.5902115147067046,-1.0577527939823153,0.36666666666666664,1.0,1.0,2/8,2.23%,ITGA5;IL1B
prerank,GO_Biological_Process_2021__positive regulation of glycogen biosynthetic process (GO:0045725),0.6331006445268671,1.0576956386090726,0.4603174603174603,0.9871851252007912,1.0,3/9,12.09%,INSR;IRS2;SORBS1
prerank,GO_Biological_Process_2021__positive regulation of gluconeogenesis (GO:0045722),0.731588990802674,1.0576162924638262,0.4696969696969697,0.9869196304056568,1.0,2/5,25.32%,DDB1;PPARGC1A
prerank,GO_Biological_Process_2021__protein polyglutamylation (GO:0018095),0.67508144361513,1.0575903182802533,0.4714285714285714,0.9864441401941356,1.0,2/7,17.85%,TTLL7;TPGS1
prerank,PanglaoDB_Augmented_2021__Luminal Epithelial Cells,0.5951234290861884,1.057580532749883,0.4691358024691358,0.985845619142383,1.0,8/21,15.94%,ANXA1;OVOL2;HIF1A;ST14;WNT5A;UXT;ESR1;CEBPD
prerank,GO_Biological_Process_2021__positive regulation of receptor catabolic process (GO:2000646),0.7001403480436079,1.0573898290083634,0.4126984126984127,0.9858966145385254,1.0,1/6,7.02%,ABCA2
prerank,GO_Biological_Process_2021__positive regulation of transport (GO:0051050),0.5081282502196387,1.0573055906003281,0.38636363636363635,0.9855709025886886,1.0,14/59,20.20%,TUB;CLIP3;IL15;ANXA1;SLC11A1;FCGR2B;BOK;DYNC1H1;CALY;PYCARD;CD151;ACSL3;HIP1R;TNF
prerank,GO_Biological_Process_2021__regulation of cardiac muscle hypertrophy (GO:0010611),0.5749109822894845,1.057047896806051,0.4578313253012048,0.9859305318682129,1.0,6/20,21.02%,AGT;RGS2;CAV3;NR4A3;ROCK1;SLC9A1
prerank,GO_Biological_Process_2021__selective autophagy (GO:0061912),0.5227066543246466,1.0567255994195945,0.48936170212765956,0.9865795166239275,1.0,15/55,25.73%,VIM;RETREG1;RPS27A;DYNC1H1;CALCOCO2;AUP1;UBA52;UBB;DYNC1I1;ATG5;LGALS8;ATG13;CFTR;DDRGK1;DYNLL1
prerank,GO_Biological_Process_2021__regulation of cellular protein metabolic process (GO:0032268),0.5602078652130681,1.0566120582602219,0.38095238095238093,0.9864388684267187,1.0,3/35,5.92%,KLF4;AGT;RBM3
prerank,GO_Biological_Process_2021__negative regulation of TOR signaling (GO:0032007),0.5508003717595368,1.0565999472879208,0.4864864864864865,0.9858303612828677,1.0,5/24,18.36%,DDIT4;DEPTOR;NPRL2;PRKAA2;SESN1
prerank,GO_Biological_Process_2021__glycogen catabolic process (GO:0005980),-0.5073984046040422,-1.0564704198769261,0.45161290322580644,1.0,1.0,1/12,1.12%,PGM2
prerank,GO_Biological_Process_2021__positive regulation of cell adhesion (GO:0045785),0.5363123353527853,1.0563464801971663,0.35714285714285715,0.9861211918992867,1.0,5/42,5.04%,TGFB2;ECM2;FRMD5;RNASE10;VEGFA
prerank,GO_Biological_Process_2021__high-density lipoprotein particle assembly (GO:0034380),0.6667951483809993,1.0563363435368065,0.47692307692307695,0.9855321294791212,1.0,3/7,23.72%,ABCA1;BMP1;PRKACB
prerank,GO_Biological_Process_2021__immune response-activating cell surface receptor signaling pathway (GO:0002429),0.5654981491125995,1.0562085182252312,0.44155844155844154,0.9853740832047163,1.0,2/14,10.42%,CR1;C5AR1
prerank,GO_Biological_Process_2021__fatty acid alpha-oxidation (GO:0001561),-0.6454018347367656,-1.0559455868721372,0.42857142857142855,1.0,1.0,1/5,1.54%,PEX13
prerank,GO_Biological_Process_2021__response to endoplasmic reticulum stress (GO:0034976),0.48750412012100053,1.0558093560100368,0.3854166666666667,0.98610690578036,1.0,13/91,16.13%,THBS1;HSPA5;TRAF2;PDIA2;EIF2AK3;HERPUD1;RNF139;PPP1R15A;RASGRF1;DNAJB9;HYOU1;ATP2A2;SYVN1
prerank,GO_Biological_Process_2021__smooth muscle contraction (GO:0006939),-0.5116447113340465,-1.055604001553799,0.39285714285714285,1.0,1.0,1/8,2.54%,ACTA2
prerank,GO_Biological_Process_2021__astral microtubule organization (GO:0030953),0.6618926898673569,1.0556033428722367,0.41025641025641024,0.9863170051531281,1.0,3/8,26.51%,TPPP;LIMK2;RAB11A
prerank,GO_Biological_Process_2021__monocyte chemotaxis (GO:0002548),-0.458595506904138,-1.055015773588575,0.34615384615384615,1.0,1.0,2/12,3.59%,CCL5;FOLR2
prerank,GO_Biological_Process_2021__nitric oxide mediated signal transduction (GO:0007263),0.6437334976276353,1.0548970287965629,0.43243243243243246,0.9881218248392717,1.0,4/9,25.21%,AGT;GUCY1B1;FPR1;KCNC2
prerank,GO_Biological_Process_2021__post-translational protein modification (GO:0043687),0.48046444130217103,1.054818473943868,0.32,0.9877418131470551,1.0,49/226,22.05%,SOCS3;TNC;DTL;ASB14;VGF;WDR5;ZBTB16;VCAN;FBXL7;CDH2;ASB16;LAMB1;GOLM1;COPS5;HIF1A;FN1;CKAP4;LTBP1;TMEM132A;STT3B;PSMB4;RBX1;DCAF6;GAN;HIF3A;ASB13;FBXO27;UBE2M;CHGB;SUMF2;KLHL2;EPAS1;APP;SUMF1;IGFBP7;FBXL13;PSMC2;FBXL5;PSMA3;FBXO7;PSMB2;SPSB3;ATG5;DDB1;P4HB;PSMD5;HSP90B1;PSMD7;RAB5A
prerank,GO_Biological_Process_2021__regulation of relaxation of cardiac muscle (GO:1901897),0.6839114195404402,1.0546595249967732,0.34782608695652173,0.9875460916522417,1.0,1/5,10.68%,PDE4B
prerank,GO_Biological_Process_2021__positive regulation of protein deubiquitination (GO:1903003),0.6855025010944937,1.0546449596572118,0.46875,0.9869648907051956,1.0,4/6,29.94%,SART3;NOP53;TNIP1;WDR48
prerank,GO_Biological_Process_2021__Golgi to plasma membrane transport (GO:0006893),0.5271324694918429,1.0544093709971514,0.42168674698795183,0.9871859987427398,1.0,8/39,20.81%,STEAP2;ANK3;NSF;STXBP6;PREPL;SPTBN1;OSBPL5;EXOC5
prerank,PanglaoDB_Augmented_2021__Proximal Tubule Cells,0.554166514046333,1.054230893547504,0.4444444444444444,0.9872478362445753,1.0,10/24,19.51%,LRP2;FAH;SLC13A3;GHR;CRYL1;FBP1;TGFBI;GBA3;NME4;SORD
prerank,GO_Biological_Process_2021__negative regulation of histone acetylation (GO:0035067),0.6550223588520241,1.0538690726384126,0.5135135135135135,0.9877679126576434,1.0,3/10,19.08%,BRCA1;CTBP1;TAF7
prerank,GO_Biological_Process_2021__heart contraction (GO:0060047),0.598480499441995,1.0535500769199369,0.4177215189873418,0.9882628926509185,1.0,8/18,22.96%,SCN3B;DMD;RYR2;SGCZ;SGCD;SOD1;ATP1A2;GAA
prerank,GO_Biological_Process_2021__negative regulation of cell junction assembly (GO:1901889),-0.4585536118303354,-1.053535738869916,0.15,1.0,1.0,2/22,2.23%,PHLDB2;IL1B
prerank,PanglaoDB_Augmented_2021__Basal Cells,0.5445832826375304,1.0534852672389,0.43956043956043955,0.987829571255553,1.0,10/37,19.11%,ITGA2;RARRES1;PPP1R13L;BACE2;BNIP3;TMEM14A;EPAS1;HSPB1;SLC16A3;CD151
prerank,GO_Biological_Process_2021__primary miRNA processing (GO:0031053),-0.5362640017482418,-1.0534077144997465,0.4,1.0,1.0,2/10,9.26%,SRRT;PUS10
prerank,GO_Biological_Process_2021__regulation of vesicle-mediated transport (GO:0060627),0.4981433514682332,1.0533596425974385,0.4148936170212766,0.9876834659642691,1.0,20/75,20.68%,CD22;RAB3C;STXBP5L;SEPTIN4;RAB15;RIMS2;ARFGAP1;FGR;SYT1;NSF;RNF139;PICALM;CPLX1;ITGAV;SNX17;FES;RAB21;PLD1;HIP1R;LRRK2
prerank,GO_Biological_Process_2021__response to unfolded protein (GO:0006986),0.5277211178887229,1.053352062090577,0.4588235294117647,0.987086500825458,1.0,15/38,27.66%,HSPA5;HERPUD1;STT3B;DNAJB2;BAG3;HSPB1;HSPA1B;HSPD1;HSPA2;HSPA14;HSP90AB1;HSPA9;HSPA13;PTPN1;HSPA8
prerank,GO_Biological_Process_2021__endothelial cell chemotaxis (GO:0035767),0.6801034277797685,1.053341609252309,0.4444444444444444,0.9865024836792514,1.0,2/5,5.04%,NR4A1;VEGFA
prerank,"GO_Biological_Process_2021__neurotransmitter receptor transport, endosome to postsynaptic membrane (GO:0098887)",0.6991185615468813,1.0532365362903549,0.4507042253521127,0.9862114111523619,1.0,4/5,29.78%,GRIPAP1;RAB11A;GRIP1;ARHGAP44
prerank,GO_Biological_Process_2021__ncRNA export from nucleus (GO:0097064),-0.4147081756267011,-1.0532203330841927,0.4166666666666667,1.0,1.0,7/36,13.88%,NUP42;PHAX;NUP155;NUP188;NUP214;RAE1;XPOT
prerank,GO_Biological_Process_2021__regulation of spindle organization (GO:0090224),0.6201443825233258,1.0532045214668937,0.4358974358974359,0.9857077878743845,1.0,7/13,23.90%,MAP9;DYNC1H1;GNAI1;DCTN1;GPSM2;TACC3;BORA
prerank,GO_Biological_Process_2021__regulation of nitric oxide biosynthetic process (GO:0045428),0.5629590257959819,1.0530381786794945,0.3950617283950617,0.9857702150584668,1.0,3/26,6.48%,KLF4;GLA;INSR
prerank,MSigDB_Hallmark_2020__p53 Pathway,0.49070020891006355,1.0529839312555511,0.32653061224489793,0.985352578359742,1.0,16/145,10.18%,DDIT4;KLF4;ACVR1B;PVT1;ZBTB16;IER5;NDRG1;ALOX15B;CDKN2AIP;HINT1;SLC19A2;MXD1;PLK2;ST14;TXNIP;FAM162A
prerank,GO_Biological_Process_2021__cellular response to epinephrine stimulus (GO:0071872),0.6413483643581158,1.0529226355361925,0.47297297297297297,0.9843004575375456,1.0,4/8,25.49%,RYR2;PDE4B;SLC9A1;ATP2B4
prerank,GO_Biological_Process_2021__response to epinephrine (GO:0071871),0.6413483643581158,1.0529226355361925,0.47297297297297297,0.9843004575375456,1.0,4/8,25.49%,RYR2;PDE4B;SLC9A1;ATP2B4
prerank,GO_Biological_Process_2021__regulation of synapse maturation (GO:0090128),0.6774936703970679,1.052824691676581,0.3939393939393939,0.9840361612312526,1.0,4/7,17.07%,RELN;NRXN1;CAMK2B;NEURL1
prerank,GO_Biological_Process_2021__nuclear DNA replication (GO:0033260),0.6459061438438134,1.0527739199253159,0.40350877192982454,0.9835479728561929,1.0,5/8,29.85%,DONSON;MCMDC2;ORC3;MCM3;MCM6
prerank,GO_Biological_Process_2021__lipid oxidation (GO:0034440),0.6516016319441625,1.0526876152868871,0.39655172413793105,0.983217872800551,1.0,2/8,5.56%,ALOX12;ALOX15B
prerank,GO_Biological_Process_2021__insulin-like growth factor receptor signaling pathway (GO:0048009),0.6464597380708043,1.052390472278931,0.45714285714285713,0.9836871269617111,1.0,4/10,16.96%,EIF2AK3;IGF1R;GHR;PLCB1
prerank,GO_Biological_Process_2021__negative regulation of viral release from host cell (GO:1902187),0.6569002945375395,1.0522934191529372,0.48333333333333334,0.9833876019483799,1.0,2/8,14.21%,TRIM5;TRIM26
prerank,"GO_Biological_Process_2021__DNA damage response, signal transduction by p53 class mediator (GO:0030330)",-0.3911247094368161,-1.0522396119788624,0.25,1.0,1.0,14/57,13.06%,PIDD1;BTG2;RPS6KA6;SESN2;TFAP4;ACER2;TP53;ZNF385A;EP300;BCL3;CNOT6L;PLK3;NBN;PLAGL1
prerank,GO_Biological_Process_2021__potassium ion homeostasis (GO:0055075),0.6141411932859088,1.052137936342622,0.4461538461538462,0.983306071806151,1.0,5/14,20.66%,SLC12A8;ATP1B3;KCNMA1;ATP1B2;ATP1A2
prerank,GO_Biological_Process_2021__regulation of lens fiber cell differentiation (GO:1902746),0.6819228472219174,1.0520275425172663,0.5555555555555556,0.9830554977514505,1.0,1/5,8.27%,SPRY1
prerank,GO_Biological_Process_2021__regulation of macrophage activation (GO:0043030),0.6113351371275516,1.051968131075762,0.42168674698795183,0.9826784620049823,1.0,2/16,5.61%,THBS1;FCGR2B
prerank,GO_Biological_Process_2021__epidermis development (GO:0008544),0.6152214553498861,1.0510196588589682,0.4714285714285714,0.9853969949671939,1.0,8/16,21.58%,SVEP1;OVOL2;PLOD1;ATP2A2;UGCG;STS;FGFR2;FLOT2
prerank,GO_Biological_Process_2021__regulation of secretion (GO:0051046),0.646728207068961,1.0509242996536596,0.46835443037974683,0.9850732173400871,1.0,1/8,3.66%,NRG1
prerank,GO_Biological_Process_2021__hepatocyte growth factor receptor signaling pathway (GO:0048012),-0.6084397425552894,-1.0507660421012126,0.3870967741935484,1.0,1.0,1/7,7.82%,HPN
prerank,GO_Biological_Process_2021__fatty acid derivative biosynthetic process (GO:1901570),0.5557732866405122,1.0507291684392848,0.4268292682926829,0.9852017749934018,1.0,6/25,13.55%,ALOX12;ACSS3;ACAT1;SCD5;FASN;SCD
prerank,GO_Biological_Process_2021__regulation of B cell activation (GO:0050864),-0.4801954800102214,-1.0506526134012855,0.4117647058823529,1.0,1.0,4/16,4.42%,IKZF3;SAMSN1;BANK1;IL4I1
prerank,GO_Biological_Process_2021__protein import (GO:0017038),-0.3439125096059364,-1.0506488310695703,0.2857142857142857,1.0,1.0,14/67,14.21%,RANBP6;PEX13;APPL2;NUP155;RPAIN;PHB2;NUP188;NUP214;IPO13;SYK;PEX16;PTTG1IP;ABCD3;AKT1
prerank,GO_Biological_Process_2021__regulation of cell aging (GO:0090342),-0.6294761467946043,-1.050612970697574,0.4583333333333333,1.0,1.0,3/7,16.29%,NEK6;RSL1D1;NUAK1
prerank,GO_Biological_Process_2021__negative regulation of blood coagulation (GO:0030195),-0.48714589487103177,-1.0505876697855787,0.3333333333333333,1.0,1.0,3/13,9.06%,SERPINF2;A2M;KLKB1
prerank,PanglaoDB_Augmented_2021__Myoblasts,0.5061979816316584,1.0502651023049887,0.4642857142857143,0.986197315177817,1.0,10/44,15.50%,ZBTB16;FBXL7;SYNC;LAMB1;RND3;PALLD;FN1;UACA;TIMP3;ANGPT2
prerank,GO_Biological_Process_2021__negative regulation of bone mineralization (GO:0030502),0.6758981917527995,1.0502381408042203,0.5,0.9857231951095116,1.0,1/7,4.57%,SRGN
prerank,GO_Biological_Process_2021__positive regulation of granulocyte differentiation (GO:0030854),0.6870444670048672,1.049752784215928,0.4393939393939394,0.986741201987526,1.0,1/5,11.83%,HCLS1
prerank,GO_Biological_Process_2021__adenosine to inosine editing (GO:0006382),0.7074371321116844,1.0496515696742545,0.4925373134328358,0.9864777022681008,1.0,2/6,6.63%,NUDT16;ADARB2
prerank,GO_Biological_Process_2021__carbohydrate homeostasis (GO:0033500),0.5370521800917699,1.0496283968130498,0.3953488372093023,0.9859562511127985,1.0,10/41,12.65%,VGF;SOX4;PDK4;INSR;CAV3;RPS6;IGF1R;ADCY8;TENT4B;BACE2
prerank,GO_Biological_Process_2021__establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197),0.5699090026017066,1.0492789776300184,0.37037037037037035,0.9865699923522379,1.0,4/24,16.54%,MTCL1;PARD3;LRRC7;CRB1
prerank,GO_Biological_Process_2021__positive regulation of lipid localization (GO:1905954),-0.6860348483184358,-1.0492504830686387,0.4594594594594595,1.0,1.0,2/5,9.86%,C3;LPL
prerank,GO_Biological_Process_2021__melanocyte differentiation (GO:0030318),-0.6316329803193097,-1.0492334325673662,0.52,1.0,1.0,3/5,22.31%,ENPP1;LRMDA;MEF2C
prerank,GO_Biological_Process_2021__macropinocytosis (GO:0044351),0.707818586549796,1.0490777294833369,0.42857142857142855,0.986607051448116,1.0,2/5,14.63%,CARMIL1;PYCARD
prerank,"GO_Biological_Process_2021__negative regulation of translation, ncRNA-mediated (GO:0040033)",-0.5712012804563625,-1.0490376603382423,0.3870967741935484,1.0,1.0,3/8,17.16%,AGO1;ZFP36;RBM4
prerank,GO_Biological_Process_2021__miRNA mediated inhibition of translation (GO:0035278),-0.5712012804563625,-1.0490376603382423,0.3870967741935484,1.0,1.0,3/8,17.16%,AGO1;ZFP36;RBM4
prerank,GO_Biological_Process_2021__regulation of fatty acid metabolic process (GO:0019217),0.6506888401822476,1.0490252385653647,0.4520547945205479,0.9861644438906019,1.0,4/11,19.04%,PDK4;PRKAG2;PRKAA2;PPARA
prerank,GO_Biological_Process_2021__chromosome organization (GO:0051276),0.5085574314093083,1.0487239430580395,0.46808510638297873,0.9866091318191345,1.0,8/75,11.07%,TOP2A;HMGB2;NUP133;COPS5;TCF7L1;RPS27A;FAM50A;RBX1
prerank,GO_Biological_Process_2021__positive regulation of vascular associated smooth muscle cell migration (GO:1904754),0.6881512167148857,1.0486926540220658,0.5,0.9860892407307669,1.0,2/5,12.83%,DOCK5;NR4A3
prerank,GO_Biological_Process_2021__glomerular visceral epithelial cell differentiation (GO:0072112),0.7011125946157277,1.0485094956201146,0.4852941176470588,0.9861863484451384,1.0,3/6,20.40%,MAGI2;IQGAP1;BASP1
prerank,GO_Biological_Process_2021__fatty acid transmembrane transport (GO:1902001),0.6240909551730373,1.048421456033433,0.4878048780487805,0.9858527626477916,1.0,5/14,20.77%,MID1IP1;CPT1A;PRKAG2;PRKAA2;ACACB
prerank,GO_Biological_Process_2021__cellular protein metabolic process (GO:0044267),0.4860352222598373,1.0484130705894639,0.37,0.9852626114420161,1.0,68/275,22.94%,TNC;ARAF;EEF1A2;PAPPA2;RPL23;VGF;VCAN;CDH2;RPL37A;LAMB1;RPS6KB2;GOLM1;FBXL2;RPL38;COPS5;FN1;RPS6;RPS27A;RPL23A;CKAP4;RPS25;DARS1;LTBP1;RPS27;TMEM132A;CHRM3;RPS11;SLC35A1;RPS20;RPL9;L2HGDH;RPLP2;RPS18;MRPL43;SERP1;RPL37;UBE2M;RPL14;CHGB;CPE;LTA4H;MRPL55;MRPL27;RPS4X;RPL11;RPS24;RPS9;APP;RPL36;IGFBP7;UBA52;ERO1A;MRPL3;RPS3A;MRPS14;RPL35;RPL4;P4HB;RPL32;DUSP12;TNIP1;HSP90B1;EEF1A1;SPCS3;RPL24;SPARCL1;RPL27A;RPL3
prerank,GO_Biological_Process_2021__regulation of lipid biosynthetic process (GO:0046890),0.5823906573124509,1.0482812911165407,0.4523809523809524,0.9851390679619859,1.0,7/22,19.04%,ASXL3;PDK4;MID1IP1;PRKAG2;SORBS1;PRKAA2;PPARA
prerank,PanglaoDB_Augmented_2021__Tuft Cells,-0.3909290816404589,-1.0482005935043452,0.2727272727272727,1.0,1.0,12/53,10.95%,CD300LF;ITGAM;PTAFR;P2RX1;MPEG1;LGALS9;P2RY13;AOAH;ALOX5;HCK;PTGS1;IRAG2
prerank,GO_Biological_Process_2021__regulation of apoptotic process (GO:0042981),0.4701929231739682,1.048129400836669,0.33,0.9851231196645142,1.0,85/482,18.46%,TOP2A;HTR2B;THBS1;DAPK2;LRP2;RHOB;ARAF;PRLR;CLIP3;GADD45B;NAA38;PNMA1;TFRC;AGT;ATAD3A;ANXA1;RNF144B;FIGNL1;VEGFA;SOX4;HSPA5;PHLPP1;TRAF2;NDRG1;IL7;NSMF;DAPK1;COPS5;NGEF;FMN2;CSRNP3;PAX8;SEPTIN4;BEX2;BNIP3L;FAIM2;RPS6;BOK;IGF1R;RRP1B;RPS27A;MCL1;PLK2;SRA1;ALK;FAM162A;ARHGEF4;PNMA2;RPS6KA2;KALRN;PPID;RIPK2;GRID2;RBM5;IFIT2;BNIP3;PINK1;PRELID1;BCL2L2;C3ORF38;ITSN1;TMEM14A;PYCARD;WNT5A;CASP3;CFL1;BAG3;CIDEB;NUAK2;SHQ1;KCNMA1;NEURL1;EGLN3;ARHGDIA;HSPB1;BCL6;HSPA1B;GSTP1;OLFM1;PRKAA2;TAF9B;FGD4;SOD1;UBA52;HSPD1
prerank,GO_Biological_Process_2021__SNARE complex assembly (GO:0035493),0.6568277920081446,1.0479463802088702,0.4057971014492754,0.9851250868120353,1.0,1/8,15.48%,STXBP6
prerank,GO_Biological_Process_2021__regulation of mononuclear cell migration (GO:0071675),0.5978942013798078,1.0478881831656677,0.44285714285714284,0.9846322554219094,1.0,1/14,0.28%,THBS1
prerank,GO_Biological_Process_2021__regulation of endodeoxyribonuclease activity (GO:0032071),-0.6297257622411211,-1.0477793829299313,0.4666666666666667,1.0,1.0,2/7,27.40%,AKT1;NPM1
prerank,GO_Biological_Process_2021__dephosphorylation (GO:0016311),0.48512239629326637,1.0475980510663665,0.3804347826086957,0.985027733472303,1.0,26/107,21.34%,PLPP3;PTPRD;PPP2R3B;PPP2R5B;PLPPR4;PTPRG;PTPRK;PPP2R5A;PTPRZ1;MTMR7;PP2D1;PTPRT;FBP1;PPM1E;PPM1L;ACP3;DUSP10;PTPN9;PPP2R3A;PTPN5;DUSP16;CTDSP1;SSH2;DUSP6;PTPRS;DUSP12
prerank,GO_Biological_Process_2021__regulation of neurotransmitter secretion (GO:0046928),0.5464700545175036,1.0474374287347417,0.42857142857142855,0.9849344938399134,1.0,10/22,25.30%,RIMS2;RIMS3;CPLX1;MCTP1;PREPL;PNKD;LRRK2;RAB5A;SYT11;RIMS1
prerank,GO_Biological_Process_2021__calcium ion homeostasis (GO:0055074),0.49715263399526755,1.0473408142868916,0.3793103448275862,0.9845557613852345,1.0,10/45,15.70%,HTR2B;SLC24A2;VAPB;ANK2;TMTC2;RYR2;SLC24A1;FAM20A;ATP2A2;SLC24A3
prerank,GO_Biological_Process_2021__organic heteropentacyclic compound metabolic process (GO:1901376),0.7174120756482565,1.0467272394676272,0.547945205479452,0.9847408721012529,1.0,1/5,2.19%,CYP3A5
prerank,GO_Biological_Process_2021__mycotoxin metabolic process (GO:0043385),0.7174120756482565,1.0467272394676272,0.547945205479452,0.9847408721012529,1.0,1/5,2.19%,CYP3A5
prerank,GO_Biological_Process_2021__aflatoxin metabolic process (GO:0046222),0.7174120756482565,1.0467272394676272,0.547945205479452,0.9847408721012529,1.0,1/5,2.19%,CYP3A5
prerank,GO_Biological_Process_2021__adiponectin-activated signaling pathway (GO:0033211),-0.6336731518725449,-1.0466607918277728,0.4146341463414634,1.0,1.0,1/5,4.51%,APPL2
prerank,GO_Biological_Process_2021__positive regulation of vascular associated smooth muscle cell apoptotic process (GO:1905461),0.688224314979086,1.0464430144047787,0.49206349206349204,0.9851229295250582,1.0,3/5,22.38%,SOD2;MFN2;PDCD4
prerank,GO_Biological_Process_2021__cellular response to insulin stimulus (GO:0032869),0.4722533906790013,1.04643783074056,0.4845360824742268,0.9845257912465026,1.0,12/90,15.02%,NAMPT;PDK4;INSR;GRB10;RAB15;IRS2;IGF1R;SORBS1;GAB1;PKM;INSIG1;CPEB2
prerank,GO_Biological_Process_2021__fatty acid beta-oxidation using acyl-CoA dehydrogenase (GO:0033539),0.664047977422241,1.0462985351563059,0.43478260869565216,0.9843621367610484,1.0,1/8,6.02%,ETFB
prerank,GO_Biological_Process_2021__substrate-dependent cell migration (GO:0006929),0.6153527262010513,1.0462625752772583,0.4696969696969697,0.9838965504708753,1.0,2/10,14.72%,ITGA2;SDCBP
prerank,GO_Biological_Process_2021__negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176),0.585251329443787,1.0461418558979814,0.4857142857142857,0.9837038892591168,1.0,5/15,23.47%,HIF1A;SOD2;PINK1;HSPB1;TRAP1
prerank,GO_Biological_Process_2021__protein monoubiquitination (GO:0006513),0.549260493704943,1.0459526540525588,0.4567901234567901,0.9837836433030862,1.0,6/31,17.71%,DTL;TRIM25;RBX1;RNF126;NEURL1;FANCL
prerank,GO_Biological_Process_2021__regulation of membrane repolarization (GO:0060306),0.659408156746166,1.0458932504698055,0.4155844155844156,0.9833961574177275,1.0,1/8,6.56%,AKAP6
prerank,PanglaoDB_Augmented_2021__Cholangiocytes,0.5898011984140057,1.045865299686868,0.4605263157894737,0.9828673255830778,1.0,2/13,9.75%,OVOL2;ST14
prerank,GO_Biological_Process_2021__mitochondrial respiratory chain complex assembly (GO:0033108),0.5127728736439356,1.045621521343099,0.43010752688172044,0.9830124149045901,1.0,22/68,30.57%,NDUFA2;NDUFB9;SCO2;NDUFA3;NDUFS8;ACAD9;NDUFB6;UQCRFS1;TIMMDC1;SCO1;NDUFAF4;DMAC1;ECSIT;COX20;NDUFS5;NDUFV1;NDUFS7;TMEM126A;NDUFAF1;NDUFA1;IMMP2L;NDUFA10
prerank,GO_Biological_Process_2021__positive regulation of phospholipid transport (GO:2001140),0.6473139387167844,1.0450347369432378,0.4838709677419355,0.9846033518963675,1.0,4/7,31.30%,PRELID1;ABCB4;DBI;ABCA3
prerank,GO_Biological_Process_2021__negative regulation of proteolysis involved in cellular protein catabolic process (GO:1903051),0.5753681682028481,1.0449263742004364,0.48717948717948717,0.9843519845858603,1.0,5/20,22.43%,RPL23;EPHA4;RPL11;ALAD;HFE
prerank,GO_Biological_Process_2021__response to host defenses (GO:0052200),0.7009608620536668,1.0445656687359133,0.5072463768115942,0.9842920232976626,1.0,5/7,26.10%,RPS27A;UBA52;UBB;MRC1;TLR2
prerank,GO_Biological_Process_2021__modulation by symbiont of host defense response (GO:0052031),0.7009608620536668,1.0445656687359133,0.5072463768115942,0.9842920232976626,1.0,5/7,26.10%,RPS27A;UBA52;UBB;MRC1;TLR2
prerank,GO_Biological_Process_2021__histone H3 acetylation (GO:0043966),0.5469291158968579,1.0445199884786158,0.44047619047619047,0.9837999274851231,1.0,4/34,13.64%,WDR5;YEATS2;PER1;TRIM16
prerank,GO_Biological_Process_2021__negative regulation of Ras protein signal transduction (GO:0046580),0.5377191327223695,1.0444995183781303,0.5280898876404494,0.9832496022612496,1.0,5/29,12.53%,TGFB2;STMN3;KANK1;SPRY1;FBP1
prerank,GO_Biological_Process_2021__regulation of supramolecular fiber organization (GO:1902903),0.5975938476622957,1.0442440342124784,0.46153846153846156,0.983423227748316,1.0,3/18,9.38%,MAPT;MAP2;MAP1B
prerank,GO_Biological_Process_2021__regulation of non-canonical Wnt signaling pathway (GO:2000050),0.643624139775414,1.0439503542202822,0.47692307692307695,0.9838023196344419,1.0,1/8,5.06%,DAAM2
prerank,GO_Biological_Process_2021__receptor metabolic process (GO:0043112),-0.3695092204507713,-1.043929686517583,0.4,1.0,1.0,11/44,13.23%,NEDD4;RAMP1;PLEKHJ1;LILRB4;GRK2;SNX25;TGFB1;SMURF1;ITGB2;ARRB2;SYK
prerank,GO_Biological_Process_2021__positive regulation of protein import into nucleus (GO:0042307),-0.4696810897641883,-1.043897977126576,0.35294117647058826,1.0,1.0,3/21,7.51%,FLNA;ZPR1;TGFB1
prerank,GO_Biological_Process_2021__positive regulation of macrophage activation (GO:0043032),0.6587225789836896,1.0436743401882056,0.49206349206349204,0.9841633240106474,1.0,1/8,0.28%,THBS1
prerank,GO_Biological_Process_2021__regulation of telomerase activity (GO:0051972),0.5508373258262926,1.0435937683164835,0.42528735632183906,0.9838312997508311,1.0,1/33,0.30%,KLF4
prerank,GO_Biological_Process_2021__nucleoside diphosphate catabolic process (GO:0009134),0.7129223068288222,1.0435402428771736,0.42857142857142855,0.9834292967375607,1.0,1/6,4.09%,ENTPD3
prerank,GO_Biological_Process_2021__regulation of regulated secretory pathway (GO:1903305),0.5441949479721311,1.043527880957951,0.42168674698795183,0.9828460645226529,1.0,11/22,26.10%,SYT4;RAB15;RIMS2;SYT1;RIMS3;PREPL;LRRK2;RAB5A;SYT11;RIMS1;SYT9
prerank,GO_Biological_Process_2021__regulation of autophagy (GO:0010506),0.4806637637921003,1.043410785285736,0.3838383838383838,0.982603343819348,1.0,31/178,21.88%,DEPP1;HTR2B;DAPK2;EEF1A2;GFAP;MAPT;FBXL2;DAPK1;TRIM5;BOK;MCL1;PLK2;PRKAG2;BNIP3;PINK1;CASP3;ROCK1;HSPB1;NPRL2;MTMR9;PRKAA2;TRIM65;CDK5R1;ATP6V0B;UCHL1;LRRK2;TRIM14;LEPR;TBC1D14;ATP6V1B2;EEF1A1
prerank,GO_Biological_Process_2021__histone methylation (GO:0016571),-0.4701023465163568,-1.043307985657228,0.39285714285714285,1.0,1.0,2/17,2.37%,FBL;SETD6
prerank,GO_Biological_Process_2021__eye photoreceptor cell differentiation (GO:0001754),0.645666609011416,1.0431676234115015,0.43283582089552236,0.9827414893714022,1.0,3/8,7.57%,RORB;VEGFA;AGTPBP1
prerank,GO_Biological_Process_2021__sulfur compound transport (GO:0072348),0.5774698365101267,1.0428185670189238,0.45454545454545453,0.9832246899637145,1.0,4/18,12.28%,RACGAP1;SLC13A4;SLC19A2;SLC35F3
prerank,GO_Biological_Process_2021__negative regulation of leukocyte apoptotic process (GO:2000107),0.6317219563277956,1.0425501360013416,0.5342465753424658,0.9834266075297833,1.0,2/9,11.83%,NOD2;HCLS1
prerank,GO_Biological_Process_2021__gamma-aminobutyric acid metabolic process (GO:0009448),0.6972876790304072,1.0422499727012278,0.4925373134328358,0.9837977549658172,1.0,3/5,14.58%,GAD1;GAD2;ALDH1A1
prerank,GO_Biological_Process_2021__regulation of intracellular pH (GO:0051453),0.5779988327849408,1.0422366529007685,0.4642857142857143,0.9832456495367271,1.0,10/23,25.82%,SLC4A10;CA2;SLC9A7;SLC9A6;LRRK2;SLC9A1;SLC26A3;CHP1;CFTR;GPR89B
prerank,GO_Biological_Process_2021__regulation of mast cell activation involved in immune response (GO:0033006),0.6592836330703162,1.042198926903342,0.5076923076923077,0.9827876127294708,1.0,3/9,18.43%,CD300A;STXBP2;FES
prerank,GO_Biological_Process_2021__microtubule nucleation (GO:0007020),-0.47252730314091923,-1.0420962064346362,0.34615384615384615,1.0,1.0,1/17,0.77%,NDE1
prerank,"GO_Biological_Process_2021__positive regulation of protein localization to chromosome, telomeric region (GO:1904816)",0.6173341053224228,1.0419204791136125,0.463768115942029,0.9831176357142104,1.0,4/11,27.75%,TCP1;GNL3;CCT8;DKC1
prerank,GO_Biological_Process_2021__amyloid fibril formation (GO:1990000),0.5247003091230158,1.0417602428637418,0.4318181818181818,0.9831441075095008,1.0,6/35,18.81%,MAPT;RPS27A;TGFBI;APP;UBA52;UBB
prerank,GO_Biological_Process_2021__negative regulation of protein polymerization (GO:0032272),0.5729169061573354,1.0415662726227093,0.4305555555555556,0.9833453316832077,1.0,8/22,20.28%,CLIP3;TUBB4A;KANK1;MAP2;STMN2;EML2;HIP1R;SSH2
prerank,"GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",-0.3963940340647757,-1.0415609828421817,0.4444444444444444,1.0,1.0,10/62,10.78%,PSMB3;PSME3;CHUK;ITGB5;PSMC4;PSMD12;PSME4;HLA-E;IKBKB;FCGR1A
prerank,GO_Biological_Process_2021__regulation of epithelial cell proliferation (GO:0050678),0.5190213730172137,1.0414979879720048,0.46511627906976744,0.9828650660700143,1.0,11/42,16.29%,FGF1;TGFB2;NR4A1;VEGFA;LAMB1;C5AR1;NOD2;DEAF1;NR4A3;DUSP10;EPB41L4B
prerank,GO_Biological_Process_2021__positive regulation of innate immune response (GO:0045089),-0.396355710417885,-1.0414733975109431,0.3333333333333333,1.0,1.0,4/23,13.17%,CCL5;HLA-E;NMI;TASL
prerank,GO_Biological_Process_2021__protein targeting to peroxisome (GO:0006625),-0.42094919586766555,-1.0413151633855309,0.3333333333333333,1.0,1.0,7/22,20.48%,PEX13;PEX16;ABCD3;FIS1;ACBD5;PEX2;SLC25A17
prerank,GO_Biological_Process_2021__protein localization to basolateral plasma membrane (GO:1903361),-0.625926711287371,-1.0412456217816441,0.41935483870967744,1.0,1.0,2/5,22.85%,AP4M1;LIN7B
prerank,PanglaoDB_Augmented_2021__Ductal Cells,-0.49402564313187114,-1.0410784489178706,0.45,1.0,1.0,3/12,5.41%,HHEX;C3;ANXA4
prerank,GO_Biological_Process_2021__steroid biosynthetic process (GO:0006694),0.5610521190603788,1.0410611912671897,0.41975308641975306,0.9837935928951049,1.0,6/31,14.37%,PRLR;TM7SF2;FAXDC2;PRKAG2;INSIG1;FDFT1
prerank,GO_Biological_Process_2021__regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),-0.3704309988505606,-1.0410267847551853,0.35714285714285715,1.0,1.0,6/50,3.56%,CEBPA;TFAP4;CCND1;ACTB;HHEX;LATS2
prerank,GO_Biological_Process_2021__mitotic DNA replication (GO:1902969),0.6518155823633663,1.0404968564180566,0.4925373134328358,0.9850408337633176,1.0,6/7,34.41%,GINS1;MCMDC2;MCM3;MCM6;POLA1;GINS3
prerank,GO_Biological_Process_2021__positive regulation of smooth muscle cell apoptotic process (GO:0034393),0.6627639280173522,1.0401811403774113,0.47761194029850745,0.9854670699686306,1.0,3/6,22.38%,SOD2;MFN2;PDCD4
prerank,GO_Biological_Process_2021__positive regulation of phosphatase activity (GO:0010922),0.6441544802539696,1.0400781483934405,0.47297297297297297,0.9851551239934951,1.0,5/12,17.76%,CALM3;MAGI2;CD300A;PPP1R15A;MTMR9
prerank,GO_Biological_Process_2021__apoptotic process (GO:0006915),0.47591493490391057,1.039753107000212,0.4,0.9855517455939791,1.0,28/160,16.04%,DDIT4;DAPK2;RHOB;MAL;DCC;PRKCE;ZBTB16;ERCC2;CIT;ADAM15;ALOX15B;DAPK1;SEMA6A;GLRX2;SEPTIN4;BOK;CASP5;TCHP;FAM162A;IFIT2;PAK5;BNIP3;PPP1R15A;PYCARD;SCN2A;CASP3;CIDEB;IFI27L2
prerank,GO_Biological_Process_2021__positive regulation of protein binding (GO:0032092),-0.39342292560152453,-1.039693824049998,0.42857142857142855,1.0,1.0,4/42,6.66%,RALB;IDE;NVL;TRIB3
prerank,GO_Biological_Process_2021__positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),0.570930053955244,1.039186105141097,0.4375,0.9868006686068322,1.0,6/24,12.31%,SOCS3;IL15;VEGFA;GHR;HCLS1;CRLF1
prerank,GO_Biological_Process_2021__cellular response to oxidative stress (GO:0034599),0.49312082841450194,1.038998739770313,0.4166666666666667,0.9868943206035043,1.0,20/93,21.24%,ALDH3B1;MAPT;TMEM161A;PTPRK;ERMP1;DAPK1;HIF1A;CYCS;SOD2;PINK1;CPEB2;HSPA1B;GSTP1;PRKAA2;SOD1;ERO1A;STX2;FOS;LRRK2;VRK2
prerank,GO_Biological_Process_2021__negative regulation of lymphocyte proliferation (GO:0050672),0.5611003882506354,1.0387189323880162,0.4533333333333333,0.987283362002461,1.0,5/23,13.83%,CR1;GPNMB;FCGR2B;PDCD1LG2;CD300A
prerank,"GO_Biological_Process_2021__retrograde protein transport, ER to cytosol (GO:0030970)",0.557821642614046,1.0383273814488696,0.4782608695652174,0.9881409725139896,1.0,5/17,21.46%,SEC61B;HERPUD1;AUP1;SYVN1;HSP90B1
prerank,GO_Biological_Process_2021__detection of calcium ion (GO:0005513),0.6708782687779546,1.038325455070129,0.4714285714285714,0.987544968553319,1.0,4/9,12.47%,CALM3;RYR2;KCNMB1;SYT1
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial translation (GO:0070131),-0.5382516961840105,-1.038248744758873,0.4,1.0,1.0,4/10,14.28%,RPUSD3;UQCC2;FASTKD2;RPUSD4
prerank,GO_Biological_Process_2021__regulation of T cell cytokine production (GO:0002724),0.6026939836341548,1.0381513667403357,0.4657534246575342,0.9874991329260328,1.0,3/13,12.72%,TRAF2;CD55;TNFRSF1B
prerank,GO_Biological_Process_2021__filopodium assembly (GO:0046847),0.6141097615948775,1.0378626620687772,0.47058823529411764,0.9879099802242921,1.0,4/9,18.24%,DNM3;ARHGEF4;FGD6;FGD4
prerank,GO_Biological_Process_2021__phosphatidylinositol metabolic process (GO:0046488),-0.35384521872998614,-1.037715084386562,0.5,1.0,1.0,20/86,16.24%,INPP5K;PLA2G4C;PIK3R6;CSF1R;PIK3C2B;MTMR14;INPP5E;PIP4K2B;PLA2G12A;INPP5D;PLEK;OCRL;PI4KB;VAC14;PI4KA;MTMR10;RAB4A;PIK3R5;MTMR1;PLCB2
prerank,GO_Biological_Process_2021__positive regulation of T cell differentiation (GO:0045582),0.5389924712471054,1.0374717312481954,0.4642857142857143,0.9884762955899755,1.0,6/23,18.90%,CR1;SOX4;IL7;DUSP10;BCL6;RHOH
prerank,GO_Biological_Process_2021__mitotic spindle organization (GO:0007052),0.47693928270367575,1.0373899412069867,0.422680412371134,0.9881182320458161,1.0,25/107,20.55%,CENPF;CENPE;NUP133;RCC1;MAP9;XPO1;CENPP;SBDS;PLK2;RPS27;CLASP2;DYNC1H1;SPAST;CKAP5;CENPK;CENPI;INCENP;KIF11;TOGARAM1;SEH1L;GPSM2;SUN2;KNTC1;DYNC1I1;CENPT
prerank,GO_Biological_Process_2021__positive regulation of DNA methylation-dependent heterochromatin assembly (GO:0090309),-0.511874223771526,-1.0372211901797328,0.4,1.0,1.0,2/10,11.82%,SETDB1;TASOR
prerank,GO_Biological_Process_2021__long-chain fatty acid metabolic process (GO:0001676),0.5363338518948035,1.0365657224953266,0.4157303370786517,0.9901607412216025,1.0,12/36,19.55%,FAAH;ACSL1;FAAH2;ALOX12;ALOX15B;CPT1A;ACAD9;LTA4H;PNPLA8;GSTP1;HACL1;ACSL3
prerank,GO_Biological_Process_2021__histone H4-K16 acetylation (GO:0043984),0.5546265460089089,1.0364904189451145,0.42857142857142855,0.9898020901055113,1.0,2/19,7.60%,WDR5;HCFC1
prerank,GO_Biological_Process_2021__interstrand cross-link repair (GO:0036297),0.5398430364681308,1.0363726102182602,0.5,0.989651326308752,1.0,11/35,18.81%,RPA2;FANCB;FANCM;FANCI;RPS27A;XRCC3;FAN1;FANCL;FANCA;UBA52;UBB
prerank,GO_Biological_Process_2021__neuronal ion channel clustering (GO:0045161),0.6966620537994856,1.0362156245028589,0.4603174603174603,0.9895871313386516,1.0,4/7,21.28%,CNTNAP2;SPTBN4;CNTN2;MTCH1
prerank,GO_Biological_Process_2021__regulation of apoptotic signaling pathway (GO:2001233),0.5345696243039579,1.0361857891386048,0.48863636363636365,0.9890855897536978,1.0,3/29,9.06%,DAPK2;NR4A2;DEPTOR
prerank,GO_Biological_Process_2021__positive regulation of protein phosphorylation (GO:0001934),0.47338861454114517,1.036131673873083,0.37373737373737376,0.9886594326611037,1.0,31/226,12.29%,FGF1;ARAF;TGFB2;TOM1L1;CENPE;ENPP2;CLIP3;FAXDC2;IL15;RELN;TFRC;AGT;CHI3L1;ACVR2A;MTCP1;CEMIP;VEGFA;SPDYA;GPNMB;INSR;SLCO3A1;RAPGEF3;CALM3;TXN;GHR;NTRK3;PRKAG2;FAM20A;NTRK2;HCLS1;RIPK2
prerank,GO_Biological_Process_2021__synaptic vesicle fusion to presynaptic active zone membrane (GO:0031629),-0.5534603793926165,-1.036106569700794,0.45161290322580644,1.0,1.0,1/10,0.19%,SNAP47
prerank,GO_Biological_Process_2021__anterograde axonal transport (GO:0008089),0.5547600916829293,1.0359393389462506,0.44594594594594594,0.9887799100984638,1.0,15/27,27.05%,AP3B2;KIF1B;SPAST;NEFL;KIF5A;KIF3A;HSPB1;SOD1;RAB21;KIF5C;MAP1A;AP3B1;AP3S1;RAB27B;AP3M2
prerank,"GO_Biological_Process_2021__energy coupled proton transport, down electrochemical gradient (GO:0015985)",0.6191521993244482,1.0358827733830447,0.4567901234567901,0.9883372176894015,1.0,7/9,36.30%,ATP5F1A;ATP5F1D;ATP5MC1;ATP5PB;ATP5PD;VPS9D1;ATP5MC3
prerank,GO_Biological_Process_2021__long-chain fatty-acyl-CoA biosynthetic process (GO:0035338),0.6312874698126446,1.035878024539991,0.475,0.9877630017731974,1.0,3/11,19.55%,ACSL1;HSD17B12;ACSL3
prerank,GO_Biological_Process_2021__membrane raft distribution (GO:0031580),0.674861839132002,1.0358236297784702,0.5138888888888888,0.9873731019456446,1.0,1/5,2.10%,MAL
prerank,GO_Biological_Process_2021__regulation of cell population proliferation (GO:0042127),0.4681557740381979,1.0354344800148219,0.38,0.9879757832603572,1.0,82/400,18.65%,HTR2B;THBS1;KLF4;NAMPT;FGF1;ST18;PRLR;TSHR;TGFB2;CR1;TBRG4;RPL23;CCPG1;HMGB2;TBC1D8;IL15;TFRC;AGT;OSMR;NRG1;MEIS2;KITLG;LIFR;PTPRK;VEGFA;SPDYA;SOX4;IER5;GPNMB;ALOX15B;IL7;SHANK2;MVD;INSR;RBFOX2;CAMK2N1;FN1;ID2;RPS6;BOK;PTN;IRS2;IGF1R;NTRK3;ALK;DNAJB2;RPS6KA2;FLT1;NTRK2;HCLS1;IFNLR1;RNF126;MAGI2;CRLF1;RBM5;NR4A3;SOD2;CLMN;RNF139;E2F7;SDCBP;COPS9;THAP12;RPS4X;IL11RA;CTBP1;ITGAV;CHD5;RPS9;PRKRA;NEURL1;EGLN3;BCL6;HSPA1B;APP;RGCC;IGFBP7;FTH1;GTPBP4;FES;AQP11;EZH2
prerank,GO_Biological_Process_2021__depurination (GO:0045007),0.6768176639607127,1.035394172931333,0.5070422535211268,0.9875231812965835,1.0,1/6,7.13%,MPG
prerank,GO_Biological_Process_2021__steroid metabolic process (GO:0008202),0.5542172805041462,1.034703042969464,0.4457831325301205,0.9893164341178365,1.0,4/31,4.44%,LRP2;PRLR;CYP3A5;PIAS4
prerank,GO_Biological_Process_2021__response to X-ray (GO:0010165),0.6103543323553724,1.034611544742614,0.4666666666666667,0.9890009549319547,1.0,1/13,3.87%,ANXA1
prerank,GO_Biological_Process_2021__maintenance of synapse structure (GO:0099558),0.6663433611161469,1.034506974858971,0.5507246376811594,0.9886858556126422,1.0,3/6,18.00%,ERC2;CBLN2;DCTN1
prerank,GO_Biological_Process_2021__water-soluble vitamin metabolic process (GO:0006767),-0.43305864536452277,-1.034301216677094,0.4444444444444444,1.0,1.0,9/45,9.65%,CYB5A;FOLR2;SLC46A1;MMAA;MTHFD2L;MTHFD1L;HLCS;CYB5R3;ENPP1
prerank,GO_Biological_Process_2021__mitotic DNA damage checkpoint signaling (GO:0044773),0.5089604659638685,1.0339790894266994,0.45348837209302323,0.9899148578900397,1.0,7/45,12.87%,NEK11;DTL;CLSPN;RPA2;EME2;DONSON;BRCA1
prerank,GO_Biological_Process_2021__microtubule anchoring at microtubule organizing center (GO:0072393),0.6305044411595453,1.0337728250044589,0.4117647058823529,0.9900395700053858,1.0,4/9,21.37%,HOOK3;KIF3A;DCTN1;NIN
prerank,GO_Biological_Process_2021__regulation of cell migration (GO:0030334),0.4622800450327603,1.033453425532547,0.45454545454545453,0.9904553737670714,1.0,46/252,16.10%,THBS1;RHOB;FGF1;SEMA3A;ENPP2;ANXA1;FRMD5;CEMIP;TTBK2;ADAM15;PTPRK;VEGFA;HSPA5;GPNMB;SEMA3B;ALOX15B;LAMB1;INSR;SEMA6A;SRCIN1;PTPRT;KANK1;TMEFF2;ROBO1;IGF1R;FGR;CARMIL1;NTRK3;SEMA5A;CAMK2B;FLT1;SASH1;MAGI2;EPHA4;SOD2;LIMCH1;CTNNA2;SERPINE2;PLXNB1;SDCBP;DUSP10;THY1;MCTP1;PHACTR1;LDB2;CLIC4
prerank,GO_Biological_Process_2021__endomembrane system organization (GO:0010256),0.46259222969947855,1.0326330154818528,0.42857142857142855,0.9926798568650562,1.0,31/144,22.08%,CR1;SRGN;EIF2AK3;VAPB;ANK3;SYP;VPS11;ATP8B1;CAV3;DNM1;CLASP2;SNX10;GOLGA8B;SERP1;VMP1;HOOK3;REEP3;SPTBN5;TMED10;FAM174B;UBXN2B;SPTBN1;VPS51;SYNGR1;SUN2;SURF4;LRRK2;RAB30;DYNC2H1;BNIP1;HACE1
prerank,GO_Biological_Process_2021__motor neuron axon guidance (GO:0008045),0.6163609018028091,1.0324362572440084,0.4788732394366197,0.9926886094862966,1.0,3/9,12.45%,SEMA3A;CHN1;EPHA4
prerank,GO_Biological_Process_2021__regulation of interleukin-12 production (GO:0032655),0.5079087954089533,1.0324260846527102,0.4625,0.9921216171263556,1.0,1/30,0.28%,THBS1
prerank,GO_Biological_Process_2021__cellular metal ion homeostasis (GO:0006875),0.48395108984205343,1.0324195259207447,0.45054945054945056,0.9915610015372857,1.0,16/52,21.26%,HTR2B;SLC24A2;VAPB;ANK2;RYR2;SLC24A1;ATP2A2;SLC24A3;ATP1B3;KCNMA1;ATP1B2;ATP13A4;ATP1A2;SLC24A4;SLC9A1;RMDN3
prerank,GO_Biological_Process_2021__positive regulation of glycoprotein biosynthetic process (GO:0010560),0.6651123465638049,1.0321117677273985,0.410958904109589,0.9920714377281141,1.0,2/8,7.02%,ALG10B;ABCA2
prerank,GO_Biological_Process_2021__mitochondrial DNA metabolic process (GO:0032042),0.6640228177144649,1.0316912468965302,0.5074626865671642,0.9929340488958174,1.0,3/7,30.33%,DNA2;TOP3A;LIG3
prerank,GO_Biological_Process_2021__regulation of cell communication by electrical coupling involved in cardiac conduction (GO:1901844),0.6931740479787332,1.0316669805182228,0.4444444444444444,0.992402387083206,1.0,1/5,8.65%,CALM3
prerank,GO_Biological_Process_2021__phosphatidylinositol-mediated signaling (GO:0048015),0.5146702494750559,1.031416044707334,0.4666666666666667,0.9925931396835304,1.0,5/46,11.25%,HTR2B;NYAP2;IRS2;IGF1R;TYRO3
prerank,GO_Biological_Process_2021__establishment of protein localization to mitochondrion (GO:0072655),0.5335901067471962,1.0314044638456676,0.4166666666666667,0.9920566373232469,1.0,9/31,24.88%,TIMM13;TOMM20;PINK1;GRPEL1;HSPD1;FBXO7;MFN2;TOMM40;TIMM22
prerank,GO_Biological_Process_2021__COPII-coated vesicle cargo loading (GO:0090110),0.5819846805434622,1.0313835596452439,0.42028985507246375,0.9915491584696453,1.0,5/14,32.52%,SEC24C;MIA3;SEC31A;SEC23B;RAB1A
prerank,GO_Biological_Process_2021__negative regulation of cell-substrate adhesion (GO:0010812),0.5353481207807285,1.0312881032059682,0.47619047619047616,0.9912351715007405,1.0,4/28,7.71%,THBS1;SPOCK1;ADAM15;KANK1
prerank,GO_Biological_Process_2021__glycolipid biosynthetic process (GO:0009247),0.5277701215023247,1.0312199480900175,0.4074074074074074,0.990921559217956,1.0,12/27,29.60%,PIGU;PIGQ;PIGF;ST6GALNAC5;ST8SIA3;PIGL;PIGG;B4GALT6;PIGA;LARGE1;MPPE1;SCCPDH
prerank,GO_Biological_Process_2021__regulation of mitochondrion organization (GO:0010821),0.5354816795506024,1.0306883511471017,0.4606741573033708,0.9923082259765832,1.0,4/35,13.26%,MAPT;INF2;PDE2A;PINK1
prerank,GO_Biological_Process_2021__regulation of ion transmembrane transport (GO:0034765),0.5618743413460059,1.030584684689273,0.4430379746835443,0.9920792926011192,1.0,5/19,18.22%,KCNJ13;AKAP6;CHRM3;KCNJ6;KCNJ3
prerank,GO_Biological_Process_2021__positive regulation of protein tyrosine kinase activity (GO:0061098),0.5565422897425711,1.030579236125009,0.4782608695652174,0.9914884175012971,1.0,6/24,12.45%,RELN;AGT;SRCIN1;GPRC5B;NTRK2;EPHA4
prerank,GO_Biological_Process_2021__ceramide catabolic process (GO:0046514),0.6038627163355611,1.030545678989963,0.4927536231884058,0.990994401761463,1.0,1/10,2.27%,GLA
prerank,GO_Biological_Process_2021__ear morphogenesis (GO:0042471),0.6665881565126455,1.0297391115584456,0.5074626865671642,0.9931521683155421,1.0,2/6,20.85%,PAX8;FGFR2
prerank,GO_Biological_Process_2021__mitochondrial cytochrome c oxidase assembly (GO:0033617),0.6078734681833995,1.0296815348249904,0.4264705882352941,0.9927481429360839,1.0,3/13,24.78%,SCO2;SCO1;COX20
prerank,GO_Biological_Process_2021__mitral valve morphogenesis (GO:0003183),0.6627174744635886,1.029377550578626,0.4444444444444444,0.9932310431052594,1.0,1/7,5.16%,SOX4
prerank,GO_Biological_Process_2021__positive regulation of IRE1-mediated unfolded protein response (GO:1903896),-0.612991816692989,-1.0293768893144621,0.4864864864864865,1.0,1.0,1/5,3.78%,DAB2IP
prerank,GO_Biological_Process_2021__spliceosomal tri-snRNP complex assembly (GO:0000244),0.6061645683467396,1.0290874053458927,0.527027027027027,0.993566657053084,1.0,3/12,19.84%,SRSF12;SART3;PRPF6
prerank,GO_Biological_Process_2021__defense response to protozoan (GO:0042832),0.6464016767768471,1.028585311904494,0.515625,0.9945334907697595,1.0,2/8,16.45%,SLC11A1;GBP2
prerank,GO_Biological_Process_2021__vesicle transport along microtubule (GO:0047496),-0.45639919254610506,-1.0284345316123467,0.3333333333333333,1.0,1.0,4/20,7.71%,NDE1;KIF3B;KIF1C;TRAK2
prerank,GO_Biological_Process_2021__ketone body biosynthetic process (GO:0046951),0.6402287532430581,1.02787627606645,0.4666666666666667,0.9964291345296742,1.0,2/7,7.92%,ACSS3;ACAT1
prerank,GO_Biological_Process_2021__mammary gland epithelial cell differentiation (GO:0060644),-0.5571225746322161,-1.0278510495212365,0.38235294117647056,1.0,1.0,1/6,0.95%,ZNF703
prerank,GO_Biological_Process_2021__establishment of spindle localization (GO:0051293),0.661384336992572,1.027298570484507,0.45714285714285713,0.9977085599027187,1.0,3/7,15.33%,CLASP2;DYNC1H1;CFL1
prerank,GO_Biological_Process_2021__negative regulation of cellular amide metabolic process (GO:0034249),0.48016604139400637,1.0271199899184495,0.46153846153846156,0.9977085899352162,1.0,10/70,13.41%,EIF4A3;RIDA;ENC1;RTN1;EIF2AK3;DAPK1;PUS7;ZNF540;NTRK2;RNF139
prerank,GO_Biological_Process_2021__negative regulation of inflammatory response to antigenic stimulus (GO:0002862),0.514335119672543,1.0270592262934843,0.4631578947368421,0.9973766805144584,1.0,10/52,10.89%,TSHR;CD163;HTR7;PRKAR2B;ADCY3;FCGR2B;PLK2;FGR;ADCY8;RXFP1
prerank,GO_Biological_Process_2021__peptidyl-proline hydroxylation (GO:0019511),0.6760124079980637,1.0265415353307354,0.581081081081081,0.9985127049706819,1.0,2/8,9.86%,P4HA3;P4HA1
prerank,GO_Biological_Process_2021__regulation of macrophage apoptotic process (GO:2000109),0.6664622096052127,1.0264863505853883,0.4794520547945205,0.9980739432678661,1.0,1/6,10.87%,NOD2
prerank,GO_Biological_Process_2021__vasodilation (GO:0042311),0.6710427217894626,1.0261531826146706,0.5616438356164384,0.9985848238819018,1.0,3/5,18.25%,SOD2;KCNMA1;SOD1
prerank,GO_Biological_Process_2021__cellular response to radiation (GO:0071478),0.5516788286018943,1.0261230374120356,0.4235294117647059,0.9981072483107127,1.0,2/23,4.86%,RHOB;FIGNL1
prerank,GO_Biological_Process_2021__vasculogenesis (GO:0001570),-0.4997692833269216,-1.0260164123735884,0.43478260869565216,1.0,1.0,4/13,9.02%,TGFBR3;EGFL7;TGFB1;ENG
prerank,GO_Biological_Process_2021__positive regulation of protein import (GO:1904591),-0.469574012163559,-1.0259428236770434,0.4375,1.0,1.0,3/22,7.51%,FLNA;ZPR1;TGFB1
prerank,GO_Biological_Process_2021__acylglycerol biosynthetic process (GO:0046463),0.6256998973760179,1.0259069116854826,0.5454545454545454,0.9983258128331877,1.0,3/12,20.38%,DGAT1;GK;GPAT4
prerank,GO_Biological_Process_2021__positive regulation of synapse maturation (GO:0090129),0.6778090278438196,1.02587805287252,0.4626865671641791,0.9978209226995952,1.0,4/6,17.07%,RELN;NRXN1;CAMK2B;NEURL1
prerank,GO_Biological_Process_2021__positive regulation of actin filament depolymerization (GO:0030836),0.6390221564391202,1.0258402308779806,0.4657534246575342,0.9973558480518033,1.0,2/8,10.26%,CARMIL1;SEMA5A
prerank,GO_Biological_Process_2021__UV-damage excision repair (GO:0070914),-0.5120939435787308,-1.0256587553201046,0.4782608695652174,1.0,1.0,2/11,4.08%,POLD3;DDB2
prerank,GO_Biological_Process_2021__response to metal ion (GO:0010038),0.5179561228746304,1.0256006376688065,0.4222222222222222,0.9977816530357574,1.0,5/43,8.65%,THBS1;MAPT;NDRG1;HIF1A;CALM3
prerank,GO_Biological_Process_2021__regulation of phospholipase C activity (GO:1900274),0.6005903802003224,1.0255867993358587,0.5074626865671642,0.9972388015043722,1.0,3/10,15.56%,NTRK3;FLT1;ESR1
prerank,GO_Biological_Process_2021__negative regulation of immune response (GO:0050777),0.4911932558683837,1.025551279875428,0.42857142857142855,0.9967916696184506,1.0,12/77,11.25%,TSHR;CR1;CD163;HTR7;PRKAR2B;ADCY3;FCGR2B;PLK2;FGR;ADCY8;RXFP1;TYRO3
prerank,GO_Biological_Process_2021__response to leptin (GO:0044321),0.6661423086560208,1.0254921849041685,0.5,0.9963674225208486,1.0,1/7,0.62%,LRP2
prerank,GO_Biological_Process_2021__pyrimidine-containing compound metabolic process (GO:0072527),0.5811449324155095,1.0251442014741001,0.4583333333333333,0.9968877761116075,1.0,4/10,28.16%,SLC19A2;DCK;TPK1;TYMP
prerank,GO_Biological_Process_2021__response to calcium ion (GO:0051592),0.5049801304897441,1.025079491312658,0.5,0.9964974697908915,1.0,20/67,22.92%,THBS1;SYT4;NLGN1;CALM3;RYR2;KCNMB1;ADCY8;RYR3;SYT1;WNT5A;CLIC4;KCNMA1;IQGAP1;PRKAA2;ECT2;CPNE8;CPNE2;SYT11;CPNE3;TRPC1
prerank,GO_Biological_Process_2021__zinc ion transport (GO:0006829),-0.49131899678913743,-1.0249660824472198,0.4074074074074074,1.0,1.0,1/14,1.69%,SLC30A5
prerank,GO_Biological_Process_2021__calcium-ion regulated exocytosis (GO:0017156),0.5683677977134587,1.0247303361875044,0.4868421052631579,0.9970059762338893,1.0,7/16,26.10%,SYT4;RIMS2;SYT1;RIMS3;SYT11;RIMS1;SYT9
prerank,GO_Biological_Process_2021__electron transport chain (GO:0022900),0.5978706428178627,1.0245693077871882,0.4935064935064935,0.9968893104050002,1.0,3/13,25.32%,ETFB;UQCRFS1;PPARGC1A
prerank,GO_Biological_Process_2021__lipoxygenase pathway (GO:0019372),0.6108050474814644,1.024367440178158,0.5147058823529411,0.9970402996189961,1.0,2/8,5.56%,ALOX12;ALOX15B
prerank,GO_Biological_Process_2021__negative regulation of cell cycle phase transition (GO:1901988),0.6481965613251071,1.0238621333423845,0.5074626865671642,0.9980544662837406,1.0,4/6,32.96%,RGCC;PTEN;MACROH2A1;ATF5
prerank,GO_Biological_Process_2021__cellular macromolecule biosynthetic process (GO:0034645),0.4698475051694738,1.0237427367159213,0.44329896907216493,0.9979095574331598,1.0,64/233,24.35%,BRIP1;EEF1A2;RPL23;NR4A2;CLSPN;RPA2;RPL37A;RPS6KB2;RPL38;COPS5;PAX8;DNA2;RPS6;RPS27A;RPL23A;RPS25;DARS1;RPS27;DONSON;B4GALT5;RPS11;RPS20;RPL9;RPLP2;BRCA1;EEF1B2;RPS18;MRPL43;RPL37;RFC4;RPL14;POLE2;MRPL55;GCNT1;MRPL27;RPS4X;ORC6;RPL11;RPS24;POLR2D;RPS9;POLL;RPL36;DBF4;TIMELESS;MRPL3;RPS3A;MRPS14;RPL35;RPL4;RBBP8;POLR2G;RPL32;TNIP1;EEF1A1;BARD1;RPL24;RPL27A;RPL3;RPA3;ORC3;RPS16;RPL30;MCM3
prerank,GO_Biological_Process_2021__regulation of plasma membrane bounded cell projection organization (GO:0120035),0.516851898055302,1.0236484247296116,0.4444444444444444,0.997686929174148,1.0,8/23,24.09%,IL1RAPL1;FCGR2B;ZNF804A;CTNNA2;NTNG1;FBXO7;PTEN;BRSK1
prerank,GO_Biological_Process_2021__microtubule depolymerization (GO:0007019),0.6472563181234394,1.0232535491892183,0.4714285714285714,0.9984542861433756,1.0,3/8,13.71%,STMN3;CKAP5;STMN2
prerank,GO_Biological_Process_2021__negative regulation of leukocyte mediated cytotoxicity (GO:0001911),-0.5216980815976394,-1.022780253921195,0.34782608695652173,1.0,1.0,4/10,12.78%,CX3CR1;LGALS9;HLA-E;ARRB2
prerank,GO_Biological_Process_2021__dynamin family protein polymerization involved in membrane fission (GO:0003373),0.6925273019235847,1.0227124975859287,0.5303030303030303,0.9990032951307698,1.0,5/7,30.45%,DNM3;DNM1;OPA1;MX2;MX1
prerank,GO_Biological_Process_2021__dynamin family protein polymerization involved in mitochondrial fission (GO:0003374),0.6925273019235847,1.0227124975859287,0.5303030303030303,0.9990032951307698,1.0,5/7,30.45%,DNM3;DNM1;OPA1;MX2;MX1
prerank,GO_Biological_Process_2021__nucleotide catabolic process (GO:0009166),-0.5819366348036015,-1.0226561221936614,0.45161290322580644,1.0,1.0,3/10,13.42%,ITPA;NT5C;GPX1
prerank,GO_Biological_Process_2021__regulation of ventricular cardiac muscle cell action potential (GO:0098911),0.6561713252034211,1.02245349978415,0.4788732394366197,0.9992079372546404,1.0,2/9,9.36%,PKP2;RYR2
prerank,GO_Biological_Process_2021__positive regulation of insulin secretion (GO:0032024),0.5636747372122429,1.0224131032988828,0.45454545454545453,0.9987522156270181,1.0,5/23,16.90%,SOX4;MYRIP;IRS2;ADCY8;C2CD2L
prerank,GO_Biological_Process_2021__negative regulation of histone modification (GO:0031057),0.6218140787853147,1.022300445179831,0.4647887323943662,0.998507698940345,1.0,6/10,30.16%,BRCA1;CTBP1;TAF7;JARID2;MACROH2A1;SET
prerank,GO_Biological_Process_2021__positive regulation of actin nucleation (GO:0051127),-0.47489080581450555,-1.0221925129610654,0.3870967741935484,1.0,1.0,4/11,11.55%,WHAMM;WASF3;CYFIP1;GSN
prerank,GO_Biological_Process_2021__regulation of B cell apoptotic process (GO:0002902),0.6739668353489237,1.0217084892434618,0.5352112676056338,0.9997650237449603,1.0,3/6,17.56%,IRS2;BCL6;FOXP1
prerank,GO_Biological_Process_2021__T cell migration (GO:0072678),0.5974624220029657,1.021670966991579,0.4745762711864407,0.9992876239133874,1.0,4/9,33.30%,GPR183;MYO1G;CD99;SLC12A2
prerank,GO_Biological_Process_2021__glycerolipid biosynthetic process (GO:0045017),0.6543751522155987,1.0213397883195043,0.5074626865671642,0.9997460843476095,1.0,2/5,28.76%,CPNE3;AGK
prerank,GO_Biological_Process_2021__myoblast differentiation (GO:0045445),0.5976230484525951,1.0212500107917717,0.5256410256410257,0.9994462472343336,1.0,3/12,16.59%,NRG1;HINFP;EPAS1
prerank,GO_Biological_Process_2021__cell cycle G1/S phase transition (GO:0044843),0.49522449563374055,1.0212129593314776,0.43333333333333335,0.9990362008670542,1.0,5/44,12.03%,ACVR1B;SPDYA;RCC1;PLK2;HINFP
prerank,GO_Biological_Process_2021__leukocyte adhesion to vascular endothelial cell (GO:0061756),-0.512371022274124,-1.0207693314494743,0.35714285714285715,1.0,1.0,2/13,2.53%,CX3CR1;SELPLG
prerank,GO_Biological_Process_2021__glucose metabolic process (GO:0006006),0.518708946996757,1.020670377578268,0.45454545454545453,1.0,1.0,11/40,20.23%,MDH1;ENO2;PGAM1;IRS2;GPI;FBP1;SLC39A14;SORD;PGK1;PGM1;ENO1
prerank,GO_Biological_Process_2021__positive regulation of lipopolysaccharide-mediated signaling pathway (GO:0031666),-0.6357830177212083,-1.0205405290541631,0.5116279069767442,1.0,1.0,2/6,4.52%,LY86;SCIMP
prerank,GO_Biological_Process_2021__peptidyl-asparagine modification (GO:0018196),0.5522337979428206,1.0202501959147978,0.5125,1.0,1.0,5/23,14.24%,TUSC3;MGAT1;STT3B;MCFD2;MAGT1
prerank,GO_Biological_Process_2021__sarcomere organization (GO:0045214),0.6632178420737234,1.0201944851408178,0.5277777777777778,1.0,1.0,4/7,31.19%,CSRP1;FHOD3;TTN;ACTN2
prerank,GO_Biological_Process_2021__negative regulation of myotube differentiation (GO:0010832),-0.5563644951644453,-1.0201843887819784,0.42857142857142855,1.0,1.0,4/8,24.37%,TMEM119;BHLHE41;HDAC5;NOTCH1
prerank,GO_Biological_Process_2021__protein localization to perinuclear region of cytoplasm (GO:1905719),0.712405582344729,1.0200847521801084,0.45714285714285713,1.0,1.0,1/5,13.85%,HOOK3
prerank,GO_Biological_Process_2021__aspartate family amino acid catabolic process (GO:0009068),0.5736511016211441,1.0200155439454128,0.5,0.9999419564759827,1.0,1/13,1.94%,ASPA
prerank,GO_Biological_Process_2021__negative regulation of mast cell activation (GO:0033004),-0.6512349402725557,-1.019976190417377,0.46875,1.0,1.0,2/6,8.64%,CD300LF;MILR1
prerank,GO_Biological_Process_2021__regulation of macrophage chemotaxis (GO:0010758),0.5664360656474651,1.0199426575408364,0.45569620253164556,0.9996266965107566,1.0,1/12,0.28%,THBS1
prerank,GO_Biological_Process_2021__cellular response to catecholamine stimulus (GO:0071870),0.5775961872373541,1.0197597904730893,0.5,0.999581570673853,1.0,7/20,25.49%,RYR2;PDE4B;NR4A3;APLP1;LRRK2;SLC9A1;ATP2B4
prerank,GO_Biological_Process_2021__negative regulation of ubiquitin-dependent protein catabolic process (GO:2000059),0.5442523189684856,1.0196581716867565,0.524390243902439,0.9993164051658181,1.0,10/33,26.55%,RPL23;CAMLG;SDCBP;RPL11;NOP53;HFE;MAP1A;DDRGK1;HSP90AB1;BAG6
prerank,GO_Biological_Process_2021__carboxylic acid biosynthetic process (GO:0046394),0.7138599877693945,1.0194488822719145,0.5217391304347826,0.9993045058089933,1.0,1/6,3.25%,CARNS1
prerank,GO_Biological_Process_2021__protein N-linked glycosylation via asparagine (GO:0018279),0.5546351701714748,1.0186792907943272,0.5443037974683544,1.0,1.0,5/22,14.24%,TUSC3;MGAT1;STT3B;MCFD2;MAGT1
prerank,GO_Biological_Process_2021__regulation of T-helper 2 cell differentiation (GO:0045628),0.6733671278802752,1.0184729116694886,0.5483870967741935,1.0,1.0,2/5,15.83%,ANXA1;IL18
prerank,GO_Biological_Process_2021__nucleic acid transport (GO:0050657),-0.49449054393179215,-1.0182846514186012,0.3548387096774194,1.0,1.0,1/8,1.79%,SIDT1
prerank,GO_Biological_Process_2021__regulation of toll-like receptor 4 signaling pathway (GO:0034143),0.5632183649499887,1.0181853583426175,0.4788732394366197,1.0,1.0,1/16,0.81%,RAB7B
prerank,GO_Biological_Process_2021__positive regulation of nuclear cell cycle DNA replication (GO:0010571),0.6562340343857878,1.0181837341102882,0.5074626865671642,1.0,1.0,2/6,21.19%,DBF4;WIZ
prerank,GO_Biological_Process_2021__hematopoietic stem cell differentiation (GO:0060218),-0.5902894020174455,-1.0176647795889964,0.48717948717948717,1.0,1.0,1/5,6.50%,TP53
prerank,GO_Biological_Process_2021__regulation of feeding behavior (GO:0060259),0.6650817783301815,1.0174166771443038,0.5342465753424658,1.0,1.0,3/5,20.93%,SGIP1;NR4A3;LEPR
prerank,GO_Biological_Process_2021__regulation of chromosome separation (GO:1905818),-0.5646034537597435,-1.0173512016572621,0.42857142857142855,1.0,1.0,3/5,30.22%,CSNK2A2;NUMA1;TPR
prerank,GO_Biological_Process_2021__regulation of osteoblast differentiation (GO:0045667),0.4988302808937872,1.017345350600415,0.46808510638297873,1.0,1.0,7/50,9.23%,FBN2;ACVR2A;BMPR1B;RORB;NOCT;RANBP3L;LIMD1
prerank,GO_Biological_Process_2021__positive regulation of histone phosphorylation (GO:0033129),-0.615528420790109,-1.0170446955589583,0.4857142857142857,1.0,1.0,1/6,2.23%,IL1B
prerank,GO_Biological_Process_2021__regulation of T cell differentiation (GO:0045580),0.5592738367499637,1.0169349316480776,0.5238095238095238,1.0,1.0,7/20,18.90%,CR1;TCF7;IL7;PRELID1;FANCA;SOD1;RHOH
prerank,GO_Biological_Process_2021__response to nitric oxide (GO:0071731),0.6817799261400842,1.0167417176024138,0.5797101449275363,1.0,1.0,4/6,29.72%,TXN;GUCY1B1;KCNC2;FOXO1
prerank,GO_Biological_Process_2021__positive regulation of glucose import (GO:0046326),0.5639550983662965,1.0167214639861124,0.5119047619047619,1.0,1.0,5/16,21.87%,INSR;IRS2;SORBS1;CLTCL1;APPL1
prerank,GO_Biological_Process_2021__phospholipid biosynthetic process (GO:0008654),0.5415769909057807,1.0163314940317343,0.4878048780487805,1.0,1.0,2/24,6.40%,IDI1;MVD
prerank,GO_Biological_Process_2021__miRNA catabolic process (GO:0010587),0.7018074739579374,1.0162784672909408,0.5211267605633803,1.0,1.0,2/5,16.76%,TENT4B;SND1
prerank,GO_Biological_Process_2021__negative regulation of DNA repair (GO:0045738),0.6768551931652211,1.0158778902008432,0.5915492957746479,1.0,1.0,2/5,26.61%,RNF169;UBR5
prerank,GO_Biological_Process_2021__carboxylic acid metabolic process (GO:0019752),-0.4606263969663592,-1.0158424216249708,0.3888888888888889,1.0,1.0,4/18,9.03%,CYB5A;CYP2S1;ST6GAL1;CYB5R3
prerank,GO_Biological_Process_2021__bicarbonate transport (GO:0015701),0.6084092324282898,1.0156565935568735,0.5135135135135135,1.0,1.0,2/12,6.90%,SLC4A10;CA2
prerank,GO_Biological_Process_2021__medium-chain fatty acid metabolic process (GO:0051791),0.6894956380446616,1.0155948828444248,0.463768115942029,1.0,1.0,1/6,12.40%,ACAD9
prerank,GO_Biological_Process_2021__negative regulation of mitochondrion organization (GO:0010823),0.5490121457851975,1.0155911424940556,0.5125,1.0,1.0,6/20,14.32%,MAPT;TFRC;BNIP3;PINK1;PRELID1;TMEM14A
prerank,GO_Biological_Process_2021__positive regulation of leukocyte chemotaxis (GO:0002690),0.5172295892004136,1.0153661955892392,0.45977011494252873,1.0,1.0,3/26,8.95%,THBS1;VEGFA;PTN
prerank,GO_Biological_Process_2021__vitamin transport (GO:0051180),-0.5130388475665723,-1.0151049427705106,0.4634146341463415,1.0,1.0,4/10,4.38%,ABCG2;FOLR2;SLC46A1;SLC2A8
prerank,GO_Biological_Process_2021__regulation of cellular component organization (GO:0051128),0.47067160215839,1.0149597041187022,0.4421052631578947,1.0,1.0,25/103,22.05%,PAPPA2;GFAP;SPOCK1;CD22;TFRC;AGT;ATAD3A;TRAF2;HCFC1;ERMN;ARFGAP1;NRG3;PAK5;PINK1;PICALM;WNT5A;SNX17;ROCK1;CHPT1;HIP1R;TNF;METTL4;IRAK3;HNRNPU;RAB5A
prerank,GO_Biological_Process_2021__positive regulation of calcium ion transmembrane transport (GO:1904427),0.630918781640704,1.0149153475724086,0.463768115942029,1.0,1.0,4/11,6.56%,CACNB2;CEMIP;ANK2;AKAP6
prerank,GO_Biological_Process_2021__eye photoreceptor cell development (GO:0042462),0.6126583072189198,1.0149087449075638,0.47619047619047616,1.0,1.0,3/9,15.39%,RORB;VEGFA;THY1
prerank,GO_Biological_Process_2021__positive regulation of neural precursor cell proliferation (GO:2000179),0.5789942095652694,1.014696297569744,0.475,1.0,1.0,3/13,9.50%,LRP2;VEGFA;KDM1A
prerank,GO_Biological_Process_2021__response to organophosphorus (GO:0046683),0.6248472286244404,1.0143325520418998,0.5569620253164557,1.0,1.0,2/10,13.64%,VGF;TRIM16
prerank,GO_Biological_Process_2021__cell differentiation in hindbrain (GO:0021533),0.6501292329397319,1.0143058308481063,0.5342465753424658,1.0,1.0,3/7,12.37%,AGTPBP1;FAIM2;GRID2
prerank,GO_Biological_Process_2021__positive regulation of autophagy of mitochondrion in response to mitochondrial depolarization (GO:1904925),0.6682115686034039,1.014070889224962,0.5194805194805194,1.0,1.0,2/6,21.55%,PINK1;ATP5IF1
prerank,GO_Biological_Process_2021__positive regulation of DNA biosynthetic process (GO:2000573),0.5093640731821487,1.0137387480380657,0.47191011235955055,1.0,1.0,6/45,19.15%,KLF4;POLG2;RFC4;TCP1;RGCC;PARM1
prerank,GO_Biological_Process_2021__embryonic cranial skeleton morphogenesis (GO:0048701),0.6453436451338254,1.013652835093085,0.5135135135135135,1.0,1.0,1/7,2.61%,EIF4A3
prerank,GO_Biological_Process_2021__mitotic sister chromatid segregation (GO:0000070),0.5086984393586271,1.013636891441754,0.5161290322580645,1.0,1.0,5/64,6.47%,KNSTRN;CENPE;TEX14;SMC4;NCAPH2
prerank,GO_Biological_Process_2021__neurotransmitter receptor transport to postsynaptic membrane (GO:0098969),0.6569676210260907,1.013392019383733,0.5285714285714286,1.0,1.0,4/7,29.78%,GRIPAP1;RAB11A;GRIP1;ARHGAP44
prerank,GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),0.4886463819686297,1.01331141729069,0.43956043956043955,1.0,1.0,14/73,20.29%,CENPE;RACGAP1;KIF15;FCGR2B;ACTR1B;SEC24C;DYNC1H1;SH3GL2;KIF11;KIF5A;KIF3A;DCTN1;AP2A2;DYNC1I1
prerank,GO_Biological_Process_2021__branching involved in blood vessel morphogenesis (GO:0001569),0.6693928650366363,1.0132542001079947,0.5625,1.0,1.0,1/5,5.04%,VEGFA
prerank,GO_Biological_Process_2021__negative regulation of epidermal growth factor-activated receptor activity (GO:0007175),0.6542814248283417,1.0132497766667607,0.5344827586206896,1.0,1.0,1/8,10.28%,ERRFI1
prerank,GO_Biological_Process_2021__positive regulation of calcium ion transmembrane transporter activity (GO:1901021),0.606081517979264,1.0130644585370387,0.47368421052631576,1.0,1.0,5/13,13.52%,ANK2;AKAP6;CALM3;RYR2;VMP1
prerank,GO_Biological_Process_2021__positive regulation of leukocyte degranulation (GO:0043302),-0.4947995259456511,-1.0129188845030181,0.4,1.0,1.0,3/10,13.23%,ITGAM;ITGB2;SYK
prerank,GO_Biological_Process_2021__respiratory chain complex IV assembly (GO:0008535),0.5807558236136424,1.012825416146272,0.4492753623188406,1.0,1.0,4/15,28.45%,SCO2;SCO1;COX20;COA6
prerank,GO_Biological_Process_2021__valine metabolic process (GO:0006573),0.6692361113128077,1.0127686977937773,0.578125,1.0,1.0,1/5,11.64%,ALDH6A1
prerank,GO_Biological_Process_2021__hematopoietic stem cell proliferation (GO:0071425),0.6692794607382309,1.0126056451558232,0.5362318840579711,1.0,1.0,2/7,15.06%,ARIH2;WNT5A
prerank,GO_Biological_Process_2021__regulation of phospholipase activity (GO:0010517),0.6205363151665364,1.0123029655120277,0.49230769230769234,1.0,1.0,2/8,20.85%,RGS2;FGFR2
prerank,GO_Biological_Process_2021__protein targeting to mitochondrion (GO:0006626),0.49827854787334647,1.012107926900516,0.5,1.0,1.0,12/36,31.18%,TIMM13;TOMM20;PMPCA;GRPEL1;HSPD1;FBXO7;MFN2;TOMM40;TIMM22;AGK;IMMP2L;PMPCB
prerank,GO_Biological_Process_2021__purine nucleoside monophosphate biosynthetic process (GO:0009127),0.6026779420791103,1.012084873062217,0.4857142857142857,1.0,1.0,5/10,33.92%,PAICS;PFAS;IMPDH1;PPAT;GART
prerank,GO_Biological_Process_2021__positive regulation of double-strand break repair (GO:2000781),0.5390702028289655,1.0115942270352223,0.4943820224719101,1.0,1.0,14/31,30.58%,SLF1;FANCB;SPIRE2;FMN2;ZCWPW1;ERCC6;TIMELESS;KMT5C;SPIDR;ARID2;PARP9;WDR48;RIF1;PRKDC
prerank,GO_Biological_Process_2021__regulation of synaptic vesicle exocytosis (GO:2000300),0.5635049181890139,1.0114750157658945,0.5217391304347826,1.0,1.0,7/15,25.30%,NLGN1;RIMS2;RIMS3;PREPL;LRRK2;RAB5A;RIMS1
prerank,GO_Biological_Process_2021__endoplasmic reticulum mannose trimming (GO:1904380),0.5796101724347025,1.011351092065573,0.46987951807228917,1.0,1.0,5/17,18.81%,RPS27A;RNF139;SYVN1;UBA52;UBB
prerank,GO_Biological_Process_2021__regulation of histone H3-K9 acetylation (GO:2000615),0.5943638962517253,1.0113082044820834,0.47761194029850745,1.0,1.0,2/10,12.87%,RAPGEF3;BRCA1
prerank,GO_Biological_Process_2021__regulation of protein kinase activity (GO:0045859),0.4798107350756488,1.0110060262746665,0.5054945054945055,1.0,1.0,20/84,20.20%,CENPE;RELN;SPDYA;CAMK2N1;CAV3;GSKIP;DEPTOR;FGR;C5AR1;PRKAG2;PPM1E;THY1;IQGAP1;HSPB1;GSTP1;SOD1;GNAQ;TAF7;ECT2;TNF
prerank,GO_Biological_Process_2021__proton transmembrane transport (GO:1902600),-0.42681908721666995,-1.0107910727348315,0.4375,1.0,1.0,3/18,11.59%,SLC46A1;UCP2;HVCN1
prerank,GO_Biological_Process_2021__DNA biosynthetic process (GO:0071897),-0.5193509572762988,-1.0102418607132124,0.45161290322580644,1.0,1.0,2/11,11.72%,POLD3;TYMS
prerank,GO_Biological_Process_2021__regulation of extrinsic apoptotic signaling pathway (GO:2001236),0.49341955567792783,1.0098246212340278,0.47191011235955055,1.0,1.0,4/48,9.06%,THBS1;AGT;TRAF2;DEPTOR
prerank,GO_Biological_Process_2021__negative regulation of transmembrane transport (GO:0034763),0.6262242922200166,1.0094681895970237,0.5128205128205128,1.0,1.0,1/8,0.28%,THBS1
prerank,GO_Biological_Process_2021__regulation of endothelial cell development (GO:1901550),-0.5001570302575549,-1.0093157681750593,0.4117647058823529,1.0,1.0,3/9,10.46%,IL1B;ZDHHC21;IKBKB
prerank,GO_Biological_Process_2021__negative regulation of keratinocyte proliferation (GO:0010839),0.6698285229548258,1.00928642681536,0.5396825396825397,1.0,1.0,3/5,20.85%,PTPRK;KLF9;FGFR2
prerank,GO_Biological_Process_2021__endosome organization (GO:0007032),-0.41726087261024936,-1.0090994094336094,0.21428571428571427,1.0,1.0,6/28,9.99%,RAB22A;PLEKHJ1;LAPTM4B;LAMTOR1;WASHC5;CHMP2B
prerank,GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process (GO:0000956),0.45496256086685816,1.0088810618621638,0.5102040816326531,1.0,1.0,47/153,26.89%,RPL23;EIF4A3;RPL37A;RPL38;RPS6;RPS27A;RPL23A;RPS25;RPS27;TENT4B;RPS11;RPS20;EIF3E;RPL9;UPF3A;RPLP2;RPS18;RPL37;RPL14;RPS4X;RPL11;RPS24;POLR2D;RPS9;RPL36;PYM1;UBA52;SAMD4A;RPS3A;RPL35;RPL4;POLR2G;RPL32;MRTO4;RPL24;RPL27A;CNOT6;RPL3;RPS16;RPL30;PAN2;RPL21;RPL7;RPL12;RPL10A;RPS12;CNOT7
prerank,GO_Biological_Process_2021__regulation of interleukin-17 production (GO:0032660),0.5424545532588225,1.0088505860205534,0.52,1.0,1.0,3/16,15.83%,IL15;NOD2;IL18
prerank,GO_Biological_Process_2021__regulation of microglial cell activation (GO:1903978),-0.4979501156765487,-1.0087874148972038,0.45161290322580644,1.0,1.0,2/10,10.32%,CST7;TREM2
prerank,GO_Biological_Process_2021__regulation of response to stress (GO:0080134),0.6474325707355325,1.0087691542685755,0.5,1.0,1.0,5/8,30.47%,ADCY8;CORO2B;MACROH2A1;CRHBP;EIF4G1
prerank,PanglaoDB_Augmented_2021__Myeloid-derived Suppressor Cells,-0.33474929829862105,-1.008682156862822,0.2727272727272727,1.0,1.0,19/73,13.61%,CD300LF;ITGAM;LY86;PTAFR;BIN2;MPEG1;ICAM1;ITGAX;AOAH;MYO1F;IGSF6;PLEK;HCK;ITGB2;CYTH4;LCP2;TYROBP;CD53;SNX20
prerank,GO_Biological_Process_2021__antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),0.4855385989047832,1.0085017142644102,0.46153846153846156,1.0,1.0,14/75,20.29%,CENPE;RACGAP1;KIF15;FCGR2B;ACTR1B;SEC24C;DYNC1H1;SH3GL2;KIF11;KIF5A;KIF3A;DCTN1;AP2A2;DYNC1I1
prerank,MSigDB_Hallmark_2020__Unfolded Protein Response,0.4618432024606031,1.0084405001461887,0.4838709677419355,1.0,1.0,22/93,22.81%,DDIT4;EIF4A3;VEGFA;HSPA5;EIF2AK3;IMP3;HERPUD1;ARFGAP1;NHP2;SERP1;DNAJB9;TUBB2A;HYOU1;BAG3;CXXC1;DCTN1;ERO1A;SRPRA;ATF3;HSP90B1;SPCS3;CNOT6
prerank,GO_Biological_Process_2021__synaptic vesicle localization (GO:0097479),0.5874333916607123,1.0084014412367304,0.5405405405405406,1.0,1.0,4/11,21.23%,NLGN1;KIF5A;SPG11;KIF5C
prerank,GO_Biological_Process_2021__monocarboxylic acid metabolic process (GO:0032787),0.480174915632917,1.0082139027466779,0.4948453608247423,1.0,1.0,20/80,23.02%,FA2H;CYP3A5;CKMT2;ALOX12;CKB;CPT1A;FASN;PNPLA8;SLC16A3;SLC16A1;HACL1;PPARA;MSMO1;SCPEP1;ACSL3;SLC5A6;PDHB;BTD;ALDH1A2;ECHDC3
prerank,GO_Biological_Process_2021__mitral valve development (GO:0003174),0.682625464192177,1.0081837082629883,0.576271186440678,1.0,1.0,1/5,5.16%,SOX4
prerank,GO_Biological_Process_2021__regulation of protein binding (GO:0043393),-0.3169303287019351,-1.0081462448914604,0.6,1.0,1.0,7/88,6.66%,RALB;GTF2F1;IDE;ACTB;BTBD1;NVL;TRIB3
prerank,GO_Biological_Process_2021__regulation of peptidyl-cysteine S-nitrosylation (GO:2000169),0.6550933916033642,1.007629460612825,0.5245901639344263,1.0,1.0,2/5,8.84%,DMD;TXN
prerank,GO_Biological_Process_2021__regulation of protein neddylation (GO:2000434),0.6266017137175101,1.0075001393630714,0.5211267605633803,1.0,1.0,4/9,16.59%,HIF1A;COPS9;RPL11;EPAS1
prerank,GO_Biological_Process_2021__phospholipid translocation (GO:0045332),0.5327847045733739,1.0069696574651672,0.45348837209302323,1.0,1.0,9/24,28.64%,ATP8B1;ABCA1;MFSD2A;ATP10B;ABCB4;ATP10A;ATP8A2;ATP9A;ATP11A
prerank,GO_Biological_Process_2021__in utero embryonic development (GO:0001701),0.5823593047704287,1.006875676975216,0.4794520547945205,1.0,1.0,4/14,13.96%,VEGFA;ARNT2;HINFP;PKD1
prerank,GO_Biological_Process_2021__regulation of monocyte differentiation (GO:0045655),0.6065803020336157,1.0068171283441159,0.5571428571428572,1.0,1.0,3/10,22.07%,FOXP1;FES;CTNNBIP1
prerank,GO_Biological_Process_2021__intracellular distribution of mitochondria (GO:0048312),0.689484802888588,1.0066935843821205,0.5538461538461539,1.0,1.0,1/5,2.79%,MAPT
prerank,GO_Biological_Process_2021__determination of left/right symmetry (GO:0007368),0.5620532015456322,1.0063581556725731,0.49382716049382713,1.0,1.0,4/18,15.43%,DNAH11;MMP21;CCDC39;ENKUR
prerank,GO_Biological_Process_2021__positive regulation of macrophage chemotaxis (GO:0010759),0.6291204365901414,1.0062487844750079,0.5405405405405406,1.0,1.0,1/8,0.28%,THBS1
prerank,GO_Biological_Process_2021__dermatan sulfate metabolic process (GO:0030205),0.6468213968545736,1.0058703449895714,0.5,1.0,1.0,3/8,9.58%,NCAN;VCAN;CSPG5
prerank,GO_Biological_Process_2021__regulation of stress-activated protein kinase signaling cascade (GO:0070302),0.5839770240732465,1.0058513202039747,0.5405405405405406,1.0,1.0,2/9,17.54%,RNF13;GSTP1
prerank,GO_Biological_Process_2021__macromolecule modification (GO:0043412),-0.5309980468038695,-1.005836232995358,0.4857142857142857,1.0,1.0,1/7,8.84%,ST6GAL1
prerank,GO_Biological_Process_2021__regulation of protein targeting (GO:1903533),0.6854884522381202,1.0058163523760721,0.5526315789473685,1.0,1.0,2/5,21.55%,PINK1;ATP5IF1
prerank,GO_Biological_Process_2021__regulation of cell cycle process (GO:0010564),0.488314641566478,1.005738605238116,0.47191011235955055,1.0,1.0,14/64,19.88%,KNSTRN;NUDT16;RACGAP1;IHO1;RCC1;MAP9;CALM3;PLK2;DYNC1H1;KIF11;SND1;PIK3R4;DBF4;ECT2
prerank,GO_Biological_Process_2021__regulation of fat cell proliferation (GO:0070344),-0.6584688687544132,-1.0054680949134482,0.5666666666666667,1.0,1.0,1/5,10.32%,TREM2
prerank,GO_Biological_Process_2021__nucleoside diphosphate metabolic process (GO:0009132),0.6317825425609447,1.005339814977333,0.47297297297297297,1.0,1.0,3/8,20.19%,ENTPD3;CMPK1;AK5
prerank,GO_Biological_Process_2021__ribosome biogenesis (GO:0042254),0.4466789230996092,1.0053134423539802,0.49,1.0,1.0,45/162,25.39%,RPL23;RIOK2;WDR12;WDR74;RPL37A;PES1;IMP3;RPL38;XPO1;SBDS;RPS6;RRP1B;RPL23A;GLUL;RPS25;RPS27;RRP36;HEATR3;RPL9;RPLP2;RPL37;RPL14;MPHOSPH6;RPL11;RPS24;RPS9;NOB1;RPL36;UBA52;NOP53;RPL35;RPL4;RPL32;MRTO4;MPHOSPH10;RPL24;RPL27A;RPL3;RPS16;RPL30;WDR3;PAK1IP1;RPL21;RPL7;RPL12
prerank,GO_Biological_Process_2021__polyol biosynthetic process (GO:0046173),0.5768457807749379,1.0052314744087172,0.5064935064935064,1.0,1.0,1/13,3.76%,ITPKC
prerank,GO_Biological_Process_2021__regulation of anion channel activity (GO:0010359),0.6395877742860033,1.0047525378091964,0.5238095238095238,1.0,1.0,3/5,31.33%,GRM5;PRNP;GOPC
prerank,GO_Biological_Process_2021__negative regulation of epithelial cell differentiation (GO:0030857),0.6762692063114404,1.0046213693575545,0.5846153846153846,1.0,1.0,1/5,8.27%,SPRY1
prerank,GO_Biological_Process_2021__response to interleukin-6 (GO:0070741),0.6398289353088975,1.004539714664424,0.5217391304347826,1.0,1.0,2/8,7.69%,CHI3L1;PTPRT
prerank,GO_Biological_Process_2021__chaperone cofactor-dependent protein refolding (GO:0051085),0.5620560687529516,1.0042794385048106,0.44594594594594594,1.0,1.0,10/20,27.66%,HSPA5;SDF2L1;DNAJC7;HSPA1B;ERO1A;HSPA2;HSPA14;HSPA9;HSPA13;HSPA8
prerank,GO_Biological_Process_2021__regulation of heart contraction (GO:0008016),0.49003901731208,1.0041837642653908,0.4888888888888889,1.0,1.0,12/44,16.26%,TGFB2;AGT;ANK2;CAV3;CALM3;RYR2;CELF2;FXYD7;RYR3;ASPH;ATP2A2;ATP1B3
prerank,GO_Biological_Process_2021__regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510),0.6871833839918946,1.0040394623755622,0.49295774647887325,1.0,1.0,5/5,31.31%,PDK4;PDK3;PDPR;PDP1;PDK1
prerank,GO_Biological_Process_2021__regulation of acyl-CoA biosynthetic process (GO:0050812),0.6871833839918946,1.0040394623755622,0.49295774647887325,1.0,1.0,5/5,31.31%,PDK4;PDK3;PDPR;PDP1;PDK1
prerank,GO_Biological_Process_2021__protein localization to cell surface (GO:0034394),0.5623391453556729,1.0039844196993986,0.5,1.0,1.0,5/19,6.41%,PIGU;ARF6;PTPRK;PRRT1;ANK2
prerank,GO_Biological_Process_2021__negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),0.4875604190425136,1.003954388733403,0.5280898876404494,1.0,1.0,15/68,19.68%,ASPN;LRP2;ACVR2A;BMPR1B;VASN;SPRY1;RPS27A;MAGI2;PEG10;VWC2;SMAD1;UBA52;UBB;PPARA;SMAD5
prerank,GO_Biological_Process_2021__somatic hypermutation of immunoglobulin genes (GO:0016446),0.6410416464544743,1.0038015159242932,0.5714285714285714,1.0,1.0,3/7,19.35%,POLQ;POLL;MLH1
prerank,GO_Biological_Process_2021__keratinocyte differentiation (GO:0030216),0.5633546845862423,1.0036591331321847,0.5714285714285714,1.0,1.0,7/16,16.10%,ANXA1;ST14;TXNIP;WNT5A;CASP3;UGCG;CLIC4
prerank,GO_Biological_Process_2021__organic hydroxy compound biosynthetic process (GO:1901617),0.5429706263132487,1.0036395678259542,0.5308641975308642,1.0,1.0,6/31,13.53%,TM7SF2;FAXDC2;ALOX12;ALOX15B;PRKAG2;INSIG1
prerank,GO_Biological_Process_2021__regulation of hematopoietic progenitor cell differentiation (GO:1901532),-0.3728655738936488,-1.0034914701296531,0.3076923076923077,1.0,1.0,9/59,8.38%,TCF3;TAL1;PSMB3;PSME3;LMO1;PSMC4;PSMD12;CBFB;PSME4
prerank,GO_Biological_Process_2021__regulation of actin cytoskeleton organization (GO:0032956),0.4819669598909782,1.0032053786993047,0.47368421052631576,1.0,1.0,6/62,8.60%,RHOBTB3;RHOB;GPM6B;EPHA3;RND3;RAPGEF3
prerank,GO_Biological_Process_2021__aortic valve morphogenesis (GO:0003180),0.5796487543057703,1.0030185384077943,0.5135135135135135,1.0,1.0,3/12,17.16%,ROBO2;ROBO1;ROCK1
prerank,GO_Biological_Process_2021__negative regulation of cell death (GO:0060548),0.46930848165806716,1.0029187607469539,0.47126436781609193,1.0,1.0,14/60,20.94%,HTR2B;SOX4;GPNMB;TRAF2;BNIP3L;IMPACT;TNFRSF1B;BNIP3;PINK1;DUS2;HSPA1B;NPAS2;LRRK2;ATG5
prerank,MSigDB_Hallmark_2020__Angiogenesis,0.5435386153766821,1.0029028549500387,0.5,1.0,1.0,6/19,19.50%,VCAN;VEGFA;THBD;ITGAV;APP;TNFRSF21
prerank,GO_Biological_Process_2021__negative regulation of mitotic cell cycle phase transition (GO:1901991),0.4776582276650597,1.0025094249975193,0.5,1.0,1.0,17/68,24.06%,KLF4;FBXL7;GPNMB;FHL1;PSMB4;RBX1;E2F7;RGCC;PSMC2;PSMA3;PSMB2;RBL2;PSMD5;PSMD7;PTEN;PSMD14;PSMA5
prerank,GO_Biological_Process_2021__cadmium ion transmembrane transport (GO:0070574),0.6781916593847752,1.0023753716174042,0.5507246376811594,1.0,1.0,3/5,25.52%,SLC11A1;SLC39A14;SLC11A2
prerank,GO_Biological_Process_2021__cadmium ion transport (GO:0015691),0.6781916593847752,1.0023753716174042,0.5507246376811594,1.0,1.0,3/5,25.52%,SLC11A1;SLC39A14;SLC11A2
prerank,GO_Biological_Process_2021__marginal zone B cell differentiation (GO:0002315),0.6834666411188323,1.0023417766073757,0.5084745762711864,1.0,1.0,1/5,3.54%,MFNG
prerank,GO_Biological_Process_2021__establishment or maintenance of apical/basal cell polarity (GO:0035088),0.6166390984004476,1.0018432854572066,0.5063291139240507,1.0,1.0,5/14,16.54%,MTCL1;PARD3;LRRC7;CLIC4;CRB1
prerank,GO_Biological_Process_2021__negative regulation of cellular response to insulin stimulus (GO:1900077),-0.4543661432972851,-1.001637896447323,0.4444444444444444,1.0,1.0,7/21,14.81%,INPP5K;IL1B;APPL2;PIP4K2B;ENPP1;NCK1;PTPRE
prerank,GO_Biological_Process_2021__negative regulation of biosynthetic process (GO:0009890),0.5991631193185174,1.0015080846370836,0.5131578947368421,1.0,1.0,4/9,23.47%,ASXL3;GSTP1;PPARA;TRAP1
prerank,GO_Biological_Process_2021__receptor-mediated endocytosis (GO:0006898),0.4652573495134615,1.0014138434136282,0.5306122448979592,1.0,1.0,26/101,22.12%,LRP2;SPARC;CD163;TFRC;FCGR2B;INSR;DNAJC6;NLGN3;FCHO2;DNM3;WASF1;DNM1;SGIP1;TMEM108;LRP1B;PICALM;HYOU1;GRK4;AP2A2;SNAP91;COLEC12;HIP1R;CLTCL1;HSP90B1;MSR1;CTTN
prerank,GO_Biological_Process_2021__Arp2/3 complex-mediated actin nucleation (GO:0034314),-0.5168124980838058,-1.0013952719833206,0.5,1.0,1.0,6/11,23.53%,WHAMM;ARPC2;ARPC3;ACTR3;ACTR2;ARPC5L
prerank,GO_Biological_Process_2021__mitochondrion organization (GO:0007005),0.4805588102980062,1.0013346422427387,0.4897959183673469,1.0,1.0,37/134,26.22%,ATAD3A;MTERF1;HIGD1C;AGTPBP1;HCFC1;TIMM13;BNIP3L;SIRT5;DNM3;COX7A2;WASF1;DNM1;GABPB1;CYCS;TOMM20;POLG2;SLIRP;IFIT2;BNIP3;PINK1;ATP5F1D;TFAM;SLC25A4;CHCHD3;HSPD1;SIRT3;POLRMT;FBXO7;LRRK2;MFN2;TOMM40;CLUH;SIRT4;TIMM22;PPARGC1A;MTM1;OPA1
prerank,GO_Biological_Process_2021__positive regulation of ubiquitin-protein transferase activity (GO:0051443),0.5487355073450642,1.0011586123722924,0.5443037974683544,1.0,1.0,3/22,13.26%,ARRDC3;BMI1;PINK1
prerank,GO_Biological_Process_2021__peripheral nervous system axon ensheathment (GO:0032292),0.6419049897873031,1.0008905860044364,0.56,1.0,1.0,3/7,20.25%,ADGRG6;PARD3;CNTNAP1
prerank,GO_Biological_Process_2021__Schwann cell development (GO:0014044),0.6419049897873031,1.0008905860044364,0.56,1.0,1.0,3/7,20.25%,ADGRG6;PARD3;CNTNAP1
prerank,GO_Biological_Process_2021__microtubule anchoring (GO:0034453),0.5938698238021378,1.0008377000266218,0.47619047619047616,1.0,1.0,1/9,11.49%,CLASP2
prerank,GO_Biological_Process_2021__peptidyl-proline modification (GO:0018208),0.5519310160517179,1.0008337997063514,0.5194805194805194,1.0,1.0,2/19,11.73%,FKBP5;PPID
prerank,GO_Biological_Process_2021__leukocyte tethering or rolling (GO:0050901),-0.5262621715911397,-1.000793804159053,0.39285714285714285,1.0,1.0,2/12,2.53%,CX3CR1;SELPLG
prerank,PanglaoDB_Augmented_2021__Epithelial Cells,0.5242648277121589,1.0005691923162174,0.48863636363636365,1.0,1.0,13/39,14.54%,FZD6;EMILIN2;ITGA2;ANLN;KIF15;OVOL2;BAIAP2L1;BMI1;BOK;ST14;FMO5;BRCA1;INCENP
prerank,GO_Biological_Process_2021__protein desumoylation (GO:0016926),-0.5520165777681153,-1.0005480002894513,0.5454545454545454,1.0,1.0,3/6,18.21%,SENP6;SENP1;SENP5
prerank,GO_Biological_Process_2021__ketone body metabolic process (GO:1902224),0.6143447580035388,1.0005239508358559,0.5125,1.0,1.0,2/8,7.92%,ACSS3;ACAT1
prerank,PanglaoDB_Augmented_2021__Clara Cells,0.6617089455498079,1.0004568152046271,0.5616438356164384,1.0,1.0,4/8,26.65%,ST14;ALDH1A1;LEPR;DUOX1
prerank,GO_Biological_Process_2021__positive regulation of protein serine/threonine kinase activity (GO:0071902),0.48895912453402335,1.000424681049956,0.5054945054945055,1.0,1.0,15/74,16.08%,HTR2B;FGF1;MTCP1;CEMIP;DIRAS2;VEGFA;SPDYA;ROBO1;CALM3;NOD2;FLT1;PKD1;INCENP;WNT5A;CCND3
prerank,GO_Biological_Process_2021__regulation of oxidative phosphorylation (GO:0002082),-0.5013562286742703,-1.0003688883382718,0.4,1.0,1.0,2/9,4.36%,PDE12;UQCC2
prerank,GO_Biological_Process_2021__nuclear pore organization (GO:0006999),0.6179672535244831,1.0003347439512182,0.5223880597014925,1.0,1.0,7/13,34.79%,NUP133;SEH1L;RTN4;NDC1;AHCTF1;NUP153;NUP205
prerank,GO_Biological_Process_2021__protein localization to membrane (GO:0072657),0.4630362661520135,1.00016488707612,0.4897959183673469,1.0,1.0,35/148,20.20%,SHANK3;SH3PXD2B;CACNB2;SCN3B;ZDHHC15;SYNE3;NRXN1;RAB3C;NRXN2;ANK3;ANK2;PKP2;FCHO2;NLGN1;RAB15;SAV1;CAV3;PTN;CLASP2;MAGI2;LRRC7;MAP7;CPE;THY1;ATP1B3;KCNIP4;SPTBN1;ROCK1;DPP6;KCNB2;TNFRSF1A;SPTBN4;DLG4;CYP46A1;TNF
prerank,GO_Biological_Process_2021__positive regulation of cell death (GO:0010942),0.4941181182494411,1.0000306617615127,0.4827586206896552,1.0,1.0,14/45,20.85%,DDIT4;EGR1;MAPT;FCGR2B;RIPK2;BNIP3;GRIN2B;PICALM;WNT5A;CIDEB;FOS;TNF;LRRK2;CDKN1B
prerank,PanglaoDB_Augmented_2021__Microglia,-0.4104497818686698,-1.0,1.0,1.0,1.0,47/134,14.46%,MRC2;CD300LF;ITGAM;CX3CR1;LY86;SUSD3;GIMAP8;CEBPA;PTAFR;BIN2;OLFML3;MPEG1;LGALS9;HPGDS;CSF1R;LILRB4;UCP2;P2RY13;ITGB5;SLCO2B1;OTULINL;P2RY6;ITGAX;AOAH;TMEM119;MYO1F;P2RY12;WDFY4;IGSF6;PLEK;HCK;PTGS1;TREM2;ITGB2;CYFIP1;CYTH4;APBB1IP;LCP2;SKI;LTC4S;TYROBP;ENTPD1;CD53;GIMAP4;HAVCR2;IL6R;PIK3R5
prerank,GO_Biological_Process_2021__DNA replication initiation (GO:0006270),0.5208783126951698,0.9997617358765685,0.4642857142857143,1.0,1.0,11/24,31.60%,RPA2;POLE2;ORC6;DBF4;RPA3;ORC3;MCM3;MCM6;NOC3L;POLA1;GMNN
prerank,GO_Biological_Process_2021__regulation of protein acetylation (GO:1901983),0.5633369179463926,0.9993626919130657,0.4492753623188406,1.0,1.0,4/10,34.10%,RAPGEF3;DDX3X;TERF2IP;TAOK1
prerank,GO_Biological_Process_2021__cyclooxygenase pathway (GO:0019371),0.6629625331759096,0.9991490560116439,0.5882352941176471,1.0,1.0,1/6,1.96%,CBR1
prerank,GO_Biological_Process_2021__regulation of intracellular signal transduction (GO:1902531),0.45483057653680126,0.9990672004797632,0.49,1.0,1.0,68/332,22.42%,BRIP1;DDIT4;DAPK2;RHOB;FGF1;ARAF;NLRP12;PRKAR2B;MAPT;PPP2R5B;RACGAP1;RPA2;VEGFA;PHLPP1;TRAF2;TRIP10;FBXL2;ARHGAP23;AKAP6;NGEF;PEX5L;CHN1;PPP1R13L;NLGN1;AKAP12;DNA2;MOB3B;NTRK3;PDE2A;ARHGEF4;PRR5;TTC5;PRKAG2;KALRN;NTRK2;GNAI1;BRCA1;PAK5;ITSN1;RFC4;PYCARD;WNT5A;ITGAV;RPL11;ARAP2;ARHGDIA;HSPB1;PRKAA2;STARD13;TAF9B;FGD4;RHOH;TAF7;CDK5R1;NOP53;ECT2;TNF;MEAF6;LRRK2;FAM13A;RBBP8;VRK2;PAK3;STARD8;SETD9;BARD1;VAV3;RHOU
prerank,GO_Biological_Process_2021__positive regulation of TOR signaling (GO:0032008),-0.43918632077184594,-0.9990302444704838,0.5,1.0,1.0,7/33,12.21%,TELO2;CLEC16A;LAMTOR1;MIOS;NCKAP1L;TREM2;PIH1D1
prerank,GO_Biological_Process_2021__positive regulation of smooth muscle cell migration (GO:0014911),-0.4946999959571199,-0.9990283692536271,0.48148148148148145,1.0,1.0,3/10,7.34%,CCL5;DOCK4;IGF1
prerank,GO_Biological_Process_2021__response to acidic pH (GO:0010447),0.6197406736060198,0.998933756559828,0.5584415584415584,1.0,1.0,4/8,21.98%,IMPACT;GPR65;SLC9A1;CHP1
prerank,GO_Biological_Process_2021__positive regulation of oxidoreductase activity (GO:0051353),0.6497076607353769,0.9989147249824919,0.5151515151515151,1.0,1.0,4/9,20.20%,AGT;NOD2;SIRT3;TNF
prerank,GO_Biological_Process_2021__rRNA metabolic process (GO:0016072),0.44809815051689794,0.9987626035829695,0.46464646464646464,1.0,1.0,41/137,25.39%,RPL23;MAPT;WDR12;WDR74;RPL37A;PES1;IMP3;RPL38;SBDS;RPS6;RRP1B;RPL23A;RPS25;RPS27;RRP36;RPL9;RPLP2;RPL37;RPL14;MPHOSPH6;RPL11;RPS24;RPS9;NOB1;RPL36;UBA52;NOP53;RPL35;RPL4;RPL32;MRTO4;MPHOSPH10;RPL24;RPL27A;RPL3;RPS16;RPL30;WDR3;RPL21;RPL7;RPL12
prerank,GO_Biological_Process_2021__regulation of DNA methylation-dependent heterochromatin assembly (GO:0090308),-0.47733972187381607,-0.9985507821933629,0.42857142857142855,1.0,1.0,2/11,11.82%,SETDB1;TASOR
prerank,GO_Biological_Process_2021__'de novo' posttranslational protein folding (GO:0051084),0.5484025177343875,0.998201159916547,0.5263157894736842,1.0,1.0,10/24,27.66%,HSPA5;SDF2L1;DNAJC7;HSPA1B;ERO1A;HSPA2;HSPA14;HSPA9;HSPA13;HSPA8
prerank,GO_Biological_Process_2021__cellular protein modification process (GO:0006464),0.44942195419637154,0.9973347170259618,0.54,1.0,1.0,138/716,21.46%,SOCS3;HS3ST5;TNC;THBS1;DAPK2;ALG10B;ACVR1B;ARAF;CDK14;NEK11;TGFB2;DTL;ASB14;VGF;WDR5;PRKCE;ZBTB16;PTPRD;PPP2R3B;PPP2R5B;PIGU;VCAN;ANXA1;FBXL7;PTPRG;CDH2;ACVR2A;AATK;BMPR1B;ASB16;F13A1;PTPRK;GAD1;PPP2R5A;PDK4;EIF2AK3;LAMB1;PRRT1;PTPRZ1;GOLM1;FBXL2;INSR;DAPK1;NIM1K;MTMR7;COPS5;HIF1A;PP2D1;PTPRT;FN1;PXK;SIRT5;PLK2;FGR;CKAP4;OGA;MGAT1;LTBP1;CLK2;TMEM132A;LIPE;STT3B;PSMB4;CHRM3;RBX1;DCAF6;CAMK2B;B4GALT5;PRKAG2;GAN;FAM20A;SLC35A1;HIF3A;ASB13;PPM1E;PAK5;FBXO27;PINK1;PPM1L;SERP1;UBE2M;DUSP10;MAPK10;CHGB;CPE;ST8SIA3;PDK3;UGCG;SUMF2;NUAK2;CTBP1;KLHL2;EPAS1;TXK;TEC;GRK4;NRBP2;GMFB;ROCK1;EGLN3;MAP3K13;APP;SUMF1;PIK3R4;PTPN9;PPP2R3A;PRKAA2;IGFBP7;FBXL13;UBA52;ERO1A;PSMC2;ZC3HAV1;CDK9;FBXL5;SIRT3;CDC25B;PSMA3;PTPN5;DUSP16;CTDSP1;FBXO7;PSMB2;SSH2;DUSP6;SPSB3;PTPRS;LRRK2;ATG5;IRAK3;MACROD1;VRK2;DDB1;P4HB;DUSP12;PAK3;PSMD5;HSP90B1
prerank,PanglaoDB_Augmented_2021__Keratinocytes,-0.4605983664296271,-0.9972938817859045,0.4666666666666667,1.0,1.0,2/9,5.01%,KRT10;ICAM1
prerank,"GO_Biological_Process_2021__mitochondrial electron transport, ubiquinol to cytochrome c (GO:0006122)",0.6402309785867027,0.9972765823534175,0.5194805194805194,1.0,1.0,4/9,20.15%,CYCS;UQCRFS1;UQCRC1;CYC1
prerank,GO_Biological_Process_2021__sensory perception of smell (GO:0007608),0.6580879271535022,0.9972239474250671,0.5138888888888888,1.0,1.0,1/5,2.83%,ADCY3
prerank,GO_Biological_Process_2021__RNA destabilization (GO:0050779),0.5559778263846294,0.9967399625774295,0.4861111111111111,1.0,1.0,1/14,3.44%,RIDA
prerank,GO_Biological_Process_2021__cardiac muscle contraction (GO:0060048),0.5964445738798567,0.9964417652659705,0.5194805194805194,1.0,1.0,3/16,9.36%,SCN3B;DMD;RYR2
prerank,GO_Biological_Process_2021__amyloid-beta formation (GO:0034205),-0.5796329949737523,-0.996358374154802,0.5806451612903226,1.0,1.0,1/7,7.64%,APH1A
prerank,GO_Biological_Process_2021__dendrite extension (GO:0097484),0.6773422199436023,0.9963531705637532,0.5694444444444444,1.0,1.0,3/5,12.42%,SLC9A6;TMEM108;SH3GL2
prerank,GO_Biological_Process_2021__regulation of protein-containing complex assembly (GO:0043254),0.4722508984089254,0.9962597268128799,0.5106382978723404,1.0,1.0,15/85,13.36%,GFAP;TFRC;NRG1;NAPA;SLF1;VEGFA;HSPA5;TRAF2;HCFC1;SEPTIN8;ABCA1;TFIP11;IMPACT;PINK1;TPPP
prerank,GO_Biological_Process_2021__regulation of dendritic cell chemotaxis (GO:2000508),-0.5997298302907684,-0.9962180899165637,0.5263157894736842,1.0,1.0,1/5,3.60%,LGALS9
prerank,GO_Biological_Process_2021__negative regulation of programmed cell death (GO:0043069),0.4545729066928595,0.9962136312329607,0.55,1.0,1.0,41/238,18.81%,HTR2B;THBS1;LRP2;ARAF;PRLR;NAA38;TFRC;ATAD3A;ANXA1;RNF144B;FIGNL1;VEGFA;HSPA5;IL7;COPS5;FMN2;BNIP3L;FAIM2;IGF1R;RPS27A;MCL1;PLK2;RIPK2;BNIP3;PRELID1;BCL2L2;TMEM14A;WNT5A;CASP3;CFL1;BAG3;NUAK2;ARHGDIA;HSPB1;HSPA1B;GSTP1;PRKAA2;TAF9B;UBA52;HSPD1;UBB
prerank,MSigDB_Hallmark_2020__Complement,-0.2809002114543311,-0.995513633647569,1.0,1.0,1.0,16/137,9.06%,CCL5;CASP7;ITGAM;RHOG;PFN1;SH2B3;OLR1;C3;GZMB;APOBEC3G;ERAP2;DOCK4;CASP10;FYN;SRC;KLKB1
prerank,GO_Biological_Process_2021__negative regulation of activated T cell proliferation (GO:0046007),-0.5325419221209182,-0.9954831699603243,0.5263157894736842,1.0,1.0,3/9,5.98%,LGALS9;LILRB4;CD274
prerank,GO_Biological_Process_2021__positive regulation of T cell mediated cytotoxicity (GO:0001916),-0.5492643892852337,-0.9953239387270792,0.4,1.0,1.0,2/11,14.74%,HLA-E;IL12RB1
prerank,GO_Biological_Process_2021__retinoid metabolic process (GO:0001523),0.5315058072141216,0.99497860689438,0.5128205128205128,1.0,1.0,7/26,16.55%,LRP2;CYP3A5;GPC5;AKR1B1;RDH11;ALDH1A1;NAPEPLD
prerank,GO_Biological_Process_2021__regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),0.48835493402746283,0.9947527918396066,0.4945054945054945,1.0,1.0,13/46,23.75%,CLIP3;H2BC11;TRAF2;SPPL2B;CCDC3;PYCARD;HSPA1B;GSTP1;TNFRSF1A;TNF;CASP1;TRADD;GPS2
prerank,GO_Biological_Process_2021__positive regulation of macrophage migration (GO:1905523),0.5719521026009639,0.9945322684714157,0.547945205479452,1.0,1.0,1/13,0.28%,THBS1
prerank,MSigDB_Hallmark_2020__Hedgehog Signaling,0.5251584309742149,0.9945087757606015,0.5324675324675324,1.0,1.0,7/26,15.39%,TLE1;RTN1;VEGFA;CRMP1;UNC5C;ETS2;THY1
prerank,MSigDB_Hallmark_2020__TGF-beta Signaling,0.4802720841619754,0.994119676356934,0.5116279069767442,1.0,1.0,2/45,2.03%,THBS1;TGIF1
prerank,GO_Biological_Process_2021__negative regulation of viral life cycle (GO:1903901),0.6124036725725056,0.9939885478613556,0.5147058823529411,1.0,1.0,3/10,14.21%,TRIM5;IFITM3;TRIM26
prerank,GO_Biological_Process_2021__negative regulation of phosphate metabolic process (GO:0045936),-0.532010134443436,-0.9938596125288053,0.4230769230769231,1.0,1.0,3/12,10.03%,INPP5K;TP53;PLEK
prerank,GO_Biological_Process_2021__positive regulation of glucose metabolic process (GO:0010907),0.6204598231330749,0.9937458744109522,0.5584415584415584,1.0,1.0,3/8,25.32%,IRS2;DDB1;PPARGC1A
prerank,GO_Biological_Process_2021__regulation of glial cell migration (GO:1903975),-0.6164903384410816,-0.9936962467395778,0.55,1.0,1.0,3/5,9.18%,CX3CR1;CRKL;P2RY12
prerank,GO_Biological_Process_2021__negative regulation of cytoplasmic translation (GO:2000766),0.668605365258349,0.9936666672549996,0.5555555555555556,1.0,1.0,2/5,20.52%,CPEB2;CPEB4
prerank,GO_Biological_Process_2021__detection of mechanical stimulus involved in sensory perception (GO:0050974),0.6146508151792394,0.9935303781715366,0.527027027027027,1.0,1.0,4/8,19.60%,COL11A1;SCN1A;PIEZO2;LHFPL5
prerank,GO_Biological_Process_2021__detection of visible light (GO:0009584),-0.5340026374977265,-0.9935034770997688,0.46511627906976744,1.0,1.0,1/6,0.30%,EYS
prerank,GO_Biological_Process_2021__lipoxin metabolic process (GO:2001300),0.6428067923629947,0.9934414054964272,0.5873015873015873,1.0,1.0,1/5,4.32%,ALOX12
prerank,GO_Biological_Process_2021__protein localization to nucleus (GO:0034504),-0.3129296813196459,-0.993421196243655,0.3333333333333333,1.0,1.0,18/80,16.57%,RANBP6;ARL2BP;HHEX;APPL2;NUP155;RPAIN;PHB2;BCL3;NUP188;NUP214;IPO13;CHCHD10;SYK;PTTG1IP;AKT1;TAF8;XPA;RPF2
prerank,GO_Biological_Process_2021__detection of bacterium (GO:0016045),0.6494029339452053,0.9933374836165119,0.4864864864864865,1.0,1.0,1/7,10.87%,NOD2
prerank,GO_Biological_Process_2021__positive regulation of circadian rhythm (GO:0042753),0.6893435005401249,0.9931726156529056,0.6140350877192983,1.0,1.0,2/5,22.96%,NLGN1;RORA
prerank,GO_Biological_Process_2021__regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),0.46181315835641473,0.9926775255631809,0.5274725274725275,1.0,1.0,20/85,24.39%,ARAF;RNF144B;HERPUD1;XPO1;ARIH2;RNF144A;RBX1;PRICKLE1;DNAJB2;CAMLG;SDCBP;RPL11;HSPA1B;NOP53;LRRK2;HFE;MAP1A;USP5;BBS7;DDRGK1
prerank,GO_Biological_Process_2021__box C/D snoRNP assembly (GO:0000492),-0.5620315464847104,-0.9920584668525334,0.48484848484848486,1.0,1.0,3/6,12.41%,NUFIP1;PIH1D1;ZNHIT6
prerank,GO_Biological_Process_2021__regulation of voltage-gated calcium channel activity (GO:1901385),0.5823072921641088,0.9917715454525172,0.5324675324675324,1.0,1.0,4/12,14.09%,CACNB2;DMD;PDE4B;AHNAK
prerank,GO_Biological_Process_2021__regulation of mRNA processing (GO:0050684),-0.4167085261569651,-0.9916344635768766,0.4117647058823529,1.0,1.0,9/32,18.36%,RBM23;JMJD6;CDK11B;METTL16;KHDRBS3;SON;SAFB;CPSF4;LARP7
prerank,GO_Biological_Process_2021__negative regulation of neuroinflammatory response (GO:0150079),-0.49413113086944815,-0.9914513530642709,0.38461538461538464,1.0,1.0,4/12,10.32%,CST7;IGF1;CD200R1;TREM2
prerank,GO_Biological_Process_2021__regulation of vasoconstriction (GO:0019229),0.608381635085004,0.9912050343194124,0.5365853658536586,1.0,1.0,2/10,11.06%,AGT;CHRM3
prerank,GO_Biological_Process_2021__peptidyl-lysine trimethylation (GO:0018023),0.5418995986358979,0.990871175882858,0.5121951219512195,1.0,1.0,4/22,10.93%,SUV39H2;ANTKMT;CSKMT;SMYD5
prerank,GO_Biological_Process_2021__icosanoid metabolic process (GO:0006690),0.5189164160007437,0.9907133062284231,0.5569620253164557,1.0,1.0,4/27,5.56%,FAAH;FAAH2;ALOX12;ALOX15B
prerank,GO_Biological_Process_2021__response to iron ion (GO:0010039),0.6182050119891453,0.99066542256148,0.5294117647058824,1.0,1.0,5/9,25.52%,HIF1A;HAMP;HFE;TF;SLC11A2
prerank,GO_Biological_Process_2021__mitotic intra-S DNA damage checkpoint signaling (GO:0031573),0.5710961771430656,0.9904419737590712,0.4868421052631579,1.0,1.0,2/12,9.73%,NEK11;EME2
prerank,GO_Biological_Process_2021__cardiac ventricle morphogenesis (GO:0003208),0.5355576931708164,0.9902667447621607,0.44871794871794873,1.0,1.0,4/18,9.26%,TGFB2;SOX4;PKP2;RBPJ
prerank,GO_Biological_Process_2021__toll-like receptor 4 signaling pathway (GO:0034142),-0.47547116247417254,-0.9901698725691694,0.44,1.0,1.0,5/13,10.89%,ITGAM;LGALS9;SCIMP;NMI;ITGB2
prerank,GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),-0.39363257327378637,-0.9900035385523801,0.5714285714285714,1.0,1.0,10/65,10.78%,PSMB3;PSME3;CHUK;ITGB5;PSMC4;PSMD12;PSME4;HLA-E;IKBKB;FCGR1A
prerank,GO_Biological_Process_2021__negative regulation of cell migration (GO:0030336),-0.3455969900984218,-0.9898901584297695,0.5,1.0,1.0,10/91,6.02%,PHLDB2;NEXMIF;EVL;ADARB1;TMIGD3;DAB2IP;DUSP3;ARHGDIB;TRIB1;NF2
prerank,GO_Biological_Process_2021__positive regulation of lipid catabolic process (GO:0050996),-0.5587437446404417,-0.9896333405338122,0.44,1.0,1.0,3/9,5.82%,IL1B;DAGLB;MTLN
prerank,GO_Biological_Process_2021__regulation of extracellular matrix assembly (GO:1901201),0.6427915295220672,0.9896324273235244,0.5151515151515151,1.0,1.0,2/5,17.58%,AGT;RGCC
prerank,GO_Biological_Process_2021__modulation by host of viral process (GO:0044788),0.6333625657613006,0.9894176491984733,0.5166666666666667,1.0,1.0,3/5,26.37%,CFL1;PPIB;IGF2R
prerank,GO_Biological_Process_2021__pattern recognition receptor signaling pathway (GO:0002221),0.4771225086021256,0.9893355927377087,0.46808510638297873,1.0,1.0,3/42,10.87%,CLEC4E;RPS27A;NOD2
prerank,GO_Biological_Process_2021__negative regulation of phosphorylation (GO:0042326),0.4771829598093824,0.9886125782376638,0.5106382978723404,1.0,1.0,16/61,21.98%,PLPP3;MAPT;PAQR3;IRS2;NTRK3;IMPACT;IBTK;SH3GL2;FBP1;ROCK1;NPRL2;PPARA;LRRK2;CDKN1B;HNRNPU;CHP1
prerank,GO_Biological_Process_2021__organelle organization (GO:0006996),0.4419563642611105,0.9885992402780576,0.5757575757575758,1.0,1.0,62/304,25.61%,DIAPH3;SYNE3;ATAD3A;EIF2AK3;MTERF1;VAPB;SEMA6A;VPS11;AGTPBP1;HCFC1;ATP8B1;PALLD;SIRT5;LIMD1;CSPG5;SH3D19;GABPB1;CLASP2;PPID;CYCS;POLG2;PAK5;GOLGA8B;PINK1;VMP1;AUP1;SPTBN5;PEX3;TMED10;CFL1;THY1;FGD6;FAM174B;UBXN2B;KIF3A;TFAM;FGD4;SIRT3;VPS51;SURF4;POLRMT;CNTNAP1;CENPT;LRRK2;RAB30;KIF5C;DYNC2H1;BRWD1;BNIP1;HACE1;CHMP5;RHOU;SORT1;MAST4;PDCD6IP;CLUH;SIRT4;CHMP7;PEX10;PPARGC1A;GOLGB1;VAPA
prerank,GO_Biological_Process_2021__negative regulation of vascular associated smooth muscle cell proliferation (GO:1904706),0.5840110354897317,0.9882432808680114,0.5588235294117647,1.0,1.0,5/10,26.11%,SOD2;CDKN1B;PDCD4;PTEN;PRKG1
prerank,GO_Biological_Process_2021__blood circulation (GO:0008015),0.5273452299562553,0.9878134648948302,0.5443037974683544,1.0,1.0,9/23,21.83%,HTR7;TBC1D8;SGCZ;GUCY1B1;ROCK1;SGCD;SOD1;SCPEP1;STAT1
prerank,GO_Biological_Process_2021__regulation of cytokine production (GO:0001817),0.46375963441766804,0.9875277489530785,0.5268817204301075,1.0,1.0,11/86,5.74%,HTR2B;NLRP12;CADM1;IL15;AGT;ANXA1;SLC11A1;SRGN;GPNMB;FCGR2B;MOG
prerank,GO_Biological_Process_2021__positive regulation of G2/M transition of mitotic cell cycle (GO:0010971),0.5727604352213185,0.98741838301482,0.5294117647058824,1.0,1.0,1/12,1.41%,DTL
prerank,GO_Biological_Process_2021__negative regulation of cytokine production involved in immune response (GO:0002719),0.5826422112853817,0.9872386769186672,0.45161290322580644,1.0,1.0,1/11,1.28%,TGFB2
prerank,GO_Biological_Process_2021__mitochondrion morphogenesis (GO:0070584),0.6013992200297701,0.9871279764179743,0.575,1.0,1.0,2/11,12.68%,WASF1;SLIRP
prerank,GO_Biological_Process_2021__negative regulation of inflammatory response (GO:0050728),0.46988148673611724,0.9866960134976258,0.4489795918367347,1.0,1.0,7/94,2.83%,KLF4;TSHR;NLRP12;CD163;HTR7;PRKAR2B;ADCY3
prerank,GO_Biological_Process_2021__zymogen activation (GO:0031638),0.5504412026251364,0.9866165056497307,0.5375,1.0,1.0,5/18,20.08%,GRIN2A;RIPK2;ASPH;CIDEB;PGK1
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),0.5026637025096863,0.9865776774646964,0.5232558139534884,1.0,1.0,8/41,15.86%,DDIT4;BOK;MCL1;TNFRSF1B;BRCA1;BCL2L2;PYCARD;CIDEB
prerank,GO_Biological_Process_2021__alpha-linolenic acid metabolic process (GO:0036109),0.6067276661940676,0.9865674380231444,0.5512820512820513,1.0,1.0,1/10,2.03%,ACSL1
prerank,GO_Biological_Process_2021__cyclic purine nucleotide metabolic process (GO:0052652),0.5660301420169358,0.9861181259926267,0.4935064935064935,1.0,1.0,5/13,17.50%,ADCY3;ADCY10;ADCY8;GUCY1B1;GUCY2C
prerank,GO_Biological_Process_2021__positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),0.48149268846172794,0.9859469503988205,0.5684210526315789,1.0,1.0,13/70,12.45%,SOCS3;ENPP2;IL15;RELN;AGT;VEGFA;SRCIN1;GHR;GPRC5B;HCLS1;RIPK2;CRLF1;EPHA4
prerank,GO_Biological_Process_2021__activation of adenylate cyclase activity (GO:0007190),0.5535632900586905,0.9857757610636548,0.5384615384615384,1.0,1.0,4/17,10.89%,TSHR;ADCY3;ADCY8;RXFP1
prerank,GO_Biological_Process_2021__cholesterol efflux (GO:0033344),-0.4859774159096056,-0.9857494176872289,0.44,1.0,1.0,2/12,2.97%,NPC2;NPC1
prerank,GO_Biological_Process_2021__positive regulation of neuron projection arborization (GO:0150012),0.6286428183649541,0.985405991215439,0.547945205479452,1.0,1.0,4/7,26.74%,WNT5A;MAP3K13;DLG4;GRIP1
prerank,GO_Biological_Process_2021__negative regulation of cell-cell adhesion mediated by cadherin (GO:2000048),-0.5995178293044426,-0.9852961463128602,0.47368421052631576,1.0,1.0,1/5,0.17%,NEXMIF
prerank,GO_Biological_Process_2021__positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),0.5518433708241454,0.9850775787032189,0.5185185185185185,1.0,1.0,4/20,9.26%,VEGFA;HSPA5;HIF1A;RBPJ
prerank,GO_Biological_Process_2021__vasculature development (GO:0001944),0.654618400377765,0.9847717233628032,0.5507246376811594,1.0,1.0,1/6,10.28%,ERRFI1
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle cell migration (GO:1904752),0.6083418909125462,0.98456399673291,0.527027027027027,1.0,1.0,2/8,12.83%,DOCK5;NR4A3
prerank,GO_Biological_Process_2021__myelination in peripheral nervous system (GO:0022011),0.5907114113614829,0.9845292343459304,0.5443037974683544,1.0,1.0,6/10,28.85%,ADGRG6;PARD3;SOD1;CNTNAP1;NCMAP;DICER1
prerank,GO_Biological_Process_2021__translation (GO:0006412),0.44222834752226886,0.9845198336194264,0.5463917525773195,1.0,1.0,48/175,25.39%,EEF1A2;RPL23;RPL37A;RPS6KB2;FTSJ1;RPL38;COPS5;RPS6;RPS27A;RPL23A;RPS25;DARS1;RPS27;RPS11;RPS20;RPL9;RPLP2;EEF1B2;DRG2;RPS18;PPA1;MRPL43;RPL37;RPL14;MRPL55;MRPL27;RPS4X;RPL11;RPS24;RPS9;RPL36;UBA52;MRPL3;RPS3A;MRPS14;RPL35;RPL4;RPL32;TNIP1;EEF1A1;RPL24;RPL27A;RPL3;RPS16;RPL30;RPL21;RPL7;RPL12
prerank,GO_Biological_Process_2021__positive regulation of cell development (GO:0010720),0.5356038633902162,0.9844280705529017,0.5,1.0,1.0,1/17,0.62%,LRP2
prerank,GO_Biological_Process_2021__regulation of organelle organization (GO:0033043),0.4931238785987115,0.984075015671859,0.4945054945054945,1.0,1.0,15/61,25.99%,MAPT;STMN3;VPS11;PDE2A;PDE4DIP;PINK1;CENPV;PLXNB1;CLIC4;SURF4;RDX;SYT11;TJP1;MTM1;TMEM33
prerank,GO_Biological_Process_2021__membrane fission (GO:0090148),0.61952612430592,0.9838268159684898,0.5522388059701493,1.0,1.0,3/7,34.46%,SPAST;CHMP4B;CORO1C
prerank,GO_Biological_Process_2021__regulation of tyrosine phosphorylation of STAT protein (GO:0042509),0.5206323799849375,0.9837345252914758,0.5487804878048781,1.0,1.0,6/30,12.31%,SOCS3;IL15;VEGFA;GHR;HCLS1;CRLF1
prerank,GO_Biological_Process_2021__negative regulation of reactive oxygen species metabolic process (GO:2000378),0.5876066344300086,0.9836078494787803,0.5875,1.0,1.0,5/13,23.47%,SIRT5;BRCA1;PINK1;PPARA;TRAP1
prerank,GO_Biological_Process_2021__regulation of sodium ion transport (GO:0002028),0.5495680657930939,0.9835497789758614,0.5365853658536586,1.0,1.0,5/23,11.98%,SCN3B;ANK3;PKP2;PER1;NKAIN2
prerank,GO_Biological_Process_2021__genitalia development (GO:0048806),0.6776331903033632,0.9833572187766955,0.5737704918032787,1.0,1.0,2/5,15.06%,PKD1;WNT5A
prerank,GO_Biological_Process_2021__negative regulation of viral entry into host cell (GO:0046597),0.6143289294682102,0.9828494162130795,0.5522388059701493,1.0,1.0,3/8,14.21%,TRIM5;IFITM3;TRIM26
prerank,GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen (GO:0002478),0.4702371039641347,0.9824544063043104,0.4891304347826087,1.0,1.0,14/77,20.29%,CENPE;RACGAP1;KIF15;FCGR2B;ACTR1B;SEC24C;DYNC1H1;SH3GL2;KIF11;KIF5A;KIF3A;DCTN1;AP2A2;DYNC1I1
prerank,GO_Biological_Process_2021__positive regulation of mitophagy in response to mitochondrial depolarization (GO:0098779),0.6413722401021895,0.9824338266055861,0.5138888888888888,1.0,1.0,2/7,21.14%,PINK1;MFN2
prerank,GO_Biological_Process_2021__error-free translesion synthesis (GO:0070987),0.5556015081244972,0.9823960344688578,0.5465116279069767,1.0,1.0,7/19,23.25%,RPA2;RPS27A;RFC4;UBA52;UBB;RFC1;RPA3
prerank,GO_Biological_Process_2021__intracellular steroid hormone receptor signaling pathway (GO:0030518),-0.391062554303251,-0.9823593364741553,0.5714285714285714,1.0,1.0,5/30,10.48%,NCOA4;NEDD4;PMEPA1;SRC;ZMIZ1
prerank,GO_Biological_Process_2021__regulation of ATP biosynthetic process (GO:2001169),0.6005070609717732,0.98219663326342,0.5512820512820513,1.0,1.0,5/12,25.32%,ANTKMT;PINK1;PPARA;ENO1;PPARGC1A
prerank,GO_Biological_Process_2021__regulation of G1/S transition of mitotic cell cycle (GO:2000045),0.49186210757702414,0.9818128368875346,0.5,1.0,1.0,13/48,21.87%,KLF4;ANXA1;GPNMB;FHL1;ID2;PKD1;E2F7;CCND3;PLCB1;RGCC;RBL2;RDX;APPL1
prerank,GO_Biological_Process_2021__establishment of mitotic spindle orientation (GO:0000132),-0.4778834869479477,-0.9817609510149382,0.391304347826087,1.0,1.0,1/15,0.77%,NDE1
prerank,GO_Biological_Process_2021__induction of positive chemotaxis (GO:0050930),0.6532086608962779,0.9817413309662804,0.5757575757575758,1.0,1.0,1/5,5.04%,VEGFA
prerank,GO_Biological_Process_2021__regulation of myelination (GO:0031641),0.526805918921621,0.981624465603207,0.5581395348837209,1.0,1.0,9/21,19.50%,MYRF;EIF2AK3;PTPRZ1;PTN;PARD3;TNFRSF1B;TPPP;NKX6-2;TNFRSF21
prerank,GO_Biological_Process_2021__positive regulation of potassium ion transmembrane transporter activity (GO:1901018),0.6736977713334966,0.9816205574342148,0.5384615384615384,1.0,1.0,3/7,18.33%,ANK2;ATP1B3;ATP1B2
prerank,GO_Biological_Process_2021__cardiolipin metabolic process (GO:0032048),0.5760986575134278,0.9813980670232312,0.5571428571428572,1.0,1.0,4/9,37.51%,PNPLA8;PGS1;PLA2G4A;HADHA
prerank,GO_Biological_Process_2021__negative regulation of cellular protein localization (GO:1903828),0.5379114461063813,0.9813582164635959,0.6282051282051282,1.0,1.0,7/28,16.88%,MAPT;GPM6B;TTBK2;CAV3;OTUD7B;PICALM;UBXN2B
prerank,GO_Biological_Process_2021__synaptic vesicle cycle (GO:0099504),0.5474728063284512,0.9808874999697198,0.5211267605633803,1.0,1.0,7/16,25.30%,SNAP25;NLGN1;SLC17A7;CPLX1;RAB5A;BRSK1;RIMS1
prerank,GO_Biological_Process_2021__positive regulation of mitotic nuclear division (GO:0045840),-0.39874070733653394,-0.9807327799781633,0.45,1.0,1.0,5/18,14.32%,IL1B;IL1A;IGF1;TGFA;ANAPC4
prerank,GO_Biological_Process_2021__negative regulation of signaling receptor activity (GO:2000272),-0.43583437258206653,-0.9805237247393283,0.47058823529411764,1.0,1.0,2/17,4.46%,CALCR;LILRB4
prerank,GO_Biological_Process_2021__positive regulation of macrophage cytokine production (GO:0060907),0.6195446703116437,0.980497961743332,0.5512820512820513,1.0,1.0,2/8,15.06%,GPRC5B;WNT5A
prerank,GO_Biological_Process_2021__negative regulation of ATP metabolic process (GO:1903579),-0.4936742955786805,-0.9799634687840121,0.4,1.0,1.0,1/12,0.82%,PDE12
prerank,GO_Biological_Process_2021__positive regulation of actin filament bundle assembly (GO:0032233),-0.4016721608862559,-0.9797891163082759,0.3333333333333333,1.0,1.0,9/32,12.15%,SERPINF2;PFN1;EVL;LPAR1;NF2;SORBS3;PLEK;ABL1;PPM1F
prerank,MSigDB_Hallmark_2020__Interferon Gamma Response,0.46079184282795793,0.9797068520267325,0.53125,1.0,1.0,19/150,15.15%,SOCS3;GPR18;NAMPT;IL15;ARID5B;IL7;HIF1A;TRIM25;IFITM3;TXNIP;PDE4B;SLC25A28;FGL2;RIPK2;IFIT2;SOD2;TRIM26;PELI1;CASP3
prerank,GO_Biological_Process_2021__protein localization to mitochondrion (GO:0070585),-0.5353344117470996,-0.9795855145877483,0.5,1.0,1.0,1/11,0.88%,MAIP1
prerank,GO_Biological_Process_2021__positive regulation of transcription by RNA polymerase III (GO:0045945),-0.5122514414750831,-0.9789481463908815,0.45454545454545453,1.0,1.0,1/9,2.10%,CEBPA
prerank,GO_Biological_Process_2021__cellular response to ionizing radiation (GO:0071479),0.49738856204533216,0.9788630353822708,0.5,1.0,1.0,3/36,9.50%,RHOB;FIGNL1;KDM1A
prerank,GO_Biological_Process_2021__negative regulation of amyloid precursor protein catabolic process (GO:1902992),0.5369354000392859,0.9787130118122283,0.527027027027027,1.0,1.0,7/17,22.83%,RTN1;NTRK2;PICALM;ROCK1;RTN3;FLOT2;RTN4
prerank,GO_Biological_Process_2021__alpha-beta T cell differentiation (GO:0046632),-0.5789383079990374,-0.9784066670277554,0.47619047619047616,1.0,1.0,1/5,0.24%,ITK
prerank,GO_Biological_Process_2021__regulation of epidermis development (GO:0045682),-0.5890181480558302,-0.9781228687660303,0.475,1.0,1.0,2/6,8.70%,KRT10;MAFG
prerank,GO_Biological_Process_2021__regulation of telomere maintenance (GO:0032204),-0.3751637544592681,-0.9775877454307282,0.375,1.0,1.0,5/20,18.72%,NBN;TERF2;SMG6;UPF1;ERCC4
prerank,GO_Biological_Process_2021__regulation of ubiquitin-protein transferase activity (GO:0051438),0.5358038668478691,0.9773642782044296,0.5569620253164557,1.0,1.0,3/22,13.26%,ARRDC3;BMI1;PINK1
prerank,GO_Biological_Process_2021__cellular response to corticosteroid stimulus (GO:0071384),0.6078430421560072,0.9771578380797412,0.5416666666666666,1.0,1.0,1/9,3.87%,ANXA1
prerank,GO_Biological_Process_2021__B cell activation (GO:0042113),-0.37503751314616846,-0.9771506736500011,0.4166666666666667,1.0,1.0,5/45,3.76%,TCF3;LYL1;BANK1;HHEX;BLNK
prerank,GO_Biological_Process_2021__positive regulation of protein polymerization (GO:0032273),0.49918389070262326,0.9770997352763903,0.4946236559139785,1.0,1.0,13/47,19.33%,PRKCE;MAPT;ARF6;BAIAP2L1;CAV3;CARMIL1;PINK1;TPPP;PYCARD;TOGARAM1;DCTN1;FES;CDK5R1
prerank,GO_Biological_Process_2021__regulation of double-strand break repair via nonhomologous end joining (GO:2001032),0.5283294836665168,0.9769991104252911,0.5975609756097561,1.0,1.0,4/21,20.15%,CYREN;TFIP11;ERCC6;KMT5C
prerank,GO_Biological_Process_2021__mRNA catabolic process (GO:0006402),0.5021207639469679,0.9768277605382261,0.5402298850574713,1.0,1.0,3/39,3.44%,NUDT12;NUDT16;RIDA
prerank,GO_Biological_Process_2021__cytosolic calcium ion transport (GO:0060401),-0.4098576531018801,-0.9764562838830635,0.42857142857142855,1.0,1.0,3/22,4.64%,SMDT1;MAIP1;MICU3
prerank,GO_Biological_Process_2021__cellular response to exogenous dsRNA (GO:0071360),-0.45658794658890456,-0.9764255876968277,0.46153846153846156,1.0,1.0,2/11,7.54%,RALB;CGAS
prerank,GO_Biological_Process_2021__double-strand break repair via break-induced replication (GO:0000727),0.602500780925243,0.9760524708784686,0.55,1.0,1.0,5/7,39.33%,MCMDC2;MCM3;MCM6;MCM5;MCM7
prerank,GO_Biological_Process_2021__oxoacid metabolic process (GO:0043436),0.5596659719773965,0.9759752954386742,0.5443037974683544,1.0,1.0,1/12,1.43%,SULT4A1
prerank,MSigDB_Hallmark_2020__Myc Targets V2,0.48717799827752606,0.9758438308747948,0.5121951219512195,1.0,1.0,10/35,24.17%,TBRG4;WDR74;PES1;NDUFAF4;HSPD1;SORD;MRTO4;MPHOSPH10;GNL3;SRM
prerank,GO_Biological_Process_2021__regulation of cytokine-mediated signaling pathway (GO:0001959),0.4763597227627836,0.9757397779343162,0.5263157894736842,1.0,1.0,5/60,5.77%,SOCS3;CLIP3;LIFR;TRAF2;IL7
prerank,GO_Biological_Process_2021__RNA modification (GO:0009451),0.4816958130214521,0.9752883525254489,0.5348837209302325,1.0,1.0,3/44,6.84%,TRMT9B;FTSJ1;PUS7
prerank,GO_Biological_Process_2021__regulation of response to DNA damage stimulus (GO:2001020),0.5300388698280437,0.9752795372168136,0.5679012345679012,1.0,1.0,10/31,27.30%,MAPT;RPA2;MCL1;NSMCE1;CDK9;NPAS2;BCLAF1;ETAA1;WDR76;FEM1B
prerank,GO_Biological_Process_2021__sterol import (GO:0035376),0.6495076049605457,0.9751679957651841,0.5652173913043478,1.0,1.0,3/5,30.54%,STARD5;SCARB1;STARD4
prerank,GO_Biological_Process_2021__cholesterol import (GO:0070508),0.6495076049605457,0.9751679957651841,0.5652173913043478,1.0,1.0,3/5,30.54%,STARD5;SCARB1;STARD4
prerank,PanglaoDB_Augmented_2021__Erythroid-like And Erythroid Precursor Cells,-0.33495930108750194,-0.9750740337275868,0.36363636363636365,1.0,1.0,17/66,10.50%,NKG7;GRAP2;CD300LF;NCOA4;TAL1;LYL1;BIN2;GYPC;P2RX1;UCP2;EDRF1;RBM38;EPOR;HTATSF1;MYO1F;BTK;DCAF12
prerank,GO_Biological_Process_2021__cellular response to tumor necrosis factor (GO:0071356),-0.3140451026964547,-0.9750481806098587,0.5,1.0,1.0,16/114,8.38%,CCL5;CARD14;GBP3;INPP5K;PSMB3;PSME3;CHUK;EDA2R;DAB2IP;CDIP1;MAP3K14;PSMC4;TP53;PSMD12;ILK;PSME4
prerank,GO_Biological_Process_2021__regulation of cell adhesion mediated by integrin (GO:0033628),-0.41374572029500156,-0.9747124886138602,0.35,1.0,1.0,4/18,9.42%,NEXMIF;ACER2;P2RY12;NCKAP1L
prerank,MSigDB_Hallmark_2020__Apical Junction,0.4557091102726369,0.9745781032550449,0.5729166666666666,1.0,1.0,22/123,15.39%,CLDN18;CERCAM;ITGA2;VCAN;CDH8;CADM2;NRXN2;ADAM15;CNTN1;ALOX15B;MVD;NLGN3;ADAM23;TNFRSF11B;SGCE;GNAI1;NFASC;INSIG1;NEGR1;PKD1;TGFBI;THY1
prerank,PanglaoDB_Augmented_2021__Plasma Cells,0.47971761756704867,0.9745573357790079,0.5517241379310345,1.0,1.0,6/48,12.41%,KLF4;NAPSB;FCGR2B;FGR;CD93;CYCS
prerank,GO_Biological_Process_2021__chromatin silencing at telomere (GO:0006348),0.6502409470200881,0.9745327579762989,0.5714285714285714,1.0,1.0,4/6,31.55%,EZH2;DOT1L;RIF1;EZH1
prerank,GO_Biological_Process_2021__response to organic cyclic compound (GO:0014070),-0.3545825201995826,-0.9745208955636508,0.5,1.0,1.0,6/28,8.95%,CCL5;IL1B;CYP19A1;TGFB1;TLR3;HLCS
prerank,GO_Biological_Process_2021__negative regulation of response to interferon-gamma (GO:0060331),-0.5611032008404089,-0.9741518356428466,0.45161290322580644,1.0,1.0,2/5,18.82%,NR1H3;PPARG
prerank,GO_Biological_Process_2021__negative regulation of interferon-gamma-mediated signaling pathway (GO:0060336),-0.5611032008404089,-0.9741518356428466,0.45161290322580644,1.0,1.0,2/5,18.82%,NR1H3;PPARG
prerank,GO_Biological_Process_2021__chordate embryonic development (GO:0043009),0.5120722047429985,0.9741312757210466,0.49382716049382713,1.0,1.0,8/28,15.06%,VEGFA;ARNT2;DEAF1;HINFP;SULF2;BRCA1;PKD1;WNT5A
prerank,GO_Biological_Process_2021__base-excision repair (GO:0006284),0.522455208480079,0.9740494572493164,0.5977011494252874,1.0,1.0,12/34,20.01%,RPA2;TDG;MPG;DNA2;NEIL1;POLQ;RFC4;POLL;ERCC6;NEIL2;ADPRS;RFC1
prerank,GO_Biological_Process_2021__regulation of protein localization to chromatin (GO:1905634),0.6091338885682869,0.9738266968296059,0.6290322580645161,1.0,1.0,2/6,26.92%,VCPIP1;WAPL
prerank,GO_Biological_Process_2021__regulation of execution phase of apoptosis (GO:1900117),-0.5384786106430915,-0.9738030977315748,0.5483870967741935,1.0,1.0,2/8,6.50%,BCL2L1;TP53
prerank,GO_Biological_Process_2021__phosphatidylinositol biosynthetic process (GO:0006661),0.44448079696477627,0.9736790574377826,0.5157894736842106,1.0,1.0,6/98,7.37%,SOCS3;PIGU;ITPKC;INPP4B;MTMR7;PIGQ
prerank,GO_Biological_Process_2021__positive regulation of alpha-beta T cell activation (GO:0046635),0.5832157358948982,0.973481450003868,0.5285714285714286,1.0,1.0,1/10,5.63%,CD55
prerank,GO_Biological_Process_2021__response to interferon-gamma (GO:0034341),-0.39953432807265754,-0.9731738765637591,0.45454545454545453,1.0,1.0,6/42,6.63%,CCL5;PDE12;GBP3;LGALS9;SIRPA;DAPK3
prerank,GO_Biological_Process_2021__reverse cholesterol transport (GO:0043691),0.5889144170625161,0.9731681605117825,0.5540540540540541,1.0,1.0,4/9,25.54%,ABCA1;ABCA5;ABCG1;SCARB1
prerank,GO_Biological_Process_2021__histone H3 deacetylation (GO:0070932),0.5932134913727587,0.9730946920691483,0.575,1.0,1.0,6/14,34.95%,PER1;SFPQ;SMARCAD1;HDAC9;HDAC4;HDAC3
prerank,GO_Biological_Process_2021__regulation of nuclear cell cycle DNA replication (GO:0033262),0.6226026122009312,0.9730741347202078,0.5757575757575758,1.0,1.0,2/7,21.19%,DBF4;WIZ
prerank,GO_Biological_Process_2021__basement membrane organization (GO:0071711),0.6279413021827824,0.9729911633233251,0.547945205479452,1.0,1.0,4/7,18.70%,NTN4;LAMB1;FLRT2;NTNG1
prerank,GO_Biological_Process_2021__regulation of double-strand break repair via homologous recombination (GO:0010569),0.4866706383700109,0.9723927501230715,0.5217391304347826,1.0,1.0,11/33,27.37%,RPA2;FIGNL1;FANCB;KDM1A;POLQ;ERCC6;TIMELESS;MAGEF1;SPIDR;UBQLN4;ARID2
prerank,GO_Biological_Process_2021__endochondral bone morphogenesis (GO:0060350),0.6360416069416375,0.972322179353124,0.5789473684210527,1.0,1.0,1/7,4.63%,BMPR1B
prerank,GO_Biological_Process_2021__regulation of DNA demethylation (GO:1901535),0.6650724255304094,0.9723213970397597,0.6129032258064516,1.0,1.0,2/5,25.45%,STPG4;TOX
prerank,GO_Biological_Process_2021__positive regulation of DNA demethylation (GO:1901537),0.6650724255304094,0.9723213970397597,0.6129032258064516,1.0,1.0,2/5,25.45%,STPG4;TOX
prerank,GO_Biological_Process_2021__cellular modified amino acid biosynthetic process (GO:0042398),-0.46747548749180934,-0.9721692760334534,0.4782608695652174,1.0,1.0,4/14,20.50%,GCLC;GCLM;FPGS;MGST2
prerank,PanglaoDB_Augmented_2021__Osteocytes,0.49969908813620006,0.9720743521492528,0.5875,1.0,1.0,7/40,8.95%,TNC;ENAH;FBXL7;RND3;MYO10;TCF7L1;PTN
prerank,GO_Biological_Process_2021__regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645),-0.5272420858213879,-0.9719098909878758,0.4838709677419355,1.0,1.0,1/6,2.23%,IL1B
prerank,GO_Biological_Process_2021__positive regulation of axon extension (GO:0045773),0.5518743129230091,0.9718691845488188,0.5428571428571428,1.0,1.0,3/16,10.26%,MAPT;VEGFA;SEMA5A
prerank,GO_Biological_Process_2021__negative regulation of platelet activation (GO:0010544),0.558715331292819,0.9717105543501607,0.532258064516129,1.0,1.0,3/11,14.10%,ALOX12;THBD;SERPINE2
prerank,GO_Biological_Process_2021__regulation of fatty acid biosynthetic process (GO:0042304),0.564109587378648,0.9716846053741448,0.5227272727272727,1.0,1.0,6/20,18.04%,PDK4;MID1IP1;PRKAG2;BRCA1;ERLIN1;PRKAA2
prerank,GO_Biological_Process_2021__white fat cell differentiation (GO:0050872),-0.5432824937922353,-0.9715977681002355,0.53125,1.0,1.0,2/6,11.88%,FFAR4;CTBP2
prerank,GO_Biological_Process_2021__cellular response to chemical stress (GO:0062197),0.4626486738943584,0.9712637778190258,0.5957446808510638,1.0,1.0,19/76,25.32%,ALDH3B1;TMEM161A;ERMP1;CYCS;SOD2;PINK1;CPEB2;HSPA1B;GSTP1;PRKAA2;SOD1;ERO1A;STX2;LRRK2;VRK2;FOXO3;DDX3X;TXNRD1;PPARGC1A
prerank,GO_Biological_Process_2021__respiratory system development (GO:0060541),0.5317244468049354,0.9712267021782777,0.5061728395061729,1.0,1.0,4/18,9.57%,FGF1;CHI3L1;VEGFA;CCDC39
prerank,GO_Biological_Process_2021__mitochondrial fission (GO:0000266),0.5494757132254953,0.9710604924667234,0.5432098765432098,1.0,1.0,2/15,10.71%,DNM3;DNM1
prerank,GO_Biological_Process_2021__dendritic spine maintenance (GO:0097062),0.6021420214475113,0.970942390432475,0.5522388059701493,1.0,1.0,2/7,9.30%,INSR;IGF1R
prerank,GO_Biological_Process_2021__regulation of Rho protein signal transduction (GO:0035023),0.4945580185812612,0.9709421925158569,0.6263736263736264,1.0,1.0,5/47,11.42%,GPR18;KANK1;ROBO1;ABCA1;GPR65
prerank,GO_Biological_Process_2021__negative regulation of cell morphogenesis involved in differentiation (GO:0010771),0.6029376569482963,0.970796606834886,0.5942028985507246,1.0,1.0,2/8,19.10%,KANK1;AP1AR
prerank,GO_Biological_Process_2021__negative regulation of substrate adhesion-dependent cell spreading (GO:1900025),0.6029376569482963,0.970796606834886,0.5942028985507246,1.0,1.0,2/8,19.10%,KANK1;AP1AR
prerank,GO_Biological_Process_2021__visual perception (GO:0007601),0.4909298367295695,0.9704656554674386,0.5555555555555556,1.0,1.0,4/39,4.12%,TULP2;GRM8;COL11A1;SLC4A10
prerank,GO_Biological_Process_2021__positive regulation of cytosolic calcium ion concentration (GO:0007204),0.48881546050887276,0.9701950400341656,0.5473684210526316,1.0,1.0,9/56,11.42%,GPR18;TACR1;JPH1;CD55;CAV3;RYR2;C5AR1;ADCY8;GPR65
prerank,GO_Biological_Process_2021__regulation of histone phosphorylation (GO:0033127),-0.5523303608647374,-0.9701315677294524,0.4827586206896552,1.0,1.0,5/9,20.64%,IL1B;AKAP8L;FMR1;AKAP8;RPS6KA5
prerank,GO_Biological_Process_2021__cardiac myofibril assembly (GO:0055003),0.6413471694503133,0.9698181751137501,0.6164383561643836,1.0,1.0,4/7,29.10%,NEBL;FHOD3;TTN;PROX1
prerank,GO_Biological_Process_2021__establishment of endothelial barrier (GO:0061028),-0.40390124349990636,-0.9692484005169982,0.42105263157894735,1.0,1.0,3/22,6.51%,PPP1R16B;ICAM1;RAPGEF6
prerank,GO_Biological_Process_2021__DNA replication (GO:0006260),0.459968601162124,0.9692251092677442,0.5851063829787234,1.0,1.0,19/76,23.37%,BRIP1;CLSPN;RPA2;WDHD1;DNA2;DONSON;POLG2;BRCA1;RFC4;POLE2;ORC6;POLL;DBF4;TIMELESS;RFC1;RBBP8;BARD1;RPA3;ORC3
prerank,GO_Biological_Process_2021__regulation of I-kappaB phosphorylation (GO:1903719),-0.5712219699827805,-0.9691932793856782,0.5675675675675675,1.0,1.0,2/7,6.41%,CX3CR1;SIRPA
prerank,GO_Biological_Process_2021__regulation of alcohol biosynthetic process (GO:1902930),0.607610678443159,0.9691172055635415,0.5921052631578947,1.0,1.0,1/10,7.02%,ABCA2
prerank,GO_Biological_Process_2021__mitochondrial ATP synthesis coupled proton transport (GO:0042776),0.547359584822936,0.9687440161148279,0.5875,1.0,1.0,6/14,21.98%,ATP5ME;ATP5F1A;ATP5F1D;ATP5MC1;ATP5PB;ATP5F1E
prerank,GO_Biological_Process_2021__bone morphogenesis (GO:0060349),0.6356137262736611,0.9683874562252209,0.5362318840579711,1.0,1.0,1/6,4.63%,BMPR1B
prerank,GO_Biological_Process_2021__negative regulation of NF-kappaB transcription factor activity (GO:0032088),0.49464503193202825,0.9683349460509865,0.5978260869565217,1.0,1.0,2/49,1.30%,KLF4;NLRP12
prerank,GO_Biological_Process_2021__plasma membrane bounded cell projection morphogenesis (GO:0120039),0.49361993956436434,0.9680279401965397,0.5747126436781609,1.0,1.0,11/41,22.37%,GPM6A;NYAP2;WASF1;CNTNAP2;SLC9A6;PLXNB1;UBB;CNTNAP1;LRRK2;CTTN;DCLK1
prerank,GO_Biological_Process_2021__positive regulation of DNA binding (GO:0043388),0.5343271731093473,0.9676759448290922,0.5866666666666667,1.0,1.0,2/17,8.84%,HMGB2;TXN
prerank,GO_Biological_Process_2021__protein dephosphorylation (GO:0006470),0.44441094413497106,0.9675793502322682,0.5578947368421052,1.0,1.0,25/109,21.34%,PTPRD;PPP2R3B;PPP2R5B;PTPRG;PTPRK;PPP2R5A;EYA2;PTPRZ1;MTMR7;PP2D1;PTPRT;PPP2R2B;PPM1E;PPM1L;PPP1R15A;DUSP10;PTPN9;PPP2R3A;PTPN5;DUSP16;CTDSP1;SSH2;DUSP6;PTPRS;DUSP12
prerank,MSigDB_Hallmark_2020__Androgen Response,0.4633361588134029,0.9672336520837949,0.574468085106383,1.0,1.0,23/84,22.58%,IDI1;FKBP5;LIFR;BMPR1B;ARID5B;NDRG1;INPP4B;AKAP12;TMEM50A;INSIG1;SCD;MAP7;DNAJB9;HMGCS1;CCND3;ITGAV;ELL2;SORD;ACSL3;SRP19;SELENOP;SPCS3;DBI
prerank,GO_Biological_Process_2021__positive regulation of myeloid leukocyte differentiation (GO:0002763),0.547753841642211,0.9671884567917974,0.5915492957746479,1.0,1.0,5/20,22.07%,ID2;HCLS1;FES;TNF;CTNNBIP1
prerank,GO_Biological_Process_2021__postsynaptic neurotransmitter receptor diffusion trapping (GO:0098970),0.6770516717325228,0.9671848289806851,0.6271186440677966,1.0,1.0,5/5,32.32%,CACNG2;CACNG8;DLG4;CACNG3;GPHN
prerank,GO_Biological_Process_2021__neurotransmitter receptor diffusion trapping (GO:0099628),0.6770516717325228,0.9671848289806851,0.6271186440677966,1.0,1.0,5/5,32.32%,CACNG2;CACNG8;DLG4;CACNG3;GPHN
prerank,GO_Biological_Process_2021__protein autophosphorylation (GO:0046777),0.4420315571235268,0.967067934940058,0.5454545454545454,1.0,1.0,17/125,13.26%,DAPK2;ACVR1B;RIOK2;AATK;EIF2AK3;INSR;DAPK1;IGF1R;FGR;ALK;CLK2;TYRO3;CAMK2B;FLT1;NTRK2;EPHA4;PINK1
prerank,GO_Biological_Process_2021__protein processing involved in protein targeting to mitochondrion (GO:0006627),0.6427106414962626,0.967048977190885,0.5789473684210527,1.0,1.0,3/5,31.18%,PMPCA;IMMP2L;PMPCB
prerank,GO_Biological_Process_2021__cellular respiration (GO:0045333),0.5096158573601861,0.967016544642328,0.5116279069767442,1.0,1.0,8/35,18.97%,ETFB;NDUFS8;CYCS;NR4A3;UQCRFS1;ATP5F1D;UQCRC1;SIRT3
prerank,GO_Biological_Process_2021__positive regulation of cytoplasmic translation (GO:2000767),0.6265668467567238,0.9669243146607955,0.5492957746478874,1.0,1.0,3/5,32.04%,PKM;YBX3;DHX9
prerank,GO_Biological_Process_2021__regulation of protein kinase A signaling (GO:0010738),0.5744200458052175,0.9668427203874712,0.6153846153846154,1.0,1.0,3/12,7.96%,PRKAR2B;AKAP6;AKAP12
prerank,GO_Biological_Process_2021__regulation of sodium ion transmembrane transport (GO:1902305),0.5819388643581187,0.9667888476212972,0.5753424657534246,1.0,1.0,3/16,10.73%,SCN3B;CAV3;FXYD7
prerank,GO_Biological_Process_2021__regulation of nitrogen compound metabolic process (GO:0051171),0.617584919691559,0.9662954812084128,0.6081081081081081,1.0,1.0,2/7,20.20%,MFSD2A;TNF
prerank,GO_Biological_Process_2021__negative regulation of antigen receptor-mediated signaling pathway (GO:0050858),0.5185724366987247,0.965997053913182,0.5555555555555556,1.0,1.0,4/17,15.39%,CD22;FCGR2B;CD300A;THY1
prerank,GO_Biological_Process_2021__positive regulation of ERK1 and ERK2 cascade (GO:0070374),-0.3496411745932864,-0.9659186222924395,0.5,1.0,1.0,15/94,8.91%,TNFAIP8L3;CCL5;CALCR;SERPINF2;FFAR4;LGALS9;CSF1R;SCIMP;ICAM1;P2RY6;TGFB1;PDGFD;PHB2;ROR2;CRKL
prerank,GO_Biological_Process_2021__positive regulation of SMAD protein signal transduction (GO:0060391),-0.5160135449913164,-0.9657451295431808,0.5348837209302325,1.0,1.0,2/9,13.31%,TGFB1;DAB2
prerank,"GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (GO:0002480)",-0.5571307058342864,-0.9656737576131031,0.4857142857142857,1.0,1.0,1/7,9.22%,HLA-E
prerank,GO_Biological_Process_2021__regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211),-0.4347520952484299,-0.9652784316758837,0.5,1.0,1.0,1/15,1.27%,BTG2
prerank,GO_Biological_Process_2021__membrane organization (GO:0061024),0.4409049368554955,0.9652332256699266,0.6060606060606061,1.0,1.0,61/187,26.37%,LRP2;CR1;TFRC;NAPA;TRIP10;VAPB;ANK3;ANK2;SYP;DNAJC6;FCHO2;CAV3;DNM3;RPS27A;DNM1;SGCZ;SGIP1;SH3GL2;SYT1;SPAST;SNAP29;SERP1;AGFG1;ITSN1;REEP3;PICALM;WNT5A;UBXN2B;SPTBN1;AMPH;ATP10B;UBA52;UBB;AP2A2;SYNGR1;SUN2;HIP1R;CLTCL1;CNTN2;IL7R;NAPG;MFN2;MTCH1;CHP1;RAB5A;HACE1;CTTN;CHMP5;PLEKHA3;PDCD6IP;CFTR;REPS2;CHMP7;TF;RIMS1;VAPA;AP2S1;TMEM33;SYT9;OPA1;IGF2R
prerank,GO_Biological_Process_2021__negative regulation of cell cycle (GO:0045786),0.46113380467781734,0.9651754326046559,0.5777777777777777,1.0,1.0,6/49,7.04%,RHOB;BRINP1;NR4A1;PTPRK;ALOX15B;CAMK2N1
prerank,GO_Biological_Process_2021__regulation of smooth muscle cell proliferation (GO:0048660),0.4992238672026956,0.9650753106215262,0.5411764705882353,1.0,1.0,11/29,21.83%,THBS1;OGN;ID2;NR4A3;NDRG4;IL18;FOXP1;TNF;MFN2;CX3CL1;STAT1
prerank,GO_Biological_Process_2021__negative regulation of response to external stimulus (GO:0032102),0.45326460208805763,0.9648723401852162,0.5698924731182796,1.0,1.0,18/67,23.76%,KLF4;NLRP12;TYRO3;GRID2;EPHA4;CTNNA2;MACIR;TNFRSF1A;PPARA;LRFN5;NR1D1;PTPRS;IRAK3;RTN4RL1;PTGER4;RORA;GPS2;PTEN
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell proliferation (GO:0060043),-0.4891432356386456,-0.9647316247215071,0.4444444444444444,1.0,1.0,1/13,0.57%,TGFBR3
prerank,GO_Biological_Process_2021__double-strand break repair via nonhomologous end joining (GO:0006303),0.4644965183017519,0.9643912369151478,0.5333333333333333,1.0,1.0,7/52,17.68%,CYREN;HMGB2;PIAS4;POLQ;BRCA1;POLL;ERCC6
prerank,GO_Biological_Process_2021__snRNA 3'-end processing (GO:0034472),0.5573056862672466,0.9641926178975313,0.5714285714285714,1.0,1.0,3/14,22.06%,INTS12;INTS8;INTS6
prerank,MSigDB_Hallmark_2020__Apoptosis,0.45498607112537603,0.9635135385911401,0.5319148936170213,1.0,1.0,24/114,17.45%,TOP2A;RHOB;TGFB2;DPYD;HMGB2;GADD45B;PPP2R5B;PLPPR4;ANXA1;ENO2;BNIP3L;MCL1;IFITM3;TXNIP;SPTAN1;BRCA1;SOD2;BCL2L2;TIMP3;CASP3;IL18;ROCK1;HSPB1;APP
prerank,GO_Biological_Process_2021__leukotriene biosynthetic process (GO:0019370),-0.4978747936876786,-0.9630323691574317,0.5,1.0,1.0,6/9,20.50%,GGTA1;ALOX5;LTC4S;GGT7;ALOX5AP;MGST2
prerank,GO_Biological_Process_2021__synaptic vesicle recycling (GO:0036465),0.5339097167729338,0.9627994189014881,0.5466666666666666,1.0,1.0,7/21,22.05%,NLGN3;FCHO2;NLGN1;SYT1;AMPH;NLGN4X;RAB5A
prerank,GO_Biological_Process_2021__response to increased oxygen levels (GO:0036296),-0.6099251150643983,-0.9623331690485816,0.53125,1.0,1.0,2/5,26.91%,ATP6AP1;ATP6V1G1
prerank,GO_Biological_Process_2021__regulation of RNA metabolic process (GO:0051252),0.45785014020659776,0.9622190564298947,0.5555555555555556,1.0,1.0,14/50,24.66%,PQBP1;PCBP4;RRP1B;NOVA1;CLK2;FAM50A;TNFRSF1B;AHNAK;HNRNPH1;METTL4;HNRNPH3;MBNL2;CLK1;AKAP17A
prerank,GO_Biological_Process_2021__xenobiotic transport (GO:0042908),-0.5013253271140183,-0.9621972609113774,0.5,1.0,1.0,1/11,3.38%,ABCG2
prerank,GO_Biological_Process_2021__copper ion homeostasis (GO:0055070),0.5495715325807593,0.962148864871297,0.5405405405405406,1.0,1.0,3/11,17.45%,ATOX1;SLC31A2;APP
prerank,GO_Biological_Process_2021__pyroptosis (GO:0070269),-0.46834009947575606,-0.962124405616715,0.4782608695652174,1.0,1.0,5/14,13.02%,GSDMB;NLRP1;GZMB;TREM2;NAIP
prerank,GO_Biological_Process_2021__regulation of microtubule-based movement (GO:0060632),0.6299088762790761,0.9618983093073298,0.5625,1.0,1.0,1/5,8.44%,MAP2
prerank,GO_Biological_Process_2021__positive regulation of leukocyte apoptotic process (GO:2000108),0.5876657505570277,0.961893207387856,0.5921052631578947,1.0,1.0,1/9,3.87%,ANXA1
prerank,GO_Biological_Process_2021__mitotic G2/M transition checkpoint (GO:0044818),0.47660802686774095,0.9618313880481117,0.5287356321839081,1.0,1.0,5/31,12.87%,DTL;CLSPN;DONSON;INTS3;BRCA1
prerank,GO_Biological_Process_2021__embryonic hemopoiesis (GO:0035162),-0.4921475355577106,-0.9615764710065671,0.5161290322580645,1.0,1.0,3/8,8.43%,TAL1;SH2B3;THOC5
prerank,GO_Biological_Process_2021__negative regulation of cell adhesion (GO:0007162),-0.34258733310107975,-0.961470274829942,0.6,1.0,1.0,10/49,10.29%,NEXMIF;DSCAM;ARHGDIB;ACER2;NF2;TGFB1;SIPA1;RIPOR2;PLXNA4;SEMA4D
prerank,GO_Biological_Process_2021__positive regulation of protein kinase B signaling (GO:0051897),0.4509011099830491,0.9614227515041863,0.5760869565217391,1.0,1.0,17/89,15.83%,THBS1;LRP2;FGF1;NRG1;CHI3L1;KITLG;INSR;TXN;IRS2;IGF1R;SEMA5A;HCLS1;GAB1;PINK1;NRG4;ESR1;IL18
prerank,GO_Biological_Process_2021__regulation of endocytosis (GO:0030100),0.46235816807542685,0.9613245152786817,0.47126436781609193,1.0,1.0,19/49,28.03%,CLIP3;CD22;EPHA3;ARFGAP1;CALY;PICALM;MCTP1;SNX17;ROCK1;CD151;HIP1R;RAB5A;SYT11;GPC3;AP2S1;SCAMP5;LRPAP1;PTPN1;SNX12
prerank,GO_Biological_Process_2021__response to muramyl dipeptide (GO:0032495),0.5961466083577751,0.9611840527937441,0.6307692307692307,1.0,1.0,3/11,12.29%,VIM;NOD2;RIPK2
prerank,GO_Biological_Process_2021__positive regulation of phosphorylation (GO:0042327),0.4429074305063342,0.9611799881561852,0.6326530612244898,1.0,1.0,27/161,14.72%,THBS1;FGF1;CLIP3;FAXDC2;TFRC;ACVR2A;VEGFA;GPNMB;INSR;EPHA3;HIF1A;SLCO3A1;IGF1R;NTRK3;ALK;EPHA7;TYRO3;PFKFB4;FAM20A;FLT1;NTRK2;EPHA4;PINK1;LIMCH1;EPHA6;EPHA5;SDCBP
prerank,GO_Biological_Process_2021__negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804),0.5906031134129589,0.9609785370469952,0.6,1.0,1.0,3/10,17.54%,H2BC11;CCDC3;GSTP1
prerank,GO_Biological_Process_2021__positive regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090267),0.6397530100332719,0.9607735079597975,0.5652173913043478,1.0,1.0,1/5,13.06%,XRCC3
prerank,GO_Biological_Process_2021__positive regulation of spindle checkpoint (GO:0090232),0.6397530100332719,0.9607735079597975,0.5652173913043478,1.0,1.0,1/5,13.06%,XRCC3
prerank,GO_Biological_Process_2021__lipid transport (GO:0006869),0.4471044235601809,0.9607374784905146,0.5319148936170213,1.0,1.0,15/65,15.82%,SLC51A;ACSL1;SLCO1A2;ABCA2;ATP8B1;SLCO3A1;ABCA1;MFSD2A;PLTP;SLC10A1;PRELID1;STARD5;ABCA5;PEX3;UGCG
prerank,GO_Biological_Process_2021__positive regulation of cell differentiation (GO:0045597),0.44266361329038995,0.9603545584354856,0.6082474226804123,1.0,1.0,31/144,18.65%,FBN2;TGFB2;ZBTB16;BRINP1;GLIPR2;AGT;CDH2;KITLG;ACVR2A;BMPR1B;NOCT;ALOX15B;PAX8;PPP1R13L;RANBP3L;ID2;PTN;GPRC5B;IMPACT;LMO3;SOX6;VWC2;CTNNA2;SDCBP;AKIRIN1;IL18;PLCB1;RGCC;OLFM1;FES;EZH2
prerank,GO_Biological_Process_2021__positive regulation of cell cycle G2/M phase transition (GO:1902751),0.5449428808651471,0.9602869473890282,0.5633802816901409,1.0,1.0,1/14,1.41%,DTL
prerank,GO_Biological_Process_2021__nuclear pore complex assembly (GO:0051292),0.5918484382706841,0.9597602985413648,0.6086956521739131,1.0,1.0,5/9,34.79%,RTN4;NDC1;AHCTF1;NUP153;NUP205
prerank,GO_Biological_Process_2021__positive regulation of protein localization to cell periphery (GO:1904377),0.47869761930304866,0.9597554320875877,0.5402298850574713,1.0,1.0,10/38,20.20%,PRKCE;CLIP3;ARF6;EPHA3;SORBS1;GNAI1;SPTBN1;PTPN9;GPSM2;TNF
prerank,GO_Biological_Process_2021__response to cytokine (GO:0034097),0.4487514626812817,0.9597352784124167,0.6161616161616161,1.0,1.0,25/106,24.00%,NLRP12;OSMR;CHI3L1;IL1RAPL1;ANXA1;SLC11A1;LIFR;AKAP6;MCL1;IFITM3;HCLS1;IFNLR1;CALCOCO2;TIMP3;CASP3;APP;PTPN9;CDK9;PTPN5;PTPN20;IRAK3;STAT1;ALDH1A2;CASP1;TRIM56
prerank,GO_Biological_Process_2021__regulation of protein-containing complex disassembly (GO:0043244),0.5711527287912586,0.9591751293289068,0.6025641025641025,1.0,1.0,5/15,21.01%,INSR;IGF1R;BNIP3;TNF;IRAK3
prerank,GO_Biological_Process_2021__ephrin receptor signaling pathway (GO:0048013),0.45530616180495737,0.9590500255118349,0.6063829787234043,1.0,1.0,19/63,22.42%,EPHA3;SIPA1L1;NGEF;CHN1;DNM1;EPHA7;KALRN;EPHA4;ANKS1B;EPHA6;ITSN1;EPHA5;GRIN2B;SDCBP;ROCK1;CDK5R1;AP2A2;PAK3;VAV3
prerank,GO_Biological_Process_2021__xenobiotic catabolic process (GO:0042178),-0.6206150056781544,-0.959028979707747,0.6296296296296297,1.0,1.0,2/5,9.63%,ACAA1;GSTM4
prerank,GO_Biological_Process_2021__positive regulation of protein localization to cell surface (GO:2000010),-0.5404923057525514,-0.9586080966327963,0.5333333333333333,1.0,1.0,3/10,12.54%,RIC3;GPD1L;TYROBP
prerank,GO_Biological_Process_2021__sarcoplasmic reticulum calcium ion transport (GO:0070296),0.6615939460087346,0.958332789657841,0.6666666666666666,1.0,1.0,3/5,15.68%,ANK2;RYR2;ATP2A2
prerank,GO_Biological_Process_2021__positive regulation of cardiac muscle hypertrophy (GO:0010613),0.5751429255193182,0.9582251917342424,0.5625,1.0,1.0,5/14,21.02%,AGT;AKAP6;NR4A3;ROCK1;SLC9A1
prerank,GO_Biological_Process_2021__positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),0.47940512582006073,0.9581678207802975,0.5542168674698795,1.0,1.0,14/49,15.83%,TGFB2;AGT;INSR;FN1;IRS2;IGF1R;FGR;NTRK3;FLT1;NTRK2;HCLS1;GAB1;PLXNB1;IL18
prerank,GO_Biological_Process_2021__exonucleolytic catabolism of deadenylated mRNA (GO:0043928),-0.3939821642790059,-0.9580817619958252,0.45,1.0,1.0,4/24,11.60%,NT5C3B;DCP1B;LSM6;EDC3
prerank,GO_Biological_Process_2021__relaxation of muscle (GO:0090075),0.5540053150457022,0.957951816994592,0.5735294117647058,1.0,1.0,2/11,20.66%,RGS2;ATP1A2
prerank,GO_Biological_Process_2021__ribosomal large subunit assembly (GO:0000027),0.5527784831214044,0.957915258994575,0.5897435897435898,1.0,1.0,10/17,31.73%,RPL23A;MRPL20;RPL11;NOP53;RPL24;RPL3;TRAF7;RPL6;RPLP0;MDN1
prerank,GO_Biological_Process_2021__NIK/NF-kappaB signaling (GO:0038061),-0.3581971387502114,-0.9578005016405348,0.2,1.0,1.0,16/62,15.58%,CARD14;PSMB3;PSME3;CHUK;MAP3K14;PSMC4;PSMD12;PSME4;COPS8;TLR3;BIRC2;PSMA1;AKT1;PSMA7;TIRAP;NFKB2
prerank,GO_Biological_Process_2021__maintenance of protein localization in endoplasmic reticulum (GO:0035437),0.5890061705193657,0.957781636831346,0.6515151515151515,1.0,1.0,3/10,13.53%,HSPA5;PDIA2;INSIG1
prerank,GO_Biological_Process_2021__protein glycosylation (GO:0006486),0.46392703546359476,0.9577100509832243,0.574468085106383,1.0,1.0,14/86,16.64%,ALG10B;B4GAT1;MGAT4C;TUSC3;GALNT18;OGA;MGAT1;STT3B;B4GALT5;SERP1;MAGT1;ST8SIA3;PLOD1;GFPT1
prerank,GO_Biological_Process_2021__positive regulation of immune response (GO:0050778),-0.33923358265254216,-0.9575549320046247,0.4166666666666667,1.0,1.0,5/47,3.60%,SKAP1;CCL5;ITGAM;KARS1;LGALS9
prerank,GO_Biological_Process_2021__Ras protein signal transduction (GO:0007265),-0.299766814212637,-0.9572696417411981,0.8333333333333334,1.0,1.0,16/107,10.97%,RALB;GRAP2;RHOG;SETDB1;ARHGDIB;TP53;RAPGEF6;KRAS;USP28;IGF1;ARHGEF1;PLEKHG5;CRKL;GNA12;RASGRP2;CYFIP1
prerank,GO_Biological_Process_2021__glucose 6-phosphate metabolic process (GO:0051156),-0.4683234051420737,-0.9572612464922254,0.4230769230769231,1.0,1.0,3/15,4.41%,G6PC3;PGM2;RPIA
prerank,GO_Biological_Process_2021__regulation of anatomical structure morphogenesis (GO:0022603),0.44356352880017663,0.957158697178292,0.574468085106383,1.0,1.0,16/92,12.45%,SPARC;LRRC4C;SHANK3;MAPT;ZDHHC15;INF2;CDH2;GPNMB;NSMF;SRCIN1;SIPA1L1;CHN1;SH3D19;PPFIA2;CLASP2;EPHA4
prerank,GO_Biological_Process_2021__negative regulation of transport (GO:0051051),0.4959421635363079,0.9569761968050494,0.5853658536585366,1.0,1.0,11/37,26.29%,NRG1;FCGR2B;EPHA3;PXK;MCTP1;ITGAV;HAMP;SYT11;PTEN;TLR2;SCAMP5
prerank,GO_Biological_Process_2021__cellular response to glucocorticoid stimulus (GO:0071385),0.5705735123888485,0.9562708070518506,0.5641025641025641,1.0,1.0,3/11,21.86%,ANXA1;KLF9;HNRNPU
prerank,GO_Biological_Process_2021__transition metal ion transport (GO:0000041),0.5146153476673425,0.956244974799446,0.5641025641025641,1.0,1.0,5/23,9.80%,TFRC;SLC11A1;ATOX1;TTYH1;TRPC4
prerank,GO_Biological_Process_2021__phosphatidylglycerol biosynthetic process (GO:0006655),0.647883320848194,0.9561480523567509,0.5833333333333334,1.0,1.0,2/6,26.39%,CDS2;PGS1
prerank,GO_Biological_Process_2021__cardiac muscle tissue morphogenesis (GO:0055008),-0.4866681636079352,-0.955818704671612,0.5,1.0,1.0,3/12,9.02%,TGFBR3;TGFB1;ENG
prerank,GO_Biological_Process_2021__positive regulation of cytokine production involved in immune response (GO:0002720),0.5340687595450492,0.9557312074157012,0.575,1.0,1.0,4/19,15.06%,TRAF2;CD55;NOD2;WNT5A
prerank,GO_Biological_Process_2021__negative regulation of innate immune response (GO:0045824),0.4541009146954482,0.9557016598055647,0.5061728395061729,1.0,1.0,8/29,26.89%,CR1;TYRO3;SUSD4;IRAK3;SLAMF8;STAT2;FAM3A;CNOT7
prerank,MSigDB_Hallmark_2020__Coagulation,0.46029097977348193,0.9554033994401995,0.6236559139784946,1.0,1.0,8/66,12.08%,THBS1;SPARC;ITGA2;ANXA1;FN1;RAPGEF3;CRIP2;THBD
prerank,GO_Biological_Process_2021__negative regulation of G protein-coupled receptor signaling pathway (GO:0045744),-0.48746210479434293,-0.9552116652298069,0.4583333333333333,1.0,1.0,3/14,10.03%,CCL5;GRK2;PLEK
prerank,GO_Biological_Process_2021__positive regulation of ruffle assembly (GO:1900029),-0.4968685737913696,-0.9550066743205933,0.5172413793103449,1.0,1.0,4/8,12.77%,PFN1;PLEKHM1;P2RY12;DEF8
prerank,GO_Biological_Process_2021__nucleobase-containing compound biosynthetic process (GO:0034654),-0.4972895178606045,-0.9548501273703996,0.52,1.0,1.0,5/11,12.57%,POLD3;ADK;DGUOK;TYMS;AMPD3
prerank,GO_Biological_Process_2021__nucleobase-containing small molecule interconversion (GO:0015949),0.5560076132897164,0.9546859631168514,0.5714285714285714,1.0,1.0,8/20,27.07%,NUDT13;CMPK1;GUK1;NME4;CTPS1;AK5;TXNRD1;AK6
prerank,GO_Biological_Process_2021__mRNA methylation (GO:0080009),-0.47902066689211625,-0.9545434235429731,0.4864864864864865,1.0,1.0,3/13,15.66%,METTL8;METTL16;TRMT6
prerank,GO_Biological_Process_2021__C21-steroid hormone biosynthetic process (GO:0006700),0.6144725544358571,0.9545294018612045,0.6470588235294118,1.0,1.0,2/6,22.68%,AKR1B1;TSPOAP1
prerank,GO_Biological_Process_2021__urate metabolic process (GO:0046415),0.631991000436342,0.9544769282341996,0.5833333333333334,1.0,1.0,3/5,12.55%,SLC2A9;CARMIL1;PRPS1
prerank,GO_Biological_Process_2021__import into cell (GO:0098657),0.48635754977880896,0.9544022744298115,0.6052631578947368,1.0,1.0,3/27,9.72%,LRP2;SNAP25;GLUL
prerank,GO_Biological_Process_2021__positive regulation of receptor signaling pathway via STAT (GO:1904894),-0.4856812149648958,-0.9543678040471543,0.46875,1.0,1.0,1/10,0.45%,CCL5
prerank,GO_Biological_Process_2021__myeloid cell development (GO:0061515),-0.472091885607449,-0.9541036003988888,0.38461538461538464,1.0,1.0,4/14,9.42%,SH2B3;ZNF385A;SRC;NCKAP1L
prerank,GO_Biological_Process_2021__V(D)J recombination (GO:0033151),0.5852323975171982,0.9540899269527319,0.5797101449275363,1.0,1.0,1/9,2.26%,HMGB2
prerank,PanglaoDB_Augmented_2021__Endothelial Cells (Aorta),0.45961663673693987,0.9539400919480814,0.6046511627906976,1.0,1.0,17/70,16.59%,PLPP3;SVEP1;NTN4;TAMALIN;DOCK1;PALLD;FN1;TMTC2;SH3D19;PMP22;THBD;BACE2;UACA;ENPP4;TIMP3;STXBP6;EPAS1
prerank,GO_Biological_Process_2021__hematopoietic progenitor cell differentiation (GO:0002244),-0.44061229186596623,-0.9539297614896884,0.4230769230769231,1.0,1.0,5/15,10.03%,CSF1R;MLF1;TP53;TGFB1;PLEK
prerank,GO_Biological_Process_2021__adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),0.4752522565283917,0.9538793289427786,0.5842696629213483,1.0,1.0,12/42,14.14%,TSHR;ADCY3;ADGRE1;ADGRG6;CNR1;ADGRB2;ABCA1;ADCY8;RXFP1;GPR65;ADGRL2;GNAL
prerank,GO_Biological_Process_2021__regulation of signal transduction by p53 class mediator (GO:1901796),0.45047742202752,0.9536470191508429,0.6326530612244898,1.0,1.0,27/120,24.54%,BRIP1;RPL23;RPA2;PPP1R13L;DNA2;PRR5;TTC5;PRKAG2;RPS20;BRCA1;RPL37;RFC4;RPL11;CHD5;PRKAA2;TAF9B;TAF7;CDK5R1;NOP53;MEAF6;RBBP8;HEXIM1;SETD9;BARD1;RPA3;BANP;PAK1IP1
prerank,GO_Biological_Process_2021__BMP signaling pathway (GO:0030509),0.4894118503029006,0.9536291883492625,0.5662650602409639,1.0,1.0,3/30,4.63%,TGFB2;ACVR2A;BMPR1B
prerank,GO_Biological_Process_2021__cellular response to BMP stimulus (GO:0071773),0.4894118503029006,0.9536291883492625,0.5662650602409639,1.0,1.0,3/30,4.63%,TGFB2;ACVR2A;BMPR1B
prerank,GO_Biological_Process_2021__response to lipid (GO:0033993),0.4727519676369285,0.9535741106013517,0.5957446808510638,1.0,1.0,13/62,15.56%,HMGB2;TMEM161A;ANXA1;SLC11A1;NOCT;RXRB;ABCA2;PAQR7;HNRNPA0;SCD;TRIM16;PELI1;ESR1
prerank,GO_Biological_Process_2021__lipid droplet formation (GO:0140042),-0.5682760968941403,-0.9535740906232568,0.5882352941176471,1.0,1.0,2/6,3.95%,PLA2G4C;ZFYVE1
prerank,GO_Biological_Process_2021__positive regulation of DNA metabolic process (GO:0051054),0.4594494101325969,0.95355594814439,0.5348837209302325,1.0,1.0,9/45,22.15%,TMEM161A;EYA2;STPG4;BRCA1;ZCWPW1;RGCC;ERCC6;NPAS2;GNL3
prerank,GO_Biological_Process_2021__double-strand break repair (GO:0006302),0.44385482718219565,0.9534158971664386,0.6391752577319587,1.0,1.0,15/125,15.17%,BRIP1;CYREN;HMGB2;PIAS4;RPA2;DNA2;EME2;POLQ;DDX1;BRCA1;XRCC3;NSMCE1;KDM4B;FAN1;ACTR5
prerank,GO_Biological_Process_2021__protein depolymerization (GO:0051261),0.5351940597448063,0.9528220470024455,0.569620253164557,1.0,1.0,4/17,15.33%,STMN3;CKAP5;STMN2;CFL1
prerank,GO_Biological_Process_2021__cellular response to leucine starvation (GO:1990253),-0.44751556790777003,-0.9527755806700937,0.48484848484848486,1.0,1.0,3/10,12.49%,SESN2;SESN3;EIF2AK4
prerank,GO_Biological_Process_2021__DNA replication-independent nucleosome organization (GO:0034724),-0.48353967562637407,-0.9526375909966032,0.5294117647058824,1.0,1.0,3/10,14.80%,SUPT16H;UBN1;RBBP4
prerank,GO_Biological_Process_2021__negative regulation of lymphocyte apoptotic process (GO:0070229),-0.5534433830721139,-0.9525697947143177,0.5333333333333333,1.0,1.0,1/6,0.45%,CCL5
prerank,GO_Biological_Process_2021__low-density lipoprotein particle receptor catabolic process (GO:0032802),-0.4623934785741991,-0.9522581298283308,0.5185185185185185,1.0,1.0,1/9,4.16%,CLTA
prerank,GO_Biological_Process_2021__low-density lipoprotein receptor particle metabolic process (GO:0032799),-0.4623934785741991,-0.9522581298283308,0.5185185185185185,1.0,1.0,1/9,4.16%,CLTA
prerank,GO_Biological_Process_2021__regulation of endoplasmic reticulum tubular network organization (GO:1903371),0.6324173252841728,0.9522244434974333,0.6,1.0,1.0,2/5,32.66%,TMEM33;LNPK
prerank,GO_Biological_Process_2021__response to copper ion (GO:0046688),-0.47383428843832326,-0.9517962162197168,0.4444444444444444,1.0,1.0,1/9,2.85%,IL1A
prerank,GO_Biological_Process_2021__post-Golgi vesicle-mediated transport (GO:0006892),0.4460774476152146,0.9517195013622399,0.6170212765957447,1.0,1.0,13/73,20.81%,CLVS1;NAPA;STEAP2;DNAJC6;RP2;SH3D19;SH3GL2;SCAMP3;STXBP6;APP;FTH1;OSBPL5;EXOC5
prerank,GO_Biological_Process_2021__peptidyl-tyrosine autophosphorylation (GO:0038083),-0.4545350638291151,-0.9516161325330282,0.5,1.0,1.0,2/11,3.00%,ITK;DDR1
prerank,GO_Biological_Process_2021__negative regulation of metabolic process (GO:0009892),0.47231137119169336,0.9515747151357931,0.5647058823529412,1.0,1.0,6/38,10.85%,ARRDC3;IL15;ACOT13;RBPJ;NOVA1;CCDC3
prerank,GO_Biological_Process_2021__regulation of extracellular matrix organization (GO:1903053),0.5617320705183617,0.9515228738835275,0.59375,1.0,1.0,1/8,3.59%,AGT
prerank,GO_Biological_Process_2021__negative regulation of release of cytochrome c from mitochondria (GO:0090201),-0.4872988334917506,-0.9514077243427194,0.5666666666666667,1.0,1.0,4/11,14.21%,BCL2L1;IGF1;GPX1;AKT1
prerank,GO_Biological_Process_2021__protein localization to endoplasmic reticulum (GO:0070972),0.5490913574701463,0.9512905630356951,0.6103896103896104,1.0,1.0,7/14,25.61%,HSPA5;ANK2;RYR2;PPP1R15A;LRRK2;DDRGK1;VAPA
prerank,GO_Biological_Process_2021__membrane protein proteolysis (GO:0033619),-0.3936140364129225,-0.951217815615296,0.46153846153846156,1.0,1.0,4/27,11.53%,MYH9;TGFB1;APH1A;HM13
prerank,GO_Biological_Process_2021__transepithelial transport (GO:0070633),0.5796012146319734,0.9510663626423601,0.5945945945945946,1.0,1.0,1/9,3.93%,SLC1A2
prerank,GO_Biological_Process_2021__ATP synthesis coupled proton transport (GO:0015986),0.5281251125995183,0.9509068891321029,0.5975609756097561,1.0,1.0,6/15,21.98%,ATP5ME;ATP5F1A;ATP5F1D;ATP5MC1;ATP5PB;ATP5F1E
prerank,GO_Biological_Process_2021__protein localization to chromosome (GO:0034502),0.5014182551592286,0.9507170956287782,0.5853658536585366,1.0,1.0,2/25,4.68%,SLF1;RPA2
prerank,GO_Biological_Process_2021__protein heterotetramerization (GO:0051290),-0.46249474040399163,-0.9506215262747183,0.4,1.0,1.0,2/11,5.52%,KRT10;FARSA
prerank,GO_Biological_Process_2021__regulation of receptor-mediated endocytosis (GO:0048259),0.5092342989931895,0.9505549590839188,0.6341463414634146,1.0,1.0,14/29,33.08%,ARF6;SGIP1;PICALM;RAB21;SNAP91;HIP1R;HFE;TF;LRPAP1;SMAP1;HIP1;PIK3CB;SERPINE1;BICD1
prerank,GO_Biological_Process_2021__nucleotide-sugar metabolic process (GO:0009225),0.5948743621088466,0.9504511706881066,0.6521739130434783,1.0,1.0,5/7,38.47%,GFPT1;CSGALNACT1;EXTL2;FUT8;GMDS
prerank,GO_Biological_Process_2021__proteolysis (GO:0006508),0.44225037821809104,0.9497524415237815,0.64,1.0,1.0,12/144,12.84%,PCSK1;PAPPA2;FOLH1;SRGN;ERMP1;FBXL2;ST14;SPPL2B;CPM;TYSND1;BACE2;TRHDE
prerank,GO_Biological_Process_2021__negative regulation of plasma membrane bounded cell projection assembly (GO:0120033),0.5269314505698953,0.9496828634479473,0.6025641025641025,1.0,1.0,3/18,9.43%,RAP1GAP;KANK1;TCHP
prerank,GO_Biological_Process_2021__regulation of vascular endothelial growth factor signaling pathway (GO:1900746),0.6089408550304567,0.949635760732066,0.5714285714285714,1.0,1.0,2/8,8.14%,SEMA6A;ROBO1
prerank,GO_Biological_Process_2021__positive regulation of protein sumoylation (GO:0033235),0.6552473553829824,0.9496027210541569,0.6268656716417911,1.0,1.0,1/6,4.44%,PIAS4
prerank,GO_Biological_Process_2021__positive regulation of cell growth (GO:0030307),0.47261519786233785,0.9495146122098584,0.5909090909090909,1.0,1.0,12/67,18.11%,TGFB2;MAPT;CDKN2AIP;SYT4;AKAP6;UNC13A;RIMS2;MFSD2A;SYT1;SDCBP;MAP3K13;TAF9B
prerank,GO_Biological_Process_2021__positive regulation of protein localization to cell cortex (GO:1904778),0.656236301804817,0.9494472908731766,0.5625,1.0,1.0,2/5,18.58%,GNAI1;GPSM2
prerank,GO_Biological_Process_2021__regulation of protein localization to cell cortex (GO:1904776),0.656236301804817,0.9494472908731766,0.5625,1.0,1.0,2/5,18.58%,GNAI1;GPSM2
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030),-0.45419656071763503,-0.9492695610168995,0.4166666666666667,1.0,1.0,7/23,13.78%,GZMB;TP53;BID;PPP1R13B;PPP3CC;CHCHD10;BCL2
prerank,GO_Biological_Process_2021__regulation of protein serine/threonine kinase activity (GO:0071900),-0.3358176164029659,-0.9490259917280837,0.5714285714285714,1.0,1.0,9/69,8.79%,RALB;CCND1;ACTB;DAB2IP;CSF1R;TRIB1;TRIB3;TELO2;SRC
prerank,GO_Biological_Process_2021__rRNA processing (GO:0006364),0.4321108305811504,0.9490242839652336,0.6326530612244898,1.0,1.0,43/148,25.39%,RPL23;RIOK2;WDR12;WDR74;MAK16;RPL37A;PES1;IMP3;RPL38;SBDS;RPS6;RRP1B;RPL23A;RPS25;RPS27;RRP36;NHP2;RPL9;RPLP2;RPL37;RPL14;MPHOSPH6;RPL11;RPS24;RPS9;NOB1;RPL36;UBA52;NOP53;RPL35;RPL4;RPL32;MRTO4;MPHOSPH10;RPL24;RPL27A;RPL3;RPS16;RPL30;WDR3;RPL21;RPL7;RPL12
prerank,GO_Biological_Process_2021__base conversion or substitution editing (GO:0016553),0.6373572033959132,0.9490162476428408,0.5972222222222222,1.0,1.0,2/7,6.63%,NUDT16;ADARB2
prerank,GO_Biological_Process_2021__negative regulation of glycolytic process (GO:0045820),0.6436727154644729,0.9488517228370611,0.6197183098591549,1.0,1.0,4/6,34.00%,FBP1;PPARA;GIT1;HDAC4
prerank,GO_Biological_Process_2021__negative regulation of purine nucleotide metabolic process (GO:1900543),0.6436727154644729,0.9488517228370611,0.6197183098591549,1.0,1.0,4/6,34.00%,FBP1;PPARA;GIT1;HDAC4
prerank,GO_Biological_Process_2021__protein localization to cytoplasmic stress granule (GO:1903608),0.596885198675051,0.9485166325427115,0.6164383561643836,1.0,1.0,3/6,32.04%,DDX1;DDX3X;DHX9
prerank,GO_Biological_Process_2021__sodium ion import across plasma membrane (GO:0098719),0.6019818271710322,0.94779415762252,0.6111111111111112,1.0,1.0,4/9,24.45%,SLC9A7;SLC9A6;SLC9A1;SLC6A1
prerank,GO_Biological_Process_2021__regulation of inflammatory response to antigenic stimulus (GO:0002861),0.47742310859045944,0.9477467498942319,0.5978260869565217,1.0,1.0,9/52,10.89%,TSHR;CD163;HTR7;PRKAR2B;ADCY3;PLK2;FGR;ADCY8;RXFP1
prerank,GO_Biological_Process_2021__hyaluronan catabolic process (GO:0030214),0.5671035224993067,0.9476647924697479,0.5526315789473685,1.0,1.0,4/10,21.98%,CEMIP;CEMIP2;SLC9A1;CHP1
prerank,GO_Biological_Process_2021__ERAD pathway (GO:0036503),0.4322299215993246,0.9476203869793438,0.5425531914893617,1.0,1.0,14/76,17.28%,HSPA5;SEC61B;HERPUD1;TRIM25;RNF175;STT3B;DNAJB2;FBXO27;RNF139;AUP1;DNAJB9;SYVN1;ERLIN1;UBE2J2
prerank,MSigDB_Hallmark_2020__Allograft Rejection,-0.3025964920504886,-0.9475646264541638,0.6,1.0,1.0,30/119,14.74%,STAT4;ITK;CCL5;FLNA;LY86;IL1B;CD2;ETS1;GZMB;ICAM1;CD96;GALNT1;TGFB1;TLR3;HLA-E;IGSF6;BCL3;IKBKB;NLRP3;ITGB2;LCP2;EGFR;ST8SIA4;PRF1;NCK1;EIF5A;BCL10;AKT1;CD247;IL12RB1
prerank,GO_Biological_Process_2021__microtubule-based transport (GO:0099111),0.5962141315590781,0.9475575017988475,0.6119402985074627,1.0,1.0,3/8,21.89%,ADCY10;DYNC1I1;DNAAF2
prerank,GO_Biological_Process_2021__T cell chemotaxis (GO:0010818),0.6195450837201643,0.9475410745678119,0.6206896551724138,1.0,1.0,1/6,14.98%,GPR183
prerank,GO_Biological_Process_2021__protein stabilization (GO:0050821),0.43687929755978444,0.9472042791468388,0.6421052631578947,1.0,1.0,37/137,24.15%,PLPP3;RPL23;SOX4;ANK2;HCFC1;EPHA4;PINK1;CDC37;CAMLG;CDC37L1;BAG3;SYVN1;ATP1B3;TCP1;RPL11;PRKRA;HSPA1B;MTMR9;TAF9B;GTPBP4;ATP1B2;HSPD1;GBA3;GNAQ;RAB21;NOP53;HIP1R;C10ORF90;NAPG;WIZ;FLOT2;PPIB;CHP1;RTN4;MFSD1;PTEN;CCT8
prerank,GO_Biological_Process_2021__estrogen metabolic process (GO:0008210),0.641848422089258,0.9471737292444634,0.6164383561643836,1.0,1.0,1/6,2.19%,CYP3A5
prerank,PanglaoDB_Augmented_2021__Endothelial Cells,0.4580491219673417,0.9469539003433644,0.5638297872340425,1.0,1.0,20/77,18.58%,SPARC;APOLD1;GPM6A;PLAC8;TNS1;LIFR;SRGN;CD55;MFSD2A;CD93;FLT1;THBD;SHROOM4;TIMP3;LDB2;CLIC4;EPAS1;RGCC;IGFBP7;PLEC
prerank,GO_Biological_Process_2021__regulation of hemopoiesis (GO:1903706),0.5939796404788367,0.9467712247562878,0.6029411764705882,1.0,1.0,2/8,8.95%,MAFB;PTN
prerank,GO_Biological_Process_2021__regulation of exosomal secretion (GO:1903541),-0.47887252556848514,-0.9463292191730759,0.5652173913043478,1.0,1.0,1/15,0.87%,SMPD3
prerank,GO_Biological_Process_2021__negative regulation of double-strand break repair (GO:2000780),0.5197674691659399,0.9460769981623289,0.6410256410256411,1.0,1.0,4/24,11.02%,CYREN;FANCB;TFIP11;POLQ
prerank,GO_Biological_Process_2021__homeostasis of number of cells (GO:0048872),-0.5272509384398807,-0.9460497429038639,0.53125,1.0,1.0,1/7,1.00%,CX3CR1
prerank,GO_Biological_Process_2021__muscle cell differentiation (GO:0042692),0.5304323044635886,0.9460302464058352,0.5522388059701493,1.0,1.0,6/16,23.45%,DMD;KDM1A;SGCZ;NEBL;RORA;MEGF10
prerank,GO_Biological_Process_2021__nucleotide metabolic process (GO:0009117),0.5026789589785251,0.9458813705802234,0.5324675324675324,1.0,1.0,7/18,28.17%,CMPK1;DCK;GUK1;NMNAT2;AK5;ME1;PNP
prerank,PanglaoDB_Augmented_2021__Hepatocytes,0.4715591334613348,0.9458312676393671,0.6170212765957447,1.0,1.0,18/48,20.93%,RHOB;TM7SF2;RND3;GHR;GLUL;ALDH6A1;SLC10A1;BNIP3;SAMD5;SCD;OCIAD1;HMGCS1;EPB41L4B;SPTBN1;HAMP;MSMO1;GPAT4;LEPR
prerank,GO_Biological_Process_2021__regulation of microtubule nucleation (GO:0010968),0.5604996914293855,0.9457545021779419,0.6438356164383562,1.0,1.0,4/9,18.00%,CKAP5;EML2;HSPA1B;DCTN1
prerank,GO_Biological_Process_2021__forebrain neuron development (GO:0021884),0.6176779648330213,0.9457400827472182,0.6619718309859155,1.0,1.0,3/5,20.85%,ROBO2;WNT5A;FGFR2
prerank,GO_Biological_Process_2021__establishment of spindle orientation (GO:0051294),-0.46309035691004125,-0.945705792978192,0.35294117647058826,1.0,1.0,2/18,7.58%,NDE1;LLGL2
prerank,GO_Biological_Process_2021__regulation of protein kinase B signaling (GO:0051896),0.43567095024468205,0.9452307428744111,0.631578947368421,1.0,1.0,22/114,15.83%,THBS1;LRP2;FGF1;PPP2R5B;NRG1;CHI3L1;KITLG;PHLPP1;INSR;TXN;IRS2;IGF1R;NTRK3;SEMA5A;NTRK2;HCLS1;MAGI2;GAB1;PINK1;NRG4;ESR1;IL18
prerank,GO_Biological_Process_2021__lymphocyte proliferation (GO:0046651),0.5520988161244312,0.9450119493948734,0.5789473684210527,1.0,1.0,3/13,20.36%,HSPD1;CTPS1;HELLS
prerank,GO_Biological_Process_2021__negative regulation of neuron apoptotic process (GO:0043524),0.48509100114898324,0.9443786319296137,0.5393258426966292,1.0,1.0,13/40,21.27%,PTPRZ1;HIF1A;MAG;RETREG1;TYRO3;NTRK2;CRLF1;SOD2;PINK1;NRBP2;SOD1;CPEB4;CX3CL1
prerank,"GO_Biological_Process_2021__negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518)",0.6007807859734555,0.9443516650547359,0.6266666666666667,1.0,1.0,1/9,9.50%,KDM1A
prerank,GO_Biological_Process_2021__negative regulation of muscle cell apoptotic process (GO:0010656),0.639610472474007,0.9442947488134011,0.6774193548387096,1.0,1.0,2/5,15.46%,ALOX12;BAG3
prerank,GO_Biological_Process_2021__response to purine-containing compound (GO:0014074),0.5764013872194509,0.9442686152229328,0.6578947368421053,1.0,1.0,2/11,9.36%,VGF;RYR2
prerank,MSigDB_Hallmark_2020__Notch Signaling,0.5097829074707508,0.9439518598956826,0.5844155844155844,1.0,1.0,3/19,15.06%,SAP30;RBX1;WNT5A
prerank,GO_Biological_Process_2021__cellular response to nitric oxide (GO:0071732),0.6625500939413133,0.9438131534546319,0.6716417910447762,1.0,1.0,3/5,29.72%,GUCY1B1;KCNC2;FOXO1
prerank,GO_Biological_Process_2021__cellular response to reactive nitrogen species (GO:1902170),0.6625500939413133,0.9438131534546319,0.6716417910447762,1.0,1.0,3/5,29.72%,GUCY1B1;KCNC2;FOXO1
prerank,GO_Biological_Process_2021__protein insertion into mitochondrial membrane (GO:0051204),-0.44152920310636656,-0.9435259715169044,0.5161290322580645,1.0,1.0,1/15,0.88%,MAIP1
prerank,"GO_Biological_Process_2021__negative regulation of mRNA splicing, via spliceosome (GO:0048025)",0.5677214354448821,0.9434883329402509,0.5921052631578947,1.0,1.0,2/13,8.33%,PCBP4;SRSF12
prerank,GO_Biological_Process_2021__negative regulation of signal transduction by p53 class mediator (GO:1901797),0.5516886062224134,0.943351906258007,0.5844155844155844,1.0,1.0,1/13,9.50%,KDM1A
prerank,GO_Biological_Process_2021__positive regulation of phosphate metabolic process (GO:0045937),0.5036142415895573,0.9433460185994381,0.5405405405405406,1.0,1.0,1/18,0.28%,THBS1
prerank,GO_Biological_Process_2021__regulation of stem cell differentiation (GO:2000736),-0.3311715584103276,-0.9432460091937521,0.4444444444444444,1.0,1.0,9/66,8.38%,TCF3;TAL1;PSMB3;PSME3;LMO1;PSMC4;PSMD12;CBFB;PSME4
prerank,GO_Biological_Process_2021__regulation of T-helper 17 cell differentiation (GO:2000319),0.613177369591702,0.9427192883234543,0.5972222222222222,1.0,1.0,1/6,12.23%,NFKBIZ
prerank,GO_Biological_Process_2021__piRNA metabolic process (GO:0034587),-0.5068590818814562,-0.9426086070017019,0.5454545454545454,1.0,1.0,1/6,8.54%,MYBL1
prerank,GO_Biological_Process_2021__transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),0.4479755498577875,0.94185036819113,0.6363636363636364,1.0,1.0,5/74,4.93%,ACVR1B;TGFB2;ACVR2A;BMPR1B;PTPRK
prerank,GO_Biological_Process_2021__parallel actin filament bundle assembly (GO:0030046),0.6250571335278656,0.9416168312241001,0.6461538461538462,1.0,1.0,2/5,7.44%,SPIRE2;FMN2
prerank,GO_Biological_Process_2021__regulation of heterotypic cell-cell adhesion (GO:0034114),0.5504845828345691,0.9416038649128231,0.55,1.0,1.0,1/14,0.30%,KLF4
prerank,GO_Biological_Process_2021__positive regulation of interleukin-13 production (GO:0032736),-0.5538195970937119,-0.9414182897089857,0.5121951219512195,1.0,1.0,2/5,9.22%,LGALS9;HLA-E
prerank,GO_Biological_Process_2021__regulation of neural precursor cell proliferation (GO:2000177),0.593761795225234,0.9412542469177373,0.6285714285714286,1.0,1.0,3/10,9.50%,PTPRZ1;ID2;KDM1A
prerank,GO_Biological_Process_2021__cholesterol homeostasis (GO:0042632),-0.34396764333476115,-0.9410675612082776,0.5,1.0,1.0,8/33,10.45%,NPC2;TTC39B;NPC1;LIMA1;LAMTOR1;LPL;NR1H3;LIPG
prerank,GO_Biological_Process_2021__sterol homeostasis (GO:0055092),-0.34396764333476115,-0.9410675612082776,0.5,1.0,1.0,8/33,10.45%,NPC2;TTC39B;NPC1;LIMA1;LAMTOR1;LPL;NR1H3;LIPG
prerank,GO_Biological_Process_2021__response to sterol (GO:0036314),0.5727343267116173,0.9409887319524264,0.6142857142857143,1.0,1.0,3/9,22.96%,ABCA2;INSIG1;RORA
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902110),-0.44809755490613556,-0.9409635686556475,0.4782608695652174,1.0,1.0,1/8,1.05%,STPG1
prerank,GO_Biological_Process_2021__amide transport (GO:0042886),-0.39293244463442645,-0.9408587893364613,0.4444444444444444,1.0,1.0,3/17,3.71%,ABCG2;FOLR2;SLC46A1
prerank,GO_Biological_Process_2021__phosphatidylethanolamine biosynthetic process (GO:0006646),0.5831761303685918,0.9403280395486447,0.5588235294117647,1.0,1.0,2/9,16.96%,SELENOI;ETNPPL
prerank,GO_Biological_Process_2021__triglyceride metabolic process (GO:0006641),0.5059184526181597,0.9402420963325007,0.6125,1.0,1.0,7/21,30.03%,DGAT1;CAV3;GK;GPAT4;GK5;LPGAT1;SLC27A5
prerank,GO_Biological_Process_2021__telomere maintenance (GO:0000723),-0.38188825278232785,-0.9401287776595678,0.5882352941176471,1.0,1.0,7/35,12.30%,HUS1;POLD3;TPRKB;CTC1;TEP1;LTO1;NBN
prerank,GO_Biological_Process_2021__negative regulation of translation (GO:0017148),0.44942116539075644,0.9395610855992007,0.5698924731182796,1.0,1.0,11/73,17.16%,EIF4A3;RIDA;ENC1;EIF2AK3;DAPK1;PUS7;ZNF540;EIF3E;RNF139;CPEB2;ROCK1
prerank,GO_Biological_Process_2021__regulation of mitochondrial depolarization (GO:0051900),-0.524361866675485,-0.9391268891205944,0.5384615384615384,1.0,1.0,3/5,15.85%,SRC;BCL2;MLLT11
prerank,GO_Biological_Process_2021__cell projection assembly (GO:0030031),-0.48443193058454637,-0.9387595692368139,0.47619047619047616,1.0,1.0,6/17,18.45%,RHOG;NCKAP1L;CYFIP1;GSN;CAPG;CDC42
prerank,GO_Biological_Process_2021__positive regulation of fat cell differentiation (GO:0045600),0.477555136127139,0.9385758474567926,0.5333333333333333,1.0,1.0,7/31,22.15%,ZBTB16;NOCT;ID2;LMO3;NAPEPLD;HNRNPU;AAMDC
prerank,GO_Biological_Process_2021__regulation of neuron differentiation (GO:0045664),0.46413749467082444,0.9379921186276647,0.6,1.0,1.0,13/42,20.68%,BRINP1;NLGN1;ID2;ALK;GPRC5B;IMPACT;NREP;VWC2;ROCK1;CDK5R1;ECT2;TCF4;LRRK2
prerank,GO_Biological_Process_2021__peptidyl-tyrosine phosphorylation (GO:0018108),0.47454371430829406,0.9378953682774375,0.6470588235294118,1.0,1.0,11/46,12.45%,PRLR;IL15;RELN;AATK;INSR;EPHA3;IGF1R;GHR;FGR;FLT1;EPHA4
prerank,GO_Biological_Process_2021__negative regulation of mRNA catabolic process (GO:1902373),0.5184802712604052,0.9378819128886003,0.5569620253164557,1.0,1.0,3/17,8.64%,SLC11A1;NOCT;TENT5A
prerank,GO_Biological_Process_2021__histone deubiquitination (GO:0016578),-0.4028620565603205,-0.9378401462113136,0.625,1.0,1.0,3/14,18.28%,BRCC3;ENY2;TRRAP
prerank,GO_Biological_Process_2021__positive regulation of vascular endothelial growth factor production (GO:0010575),-0.38826365187363954,-0.9376205129292261,0.4375,1.0,1.0,5/14,7.51%,IL1B;IL1A;HPSE;C3;TGFB1
prerank,GO_Biological_Process_2021__positive regulation of small GTPase mediated signal transduction (GO:0051057),0.5046539866965348,0.937557663885892,0.5529411764705883,1.0,1.0,6/20,20.17%,RELN;IRS2;RASGRF1;RASGRP4;ITGAV;NOTCH2
prerank,GO_Biological_Process_2021__negative regulation of proteasomal protein catabolic process (GO:1901799),0.48823919886434536,0.9374304373264754,0.6022727272727273,1.0,1.0,12/31,27.56%,CAMLG;SDCBP;RPL11;ALAD;AQP11;NOP53;HFE;MAP1A;DDRGK1;HSP90AB1;BAG6;USP25
prerank,GO_Biological_Process_2021__positive regulation of histone ubiquitination (GO:0033184),0.6091449233875456,0.9372616460289563,0.5909090909090909,1.0,1.0,2/5,18.85%,KDM1A;CDK9
prerank,GO_Biological_Process_2021__positive regulation of lipid biosynthetic process (GO:0046889),0.528360129846977,0.9371544651714053,0.6585365853658537,1.0,1.0,9/22,27.54%,MID1IP1;MFSD2A;SORBS1;CNEP1R1;PPARA;CHP1;SIRT4;SCARB1;LPGAT1
prerank,GO_Biological_Process_2021__glutathione biosynthetic process (GO:0006750),-0.515424422476083,-0.9370206881886174,0.5714285714285714,1.0,1.0,2/6,13.33%,GCLC;GCLM
prerank,GO_Biological_Process_2021__nonribosomal peptide biosynthetic process (GO:0019184),-0.515424422476083,-0.9370206881886174,0.5714285714285714,1.0,1.0,2/6,13.33%,GCLC;GCLM
prerank,GO_Biological_Process_2021__regulation of developmental growth (GO:0048638),0.49708791230901417,0.9364563706132848,0.6049382716049383,1.0,1.0,8/23,22.12%,INSR;GHR;MFSD2A;PLCB1;APP;OLFM1;SOD1;CTTN
prerank,GO_Biological_Process_2021__neuron apoptotic process (GO:0051402),0.5321782598327685,0.9363545489583532,0.6285714285714286,1.0,1.0,6/16,19.50%,CIT;FAM162A;BNIP3;SCN2A;APP;TNFRSF21
prerank,GO_Biological_Process_2021__modulation by host of viral genome replication (GO:0044827),0.543150737897675,0.9363411184890237,0.618421052631579,1.0,1.0,3/10,25.61%,FBXL2;PPIB;VAPA
prerank,GO_Biological_Process_2021__positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),0.5076435695532648,0.9358854793778469,0.6103896103896104,1.0,1.0,5/17,19.68%,VEGFA;HIF1A;RBPJ;SMAD1;SMAD5
prerank,GO_Biological_Process_2021__positive regulation of establishment of protein localization to telomere (GO:1904851),0.5883142520734488,0.9358647161852576,0.6119402985074627,1.0,1.0,3/9,27.75%,TCP1;CCT8;DKC1
prerank,GO_Biological_Process_2021__negative regulation of insulin receptor signaling pathway (GO:0046627),-0.4124343506642791,-0.9354810587819773,0.5,1.0,1.0,6/20,14.81%,INPP5K;IL1B;PIP4K2B;ENPP1;NCK1;PTPRE
prerank,GO_Biological_Process_2021__positive regulation of developmental process (GO:0051094),0.43725970353544014,0.9354562723427585,0.6391752577319587,1.0,1.0,30/114,17.50%,ACVR1B;COBL;SHANK3;ENPP2;ZBTB16;ZDHHC15;RELN;TFRC;NRXN1;BMPR1B;VEGFA;INSR;PPP1R13L;NLGN1;RAPGEF3;PTN;ALK;CAMK2B;B4GALT5;CLASP2;SOX6;BNIP3;PINK1;WNT5A;CFL1;NR2C2;PLCB1;NEURL1;MAP3K13;DDHD1
prerank,GO_Biological_Process_2021__positive regulation of double-strand break repair via homologous recombination (GO:1905168),0.5679484907208203,0.9350309404734679,0.5857142857142857,1.0,1.0,5/11,29.94%,FANCB;ERCC6;TIMELESS;ARID2;WDR48
prerank,"GO_Biological_Process_2021__antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-independent (GO:0002486)",-0.5652458781841959,-0.9349126757980185,0.5652173913043478,1.0,1.0,1/5,9.22%,HLA-E
prerank,GO_Biological_Process_2021__antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway (GO:0002484),-0.5652458781841959,-0.9349126757980185,0.5652173913043478,1.0,1.0,1/5,9.22%,HLA-E
prerank,"GO_Biological_Process_2021__protein alpha-1,2-demannosylation (GO:0036508)",0.5086580847518823,0.9348343242093763,0.5930232558139535,1.0,1.0,6/22,24.51%,RPS27A;RNF139;SYVN1;UBA52;UBB;MAN1A1
prerank,GO_Biological_Process_2021__regulation of T cell mediated cytotoxicity (GO:0001914),-0.43814025821025326,-0.9347504487768081,0.5357142857142857,1.0,1.0,2/14,14.74%,HLA-E;IL12RB1
prerank,GO_Biological_Process_2021__positive regulation of histone methylation (GO:0031062),0.5151659039757547,0.9346702077306985,0.5633802816901409,1.0,1.0,2/18,12.87%,WDR5;BRCA1
prerank,GO_Biological_Process_2021__carboxylic acid catabolic process (GO:0046395),-0.5506884866846297,-0.9345773702942407,0.6333333333333333,1.0,1.0,4/8,15.20%,IL4I1;NPL;GNPDA1;NAGK
prerank,GO_Biological_Process_2021__negative regulation of smooth muscle cell migration (GO:0014912),-0.48198178847985196,-0.9344905068697114,0.6060606060606061,1.0,1.0,2/11,5.16%,CORO1B;TRIB1
prerank,GO_Biological_Process_2021__regulation of protein polymerization (GO:0032271),0.5008726165861646,0.9344594099736219,0.5783132530120482,1.0,1.0,7/22,23.83%,MAPT;MAP2;HCLS1;TPPP;PAK3;CTTN;ARHGAP18
prerank,GO_Biological_Process_2021__regulation of cellular component size (GO:0032535),-0.38040272577211104,-0.9343874224353865,0.5454545454545454,1.0,1.0,1/26,0.76%,RAB22A
prerank,GO_Biological_Process_2021__cellular component maintenance (GO:0043954),0.5571858642998524,0.9341695896509286,0.5921052631578947,1.0,1.0,2/10,9.30%,INSR;IGF1R
prerank,GO_Biological_Process_2021__negative regulation of smooth muscle contraction (GO:0045986),0.6266087659133206,0.9339270455796016,0.6818181818181818,1.0,1.0,3/5,18.25%,DOCK5;KCNMA1;SOD1
prerank,GO_Biological_Process_2021__regulation of chromatin silencing (GO:0031935),0.5360059214196065,0.9338387819547835,0.589041095890411,1.0,1.0,2/11,23.87%,ATAD2;H1-0
prerank,GO_Biological_Process_2021__male meiosis I (GO:0007141),0.6029348970964664,0.9337406023961922,0.5857142857142857,1.0,1.0,1/6,7.03%,SYCP3
prerank,GO_Biological_Process_2021__positive regulation of cartilage development (GO:0061036),0.5838776226269393,0.9336781436588143,0.6521739130434783,1.0,1.0,3/9,11.78%,ZBTB16;BMPR1B;SOX6
prerank,GO_Biological_Process_2021__protein de-ADP-ribosylation (GO:0051725),0.6275823149024023,0.9333297331281134,0.6567164179104478,1.0,1.0,2/5,21.05%,ADPRS;MACROD1
prerank,GO_Biological_Process_2021__regulation of hydrogen peroxide-induced cell death (GO:1903205),0.5557067411710436,0.9332432988897775,0.6,1.0,1.0,2/8,20.68%,TXN;LRRK2
prerank,GO_Biological_Process_2021__T cell mediated immunity (GO:0002456),0.5528695685831742,0.9332114052648341,0.6086956521739131,1.0,1.0,2/11,5.63%,CADM1;CD55
prerank,GO_Biological_Process_2021__C4-dicarboxylate transport (GO:0015740),0.587563805103363,0.9331080115174313,0.631578947368421,1.0,1.0,1/8,3.93%,SLC1A2
prerank,GO_Biological_Process_2021__DNA recombination (GO:0006310),-0.35835262518533073,-0.932761188211562,0.5882352941176471,1.0,1.0,6/25,17.23%,IGHMBP2;RPAIN;RECQL;HDAC10;FBH1;THAP9
prerank,GO_Biological_Process_2021__histone arginine methylation (GO:0034969),-0.5519575586921719,-0.9327609900524351,0.5588235294117647,1.0,1.0,1/5,6.72%,COPRS
prerank,GO_Biological_Process_2021__negative regulation of oxidative stress-induced cell death (GO:1903202),0.48415106618085735,0.9323853647540169,0.5679012345679012,1.0,1.0,6/20,20.68%,TXN;SOD2;PINK1;HSPB1;FBXO7;LRRK2
prerank,GO_Biological_Process_2021__negative regulation of autophagosome assembly (GO:1902902),0.5294929161196001,0.9323219317975232,0.5974025974025974,1.0,1.0,6/11,33.36%,TMEM39A;PINK1;LRRK2;MTM1;FEZ1;CHMP4B
prerank,GO_Biological_Process_2021__microtubule polymerization (GO:0046785),0.501128413294949,0.9322413602686955,0.5853658536585366,1.0,1.0,5/25,13.36%,MAPT;HDGFL3;CLASP2;CKAP5;TPPP
prerank,GO_Biological_Process_2021__negative regulation of stress-activated MAPK cascade (GO:0032873),-0.3618113874818669,-0.9322339191204392,0.4375,1.0,1.0,5/26,10.32%,ZMYND11;ZNF675;DUSP3;SIRPA;TREM2
prerank,GO_Biological_Process_2021__alpha-beta T cell activation (GO:0046631),0.5969993124944994,0.9320928254825893,0.5972222222222222,1.0,1.0,1/6,3.87%,ANXA1
prerank,GO_Biological_Process_2021__negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),0.47877932204226586,0.9320784456371978,0.6190476190476191,1.0,1.0,6/46,10.41%,ASPN;FBN2;VASN;SPRY1;RPS27A;LTBP1
prerank,GO_Biological_Process_2021__mitotic DNA integrity checkpoint signaling (GO:0044774),-0.4721170838462154,-0.9319704198311806,0.5925925925925926,1.0,1.0,1/8,0.73%,HUS1
prerank,GO_Biological_Process_2021__regulation of dendritic spine maintenance (GO:1902950),0.6004920764794761,0.9318362585815122,0.6,1.0,1.0,2/7,14.52%,FCGR2B;GRIN2B
prerank,GO_Biological_Process_2021__positive regulation of autophagosome maturation (GO:1901098),0.6355817615357637,0.9314905016799943,0.6290322580645161,1.0,1.0,2/5,21.66%,CALCOCO2;FYCO1
prerank,GO_Biological_Process_2021__positive regulation of microglial cell migration (GO:1904141),-0.5447684625478768,-0.9314836691060827,0.5,1.0,1.0,2/5,10.32%,P2RY12;TREM2
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial fission (GO:0090141),0.545081590962156,0.9313410648315501,0.5903614457831325,1.0,1.0,3/14,17.50%,BNIP3;PINK1;DDHD1
prerank,GO_Biological_Process_2021__pre-replicative complex assembly involved in nuclear cell cycle DNA replication (GO:0006267),0.6206049745340199,0.9313391132380715,0.6851851851851852,1.0,1.0,4/6,29.85%,MCMDC2;ORC3;MCM3;MCM6
prerank,"GO_Biological_Process_2021__phagocytosis, engulfment (GO:0006911)",0.47319515493692604,0.931256677294819,0.5512820512820513,1.0,1.0,4/29,5.61%,THBS1;GULP1;DOCK1;FCGR2B
prerank,GO_Biological_Process_2021__negative regulation of protein K63-linked ubiquitination (GO:1900045),0.613500148834855,0.9311791443122474,0.6307692307692307,1.0,1.0,4/6,36.85%,GPS2;UBR5;PLAA;PARP10
prerank,GO_Biological_Process_2021__TORC2 signaling (GO:0038203),0.6037727136823096,0.9310258282727517,0.6323529411764706,1.0,1.0,2/6,13.26%,PRR5;PINK1
prerank,GO_Biological_Process_2021__B cell activation involved in immune response (GO:0002312),0.5515900637324145,0.9309898804373878,0.625,1.0,1.0,2/11,14.98%,FCGR2B;GPR183
prerank,GO_Biological_Process_2021__regulation of T cell mediated immunity (GO:0002709),-0.5058543240802806,-0.9309878056730614,0.52,1.0,1.0,1/7,2.23%,IL1B
prerank,GO_Biological_Process_2021__negative regulation of G0 to G1 transition (GO:0070317),-0.39384740404971597,-0.9309418152234641,0.6666666666666666,1.0,1.0,2/30,3.78%,RING1;DAB2IP
prerank,GO_Biological_Process_2021__regulation of G0 to G1 transition (GO:0070316),-0.39384740404971597,-0.9309418152234641,0.6666666666666666,1.0,1.0,2/30,3.78%,RING1;DAB2IP
prerank,GO_Biological_Process_2021__zinc ion import across plasma membrane (GO:0071578),0.6294208574911504,0.9306568142740903,0.6285714285714286,1.0,1.0,4/5,31.83%,SLC39A12;SLC39A14;SLC39A6;SLC39A8
prerank,GO_Biological_Process_2021__negative regulation of interferon-gamma production (GO:0032689),0.49948291644173926,0.9305667738427053,0.6049382716049383,1.0,1.0,2/16,10.74%,CR1;PDCD1LG2
prerank,GO_Biological_Process_2021__positive regulation of nervous system process (GO:0031646),0.5251029275803987,0.9305261689109721,0.6282051282051282,1.0,1.0,5/15,13.36%,MYRF;RIMS2;PARD3;TNFRSF1B;TPPP
prerank,GO_Biological_Process_2021__epithelial cilium movement involved in extracellular fluid movement (GO:0003351),0.5868058825154798,0.9302935145993464,0.6756756756756757,1.0,1.0,2/10,9.57%,ADCY10;CCDC39
prerank,GO_Biological_Process_2021__glycosphingolipid metabolic process (GO:0006687),0.4772200804816022,0.9298571473220636,0.5662650602409639,1.0,1.0,12/34,20.27%,GLA;ABCA2;ARSA;GALC;UGT8;ST6GALNAC5;ST8SIA3;UGCG;SUMF2;SUMF1;GBA3;STS
prerank,GO_Biological_Process_2021__regulation of interleukin-8 production (GO:0032677),0.4619942314134866,0.9298219483158351,0.5632183908045977,1.0,1.0,3/48,3.87%,KLF4;CHI3L1;ANXA1
prerank,GO_Biological_Process_2021__protein K11-linked deubiquitination (GO:0035871),0.5702703244201703,0.9297691878756015,0.6142857142857143,1.0,1.0,2/8,12.62%,OTUD7B;VCPIP1
prerank,GO_Biological_Process_2021__mRNA 5'-splice site recognition (GO:0000395),0.6338446743231998,0.9291379997558032,0.7058823529411765,1.0,1.0,2/5,18.94%,SRSF12;PRPF39
prerank,GO_Biological_Process_2021__negative regulation of cell-substrate junction organization (GO:0150118),-0.5249799355212316,-0.9290772523780245,0.5714285714285714,1.0,1.0,1/14,0.03%,PHLDB2
prerank,GO_Biological_Process_2021__negative regulation of focal adhesion assembly (GO:0051895),-0.5249799355212316,-0.9290772523780245,0.5714285714285714,1.0,1.0,1/14,0.03%,PHLDB2
prerank,GO_Biological_Process_2021__cellular divalent inorganic cation homeostasis (GO:0072503),0.44149012881147814,0.9288902844895744,0.5217391304347826,1.0,1.0,14/54,21.26%,HTR2B;SLC11A1;SLC24A2;VAPB;ANK2;RYR2;SLC24A1;ATP2A2;SLC24A3;SLC39A12;SLC39A14;ATP13A4;SLC24A4;RMDN3
prerank,PanglaoDB_Augmented_2021__Noradrenergic Neurons,-0.49210318487441096,-0.9288366023449643,0.5151515151515151,1.0,1.0,1/6,0.27%,FGL1
prerank,GO_Biological_Process_2021__positive regulation of supramolecular fiber organization (GO:1902905),0.4549818275012465,0.92859694004095,0.5729166666666666,1.0,1.0,16/60,22.12%,PRKCE;MAPT;ARF6;BAIAP2L1;CAV3;CARMIL1;SEMA5A;STMN2;PYCARD;TOGARAM1;APP;DCTN1;FES;CDK5R1;CX3CL1;CTTN
prerank,GO_Biological_Process_2021__macrophage derived foam cell differentiation (GO:0010742),-0.5511372268618173,-0.9285116363138803,0.5757575757575758,1.0,1.0,3/5,18.82%,TGFB1;EP300;PPARG
prerank,GO_Biological_Process_2021__foam cell differentiation (GO:0090077),-0.5511372268618173,-0.9285116363138803,0.5757575757575758,1.0,1.0,3/5,18.82%,TGFB1;EP300;PPARG
prerank,GO_Biological_Process_2021__regulation of multicellular organism growth (GO:0040014),0.5491828112158195,0.9284852417641574,0.6231884057971014,1.0,1.0,5/12,21.67%,GHR;MFSD2A;APP;SOD1;PPIB
prerank,GO_Biological_Process_2021__synaptic vesicle membrane organization (GO:0048499),-0.4395764876753002,-0.9283580184296998,0.45454545454545453,1.0,1.0,1/15,0.19%,SNAP47
prerank,GO_Biological_Process_2021__cellular response to calcium ion (GO:0071277),0.479850696938794,0.9282609981314254,0.6395348837209303,1.0,1.0,17/44,26.81%,SYT4;NLGN1;ADCY8;RYR3;SYT1;WNT5A;CLIC4;IQGAP1;PRKAA2;ECT2;CPNE8;CPNE2;SYT11;CPNE3;SYT9;SLC25A24;ADCY1
prerank,GO_Biological_Process_2021__regulation of interleukin-2 production (GO:0032663),0.4610245837535593,0.9279191678157418,0.6,1.0,1.0,4/36,10.68%,CR1;ANXA1;TRAF2;PDE4B
prerank,GO_Biological_Process_2021__regulation of focal adhesion assembly (GO:0051893),-0.33902453340752986,-0.927889341751289,0.6428571428571429,1.0,1.0,1/45,0.03%,PHLDB2
prerank,GO_Biological_Process_2021__glucose homeostasis (GO:0042593),0.46018279457040234,0.9277487465873784,0.5842696629213483,1.0,1.0,13/52,20.93%,SOX4;PDK4;INSR;HIF1A;CAV3;RPS6;IGF1R;ADCY8;BACE2;KLF7;PRKAA2;NR1D1;LEPR
prerank,GO_Biological_Process_2021__lipid translocation (GO:0034204),0.5168120900941655,0.9276294542953292,0.6375,1.0,1.0,8/21,28.64%,ATP8B1;ABCA1;ATP10B;ABCB4;ATP10A;ATP8A2;ATP9A;ATP11A
prerank,GO_Biological_Process_2021__glucosamine-containing compound catabolic process (GO:1901072),0.6059394743752353,0.9276252076384294,0.6417910447761194,1.0,1.0,2/6,12.51%,CHI3L1;AMDHD2
prerank,GO_Biological_Process_2021__regulation of glucose import (GO:0046324),0.503854509469368,0.9275778690362827,0.6091954022988506,1.0,1.0,5/24,12.09%,INSR;GRB10;IRS2;PRKAG2;SORBS1
prerank,GO_Biological_Process_2021__axon regeneration (GO:0031103),0.5877675734106623,0.9273959639481658,0.6176470588235294,1.0,1.0,4/7,36.21%,NREP;RTN4RL1;GAP43;DHFR
prerank,GO_Biological_Process_2021__negative regulation of cation channel activity (GO:2001258),0.552453449229289,0.9272603107407769,0.5833333333333334,1.0,1.0,3/11,22.47%,CALM3;CLIC2;GNB5
prerank,GO_Biological_Process_2021__glycerol metabolic process (GO:0006071),0.6328065376968149,0.9270296931710386,0.6507936507936508,1.0,1.0,4/6,31.12%,GK;COQ2;GK5;GOT1
prerank,GO_Biological_Process_2021__positive regulation of response to cytokine stimulus (GO:0060760),0.555783286796654,0.9268297672655249,0.5866666666666667,1.0,1.0,2/11,15.06%,IL7;WNT5A
prerank,GO_Biological_Process_2021__positive regulation of hydrolase activity (GO:0051345),0.4537430394071907,0.9265833051268781,0.6739130434782609,1.0,1.0,18/90,21.27%,RAP1GAP;HMGB2;MTCL1;RGS1;RAPGEF3;CALM3;PINK1;PLXNB1;RASGRF1;PICALM;THY1;MTMR9;PKP4;EZH2;GBA3;ECT2;TBC1D2;CX3CL1
prerank,GO_Biological_Process_2021__oligosaccharide-lipid intermediate biosynthetic process (GO:0006490),-0.43515037161916037,-0.9264869774949736,0.5714285714285714,1.0,1.0,2/11,13.35%,ALG1;ALG2
prerank,GO_Biological_Process_2021__peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine (GO:0018231),0.5240219878989456,0.926124810072371,0.6708860759493671,1.0,1.0,2/17,3.00%,CLIP3;ZDHHC15
prerank,GO_Biological_Process_2021__peptidyl-L-cysteine S-palmitoylation (GO:0018230),0.5240219878989456,0.926124810072371,0.6708860759493671,1.0,1.0,2/17,3.00%,CLIP3;ZDHHC15
prerank,GO_Biological_Process_2021__phosphatidylcholine metabolic process (GO:0046470),0.46344517463627205,0.9260084023757054,0.6222222222222222,1.0,1.0,13/42,25.92%,ENPP2;MBOAT2;MFSD2A;SLC44A5;PEMT;PNPLA8;CHPT1;SLC44A1;GPAT4;DBI;LPCAT4;MBOAT7;PCTP
prerank,GO_Biological_Process_2021__positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725),-0.5406457033754151,-0.9259272106656647,0.6071428571428571,1.0,1.0,1/5,2.23%,IL1B
prerank,GO_Biological_Process_2021__modification-dependent macromolecule catabolic process (GO:0043632),0.5782691501393094,0.9256851898788159,0.6133333333333333,1.0,1.0,3/8,18.81%,RPS27A;UBA52;UBB
prerank,GO_Biological_Process_2021__cytoplasmic pattern recognition receptor signaling pathway (GO:0002753),0.5044014535559966,0.9252325239823455,0.6190476190476191,1.0,1.0,5/25,18.81%,RPS27A;NOD2;RIPK2;UBA52;UBB
prerank,GO_Biological_Process_2021__nucleoside metabolic process (GO:0009116),0.6086824899510874,0.9251511763544386,0.6527777777777778,1.0,1.0,4/8,28.16%,UPP2;NME4;MACROD1;TYMP
prerank,PanglaoDB_Augmented_2021__Osteoclasts,0.4255944098152129,0.9247944219433746,0.6494845360824743,1.0,1.0,21/109,17.63%,GRM8;CD163;ITGA2;TNS1;CHI3L1;F13A1;LTB4R;CA2;HIF1A;MAFB;ABCA1;TNFRSF11B;CD93;THBD;SNX10;TGFBI;ESR1;CEBPD;ITGAV;KCNMA1;SLC39A14
prerank,GO_Biological_Process_2021__glycogen biosynthetic process (GO:0005978),-0.4751898263089407,-0.9240388626707817,0.5517241379310345,1.0,1.0,1/9,1.12%,PGM2
prerank,GO_Biological_Process_2021__glucan biosynthetic process (GO:0009250),-0.4751898263089407,-0.9240388626707817,0.5517241379310345,1.0,1.0,1/9,1.12%,PGM2
prerank,GO_Biological_Process_2021__replication fork processing (GO:0031297),0.47678106561917966,0.9235120515156675,0.5925925925925926,1.0,1.0,5/27,18.85%,DNA2;FANCM;EME2;ZGRF1;CDK9
prerank,GO_Biological_Process_2021__negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),0.4514721576395656,0.9234890455569111,0.6144578313253012,1.0,1.0,12/31,22.96%,NLRP12;TLE1;PER1;OTUD7B;PYCARD;ESR1;GSTP1;RHOH;NR1D1;TNIP1;STAT1;RORA
prerank,GO_Biological_Process_2021__early endosome to Golgi transport (GO:0034498),-0.44480837051399397,-0.9234469090867996,0.4594594594594595,1.0,1.0,4/11,24.27%,TRAPPC10;STX5;LMAN1;SNX1
prerank,GO_Biological_Process_2021__Notch signaling involved in heart development (GO:0061314),0.6049302045723207,0.9233561265023728,0.6470588235294118,1.0,1.0,2/5,20.17%,RBPJ;NOTCH2
prerank,GO_Biological_Process_2021__positive regulation of pattern recognition receptor signaling pathway (GO:0062208),-0.48161522405268575,-0.9232728130256699,0.6153846153846154,1.0,1.0,2/11,8.55%,ZDHHC5;TLR3
prerank,GO_Biological_Process_2021__regulation of granulocyte chemotaxis (GO:0071622),0.5703886544272054,0.9231808976986725,0.6962025316455697,1.0,1.0,1/11,0.28%,THBS1
prerank,GO_Biological_Process_2021__protein maturation by iron-sulfur cluster transfer (GO:0097428),-0.4275369531867108,-0.9231656660424062,0.6190476190476191,1.0,1.0,7/12,25.40%,LTO1;MMS19;CISD3;CIAO2B;NFU1;ISCA1;YAE1
prerank,GO_Biological_Process_2021__bone development (GO:0060348),0.5154603059276083,0.9230140898994176,0.6097560975609756,1.0,1.0,7/21,22.53%,SH3PXD2B;RANBP3L;SBDS;SULF2;FGFR2;PPIB;PTGER4
prerank,MSigDB_Hallmark_2020__Inflammatory Response,0.4279463588777324,0.9229703675859506,0.6391752577319587,1.0,1.0,25/120,15.83%,NAMPT;ACVR1B;TACR1;IL15;OSMR;SLC1A2;ACVR2A;RGS1;ADGRE1;RNF144B;KIF1B;CD55;HIF1A;ABCA1;MXD1;ITGB8;C5AR1;PDE4B;NOD2;RIPK2;TNFRSF1B;GPR183;SLC31A2;ATP2A2;IL18
prerank,GO_Biological_Process_2021__positive regulation of myoblast differentiation (GO:0045663),0.5776432877177661,0.9224798825911333,0.6428571428571429,1.0,1.0,3/9,16.96%,RANBP3L;AKIRIN1;PLCB1
prerank,GO_Biological_Process_2021__peptide hormone secretion (GO:0030072),0.537794899665624,0.9224044926221692,0.6666666666666666,1.0,1.0,2/12,9.12%,ANXA1;RIMS2
prerank,GO_Biological_Process_2021__steroid hormone biosynthetic process (GO:0120178),-0.43002744847409635,-0.9223732046480532,0.5172413793103449,1.0,1.0,2/12,6.52%,CYP19A1;SRD5A1
prerank,GO_Biological_Process_2021__regulation of cyclase activity (GO:0031279),-0.5612953330971242,-0.9221880567472983,0.5128205128205128,1.0,1.0,1/5,9.17%,CAP1
prerank,GO_Biological_Process_2021__receptor signaling pathway via JAK-STAT (GO:0007259),-0.4179539872434123,-0.9221625709834484,0.55,1.0,1.0,1/20,0.13%,STAT4
prerank,GO_Biological_Process_2021__positive regulation of collagen metabolic process (GO:0010714),0.563339351254589,0.9221545306073912,0.6619718309859155,1.0,1.0,1/8,1.62%,VIM
prerank,GO_Biological_Process_2021__response to potassium ion (GO:0035864),0.6165730547304047,0.9217100758652966,0.6617647058823529,1.0,1.0,4/5,37.13%,DLG4;CRHBP;SLC12A2;DLG2
prerank,GO_Biological_Process_2021__cellular response to potassium ion (GO:0035865),0.6165730547304047,0.9217100758652966,0.6617647058823529,1.0,1.0,4/5,37.13%,DLG4;CRHBP;SLC12A2;DLG2
prerank,GO_Biological_Process_2021__3'-UTR-mediated mRNA stabilization (GO:0070935),-0.4522062977692891,-0.9215698467288735,0.5862068965517241,1.0,1.0,5/12,15.53%,ELAVL4;ELAVL1;MAPKAPK2;TIRAP;ZFP36
prerank,GO_Biological_Process_2021__positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity (GO:2000373),0.6169713216196956,0.9215574387291422,0.6470588235294118,1.0,1.0,4/5,35.19%,HNRNPU;UHRF1;DHX9;SETMAR
prerank,GO_Biological_Process_2021__regulation of DNA topoisomerase (ATP-hydrolyzing) activity (GO:2000371),0.6169713216196956,0.9215574387291422,0.6470588235294118,1.0,1.0,4/5,35.19%,HNRNPU;UHRF1;DHX9;SETMAR
prerank,GO_Biological_Process_2021__positive regulation of mRNA binding (GO:1902416),0.6293525465868774,0.9205460917970494,0.6,1.0,1.0,4/5,30.47%,EIF3E;CDK9;EIF3D;EIF4G1
prerank,GO_Biological_Process_2021__homocysteine metabolic process (GO:0050667),0.6338526984272616,0.9204555228777805,0.6833333333333333,1.0,1.0,1/5,13.22%,BLMH
prerank,GO_Biological_Process_2021__cellular response to hepatocyte growth factor stimulus (GO:0035729),-0.5379956312989864,-0.920256939999068,0.5882352941176471,1.0,1.0,1/6,4.51%,APPL2
prerank,GO_Biological_Process_2021__response to hepatocyte growth factor (GO:0035728),-0.5379956312989864,-0.920256939999068,0.5882352941176471,1.0,1.0,1/6,4.51%,APPL2
prerank,GO_Biological_Process_2021__rRNA catabolic process (GO:0016075),-0.47685792190026377,-0.9200546083682497,0.5517241379310345,1.0,1.0,5/11,26.07%,EXOSC10;EXOSC9;EXOSC8;EXOSC2;XRN1
prerank,"GO_Biological_Process_2021__regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",0.4695277146484926,0.9200011134504815,0.6145833333333334,1.0,1.0,6/42,12.50%,RBFOX2;SRSF12;CELF2;KHDRBS2;NOVA1;RBM5
prerank,GO_Biological_Process_2021__brain morphogenesis (GO:0048854),0.5485185026967663,0.9196122590516183,0.6197183098591549,1.0,1.0,4/10,23.76%,SHANK3;CTNNA2;VPS51;PTEN
prerank,GO_Biological_Process_2021__integrin-mediated signaling pathway (GO:0007229),0.4593321837997555,0.9195834354062171,0.6818181818181818,1.0,1.0,12/49,16.93%,PLPP3;ITGA2;DOCK1;ADAM15;FN1;PTN;FGR;ITGB8;THY1;ITGAV;TXK;TEC
prerank,GO_Biological_Process_2021__activation of GTPase activity (GO:0090630),0.4487978434076543,0.919546510150488,0.6413043478260869,1.0,1.0,16/72,22.63%,RAP1GAP;TBC1D8;TBC1D13;SIPA1L1;NGEF;NTRK3;TBC1D15;GPR65;APC2;RASGRF1;ECT2;TBC1D2;CCDC125;TBC1D14;ARHGAP42;GARNL3
prerank,GO_Biological_Process_2021__negative regulation of peptide hormone secretion (GO:0090278),-0.4748763470926109,-0.919188207178845,0.5357142857142857,1.0,1.0,3/8,16.20%,FFAR4;REST;MIDN
prerank,GO_Biological_Process_2021__regulation of cholesterol metabolic process (GO:0090181),-0.47027235964317393,-0.919045941678039,0.47619047619047616,1.0,1.0,2/15,1.98%,TTC39B;ARV1
prerank,GO_Biological_Process_2021__positive regulation of regulatory T cell differentiation (GO:0045591),0.5568273713461257,0.918973376879247,0.6323529411764706,1.0,1.0,3/10,17.23%,CR1;DUSP10;BCL6
prerank,GO_Biological_Process_2021__histone modification (GO:0016570),0.4382933901090557,0.9189117547312395,0.6451612903225806,1.0,1.0,13/86,26.67%,NEK11;EYA2;RUVBL2;INCENP;MTA3;TBL1XR1;MORF4L2;EZH2;UHRF1;SUDS3;ATXN7L3;TAF6L;PRMT1
prerank,GO_Biological_Process_2021__ubiquitin-dependent ERAD pathway (GO:0030433),0.4202967644488013,0.9188972251708803,0.5957446808510638,1.0,1.0,13/64,17.28%,HSPA5;SEC61B;HERPUD1;TRIM25;RNF175;STT3B;DNAJB2;FBXO27;AUP1;DNAJB9;SYVN1;ERLIN1;UBE2J2
prerank,GO_Biological_Process_2021__tRNA export from nucleus (GO:0006409),-0.370707186586266,-0.9187998761593204,0.625,1.0,1.0,6/32,13.88%,NUP42;NUP155;NUP188;NUP214;RAE1;XPOT
prerank,GO_Biological_Process_2021__tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431),-0.370707186586266,-0.9187998761593204,0.625,1.0,1.0,6/32,13.88%,NUP42;NUP155;NUP188;NUP214;RAE1;XPOT
prerank,GO_Biological_Process_2021__regulation of collagen biosynthetic process (GO:0032965),0.5630600174220839,0.9185443004224557,0.6285714285714286,1.0,1.0,1/8,1.62%,VIM
prerank,GO_Biological_Process_2021__negative regulation of RNA splicing (GO:0033119),0.5221232448119119,0.918274799900837,0.64,1.0,1.0,2/18,8.33%,PCBP4;SRSF12
prerank,GO_Biological_Process_2021__phosphorylation (GO:0016310),0.4173887374327806,0.9181256462264061,0.72,1.0,1.0,47/306,18.04%,HTR2B;DAPK2;ACVR1B;CDK14;NEK11;TGFB2;PRKCE;ACVR2A;DGKI;AATK;BMPR1B;PDK4;EIF2AK3;PRRT1;INSR;DAPK1;NIM1K;PXK;LIMD1;DGKB;PLK2;FGR;ALK;CLK2;LIPE;EPHA7;CAMK2B;PRKAG2;FAM20A;PAK5;DGKG;PINK1;GK;MAPK10;PDK3;NUAK2;CTBP1;TXK;TEC;GRK4;NRBP2;GMFB;ROCK1;MAP3K13;APP;PIK3R4;PRKAA2
prerank,GO_Biological_Process_2021__regulation of complement activation (GO:0030449),0.5215963626926396,0.9179413140267088,0.6428571428571429,1.0,1.0,4/20,13.15%,CR1;CD55;C5AR1;SUSD4
prerank,GO_Biological_Process_2021__regulation of calcineurin-NFAT signaling cascade (GO:0070884),0.5136940215601353,0.9178423846039642,0.6125,1.0,1.0,7/16,30.02%,AKAP6;TNF;SLC9A1;CHP1;ATP2B4;PRNP;CAMTA1
prerank,GO_Biological_Process_2021__regulation of translational termination (GO:0006449),-0.5583388917327055,-0.9177621728919909,0.5757575757575758,1.0,1.0,3/7,23.84%,UPF1;SHFL;GSPT1
prerank,GO_Biological_Process_2021__anion transport (GO:0006820),0.527318050402332,0.9177040374395056,0.5952380952380952,1.0,1.0,3/17,6.67%,SLCO1A2;SLC13A4;SLC13A3
prerank,GO_Biological_Process_2021__amyloid-beta metabolic process (GO:0050435),-0.49747996488542967,-0.9176812290944732,0.6071428571428571,1.0,1.0,2/10,7.64%,IDE;APH1A
prerank,GO_Biological_Process_2021__neurotransmitter uptake (GO:0001504),0.5932472686608303,0.9176627770998921,0.625,1.0,1.0,3/6,20.66%,SNAP25;GLUL;ATP1A2
prerank,GO_Biological_Process_2021__regulation of Ras protein signal transduction (GO:0046578),0.4490115101223844,0.9176445240415321,0.6458333333333334,1.0,1.0,15/64,21.85%,TGFB2;ARF6;KANK1;SPRY1;IRS2;ARFGAP1;FBP1;RASGRF1;RASGRP4;ARHGDIA;STARD13;NOTCH2;MFN2;RDX;STARD8
prerank,GO_Biological_Process_2021__response to fatty acid (GO:0070542),0.5782483601209368,0.9175729472239699,0.6891891891891891,1.0,1.0,3/9,15.59%,PDK4;SCD;PDK3
prerank,GO_Biological_Process_2021__regulation of mRNA metabolic process (GO:1903311),-0.48001167936747324,-0.9174789607033892,0.56,1.0,1.0,5/11,26.62%,CDK11B;SAFB;SUPT6H;SAFB2;SRPK1
prerank,GO_Biological_Process_2021__negative regulation of chromatin silencing (GO:0031936),0.5447443676586846,0.9167942416517887,0.6,1.0,1.0,2/9,23.87%,ATAD2;H1-0
prerank,GO_Biological_Process_2021__negative regulation of chromatin organization (GO:1905268),0.5447443676586846,0.9167942416517887,0.6,1.0,1.0,2/9,23.87%,ATAD2;H1-0
prerank,GO_Biological_Process_2021__negative regulation of gene silencing (GO:0060969),0.5447443676586846,0.9167942416517887,0.6,1.0,1.0,2/9,23.87%,ATAD2;H1-0
prerank,GO_Biological_Process_2021__carbohydrate derivative catabolic process (GO:1901136),0.5487707214403388,0.9167692925315614,0.6716417910447762,1.0,1.0,3/12,13.11%,OGA;STT3B;FBXO27
prerank,GO_Biological_Process_2021__regulation of interferon-gamma production (GO:0032649),-0.3352952182837692,-0.9167004521237246,0.625,1.0,1.0,16/52,15.36%,BTN3A2;IL1B;CD276;CD2;LGALS9;LILRB4;CD274;SIRPA;TLR3;HLA-DPA1;CD226;TLR7;IL18R1;HAVCR2;IL12RB1;BTN3A1
prerank,GO_Biological_Process_2021__negative regulation of protein localization to cell periphery (GO:1904376),-0.43542412947485315,-0.9165886615393819,0.6190476190476191,1.0,1.0,5/14,13.53%,BCL2L1;ABI3;TGFB1;DAB2;PPFIA1
prerank,PanglaoDB_Augmented_2021__Gamma Delta T Cells,0.49636321122567395,0.9165702079469356,0.6623376623376623,1.0,1.0,3/25,2.26%,TOP2A;CENPF;HMGB2
prerank,GO_Biological_Process_2021__negative regulation of regulated secretory pathway (GO:1903306),0.5947619039844747,0.9164600416422347,0.6774193548387096,1.0,1.0,1/6,5.98%,SYT4
prerank,GO_Biological_Process_2021__positive regulation of signal transduction (GO:0009967),0.41444128054879564,0.9164127133988231,0.6836734693877551,1.0,1.0,25/156,13.64%,FGF1;TGFB2;SHANK3;RELN;NRXN1;CDKN2AIP;IL7;HIF1A;GRB10;NLGN3;KANK1;NLGN1;ROBO1;PDCL;RIMS2;RBPJ;NTRK3;NOD2;LMO3;TMEM108;SASH1;SORBS1;SULF2;LANCL2;TRIM16
prerank,GO_Biological_Process_2021__cognition (GO:0050890),0.4703197560151322,0.9163309451238421,0.625,1.0,1.0,8/30,20.20%,TUSC3;MFSD2A;C5AR1;GPR155;SHROOM4;MAGT1;APP;TNF
prerank,GO_Biological_Process_2021__retinal ganglion cell axon guidance (GO:0031290),0.58986073596129,0.915958084496429,0.6724137931034483,1.0,1.0,2/6,7.99%,ROBO2;ALCAM
prerank,GO_Biological_Process_2021__chromatin assembly (GO:0031497),0.45567519082461216,0.9159200116551642,0.6046511627906976,1.0,1.0,2/40,2.98%,HMGB2;H2BC11
prerank,GO_Biological_Process_2021__regulation of protein ADP-ribosylation (GO:0010835),-0.564513760199239,-0.9159131899231346,0.5675675675675675,1.0,1.0,2/6,16.05%,PUM3;WARS1
prerank,GO_Biological_Process_2021__positive regulation of cysteine-type endopeptidase activity (GO:2001056),0.45589369683086955,0.9157503759847972,0.6588235294117647,1.0,1.0,14/41,24.61%,DAPK1;GRIN2A;RIPK2;CYCS;UACA;ASPH;GRIN2B;PYCARD;AIM2;CIDEB;TNF;GRAMD4;CASP1;DDX3X
prerank,GO_Biological_Process_2021__regulation of DNA metabolic process (GO:0051052),0.4724370816477571,0.9153705695465403,0.6707317073170732,1.0,1.0,1/34,1.31%,TOM1L1
prerank,GO_Biological_Process_2021__negative regulation of protein modification process (GO:0031400),0.44429001705005755,0.9147783614101309,0.6774193548387096,1.0,1.0,10/65,13.87%,PLPP3;MAPT;DMD;PAQR3;NTRK3;IMPACT;IBTK;SH3GL2;TPPP;PPP1R15A
prerank,GO_Biological_Process_2021__protein import into mitochondrial matrix (GO:0030150),0.5360918494344035,0.9141295764480807,0.6376811594202898,1.0,1.0,3/10,23.66%,TOMM20;GRPEL1;TOMM40
prerank,PanglaoDB_Augmented_2021__Transient Cells,0.4444814888503293,0.914092916090434,0.6195652173913043,1.0,1.0,12/65,16.59%,RAP1GAP;COBL;DOCK1;GNA11;ST14;PLXNB1;HDLBP;CPE;EPB41L4B;ITGAV;MTUS1;EPAS1
prerank,GO_Biological_Process_2021__integrin activation (GO:0033622),0.5611698683438505,0.9138162868612734,0.5882352941176471,1.0,1.0,3/7,21.27%,FN1;COL16A1;CX3CL1
prerank,GO_Biological_Process_2021__negative regulation of ion transmembrane transporter activity (GO:0032413),0.5300332397532864,0.9135886249680735,0.6049382716049383,1.0,1.0,2/13,8.38%,PRKCE;CAV3
prerank,GO_Biological_Process_2021__positive regulation of lamellipodium morphogenesis (GO:2000394),0.6296269499651898,0.9135309599363628,0.7230769230769231,1.0,1.0,1/6,2.08%,ENPP2
prerank,GO_Biological_Process_2021__regulation of fatty acid beta-oxidation (GO:0031998),0.6050189347224162,0.9133727523095898,0.6349206349206349,1.0,1.0,4/8,19.04%,IRS2;MFSD2A;TYSND1;PPARA
prerank,GO_Biological_Process_2021__regulation of mitochondrial membrane permeability (GO:0046902),-0.4460389286081248,-0.9132758525274561,0.6206896551724138,1.0,1.0,1/10,1.84%,BCL2L1
prerank,GO_Biological_Process_2021__high-density lipoprotein particle remodeling (GO:0034375),0.5647972654270447,0.9131370917999576,0.64,1.0,1.0,4/9,25.54%,PLTP;ABCA5;ABCG1;SCARB1
prerank,GO_Biological_Process_2021__negative regulation of cilium assembly (GO:1902018),0.5582552234463386,0.9130773663068816,0.6923076923076923,1.0,1.0,5/9,25.80%,TCHP;ODF2L;CDK10;LIMK2;CCP110
prerank,GO_Biological_Process_2021__regulation of cAMP-mediated signaling (GO:0043949),0.521686957866086,0.913075899744871,0.6329113924050633,1.0,1.0,4/16,12.76%,PRKAR2B;PEX5L;PDE2A;GNAI1
prerank,GO_Biological_Process_2021__regulation of cell-substrate junction assembly (GO:0090109),0.5073031372046538,0.9130572875282703,0.6162790697674418,1.0,1.0,5/20,21.02%,GPM6B;EPHA3;LIMCH1;ROCK1;SLC9A1
prerank,GO_Biological_Process_2021__calcium ion import across plasma membrane (GO:0098703),0.579752873936044,0.9127556131506157,0.7,1.0,1.0,2/9,10.68%,SLC24A2;SLC24A1
prerank,GO_Biological_Process_2021__calcium ion import into cytosol (GO:1902656),0.579752873936044,0.9127556131506157,0.7,1.0,1.0,2/9,10.68%,SLC24A2;SLC24A1
prerank,GO_Biological_Process_2021__purine ribonucleoside monophosphate metabolic process (GO:0009167),0.5139974687955357,0.9126619522106638,0.6883116883116883,1.0,1.0,7/16,33.92%,PAICS;PFAS;HPRT1;IMPDH1;NT5C2;PPAT;GART
prerank,GO_Biological_Process_2021__negative regulation of amyloid precursor protein biosynthetic process (GO:0042985),0.6190825378632707,0.9125532214532214,0.6338028169014085,1.0,1.0,1/5,12.65%,BACE2
prerank,GO_Biological_Process_2021__ncRNA processing (GO:0034470),0.4059716955095735,0.9125196756724261,0.7171717171717171,1.0,1.0,47/170,25.39%,RPL23;WDR12;WDR74;RPL37A;INTS12;PES1;IMP3;RPL38;SBDS;RPS6;RRP1B;RPL23A;RPS25;RPS27;RRP36;RPL9;INTS3;RPLP2;RPL37;RPL14;MPHOSPH6;RPL11;RPS24;RPS9;SMAD1;PRKRA;NOB1;RPL36;INTS8;UBA52;NOP53;RPL35;RPL4;RPL32;MRTO4;MPHOSPH10;INTS6;RPL24;RPL27A;RPL3;RPS16;INTS10;RPL30;WDR3;RPL21;RPL7;RPL12
prerank,GO_Biological_Process_2021__positive regulation of monocyte differentiation (GO:0045657),0.5795515022037698,0.9122783767296858,0.6619718309859155,1.0,1.0,2/7,22.07%,FES;CTNNBIP1
prerank,GO_Biological_Process_2021__regulation of fatty acid oxidation (GO:0046320),0.5641405207454976,0.9122222716885213,0.6144578313253012,1.0,1.0,7/11,25.32%,PDK4;TYSND1;PRKAG2;NR4A3;PPARA;SIRT4;PPARGC1A
prerank,GO_Biological_Process_2021__positive regulation of protein modification process (GO:0031401),0.42662571115683884,0.9118761974273986,0.711340206185567,1.0,1.0,20/141,13.92%,ALG10B;FGF1;CLIP3;FAXDC2;TFRC;ACVR2A;VEGFA;GPNMB;PPP2R5A;NSMF;INSR;SLCO3A1;RAPGEF3;CALM3;TXN;NTRK3;FAM20A;NTRK2;PINK1;LIMCH1
prerank,GO_Biological_Process_2021__negative regulation of cytoskeleton organization (GO:0051494),0.48515574950016055,0.9118068514462442,0.6025641025641025,1.0,1.0,8/24,24.50%,SHANK3;KANK1;CAV3;IQCJ-SCHIP1;HIP1R;SSH2;TJP1;TWF1
prerank,GO_Biological_Process_2021__negative regulation of telomere maintenance (GO:0032205),-0.40656405768892173,-0.911780720471032,0.6521739130434783,1.0,1.0,4/12,18.72%,NBN;TERF2;SMG6;ERCC4
prerank,GO_Biological_Process_2021__cellular response to glucose starvation (GO:0042149),0.48745365947259905,0.9116492907691915,0.6,1.0,1.0,12/33,24.09%,HSPA5;EIF2AK3;NIM1K;IMPACT;PRKAG2;NUAK2;PIK3R4;PRKAA2;SESN1;CPEB4;FOXO3;BRSK1
prerank,GO_Biological_Process_2021__cytosolic transport (GO:0016482),0.4373805963129417,0.9116221654040387,0.7244897959183674,1.0,1.0,2/101,1.16%,RHOBTB3;DENND2A
prerank,GO_Biological_Process_2021__ribosome disassembly (GO:0032790),-0.49159520164711407,-0.9116217609394376,0.6410256410256411,1.0,1.0,3/7,28.04%,MTIF3;GFM2;MRRF
prerank,"GO_Biological_Process_2021__heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process (GO:0015014)",0.6249712900574557,0.911401974753694,0.7246376811594203,1.0,1.0,4/6,28.69%,HS2ST1;NDST3;CSGALNACT1;EXT1
prerank,GO_Biological_Process_2021__regulation of ruffle assembly (GO:1900027),-0.4475006957347589,-0.9111085990906864,0.5,1.0,1.0,6/14,12.77%,PFN1;EVL;ABI3;PLEKHM1;P2RY12;DEF8
prerank,GO_Biological_Process_2021__lipoprotein transport (GO:0042953),0.5811376014574396,0.9103486670104199,0.6451612903225806,1.0,1.0,5/7,31.61%,VMP1;PRKCB;MIA3;LRP1;ZDHHC17
prerank,GO_Biological_Process_2021__extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625),-0.38793621214491647,-0.90997861956412,0.5,1.0,1.0,4/23,7.86%,ZDHHC3;DAB2IP;DELE1;BID
prerank,GO_Biological_Process_2021__regulation of cell death (GO:0010941),0.4103163196372708,0.9098967560877742,0.6292134831460674,1.0,1.0,17/66,21.98%,HTR2B;DCC;SOX4;BNIP3L;IMPACT;RIPK2;TNFRSF1B;BNIP3;CIDEB;DUS2;HSPA1B;UBB;NPAS2;LRRK2;CDKN1B;ATG5;CHP1
prerank,GO_Biological_Process_2021__positive regulation of collagen biosynthetic process (GO:0032967),0.5633542272561706,0.9098134679070103,0.6527777777777778,1.0,1.0,1/7,1.62%,VIM
prerank,GO_Biological_Process_2021__positive regulation of telomere maintenance via telomere lengthening (GO:1904358),-0.35149535478115385,-0.909559577406978,0.5263157894736842,1.0,1.0,2/30,9.48%,PKIB;MAP3K4
prerank,GO_Biological_Process_2021__somatic recombination of immunoglobulin genes involved in immune response (GO:0002204),-0.49818295995357176,-0.9094578389659578,0.6296296296296297,1.0,1.0,4/7,23.72%,RNF8;RNF168;MSH6;MSH2
prerank,GO_Biological_Process_2021__regulation of plasma membrane bounded cell projection assembly (GO:0120032),0.41674780718379606,0.9091793397996566,0.6236559139784946,1.0,1.0,7/53,10.32%,TBC1D8;ARF6;TBC1D13;MYO10;ATP8B1;DYNC2LI1;TBC1D15
prerank,"GO_Biological_Process_2021__RNA splicing, via transesterification reactions (GO:0000375)",0.48026489221453683,0.9090988248314361,0.6527777777777778,1.0,1.0,6/24,21.82%,GEMIN2;DBR1;BCAS2;WDR83;PRPF6;MPHOSPH10
prerank,GO_Biological_Process_2021__negative regulation of locomotion (GO:0040013),0.5388255244070996,0.90852266583363,0.6301369863013698,1.0,1.0,4/9,20.90%,FRMD5;SPOCK3;SPINT2;CCDC125
prerank,GO_Biological_Process_2021__negative regulation of calcium ion transmembrane transport (GO:1903170),0.5902518264764711,0.9084404602614596,0.6901408450704225,1.0,1.0,1/6,4.91%,SESTD1
prerank,GO_Biological_Process_2021__cellular response to nutrient levels (GO:0031669),-0.34363678617873983,-0.9083402374941062,0.5714285714285714,1.0,1.0,5/44,9.86%,RALB;ZFYVE1;CLEC16A;WIPI1;LPL
prerank,GO_Biological_Process_2021__negative regulation of potassium ion transmembrane transporter activity (GO:1901017),0.5897551916370489,0.9082650463843972,0.6666666666666666,1.0,1.0,1/6,8.38%,CAV3
prerank,GO_Biological_Process_2021__negative regulation of nitric oxide biosynthetic process (GO:0045019),0.6182363902100189,0.9082623695665145,0.7101449275362319,1.0,1.0,1/5,2.27%,GLA
prerank,GO_Biological_Process_2021__negative regulation of nitric oxide metabolic process (GO:1904406),0.6182363902100189,0.9082623695665145,0.7101449275362319,1.0,1.0,1/5,2.27%,GLA
prerank,GO_Biological_Process_2021__positive regulation of I-kappaB phosphorylation (GO:1903721),-0.5584767011319636,-0.907651582128274,0.625,1.0,1.0,1/6,1.00%,CX3CR1
prerank,GO_Biological_Process_2021__negative regulation of cellular protein metabolic process (GO:0032269),0.4351760389364223,0.9073865063538271,0.6067415730337079,1.0,1.0,8/69,7.83%,EIF4A3;RIDA;ENC1;EIF2AK3;DAPK1;PUS7;CAMK2N1;ZNF540
prerank,GO_Biological_Process_2021__positive regulation of purine nucleotide biosynthetic process (GO:1900373),0.572866491749037,0.9071955926738169,0.7333333333333333,1.0,1.0,4/8,25.32%,PINK1;PPARA;ENO1;PPARGC1A
prerank,GO_Biological_Process_2021__positive regulation of ATP biosynthetic process (GO:2001171),0.572866491749037,0.9071955926738169,0.7333333333333333,1.0,1.0,4/8,25.32%,PINK1;PPARA;ENO1;PPARGC1A
prerank,GO_Biological_Process_2021__positive regulation of adenylate cyclase activity (GO:0045762),-0.5765701246526109,-0.9067889951577823,0.5945945945945946,1.0,1.0,2/5,15.01%,STIM1;CACNA1D
prerank,GO_Biological_Process_2021__protein ADP-ribosylation (GO:0006471),0.49023310697939343,0.906484444784026,0.6455696202531646,1.0,1.0,7/24,32.89%,SIRT5;ZC3HAV1;SIRT3;SIRT4;PARP9;TIPARP;PARP11
prerank,GO_Biological_Process_2021__mitochondrial DNA replication (GO:0006264),0.5505983098544922,0.9064630109085177,0.5694444444444444,1.0,1.0,3/7,21.42%,DNA2;POLG2;TEFM
prerank,GO_Biological_Process_2021__aromatic amino acid family metabolic process (GO:0009072),-0.497299907758094,-0.9063742139843912,0.525,1.0,1.0,2/5,4.42%,THAP4;IL4I1
prerank,GO_Biological_Process_2021__zinc ion transmembrane transport (GO:0071577),-0.41304790184068435,-0.9063287734914216,0.45161290322580644,1.0,1.0,1/14,1.69%,SLC30A5
prerank,PanglaoDB_Augmented_2021__Pulmonary Alveolar Type II Cells,0.46630380781600383,0.9063129490583515,0.6105263157894737,1.0,1.0,10/50,15.94%,KLF4;CLDN18;ALOX15B;ST14;THBD;CRLF1;FBP1;SCD;ALDH1A1;CEBPD
prerank,GO_Biological_Process_2021__regulation of Notch signaling pathway (GO:0008593),0.46387676429868263,0.9061637987363187,0.6808510638297872,1.0,1.0,4/50,10.87%,TGFB2;MFNG;RBPJ;NOD2
prerank,GO_Biological_Process_2021__long-chain fatty acid biosynthetic process (GO:0042759),0.5252546836930813,0.9060546653825948,0.5797101449275363,1.0,1.0,4/11,17.54%,ALOX12;ALOX15B;LTA4H;GSTP1
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte activation (GO:0051251),-0.39620313830455806,-0.9059402928608319,0.5909090909090909,1.0,1.0,5/20,12.54%,TICAM1;SIRPA;NCKAP1L;HLA-DPA1;TYROBP
prerank,GO_Biological_Process_2021__positive regulation of protein modification by small protein conjugation or removal (GO:1903322),0.4508789890308048,0.9056812703102317,0.6875,1.0,1.0,11/54,22.15%,PIAS4;SEPTIN4;FANCI;PRICKLE1;RIPK2;BRCA1;PINK1;UBB;LRRK2;TNIP1;GNL3
prerank,GO_Biological_Process_2021__response to molecule of bacterial origin (GO:0002237),0.47069324597857737,0.9052830754359908,0.6704545454545454,1.0,1.0,7/38,17.56%,HMGB2;SLC11A1;NOCT;FCGR2B;HNRNPA0;PELI1;FOXP1
prerank,GO_Biological_Process_2021__sensory perception of pain (GO:0019233),0.5823914300952386,0.9051817629543943,0.6538461538461539,1.0,1.0,2/7,8.50%,NIPSNAP1;RETREG1
prerank,GO_Biological_Process_2021__maintenance of protein localization in organelle (GO:0072595),-0.3826564775849909,-0.9051191799350119,0.7272727272727273,1.0,1.0,7/17,17.71%,ARL2BP;TAPT1;BCL3;CHCHD10;AKT1;TAF8;TAF3
prerank,GO_Biological_Process_2021__aerobic respiration (GO:0009060),0.4962453426574931,0.9050006450398257,0.6585365853658537,1.0,1.0,6/18,28.48%,NDUFS8;ATP5F1D;UQCRC1;SIRT3;NDUFS7;UQCRC2
prerank,GO_Biological_Process_2021__protein-containing complex assembly (GO:0065003),0.402064674393761,0.9046942923660877,0.7171717171717171,1.0,1.0,36/201,21.27%,SH3PXD2B;TLE1;NAPA;FBXL7;DMD;TRAF2;TCF7;TCF7L1;FN1;BOK;GSDMD;WASF1;DARS1;ADCY8;RBX1;SEC24C;PDE4DIP;MCFD2;PPID;PARD3;NSF;AIM2;PICALM;TMED10;TRAPPC6B;GRIA1;TNFRSF1A;FANCA;DLG4;KNTC1;TNF;LRRK2;COL16A1;SLC9A1;NAPG;CX3CL1
prerank,GO_Biological_Process_2021__regulation of response to biotic stimulus (GO:0002831),0.47909564464188786,0.9045510270042001,0.6428571428571429,1.0,1.0,7/26,21.87%,FCGR2B;CD55;TRIM5;FGR;FOXP1;CX3CL1;APPL1
prerank,GO_Biological_Process_2021__double-strand break repair via classical nonhomologous end joining (GO:0097680),0.5582227044764394,0.9044137301517192,0.5806451612903226,1.0,1.0,1/6,17.68%,ERCC6
prerank,GO_Biological_Process_2021__purine ribonucleotide biosynthetic process (GO:0009152),0.4722643793345303,0.9043952959539884,0.6888888888888889,1.0,1.0,6/34,12.93%,ADCY3;PAPSS2;ADCY10;ACAT1;ADCY8;GUCY1B1
prerank,GO_Biological_Process_2021__cardiac epithelial to mesenchymal transition (GO:0060317),0.5478762013685694,0.9042680097760242,0.6461538461538462,1.0,1.0,3/9,9.26%,TGFB2;SPRY1;RBPJ
prerank,GO_Biological_Process_2021__regulation of myotube differentiation (GO:0010830),-0.40006308261761997,-0.9042092835634215,0.6,1.0,1.0,5/15,20.44%,TMEM119;BHLHE41;MAML1;FBXO22;HDAC5
prerank,GO_Biological_Process_2021__cellular response to ketone (GO:1901655),0.4689890639314476,0.9041742836118232,0.627906976744186,1.0,1.0,5/26,16.67%,ADCY3;ADAM15;ADCY8;GNAI1;KLF9
prerank,GO_Biological_Process_2021__protein deubiquitination involved in ubiquitin-dependent protein catabolic process (GO:0071947),0.6042738754891763,0.9036847954254221,0.6206896551724138,1.0,1.0,1/5,12.22%,OTUD7B
prerank,GO_Biological_Process_2021__angiotensin-activated signaling pathway (GO:0038166),0.6280841441826159,0.903362021066648,0.6619718309859155,1.0,1.0,1/5,6.90%,CA2
prerank,GO_Biological_Process_2021__regulation of neuroinflammatory response (GO:0150077),-0.44062559706265336,-0.903166321928554,0.5384615384615384,1.0,1.0,4/10,10.32%,IL1B;IGF1;CD200R1;TREM2
prerank,GO_Biological_Process_2021__phagosome acidification (GO:0090383),0.47884566666031964,0.9030803533702543,0.64,1.0,1.0,7/21,26.87%,RAB20;ATP6V0B;SLAMF8;ATP6V1B2;ATP6V0E2;ATP6V1D;ATP6V1E2
prerank,GO_Biological_Process_2021__cellular response to cadmium ion (GO:0071276),-0.4108483208241815,-0.9030142051325967,0.5238095238095238,1.0,1.0,3/15,14.21%,CHUK;EGFR;AKT1
prerank,GO_Biological_Process_2021__nucleic acid phosphodiester bond hydrolysis (GO:0090305),-0.30094190324311687,-0.902776058265951,0.6923076923076923,1.0,1.0,6/53,4.08%,MEI4;PDE12;GTF2H5;POLD3;GTF2H2;DDB2
prerank,GO_Biological_Process_2021__cellular response to amyloid-beta (GO:1904646),0.4444833411954077,0.9027037732167652,0.6410256410256411,1.0,1.0,6/27,17.45%,FCGR2B;GRIN2A;IGF1R;EPHA4;CACNA1A;APP
prerank,GO_Biological_Process_2021__positive regulation of lipase activity (GO:0060193),0.5974333050264479,0.9026383496937895,0.6323529411764706,1.0,1.0,3/5,38.94%,FGFR2;FGFR1;FGFR3
prerank,GO_Biological_Process_2021__regulation of chemokine production (GO:0032642),0.4724194324664343,0.9023423327675081,0.6511627906976745,1.0,1.0,9/27,17.56%,EGR1;ALOX15B;IL7;HIF1A;PYCARD;WNT5A;IL18;APP;FOXP1
prerank,GO_Biological_Process_2021__regulation of T cell proliferation (GO:0042129),0.44792935701239833,0.9022974137005932,0.6629213483146067,1.0,1.0,5/39,5.36%,CR1;IL15;TFRC;ANXA1;GPNMB
prerank,GO_Biological_Process_2021__regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),0.4955194820976788,0.9019335809110628,0.6666666666666666,1.0,1.0,2/22,4.25%,TGFB2;ACVR2A
prerank,GO_Biological_Process_2021__production of siRNA involved in RNA interference (GO:0030422),0.5911617964355322,0.9018419744520596,0.6805555555555556,1.0,1.0,2/7,28.85%,PRKRA;DICER1
prerank,GO_Biological_Process_2021__mitotic DNA replication checkpoint signaling (GO:0033314),-0.494196559267145,-0.9015166922410442,0.6363636363636364,1.0,1.0,1/6,0.73%,HUS1
prerank,GO_Biological_Process_2021__negative regulation of small molecule metabolic process (GO:0062014),0.5659328943733872,0.9015113243631331,0.6714285714285714,1.0,1.0,1/5,10.55%,CLK2
prerank,GO_Biological_Process_2021__heterocycle biosynthetic process (GO:0018130),-0.5193443020478024,-0.9014297733600677,0.6666666666666666,1.0,1.0,3/8,18.09%,ALOX5;MOCS1;MOCS2
prerank,GO_Biological_Process_2021__hexose metabolic process (GO:0019318),0.497230623740035,0.9013663917827675,0.7142857142857143,1.0,1.0,6/23,24.02%,IRS2;FBP1;SORD;PGM1;GAA;GALM
prerank,GO_Biological_Process_2021__carboxylic acid transmembrane transport (GO:1905039),0.46927717603034236,0.9013620110556925,0.6341463414634146,1.0,1.0,6/28,21.00%,SLC38A4;SLC13A3;SLC25A21;SLC16A1;SLC38A10;SLC5A6
prerank,GO_Biological_Process_2021__positive regulation of extracellular matrix disassembly (GO:0090091),-0.5369972134103425,-0.9011701254802096,0.5882352941176471,1.0,1.0,1/5,2.66%,FSCN1
prerank,GO_Biological_Process_2021__regulation of establishment of protein localization to telomere (GO:0070203),0.5579994197852212,0.9011105601240658,0.6811594202898551,1.0,1.0,3/10,27.75%,TCP1;CCT8;DKC1
prerank,GO_Biological_Process_2021__transcription initiation from RNA polymerase III promoter (GO:0006384),0.6216450920311081,0.9007303647950705,0.6571428571428571,1.0,1.0,1/5,13.58%,POLR3H
prerank,GO_Biological_Process_2021__negative regulation of nucleic acid-templated transcription (GO:1903507),0.4139132234465597,0.9005094719212029,0.81,1.0,1.0,55/305,20.96%,KLF4;CENPF;NFIL3;HMGB2;TLE1;ZBTB16;NRG1;TSHZ3;PIAS4;RORB;PTPRK;ARID5B;ZNF93;SUV39H2;RUNX1T1;SFMBT1;RBFOX2;ATP8B1;ZNF540;YEATS2;BHLHE40;KCTD1;ID2;LIMD1;RBPJ;KDM1A;PER1;PRICKLE1;DEAF1;HINFP;BRCA1;LANCL2;RLIM;YAF2;DPF3;HIC2;WNT5A;MTA3;CTBP1;PLCB1;BCL6;FOXP1;ZBTB18;EZH2;TAF7;NKX6-2;CDK5R1;TIMELESS;TNF;ENO1;NR1D1;BASP1;CDKN1B;MTERF3;CBX5
prerank,GO_Biological_Process_2021__negative regulation of cellular macromolecule biosynthetic process (GO:2000113),0.41002359123160265,0.899878450199676,0.82,1.0,1.0,64/369,20.96%,KLF4;CENPF;NFIL3;HMGB2;TLE1;EIF4A3;ZBTB16;RIDA;NRG1;TSHZ3;ENC1;PIAS4;RORB;PTPRK;ARID5B;ZNF93;SUV39H2;EIF2AK3;RUNX1T1;DAPK1;SFMBT1;RBFOX2;PUS7;ATP8B1;ZNF540;YEATS2;BHLHE40;KCTD1;ID2;LIMD1;RBPJ;KDM1A;PER1;PRICKLE1;DEAF1;HINFP;BRCA1;LANCL2;RNF139;RLIM;YAF2;DPF3;HIC2;WNT5A;MTA3;CTBP1;PLCB1;BCL6;FOXP1;ZBTB18;GTPBP4;EZH2;TAF7;NKX6-2;CDK5R1;TIMELESS;SAMD4A;TNF;ENO1;NR1D1;BASP1;CDKN1B;MTERF3;CBX5
prerank,GO_Biological_Process_2021__regulation of leukocyte migration (GO:0002685),0.532441701863289,0.8997814628833084,0.6266666666666667,1.0,1.0,2/11,5.04%,ANXA1;VEGFA
prerank,GO_Biological_Process_2021__negative regulation of cell differentiation (GO:0045596),0.4199843964834551,0.8995324651034754,0.6808510638297872,1.0,1.0,28/96,23.76%,ZBTB16;MEIS2;RORB;VASN;NOCT;RUNX1T1;OVOL2;PKP2;SPRY1;RANBP3L;ID2;ABCA1;LIMD1;SRA1;ABCA5;NELFB;WNT5A;ITGAV;SUZ12;PPARA;TNF;HNRNPU;ANKRD26;PDCD4;ABCG1;RORA;GPS2;PTEN
prerank,GO_Biological_Process_2021__regulation of substrate adhesion-dependent cell spreading (GO:1900024),0.46656791024992045,0.8994843888328546,0.6470588235294118,1.0,1.0,5/35,9.76%,DOCK1;DOCK5;KANK1;CSPG5;CARMIL1
prerank,GO_Biological_Process_2021__negative regulation of phosphoprotein phosphatase activity (GO:0032515),0.5125147015967042,0.8994701457379306,0.6265060240963856,1.0,1.0,5/17,20.20%,MASTL;PPP4R4;PPP1R15A;ROCK1;TNF
prerank,GO_Biological_Process_2021__relaxation of cardiac muscle (GO:0055119),0.5356600240902887,0.8994467642369317,0.6615384615384615,1.0,1.0,2/12,20.66%,RGS2;ATP1A2
prerank,GO_Biological_Process_2021__positive regulation of smoothened signaling pathway (GO:0045880),0.5604156457615077,0.8993880866221534,0.6461538461538462,1.0,1.0,2/9,15.28%,PDCL;TXNDC15
prerank,GO_Biological_Process_2021__positive regulation of phospholipase C activity (GO:0010863),0.46093928199721357,0.8993395139521452,0.6144578313253012,1.0,1.0,9/25,18.82%,HTR2B;NTRK3;C5AR1;FLT1;NTRK2;ESR1;RASGRP4;TXK;GNAQ
prerank,GO_Biological_Process_2021__snRNA processing (GO:0016180),0.5303708016560154,0.8992592461291159,0.6962025316455697,1.0,1.0,5/13,24.04%,INTS12;INTS3;INTS8;INTS6;INTS10
prerank,GO_Biological_Process_2021__regulation of MDA-5 signaling pathway (GO:0039533),0.6235915700663517,0.8988346614099291,0.7014925373134329,1.0,1.0,3/5,37.06%,RIOK3;C1QBP;DHX58
prerank,GO_Biological_Process_2021__regulation of GTPase activity (GO:0043087),0.4203632663855145,0.8987846197202671,0.7157894736842105,1.0,1.0,31/124,22.47%,RAP1GAP;RGS1;EPHA3;STMN3;SIPA1L1;NGEF;CHN1;RAPGEF3;RRP1B;TBC1D15;NTRK2;EPHA4;PLXNB1;EPHA5;RASGRF1;CPEB2;PICALM;THY1;FGD6;PLXNC1;PKP4;FGD4;SOD1;EZH2;ECT2;TBC1D2;LRRK2;CX3CL1;RDX;VAV3;GNB5
prerank,GO_Biological_Process_2021__positive regulation of cardiac muscle cell proliferation (GO:0060045),-0.5019561537377155,-0.898747343709211,0.5769230769230769,1.0,1.0,1/10,0.57%,TGFBR3
prerank,GO_Biological_Process_2021__retinal rod cell development (GO:0046548),0.5982921012276394,0.8985968440108216,0.6229508196721312,1.0,1.0,1/5,4.88%,RORB
prerank,GO_Biological_Process_2021__retinal rod cell differentiation (GO:0060221),0.5982921012276394,0.8985968440108216,0.6229508196721312,1.0,1.0,1/5,4.88%,RORB
prerank,GO_Biological_Process_2021__positive regulation of leukocyte activation (GO:0002696),0.5514853211862685,0.8984494091953559,0.6447368421052632,1.0,1.0,1/11,0.28%,THBS1
prerank,GO_Biological_Process_2021__positive regulation of B cell receptor signaling pathway (GO:0050861),0.5668119297240138,0.8981705248013357,0.6486486486486487,1.0,1.0,2/6,22.53%,FOXP1;PRKCB
prerank,GO_Biological_Process_2021__snRNA metabolic process (GO:0016073),0.5232065352318592,0.8981692650284123,0.6835443037974683,1.0,1.0,5/14,24.04%,INTS12;INTS3;INTS8;INTS6;INTS10
prerank,GO_Biological_Process_2021__regulation of organelle assembly (GO:1902115),0.42810486323691804,0.8981579564414175,0.6931818181818182,1.0,1.0,14/63,23.39%,TBC1D8;TBC1D13;VPS11;DYNC2LI1;PLK2;TBC1D15;NPRL2;TBC1D2;C10ORF90;ATG5;RDX;TBC1D14;RAB5A;PDCD6IP
prerank,GO_Biological_Process_2021__regulation of rhodopsin mediated signaling pathway (GO:0022400),0.5597752523438845,0.8980546051034025,0.6753246753246753,1.0,1.0,4/9,36.10%,GRK4;PDE6B;FNTA;CAMKMT
prerank,GO_Biological_Process_2021__antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),-0.3797250390583189,-0.8979027861340484,0.6086956521739131,1.0,1.0,3/28,9.22%,IDE;ERAP2;HLA-E
prerank,GO_Biological_Process_2021__mitochondrial tRNA processing (GO:0090646),0.6060704751030905,0.8977144998100783,0.7142857142857143,1.0,1.0,2/5,21.82%,TRNT1;TRMT10C
prerank,GO_Biological_Process_2021__metaphase/anaphase transition of mitotic cell cycle (GO:0007091),0.5587044706670459,0.897698703245171,0.6575342465753424,1.0,1.0,2/6,30.09%,TACC3;ANAPC7
prerank,GO_Biological_Process_2021__metaphase/anaphase transition of cell cycle (GO:0044784),0.5587044706670459,0.897698703245171,0.6575342465753424,1.0,1.0,2/6,30.09%,TACC3;ANAPC7
prerank,GO_Biological_Process_2021__negative regulation of hydrolase activity (GO:0051346),0.4808159070074957,0.8976542565692096,0.6125,1.0,1.0,11/28,21.98%,SH2D4A;MAP2;RRP1B;NEIL1;CPEB2;SLC39A14;LRRK2;ZCCHC9;RDX;ATP5IF1;CHP1
prerank,GO_Biological_Process_2021__positive regulation of phospholipase activity (GO:0010518),-0.4115623673238179,-0.8976073232772472,0.6111111111111112,1.0,1.0,1/15,0.45%,CCL5
prerank,GO_Biological_Process_2021__negative regulation of protein kinase activity (GO:0006469),0.4332416208630588,0.8975495046995267,0.7362637362637363,1.0,1.0,19/67,21.98%,SH3BP5;SRCIN1;CAMK2N1;PTPRT;CAV3;GSKIP;DEPTOR;PRKAG2;PPM1E;PYCARD;DUSP10;THY1;HSPB1;GSTP1;GNAQ;TAF7;SH3BP5L;CDKN1B;CHP1
prerank,GO_Biological_Process_2021__P-body assembly (GO:0033962),0.531094595769862,0.8972612190907939,0.6052631578947368,1.0,1.0,2/12,11.90%,LIMD1;DYNC1H1
prerank,GO_Biological_Process_2021__intracellular protein transmembrane transport (GO:0065002),0.45825003782468804,0.8971573242568962,0.6436781609195402,1.0,1.0,8/32,26.04%,HSPA5;SEC61B;TOMM20;GRPEL1;HSPD1;TOMM40;PEX10;SRP54
prerank,GO_Biological_Process_2021__secondary palate development (GO:0062009),0.5710595307023795,0.8970603267026787,0.6447368421052632,1.0,1.0,1/7,1.28%,TGFB2
prerank,GO_Biological_Process_2021__negative regulation of protein import (GO:1904590),0.6003923465457662,0.8966290251955479,0.7014925373134329,1.0,1.0,3/6,34.64%,CHP1;CABP1;MDFIC
prerank,GO_Biological_Process_2021__negative regulation of protein import into nucleus (GO:0042308),0.6003923465457662,0.8966290251955479,0.7014925373134329,1.0,1.0,3/6,34.64%,CHP1;CABP1;MDFIC
prerank,GO_Biological_Process_2021__positive regulation of viral transcription (GO:0050434),-0.3908156595424243,-0.8964615566668076,0.5652173913043478,1.0,1.0,2/22,3.15%,GTF2F1;CTDP1
prerank,GO_Biological_Process_2021__regulation of vascular endothelial cell proliferation (GO:1905562),0.4826219697821891,0.8964561492014984,0.6575342465753424,1.0,1.0,1/13,11.67%,FLT1
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle cell differentiation (GO:1905063),-0.5584409926166016,-0.8960640021965767,0.625,1.0,1.0,2/6,9.02%,NFATC3;ENG
prerank,GO_Biological_Process_2021__acetyl-CoA metabolic process (GO:0006084),0.5488225242265068,0.8959024819213908,0.6447368421052632,1.0,1.0,4/11,20.77%,MVD;ACAT1;HMGCS1;ACACB
prerank,GO_Biological_Process_2021__leucine transport (GO:0015820),0.590058437991427,0.8957500676083046,0.6065573770491803,1.0,1.0,1/5,3.24%,SLC6A15
prerank,MSigDB_Hallmark_2020__Reactive Oxygen Species Pathway,0.4567927705458875,0.895665927199898,0.6395348837209303,1.0,1.0,8/40,18.57%,ERCC2;ATOX1;GLRX2;TXN;SOD2;SOD1;FES;PRDX4
prerank,PanglaoDB_Augmented_2021__Airway Epithelial Cells,0.5458370610905037,0.8955126215425432,0.6119402985074627,1.0,1.0,3/7,26.65%,CLCA4;CFTR;DUOX1
prerank,GO_Biological_Process_2021__positive regulation of translational initiation (GO:0045948),-0.40947107863665627,-0.8953713211265897,0.6176470588235294,1.0,1.0,1/16,0.45%,CCL5
prerank,GO_Biological_Process_2021__actin crosslink formation (GO:0051764),0.5337725607977191,0.8948380491339213,0.6455696202531646,1.0,1.0,2/9,6.73%,GAS2L3;BAIAP2L1
prerank,GO_Biological_Process_2021__striated muscle contraction (GO:0006941),0.5265057556104802,0.8948037185038636,0.6538461538461539,1.0,1.0,3/19,9.36%,SCN3B;DMD;RYR2
prerank,GO_Biological_Process_2021__metal ion transport (GO:0030001),0.42812402933437477,0.8947212536152589,0.6559139784946236,1.0,1.0,12/58,16.91%,LRP2;GRIN3A;SLC11A1;TUSC3;RYR2;TRPC4;CACNA1B;SLC24A1;RYR3;MAGT1;CACNA1A;CACNG8
prerank,GO_Biological_Process_2021__protein transport (GO:0015031),0.40100254570935406,0.8946100153121792,0.8,1.0,1.0,43/272,22.91%,CENPF;LRP2;ARRDC3;TBC1D8;TFRC;NAPA;ARF6;RAB3C;TVP23A;TBC1D13;ANK3;RAB20;RAB15;ABCA1;TXNIP;TBC1D15;NSF;LRP1B;VMP1;SCAMP3;TMED10;PREPL;SNX17;SPTBN1;KIF3A;ARRDC2;STXBP2;SCG5;RAB21;STX2;ATP6V0B;TBC1D2;STX19;NAPG;TBC1D14;HSP90B1;ATP6V1B2;RAB5A;CTTN;HFE;PRKCB;NDC1;ABCG1
prerank,GO_Biological_Process_2021__positive regulation of osteoblast differentiation (GO:0045669),0.4937662262501304,0.8945467984849979,0.7261904761904762,1.0,1.0,3/25,4.63%,FBN2;ACVR2A;BMPR1B
prerank,GO_Biological_Process_2021__regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),0.4318152984926356,0.8942971015694297,0.6777777777777778,1.0,1.0,16/74,14.20%,TGFB2;PPP2R5B;AGT;FBXL2;INSR;FN1;IRS2;IGF1R;FGR;NTRK3;FLT1;NTRK2;HCLS1;PIK3IP1;GAB1;PLXNB1
prerank,GO_Biological_Process_2021__regulation of primary metabolic process (GO:0080090),-0.2938056235324513,-0.8941413136983385,0.5,1.0,1.0,8/105,6.69%,TNFAIP8L3;PSMB3;NFYC;PSME3;RUBCNL;SC5D;PSMC4;PSMD12
prerank,GO_Biological_Process_2021__stress-activated MAPK cascade (GO:0051403),-0.32970621555064145,-0.8940681599080159,0.8,1.0,1.0,11/57,10.46%,CHUK;LGALS9;MAP4K2;TRIB1;SH2D3C;MAPK13;MAP3K5;MAP2K3;MAP3K10;CRKL;IKBKB
prerank,GO_Biological_Process_2021__Golgi transport vesicle coating (GO:0048200),0.5844046511427807,0.8940287835493724,0.6231884057971014,1.0,1.0,3/6,31.92%,TMED10;TMED2;ARFGAP2
prerank,GO_Biological_Process_2021__COPI-coated vesicle budding (GO:0035964),0.5844046511427807,0.8940287835493724,0.6231884057971014,1.0,1.0,3/6,31.92%,TMED10;TMED2;ARFGAP2
prerank,GO_Biological_Process_2021__COPI coating of Golgi vesicle (GO:0048205),0.5844046511427807,0.8940287835493724,0.6231884057971014,1.0,1.0,3/6,31.92%,TMED10;TMED2;ARFGAP2
prerank,GO_Biological_Process_2021__RNA 3'-end processing (GO:0031123),-0.3248659180568791,-0.8938019697959384,0.6363636363636364,1.0,1.0,15/53,16.47%,RPRD1B;DHX38;CPSF1;MTPAP;CHTOP;THOC5;WDR33;DDX39A;RPRD1A;CSTF1;SLU7;CPSF2;CPSF4;THOC7;POLDIP3
prerank,GO_Biological_Process_2021__L-ascorbic acid metabolic process (GO:0019852),-0.48168111870640906,-0.8932584599668022,0.5909090909090909,1.0,1.0,1/6,0.42%,CYB5A
prerank,GO_Biological_Process_2021__phosphorylation of RNA polymerase II C-terminal domain (GO:0070816),-0.50056022241512,-0.8931388303900255,0.5,1.0,1.0,1/8,1.43%,GTF2H5
prerank,GO_Biological_Process_2021__regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178),0.4981129858192549,0.8931384408988124,0.6282051282051282,1.0,1.0,7/17,24.25%,ADCY8;EPHA5;C2CD2L;KLF7;NR1D1;PIM3;CFTR
prerank,GO_Biological_Process_2021__negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),0.4457018009277747,0.8928711053998161,0.7272727272727273,1.0,1.0,11/45,20.68%,TMEM161A;HERPUD1;MCL1;SOD2;PINK1;BCL2L2;HYOU1;SYVN1;HSPB1;ENO1;LRRK2
prerank,GO_Biological_Process_2021__negative regulation of inclusion body assembly (GO:0090084),0.5177008495505784,0.8923051953837937,0.6285714285714286,1.0,1.0,3/9,18.75%,DNAJB2;HSPA1B;HSPA2
prerank,GO_Biological_Process_2021__determination of heart left/right asymmetry (GO:0061371),0.4925285304226031,0.8922944956018625,0.6363636363636364,1.0,1.0,3/17,15.09%,MMP21;CCDC39;NDRG4
prerank,GO_Biological_Process_2021__negative regulation of cellular catabolic process (GO:0031330),0.4336104947821227,0.8922748328286446,0.6744186046511628,1.0,1.0,9/48,21.39%,HTR2B;MCL1;MFSD2A;TIMP3;ROCK1;MTMR9;NELL1;LEPR;TBC1D14
prerank,GO_Biological_Process_2021__positive regulation of inflammatory response (GO:0050729),0.42922297892449224,0.8921899889614232,0.6777777777777778,1.0,1.0,18/53,23.60%,NLRP12;IL15;AGT;OSMR;PDE2A;GPRC5B;NFKBIZ;WNT5A;IL18;NAPEPLD;APP;TNFRSF1A;TNF;CX3CL1;TNIP1;PDCD4;PTGER4;TRADD
prerank,GO_Biological_Process_2021__proteoglycan metabolic process (GO:0006029),-0.4451857839375205,-0.8915441862472544,0.6923076923076923,1.0,1.0,5/16,8.12%,GAL3ST4;HPSE;B4GALT7;IGF1;XYLT1
prerank,GO_Biological_Process_2021__regulation of proteolysis (GO:0030162),0.4848812677405213,0.8914085608677625,0.6216216216216216,1.0,1.0,4/28,14.49%,CAMK2N1;RNF139;SERPINE2;ASPH
prerank,GO_Biological_Process_2021__ruffle organization (GO:0031529),-0.47297337286673347,-0.8909300222562354,0.6521739130434783,1.0,1.0,6/13,10.97%,INPP5K;CORO1B;CSF1R;LIMA1;PLEK;CYFIP1
prerank,GO_Biological_Process_2021__response to ionizing radiation (GO:0010212),0.4473696032344223,0.8907049684481988,0.6741573033707865,1.0,1.0,6/55,12.87%,RHOB;ANXA1;FIGNL1;CLK2;INTS3;BRCA1
prerank,GO_Biological_Process_2021__regulation of cellular localization (GO:0060341),0.4587849324162544,0.8905175829753538,0.6470588235294118,1.0,1.0,11/32,26.32%,MAP2;KDM1A;DYNC1H1;PINK1;EPHA5;STXBP2;FES;NR1D1;LRRK2;BRSK1;HSP90AB1
prerank,GO_Biological_Process_2021__calcium ion import (GO:0070509),-0.3743254344574066,-0.8904471048324455,0.5714285714285714,1.0,1.0,3/19,4.64%,SMDT1;MAIP1;MICU3
prerank,GO_Biological_Process_2021__regulation of lymphocyte proliferation (GO:0050670),-0.49079846961658147,-0.8898602212827473,0.5625,1.0,1.0,1/7,0.28%,IKZF3
prerank,GO_Biological_Process_2021__regulation by virus of viral protein levels in host cell (GO:0046719),0.5794926388690548,0.8898573983653838,0.726027397260274,1.0,1.0,2/7,21.83%,DDB1;STAT1
prerank,GO_Biological_Process_2021__phosphate-containing compound metabolic process (GO:0006796),0.41427263490084143,0.8897595642744064,0.7368421052631579,1.0,1.0,19/136,14.74%,HTR2B;PLPP3;PFKM;PTPRD;NUDT4;PLPPR4;ITPKC;ALOX15B;INPP4B;LIMD1;ALK;EPHA7;PFKFB4;GPI;FBP1;PPA1;ACP3;GK;DUSP10
prerank,GO_Biological_Process_2021__organic cyclic compound biosynthetic process (GO:1901362),0.5268012549741361,0.8897000008379948,0.64,1.0,1.0,1/14,1.11%,PRLR
prerank,GO_Biological_Process_2021__monovalent inorganic anion homeostasis (GO:0055083),0.560502336855378,0.8894334248590108,0.7121212121212122,1.0,1.0,4/7,34.80%,SLC12A8;SLC12A5;SLC12A2;SLC12A9
prerank,GO_Biological_Process_2021__chloride ion homeostasis (GO:0055064),0.560502336855378,0.8894334248590108,0.7121212121212122,1.0,1.0,4/7,34.80%,SLC12A8;SLC12A5;SLC12A2;SLC12A9
prerank,GO_Biological_Process_2021__negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144),0.4859111037655277,0.8892257373626554,0.6216216216216216,1.0,1.0,4/21,17.56%,VPS11;PER1;BRCA1;FOXP1
prerank,GO_Biological_Process_2021__ribosome assembly (GO:0042255),0.45243766094303745,0.8892147777299743,0.6666666666666666,1.0,1.0,18/37,31.73%,SBDS;RPL23A;RPS27;MRPL20;RPL11;NOP53;MTERF3;RPL24;RPL3;DDX3X;TRAF7;DHX37;RPL6;RPLP0;C1QBP;DHX29;MRPS7;MDN1
prerank,GO_Biological_Process_2021__positive regulation of cell-substrate adhesion (GO:0010811),0.4377775096118187,0.888968046596431,0.6704545454545454,1.0,1.0,6/43,9.76%,ECM2;DOCK1;DOCK5;FN1;CSPG5;CARMIL1
prerank,GO_Biological_Process_2021__purine nucleotide biosynthetic process (GO:0006164),0.5506307156917843,0.8888292727808431,0.6417910447761194,1.0,1.0,5/9,33.92%,PRPS1;HPRT1;MTHFD1;PPAT;GART
prerank,GO_Biological_Process_2021__positive regulation of nuclear division (GO:0051785),-0.4630829428751309,-0.8887414333828311,0.5652173913043478,1.0,1.0,3/9,7.34%,IL1B;IL1A;IGF1
prerank,GO_Biological_Process_2021__regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239),-0.4061240079801932,-0.8885947372568088,0.6190476190476191,1.0,1.0,3/16,2.85%,BCL2L1;IL1B;IL1A
prerank,GO_Biological_Process_2021__organelle fusion (GO:0048284),0.49357917507595594,0.8884476553669007,0.675,1.0,1.0,4/17,26.22%,VPS11;CHCHD3;MFN2;OPA1
prerank,GO_Biological_Process_2021__positive regulation of stress-activated MAPK cascade (GO:0032874),0.43123407121192586,0.8884421133955788,0.6842105263157895,1.0,1.0,12/66,17.45%,TGFB2;SEMA3A;GADD45B;VEGFA;TRAF2;FCGR2B;NOD2;SASH1;PYCARD;SDCBP;PLCB1;APP
prerank,GO_Biological_Process_2021__regulation of cellular carbohydrate metabolic process (GO:0010675),0.5497768787917542,0.8884121040196457,0.6582278481012658,1.0,1.0,3/11,22.96%,PDK4;PDK3;RORA
prerank,GO_Biological_Process_2021__regulation of oxidoreductase activity (GO:0051341),0.547349583994657,0.8882964237655226,0.6521739130434783,1.0,1.0,4/10,24.47%,NOD2;ECSIT;SLAMF8;SIRT4
prerank,MSigDB_Hallmark_2020__Xenobiotic Metabolism,0.43157760330631334,0.8882342769943794,0.75,1.0,1.0,24/115,18.77%,RAP1GAP;TGFB2;CBR1;FAH;GAD1;PDK4;PAPSS2;CA2;NDRG2;ID2;BLVRB;ETS2;ARG2;FBP1;PINK1;ESR1;ATP2A2;PEMT;SPINT2;TNFRSF1A;SSR3;ADH5;HPRT1;HACL1
prerank,GO_Biological_Process_2021__organonitrogen compound catabolic process (GO:1901565),0.4608362822309297,0.8881364208223058,0.6744186046511628,1.0,1.0,7/36,16.37%,ENPP2;CYP3A5;RIDA;AMDHD2;TRHDE;LTA4H;PNPLA8
prerank,GO_Biological_Process_2021__telomere maintenance via recombination (GO:0000722),-0.46945239879431394,-0.8881192563838437,0.5185185185185185,1.0,1.0,2/8,7.85%,TPRKB;TEP1
prerank,GO_Biological_Process_2021__regulation of homophilic cell adhesion (GO:1903385),0.6055226989479625,0.8880093457389754,0.7121212121212122,1.0,1.0,1/5,4.06%,PTPRG
prerank,GO_Biological_Process_2021__negative regulation of long-term synaptic potentiation (GO:1900272),0.5709059206276907,0.8879544858801198,0.7101449275362319,1.0,1.0,3/7,17.45%,PTN;EPHA4;APP
prerank,GO_Biological_Process_2021__establishment of mitotic spindle localization (GO:0040001),-0.3956394772055142,-0.8874065702381483,0.42857142857142855,1.0,1.0,1/18,0.77%,NDE1
prerank,GO_Biological_Process_2021__ribosomal small subunit assembly (GO:0000028),-0.4333433773776891,-0.8874056791745905,0.5882352941176471,1.0,1.0,2/14,11.33%,RRP7A;MRPS11
prerank,PanglaoDB_Augmented_2021__Dendritic Cells,0.4213435330484463,0.887300570816387,0.7872340425531915,1.0,1.0,21/140,12.83%,RAB7B;CLEC12A;KMO;CD163;PLAC8;CADM1;CD22;VCAN;ANXA1;SLC11A1;ADGRE1;FCGR2B;ITGAE;FGR;FCGR2C;PDCD1LG2;FGL2;GPR65;HCLS1;TNFRSF1B;NR4A3
prerank,GO_Biological_Process_2021__positive regulation of voltage-gated calcium channel activity (GO:1901387),0.6344688470052062,0.887045753614107,0.7391304347826086,1.0,1.0,1/5,2.72%,CACNB2
prerank,GO_Biological_Process_2021__hemostasis (GO:0007599),-0.5729505176608167,-0.8868582038966581,0.6764705882352942,1.0,1.0,2/5,9.18%,HPS4;P2RY12
prerank,GO_Biological_Process_2021__regulation of steroid metabolic process (GO:0019218),-0.4043742443023024,-0.8867772055787996,0.5,1.0,1.0,3/13,8.49%,TTC39B;ARV1;LAMTOR1
prerank,GO_Biological_Process_2021__regulation of vascular endothelial growth factor production (GO:0010574),-0.3777231190629604,-0.8859093579414324,0.5,1.0,1.0,5/15,7.51%,IL1B;IL1A;HPSE;C3;TGFB1
prerank,GO_Biological_Process_2021__rescue of stalled ribosome (GO:0072344),-0.5490449942551897,-0.8853677046755063,0.6666666666666666,1.0,1.0,3/5,38.66%,RACK1;LTN1;ZNF598
prerank,GO_Biological_Process_2021__regulation of protein phosphorylation (GO:0001932),0.4107193133217886,0.8852539908086662,0.7575757575757576,1.0,1.0,25/180,13.92%,PLPP3;FGF1;CLIP3;FAXDC2;PPP2R5B;TFRC;ACVR2A;VEGFA;GPNMB;PPP2R5A;EIF2AK3;INSR;PAQR3;SLCO3A1;FN1;FGR;NTRK3;IMPACT;IBTK;EPHA7;FAM20A;NTRK2;SH3GL2;PINK1;LIMCH1
prerank,GO_Biological_Process_2021__positive regulation of ER-associated ubiquitin-dependent protein catabolic process (GO:1903071),0.5719700522848865,0.8848716186258794,0.6666666666666666,1.0,1.0,1/6,7.35%,HERPUD1
prerank,GO_Biological_Process_2021__nucleoside phosphate biosynthetic process (GO:1901293),0.5305491655243662,0.8848379152366735,0.6231884057971014,1.0,1.0,5/9,28.17%,CMPK1;NMNAT2;AK5;ME1;PNP
prerank,GO_Biological_Process_2021__positive regulation of cell aging (GO:0090343),-0.4539498584827847,-0.8847421711819827,0.56,1.0,1.0,2/8,7.54%,ABI3;CGAS
prerank,GO_Biological_Process_2021__positive regulation of cellular senescence (GO:2000774),-0.4539498584827847,-0.8847421711819827,0.56,1.0,1.0,2/8,7.54%,ABI3;CGAS
prerank,GO_Biological_Process_2021__TOR signaling (GO:0031929),0.49823813669487194,0.8847133011483623,0.65,1.0,1.0,4/21,13.26%,RPS6KB2;RPS6;PRR5;PINK1
prerank,GO_Biological_Process_2021__negative regulation of amyloid-beta formation (GO:1902430),0.4950622293423064,0.8845880300168992,0.684931506849315,1.0,1.0,5/15,22.83%,RTN1;NTRK2;ROCK1;RTN3;RTN4
prerank,GO_Biological_Process_2021__mRNA 3'-end processing (GO:0031124),-0.32818723825169543,-0.8845501552610334,0.5,1.0,1.0,18/61,16.47%,RPRD1B;DHX38;LEO1;CPSF1;LSM11;MTPAP;CHTOP;THOC5;WDR33;DDX39A;RPRD1A;CSTF1;GRSF1;SLU7;CPSF2;CPSF4;THOC7;POLDIP3
prerank,GO_Biological_Process_2021__negative regulation of nucleocytoplasmic transport (GO:0046823),0.534757073644829,0.8841205729085744,0.6944444444444444,1.0,1.0,5/12,34.64%,CHP1;BARD1;CABP1;NUP153;MDFIC
prerank,GO_Biological_Process_2021__regulation of prostaglandin biosynthetic process (GO:0031392),0.5719768315737912,0.8840794078202997,0.6027397260273972,1.0,1.0,1/5,3.87%,ANXA1
prerank,GO_Biological_Process_2021__positive regulation of substrate adhesion-dependent cell spreading (GO:1900026),0.463470355623423,0.8837698817929831,0.6235294117647059,1.0,1.0,4/25,9.76%,DOCK1;DOCK5;CSPG5;CARMIL1
prerank,GO_Biological_Process_2021__tRNA wobble base modification (GO:0002097),0.5408431643706672,0.8835913594045872,0.6266666666666667,1.0,1.0,1/9,1.46%,TRMT9B
prerank,GO_Biological_Process_2021__regulation of protein K63-linked ubiquitination (GO:1900044),0.5613246965607017,0.8834845184290362,0.6857142857142857,1.0,1.0,4/8,24.61%,NOD2;SASH1;GPS2;DDX3X
prerank,GO_Biological_Process_2021__phosphatidylserine acyl-chain remodeling (GO:0036150),0.5464052580133724,0.8832906449039438,0.6527777777777778,1.0,1.0,4/10,22.97%,MBOAT2;OSBPL10;OSBPL5;LPCAT4
prerank,GO_Biological_Process_2021__positive regulation of cell adhesion mediated by integrin (GO:0033630),-0.4993272808157352,-0.8832840342914712,0.5416666666666666,1.0,1.0,2/9,0.45%,SKAP1;CCL5
prerank,GO_Biological_Process_2021__peptidyl-tyrosine dephosphorylation (GO:0035335),0.44179042454640177,0.8829498219570594,0.6625,1.0,1.0,7/25,20.62%,PTPRZ1;PTPRT;DUSP10;PTPN9;DUSP16;DUSP6;PTPRS
prerank,GO_Biological_Process_2021__histone H3-K36 demethylation (GO:0070544),-0.4962814699777455,-0.8828003453741775,0.5555555555555556,1.0,1.0,2/7,8.99%,PHF8;KDM7A
prerank,GO_Biological_Process_2021__regulation of glycoprotein biosynthetic process (GO:0010559),0.5855301144073359,0.8824484219342233,0.7027027027027027,1.0,1.0,2/5,17.34%,ABCA2;NECAB1
prerank,GO_Biological_Process_2021__regulation of gene expression (GO:0010468),0.3925325953861199,0.8824088296836865,0.94,1.0,1.0,98/645,17.71%,KLF4;NFIL3;ACVR1B;FGF1;SAP30;RBMS3;TGFB2;RPL23;EGR1;TLE1;MAPT;TFRC;PQBP1;SLC11A1;RORB;VEGFA;SOX4;TDG;NOCT;TCF7;EIF2AK3;MOG;APBB3;ZNF804A;ANK3;ANK2;HINT1;INSR;OVOL2;CAMK2N1;HIF1A;BMI1;GLRX2;HCFC1;FOXN2;ARNT2;ZKSCAN5;PCBP4;BHLHE40;TCF7L1;ROBO1;TRIM5;FN1;MAFB;ID2;RIMS2;LIMD1;RBPJ;RRP1B;POU5F1;NTRK3;ITGB8;PDE2A;CELSR2;PER1;NOVA1;CLK2;FAM50A;CCDC3;ZNF536;TULP3;SOX6;NTRK2;HCLS1;HINFP;CIAO3;NFKBIZ;SH3GL2;BRCA1;DRAP1;PINK1;RLIM;YAF2;ZNF143;AHNAK;TRIM26;PICALM;WNT5A;ACTR5;MLF2;ESR1;SLC24A3;HNRNPH1;NR2C2;EPB41L4B;RPL11;TXK;CXXC1;SMAD1;ROCK1;BCL6;SART3;HSPA1B;APP;APBB2;FOXP1;RGCC;OLFM1
prerank,GO_Biological_Process_2021__t-circle formation (GO:0090656),0.5589300185338119,0.8823470912599146,0.6619718309859155,1.0,1.0,4/9,29.84%,DNA2;XRCC3;SLX4;BLM
prerank,GO_Biological_Process_2021__formation of extrachromosomal circular DNA (GO:0001325),0.5589300185338119,0.8823470912599146,0.6619718309859155,1.0,1.0,4/9,29.84%,DNA2;XRCC3;SLX4;BLM
prerank,GO_Biological_Process_2021__telomere maintenance via telomere trimming (GO:0090737),0.5589300185338119,0.8823470912599146,0.6619718309859155,1.0,1.0,4/9,29.84%,DNA2;XRCC3;SLX4;BLM
prerank,GO_Biological_Process_2021__negative regulation of macromolecule biosynthetic process (GO:0010558),0.5887790599894702,0.8823083025627255,0.7142857142857143,1.0,1.0,3/8,19.08%,TMEFF2;GSTP1;TAF7
prerank,GO_Biological_Process_2021__negative regulation of mitotic cell cycle (GO:0045930),0.4421947310036121,0.8811947928151942,0.7391304347826086,1.0,1.0,3/30,9.63%,TOM1L1;BRINP1;PLK2
prerank,GO_Biological_Process_2021__regulation of glucose transmembrane transport (GO:0010827),-0.42677412492427175,-0.8810969473980946,0.631578947368421,1.0,1.0,5/14,6.66%,INPP5K;IL1B;FFAR4;C3;TRIB3
prerank,GO_Biological_Process_2021__regulation of exit from mitosis (GO:0007096),0.4874294069165741,0.8808769956516196,0.7,1.0,1.0,6/26,20.05%,ANLN;RPS27A;RGCC;UBA52;UBB;KNTC1
prerank,GO_Biological_Process_2021__histone H4 acetylation (GO:0043967),0.44320579306270674,0.8806515626388896,0.6470588235294118,1.0,1.0,8/43,20.58%,WDR5;HCFC1;RUVBL2;PER1;TRIM16;CHD5;MORF4L2;MEAF6
prerank,GO_Biological_Process_2021__positive regulation of protein targeting to membrane (GO:0090314),0.49890706481137337,0.8804448421936562,0.686046511627907,1.0,1.0,3/18,6.39%,MTCL1;CEMIP;ANK3
prerank,GO_Biological_Process_2021__negative regulation of DNA-dependent DNA replication (GO:2000104),0.5366237917466181,0.8804084132837916,0.7,1.0,1.0,6/12,33.03%,DONSON;TIMELESS;BLM;LIG3;GMNN;ZRANB3
prerank,GO_Biological_Process_2021__establishment of protein localization to endoplasmic reticulum (GO:0072599),0.5010189827514743,0.8804036709980645,0.676056338028169,1.0,1.0,6/17,30.80%,RYR2;SRPRA;SPCS3;MAN1A1;SRP54;SRP14
prerank,GO_Biological_Process_2021__negative regulation of cytokine production involved in inflammatory response (GO:1900016),-0.4471625221773329,-0.8803451630899345,0.72,1.0,1.0,5/13,12.43%,LILRB4;APPL2;SIRPA;TREM2;CHID1
prerank,GO_Biological_Process_2021__positive regulation of protein export from nucleus (GO:0046827),-0.42503775538207184,-0.8802924985387217,0.5555555555555556,1.0,1.0,2/14,6.50%,IL1B;TP53
prerank,GO_Biological_Process_2021__response to nutrient levels (GO:0031667),0.5331393228475685,0.8801859465226116,0.6285714285714286,1.0,1.0,5/10,38.56%,PRKAA2;KCNB1;EIF4G1;ULK1;MTOR
prerank,GO_Biological_Process_2021__replicative senescence (GO:0090399),-0.5326644041495356,-0.8799721052778742,0.6129032258064516,1.0,1.0,1/6,6.50%,TP53
prerank,GO_Biological_Process_2021__regulation of protein lipidation (GO:1903059),-0.4755152170452261,-0.8795452099595071,0.6486486486486487,1.0,1.0,1/5,8.61%,SVIP
prerank,GO_Biological_Process_2021__positive regulation of interleukin-12 production (GO:0032735),-0.3861970820809533,-0.8793452514408586,0.6521739130434783,1.0,1.0,8/19,19.17%,LGALS9;SCIMP;TLR3;IRF5;SYK;TIRAP;IL16;PLCG2
prerank,GO_Biological_Process_2021__interleukin-12-mediated signaling pathway (GO:0035722),-0.3467217188367176,-0.8792795120149872,0.5,1.0,1.0,1/34,0.13%,STAT4
prerank,GO_Biological_Process_2021__regulation of mitotic spindle organization (GO:0060236),0.46912411423958555,0.8792358800195299,0.6590909090909091,1.0,1.0,11/26,23.90%,MAP9;DYNC1H1;GNAI1;HSPA1B;DCTN1;GPSM2;TACC3;HNRNPU;CHMP5;PDCD6IP;BORA
prerank,GO_Biological_Process_2021__skeletal muscle tissue regeneration (GO:0043403),-0.5198106959867348,-0.8792319568809717,0.5294117647058824,1.0,1.0,1/6,0.30%,EYS
prerank,GO_Biological_Process_2021__positive regulation of cytoplasmic transport (GO:1903651),0.5021222208273278,0.8789967151295882,0.6363636363636364,1.0,1.0,3/11,21.38%,VPS11;RAB21;RDX
prerank,GO_Biological_Process_2021__7-methylguanosine RNA capping (GO:0009452),-0.37419137221011073,-0.8787436964087375,0.5333333333333333,1.0,1.0,3/27,3.48%,GTF2H5;GTF2F1;GTF2H2
prerank,GO_Biological_Process_2021__7-methylguanosine mRNA capping (GO:0006370),-0.37419137221011073,-0.8787436964087375,0.5333333333333333,1.0,1.0,3/27,3.48%,GTF2H5;GTF2F1;GTF2H2
prerank,GO_Biological_Process_2021__regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235),0.46432195807785553,0.8778016451567705,0.6493506493506493,1.0,1.0,5/17,20.68%,EIF2AK3;HERPUD1;BOK;SYVN1;LRRK2
prerank,GO_Biological_Process_2021__positive regulation of telomere maintenance via telomerase (GO:0032212),-0.3559535458794949,-0.8777477436130121,0.7222222222222222,1.0,1.0,2/28,9.48%,PKIB;MAP3K4
prerank,GO_Biological_Process_2021__positive regulation of DNA-binding transcription factor activity (GO:0051091),0.40294143951802885,0.877714846267043,0.8383838383838383,1.0,1.0,40/179,21.58%,PLPP3;RAB7B;RELN;TFRC;AGT;ARID5B;VEGFA;TRAF2;COPS5;SLCO3A1;TRIM5;RPS27A;KDM1A;TRIM25;ALK;CRTC3;ADCY8;NOD2;HCLS1;RIPK2;TRIM26;EPHA5;PYCARD;AIM2;WNT5A;ESR1;DHX33;IL18;MAP3K13;HSPA1B;APP;RGCC;UBA52;UBB;BEX1;TNF;TRIM14;IRAK3;CX3CL1;FLOT2
prerank,GO_Biological_Process_2021__regulation of B cell proliferation (GO:0030888),0.48332149196772134,0.8775096648784421,0.6875,1.0,1.0,7/28,14.98%,CD22;TFRC;FCGR2B;IL7;IRS2;CD300A;GPR183
prerank,GO_Biological_Process_2021__negative regulation of mRNA processing (GO:0050686),0.5138503702477158,0.8770665170136506,0.6875,1.0,1.0,2/14,8.33%,PCBP4;SRSF12
prerank,GO_Biological_Process_2021__response to reactive oxygen species (GO:0000302),0.44014179581103335,0.8766454209196799,0.6818181818181818,1.0,1.0,8/45,19.53%,MAPT;PTPRK;HIF1A;GLRX2;SOD2;GSTP1;SOD1;FOS
prerank,GO_Biological_Process_2021__epithelium development (GO:0060429),0.4255073115211687,0.8765308256265354,0.6774193548387096,1.0,1.0,17/44,23.57%,CBR1;VEGFA;PAX8;MFSD2A;ERRFI1;CPT1A;PKD1;NDRG4;PPP2R3A;TIMELESS;PGK1;FGFR2;IFT122;STAT1;MTHFD1;ALDH1A2;HNRNPH3
prerank,GO_Biological_Process_2021__cellular response to hydroxyurea (GO:0072711),0.5602230213389837,0.8763059304067506,0.6911764705882353,1.0,1.0,3/8,29.84%,TIMELESS;SPIDR;BLM
prerank,GO_Biological_Process_2021__negative regulation of protein localization to nucleus (GO:1900181),-0.4226646765238441,-0.8760186745394003,0.5,1.0,1.0,2/16,4.46%,LATS2;LILRB4
prerank,GO_Biological_Process_2021__regulation of macrophage differentiation (GO:0045649),0.5373981244091218,0.8759281276179718,0.6349206349206349,1.0,1.0,1/7,8.86%,ID2
prerank,GO_Biological_Process_2021__regulation of mitotic nuclear division (GO:0007088),0.47818821531044053,0.8756424804102733,0.6025641025641025,1.0,1.0,3/24,6.86%,TOM1L1;INSR;RCC1
prerank,GO_Biological_Process_2021__negative regulation of cellular process (GO:0048523),0.394365098172478,0.875210015147112,0.89,1.0,1.0,60/332,18.63%,HTR2B;KLF4;ACVR1B;RHOB;ST18;TGFB2;CR1;BRINP1;NR4A1;ADAM15;TP53TG5;PTPRK;SOX4;GPNMB;ALOX15B;CDKN2AIP;FCGR2B;EIF2AK3;FHL1;CAMK2N1;BNIP3L;TCHP;TXNIP;SEMA5A;IMPACT;SMYD5;ING1;DNAJB2;RPS6KA2;IFNLR1;MAGI2;RBM5;FBP1;TNFRSF1B;SOD2;BNIP3;CLMN;RNF139;PLXNB1;E2F7;TGFBI;THAP12;DUS2;CTBP1;ORC6;CHD5;PRKRA;NEURL1;ARHGDIA;BCL6;HSPA1B;APP;APBB2;RGCC;PLXNC1;IGFBP7;FTH1;GTPBP4;SUZ12;AQP11
prerank,GO_Biological_Process_2021__regulation of systemic arterial blood pressure (GO:0003073),-0.5238166446975745,-0.8747428917677876,0.6206896551724138,1.0,1.0,2/5,27.06%,PRCP;PLCB3
prerank,GO_Biological_Process_2021__regulation of glucose metabolic process (GO:0010906),0.48841770955888575,0.8747019788606659,0.6436781609195402,1.0,1.0,4/22,15.59%,PDK4;IRS2;FBP1;PDK3
prerank,GO_Biological_Process_2021__lipid biosynthetic process (GO:0008610),0.4469816759374871,0.8746228650466861,0.7446808510638298,1.0,1.0,8/45,14.37%,PRLR;ACSL1;MVD;SCD5;ELOVL4;AGPS;SCD;FDFT1
prerank,GO_Biological_Process_2021__mitochondrion distribution (GO:0048311),0.5493711811126668,0.8745623572746746,0.7297297297297297,1.0,1.0,1/10,2.79%,MAPT
prerank,GO_Biological_Process_2021__DNA modification (GO:0006304),0.4959700296321214,0.8744901481037088,0.675,1.0,1.0,3/14,9.68%,TDG;MPG;NEIL1
prerank,GO_Biological_Process_2021__macrophage activation (GO:0042116),0.45920127495491614,0.8744299556621705,0.6951219512195121,1.0,1.0,9/27,21.27%,MAPT;SLC11A1;C5AR1;CD93;CRTC3;APP;FOXP1;TNF;CX3CL1
prerank,GO_Biological_Process_2021__sphingomyelin metabolic process (GO:0006684),-0.5562617007555919,-0.8741438554425294,0.7333333333333333,1.0,1.0,1/6,0.87%,SMPD3
prerank,GO_Biological_Process_2021__protein destabilization (GO:0031648),-0.36606492147000036,-0.8740936000409611,0.6956521739130435,1.0,1.0,11/25,22.80%,CCDC88C;EP300;GSN;PYHIN1;FBXL3;PEX2;CTSH;CUL3;BTRC;PRKN;CDC73
prerank,GO_Biological_Process_2021__positive regulation of vascular endothelial cell proliferation (GO:1905564),0.47799093058628145,0.8740922637798708,0.6712328767123288,1.0,1.0,6/10,46.81%,ADAM17;FGFR1;FGF2;AKT3;SIRT6;PLCG1
prerank,GO_Biological_Process_2021__positive regulation of secretion by cell (GO:1903532),0.43112951523130166,0.8738567433109143,0.7037037037037037,1.0,1.0,9/52,17.58%,TGFB2;ARF6;APBB3;CADPS;CLASP2;PPID;TMED10;RAB2B;RGCC
prerank,GO_Biological_Process_2021__endocytic recycling (GO:0032456),-0.32440971396685325,-0.87368770255726,0.7692307692307693,1.0,1.0,2/42,2.62%,EHD4;DENND1C
prerank,GO_Biological_Process_2021__pore complex assembly (GO:0046931),0.5088798708696117,0.8736008689653311,0.6712328767123288,1.0,1.0,6/16,34.79%,GSDMD;RTN4;NDC1;AHCTF1;NUP153;NUP205
prerank,GO_Biological_Process_2021__beta-catenin-TCF complex assembly (GO:1904837),0.47577967892840095,0.873262263143493,0.75,1.0,1.0,3/23,7.98%,TLE1;TCF7;TCF7L1
prerank,PanglaoDB_Augmented_2021__Hematopoietic Stem Cells,0.39972901852938975,0.8731592484054378,0.7473684210526316,1.0,1.0,14/114,12.08%,TGFB2;CLEC12A;CD163;EGR1;TNS1;CDH2;KITLG;F13A1;BAALC;BMI1;TXNIP;CD93;FGL2;THBD
prerank,GO_Biological_Process_2021__neuromuscular synaptic transmission (GO:0007274),0.5568341365554317,0.8730221207424544,0.7195121951219512,1.0,1.0,2/9,8.25%,KIF1B;ERC2
prerank,GO_Biological_Process_2021__antiviral innate immune response (GO:0140374),0.5284975403797282,0.8729671768233881,0.7183098591549296,1.0,1.0,1/9,3.70%,ATAD3A
prerank,GO_Biological_Process_2021__GPI anchor biosynthetic process (GO:0006506),0.46050061857672214,0.8727888642951769,0.6875,1.0,1.0,5/22,19.17%,PIGU;PIGQ;PIGF;PIGL;PIGG
prerank,GO_Biological_Process_2021__negative regulation of DNA biosynthetic process (GO:2000279),-0.3882002175896049,-0.8726263482339335,0.8260869565217391,1.0,1.0,7/19,20.91%,CTC1;TP53;SRC;TERF2;EXOSC10;ERCC4;CDKN1A
prerank,GO_Biological_Process_2021__regulation of cellular amine metabolic process (GO:0033238),-0.3407316620308298,-0.8725112507362479,0.625,1.0,1.0,5/40,8.38%,PSMB3;PSME3;PSMC4;PSMD12;PSME4
prerank,GO_Biological_Process_2021__negative regulation of cell development (GO:0010721),-0.40355222780476746,-0.8722821512699265,0.5652173913043478,1.0,1.0,5/16,12.50%,IL1B;APPL2;IGF1;REST;SORL1
prerank,GO_Biological_Process_2021__pathway-restricted SMAD protein phosphorylation (GO:0060389),0.544675398032873,0.8721388150965119,0.71875,1.0,1.0,1/8,1.28%,TGFB2
prerank,GO_Biological_Process_2021__regulation of melanin biosynthetic process (GO:0048021),0.5444746058998169,0.8717908688962753,0.6666666666666666,1.0,1.0,2/7,26.20%,APPL1;CTNS
prerank,GO_Biological_Process_2021__positive regulation of mast cell activation (GO:0033005),-0.5044575766784929,-0.8717900158893547,0.5757575757575758,1.0,1.0,2/5,10.73%,HAVCR1;CD226
prerank,GO_Biological_Process_2021__negative regulation of erythrocyte differentiation (GO:0045647),0.608240056634789,0.8715301656950329,0.7076923076923077,1.0,1.0,1/5,8.46%,MAFB
prerank,GO_Biological_Process_2021__retrograde axonal transport (GO:0008090),0.4928799489244256,0.8709420218086305,0.6388888888888888,1.0,1.0,6/14,22.60%,TMEM108;DYNC1H1;NEFL;KIF5A;SOD1;MAP1A
prerank,GO_Biological_Process_2021__regulation of neurogenesis (GO:0050767),0.45350711947134725,0.8708840054195602,0.6705882352941176,1.0,1.0,3/31,7.92%,LRP2;HMGB2;BHLHE40
prerank,GO_Biological_Process_2021__COPII-coated vesicle budding (GO:0090114),0.402750078866928,0.8705781537574024,0.7191011235955056,1.0,1.0,8/57,17.39%,NAPA;VAPB;SEC24C;MCFD2;NSF;TMED10;TRAPPC6B;GRIA1
prerank,GO_Biological_Process_2021__membrane protein ectodomain proteolysis (GO:0006509),-0.3992913784737175,-0.8705212363433904,0.5806451612903226,1.0,1.0,3/17,11.53%,MYH9;APH1A;HM13
prerank,GO_Biological_Process_2021__positive regulation of protein depolymerization (GO:1901881),0.5654031084091868,0.8699645892507921,0.7121212121212122,1.0,1.0,2/6,13.71%,SEMA5A;STMN2
prerank,GO_Biological_Process_2021__regulation of chemokine-mediated signaling pathway (GO:0070099),0.5674547067598437,0.8698400835789729,0.6805555555555556,1.0,1.0,2/6,8.14%,HIF1A;ROBO1
prerank,GO_Biological_Process_2021__protein K48-linked deubiquitination (GO:0071108),0.46045142243855885,0.8695765501531466,0.6790123456790124,1.0,1.0,3/20,12.62%,MINDY1;OTUD7B;VCPIP1
prerank,GO_Biological_Process_2021__positive regulation of isomerase activity (GO:0010912),-0.4669154243444021,-0.8694788133509017,0.6071428571428571,1.0,1.0,1/8,0.91%,ITGAM
prerank,GO_Biological_Process_2021__positive regulation of histone acetylation (GO:0035066),-0.36917912799718394,-0.8693770589574384,0.6,1.0,1.0,2/19,2.75%,IL1B;TADA2B
prerank,GO_Biological_Process_2021__positive regulation of focal adhesion assembly (GO:0051894),0.4868664257019172,0.8692953866630754,0.6933333333333334,1.0,1.0,4/13,20.96%,VEGFA;THY1;ROCK1;COL16A1
prerank,GO_Biological_Process_2021__mitotic G1 DNA damage checkpoint signaling (GO:0031571),-0.3022583392678909,-0.8691761237231662,0.6875,1.0,1.0,11/48,13.06%,PIDD1;BTG2;CCND1;TP53;ZNF385A;RFWD3;EP300;CNOT6L;PLK3;SDE2;PLAGL1
prerank,GO_Biological_Process_2021__telomere organization (GO:0032200),-0.3590472456924062,-0.8689153085820948,0.6470588235294118,1.0,1.0,3/30,5.69%,HUS1;POLD3;CTC1
prerank,GO_Biological_Process_2021__blood vessel endothelial cell migration (GO:0043534),0.5029690714359095,0.868542004257312,0.75,1.0,1.0,3/11,8.14%,NR4A1;VEGFA;ROBO1
prerank,GO_Biological_Process_2021__regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),0.4112736990764498,0.868175778887796,0.7096774193548387,1.0,1.0,19/62,24.06%,VEGFA;HIF1A;LIMD1;RBPJ;RPS27A;PSMB4;RBX1;HIF3A;EPAS1;EGLN3;UBA52;UBB;PSMC2;PSMA3;PSMB2;PSMD5;PSMD7;PSMD14;PSMA5
prerank,GO_Biological_Process_2021__endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),0.39547999372657805,0.8676505611829951,0.7368421052631579,1.0,1.0,22/137,18.98%,NAPA;CNIH4;CD55;VAPB;ANK3;ANK2;ARFGAP1;SPTAN1;SEC24C;MCFD2;DYNC1H1;SPAST;NSF;SPTBN5;TMED10;HYOU1;TRAPPC6B;SPTBN1;NRBP2;GRIA1;DCTN1;SPTBN4
prerank,GO_Biological_Process_2021__regulation of protein modification process (GO:0031399),-0.3198466863481867,-0.8675585409226841,0.6666666666666666,1.0,1.0,2/38,1.45%,PPP1R16B;SESN2
prerank,GO_Biological_Process_2021__protein-containing complex disassembly (GO:0032984),0.42428149861471987,0.8668298247486346,0.7191011235955056,1.0,1.0,3/36,18.23%,RPL23;SNAP29;PYM1
prerank,GO_Biological_Process_2021__negative regulation of apoptotic signaling pathway (GO:2001234),0.4209052235415073,0.8665188440319455,0.6976744186046512,1.0,1.0,13/56,21.27%,THBS1;NR4A2;HERPUD1;MCL1;PINK1;PRELID1;BCL2L2;TMEM14A;ITGAV;GSTP1;MAPK8IP2;TNF;CX3CL1
prerank,GO_Biological_Process_2021__protein localization to microtubule cytoskeleton (GO:0072698),-0.5073189355289679,-0.866503364139344,0.6666666666666666,1.0,1.0,3/6,30.18%,MAPRE1;DIAPH1;KIF20B
prerank,GO_Biological_Process_2021__regulation of protein ubiquitination (GO:0031396),0.42041981908217513,0.8661773217368218,0.75,1.0,1.0,15/83,21.98%,SOX4;SEPTIN4;FANCI;PRICKLE1;DNAJB2;SASH1;RIPK2;BRCA1;PINK1;CAMLG;HSPA1B;GTPBP4;UBB;LRRK2;CHP1
prerank,GO_Biological_Process_2021__axon choice point recognition (GO:0016198),0.5918733627637884,0.866171210975583,0.7142857142857143,1.0,1.0,3/5,17.45%,ROBO2;ROBO1;APP
prerank,GO_Biological_Process_2021__signal transduction in response to DNA damage (GO:0042770),0.44211931780621083,0.865947173146959,0.6923076923076923,1.0,1.0,6/39,14.23%,BRIP1;CLSPN;NDRG1;DONSON;HINFP;E2F7
prerank,GO_Biological_Process_2021__regulation of DNA repair (GO:0006282),0.4407387392007513,0.8658307376914132,0.6547619047619048,1.0,1.0,6/34,20.52%,TMEM161A;EYA2;BRCA1;ERCC6;CDK9;NPAS2
prerank,GO_Biological_Process_2021__negative regulation of glycoprotein biosynthetic process (GO:0010561),0.57221338811172,0.8656403025196605,0.7323943661971831,1.0,1.0,1/7,12.65%,BACE2
prerank,GO_Biological_Process_2021__ncRNA metabolic process (GO:0034660),0.48210559141486864,0.8654375277140762,0.7469879518072289,1.0,1.0,3/23,17.00%,MAPT;TENT4B;PRKRA
prerank,GO_Biological_Process_2021__regulation of gluconeogenesis (GO:0006111),0.495498250931802,0.8651310215921313,0.7051282051282052,1.0,1.0,5/17,29.48%,CLK2;FBP1;DDB1;PPARGC1A;DGKQ
prerank,GO_Biological_Process_2021__neutrophil activation (GO:0042119),-0.4225348011559425,-0.8650405302495674,0.6521739130434783,1.0,1.0,1/10,0.45%,CCL5
prerank,GO_Biological_Process_2021__cellular response to acidic pH (GO:0071468),0.5871227961569747,0.8650293825972717,0.7083333333333334,1.0,1.0,3/5,21.98%,IMPACT;SLC9A1;CHP1
prerank,GO_Biological_Process_2021__regulation of MHC class II biosynthetic process (GO:0045346),-0.47919659907600853,-0.8642543472182512,0.631578947368421,1.0,1.0,1/7,5.75%,TMEM106A
prerank,GO_Biological_Process_2021__response to cadmium ion (GO:0046686),-0.37781075033109585,-0.8641806088307429,0.6666666666666666,1.0,1.0,3/16,14.21%,CHUK;EGFR;AKT1
prerank,GO_Biological_Process_2021__regulation of myoblast differentiation (GO:0045661),0.5025985239717268,0.8639348822751389,0.6891891891891891,1.0,1.0,5/15,21.58%,RANBP3L;SRA1;AKIRIN1;PLCB1;FLOT2
prerank,GO_Biological_Process_2021__mitochondrial tRNA modification (GO:0070900),-0.5739228374254783,-0.8636986527402786,0.6585365853658537,1.0,1.0,1/6,1.88%,PUS1
prerank,GO_Biological_Process_2021__myofibril assembly (GO:0030239),-0.39717964573842646,-0.8636014209423873,0.6190476190476191,1.0,1.0,1/14,2.93%,FLII
prerank,GO_Biological_Process_2021__positive regulation of cell-matrix adhesion (GO:0001954),-0.3552878985161857,-0.8632715404133892,0.6296296296296297,1.0,1.0,5/26,12.15%,SKAP1;MAP4K4;ABL1;RIN2;PPM1F
prerank,GO_Biological_Process_2021__negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240),-0.4216529560631763,-0.8631474090796704,0.7083333333333334,1.0,1.0,3/13,2.85%,BCL2L1;IL1B;IL1A
prerank,GO_Biological_Process_2021__negative regulation of signal transduction in absence of ligand (GO:1901099),-0.4216529560631763,-0.8631474090796704,0.7083333333333334,1.0,1.0,3/13,2.85%,BCL2L1;IL1B;IL1A
prerank,GO_Biological_Process_2021__L-glutamate transmembrane transport (GO:0015813),0.5930001192826583,0.8629661639242424,0.75,1.0,1.0,1/6,3.93%,SLC1A2
prerank,GO_Biological_Process_2021__negative regulation of JNK cascade (GO:0046329),-0.3602152511298039,-0.8627427922557719,0.7058823529411765,1.0,1.0,4/22,6.41%,ZMYND11;ZNF675;DUSP3;SIRPA
prerank,GO_Biological_Process_2021__positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060),0.4140013129290655,0.8626950492646773,0.7701149425287356,1.0,1.0,16/64,24.39%,RNF144B;CAV3;ARIH2;RNF144A;RBX1;PRICKLE1;DNAJB2;RNF139;HSPA1B;NOP53;LRRK2;MAGEF1;USP5;PTEN;BBS7;DDRGK1
prerank,GO_Biological_Process_2021__endothelial cell proliferation (GO:0001935),0.5620115258669834,0.8626639328568046,0.7101449275362319,1.0,1.0,1/9,10.26%,SEMA5A
prerank,GO_Biological_Process_2021__regulation of mitochondrial gene expression (GO:0062125),0.5437928633044192,0.8624278236508276,0.676056338028169,1.0,1.0,1/6,20.26%,METTL4
prerank,GO_Biological_Process_2021__positive regulation of protein metabolic process (GO:0051247),0.4207884334940999,0.8623071944163051,0.7052631578947368,1.0,1.0,16/78,22.36%,KLF4;DTL;AGT;ABCA2;PLK2;NSF;APC2;WNT5A;IL18;HECW2;APP;TNF;CDKN1B;DDB1;HACE1;BARD1
prerank,GO_Biological_Process_2021__embryonic heart tube development (GO:0035050),0.5668381103989196,0.8622791827355114,0.6901408450704225,1.0,1.0,3/6,21.12%,RYR2;NDRG4;IFT122
prerank,GO_Biological_Process_2021__aminoglycan catabolic process (GO:0006026),0.4926654977278936,0.8618377751782025,0.6986301369863014,1.0,1.0,3/17,6.20%,CHI3L1;GPC5;GNS
prerank,GO_Biological_Process_2021__regulation of granulocyte differentiation (GO:0030852),0.5427021887836552,0.8616939932887964,0.7222222222222222,1.0,1.0,1/7,11.83%,HCLS1
prerank,GO_Biological_Process_2021__mitochondrial membrane organization (GO:0007006),-0.3944571674763964,-0.8616245372770078,0.6,1.0,1.0,2/26,1.84%,MAIP1;BCL2L1
prerank,"GO_Biological_Process_2021__base-excision repair, gap-filling (GO:0006287)",0.46403643665713185,0.861594364242575,0.75,1.0,1.0,8/26,20.01%,RPA2;TDG;MPG;NEIL1;RFC4;POLL;ADPRS;RFC1
prerank,GO_Biological_Process_2021__regulation of dopamine secretion (GO:0014059),0.5152737227529611,0.8615035234429791,0.6716417910447762,1.0,1.0,4/11,26.10%,SYT4;SYT1;SYT11;SYT9
prerank,GO_Biological_Process_2021__protein-DNA complex disassembly (GO:0032986),0.5173047753830652,0.8610143684585402,0.7162162162162162,1.0,1.0,4/12,22.09%,RPL23;SMARCD3;SMARCC1;SMARCD2
prerank,GO_Biological_Process_2021__cellular response to unfolded protein (GO:0034620),0.47164407996328,0.8608010982232718,0.7073170731707317,1.0,1.0,10/23,27.66%,HSPA5;BAG3;HSPA1B;HSPD1;HSPA2;HSPA14;HSPA9;HSPA13;PTPN1;HSPA8
prerank,GO_Biological_Process_2021__negative regulation of type I interferon-mediated signaling pathway (GO:0060339),0.4989920986283131,0.8607404318875254,0.7101449275362319,1.0,1.0,3/10,35.76%,STAT2;CNOT7;NLRC5
prerank,GO_Biological_Process_2021__leukocyte cell-cell adhesion (GO:0007159),-0.40275171612047406,-0.8602322141064208,0.7916666666666666,1.0,1.0,6/17,13.23%,CCL5;OLR1;ICAM1;SEMA4D;ITGB2;SYK
prerank,GO_Biological_Process_2021__regulation of keratinocyte migration (GO:0051547),0.5475052891650506,0.8601732962637887,0.6571428571428571,1.0,1.0,4/8,23.89%,ARF6;EPB41L4B;PTEN;IQSEC1
prerank,GO_Biological_Process_2021__positive regulation of cell-substrate junction organization (GO:0150117),0.46857491185169575,0.859995305235801,0.6582278481012658,1.0,1.0,6/18,23.89%,ARF6;VEGFA;THY1;ROCK1;COL16A1;IQSEC1
prerank,PanglaoDB_Augmented_2021__Platelets,0.3889342794017987,0.8596679030694052,0.7628865979381443,1.0,1.0,20/143,12.72%,THBS1;SPARC;CLEC12A;PRKAR2B;ITGA2;SLC2A3;ALOX12;SRGN;F13A1;VEGFA;FHL1;SIRPB2;CA2;PALLD;FGR;CD93;NOD2;FGL2;HCLS1;TNFRSF1B
prerank,GO_Biological_Process_2021__dorsal/ventral pattern formation (GO:0009953),0.5383986794488462,0.8596425504048568,0.7121212121212122,1.0,1.0,2/8,15.71%,BMPR1B;AIDA
prerank,GO_Biological_Process_2021__regulation of reactive oxygen species biosynthetic process (GO:1903426),-0.41350875481827903,-0.8595073314043108,0.625,1.0,1.0,10/15,26.54%,ABCB7;ALOX5;SLC25A33;PLCG2;SPHK2;SLC30A10;PIKFYVE;RAB27A;CYBA;CD36
prerank,GO_Biological_Process_2021__double-strand break repair via homologous recombination (GO:0000724),0.41883985080032166,0.8594847696857271,0.7802197802197802,1.0,1.0,21/67,25.89%,RPA2;FANCB;FANCM;POLQ;BRCA1;XRCC3;MCMDC2;NSMCE1;FAN1;POLL;SWI5;RBBP8;RNF138;SFPQ;RPA3;SLX4;PSMD14;RAD54B;MCM3;SPIDR;REV3L
prerank,GO_Biological_Process_2021__establishment of protein localization to chromosome (GO:0070199),0.5274463112829729,0.8593230396338297,0.6615384615384615,1.0,1.0,1/7,7.76%,RUVBL2
prerank,GO_Biological_Process_2021__negative regulation of interleukin-6 production (GO:0032715),0.47123450673467676,0.8590959443128527,0.7763157894736842,1.0,1.0,1/19,1.30%,NLRP12
prerank,GO_Biological_Process_2021__regulation of inclusion body assembly (GO:0090083),0.5028901057759192,0.8590168263289691,0.7391304347826086,1.0,1.0,3/10,18.75%,DNAJB2;HSPA1B;HSPA2
prerank,GO_Biological_Process_2021__molybdopterin cofactor biosynthetic process (GO:0032324),-0.5567899524688197,-0.8587087756163994,0.7083333333333334,1.0,1.0,2/5,18.09%,MOCS1;MOCS2
prerank,GO_Biological_Process_2021__negative regulation of cholesterol storage (GO:0010887),-0.4058917237616039,-0.8585693088750104,0.6666666666666666,1.0,1.0,4/9,12.05%,TTC39B;NR1H3;TREM2;PPARD
prerank,GO_Biological_Process_2021__retinoic acid metabolic process (GO:0042573),0.5540707009452963,0.858372039918782,0.7101449275362319,1.0,1.0,1/5,2.19%,CYP3A5
prerank,GO_Biological_Process_2021__regulation of cellular metabolic process (GO:0031323),0.4475481190424677,0.8581735682014592,0.7375,1.0,1.0,11/36,24.29%,PDK4;ABCA2;PINK1;FASN;PDK3;PPARA;ACACB;CNDP1;ABCG1;BTN2A2;MBOAT7
prerank,GO_Biological_Process_2021__toll-like receptor 2 signaling pathway (GO:0034134),-0.4734538800809085,-0.8580148004064039,0.6111111111111112,1.0,1.0,1/5,3.60%,LGALS9
prerank,GO_Biological_Process_2021__positive regulation of protein localization to plasma membrane (GO:1903078),0.43608845021074155,0.8577233406210929,0.7108433734939759,1.0,1.0,9/37,20.20%,PRKCE;CLIP3;ARF6;EPHA3;SORBS1;SPTBN1;PTPN9;ACSL3;TNF
prerank,GO_Biological_Process_2021__cellular zinc ion homeostasis (GO:0006882),-0.40044488259435046,-0.8576694013349503,0.68,1.0,1.0,1/14,1.69%,SLC30A5
prerank,GO_Biological_Process_2021__cell-cell junction assembly (GO:0007043),0.44137750304919415,0.8570952090725965,0.7647058823529411,1.0,1.0,7/39,9.37%,CDH8;CDH2;CDH9;CTNND2;PKP2;CDH20;CDH12
prerank,"GO_Biological_Process_2021__establishment of mitochondrion localization, microtubule-mediated (GO:0034643)",0.5642684058361904,0.8570063550235455,0.7432432432432432,1.0,1.0,2/6,18.81%,UXT;UBB
prerank,GO_Biological_Process_2021__positive regulation of stress fiber assembly (GO:0051496),-0.34579741951232434,-0.8568967653126115,0.631578947368421,1.0,1.0,7/29,12.15%,SERPINF2;EVL;LPAR1;NF2;SORBS3;ABL1;PPM1F
prerank,GO_Biological_Process_2021__regulation of keratinocyte proliferation (GO:0010837),0.4916577988832827,0.8568248893819728,0.6753246753246753,1.0,1.0,5/11,20.85%,PTPRK;EPB41L4B;KLF9;NOTCH2;FGFR2
prerank,GO_Biological_Process_2021__regulation of cholesterol storage (GO:0010885),-0.37477265445965635,-0.8564468249428747,0.6071428571428571,1.0,1.0,5/13,12.05%,TTC39B;LPL;NR1H3;TREM2;PPARD
prerank,GO_Biological_Process_2021__negative regulation of homotypic cell-cell adhesion (GO:0034111),-0.44657059713114233,-0.856430013252028,0.6666666666666666,1.0,1.0,2/9,3.04%,ZNF703;SH2B3
prerank,GO_Biological_Process_2021__erythrocyte differentiation (GO:0030218),-0.3581773772493106,-0.8563797766645221,0.631578947368421,1.0,1.0,3/34,3.04%,TGFBR3;TAL1;SH2B3
prerank,GO_Biological_Process_2021__cardiac conduction system development (GO:0003161),0.5246006881949381,0.8562584881417414,0.6716417910447762,1.0,1.0,5/7,33.13%,SMAD1;SMAD5;NOTCH2;GJA1;BMPR1A
prerank,GO_Biological_Process_2021__positive regulation of pinocytosis (GO:0048549),-0.5438102807468038,-0.8559857128044728,0.6363636363636364,1.0,1.0,1/6,4.51%,APPL2
prerank,GO_Biological_Process_2021__positive regulation of non-canonical Wnt signaling pathway (GO:2000052),-0.48609002094453374,-0.8559656120847466,0.7096774193548387,1.0,1.0,3/7,20.19%,NKD1;DAB2;WNT5B
prerank,GO_Biological_Process_2021__granulocyte chemotaxis (GO:0071621),0.46570588652235034,0.8559228059019571,0.7023809523809523,1.0,1.0,3/24,10.68%,TGFB2;ANXA1;PDE4B
prerank,GO_Biological_Process_2021__tumor necrosis factor-mediated signaling pathway (GO:0033209),-0.2774895407985546,-0.8558557773206202,0.7777777777777778,1.0,1.0,19/82,13.68%,CARD14;PSMB3;PSME3;CHUK;EDA2R;CDIP1;MAP3K14;PSMC4;TP53;PSMD12;ILK;PSME4;EDA;IKBKB;NFKBIA;BIRC2;PLVAP;EIF5A;PSMA1
prerank,GO_Biological_Process_2021__peptidyl-lysine acetylation (GO:0018394),-0.46958776080177766,-0.8557687320176591,0.7619047619047619,1.0,1.0,3/9,18.81%,EP300;KAT7;KAT5
prerank,GO_Biological_Process_2021__regulation of leukocyte chemotaxis (GO:0002688),0.5218542985278769,0.8557134603352141,0.7246376811594203,1.0,1.0,3/9,25.86%,PTN;MTUS1;PTK2B
prerank,GO_Biological_Process_2021__positive regulation of myelination (GO:0031643),0.503583898411563,0.8557104603895335,0.6578947368421053,1.0,1.0,4/10,13.36%,MYRF;PARD3;TNFRSF1B;TPPP
prerank,GO_Biological_Process_2021__tRNA wobble uridine modification (GO:0002098),0.5430219088148275,0.8552432943410745,0.7792207792207793,1.0,1.0,1/9,1.46%,TRMT9B
prerank,GO_Biological_Process_2021__zinc ion homeostasis (GO:0055069),-0.3903200259553986,-0.855103899503117,0.75,1.0,1.0,1/16,1.69%,SLC30A5
prerank,GO_Biological_Process_2021__positive regulation of potassium ion import across plasma membrane (GO:1903288),0.5547510378657426,0.8545220926125806,0.703125,1.0,1.0,2/6,18.33%,ATP1B3;ATP1B2
prerank,GO_Biological_Process_2021__striated muscle cell differentiation (GO:0051146),0.5355997808364911,0.8544922312343788,0.78125,1.0,1.0,4/10,22.52%,NRG1;PLD3;KDM6B;SORT1
prerank,GO_Biological_Process_2021__positive regulation of posttranscriptional gene silencing (GO:0060148),0.5334340467593114,0.8540047800413462,0.6875,1.0,1.0,1/9,9.23%,LIMD1
prerank,GO_Biological_Process_2021__calcium-mediated signaling using intracellular calcium source (GO:0035584),0.4892582431333849,0.8539913181361075,0.7205882352941176,1.0,1.0,4/11,30.93%,RYR2;GRM5;PRNP;ADGRL1
prerank,GO_Biological_Process_2021__regulation of biomineral tissue development (GO:0070167),-0.4301577421019227,-0.8539654573165971,0.55,1.0,1.0,2/12,9.65%,TGFB1;ENPP1
prerank,GO_Biological_Process_2021__regulation of pinocytosis (GO:0048548),-0.5138808926713175,-0.853950555021875,0.7741935483870968,1.0,1.0,2/6,18.45%,NR1H3;CDC42
prerank,GO_Biological_Process_2021__manganese ion transport (GO:0006828),0.5247688484060322,0.8539244307844659,0.7246376811594203,1.0,1.0,5/10,25.52%,SLC11A1;TRPC4;SLC39A14;TRPC1;SLC11A2
prerank,GO_Biological_Process_2021__IMP biosynthetic process (GO:0006188),0.574938366527204,0.8538521796246997,0.734375,1.0,1.0,2/5,18.34%,PFAS;HPRT1
prerank,GO_Biological_Process_2021__production of miRNAs involved in gene silencing by miRNA (GO:0035196),-0.3462521533378933,-0.8538477056051629,0.75,1.0,1.0,3/24,9.60%,SRRT;PUS10;AGO1
prerank,GO_Biological_Process_2021__positive regulation of biosynthetic process (GO:0009891),-0.3326485401671062,-0.8535342276511344,0.631578947368421,1.0,1.0,2/24,1.86%,CCL5;SERPINF2
prerank,GO_Biological_Process_2021__regulation of vacuole organization (GO:0044088),0.46938431798942176,0.8532297203371978,0.6829268292682927,1.0,1.0,7/20,25.64%,ENO2;ENO4;NPRL2;ENO1;TBC1D14;RAB5A;MTM1
prerank,GO_Biological_Process_2021__negative regulation of transcription by RNA polymerase II (GO:0000122),0.3882259875162199,0.8530160635379807,0.94,1.0,1.0,88/426,24.08%,KLF4;NFIL3;SAP30;RPL23;TGIF1;NFIX;ZBTB16;NR4A2;NFIB;MEIS2;ARID5B;VEGFA;SUV39H2;BMI1;HCFC1;POU6F1;YEATS2;BHLHE40;TRPS1;KCTD1;ID2;RBPJ;RPS27A;KDM1A;POU5F1;MXD1;PDE2A;PER1;IMPACT;NR2F1;MXI1;ZNF536;DEAF1;PPID;ETS2;OTUD7B;FBP1;ZNF550;NR4A3;DRAP1;E2F7;SDCBP;ZNF248;UXT;BAG3;ESR1;MTA3;NR2C2;LDB2;TBL1XR1;CTBP1;HAMP;BCL6;KLF7;FOXP1;ZBTB18;TAF9B;ZNF778;UBA52;EZH2;UBB;PPARA;TAF7;ZNF684;NOP53;TNF;ENO1;NR1D1;BCL11A;FGFR2;CBX5;ATF3;HEXIM1;STAT1;HNRNPU;CGGBP1;MYT1L;SFPQ;JUN;PHF21A;MNT;UHRF1;GPS2;H1-0;NACC2;ZNF141;ZNF169;FOXO3
prerank,GO_Biological_Process_2021__cellular response to interleukin-12 (GO:0071349),-0.3309787675747932,-0.8529668733031576,0.5714285714285714,1.0,1.0,1/36,0.13%,STAT4
prerank,GO_Biological_Process_2021__glycolipid metabolic process (GO:0006664),0.44291313579312985,0.8528006932535319,0.7407407407407407,1.0,1.0,10/35,20.27%,GLA;ABCA2;ARSA;GALC;UGT8;UGCG;SUMF2;SUMF1;GBA3;STS
prerank,GO_Biological_Process_2021__regulation of rRNA processing (GO:2000232),0.5092476069325722,0.8521502763513614,0.7183098591549296,1.0,1.0,2/13,3.26%,NUDT16;RIOK2
prerank,GO_Biological_Process_2021__positive regulation of response to external stimulus (GO:0032103),0.38430245986710176,0.8521337682679643,0.7473684210526316,1.0,1.0,16/87,17.86%,THBS1;NLRP12;IL15;AGT;POLR3F;PTN;PDE2A;GPRC5B;SASH1;THBD;NFKBIZ;WNT5A;IL18;NAPEPLD;APP;TNFRSF1A
prerank,GO_Biological_Process_2021__synaptonemal complex organization (GO:0070193),0.5769694351460974,0.8520873423384091,0.7121212121212122,1.0,1.0,3/5,30.41%,SYCE2;BAG6;RAD21
prerank,GO_Biological_Process_2021__synaptonemal complex assembly (GO:0007130),0.5769694351460974,0.8520873423384091,0.7121212121212122,1.0,1.0,3/5,30.41%,SYCE2;BAG6;RAD21
prerank,GO_Biological_Process_2021__positive regulation of peptide hormone secretion (GO:0090277),0.4850637143234289,0.851955035148932,0.7272727272727273,1.0,1.0,3/18,9.28%,SOX4;MYRIP;IRS2
prerank,GO_Biological_Process_2021__regulation of potassium ion import (GO:1903286),0.5496728218406604,0.8518935317687779,0.6911764705882353,1.0,1.0,2/7,18.33%,ATP1B3;ATP1B2
prerank,GO_Biological_Process_2021__regulation of sequestering of calcium ion (GO:0051282),0.540070326944774,0.851804098270677,0.6764705882352942,1.0,1.0,2/7,9.36%,ANK2;RYR2
prerank,GO_Biological_Process_2021__regulation of hepatocyte proliferation (GO:2000345),0.5772966703772748,0.8516088595613528,0.7101449275362319,1.0,1.0,1/5,8.95%,PTN
prerank,GO_Biological_Process_2021__ribonucleoside bisphosphate biosynthetic process (GO:0034030),-0.39912837648391286,-0.8513581163402602,0.72,1.0,1.0,3/10,13.67%,PANK1;PPCDC;PPCS
prerank,GO_Biological_Process_2021__coenzyme A biosynthetic process (GO:0015937),-0.39912837648391286,-0.8513581163402602,0.72,1.0,1.0,3/10,13.67%,PANK1;PPCDC;PPCS
prerank,GO_Biological_Process_2021__purine nucleoside bisphosphate biosynthetic process (GO:0034033),-0.39912837648391286,-0.8513581163402602,0.72,1.0,1.0,3/10,13.67%,PANK1;PPCDC;PPCS
prerank,GO_Biological_Process_2021__positive regulation of T cell mediated immunity (GO:0002711),0.4820559277126768,0.8512852214775934,0.675,1.0,1.0,2/20,5.63%,TRAF2;CD55
prerank,GO_Biological_Process_2021__regulation of transcription elongation from RNA polymerase II promoter (GO:0034243),-0.3819144182790822,-0.8511408643102158,0.65,1.0,1.0,5/25,12.55%,ZMYND11;LEO1;SUPT16H;RNF8;BRD4
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA gap filling (GO:0006297)",0.4933261215098191,0.8508400884621174,0.7435897435897436,1.0,1.0,7/19,23.25%,RPA2;RPS27A;RFC4;UBA52;UBB;RFC1;RPA3
prerank,GO_Biological_Process_2021__regulation of peptide hormone secretion (GO:0090276),-0.3651089442378464,-0.8507605664345053,0.7058823529411765,1.0,1.0,6/36,8.65%,CCL5;IL1B;UQCC2;ITPR2;PASK;ALOX5
prerank,GO_Biological_Process_2021__vesicle transport along actin filament (GO:0030050),-0.4188114865377499,-0.8504934385262443,0.6363636363636364,1.0,1.0,3/12,18.04%,MYO1F;MYO1D;MYO7A
prerank,GO_Biological_Process_2021__peptidyl-lysine dimethylation (GO:0018027),0.48301069478089687,0.85039208890236,0.7368421052631579,1.0,1.0,2/16,8.08%,SUV39H2;CSKMT
prerank,PanglaoDB_Augmented_2021__Hemangioblasts,-0.35922961004585907,-0.8502275665052432,0.8,1.0,1.0,6/33,8.01%,TAL1;LYL1;RHOG;HHEX;FAM78A;EPOR
prerank,GO_Biological_Process_2021__regulation of protein targeting to mitochondrion (GO:1903214),0.4475844635991195,0.849945126040455,0.6951219512195121,1.0,1.0,10/31,23.17%,VPS11;MICALL2;ARIH2;PINK1;ABLIM3;UBE2J2;LRRK2;ATP5IF1;RHOU;ATG13
prerank,GO_Biological_Process_2021__regulation of histone H4-K16 acetylation (GO:2000618),0.5843349934646033,0.8498717893886276,0.7230769230769231,1.0,1.0,1/5,12.87%,BRCA1
prerank,MSigDB_Hallmark_2020__Oxidative Phosphorylation,0.393208370141442,0.8495856146950566,0.7857142857142857,1.0,1.0,34/167,22.98%,MDH1;NDUFA2;PDK4;ETFB;TIMM13;ACAT1;COX7A2;NDUFA3;NDUFS8;CPT1A;ALDH6A1;COX7C;GPI;CYCS;PMPCA;ATP5ME;NDUFB6;GRPEL1;ATP5F1A;UQCRFS1;ATP5F1D;UQCRC1;SLC25A4;ATP5MC1;ATP6V0B;CYC1;COX4I1;PDHB;MFN2;IMMT;ATP5PB;ATP5F1E;COX6C;ISCU
prerank,GO_Biological_Process_2021__inner dynein arm assembly (GO:0036159),0.5756911555329446,0.8493421286813703,0.7571428571428571,1.0,1.0,3/5,22.26%,CCDC39;DNAH7;DNAAF5
prerank,GO_Biological_Process_2021__protein K6-linked ubiquitination (GO:0085020),0.5759605467101035,0.8492899510191897,0.7301587301587301,1.0,1.0,3/6,31.26%,BRCA1;BARD1;RNF6
prerank,GO_Biological_Process_2021__muscle cell migration (GO:0014812),-0.47743113811359666,-0.8492851734059739,0.6129032258064516,1.0,1.0,1/7,3.00%,DDR1
prerank,GO_Biological_Process_2021__protein transmembrane import into intracellular organelle (GO:0044743),0.4559953605578583,0.8492157727035755,0.6756756756756757,1.0,1.0,5/20,25.05%,TOMM20;GRPEL1;HSPD1;TOMM40;PEX10
prerank,PanglaoDB_Augmented_2021__Trophoblast Progenitor Cells,-0.28182597172387697,-0.8491575607884936,1.0,1.0,1.0,16/66,15.86%,LRP10;DENND1C;ARAP1;TC2N;MAPK13;MAP2K3;NBEAL2;HLA-E;BCL3;ARHGAP27;PSD4;DEF6;ZFP36;NFKB2;RPS6KA1;OSTF1
prerank,GO_Biological_Process_2021__histone mRNA metabolic process (GO:0008334),-0.38462005917649905,-0.8489868407886344,0.6666666666666666,1.0,1.0,7/22,19.44%,LSM11;MTPAP;SNRPB;EXOSC10;CPSF2;UPF1;TUT7
prerank,"GO_Biological_Process_2021__DNA-templated transcription, initiation (GO:0006352)",0.39515714609947905,0.8489155745228855,0.8041237113402062,1.0,1.0,25/119,21.28%,ERCC2;NR4A2;NR4A1;RORB;RXRB;RBPJ;POLR1C;NR2F1;NR4A3;POLR3H;GTF2H3;ESR1;NR2C2;TBL1XR1;POLR2D;TFAM;TAF9B;ESRRG;CDK9;PPARA;TAF7;POLRMT;NOTCH2;NR1D1;POLR2G
prerank,GO_Biological_Process_2021__heme biosynthetic process (GO:0006783),0.4753011564772832,0.84885333680812,0.6666666666666666,1.0,1.0,5/15,23.82%,PPOX;FLVCR1;ALAD;ATP5IF1;UROS
prerank,GO_Biological_Process_2021__regulation of fat cell differentiation (GO:0045598),0.4159886866745971,0.848820278481514,0.7717391304347826,1.0,1.0,12/49,23.75%,ZBTB16;NOCT;RUNX1T1;ID2;LMO3;WNT5A;TNF;NR1D1;AAMDC;ANKRD26;RORA;GPS2
prerank,MSigDB_Hallmark_2020__Protein Secretion,0.3989895781230414,0.8487482958785223,0.8,1.0,1.0,10/88,15.33%,TOM1L1;GLA;NAPA;KIF1B;ABCA1;GALC;SH3GL2;BNIP3;SCAMP3;TMED10
prerank,GO_Biological_Process_2021__positive regulation of muscle hypertrophy (GO:0014742),0.5172003088993768,0.8487371515338046,0.7922077922077922,1.0,1.0,4/13,21.02%,AGT;NR4A3;ROCK1;SLC9A1
prerank,GO_Biological_Process_2021__dendrite self-avoidance (GO:0070593),-0.44561682862266905,-0.8487166535423049,0.6857142857142857,1.0,1.0,4/10,13.33%,DSCAM;ROBO3;BSG;DSCAML1
prerank,GO_Biological_Process_2021__hippo signaling (GO:0035329),-0.3571545081274873,-0.8487015414988285,0.5238095238095238,1.0,1.0,3/17,6.40%,LATS2;WWTR1;MOB1A
prerank,GO_Biological_Process_2021__negative regulation of platelet aggregation (GO:0090331),0.5216360662845092,0.8485945867228719,0.7258064516129032,1.0,1.0,2/7,14.10%,ALOX12;SERPINE2
prerank,GO_Biological_Process_2021__purine ribonucleotide metabolic process (GO:0009150),0.4451399341537672,0.8483232896724059,0.7386363636363636,1.0,1.0,4/40,7.92%,SULT4A1;HINT1;ACOT13;ACAT1
prerank,GO_Biological_Process_2021__negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),-0.33639015861350774,-0.8482142291718342,0.8571428571428571,1.0,1.0,4/31,5.06%,DAB2IP;EPS15L1;DUSP3;STAM2
prerank,GO_Biological_Process_2021__positive regulation of establishment of protein localization (GO:1904951),0.502985606873274,0.8480340471067956,0.726027397260274,1.0,1.0,6/16,28.00%,TCP1;TNF;CHP1;CCT8;DKC1;CORO2B
prerank,GO_Biological_Process_2021__ethanol oxidation (GO:0006069),0.5769693613477468,0.8479377302702626,0.696969696969697,1.0,1.0,2/5,18.02%,ALDH1A1;ADH5
prerank,GO_Biological_Process_2021__ethanol metabolic process (GO:0006067),0.5769693613477468,0.8479377302702626,0.696969696969697,1.0,1.0,2/5,18.02%,ALDH1A1;ADH5
prerank,GO_Biological_Process_2021__RIG-I signaling pathway (GO:0039529),0.5722611533097899,0.8478616018500021,0.7761194029850746,1.0,1.0,1/5,9.61%,TRIM25
prerank,GO_Biological_Process_2021__regulation of actin filament organization (GO:0110053),-0.44543784227919836,-0.8478075317201255,0.6785714285714286,1.0,1.0,2/7,12.16%,ARHGAP35;CXCL12
prerank,GO_Biological_Process_2021__peptidyl-lysine modification (GO:0018205),-0.2683514398266174,-0.8477774490844262,1.0,1.0,1.0,13/80,14.72%,NUP42;LOXL3;NNAT;NUP155;EP300;NUP188;NUP214;RAE1;NDUFAB1;SENP6;VCPKMT;SENP1;HDAC10
prerank,GO_Biological_Process_2021__cellular calcium ion homeostasis (GO:0006874),0.389988221575954,0.847607872960218,0.7666666666666667,1.0,1.0,10/76,10.81%,HTR2B;SLC24A2;VAPB;ANK2;HERPUD1;CAV3;RYR2;TRPC4;SLC24A1;ADCY8
prerank,GO_Biological_Process_2021__negative regulation of osteoclast differentiation (GO:0045671),-0.3911465966697739,-0.8473053356055243,0.6153846153846154,1.0,1.0,3/13,8.55%,ZNF675;LILRB4;TLR3
prerank,GO_Biological_Process_2021__digestive tract morphogenesis (GO:0048546),0.5442725745031349,0.8470386408489741,0.6935483870967742,1.0,1.0,3/5,23.77%,ID2;FGFR2;BBS7
prerank,GO_Biological_Process_2021__regulation of necrotic cell death (GO:0010939),0.5729489337928138,0.8463582711737828,0.8135593220338984,1.0,1.0,2/5,33.24%,ASAH1;SLC6A6
prerank,GO_Biological_Process_2021__regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175),0.46999980407617,0.846317897648473,0.6575342465753424,1.0,1.0,5/14,22.54%,SOD2;HSPB1;SOD1;P4HB;SFPQ
prerank,GO_Biological_Process_2021__phagosome maturation (GO:0090382),0.4382372385220698,0.8458186680890365,0.7051282051282052,1.0,1.0,9/28,30.92%,RAB20;ATP6V0B;SLAMF8;ATP6V1B2;ATP6V0E2;ATP6V1D;ATP6V1E2;ATP6V0A1;MCOLN1
prerank,GO_Biological_Process_2021__cytoplasmic pattern recognition receptor signaling pathway in response to virus (GO:0039528),0.5070298170740056,0.8456706200168614,0.7777777777777778,1.0,1.0,1/8,9.61%,TRIM25
prerank,GO_Biological_Process_2021__positive regulation of NLRP3 inflammasome complex assembly (GO:1900227),0.549673410387073,0.8452761277073801,0.6333333333333333,1.0,1.0,2/6,24.61%,DHX33;DDX3X
prerank,GO_Biological_Process_2021__regulation of insulin secretion (GO:0050796),-0.3025827484769983,-0.845094275773889,0.8,1.0,1.0,8/56,8.65%,CCL5;IL1B;STXBP4;NNAT;UQCC2;ITPR2;AACS;ALOX5
prerank,GO_Biological_Process_2021__positive regulation of protein localization to membrane (GO:1905477),0.4098928552829702,0.8449609253838642,0.7684210526315789,1.0,1.0,7/71,6.80%,PRKCE;CLIP3;ARF6;MTCL1;CEMIP;ANK3;EPHA3
prerank,GO_Biological_Process_2021__regulation of cellular amino acid metabolic process (GO:0006521),-0.3367484432400167,-0.8447603674602449,0.5714285714285714,1.0,1.0,5/41,8.38%,PSMB3;PSME3;PSMC4;PSMD12;PSME4
prerank,GO_Biological_Process_2021__regulation of membrane tubulation (GO:1903525),-0.48745426782062307,-0.8442109149670217,0.6666666666666666,1.0,1.0,1/6,7.42%,PLEKHM2
prerank,GO_Biological_Process_2021__positive regulation of cytokine production (GO:0001819),0.3845889025452634,0.844143330979422,0.87,1.0,1.0,38/214,18.46%,HTR2B;RAB7B;EGR1;CADM1;IL15;AGT;CHI3L1;PQBP1;ANXA1;SLC11A1;POLR3F;TRAF2;ALOX15B;EIF2AK3;IL7;HIF1A;FGR;POLR1C;PDE4B;NOD2;SULF2;RIPK2;BRCA1;POLR3H;PYCARD;WNT5A;TMED10;DHX33;IL18;TXK;SPTBN1;PLCB1;HSPA1B;APP;FOXP1;RGCC;SOD1;HSPD1
prerank,GO_Biological_Process_2021__regulation of telomere maintenance via telomerase (GO:0032210),-0.32585265150147574,-0.8440715125350077,0.8,1.0,1.0,7/43,15.93%,PKIB;CTC1;SRC;MAP3K4;TERF2;SMG6;EXOSC10
prerank,GO_Biological_Process_2021__positive regulation of calcineurin-mediated signaling (GO:0106058),0.5375719896848667,0.8439504456008879,0.76,1.0,1.0,3/8,21.02%,AKAP6;TNF;SLC9A1
prerank,GO_Biological_Process_2021__positive regulation of calcineurin-NFAT signaling cascade (GO:0070886),0.5375719896848667,0.8439504456008879,0.76,1.0,1.0,3/8,21.02%,AKAP6;TNF;SLC9A1
prerank,GO_Biological_Process_2021__regulation of cardiac conduction (GO:1903779),0.4352177992567956,0.8435058114706024,0.6941176470588235,1.0,1.0,14/27,26.47%,AGT;ANK2;RYR2;FXYD7;RYR3;ASPH;ATP2A2;ATP1B3;ATP1B2;ATP1A2;TRPC1;ATP2B2;ATP2B4;TMEM65
prerank,GO_Biological_Process_2021__fatty acid beta-oxidation (GO:0006635),-0.3418380295517406,-0.8432551484227447,0.7777777777777778,1.0,1.0,8/36,13.97%,EHHADH;ACOX1;MTLN;ACAA1;ECI1;IVD;PPARD;ABCD3
prerank,GO_Biological_Process_2021__positive regulation of p38MAPK cascade (GO:1900745),0.4783297692530479,0.8430590310108315,0.6842105263157895,1.0,1.0,3/16,11.93%,GADD45B;VEGFA;SASH1
prerank,GO_Biological_Process_2021__regulation of gene silencing by RNA (GO:0060966),-0.32750964124386106,-0.8423220087393156,0.75,1.0,1.0,7/47,12.38%,NUP42;NUP155;AGO1;NUP188;NUP214;RAE1;POLR2C
prerank,GO_Biological_Process_2021__regulation of posttranscriptional gene silencing (GO:0060147),-0.32750964124386106,-0.8423220087393156,0.75,1.0,1.0,7/47,12.38%,NUP42;NUP155;AGO1;NUP188;NUP214;RAE1;POLR2C
prerank,GO_Biological_Process_2021__clathrin-dependent endocytosis (GO:0072583),0.4612903855123271,0.842283619742857,0.7469879518072289,1.0,1.0,7/25,19.66%,DNAJC6;FCHO2;SGIP1;ITSN1;PICALM;AP2A2;SNAP91
prerank,"GO_Biological_Process_2021__base-excision repair, AP site formation (GO:0006285)",0.5215758662375504,0.8422585578608072,0.7464788732394366,1.0,1.0,3/11,9.68%,TDG;MPG;NEIL1
prerank,GO_Biological_Process_2021__cellular response to UV (GO:0034644),0.4136289503453363,0.8422283628589381,0.7252747252747253,1.0,1.0,8/49,15.73%,TMEM161A;PTPRK;RUVBL2;KDM1A;IMPACT;PPID;ACTR5;COPS9
prerank,GO_Biological_Process_2021__regulation of peptidase activity (GO:0052547),-0.43852472183279523,-0.8422256835575753,0.7272727272727273,1.0,1.0,1/12,1.38%,CST7
prerank,GO_Biological_Process_2021__defense response to symbiont (GO:0140546),-0.3221752931455603,-0.842121021973917,0.8,1.0,1.0,12/77,8.55%,RNASEL;FLNA;PDE12;BCL2L1;ZMYND11;NLRP1;MLKL;APOBEC3G;MAP3K14;CGAS;NCBP3;TLR3
prerank,GO_Biological_Process_2021__DNA double-strand break processing (GO:0000729),0.4742314377985687,0.8421207301397515,0.6835443037974683,1.0,1.0,8/17,29.84%,DNA2;BRCA1;RBBP8;RNF138;BARD1;SLX4;SMARCAD1;BLM
prerank,GO_Biological_Process_2021__positive regulation of cyclase activity (GO:0031281),-0.4914555418972404,-0.8416060504776604,0.6666666666666666,1.0,1.0,2/8,15.01%,STIM1;CACNA1D
prerank,GO_Biological_Process_2021__peptide catabolic process (GO:0043171),-0.3823855228418219,-0.8415237673871653,0.5714285714285714,1.0,1.0,3/13,12.46%,IDE;ERAP2;GGT7
prerank,GO_Biological_Process_2021__organelle fission (GO:0048285),0.4583163380263522,0.8414480928465207,0.6987951807228916,1.0,1.0,2/19,10.71%,DNM3;DNM1
prerank,GO_Biological_Process_2021__chemical homeostasis (GO:0048878),0.4325042451834179,0.8413656035462425,0.735632183908046,1.0,1.0,6/35,18.63%,VGF;SLC4A10;IRS2;TENT4B;PNPLA8;AQP11
prerank,GO_Biological_Process_2021__establishment of protein localization to chromatin (GO:0071169),0.5360897542865316,0.8413248057516413,0.7540983606557377,1.0,1.0,1/5,7.76%,RUVBL2
prerank,GO_Biological_Process_2021__histone acetylation (GO:0016573),0.4171082830748646,0.8412833676277175,0.7222222222222222,1.0,1.0,8/59,20.58%,WDR5;RUVBL2;YEATS2;PER1;TRIM16;CHD5;MORF4L2;MEAF6
prerank,GO_Biological_Process_2021__regulation of cell cycle checkpoint (GO:1901976),0.5741163418284185,0.8412021011894546,0.78125,1.0,1.0,4/6,27.30%,RPA2;ETAA1;WDR76;FEM1B
prerank,GO_Biological_Process_2021__lipid droplet organization (GO:0034389),-0.44388530907108886,-0.841035881814627,0.7,1.0,1.0,2/11,3.95%,PLA2G4C;ZFYVE1
prerank,GO_Biological_Process_2021__cytoplasmic sequestering of transcription factor (GO:0042994),-0.4232348828450675,-0.8404447043764672,0.68,1.0,1.0,2/9,11.00%,NFKBIE;NFKBIA
prerank,GO_Biological_Process_2021__regulation of neuron projection arborization (GO:0150011),0.48722757770205893,0.840049155922906,0.7402597402597403,1.0,1.0,5/14,19.39%,MFSD2A;WNT5A;MAP3K13;NTNG1;DLG4
prerank,GO_Biological_Process_2021__regulation of endopeptidase activity (GO:0052548),0.4185646648224416,0.8398103736148949,0.6805555555555556,1.0,1.0,7/35,15.03%,SPOCK1;AGT;SPOCK3;PRELID1;SERPINE2;TIMP3;PICALM
prerank,GO_Biological_Process_2021__lipoprotein catabolic process (GO:0042159),-0.43038412694168615,-0.8398103550462211,0.6,1.0,1.0,3/7,15.72%,ABHD17A;ABHD10;LYPLA1
prerank,GO_Biological_Process_2021__tRNA processing (GO:0008033),0.3975270035236252,0.8397091696135592,0.7209302325581395,1.0,1.0,5/46,13.04%,TRMT9B;FTSJ1;TRNT1;DDX1;TSEN54
prerank,GO_Biological_Process_2021__granulocyte activation (GO:0036230),-0.5031734696102227,-0.8396998400375502,0.6136363636363636,1.0,1.0,1/5,0.45%,CCL5
prerank,GO_Biological_Process_2021__positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress (GO:1990440),0.5222474840827417,0.8396056115998994,0.7222222222222222,1.0,1.0,1/9,5.27%,HSPA5
prerank,GO_Biological_Process_2021__positive regulation of growth (GO:0045927),0.42951555865974733,0.839251607170329,0.797752808988764,1.0,1.0,8/48,18.11%,TGFB2;CDKN2AIP;INSR;AKAP6;MFSD2A;SDCBP;PLCB1;TAF9B
prerank,GO_Biological_Process_2021__neutrophil degranulation (GO:0043312),0.37030311651415543,0.8390923417014996,0.82,1.0,1.0,54/346,20.42%,CRISPLD2;ALDH3B1;CLEC12A;CR1;GLA;PLAC8;SLC2A3;CHI3L1;SLC11A1;CD55;DGAT1;GNS;ACTR1B;PGAM1;SNAP25;GSDMD;FGR;MGAM;CKAP4;C5AR1;CD93;SPTAN1;ARSA;FGL2;DYNC1H1;GPI;TNFRSF1B;NFASC;SNAP29;PKM;ACP3;LRRC7;CD300A;MAGT1;ENPP4;PYCARD;SDCBP;LTA4H;ITGAV;IQGAP1;ROCK1;HSPA1B;GSTP1;STXBP2;FTH1;ALAD;PRDX4;PSMC2;AP2A2;SYNGR1;PLD1;SURF4;PGM1;SELL
prerank,GO_Biological_Process_2021__positive regulation of muscle cell differentiation (GO:0051149),0.47814351140373407,0.8388782775635,0.7307692307692307,1.0,1.0,2/18,4.08%,NRG1;CDH2
prerank,GO_Biological_Process_2021__energy derivation by oxidation of organic compounds (GO:0015980),0.4816365584292014,0.8384953762521813,0.6923076923076923,1.0,1.0,5/16,25.32%,CYCS;NR4A3;GFPT1;LEPR;PPARGC1A
prerank,GO_Biological_Process_2021__positive regulation of mRNA processing (GO:0050685),0.46942158107647286,0.8381868188543206,0.6428571428571429,1.0,1.0,1/17,5.92%,RBM3
prerank,GO_Biological_Process_2021__negative regulation of T cell proliferation (GO:0042130),0.4527097272776875,0.8378199707656221,0.7283950617283951,1.0,1.0,3/22,10.74%,CR1;GPNMB;PDCD1LG2
prerank,GO_Biological_Process_2021__B cell proliferation (GO:0042100),0.5049689430472175,0.8378141515165681,0.7037037037037037,1.0,1.0,2/9,20.16%,HSPD1;CTPS1
prerank,GO_Biological_Process_2021__glycerophospholipid metabolic process (GO:0006650),0.4151602298985295,0.8372146738980506,0.7261904761904762,1.0,1.0,8/47,22.66%,GDPD1;PIGQ;PIGF;PLCB1;PIGL;PIGG;SERINC5;CPNE3
prerank,GO_Biological_Process_2021__fatty acid oxidation (GO:0019395),-0.34877843567230843,-0.8371951659803211,0.7692307692307693,1.0,1.0,7/39,8.73%,PEX13;EHHADH;ACOX1;MTLN;ACAA1;ECI1;CYP4V2
prerank,GO_Biological_Process_2021__protein phosphorylation (GO:0006468),0.3770425630155749,0.8369777976441956,0.89,1.0,1.0,61/366,19.02%,DAPK2;ACVR1B;CDK14;NEK11;TGFB2;PRKCE;RELN;CIT;RIOK2;CLSPN;ACVR2A;TTBK2;AATK;BMPR1B;MASTL;PDK4;EIF2AK3;PRRT1;RPS6KB2;INSR;DAPK1;NIM1K;EPHA3;PXK;IGF1R;PLK2;FGR;ALK;CLK2;LIPE;TYRO3;CAMK2B;PRKAG2;RPS6KA2;FAM20A;FLT1;NTRK2;EPHA4;PAK5;PINK1;PKD1;INCENP;MAPK10;GTF2H3;PDK3;NUAK2;CTBP1;TXK;TEC;GRK4;NRBP2;GMFB;ROCK1;MAP3K13;APP;PIK3R4;PRKAA2;FES;PRDX4;CDK9;CDC25B
prerank,GO_Biological_Process_2021__regulation of chromatin binding (GO:0035561),0.5007257649786233,0.8369034446854203,0.6829268292682927,1.0,1.0,5/9,37.27%,WAPL;PARP9;GMNN;MED25;HMBOX1
prerank,GO_Biological_Process_2021__histone H3-K36 methylation (GO:0010452),-0.4875085209544076,-0.8365335364667749,0.5853658536585366,1.0,1.0,1/5,16.06%,SETD3
prerank,GO_Biological_Process_2021__positive regulation of triglyceride biosynthetic process (GO:0010867),0.5262447874940948,0.8365007103014023,0.6486486486486487,1.0,1.0,4/8,30.59%,MFSD2A;CNEP1R1;SCARB1;NR1H2
prerank,GO_Biological_Process_2021__cellular response to cold (GO:0070417),0.5725621572334982,0.8364866770087253,0.7435897435897436,1.0,1.0,1/5,5.64%,EIF2AK3
prerank,GO_Biological_Process_2021__carbohydrate biosynthetic process (GO:0016051),0.5491758357755736,0.8362898357115921,0.8064516129032258,1.0,1.0,3/8,34.86%,ST6GALNAC5;FUT9;FUT8
prerank,GO_Biological_Process_2021__oligosaccharide biosynthetic process (GO:0009312),0.5491758357755736,0.8362898357115921,0.8064516129032258,1.0,1.0,3/8,34.86%,ST6GALNAC5;FUT9;FUT8
prerank,GO_Biological_Process_2021__regulation of carbohydrate biosynthetic process (GO:0043255),0.5474809347907995,0.8359616694792396,0.7671232876712328,1.0,1.0,1/8,12.53%,FBP1
prerank,GO_Biological_Process_2021__innate immune response (GO:0045087),0.3938618232472047,0.835751195923613,0.8526315789473684,1.0,1.0,15/134,14.21%,CLEC4E;CR1;H2BC11;ATAD3A;SLC11A1;ADAM15;TRIM5;TRIM25;IFITM3;FGR;NOD2;IFNLR1;RIPK2;CALCOCO2;TRIM26
prerank,GO_Biological_Process_2021__positive regulation of microtubule nucleation (GO:0090063),0.5069670664319197,0.8352507566537722,0.72,1.0,1.0,3/7,18.00%,CKAP5;HSPA1B;DCTN1
prerank,GO_Biological_Process_2021__mitochondrial fragmentation involved in apoptotic process (GO:0043653),0.5241828762618799,0.8351168506839767,0.7,1.0,1.0,1/9,13.05%,BNIP3
prerank,GO_Biological_Process_2021__mRNA polyadenylation (GO:0006378),-0.36291438111487945,-0.8350356310924749,0.7083333333333334,1.0,1.0,6/21,16.16%,LEO1;CPSF1;MTPAP;WDR33;GRSF1;CPSF2
prerank,GO_Biological_Process_2021__RNA polyadenylation (GO:0043631),-0.36291438111487945,-0.8350356310924749,0.7083333333333334,1.0,1.0,6/21,16.16%,LEO1;CPSF1;MTPAP;WDR33;GRSF1;CPSF2
prerank,GO_Biological_Process_2021__granulocyte migration (GO:0097530),0.5434519479024592,0.8349037377999897,0.7142857142857143,1.0,1.0,1/6,3.87%,ANXA1
prerank,GO_Biological_Process_2021__import into nucleus (GO:0051170),-0.2951170427920089,-0.8345048370674386,0.875,1.0,1.0,13/58,14.34%,RANBP6;SNUPN;APPL2;NUP155;RPAIN;PHB2;NUP188;NUP214;IPO13;SYK;PTTG1IP;AKT1;SNRPB
prerank,GO_Biological_Process_2021__regulation of interleukin-1 beta production (GO:0032651),0.4001066038831886,0.8344936670669849,0.7159090909090909,1.0,1.0,13/52,17.56%,NLRP12;EGR1;GSDMD;NOD2;RIPK2;TRIM16;PYCARD;AIM2;WNT5A;HSPB1;APP;GSTP1;FOXP1
prerank,GO_Biological_Process_2021__mitotic G1/S transition checkpoint signaling (GO:0044819),-0.4454058893923017,-0.8339954541241432,0.6842105263157895,1.0,1.0,5/10,12.81%,CCND1;TP53;RFWD3;PLK3;SDE2
prerank,GO_Biological_Process_2021__respiratory chain complex III assembly (GO:0017062),-0.4837362628107068,-0.8338226359633923,0.8076923076923077,1.0,1.0,2/7,11.69%,UQCC2;SLC25A33
prerank,GO_Biological_Process_2021__mitochondrial respiratory chain complex III assembly (GO:0034551),-0.4837362628107068,-0.8338226359633923,0.8076923076923077,1.0,1.0,2/7,11.69%,UQCC2;SLC25A33
prerank,GO_Biological_Process_2021__negative regulation of oxidoreductase activity (GO:0051354),-0.5239279784157317,-0.8337699694084403,0.625,1.0,1.0,1/5,22.47%,PRKN
prerank,GO_Biological_Process_2021__monocyte differentiation (GO:0030224),-0.5189115250722038,-0.83360497828289,0.6538461538461539,1.0,1.0,3/8,8.43%,MYH9;CSF1R;THOC5
prerank,GO_Biological_Process_2021__oogenesis (GO:0048477),0.5283943771536902,0.833575090125915,0.7681159420289855,1.0,1.0,3/7,8.95%,IHO1;FMN2;PTN
prerank,GO_Biological_Process_2021__regulation of platelet aggregation (GO:0090330),0.44413648227446123,0.8330839150562562,0.704225352112676,1.0,1.0,2/14,14.10%,ALOX12;SERPINE2
prerank,GO_Biological_Process_2021__regulation of Golgi organization (GO:1903358),0.4873114990445038,0.8330565127620414,0.7469879518072289,1.0,1.0,1/15,11.29%,PDE4DIP
prerank,GO_Biological_Process_2021__regulation of filopodium assembly (GO:0051489),0.4213619348588967,0.8330237486633407,0.7283950617283951,1.0,1.0,4/31,7.94%,GPM6A;ARF6;MYO10;NLGN1
prerank,GO_Biological_Process_2021__positive regulation of histone deacetylation (GO:0031065),0.5149312919585047,0.8325953978155161,0.7166666666666667,1.0,1.0,2/10,16.30%,VEGFA;CTBP1
prerank,GO_Biological_Process_2021__negative regulation of macrophage derived foam cell differentiation (GO:0010745),0.5266419903932813,0.8316127482542481,0.7272727272727273,1.0,1.0,5/9,22.91%,ABCA1;ABCA5;ITGAV;PPARA;ABCG1
prerank,GO_Biological_Process_2021__regulation of regulatory T cell differentiation (GO:0045589),0.4876461581305246,0.8314196573213269,0.7777777777777778,1.0,1.0,4/14,18.18%,CR1;DUSP10;BCL6;FANCA
prerank,GO_Biological_Process_2021__coenzyme A metabolic process (GO:0015936),-0.3974868311275461,-0.8312936208704702,0.7368421052631579,1.0,1.0,3/12,13.67%,PANK1;PPCDC;PPCS
prerank,GO_Biological_Process_2021__cholesterol transport (GO:0030301),-0.35814600399425,-0.8311449539347215,0.7777777777777778,1.0,1.0,3/30,5.72%,NPC2;NPC1;LIMA1
prerank,GO_Biological_Process_2021__interleukin-1-mediated signaling pathway (GO:0070498),0.3922491209367102,0.8301943040862823,0.8144329896907216,1.0,1.0,19/82,22.13%,ST18;EGR1;MAP3K8;RPS27A;NOD2;PSMB4;RBX1;RIPK2;PELI1;PLCB1;UBA52;UBB;PSMC2;PSMA3;PSMB2;IRAK3;PSMD5;PSMD7;MAP3K3
prerank,GO_Biological_Process_2021__neutrophil activation involved in immune response (GO:0002283),0.3668008902105616,0.829936874597714,0.88,1.0,1.0,54/349,20.42%,CRISPLD2;ALDH3B1;CLEC12A;CR1;GLA;PLAC8;SLC2A3;CHI3L1;SLC11A1;CD55;DGAT1;GNS;ACTR1B;PGAM1;SNAP25;GSDMD;FGR;MGAM;CKAP4;C5AR1;CD93;SPTAN1;ARSA;FGL2;DYNC1H1;GPI;TNFRSF1B;NFASC;SNAP29;PKM;ACP3;LRRC7;CD300A;MAGT1;ENPP4;PYCARD;SDCBP;LTA4H;ITGAV;IQGAP1;ROCK1;HSPA1B;GSTP1;STXBP2;FTH1;ALAD;PRDX4;PSMC2;AP2A2;SYNGR1;PLD1;SURF4;PGM1;SELL
prerank,GO_Biological_Process_2021__regulation of intracellular protein transport (GO:0033157),-0.3483503611723528,-0.829791714846188,0.8571428571428571,1.0,1.0,6/27,18.20%,TGFB1;LCP1;PRR5L;PLK3;RAB29;CEP290
prerank,GO_Biological_Process_2021__alcohol catabolic process (GO:0046164),0.5479091991173414,0.829650731929739,0.7846153846153846,1.0,1.0,2/6,20.00%,SNX17;CYP46A1
prerank,GO_Biological_Process_2021__cholesterol catabolic process (GO:0006707),0.5479091991173414,0.829650731929739,0.7846153846153846,1.0,1.0,2/6,20.00%,SNX17;CYP46A1
prerank,GO_Biological_Process_2021__sterol catabolic process (GO:0016127),0.5479091991173414,0.829650731929739,0.7846153846153846,1.0,1.0,2/6,20.00%,SNX17;CYP46A1
prerank,GO_Biological_Process_2021__regulation of actin polymerization or depolymerization (GO:0008064),-0.3788551576689634,-0.8295560636584416,0.7272727272727273,1.0,1.0,3/18,12.16%,PFN1;ARHGAP35;CXCL12
prerank,GO_Biological_Process_2021__cellular response to lipid (GO:0071396),0.39183044153391683,0.8288869413344464,0.8762886597938144,1.0,1.0,21/113,15.59%,VIM;HMGB2;ADCY3;BRINP1;ADAM15;RORB;PDK4;EPHA3;RUVBL2;PTK7;PDE4B;PDCD1LG2;ADCY8;NOD2;TNFRSF1B;GNAI1;INSIG1;PYCARD;WNT5A;ESR1;PDK3
prerank,GO_Biological_Process_2021__positive regulation of neuroinflammatory response (GO:0150078),-0.5113456598761583,-0.8288470095271363,0.6666666666666666,1.0,1.0,2/5,10.32%,IL1B;TREM2
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway (GO:0097193),0.40198487729386867,0.8281358814789201,0.8085106382978723,1.0,1.0,14/77,15.86%,TRAF2;HINT1;GSKIP;BOK;MCL1;ZNF385B;TNFRSF1B;BRCA1;BNIP3;BCL2L2;PPP1R15A;PYCARD;SCN2A;CIDEB
prerank,GO_Biological_Process_2021__formation of translation preinitiation complex (GO:0001731),-0.44989709396718913,-0.8278323388356081,0.7037037037037037,1.0,1.0,1/9,14.03%,EIF2S2
prerank,GO_Biological_Process_2021__plus-end-directed organelle transport along microtubule (GO:0072386),0.5915390882987173,0.8276698992528346,0.7777777777777778,1.0,1.0,3/6,21.66%,MAPT;KIF3A;FYCO1
prerank,GO_Biological_Process_2021__positive regulation of intracellular signal transduction (GO:1902533),0.37368859169792074,0.827431952673315,0.91,1.0,1.0,59/347,17.45%,HTR2B;THBS1;LRP2;FGF1;TGFB2;NLRP12;IFIT5;RPL23;RELN;TFRC;AGT;NRG1;CHI3L1;KITLG;VEGFA;TRAF2;INSR;NLGN1;SEPTIN4;TRIM5;FN1;TXN;BOK;IRS2;IGF1R;TRIM25;PLK2;FGR;NTRK3;SEMA5A;GPRC5B;NOD2;FLT1;NTRK2;HCLS1;SASH1;RPS20;RIPK2;DDX1;GAB1;PINK1;RPL37;RUNDC3A;PLXNB1;PELI1;IQCJ-SCHIP1;WNT5A;NRG4;ESR1;SEH1L;DHX33;IL18;ITGAV;RNF13;LITAF;CHD5;IQGAP1;ROCK1;APP
prerank,GO_Biological_Process_2021__positive regulation of JNK cascade (GO:0046330),0.41031123807053005,0.8272956001566414,0.7362637362637363,1.0,1.0,10/48,18.89%,SEMA3A;GADD45B;TRAF2;FCGR2B;NOD2;PYCARD;SDCBP;PLCB1;APP;ANKRD6
prerank,GO_Biological_Process_2021__regulation of insulin receptor signaling pathway (GO:0046626),-0.34431526030867377,-0.8269628335857895,0.8571428571428571,1.0,1.0,7/30,14.81%,INPP5K;IL1B;PIP4K2B;ENPP1;SORL1;NCK1;PTPRE
prerank,GO_Biological_Process_2021__central nervous system neuron axonogenesis (GO:0021955),0.4787144161657965,0.8269174193167369,0.6533333333333333,1.0,1.0,5/11,26.32%,B4GALT5;SPTBN4;PTEN;B4GALT6;HSP90AB1
prerank,GO_Biological_Process_2021__regulation of stem cell division (GO:2000035),0.5672018845713651,0.8269005897621851,0.7692307692307693,1.0,1.0,4/6,32.90%,SMYD5;PRDM15;MLLT3;NCOA3
prerank,GO_Biological_Process_2021__endosomal vesicle fusion (GO:0034058),0.5372247223076939,0.8268900976746165,0.6825396825396826,1.0,1.0,1/8,7.42%,VPS11
prerank,GO_Biological_Process_2021__positive regulation of smooth muscle cell proliferation (GO:0048661),0.43067230645998444,0.8268703136778854,0.7468354430379747,1.0,1.0,10/29,22.86%,THBS1;ID2;NR4A3;IL18;FOXP1;TNF;MFN2;CX3CL1;STAT1;JUN
prerank,GO_Biological_Process_2021__transcription initiation from RNA polymerase II promoter (GO:0006367),0.39091016999197403,0.8264273478882681,0.8210526315789474,1.0,1.0,21/97,21.28%,ERCC2;NR4A2;NR4A1;RORB;RXRB;RBPJ;NR2F1;NR4A3;GTF2H3;ESR1;NR2C2;TBL1XR1;POLR2D;TAF9B;ESRRG;CDK9;PPARA;TAF7;NOTCH2;NR1D1;POLR2G
prerank,GO_Biological_Process_2021__very long-chain fatty acid biosynthetic process (GO:0042761),-0.43894067403000525,-0.8263815322205372,0.5714285714285714,1.0,1.0,2/8,7.93%,TECR;HACD4
prerank,GO_Biological_Process_2021__fatty acid elongation (GO:0030497),-0.43894067403000525,-0.8263815322205372,0.5714285714285714,1.0,1.0,2/8,7.93%,TECR;HACD4
prerank,GO_Biological_Process_2021__positive regulation of B cell activation (GO:0050871),0.4430837353087585,0.82632222870316,0.8072289156626506,1.0,1.0,5/34,14.98%,TFRC;IL7;IRS2;NOD2;GPR183
prerank,GO_Biological_Process_2021__negative regulation of DNA metabolic process (GO:0051053),0.44784110629721013,0.8262713322862026,0.7721518987341772,1.0,1.0,1/24,5.20%,ZNF93
prerank,GO_Biological_Process_2021__positive regulation of receptor recycling (GO:0001921),0.5263406568423573,0.8261608733537782,0.746268656716418,1.0,1.0,1/8,12.94%,NSF
prerank,GO_Biological_Process_2021__positive regulation of neuron apoptotic process (GO:0043525),0.48293591702650596,0.825894891134305,0.75,1.0,1.0,3/19,11.11%,TGFB2;MCL1;EPHA7
prerank,GO_Biological_Process_2021__neutrophil mediated immunity (GO:0002446),0.3643223205697355,0.8258488588034245,0.87,1.0,1.0,54/350,20.42%,CRISPLD2;ALDH3B1;CLEC12A;CR1;GLA;PLAC8;SLC2A3;CHI3L1;SLC11A1;CD55;DGAT1;GNS;ACTR1B;PGAM1;SNAP25;GSDMD;FGR;MGAM;CKAP4;C5AR1;CD93;SPTAN1;ARSA;FGL2;DYNC1H1;GPI;TNFRSF1B;NFASC;SNAP29;PKM;ACP3;LRRC7;CD300A;MAGT1;ENPP4;PYCARD;SDCBP;LTA4H;ITGAV;IQGAP1;ROCK1;HSPA1B;GSTP1;STXBP2;FTH1;ALAD;PRDX4;PSMC2;AP2A2;SYNGR1;PLD1;SURF4;PGM1;SELL
prerank,GO_Biological_Process_2021__toxin transport (GO:1901998),0.5632490953866963,0.8256978429553942,0.7457627118644068,1.0,1.0,1/5,13.33%,ANTXR2
prerank,GO_Biological_Process_2021__cellular response to light stimulus (GO:0071482),0.424701437663734,0.8255536403654037,0.8023255813953488,1.0,1.0,4/37,9.50%,TMEM161A;PTPRK;RUVBL2;KDM1A
prerank,GO_Biological_Process_2021__positive regulation of protein localization to Cajal body (GO:1904871),0.49890078831522955,0.8254788623775805,0.7941176470588235,1.0,1.0,3/11,27.75%,TCP1;CCT8;DKC1
prerank,GO_Biological_Process_2021__regulation of protein localization to Cajal body (GO:1904869),0.49890078831522955,0.8254788623775805,0.7941176470588235,1.0,1.0,3/11,27.75%,TCP1;CCT8;DKC1
prerank,GO_Biological_Process_2021__positive regulation of receptor-mediated endocytosis (GO:0048260),0.4272267021447598,0.8254328415898543,0.7317073170731707,1.0,1.0,4/30,11.99%,VEGFA;INSR;SGIP1;MAGI2
prerank,GO_Biological_Process_2021__protein insertion into mitochondrial inner membrane (GO:0045039),0.5398011206365522,0.8250688936732726,0.7681159420289855,1.0,1.0,3/6,28.76%,TIMM13;TIMM22;AGK
prerank,GO_Biological_Process_2021__ornithine metabolic process (GO:0006591),-0.4702812183971116,-0.8248558159724353,0.6410256410256411,1.0,1.0,3/6,11.41%,AZIN2;ASL;ALDH18A1
prerank,GO_Biological_Process_2021__regulation of autophagosome assembly (GO:2000785),-0.37475729661422674,-0.8245541397076456,0.6470588235294118,1.0,1.0,3/32,9.13%,RALB;PIP4K2B;UBQLN2
prerank,GO_Biological_Process_2021__regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045898),-0.39070083247753606,-0.8245162988041254,0.7419354838709677,1.0,1.0,2/10,6.50%,PSMC4;TP53
prerank,GO_Biological_Process_2021__icosanoid transport (GO:0071715),0.5573305451499779,0.8244882731032075,0.7868852459016393,1.0,1.0,1/5,8.19%,SLCO3A1
prerank,GO_Biological_Process_2021__regulation of cellular response to heat (GO:1900034),0.4027835818683391,0.8240134030277597,0.7888888888888889,1.0,1.0,9/73,17.43%,MAPT;RPA2;IER5;NUP133;DNAJC7;CAMK2B;BAG3;SEH1L;HSPA1B
prerank,GO_Biological_Process_2021__regulation of programmed cell death (GO:0043067),0.38484073471297503,0.8240012841970782,0.84375,1.0,1.0,15/122,13.42%,DAPK2;AGT;PHLPP1;TRAF2;NDRG1;DAPK1;PAX8;SEPTIN4;BEX2;BNIP3L;SRA1;ALK;BNIP3;PINK1;PRELID1
prerank,GO_Biological_Process_2021__positive regulation of ERBB signaling pathway (GO:1901186),0.4511049790493117,0.8239404108480249,0.7307692307692307,1.0,1.0,2/16,9.26%,AGT;RBPJ
prerank,GO_Biological_Process_2021__internal peptidyl-lysine acetylation (GO:0018393),0.4429725455420086,0.8238893205165954,0.7307692307692307,1.0,1.0,6/23,28.37%,RUVBL2;ATAT1;MORF4L2;TAF6L;BAG6;MSL3
prerank,GO_Biological_Process_2021__glutathione derivative metabolic process (GO:1901685),-0.39469348723536357,-0.8238037125649708,0.6666666666666666,1.0,1.0,2/12,9.63%,HPGDS;GSTM4
prerank,GO_Biological_Process_2021__glutathione derivative biosynthetic process (GO:1901687),-0.39469348723536357,-0.8238037125649708,0.6666666666666666,1.0,1.0,2/12,9.63%,HPGDS;GSTM4
prerank,GO_Biological_Process_2021__lymphocyte differentiation (GO:0030098),0.4029474106988354,0.8237428084919133,0.7065217391304348,1.0,1.0,2/44,5.16%,NFIL3;SOX4
prerank,GO_Biological_Process_2021__RNA stabilization (GO:0043489),0.4498112337968,0.8235999906813941,0.6883116883116883,1.0,1.0,3/23,8.64%,SLC11A1;NOCT;TENT5A
prerank,GO_Biological_Process_2021__negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),-0.36067862497972647,-0.8232205949142326,0.85,1.0,1.0,6/24,13.95%,LGALS9;CD274;SIRPA;IGF1;ILRUN;HAVCR2
prerank,GO_Biological_Process_2021__negative regulation of DNA-binding transcription factor activity (GO:0043433),0.4005254920404965,0.8230021227230588,0.8469387755102041,1.0,1.0,10/86,15.56%,KLF4;NLRP12;FZD6;BHLHE40;ID2;KDM1A;PKD1;PYCARD;AIM2;ESR1
prerank,GO_Biological_Process_2021__DNA metabolic process (GO:0006259),0.38026238833339016,0.8229106349758928,0.89,1.0,1.0,36/198,21.25%,TOP2A;HMGB2;RPA2;TDG;MPG;GLRX2;ENDOV;WDHD1;DNA2;RPS27A;NEIL1;POLQ;HINFP;INTS3;BRCA1;XRCC3;FAN1;RFC4;UHRF2;GTF2H3;POLE2;ORC6;POLL;FANCL;ADPRS;FANCA;UBA52;DBF4;UBB;TIMELESS;NOP53;RFC1;KMT5C;HELLS;RBBP8;DDB1
prerank,GO_Biological_Process_2021__regulation of actin filament bundle assembly (GO:0032231),0.45434446212144447,0.8228897359159243,0.7692307692307693,1.0,1.0,6/18,22.53%,SHANK3;ROCK1;SLC9A1;CX3CL1;RDX;PTGER4
prerank,GO_Biological_Process_2021__positive regulation of filopodium assembly (GO:0051491),0.44984565951708566,0.8228711957690379,0.7297297297297297,1.0,1.0,2/18,7.94%,GPM6A;NLGN1
prerank,GO_Biological_Process_2021__positive regulation of axon extension involved in axon guidance (GO:0048842),0.5542903011527764,0.8228519860147115,0.7692307692307693,1.0,1.0,2/5,10.26%,VEGFA;SEMA5A
prerank,GO_Biological_Process_2021__regulation of protein localization to nucleolus (GO:1904749),0.5781821549627852,0.8225383091754922,0.8,1.0,1.0,2/5,12.11%,GLUL;NMD3
prerank,GO_Biological_Process_2021__regulation of p38MAPK cascade (GO:1900744),0.4314449623136919,0.8224852304081627,0.7272727272727273,1.0,1.0,6/29,14.74%,GADD45B;VEGFA;PHLPP1;PER1;SASH1;DUSP10
prerank,GO_Biological_Process_2021__regulation of viral release from host cell (GO:1902186),0.47113714595718736,0.8215251511085448,0.7285714285714285,1.0,1.0,4/16,21.25%,TRIM5;TRIM25;TRIM26;DDB1
prerank,GO_Biological_Process_2021__regulation of transmembrane transport (GO:0034762),-0.3799200548758351,-0.8213639185726955,0.7894736842105263,1.0,1.0,4/18,6.66%,NEDD4;FFAR4;ACTB;TRIB3
prerank,GO_Biological_Process_2021__regulation of protein localization to nucleus (GO:1900180),-0.34053761155457934,-0.8212499982813585,0.6363636363636364,1.0,1.0,6/29,7.51%,SESN2;LATS2;LILRB4;WWTR1;NVL;TGFB1
prerank,"GO_Biological_Process_2021__negative regulation of CD8-positive, alpha-beta T cell activation (GO:2001186)",-0.4841022397973437,-0.8208227951618429,0.625,1.0,1.0,1/5,5.98%,CD274
prerank,GO_Biological_Process_2021__positive regulation of mast cell degranulation (GO:0043306),0.5267571346645031,0.8208129264811528,0.7727272727272727,1.0,1.0,1/7,9.71%,FGR
prerank,GO_Biological_Process_2021__protein localization to nuclear envelope (GO:0090435),-0.47734018038839027,-0.8206113307276957,0.6153846153846154,1.0,1.0,1/5,7.83%,NUP155
prerank,GO_Biological_Process_2021__regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266),0.5032029047868343,0.8205268705902768,0.7272727272727273,1.0,1.0,1/8,13.06%,XRCC3
prerank,GO_Biological_Process_2021__regulation of cellular protein localization (GO:1903827),0.43517920845572894,0.8203634198916513,0.8095238095238095,1.0,1.0,6/37,12.62%,MAPT;GPC5;ABCA2;MAP2;KDM1A;VCPIP1
prerank,GO_Biological_Process_2021__regulation of stress-activated MAPK cascade (GO:0032872),0.4120101888127742,0.8197194244299408,0.8131868131868132,1.0,1.0,6/42,10.87%,TGFB2;PHLPP1;COPS5;IGF1R;PER1;NOD2
prerank,GO_Biological_Process_2021__positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),-0.2871726404793923,-0.8196871267518295,1.0,1.0,1.0,19/126,8.42%,LURAP1;FLNA;TICAM1;TRIM38;CHUK;EDA2R;LGALS9;IRAK4;LPAR1;TMEM9B;ATP2C1;TMED4;NEK6;TMEM106A;MAP3K14;ZDHHC13;CASP10;TNFSF10;PLEKHG5
prerank,GO_Biological_Process_2021__pyrimidine nucleoside metabolic process (GO:0006213),0.5037861871465688,0.819675107443399,0.7974683544303798,1.0,1.0,1/12,1.95%,DPYD
prerank,GO_Biological_Process_2021__sterol metabolic process (GO:0016125),0.434890587096099,0.8196012140096106,0.7777777777777778,1.0,1.0,9/36,20.18%,TM7SF2;FAXDC2;ABCA1;PRKAG2;INSIG1;ABCA5;MSMO1;CYP46A1;OSBPL5
prerank,GO_Biological_Process_2021__positive regulation of T cell cytokine production (GO:0002726),0.468586936232131,0.8195925694807588,0.7142857142857143,1.0,1.0,2/15,5.63%,TRAF2;CD55
prerank,GO_Biological_Process_2021__neural tube development (GO:0021915),0.5155082686662604,0.8195615888174288,0.7424242424242424,1.0,1.0,3/10,22.49%,SOX4;PKD1;ALDH1A2
prerank,GO_Biological_Process_2021__regulation of peptidyl-tyrosine phosphorylation (GO:0050730),0.3985523543755127,0.8185641006631994,0.8,1.0,1.0,9/58,12.29%,ENPP2;IL15;RELN;AGT;VEGFA;GHR;EPHA7;HCLS1;RIPK2
prerank,GO_Biological_Process_2021__replication fork protection (GO:0048478),0.5259133612554098,0.8185428899530095,0.7205882352941176,1.0,1.0,4/8,33.03%,DONSON;TIMELESS;BLM;ZRANB3
prerank,GO_Biological_Process_2021__regulation of nuclear division (GO:0051783),0.5177466418495055,0.8184068171666411,0.78125,1.0,1.0,1/9,6.86%,RCC1
prerank,GO_Biological_Process_2021__negative regulation of ERBB signaling pathway (GO:1901185),-0.32960738409802637,-0.8183957143385656,0.8571428571428571,1.0,1.0,4/29,5.06%,DAB2IP;EPS15L1;DUSP3;STAM2
prerank,GO_Biological_Process_2021__regulation of transcription from RNA polymerase II promoter in response to oxidative stress (GO:0043619),-0.4869932314727352,-0.8182887028106719,0.6875,1.0,1.0,1/7,1.45%,SESN2
prerank,GO_Biological_Process_2021__nucleoside triphosphate metabolic process (GO:0009141),-0.49754581891793054,-0.8179673927453706,0.6578947368421053,1.0,1.0,2/7,9.65%,ITPA;ENPP1
prerank,GO_Biological_Process_2021__aminoglycan metabolic process (GO:0006022),-0.5371728127305377,-0.8177457157645001,0.8055555555555556,1.0,1.0,2/6,8.12%,B4GALT7;XYLT1
prerank,GO_Biological_Process_2021__negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042),-0.33407272322900117,-0.8176712551578564,0.7727272727272727,1.0,1.0,4/26,8.28%,BCL2L1;FAIM;ICAM1;TNFSF10
prerank,GO_Biological_Process_2021__regulation of synapse organization (GO:0050807),0.4609680065974426,0.8176669616376963,0.6463414634146342,1.0,1.0,5/18,15.06%,IL1RAPL1;CAMK2B;EPHA4;CTNNA2;WNT5A
prerank,GO_Biological_Process_2021__regulation of T cell mediated immune response to tumor cell (GO:0002840),-0.552435919733072,-0.8174691147381332,0.775,1.0,1.0,1/5,4.42%,IL4I1
prerank,GO_Biological_Process_2021__MAPK cascade (GO:0000165),0.38029222173170096,0.8173244040619873,0.9090909090909091,1.0,1.0,45/209,22.53%,HTR2B;FGF1;ARAF;SHANK3;NRG1;KITLG;MAP3K8;PAQR3;SHC2;IRS2;RPS27A;SPTAN1;PSMB4;RBX1;CAMK2B;ZDHHC9;LRRC7;PEBP1;RASGRF1;GRIN2B;NEFL;SPTBN5;WDR83;NRG4;IL18;RASGRP4;ITGAV;SPTBN1;UBA52;UBB;PSMC2;NRG2;SPTBN4;PSMA3;DLG4;NCAM1;TNF;PSMB2;DUSP6;LRRK2;FGFR2;PSMD5;PSMD7;MAP3K3;PTGER4
prerank,GO_Biological_Process_2021__transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery (GO:0000972),0.5504323478351775,0.8170078848838623,0.7777777777777778,1.0,1.0,1/6,6.24%,NUP133
prerank,GO_Biological_Process_2021__porphyrin-containing compound biosynthetic process (GO:0006779),0.4403389223085528,0.8169124529635323,0.6708860759493671,1.0,1.0,5/17,23.82%,PPOX;FLVCR1;ALAD;ATP5IF1;UROS
prerank,GO_Biological_Process_2021__membrane invagination (GO:0010324),0.5397975328216612,0.8168692709053281,0.7777777777777778,1.0,1.0,1/6,7.58%,FCHO2
prerank,GO_Biological_Process_2021__cellular response to interleukin-9 (GO:0071355),0.5473014895161499,0.8165258200259987,0.7945205479452054,1.0,1.0,4/6,42.91%,STAT1;JAK3;STAT5B;STAT5A
prerank,GO_Biological_Process_2021__interleukin-9-mediated signaling pathway (GO:0038113),0.5473014895161499,0.8165258200259987,0.7945205479452054,1.0,1.0,4/6,42.91%,STAT1;JAK3;STAT5B;STAT5A
prerank,GO_Biological_Process_2021__protein localization to endoplasmic reticulum exit site (GO:0070973),0.5489355000393964,0.8163177566449569,0.8208955223880597,1.0,1.0,2/5,28.64%,LRRK2;MIA3
prerank,GO_Biological_Process_2021__RNA splicing (GO:0008380),-0.2899032619026869,-0.8161602700381019,0.8333333333333334,1.0,1.0,8/84,10.94%,SCNM1;RP9;SNRNP35;KHSRP;SMU1;DDX23;IVNS1ABP;LSM6
prerank,GO_Biological_Process_2021__positive regulation of protein targeting to mitochondrion (GO:1903955),0.4440179406509492,0.815862890077662,0.7530864197530864,1.0,1.0,8/25,23.17%,VPS11;MICALL2;ARIH2;PINK1;ABLIM3;UBE2J2;RHOU;ATG13
prerank,GO_Biological_Process_2021__nucleosome organization (GO:0034728),0.40493708574300485,0.8152204695655646,0.7471264367816092,1.0,1.0,12/55,27.37%,HMGB2;H2BC11;SMARCD3;ACTR6;SART3;SMARCC1;SMARCD2;H1-0;NASP;NAP1L2;SMARCA5;ARID2
prerank,GO_Biological_Process_2021__cation homeostasis (GO:0055080),0.5483304382828943,0.8150055235636142,0.7962962962962963,1.0,1.0,2/6,19.75%,UNC80;TRPM7
prerank,GO_Biological_Process_2021__myeloid dendritic cell activation (GO:0001773),0.5163878758022282,0.8147700486129558,0.7464788732394366,1.0,1.0,1/7,14.63%,PYCARD
prerank,GO_Biological_Process_2021__regulation of glycolytic process (GO:0006110),0.4026004202109752,0.8146468565736483,0.7692307692307693,1.0,1.0,11/57,19.04%,NUP133;PGAM1;INSR;HIF1A;PRKAG2;PFKFB4;FBP1;SEH1L;APP;PRKAA2;PPARA
prerank,GO_Biological_Process_2021__transition metal ion homeostasis (GO:0055076),0.45797719859160557,0.8146451728149463,0.7402597402597403,1.0,1.0,9/23,29.61%,SLC11A1;PICALM;SLC39A14;FBXL5;HFE;NEO1;TF;CUTC;HMOX1
prerank,GO_Biological_Process_2021__negative regulation of transposition (GO:0010529),0.4892064600887017,0.814467808436973,0.7808219178082192,1.0,1.0,2/12,10.93%,ZNF93;SMYD5
prerank,GO_Biological_Process_2021__icosanoid biosynthetic process (GO:0046456),-0.3960047706524639,-0.8137232162681408,0.6666666666666666,1.0,1.0,6/8,23.66%,ALOX5;LTC4S;FADS1;ALOX5AP;MGST2;MGST3
prerank,GO_Biological_Process_2021__proteoglycan biosynthetic process (GO:0030166),-0.33855018149357263,-0.8136871516205029,0.8,1.0,1.0,4/23,8.12%,GAL3ST4;B4GALT7;IGF1;XYLT1
prerank,GO_Biological_Process_2021__DNA repair (GO:0006281),0.3767772836855736,0.813549456051687,0.9,1.0,1.0,41/218,20.15%,BRIP1;ERCC2;PIAS4;RPA2;TDG;FANCB;MPG;ENDOV;WDHD1;DNA2;FANCM;FANCI;RPS27A;NEIL1;EME2;POLQ;HINFP;INTS3;DDX1;VCPIP1;BRCA1;XRCC3;NSMCE1;KDM4B;FAN1;RFC4;GTF2H3;ACTR5;POLE2;POLL;ERCC6;NEIL2;FANCL;ADPRS;FANCA;UBA52;UBB;MLH1;TIMELESS;NOP53;KMT5C
prerank,GO_Biological_Process_2021__positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),0.3900858597831302,0.8135339466524366,0.7469879518072289,1.0,1.0,1/52,0.28%,THBS1
prerank,GO_Biological_Process_2021__amino acid import across plasma membrane (GO:0089718),0.48700785924508594,0.8134926739212958,0.7654320987654321,1.0,1.0,1/11,3.93%,SLC1A2
prerank,PanglaoDB_Augmented_2021__Microfold Cells,0.4060105156099726,0.813436577095565,0.8297872340425532,1.0,1.0,9/80,10.33%,KLF4;ANKRD22;NFIB;RAB20;MARCKSL1;BHLHE40;FOSL2;ST14;MGAT1
prerank,GO_Biological_Process_2021__axonal fasciculation (GO:0007413),0.4991334764092342,0.8132595163582862,0.7733333333333333,1.0,1.0,5/11,22.83%,EPHA3;SEMA5A;EPHA4;CDK5R1;RTN4
prerank,GO_Biological_Process_2021__mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),-0.29744913956071956,-0.813051472086315,0.7142857142857143,1.0,1.0,18/81,16.47%,NUP42;HHEX;DHX38;CPSF1;NUP155;CHTOP;THOC5;NUP188;WDR33;NUP214;DDX39A;RAE1;SLU7;SMG6;CPSF2;CPSF4;THOC7;POLDIP3
prerank,GO_Biological_Process_2021__positive regulation of striated muscle cell differentiation (GO:0051155),0.49004727859244235,0.812975854132003,0.7564102564102564,1.0,1.0,2/12,6.56%,NRG1;AKAP6
prerank,GO_Biological_Process_2021__positive regulation of epithelial cell differentiation (GO:0030858),-0.48658343199173626,-0.8129267631193646,0.6923076923076923,1.0,1.0,1/6,16.72%,VEZF1
prerank,GO_Biological_Process_2021__intestinal absorption (GO:0050892),-0.47951404274764353,-0.8126246221744396,0.6333333333333333,1.0,1.0,1/6,3.71%,SLC46A1
prerank,GO_Biological_Process_2021__interferon-gamma-mediated signaling pathway (GO:0060333),-0.34310401754679976,-0.8124238913721203,0.625,1.0,1.0,9/51,11.78%,TRIM38;PTAFR;ICAM1;HLA-E;IRF5;HCK;HLA-DPA1;FCGR1A;OAS2
prerank,GO_Biological_Process_2021__positive regulation of calcium ion transport into cytosol (GO:0010524),0.4669726216009647,0.8122421577343675,0.7066666666666667,1.0,1.0,5/12,22.92%,CEMIP;AKAP6;THY1;CX3CL1;TRPC1
prerank,GO_Biological_Process_2021__regulation of cellular macromolecule biosynthetic process (GO:2000112),0.3680175596010772,0.8121531316539036,0.9387755102040817,1.0,1.0,37/310,15.98%,NFIL3;ACVR1B;SAP30;TOM1L1;PQBP1;RORB;SOX4;TCF7;RBM3;APBB3;HINT1;INSR;HIF1A;GLRX2;HCFC1;FOXN2;ARNT2;ZKSCAN5;BHLHE40;TCF7L1;MAFB;LIMD1;POU5F1;CELSR2;ZNF536;TULP3;SOX6;HCLS1;HINFP;RBM4B;DRAP1;YAF2;ZNF143;ACTR5;MLF2;ESR1;NR2C2
prerank,GO_Biological_Process_2021__nucleobase-containing compound catabolic process (GO:0034655),0.44076936112446496,0.8120201330556065,0.813953488372093,1.0,1.0,3/28,4.09%,NUDT16;RNASEH2C;ENTPD3
prerank,GO_Biological_Process_2021__polarized epithelial cell differentiation (GO:0030859),-0.4638716694503663,-0.8115306042673395,0.71875,1.0,1.0,3/10,20.12%,OPHN1;CDC42;RAP2A
prerank,GO_Biological_Process_2021__prostanoid biosynthetic process (GO:0046457),-0.47744474625068345,-0.8112563862821731,0.6923076923076923,1.0,1.0,2/7,10.10%,DAGLB;PTGS1
prerank,GO_Biological_Process_2021__activation of NF-kappaB-inducing kinase activity (GO:0007250),0.5037828102577141,0.8109376646557557,0.75,1.0,1.0,2/12,5.44%,CHI3L1;TRAF2
prerank,GO_Biological_Process_2021__regulation of membrane protein ectodomain proteolysis (GO:0051043),0.48248467464946904,0.8108665632447114,0.7272727272727273,1.0,1.0,5/11,20.20%,SH3D19;TNFRSF1B;TIMP3;ROCK1;TNF
prerank,GO_Biological_Process_2021__protein targeting (GO:0006605),0.3880090980600316,0.8108112483034342,0.8369565217391305,1.0,1.0,24/90,26.45%,ZDHHC15;VPS37C;AKAP6;TIMM13;NLGN1;TOMM20;PARD3;ZDHHC9;CDC37;SDCBP;RPL11;NACA;AQP11;HACL1;SRPRA;FBXO7;MFN2;SPCS3;TOMM40;MAN1A1;TIMM22;SRP54;ZDHHC7;ZDHHC18
prerank,GO_Biological_Process_2021__positive regulation of endocytosis (GO:0045807),0.40203517462854294,0.8106876963913489,0.7692307692307693,1.0,1.0,9/36,25.12%,CLIP3;NLGN1;SGIP1;CALY;CD151;RAB21;HFE;GPC3;TF
prerank,GO_Biological_Process_2021__negative regulation of leukocyte chemotaxis (GO:0002689),0.4695950132071848,0.8106679294921162,0.7258064516129032,1.0,1.0,4/7,35.43%,SLAMF8;DUSP1;C5;PADI2
prerank,GO_Biological_Process_2021__positive regulation of tumor necrosis factor production (GO:0032760),0.3985752317649625,0.8106260483397352,0.782051282051282,1.0,1.0,6/50,17.45%,THBS1;NOD2;PYCARD;WNT5A;HSPB1;APP
prerank,GO_Biological_Process_2021__positive regulation of transcription by RNA polymerase II (GO:0045944),0.3684445428562054,0.8105134757752283,0.98,1.0,1.0,103/564,22.15%,KLF4;NAMPT;MACC1;FGF1;ST18;TGFB2;EGR1;HMGB2;PLAC8;PFKM;NFIX;NR4A2;NFIB;NR4A1;MEIS2;SLC11A1;ACVR2A;BMPR1B;ASXL3;RORB;VEGFA;SOX4;IER5;RXRB;COPS5;HIF1A;HSF2;HCFC1;CSRNP3;ARNT2;RUVBL2;PAX8;FOSL2;SS18L1;ATAD2;RBPJ;RRP1B;RPS27A;KDM1A;POU5F1;PTOV1;PER1;CRTC3;NR2F1;NOD2;GABPB1;DCAF6;HCLS1;HINFP;CCNC;CSRNP2;RIPK2;NR4A3;BRCA1;DRAP1;ZNF143;PKD1;E2F7;DPF3;WNT5A;SMARCD3;ESR1;AKIRIN1;IL18;NR2C2;LDB2;TBL1XR1;EPAS1;LITAF;TXK;SMAD1;APP;KLF7;RGCC;ZBTB18;TNFRSF1A;UBA52;UBB;CDK9;PPARA;TAF7;FOS;PRDM15;SMAD5;PRPF6;KDM6B;PCGF5;BEX1;TNF;NR1D1;NPAS2;TCF4;FGFR2;SLC9A1;ATF3;CX3CL1;TNIP1;MTF1;STAT1;HNRNPU;PLAG1;SMARCD2;GNL3
prerank,GO_Biological_Process_2021__positive regulation of lipid metabolic process (GO:0045834),0.46119472356006935,0.8103468988630367,0.7466666666666667,1.0,1.0,2/14,12.09%,EEF1A2;SORBS1
prerank,GO_Biological_Process_2021__regulation of platelet activation (GO:0010543),0.4656088502883773,0.8102514388296862,0.7014925373134329,1.0,1.0,3/13,16.93%,THBD;TXK;TEC
prerank,GO_Biological_Process_2021__ribose phosphate biosynthetic process (GO:0046390),0.5452229766946619,0.8102349651031836,0.828125,1.0,1.0,1/5,12.55%,PRPS1
prerank,"GO_Biological_Process_2021__negative regulation of transcription, DNA-templated (GO:0045892)",0.36803124166141565,0.8101523093477834,0.98,1.0,1.0,101/599,21.09%,KLF4;CENPF;NFIL3;SAP30;RPL23;TGIF1;HMGB2;TLE1;NFIX;ZBTB16;NR4A2;NRG1;MEIS2;TSHZ3;PIAS4;RORB;PTPRK;ARID5B;VEGFA;ZNF93;SUV39H2;RUNX1T1;SFMBT1;RBFOX2;BMI1;HCFC1;ATP8B1;POU6F1;ZNF540;YEATS2;BHLHE40;TRPS1;KCTD1;ID2;LIMD1;RBPJ;RPS27A;KDM1A;POU5F1;MXD1;PDE2A;PER1;IMPACT;NR2F1;MXI1;PRICKLE1;ZNF536;DEAF1;PPID;ETS2;HINFP;OTUD7B;FBP1;ZNF550;NR4A3;BRCA1;DRAP1;LANCL2;RLIM;YAF2;E2F7;SDCBP;DPF3;ZNF248;HIC2;WNT5A;UXT;ESR1;MTA3;NR2C2;LDB2;TBL1XR1;CTBP1;PLCB1;HAMP;BCL6;KLF7;FOXP1;ZBTB18;TAF9B;ZNF778;UBA52;EZH2;UBB;PPARA;TAF7;NKX6-2;CDK5R1;ZNF684;TIMELESS;NOP53;TNF;ENO1;NR1D1;BASP1;BCL11A;CDKN1B;FGFR2;MTERF3;CBX5;ATF3
prerank,GO_Biological_Process_2021__regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903798),-0.40679984891723386,-0.8101501813257952,0.7307692307692307,1.0,1.0,3/11,12.07%,TP53;TGFB1;EGFR
prerank,GO_Biological_Process_2021__homologous chromosome pairing at meiosis (GO:0007129),-0.40298735568394506,-0.8099446778157486,0.7307692307692307,1.0,1.0,1/11,0.55%,MEI4
prerank,GO_Biological_Process_2021__positive regulation of chemokine production (GO:0032722),0.41878191407914456,0.8098880276422838,0.8,1.0,1.0,8/34,17.45%,EGR1;ALOX15B;IL7;HIF1A;PYCARD;WNT5A;IL18;APP
prerank,GO_Biological_Process_2021__protein localization to microtubule organizing center (GO:1905508),0.45364185435693616,0.8098156038364074,0.7432432432432432,1.0,1.0,2/15,13.85%,SNX10;HOOK3
prerank,GO_Biological_Process_2021__positive regulation of catalytic activity (GO:0043085),-0.3086549985806449,-0.8097656333528105,0.8,1.0,1.0,5/28,10.62%,AZIN2;APH1A;CHTOP;SSBP1;ABL1
prerank,GO_Biological_Process_2021__regulation of acute inflammatory response (GO:0002673),0.519717005670911,0.8094400485051672,0.7375,1.0,1.0,1/6,3.65%,OSMR
prerank,GO_Biological_Process_2021__histone H3-K9 demethylation (GO:0033169),0.5329156016139076,0.8094314779492134,0.8115942028985508,1.0,1.0,3/8,13.77%,KDM3A;KDM1A;KDM4B
prerank,GO_Biological_Process_2021__negative regulation of proteolysis (GO:0045861),0.4372490097500223,0.8085301640561285,0.7808219178082192,1.0,1.0,10/18,29.19%,CAMK2N1;EPHA4;SERPINE2;TIMP3;ROCK1;LRRK2;CSTB;BAG6;SNX12;PRNP
prerank,PanglaoDB_Augmented_2021__Kupffer Cells,0.37697572759542325,0.8084337582866096,0.8350515463917526,1.0,1.0,15/100,13.83%,CLEC4E;CLEC12A;CD163;SLC11A1;ADGRE1;FCGR2B;SIRPB2;FGR;C5AR1;FCGR2C;FGL2;PLTP;TNFRSF1B;STARD5;CD300A
prerank,GO_Biological_Process_2021__negative regulation of protein-containing complex disassembly (GO:0043242),0.47475485460544276,0.8084122382708847,0.6956521739130435,1.0,1.0,4/8,27.13%,TMEM39A;TNF;IRAK3;UBQLN4
prerank,GO_Biological_Process_2021__cellular response to copper ion (GO:0071280),0.5366012337790155,0.8083863584646254,0.75,1.0,1.0,5/6,45.77%,PRNP;HSF1;DAXX;SNCA;MT2A
prerank,GO_Biological_Process_2021__negative regulation of cell activation (GO:0050866),0.5026497765639166,0.8083800250540919,0.71875,1.0,1.0,2/8,20.32%,THBD;NR1D1
prerank,GO_Biological_Process_2021__prostaglandin biosynthetic process (GO:0001516),0.5020517514497553,0.8083327996939443,0.68,1.0,1.0,1/10,1.96%,CBR1
prerank,GO_Biological_Process_2021__telomere maintenance in response to DNA damage (GO:0043247),0.5436506408403299,0.8082876462274673,0.7727272727272727,1.0,1.0,4/6,33.67%,TFIP11;DCLRE1C;RIF1;TERF2IP
prerank,GO_Biological_Process_2021__leukotriene metabolic process (GO:0006691),0.4546402912093337,0.8080890432688913,0.775,1.0,1.0,2/14,15.55%,ALOX12;LTA4H
prerank,GO_Biological_Process_2021__response to UV-A (GO:0070141),-0.5202605031204295,-0.8080401342767839,0.7027027027027027,1.0,1.0,3/6,14.21%,CCND1;EGFR;AKT1
prerank,GO_Biological_Process_2021__lymphocyte mediated immunity (GO:0002449),-0.36804002077962444,-0.807970677258396,0.6571428571428571,1.0,1.0,1/9,1.36%,BTN3A2
prerank,GO_Biological_Process_2021__telomeric loop disassembly (GO:0090657),0.5110872520993311,0.8079370649654201,0.7605633802816901,1.0,1.0,3/7,29.84%,XRCC3;SLX4;BLM
prerank,"GO_Biological_Process_2021__vesicle targeting, rough ER to cis-Golgi (GO:0048207)",0.3797906651641276,0.8078772164535584,0.813953488372093,1.0,1.0,7/50,17.39%,NAPA;SEC24C;MCFD2;NSF;TMED10;TRAPPC6B;GRIA1
prerank,GO_Biological_Process_2021__vesicle coating (GO:0006901),0.3797906651641276,0.8078772164535584,0.813953488372093,1.0,1.0,7/50,17.39%,NAPA;SEC24C;MCFD2;NSF;TMED10;TRAPPC6B;GRIA1
prerank,GO_Biological_Process_2021__COPII vesicle coating (GO:0048208),0.3797906651641276,0.8078772164535584,0.813953488372093,1.0,1.0,7/50,17.39%,NAPA;SEC24C;MCFD2;NSF;TMED10;TRAPPC6B;GRIA1
prerank,GO_Biological_Process_2021__positive regulation of T-helper 17 type immune response (GO:2000318),0.5018421870525813,0.8078664738193838,0.7647058823529411,1.0,1.0,1/7,12.23%,NFKBIZ
prerank,GO_Biological_Process_2021__regulation of isotype switching (GO:0045191),0.5130455025590507,0.8073806081533805,0.8194444444444444,1.0,1.0,1/11,3.57%,TFRC
prerank,GO_Biological_Process_2021__cellular response to oxygen levels (GO:0071453),0.5002943268358784,0.8068463284453569,0.8088235294117647,1.0,1.0,1/8,20.52%,CPEB4
prerank,GO_Biological_Process_2021__histone H3-K27 demethylation (GO:0071557),-0.5140091775700069,-0.8067771109926258,0.6904761904761905,1.0,1.0,2/5,8.99%,PHF8;KDM7A
prerank,GO_Biological_Process_2021__regulation of cytoskeleton organization (GO:0051493),0.3854963877914351,0.8066627971646405,0.8350515463917526,1.0,1.0,7/77,7.17%,RHOBTB3;RHOB;MAPT;GPM6B;EPHA3;STMN3;RND3
prerank,GO_Biological_Process_2021__positive regulation of histone H3-K9 acetylation (GO:2000617),0.5191668993689843,0.806602135659514,0.7121212121212122,1.0,1.0,1/5,12.87%,BRCA1
prerank,GO_Biological_Process_2021__positive regulation of keratinocyte migration (GO:0051549),0.530664465449248,0.8064062098000886,0.7391304347826086,1.0,1.0,3/7,23.89%,ARF6;EPB41L4B;IQSEC1
prerank,GO_Biological_Process_2021__embryonic skeletal system development (GO:0048706),0.5023544548198509,0.8059760225222217,0.7971014492753623,1.0,1.0,3/9,15.06%,DEAF1;SULF2;WNT5A
prerank,GO_Biological_Process_2021__regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),0.38298083590217114,0.8059362625260296,0.8172043010752689,1.0,1.0,21/70,24.06%,VEGFA;HIF1A;LIMD1;RPS27A;IMPACT;PSMB4;RBX1;HIF3A;BAG3;EPAS1;EGLN3;UBA52;UBB;PSMC2;PSMA3;PSMB2;ATF3;PSMD5;PSMD7;PSMD14;PSMA5
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell differentiation (GO:2000725),-0.5316511762337894,-0.8057353113397571,0.8076923076923077,1.0,1.0,2/5,7.51%,EFNB2;TGFB1
prerank,GO_Biological_Process_2021__tRNA transport (GO:0051031),-0.3220634945964795,-0.8057309581199971,0.9166666666666666,1.0,1.0,6/34,13.88%,NUP42;NUP155;NUP188;NUP214;RAE1;XPOT
prerank,GO_Biological_Process_2021__ribonucleoprotein complex assembly (GO:0022618),0.37985785963156776,0.8057258091388227,0.8315789473684211,1.0,1.0,32/103,32.04%,GEMIN2;RPL38;RPL23A;CELF2;RPS27;DDX1;RBM5;MRPL20;SHQ1;RPL11;POLR2D;SART3;PRPF6;NOP53;SRSF5;SNRPD2;RPL24;RPL3;EIF3A;TRAF7;SRSF9;CPSF6;HSP90AB1;DICER1;RPL6;RPLP0;PRKDC;DHX29;MRPS7;PRPF19;MDN1;DHX9
prerank,GO_Biological_Process_2021__negative regulation of cellular biosynthetic process (GO:0031327),0.4513260582639552,0.8051919978481628,0.8235294117647058,1.0,1.0,5/27,17.10%,GLA;ABCA2;CLK2;BRCA1;ERLIN1
prerank,GO_Biological_Process_2021__regulation of fibroblast proliferation (GO:0048145),0.428300682775042,0.80512356861751,0.7647058823529411,1.0,1.0,7/34,18.28%,AGT;BMI1;FN1;CD300A;WNT5A;GSTP1;FTH1
prerank,GO_Biological_Process_2021__regulation of inflammatory response (GO:0050727),0.37233733710296396,0.8050099173294634,0.8686868686868687,1.0,1.0,32/113,23.75%,KLF4;NLRP12;IL15;AGT;ANXA1;CASP5;PDE2A;GPRC5B;NOD2;TYRO3;NFKBIZ;TNFRSF1B;WNT5A;IL18;NAPEPLD;BCL6;APP;FOXP1;MACIR;TNFRSF1A;PPARA;LRFN5;TNF;NR1D1;CX3CL1;TNIP1;PDCD4;PTGER4;RORA;CASP1;TRADD;GPS2
prerank,GO_Biological_Process_2021__calcium ion transport (GO:0006816),0.38884802484095543,0.8048288404137591,0.7912087912087912,1.0,1.0,19/69,20.83%,CACNB2;GRIN3A;SLC24A2;ANK2;RYR2;TRPC4;CACNA1B;SLC24A1;NALCN;RYR3;PKD1;ATP2A2;SLC24A3;CACNA1A;ITGAV;CACNG8;TRPM7;SLC3A2;SLC24A4
prerank,GO_Biological_Process_2021__protein neddylation (GO:0045116),0.5046973671703978,0.8045418888259502,0.7605633802816901,1.0,1.0,2/8,14.48%,RBX1;UBE2M
prerank,GO_Biological_Process_2021__regulation of cell cycle G1/S phase transition (GO:1902806),-0.34232721814593015,-0.8045232881242154,0.8214285714285714,1.0,1.0,4/21,8.31%,PSME3;STXBP4;APPL2;PHB2
prerank,GO_Biological_Process_2021__C21-steroid hormone metabolic process (GO:0008207),0.5066267631711266,0.8043053518055253,0.7692307692307693,1.0,1.0,3/8,22.68%,AKR1B1;CYP46A1;TSPOAP1
prerank,GO_Biological_Process_2021__mRNA export from nucleus (GO:0006406),-0.2893760454554652,-0.8039652676716389,0.8,1.0,1.0,19/85,16.47%,NUP42;HHEX;DHX38;CPSF1;NUP155;CHTOP;THOC5;NUP188;WDR33;NUP214;DDX39A;RAE1;ENY2;SLU7;SMG6;CPSF2;CPSF4;THOC7;POLDIP3
prerank,GO_Biological_Process_2021__protein O-linked glycosylation via serine (GO:0018242),0.5439257108138502,0.8038064270378334,0.7758620689655172,1.0,1.0,1/6,6.35%,GALNT13
prerank,"GO_Biological_Process_2021__SRP-dependent cotranslational protein targeting to membrane, translocation (GO:0006616)",0.5094458775213644,0.8034130381840667,0.7666666666666667,1.0,1.0,1/5,5.78%,SEC61B
prerank,GO_Biological_Process_2021__regulation of 3'-UTR-mediated mRNA stabilization (GO:1905868),-0.4947548832584717,-0.8033714751318013,0.75,1.0,1.0,2/5,9.94%,ELAVL4;METTL16
prerank,GO_Biological_Process_2021__regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process (GO:1902959),0.48683528643478585,0.8031942976553291,0.6721311475409836,1.0,1.0,2/7,15.03%,EPHA4;PICALM
prerank,GO_Biological_Process_2021__protein palmitoylation (GO:0018345),0.4395103622724196,0.8028474016884775,0.7901234567901234,1.0,1.0,4/24,12.86%,CLIP3;ZDHHC15;GLUL;ZDHHC9
prerank,GO_Biological_Process_2021__very long-chain fatty acid metabolic process (GO:0000038),0.4662200075856347,0.8027910750665732,0.7297297297297297,1.0,1.0,2/16,9.95%,ACSL1;ELOVL4
prerank,GO_Biological_Process_2021__negative regulation of JUN kinase activity (GO:0043508),0.4938436780353307,0.8026347433642587,0.7428571428571429,1.0,1.0,5/9,22.90%,DUSP10;AIDA;GSTP1;PDCD4;MAPK8IP1
prerank,GO_Biological_Process_2021__endoderm formation (GO:0001706),0.4524363854079256,0.8023862290593168,0.7866666666666666,1.0,1.0,3/14,8.46%,COL11A1;LAMB1;FN1
prerank,GO_Biological_Process_2021__cell-substrate junction assembly (GO:0007044),0.44377189052487026,0.8023343237813649,0.7341772151898734,1.0,1.0,7/22,22.12%,PTPRK;FN1;SORBS1;THY1;PLEC;CD151;CTTN
prerank,GO_Biological_Process_2021__protein export from nucleus (GO:0006611),-0.360327821046195,-0.8023090455321028,0.8666666666666667,1.0,1.0,5/24,10.83%,NUP42;CCHCR1;TGFB1;SMURF1;NUP214
prerank,"GO_Biological_Process_2021__regulation of mRNA splicing, via spliceosome (GO:0048024)",0.3959682932018753,0.8020800120731861,0.8105263157894737,1.0,1.0,8/73,12.50%,RBM3;RBFOX2;PCBP4;SRSF12;CELF2;KHDRBS2;NOVA1;RBM5
prerank,GO_Biological_Process_2021__protein-DNA covalent cross-linking repair (GO:0106300),0.5429904665275583,0.8015073167447943,0.8405797101449275,1.0,1.0,1/5,12.62%,VCPIP1
prerank,"GO_Biological_Process_2021__exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000467)",0.48443423552412423,0.8014054936804514,0.7681159420289855,1.0,1.0,1/8,10.65%,ERI2
prerank,GO_Biological_Process_2021__exonucleolytic trimming involved in rRNA processing (GO:0000459),0.48443423552412423,0.8014054936804514,0.7681159420289855,1.0,1.0,1/8,10.65%,ERI2
prerank,GO_Biological_Process_2021__positive regulation of peptidase activity (GO:0010952),-0.34573703390647875,-0.801182873180874,0.8421052631578947,1.0,1.0,2/16,7.64%,PSME3;APH1A
prerank,GO_Biological_Process_2021__cellular response to estrogen stimulus (GO:0071391),-0.4140997249192872,-0.8011163570246048,0.6666666666666666,1.0,1.0,2/10,8.88%,NCOA4;SERPINB9
prerank,GO_Biological_Process_2021__snRNA modification (GO:0040031),0.5121820784142969,0.8010895160299186,0.8113207547169812,1.0,1.0,3/6,27.75%,NHP2;METTL4;DKC1
prerank,GO_Biological_Process_2021__endoplasmic reticulum organization (GO:0007029),0.3776208455768946,0.801037202037659,0.7555555555555555,1.0,1.0,20/55,29.61%,EIF2AK3;SEC61B;VAPB;VCPIP1;SERP1;REEP3;UBE2J2;APP;RTN3;REEP2;LRRK2;BNIP1;RTN4;VAPA;TMEM33;MIA3;PRNP;SEC31A;REEP1;HMOX1
prerank,"GO_Biological_Process_2021__DNA-templated transcription, termination (GO:0006353)",-0.3054686563337891,-0.8010076352941344,0.9,1.0,1.0,13/51,16.58%,GTF2H5;GTF2H2;UBTF;CPSF1;LSM11;WDR33;TTF1;SNRPB;CSTF1;CPSF2;CPSF4;TTF2;POLR1F
prerank,GO_Biological_Process_2021__epithelial cell differentiation (GO:0030855),0.3983676223534774,0.8009119251405553,0.7956989247311828,1.0,1.0,10/43,20.85%,CBR1;ANXA1;VEGFA;OVOL2;CPT1A;E2F7;KDM6B;PGK1;BASP1;FGFR2
prerank,GO_Biological_Process_2021__protein-DNA complex assembly (GO:0065004),0.3802076604217805,0.8004428219899677,0.851063829787234,1.0,1.0,25/98,24.35%,HMGB2;H2BC11;ERCC2;RPA2;RPS27A;PSMB4;RBX1;CENPV;GTF2H3;ORC6;SART3;UBA52;UBB;PSMC2;PSMA3;PSMB2;TCF4;DDB1;PSMD5;PSMD7;RPA3;ORC3;PSMD14;PSMA5;MCM3
prerank,GO_Biological_Process_2021__positive regulation of protein transport (GO:0051222),0.39752914888303476,0.8004090554042275,0.8072289156626506,1.0,1.0,9/53,22.91%,TGFB2;ARF6;APBB3;PPID;TMED10;ACSL3;TNF;CHP1;ABCG1
prerank,GO_Biological_Process_2021__intraciliary retrograde transport (GO:0035721),-0.3411344522604589,-0.8003900198820113,0.7083333333333334,1.0,1.0,3/11,11.12%,WDR35;TTC21B;IFT43
prerank,GO_Biological_Process_2021__mRNA transport (GO:0051028),-0.2906860541830622,-0.800295747309902,0.8571428571428571,1.0,1.0,19/85,16.47%,NUP42;HHEX;DHX38;CPSF1;NUP155;CHTOP;THOC5;NUP188;WDR33;NUP214;DDX39A;RAE1;SLU7;SMG6;ZFP36;CPSF2;CPSF4;THOC7;POLDIP3
prerank,GO_Biological_Process_2021__positive regulation of defense response (GO:0031349),0.3785733731720578,0.8001916904517091,0.7684210526315789,1.0,1.0,18/62,22.53%,NLRP12;IL15;AGT;POLR3F;PDE2A;GPRC5B;NFKBIZ;WNT5A;IL18;NAPEPLD;APP;TNFRSF1A;TNF;NPAS2;CX3CL1;TNIP1;PDCD4;PTGER4
prerank,GO_Biological_Process_2021__cilium assembly (GO:0060271),0.3624114089357546,0.7997898215103623,0.9494949494949495,1.0,1.0,29/207,18.00%,TUBA4A;PRKAR2B;HAUS6;DZIP1;TUBB4A;LRGUK;TTBK2;CEP152;RFX2;TUBA1A;DYNC2LI1;NPHP1;ATAT1;CCDC39;RP2;IFT74;CFAP54;DYNC1H1;CKAP5;SNX10;SNAP29;PKD1;ABLIM3;TOGARAM1;TXNDC15;CC2D2A;KIF3A;MACIR;DCTN1
prerank,GO_Biological_Process_2021__positive regulation of interferon-alpha production (GO:0032727),-0.38160003806925746,-0.799788040780286,0.7241379310344828,1.0,1.0,4/16,11.22%,CHUK;TLR3;IRF5;TLR7
prerank,GO_Biological_Process_2021__mitotic metaphase plate congression (GO:0007080),0.4422389011547314,0.7996762340770427,0.8235294117647058,1.0,1.0,1/31,1.81%,CENPE
prerank,GO_Biological_Process_2021__positive regulation of cytoskeleton organization (GO:0051495),0.40810258461895704,0.7995480472710461,0.7692307692307693,1.0,1.0,11/47,18.58%,PRKCE;ARF6;BAIAP2L1;CARMIL1;NTRK3;SEMA5A;HCLS1;DYNC1H1;PYCARD;FES;GPSM2
prerank,PanglaoDB_Augmented_2021__B Cells Naive,0.3706086575653301,0.7989705921550745,0.8526315789473684,1.0,1.0,6/99,5.61%,GPR18;NAPSB;CR1;CD22;LINC00926;FCGR2B
prerank,GO_Biological_Process_2021__stress-induced premature senescence (GO:0090400),-0.5177626312277867,-0.7988434127077133,0.7428571428571429,1.0,1.0,1/5,6.50%,TP53
prerank,GO_Biological_Process_2021__mitotic chromosome condensation (GO:0007076),0.47386535826468024,0.7987913094364761,0.8148148148148148,1.0,1.0,2/18,6.47%,SMC4;NCAPH2
prerank,GO_Biological_Process_2021__amino acid transmembrane transport (GO:0003333),0.4261785234161088,0.7986975950299361,0.7560975609756098,1.0,1.0,1/26,0.80%,SLC38A4
prerank,GO_Biological_Process_2021__N-acetylneuraminate metabolic process (GO:0006054),-0.4556932701965552,-0.7986094692761323,0.6428571428571429,1.0,1.0,4/9,15.20%,NPL;GNPDA1;ST6GAL1;NAGK
prerank,GO_Biological_Process_2021__purine-containing compound catabolic process (GO:0072523),0.521560294020406,0.798605591962705,0.828125,1.0,1.0,1/7,1.95%,DPYD
prerank,GO_Biological_Process_2021__regulation of cytokine production involved in inflammatory response (GO:1900015),-0.31221875112887354,-0.7985471187656247,0.8235294117647058,1.0,1.0,8/29,12.43%,TICAM1;LILRB4;APPL2;SIRPA;ALOX5;IL17RA;TREM2;CHID1
prerank,GO_Biological_Process_2021__protein depalmitoylation (GO:0002084),-0.45876500163674444,-0.7982577992329054,0.6428571428571429,1.0,1.0,3/6,15.72%,ABHD17A;ABHD10;LYPLA1
prerank,GO_Biological_Process_2021__macromolecule depalmitoylation (GO:0098734),-0.45876500163674444,-0.7982577992329054,0.6428571428571429,1.0,1.0,3/6,15.72%,ABHD17A;ABHD10;LYPLA1
prerank,GO_Biological_Process_2021__positive regulation of protein dephosphorylation (GO:0035307),0.4313308767583164,0.7976339903329421,0.7142857142857143,1.0,1.0,7/25,16.31%,PPP2R5A;NSMF;CALM3;MAGI2;CD300A;PPP1R15A;CNEP1R1
prerank,GO_Biological_Process_2021__regulation of protein deubiquitination (GO:0090085),0.5173269410647421,0.7975634065336533,0.75,1.0,1.0,2/5,29.94%,TNIP1;WDR48
prerank,GO_Biological_Process_2021__regulation of activated T cell proliferation (GO:0046006),-0.38178611824713965,-0.7975384533723833,0.7142857142857143,1.0,1.0,4/17,7.34%,LGALS9;LILRB4;CD274;IGF1
prerank,GO_Biological_Process_2021__mitotic cell cycle checkpoint signaling (GO:0007093),0.48316860720115773,0.7974750481289443,0.75,1.0,1.0,2/11,12.34%,PLK2;INTS3
prerank,GO_Biological_Process_2021__negative regulation of myeloid leukocyte differentiation (GO:0002762),-0.3703764099985946,-0.7972528265365231,0.6538461538461539,1.0,1.0,3/16,8.55%,ZNF675;LILRB4;TLR3
prerank,GO_Biological_Process_2021__ganglioside metabolic process (GO:0001573),0.4661063600086294,0.7972193300114104,0.7763157894736842,1.0,1.0,3/11,15.35%,ABCA2;ST6GALNAC5;ST8SIA3
prerank,GO_Biological_Process_2021__negative regulation of fatty acid biosynthetic process (GO:0045717),0.48453834313482763,0.7970034267626636,0.7105263157894737,1.0,1.0,2/10,17.10%,BRCA1;ERLIN1
prerank,GO_Biological_Process_2021__skeletal muscle tissue development (GO:0007519),0.4954961526416994,0.7967926389327744,0.7945205479452054,1.0,1.0,4/11,22.29%,SVIL;IGSF8;ZBTB18;MYL6
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)",-0.33296741702817034,-0.796790137510156,0.85,1.0,1.0,4/26,11.60%,NT5C3B;DCP1B;LSM6;EDC3
prerank,GO_Biological_Process_2021__DNA-dependent DNA replication maintenance of fidelity (GO:0045005),0.4083287542334901,0.7967542469750842,0.7974683544303798,1.0,1.0,5/30,19.61%,FANCM;EME2;DONSON;CDK9;TIMELESS
prerank,GO_Biological_Process_2021__rRNA pseudouridine synthesis (GO:0031118),-0.44348974665888885,-0.7966688180089001,0.7435897435897436,1.0,1.0,3/7,14.39%,RPUSD3;RPUSD4;GAR1
prerank,GO_Biological_Process_2021__positive regulation of cell cycle phase transition (GO:1901989),-0.4109691818671012,-0.7965494358707803,0.6538461538461539,1.0,1.0,5/11,19.64%,STXBP4;PHB2;KLHL18;PLCG2;CUL3
prerank,GO_Biological_Process_2021__regulation of phosphate metabolic process (GO:0019220),0.4809666558856638,0.7965427557328759,0.7702702702702703,1.0,1.0,1/11,6.33%,PGAM1
prerank,GO_Biological_Process_2021__positive regulation of actin filament polymerization (GO:0030838),0.42096629897267124,0.7964772760959627,0.7752808988764045,1.0,1.0,5/31,9.76%,PRKCE;ARF6;BAIAP2L1;SPIRE2;CARMIL1
prerank,GO_Biological_Process_2021__negative regulation of sodium ion transmembrane transport (GO:1902306),0.5069501339711979,0.7961381064498237,0.8,1.0,1.0,1/8,2.53%,PRKCE
prerank,GO_Biological_Process_2021__establishment of endothelial intestinal barrier (GO:0090557),-0.3959461404519145,-0.7960832432478127,0.6818181818181818,1.0,1.0,1/9,6.51%,RAPGEF6
prerank,GO_Biological_Process_2021__negative regulation of response to biotic stimulus (GO:0002832),-0.33515753392467423,-0.7959597979358612,0.7916666666666666,1.0,1.0,7/21,19.26%,TRIB1;NMI;ILRUN;TRAFD1;LILRA2;SIGIRR;NLRC3
prerank,GO_Biological_Process_2021__regulation of cell-matrix adhesion (GO:0001952),0.3959769627375085,0.7956831653104857,0.8241758241758241,1.0,1.0,4/49,6.80%,THBS1;GPM6B;ADAM15;EPHA3
prerank,GO_Biological_Process_2021__regulation of defense response to virus by host (GO:0050691),0.4065809788527779,0.7956621472463196,0.7738095238095238,1.0,1.0,7/24,27.83%,PQBP1;IFNLR1;AIM2;STAT1;TRAF3IP2;MICB;PARP9
prerank,GO_Biological_Process_2021__O-glycan processing (GO:0016266),0.44332596978407646,0.7956510799838113,0.8,1.0,1.0,4/22,15.93%,GALNT8;GALNT13;B4GALT5;GCNT1
prerank,GO_Biological_Process_2021__protein trimerization (GO:0070206),0.5231943384731936,0.795429270862014,0.7866666666666666,1.0,1.0,2/7,14.99%,SLC1A2;DISP1
prerank,GO_Biological_Process_2021__protein homotrimerization (GO:0070207),0.5231943384731936,0.795429270862014,0.7866666666666666,1.0,1.0,2/7,14.99%,SLC1A2;DISP1
prerank,GO_Biological_Process_2021__regulation of immune response (GO:0050776),0.3856234754209758,0.7952816190062051,0.8172043010752689,1.0,1.0,9/92,10.46%,PIANP;TGFB2;IL15;CD22;CLEC2B;FCGR2B;FGR;SPPL2B;FCGR2C
prerank,PanglaoDB_Augmented_2021__Serotonergic Neurons,0.47164116508509707,0.7952570081755246,0.72,1.0,1.0,6/15,21.72%,CYP3A5;SLC5A9;FMO5;GIPC2;GBA3;SLC26A3
prerank,GO_Biological_Process_2021__negative regulation of sodium ion transmembrane transporter activity (GO:2000650),0.5068801739306741,0.7952472911662939,0.7808219178082192,1.0,1.0,1/8,2.53%,PRKCE
prerank,GO_Biological_Process_2021__cellular response to X-ray (GO:0071481),0.5454793035969361,0.7952201923543789,0.7719298245614035,1.0,1.0,2/5,38.48%,NIPBL;XRCC6
prerank,GO_Biological_Process_2021__negative regulation by symbiont of host programmed cell death (GO:0052041),-0.4481831650708462,-0.7947903406081007,0.6666666666666666,1.0,1.0,3/7,18.63%,SERPINB9;RNF213;RAB7A
prerank,GO_Biological_Process_2021__positive regulation of execution phase of apoptosis (GO:1900119),0.5495273928660667,0.7945636905164764,0.8253968253968254,1.0,1.0,1/5,8.90%,BOK
prerank,GO_Biological_Process_2021__ER overload response (GO:0006983),0.49955622217274687,0.7943431966923276,0.7910447761194029,1.0,1.0,1/8,5.64%,EIF2AK3
prerank,GO_Biological_Process_2021__negative regulation of fibroblast proliferation (GO:0048147),-0.38988073500832315,-0.7943055924330875,0.7142857142857143,1.0,1.0,4/15,11.73%,DAB2IP;B4GALT7;TP53;SKI
prerank,GO_Biological_Process_2021__positive regulation of receptor signaling pathway via JAK-STAT (GO:0046427),0.47439729110808804,0.7940428111996463,0.7681159420289855,1.0,1.0,3/12,14.73%,PRLR;GHR;OCIAD1
prerank,GO_Biological_Process_2021__myeloid leukocyte differentiation (GO:0002573),-0.3195384502840562,-0.7933584007280767,0.6923076923076923,1.0,1.0,7/44,10.32%,MYH9;CEBPA;LGALS9;CSF1R;THOC5;EP300;TREM2
prerank,GO_Biological_Process_2021__nuclear membrane organization (GO:0071763),0.4400997942291519,0.793100502160513,0.7236842105263158,1.0,1.0,8/16,33.36%,SPAST;UBXN2B;DCTN1;CHMP7;NSFL1C;NEMP1;TARDBP;CHMP4B
prerank,GO_Biological_Process_2021__negative regulation of peptidase activity (GO:0010466),0.39421492834806854,0.7930411077621958,0.7792207792207793,1.0,1.0,5/25,14.87%,SPOCK1;AGT;SPOCK3;SERPINE2;TIMP3
prerank,GO_Biological_Process_2021__cardiolipin acyl-chain remodeling (GO:0035965),0.5235448261135702,0.7930005769569484,0.7397260273972602,1.0,1.0,2/5,37.51%,PLA2G4A;HADHA
prerank,GO_Biological_Process_2021__tRNA transcription by RNA polymerase III (GO:0042797),-0.48449500315343236,-0.7928642590301518,0.7105263157894737,1.0,1.0,2/6,19.93%,GTF3C2;GTF3C3
prerank,GO_Biological_Process_2021__5S class rRNA transcription by RNA polymerase III (GO:0042791),-0.48449500315343236,-0.7928642590301518,0.7105263157894737,1.0,1.0,2/6,19.93%,GTF3C2;GTF3C3
prerank,GO_Biological_Process_2021__protein import into peroxisome matrix (GO:0016558),-0.4057614987075283,-0.7926833512450585,0.6333333333333333,1.0,1.0,1/10,1.54%,PEX13
prerank,GO_Biological_Process_2021__protein retention in Golgi apparatus (GO:0045053),-0.4580985221585944,-0.7923186948843045,0.6829268292682927,1.0,1.0,1/5,12.50%,SORL1
prerank,GO_Biological_Process_2021__negative regulation of calcium ion transport (GO:0051926),-0.42271975815460394,-0.7921430669187791,0.7575757575757576,1.0,1.0,1/10,1.50%,INPP5K
prerank,GO_Biological_Process_2021__signal transduction by p53 class mediator (GO:0072331),0.41584518522570585,0.7917248097485805,0.7738095238095238,1.0,1.0,6/26,14.63%,NDRG1;HINT1;BOK;ZNF385B;E2F7;PYCARD
prerank,GO_Biological_Process_2021__regulation of mRNA stability (GO:0043488),0.3661136297328731,0.791480241805111,0.9042553191489362,1.0,1.0,22/120,21.94%,VIM;TBRG4;RIDA;SLC11A1;NOCT;CARHSP1;PCBP4;XPO1;TENT5A;RPS27A;PSMB4;ROCK1;HSPB1;UBA52;UBB;PSMC2;PSMA3;SAMD4A;PSMB2;PSMD5;HNRNPU;PSMD7
prerank,GO_Biological_Process_2021__regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640),0.48442279208295114,0.79142602151068,0.7272727272727273,1.0,1.0,1/8,15.09%,NDRG4
prerank,GO_Biological_Process_2021__regulation of proteasomal protein catabolic process (GO:0061136),0.39182397321795115,0.7914129149149979,0.8409090909090909,1.0,1.0,7/44,18.83%,ARAF;XPO1;PINK1;PKD1;ALAD;UBB;PSMC2
prerank,GO_Biological_Process_2021__negative regulation of fatty acid metabolic process (GO:0045922),-0.386957415384827,-0.7913595064313433,0.8947368421052632,1.0,1.0,2/11,6.66%,APPL2;TRIB3
prerank,MSigDB_Hallmark_2020__DNA Repair,-0.2643743260855705,-0.7913424352427809,1.0,1.0,1.0,19/113,12.89%,NPR2;GTF2H5;ITPA;POLD3;ELOA;GTF2F1;DDB2;GPX4;TAF13;TP53;DGUOK;VPS37B;NT5C;RAE1;ADRM1;TYMS;DAD1;POLR2C;XPC
prerank,GO_Biological_Process_2021__glycoprotein metabolic process (GO:0009100),-0.2881676706938615,-0.7913103702502419,0.875,1.0,1.0,8/39,12.58%,GAL3ST4;ST6GALNAC3;GANC;HPSE;B4GALT7;MAN2B1;NGLY1;ST8SIA4
prerank,GO_Biological_Process_2021__positive regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045899),-0.43782658757477977,-0.7911776919350949,0.6923076923076923,1.0,1.0,2/7,6.50%,PSMC4;TP53
prerank,GO_Biological_Process_2021__regulation of DNA binding (GO:0051101),0.39332362408561383,0.7910605376842139,0.797752808988764,1.0,1.0,3/30,9.50%,HMGB2;TXN;KDM1A
prerank,GO_Biological_Process_2021__regulation of retinoic acid receptor signaling pathway (GO:0048385),0.4648456512394878,0.7909824758706484,0.75,1.0,1.0,4/9,34.02%,TRIM16;EZH2;KLF2;DHRS3
prerank,GO_Biological_Process_2021__positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002824),0.49290801930490835,0.7908550564205601,0.7777777777777778,1.0,1.0,1/7,4.13%,SLC11A1
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, preincision complex assembly (GO:0006294)",0.4339040865672839,0.7908208063843355,0.7840909090909091,1.0,1.0,9/25,23.25%,ERCC2;RPA2;RPS27A;RBX1;GTF2H3;UBA52;UBB;DDB1;RPA3
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle contraction (GO:0003056),0.5372774715407906,0.7904341865559872,0.7611940298507462,1.0,1.0,2/5,11.06%,DOCK5;CHRM3
prerank,GO_Biological_Process_2021__diol biosynthetic process (GO:0034312),0.4514207331033204,0.789759435932953,0.7142857142857143,1.0,1.0,2/12,13.49%,ABCA2;SPTLC2
prerank,GO_Biological_Process_2021__ATP synthesis coupled electron transport (GO:0042773),0.5234087897835706,0.7891917903943253,0.8208955223880597,1.0,1.0,3/6,28.45%,NDUFB6;NDUFV1;COA6
prerank,GO_Biological_Process_2021__purine ribonucleoside monophosphate biosynthetic process (GO:0009168),0.4616641460390073,0.7891331232908344,0.7808219178082192,1.0,1.0,3/13,23.92%,PAICS;PFAS;IMPDH1
prerank,GO_Biological_Process_2021__negative regulation of histone H4 acetylation (GO:0090241),0.5328926199394324,0.7885613145935318,0.7611940298507462,1.0,1.0,2/5,19.08%,CTBP1;TAF7
prerank,GO_Biological_Process_2021__negative regulation of immune system process (GO:0002683),0.5122525131582495,0.7881430268128649,0.7777777777777778,1.0,1.0,1/6,5.61%,FCGR2B
prerank,GO_Biological_Process_2021__response to interferon-beta (GO:0035456),0.41883212177576595,0.7879181160452478,0.7692307692307693,1.0,1.0,4/17,27.62%,IFITM3;AIM2;STAT1;IRF1
prerank,GO_Biological_Process_2021__positive regulation of mitochondrion organization (GO:0010822),0.3947419671166021,0.7879137174320152,0.788235294117647,1.0,1.0,9/41,20.22%,BOK;FAM162A;BNIP3;PINK1;PYCARD;CIDEB;DDHD1;HIP1R;FBXO7
prerank,GO_Biological_Process_2021__mRNA modification (GO:0016556),-0.3710211459607811,-0.7878994477580856,0.7058823529411765,1.0,1.0,3/18,9.94%,PUS1;METTL8;METTL16
prerank,GO_Biological_Process_2021__positive regulation of canonical Wnt signaling pathway (GO:0090263),0.3682907924229123,0.7877715162577938,0.8229166666666666,1.0,1.0,24/96,24.95%,DKK2;GPC5;DAAM2;SOX4;KANK1;PTK7;GSKIP;SEMA5A;GPRC5B;PSMB4;TBL1XR1;PSMC2;PSMA3;PRDM15;PSMB2;LRRK2;FGFR2;PSMD5;PSMD7;PSMD14;PSMA5;RNF220;DDX3X;GPC3
prerank,GO_Biological_Process_2021__morphogenesis of an epithelium (GO:0002009),-0.37951145041496415,-0.7877213997672234,0.6666666666666666,1.0,1.0,2/13,11.68%,ACTB;ARHGAP12
prerank,GO_Biological_Process_2021__vascular endothelial growth factor receptor signaling pathway (GO:0048010),0.38969494728673965,0.7875085591228723,0.8636363636363636,1.0,1.0,7/53,17.22%,DOCK1;VEGFA;SHC2;FLT1;ITGAV;ROCK1;HSPB1
prerank,GO_Biological_Process_2021__T cell activation involved in immune response (GO:0002286),0.5020971526572204,0.787159880223967,0.7301587301587301,1.0,1.0,1/8,4.13%,SLC11A1
prerank,GO_Biological_Process_2021__blood vessel morphogenesis (GO:0048514),-0.3765348856017789,-0.7870787198979676,0.7142857142857143,1.0,1.0,6/22,9.02%,TGFBR3;SERPINF2;EGFL7;EFNB2;TGFB1;ENG
prerank,GO_Biological_Process_2021__RNA export from nucleus (GO:0006405),-0.296408455119275,-0.786657006293233,0.8333333333333334,1.0,1.0,18/83,16.47%,NUP42;HHEX;DHX38;CPSF1;NUP155;CHTOP;THOC5;NUP188;WDR33;NUP214;DDX39A;RAE1;SLU7;SMG6;CPSF2;CPSF4;THOC7;POLDIP3
prerank,GO_Biological_Process_2021__synaptic vesicle exocytosis (GO:0016079),0.4205963717548612,0.7864859202943077,0.7435897435897436,1.0,1.0,10/24,21.08%,SNAP25;UNC13A;RIMS2;SYT1;SNAP29;UNC13C;RIMS3;CPLX1;STX2;STX19
prerank,GO_Biological_Process_2021__cellular response to alkaloid (GO:0071312),-0.4081571136944976,-0.7863621880905733,0.7391304347826086,1.0,1.0,2/10,5.60%,CASP7;RYR1
prerank,GO_Biological_Process_2021__axoneme assembly (GO:0035082),0.46293439335853737,0.786358102434244,0.8481012658227848,1.0,1.0,3/11,15.04%,LRGUK;CCDC39;TOGARAM1
prerank,GO_Biological_Process_2021__positive regulation of organelle organization (GO:0010638),0.42248128375907723,0.786303556796306,0.8311688311688312,1.0,1.0,9/27,33.78%,ANXA1;CALCOCO2;SURF4;FYCO1;PPARGC1A;PFDN2;C2CD5;LNPK;HTRA2
prerank,GO_Biological_Process_2021__vesicle cytoskeletal trafficking (GO:0099518),-0.3394360775987475,-0.7862974091910709,0.9411764705882353,1.0,1.0,4/28,10.71%,NDE1;TRAK2;MYO1F;MYO1D
prerank,GO_Biological_Process_2021__cellular lipid biosynthetic process (GO:0097384),0.5432849715682129,0.7860732726064437,0.8181818181818182,1.0,1.0,1/5,11.37%,AGPS
prerank,GO_Biological_Process_2021__glycerol ether biosynthetic process (GO:0046504),0.5432849715682129,0.7860732726064437,0.8181818181818182,1.0,1.0,1/5,11.37%,AGPS
prerank,GO_Biological_Process_2021__extracellular transport (GO:0006858),0.5097316544969837,0.785978383406033,0.7428571428571429,1.0,1.0,2/7,21.89%,ADCY10;DNAAF2
prerank,GO_Biological_Process_2021__response to UV (GO:0009411),0.3861389470502286,0.785401684669663,0.8850574712643678,1.0,1.0,6/71,9.50%,DTL;ERCC2;TMEM161A;PTPRK;RUVBL2;KDM1A
prerank,GO_Biological_Process_2021__regulation of cell-cell adhesion (GO:0022407),0.4026012915716717,0.7852457441891172,0.8205128205128205,1.0,1.0,8/27,23.45%,PTPRG;RNASE10;CELSR2;EPHA7;SPINT2;GTPBP4;FLOT2;MEGF10
prerank,GO_Biological_Process_2021__sphingosine biosynthetic process (GO:0046512),0.48449309550012426,0.7848009323023767,0.8235294117647058,1.0,1.0,2/9,13.49%,ABCA2;SPTLC2
prerank,GO_Biological_Process_2021__sphingoid biosynthetic process (GO:0046520),0.48449309550012426,0.7848009323023767,0.8235294117647058,1.0,1.0,2/9,13.49%,ABCA2;SPTLC2
prerank,PanglaoDB_Augmented_2021__Neutrophils,0.3691368129345385,0.7847275372809471,0.8333333333333334,1.0,1.0,11/83,16.48%,CLEC4E;CLEC12A;CR1;SLC11A1;SIRPB2;FGR;C5AR1;ARG2;CD300A;RASGRP4;LRRC25
prerank,GO_Biological_Process_2021__acidic amino acid transport (GO:0015800),0.48231388295880673,0.7844777038603366,0.7721518987341772,1.0,1.0,1/11,3.93%,SLC1A2
prerank,GO_Biological_Process_2021__positive regulation of insulin receptor signaling pathway (GO:0046628),0.47829420719733456,0.7840942990612568,0.6875,1.0,1.0,1/8,12.09%,SORBS1
prerank,GO_Biological_Process_2021__regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901028),0.46704524552567284,0.7838212115328969,0.7236842105263158,1.0,1.0,3/9,20.03%,BOK;TMEM14A;HIP1R
prerank,GO_Biological_Process_2021__positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),0.36624926358919424,0.7836907508676636,0.875,1.0,1.0,13/63,24.39%,RNF144B;HERPUD1;ARIH2;RNF144A;RBX1;PRICKLE1;DNAJB2;HSPA1B;NOP53;LRRK2;USP5;BBS7;DDRGK1
prerank,GO_Biological_Process_2021__microglial cell activation (GO:0001774),-0.3727456898782036,-0.7834295878283664,0.8235294117647058,1.0,1.0,2/18,1.00%,ITGAM;CX3CR1
prerank,GO_Biological_Process_2021__cellular nitrogen compound biosynthetic process (GO:0044271),0.4293430932731519,0.7831528823774178,0.7209302325581395,1.0,1.0,3/15,13.49%,ABCA2;ARG2;SPTLC2
prerank,GO_Biological_Process_2021__positive regulation of cellular response to insulin stimulus (GO:1900078),0.4799141178407273,0.7830832105025802,0.746268656716418,1.0,1.0,3/9,29.80%,SORBS1;ECHDC3;ZBTB7B
prerank,GO_Biological_Process_2021__lamellipodium organization (GO:0097581),0.4233897488510647,0.783082324119992,0.759493670886076,1.0,1.0,4/23,14.17%,CARMIL1;WASF1;ARHGEF4;ABLIM3
prerank,GO_Biological_Process_2021__regulation of anoikis (GO:2000209),0.4427464632785405,0.7830086730381581,0.7974683544303798,1.0,1.0,3/14,9.52%,TLE1;PDK4;MCL1
prerank,GO_Biological_Process_2021__positive regulation of intracellular transport (GO:0032388),-0.3398508170586624,-0.78276796555748,0.7894736842105263,1.0,1.0,7/29,19.54%,NEDD4;PRR5L;PLK3;SORL1;RAB29;CEP290;STX18
prerank,GO_Biological_Process_2021__mRNA cleavage involved in gene silencing by miRNA (GO:0035279),-0.48901370809503325,-0.7826777363873769,0.6842105263157895,1.0,1.0,2/5,21.30%,AGO1;MOV10
prerank,GO_Biological_Process_2021__lysosome organization (GO:0007040),0.41313113743994007,0.7824756884024086,0.810126582278481,1.0,1.0,9/28,24.23%,CLVS1;ABCA1;ACP3;HOOK3;ATP10B;LRRK2;GAA;TMEM106B;CLVS2
prerank,GO_Biological_Process_2021__regulation of bicellular tight junction assembly (GO:2000810),0.44515011711648866,0.7822640056482126,0.8048780487804879,1.0,1.0,4/13,22.82%,NPHP1;ROCK1;TNF;TJP1
prerank,GO_Biological_Process_2021__negative regulation of catabolic process (GO:0009895),-0.34565288116846027,-0.7820934707269089,0.8461538461538461,1.0,1.0,3/29,5.22%,FLNA;IL1B;AZIN2
prerank,GO_Biological_Process_2021__positive regulation of extracellular matrix organization (GO:1903055),-0.4165912822440009,-0.7819977346410956,0.8461538461538461,1.0,1.0,2/11,7.51%,FSCN1;TGFB1
prerank,GO_Biological_Process_2021__pyrimidine-containing compound biosynthetic process (GO:0072528),-0.4045067549327257,-0.781844522009785,0.65,1.0,1.0,1/7,2.11%,DHODH
prerank,GO_Biological_Process_2021__regulation of calcium ion-dependent exocytosis (GO:0017158),0.43868444313147015,0.7810739635198417,0.7714285714285715,1.0,1.0,6/15,26.29%,SYT4;SYT1;SYT11;KCNB1;SYT9;SCAMP5
prerank,GO_Biological_Process_2021__smoothened signaling pathway (GO:0007224),0.43267710555784905,0.7810284100670469,0.8115942028985508,1.0,1.0,2/17,16.69%,TTBK2;CC2D2A
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA incision (GO:0033683)",0.42394834778967855,0.7810227306726862,0.8636363636363636,1.0,1.0,12/30,23.25%,ERCC2;RPA2;RPS27A;RBX1;FAN1;RFC4;GTF2H3;UBA52;UBB;RFC1;DDB1;RPA3
prerank,GO_Biological_Process_2021__regulation of nucleic acid-templated transcription (GO:1903506),0.3502488336116039,0.7810226548414467,0.9494949494949495,1.0,1.0,34/281,15.98%,NFIL3;ACVR1B;SAP30;PQBP1;RORB;SOX4;TCF7;APBB3;HINT1;INSR;HIF1A;GLRX2;HCFC1;FOXN2;ARNT2;ZKSCAN5;BHLHE40;TCF7L1;MAFB;LIMD1;POU5F1;CELSR2;ZNF536;TULP3;SOX6;HCLS1;HINFP;DRAP1;YAF2;ZNF143;ACTR5;MLF2;ESR1;NR2C2
prerank,GO_Biological_Process_2021__peroxisome fission (GO:0016559),-0.4940166182606741,-0.7809652431527289,0.7586206896551724,1.0,1.0,1/5,15.49%,FIS1
prerank,GO_Biological_Process_2021__gene silencing by miRNA (GO:0035195),0.41592606299735985,0.7809253155765092,0.8589743589743589,1.0,1.0,7/25,30.08%,LIMD1;PRKRA;CNOT6;CNOT7;AGO4;DICER1;CNOT8
prerank,GO_Biological_Process_2021__female gamete generation (GO:0007292),0.45155431019382997,0.7808506185265809,0.7631578947368421,1.0,1.0,3/13,8.95%,IHO1;FMN2;PTN
prerank,GO_Biological_Process_2021__regulation of epidermal growth factor-activated receptor activity (GO:0007176),0.4582854789936637,0.7808008866357664,0.7333333333333333,1.0,1.0,2/14,17.45%,ERRFI1;APP
prerank,PanglaoDB_Augmented_2021__B Cells Memory,0.3578230597512071,0.7804456990804582,0.8571428571428571,1.0,1.0,5/89,5.77%,GPR18;NAPSB;CD22;FCGR2B;IL7
prerank,GO_Biological_Process_2021__regulation of T cell receptor signaling pathway (GO:0050856),-0.3430998229839416,-0.7803413801254659,0.8,1.0,1.0,10/25,23.28%,DUSP3;LILRB4;CD226;BCL10;CARD11;RAB29;CD81;PRKD2;RELA;LAPTM5
prerank,GO_Biological_Process_2021__regulation of macromolecule metabolic process (GO:0060255),-0.2630954491640743,-0.7793349381692992,1.0,1.0,1.0,16/113,12.19%,ATRAID;ZNF711;TRIM38;PRDM10;RNF187;IGF2BP3;KHSRP;SIRPA;PCBP3;IGF1;HMG20A;LAMTOR1;TREM2;ADNP2;REST;TRIM11
prerank,GO_Biological_Process_2021__positive regulation of MAPK cascade (GO:0043410),0.3577466794249745,0.7793344896676009,0.9183673469387755,1.0,1.0,17/146,11.79%,HTR2B;FGF1;TGFB2;GLIPR2;CHI3L1;DIRAS2;VEGFA;GPNMB;INSR;ROBO1;TRIM5;IGF1R;NTRK3;C5AR1;NOD2;FLT1;NTRK2
prerank,GO_Biological_Process_2021__positive regulation of release of cytochrome c from mitochondria (GO:0090200),0.4736951966901228,0.7792215260297859,0.8493150684931506,1.0,1.0,5/18,15.86%,FAM162A;BNIP3;PINK1;PYCARD;CIDEB
prerank,GO_Biological_Process_2021__regulation of defense response to bacterium (GO:1900424),0.5153300823480355,0.7788937924565791,0.7402597402597403,1.0,1.0,1/5,17.56%,FOXP1
prerank,MSigDB_Hallmark_2020__heme Metabolism,0.3645937000614956,0.7787571210203846,0.9473684210526315,1.0,1.0,22/144,16.08%,RAP1GAP;PPP2R5B;TNS1;NUDT4;TFRC;MBOAT2;CA2;PPOX;PIGQ;ENDOD1;BNIP3L;BLVRB;NARF;MXI1;ALDH6A1;MPP1;RBM5;SDCBP;TMCC2;PICALM;OSBP2;CCND3
prerank,GO_Biological_Process_2021__negative regulation of leukocyte activation (GO:0002695),-0.36991808588570335,-0.7786382028306073,0.7307692307692307,1.0,1.0,3/10,9.89%,CD300LF;MILR1;NR1H3
prerank,GO_Biological_Process_2021__cell cycle checkpoint signaling (GO:0000075),0.5054323874817785,0.7786156216128469,0.8181818181818182,1.0,1.0,2/6,24.69%,PLK2;PRCC
prerank,GO_Biological_Process_2021__positive regulation of cell-cell adhesion (GO:0022409),0.4152449661893549,0.7784265772163843,0.8271604938271605,1.0,1.0,3/26,6.39%,PLPP3;RNASE10;ANK3
prerank,GO_Biological_Process_2021__response to insulin (GO:0032868),0.3693794719279805,0.7782504131610561,0.8791208791208791,1.0,1.0,8/59,17.63%,INSR;RAB15;IRS2;SORBS1;PKM;INSIG1;CPEB2;SLC39A14
prerank,GO_Biological_Process_2021__plasma membrane bounded cell projection assembly (GO:0120031),-0.24260891841801305,-0.7781922059659424,1.0,1.0,1.0,31/189,14.14%,EHD4;KIF27;FLNA;INPP5K;FSCN1;WDR35;WHAMM;MKKS;MAP4K4;KIF3B;RAPGEF6;INPP5E;BBS9;EXOC7;P2RY12;TMEM67;TCTN3;OCRL;ABCC4;CYFIP1;SRGAP2;IFT43;GSN;OPHN1;CCDC66;NUDCD3;PPP1R9B;STK26;GALNT11;DISC1;RAP1A
prerank,GO_Biological_Process_2021__hydrogen peroxide metabolic process (GO:0042743),-0.41012155517267496,-0.7780234423527863,0.8518518518518519,1.0,1.0,3/12,13.42%,ACOX1;PXDNL;GPX1
prerank,GO_Biological_Process_2021__positive regulation of keratinocyte differentiation (GO:0045618),0.4853725402676379,0.7780119198354867,0.7727272727272727,1.0,1.0,4/7,32.90%,TRIM16;MACROH2A2;MACROH2A1;NCOA3
prerank,GO_Biological_Process_2021__positive regulation of epidermal cell differentiation (GO:0045606),0.4853725402676379,0.7780119198354867,0.7727272727272727,1.0,1.0,4/7,32.90%,TRIM16;MACROH2A2;MACROH2A1;NCOA3
prerank,GO_Biological_Process_2021__negative regulation of pri-miRNA transcription by RNA polymerase II (GO:1902894),0.4640390497363289,0.777913370939687,0.8,1.0,1.0,2/10,9.56%,NFIB;POU5F1
prerank,GO_Biological_Process_2021__cellular response to interferon-beta (GO:0035458),0.44393276234025475,0.7778896481962555,0.7432432432432432,1.0,1.0,7/11,40.43%,AIM2;STAT1;IRF1;HTRA2;UBE2G2;UBE2K;PNPT1
prerank,GO_Biological_Process_2021__chondroitin sulfate proteoglycan metabolic process (GO:0050654),0.47744474391566805,0.7777657025727246,0.803030303030303,1.0,1.0,5/8,26.94%,B3GAT1;CSGALNACT2;CSGALNACT1;B3GAT2;DSE
prerank,GO_Biological_Process_2021__protein-containing complex subunit organization (GO:0043933),0.3800507661835498,0.7776453647039067,0.8494623655913979,1.0,1.0,18/83,25.86%,TRAF2;NUP133;WASF1;DARS1;PPID;PARD3;PICALM;SEH1L;FANCA;DLG4;KNTC1;NAPG;HFE;NDC1;REPS2;RIMS1;PPARGC1A;PTK2B
prerank,GO_Biological_Process_2021__regulation of actin filament polymerization (GO:0030833),0.38589700685510075,0.7776246552526695,0.7692307692307693,1.0,1.0,13/47,24.50%,PRKCE;ARF6;BAIAP2L1;KANK1;CARMIL1;HCLS1;PYCARD;HIP1R;SSH2;PAK3;CTTN;ARHGAP18;TWF1
prerank,GO_Biological_Process_2021__cellular component disassembly (GO:0022411),0.4049570399596386,0.7776076746626527,0.8023255813953488,1.0,1.0,2/26,4.57%,SH3PXD2B;ADAM15
prerank,GO_Biological_Process_2021__apoptotic DNA fragmentation (GO:0006309),0.4650787564720027,0.7775845353637337,0.7777777777777778,1.0,1.0,1/12,2.26%,HMGB2
prerank,"GO_Biological_Process_2021__DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",-0.28896084024084984,-0.7773510340527044,0.9411764705882353,1.0,1.0,8/40,13.06%,PIDD1;BTG2;TP53;ZNF385A;EP300;CNOT6L;PLK3;PLAGL1
prerank,GO_Biological_Process_2021__negative regulation of endoplasmic reticulum unfolded protein response (GO:1900102),0.4657276541664681,0.7773136381794584,0.8421052631578947,1.0,1.0,3/13,14.62%,HSPA5;PPP1R15A;DNAJB9
prerank,GO_Biological_Process_2021__gene expression (GO:0010467),0.3494915443633463,0.7772216976417976,0.93,1.0,1.0,72/291,26.42%,EEF1A2;RPL23;EIF4A3;NR4A2;RPL37A;RBM3;RPS6KB2;NUP133;ADARB2;RPL38;COPS5;PAX8;RPS6;RPS27A;RPL23A;TFIP11;CELF2;RPS25;DARS1;RPS27;NOVA1;RPS11;RPS20;RPL9;RBM5;RPLP2;RPS18;MRPL43;RPL37;AGFG1;NXF1;RPL14;ANGPT2;MRPL55;SEH1L;HNRNPH1;MRPL27;RPS4X;RPL11;RPS24;POLR2D;RPS9;RPL36;HSPD1;MRPL3;RPS3A;MRPS14;RPL35;RPL4;SRSF5;POLR2G;RPL32;TNIP1;MPHOSPH10;HNRNPU;EEF1A1;RPL24;RPL27A;NDC1;RPL3;HNRNPH3;SRSF3;RPS16;RPL30;RPL21;POM121;RPL7;RPL12;SYNCRIP;SRSF9;EIF4EBP2;RPL10A
prerank,GO_Biological_Process_2021__regulation of histone methylation (GO:0031060),-0.41833897430845446,-0.7764789135937826,0.696969696969697,1.0,1.0,3/9,16.89%,CHTOP;PIH1D1;ZNF335
prerank,GO_Biological_Process_2021__positive regulation of protein localization to nucleus (GO:1900182),-0.28754632811230424,-0.7764549785013806,1.0,1.0,1.0,5/47,7.51%,FLNA;SESN2;ZPR1;WWTR1;TGFB1
prerank,GO_Biological_Process_2021__negative regulation of gene silencing by miRNA (GO:0060965),0.48354755139844163,0.7764154349034734,0.7428571428571429,1.0,1.0,3/8,20.20%,POU5F1;ESR1;TNF
prerank,GO_Biological_Process_2021__protein lipidation (GO:0006497),0.378868236299805,0.7760176563309158,0.8295454545454546,1.0,1.0,10/44,20.94%,ZDHHC15;PIGU;PIGQ;GLUL;ZDHHC9;PIGF;UGCG;PIGL;PIGG;ATG5
prerank,GO_Biological_Process_2021__tRNA transcription (GO:0009304),-0.463315528056979,-0.7756544723141893,0.8285714285714286,1.0,1.0,2/7,19.93%,GTF3C2;GTF3C3
prerank,GO_Biological_Process_2021__regulation of lamellipodium organization (GO:1902743),0.4450427980681733,0.7754447500656718,0.8115942028985508,1.0,1.0,2/10,24.50%,CARMIL1;TWF1
prerank,GO_Biological_Process_2021__sno(s)RNA 3'-end processing (GO:0031126),-0.4476442116043851,-0.7753637335290866,0.6923076923076923,1.0,1.0,1/8,1.82%,FBL
prerank,GO_Biological_Process_2021__regulation of interleukin-13 production (GO:0032656),-0.4422858555047664,-0.7753424554657226,0.6956521739130435,1.0,1.0,2/6,9.22%,LGALS9;HLA-E
prerank,GO_Biological_Process_2021__negative regulation of catalytic activity (GO:0043086),-0.3562848266684986,-0.7751814577484079,0.8947368421052632,1.0,1.0,1/17,6.50%,TP53
prerank,GO_Biological_Process_2021__mitotic recombination (GO:0006312),-0.40387604537664523,-0.7751037373340195,0.625,1.0,1.0,2/11,7.85%,TPRKB;TEP1
prerank,GO_Biological_Process_2021__regulation of miRNA mediated inhibition of translation (GO:1905616),0.48970684076777793,0.7748990215101503,0.765625,1.0,1.0,4/7,46.18%,EIF4G1;EIF4E2;EIF4ENIF1;DDX6
prerank,GO_Biological_Process_2021__positive regulation of miRNA mediated inhibition of translation (GO:1905618),0.48970684076777793,0.7748990215101503,0.765625,1.0,1.0,4/7,46.18%,EIF4G1;EIF4E2;EIF4ENIF1;DDX6
prerank,GO_Biological_Process_2021__regulation of RNA polymerase II regulatory region sequence-specific DNA binding (GO:1903025),-0.43866664660925214,-0.7748798782303351,0.75,1.0,1.0,1/7,9.74%,EP300
prerank,GO_Biological_Process_2021__small nucleolar ribonucleoprotein complex assembly (GO:0000491),-0.47802684256609873,-0.7747745663856553,0.7241379310344828,1.0,1.0,3/8,12.41%,NUFIP1;PIH1D1;ZNHIT6
prerank,GO_Biological_Process_2021__response to amyloid-beta (GO:1904645),0.37965262894127355,0.7746555221551088,0.8227848101265823,1.0,1.0,7/30,17.45%,FCGR2B;GRIN2A;IGF1R;CACNA1B;EPHA4;CACNA1A;APP
prerank,GO_Biological_Process_2021__negative regulation of transcription from RNA polymerase II promoter in response to stress (GO:0097201),0.478732698401122,0.7746195146749937,0.7837837837837838,1.0,1.0,3/10,22.86%,IMPACT;BAG3;JUN
prerank,GO_Biological_Process_2021__regulation of cellular response to stress (GO:0080135),0.37502227183640463,0.7740687949797451,0.8817204301075269,1.0,1.0,12/104,17.43%,MAPT;MANF;RPA2;NUP133;DNAJC7;MCL1;ADCY8;CAMK2B;PINK1;BAG3;SEH1L;HSPA1B
prerank,GO_Biological_Process_2021__positive regulation of production of molecular mediator of immune response (GO:0002702),0.4159688622186281,0.7737603532175926,0.8552631578947368,1.0,1.0,4/19,15.06%,NOD2;GPI;DNAJB9;WNT5A
prerank,GO_Biological_Process_2021__semaphorin-plexin signaling pathway (GO:0071526),0.4378055981011951,0.7736300292216841,0.8108108108108109,1.0,1.0,6/23,17.21%,SEMA3A;SEMA3B;SEMA6A;SEMA5A;PLXNB1;ARHGDIA
prerank,GO_Biological_Process_2021__lytic vacuole organization (GO:0080171),0.41815847975984677,0.7734165410576521,0.8,1.0,1.0,8/24,24.23%,CLVS1;ABCA1;ACP3;HOOK3;LRRK2;GAA;TMEM106B;CLVS2
prerank,GO_Biological_Process_2021__DNA dealkylation involved in DNA repair (GO:0006307),0.49649804747561893,0.7732328956339021,0.8507462686567164,1.0,1.0,1/9,7.13%,MPG
prerank,GO_Biological_Process_2021__DNA dealkylation (GO:0035510),0.49649804747561893,0.7732328956339021,0.8507462686567164,1.0,1.0,1/9,7.13%,MPG
prerank,GO_Biological_Process_2021__myeloid cell differentiation (GO:0030099),0.39149158894649494,0.7730857122874487,0.8409090909090909,1.0,1.0,5/38,15.95%,ZBTB16;FLVCR1;HCLS1;CASP3;RASGRP4
prerank,GO_Biological_Process_2021__regulation of nucleobase-containing compound metabolic process (GO:0019219),0.4784332978431566,0.7729603211554125,0.796875,1.0,1.0,2/8,10.44%,PCBP4;NOVA1
prerank,GO_Biological_Process_2021__intra-Golgi vesicle-mediated transport (GO:0006891),0.4067993137754556,0.7726005390408952,0.7710843373493976,1.0,1.0,2/26,12.94%,NAPA;NSF
prerank,GO_Biological_Process_2021__leucine catabolic process (GO:0006552),-0.5030442767369261,-0.7724697384116175,0.7241379310344828,1.0,1.0,2/5,19.66%,IVD;MCCC1
prerank,GO_Biological_Process_2021__pyrimidine deoxyribonucleotide catabolic process (GO:0009223),0.46845124565789403,0.7722972434783623,0.8026315789473685,1.0,1.0,4/10,17.78%,TDG;NEIL1;NEIL2;UPP2
prerank,GO_Biological_Process_2021__regulation of intracellular transport (GO:0032386),0.4255477065601352,0.7715891596565618,0.8378378378378378,1.0,1.0,8/27,27.46%,ANTKMT;MAP2;DYNC1H1;RNF139;LRRK2;GRIPAP1;ATP9A;PTPN1
prerank,GO_Biological_Process_2021__regulation of neuroblast proliferation (GO:1902692),0.4478967371109123,0.7715667544736757,0.8493150684931506,1.0,1.0,6/13,21.27%,VEGFA;PTN;KDM1A;SMARCD3;LRRK2;CX3CL1
prerank,GO_Biological_Process_2021__toll-like receptor 9 signaling pathway (GO:0034162),-0.4084240399195319,-0.7695681201528245,0.8275862068965517,1.0,1.0,2/12,11.22%,IRAK4;TLR7
prerank,GO_Biological_Process_2021__female gonad development (GO:0008585),0.47831155547558196,0.7694721395648229,0.782608695652174,1.0,1.0,3/9,18.25%,VEGFA;EIF2B2;SOD1
prerank,GO_Biological_Process_2021__phospholipid metabolic process (GO:0006644),0.4047072384117063,0.7694267153191301,0.8260869565217391,1.0,1.0,5/43,7.02%,PLPP3;ENPP2;PLPPR4;ALOX15B;ABCA2
prerank,GO_Biological_Process_2021__regulation of protein localization to cell surface (GO:2000008),0.41969274136496404,0.7692432290557364,0.8024691358024691,1.0,1.0,7/25,22.60%,GPM6B;ABCA2;CAV3;PICALM;TNF;HFE;MAP1A
prerank,GO_Biological_Process_2021__homologous chromosome segregation (GO:0045143),0.4500331472147371,0.7691098601723333,0.7792207792207793,1.0,1.0,3/9,13.31%,IHO1;FMN2;ZCWPW1
prerank,GO_Biological_Process_2021__positive regulation of rRNA processing (GO:2000234),-0.41273931152313614,-0.768700610466185,0.8,1.0,1.0,2/8,7.26%,BUD23;RIOK1
prerank,GO_Biological_Process_2021__nucleic acid-templated transcription (GO:0097659),0.4016936523818583,0.7683036742169101,0.7752808988764045,1.0,1.0,2/27,7.86%,NR4A2;PAX8
prerank,GO_Biological_Process_2021__cellular protein localization (GO:0034613),0.3507333740492509,0.7682242911303867,0.9494949494949495,1.0,1.0,47/240,24.92%,SH3PXD2B;ZDHHC15;TBC1D8;PIGU;NAPA;ARF6;DMD;PTPRK;TBC1D13;PRRT1;ANK2;RAB20;SEPTIN4;SEPTIN8;NPHP1;TBC1D15;CNTNAP2;GRID2;NSF;ITSN1;WNT5A;CPE;TMED10;SNX17;STXBP2;CEP68;SCG5;RAB21;STX2;CNTNAP1;TBC1D2;LRRK2;CNTN2;STX19;NAPG;MFN2;TBC1D14;RAB5A;CTTN;AMOT;ATG13;SEPTIN11;JAM3;AP3B1;VPS26B;EPB41L3;ARMCX3
prerank,GO_Biological_Process_2021__receptor internalization (GO:0031623),-0.3134807421827077,-0.7680260238734682,0.9166666666666666,1.0,1.0,9/37,13.23%,NEDD4;RAMP1;GTF2H2;LILRB4;GRK2;SCYL2;ITGB2;ARRB2;SYK
prerank,GO_Biological_Process_2021__activation of phospholipase C activity (GO:0007202),0.422492474479921,0.767684742801163,0.7972972972972973,1.0,1.0,6/19,18.82%,HTR2B;C5AR1;NTRK2;RASGRP4;TXK;GNAQ
prerank,GO_Biological_Process_2021__peptidyl-arginine modification (GO:0018195),0.5237110415460287,0.7676726832054965,0.8955223880597015,1.0,1.0,3/5,41.13%,PRMT1;PADI2;NDUFAF5
prerank,GO_Biological_Process_2021__rRNA 3'-end processing (GO:0031125),0.4549788929339938,0.7673559025185931,0.782608695652174,1.0,1.0,1/9,10.65%,ERI2
prerank,GO_Biological_Process_2021__establishment of protein localization to membrane (GO:0090150),0.38291842935454135,0.767130727925472,0.8555555555555555,1.0,1.0,8/51,18.63%,ZDHHC15;SYNE3;VPS37C;PARD3;ZDHHC9;SDCBP;NACA;AQP11
prerank,GO_Biological_Process_2021__entry of bacterium into host cell (GO:0035635),-0.5142928282891487,-0.7671195615532299,0.75,1.0,1.0,2/5,15.95%,SRC;CBL
prerank,GO_Biological_Process_2021__inner ear morphogenesis (GO:0042472),0.467879520459094,0.76685323707041,0.7857142857142857,1.0,1.0,3/8,24.65%,PAX8;FGFR2;TTC39C
prerank,GO_Biological_Process_2021__intracellular lipid transport (GO:0032365),-0.37204921655222917,-0.7668055186201983,0.8333333333333334,1.0,1.0,2/15,1.98%,NPC2;ARV1
prerank,GO_Biological_Process_2021__protein localization to vacuole (GO:0072665),0.49105495176517633,0.7665013288197184,0.8311688311688312,1.0,1.0,2/9,23.04%,RTN4;MFSD1
prerank,GO_Biological_Process_2021__plasma membrane invagination (GO:0099024),0.4058025458322566,0.7664971166810803,0.7926829268292683,1.0,1.0,4/25,6.84%,GULP1;DOCK1;FCGR2B;SPIRE2
prerank,GO_Biological_Process_2021__regulation of DNA damage checkpoint (GO:2000001),0.4680713879312902,0.7662372863531949,0.7605633802816901,1.0,1.0,1/9,4.68%,RPA2
prerank,GO_Biological_Process_2021__positive regulation of type I interferon production (GO:0032481),0.3482650894582907,0.7660873082534281,0.8695652173913043,1.0,1.0,16/65,28.80%,PQBP1;POLR3F;POLR1C;RIPK2;POLR3H;DHX33;HSPD1;STAT1;STAT6;TRIM56;DDX3X;TLR2;CTNNB1;POLR3E;IRF1;RIOK3
prerank,GO_Biological_Process_2021__negative regulation of viral transcription (GO:0032897),0.45927375341320376,0.765959290407675,0.8481012658227848,1.0,1.0,3/10,21.36%,IFITM3;TRIM14;HEXIM1
prerank,GO_Biological_Process_2021__negative regulation of appetite (GO:0032099),-0.48832146277835564,-0.7655933892258626,0.7931034482758621,1.0,1.0,3/5,19.32%,MKKS;NENF;BBS2
prerank,GO_Biological_Process_2021__regulation of small GTPase mediated signal transduction (GO:0051056),0.35457129031895995,0.7655920555125673,0.8958333333333334,1.0,1.0,23/109,22.42%,RHOB;RELN;RACGAP1;CGNL1;TRIP10;ARHGAP23;NGEF;CHN1;ARHGEF4;KALRN;ITSN1;RASGRF1;ITGAV;ARAP2;ARHGDIA;STARD13;FGD4;RHOH;ECT2;FAM13A;STARD8;VAV3;RHOU
prerank,GO_Biological_Process_2021__DNA duplex unwinding (GO:0032508),0.39266610403578334,0.7655542524757459,0.8620689655172413,1.0,1.0,9/40,18.81%,ERCC2;ANXA1;RPS27A;RBX1;DDX1;MCMDC2;GTF2H3;UBA52;UBB
prerank,GO_Biological_Process_2021__hydrogen peroxide catabolic process (GO:0042744),-0.47532371856511885,-0.7655358331597725,0.7407407407407407,1.0,1.0,2/7,13.42%,PXDNL;GPX1
prerank,GO_Biological_Process_2021__negative regulation of anoikis (GO:2000811),0.4472066318369131,0.7654933176331407,0.8375,1.0,1.0,3/11,9.52%,TLE1;PDK4;MCL1
prerank,GO_Biological_Process_2021__negative regulation of protein serine/threonine kinase activity (GO:0071901),0.36294899459747576,0.7653276258907358,0.8617021276595744,1.0,1.0,7/56,8.38%,PKIA;PRKAR2B;AGT;RGS2;PAQR3;SPRY1;CAV3
prerank,GO_Biological_Process_2021__organelle assembly (GO:0070925),0.3465958135167616,0.7652017310461909,0.9696969696969697,1.0,1.0,31/285,17.59%,CENPF;CENPE;SH3PXD2B;HAUS6;MAPT;ANLN;DZIP1;TTBK2;RFX2;TMEM41B;VPS37C;RCC1;ATAT1;LIMD1;RP2;IFT74;CFAP54;DYNC1H1;SNX10;SNAP29;GOLGA8B;VMP1;AUP1;PKD1;ABLIM3;TXNDC15;ATP2A2;CC2D2A;UBXN2B;KIF3A;MACIR
prerank,GO_Biological_Process_2021__Rho protein signal transduction (GO:0007266),0.41043699106629833,0.7648519946829149,0.8518518518518519,1.0,1.0,1/32,0.66%,RHOB
prerank,GO_Biological_Process_2021__positive regulation of interleukin-8 production (GO:0032757),-0.31195299313591174,-0.7648294376604203,0.8823529411764706,1.0,1.0,10/35,15.45%,IL1B;CD2;LGALS9;TLR3;TLR7;HSPA1A;SYK;BCL10;LILRA2;TIRAP
prerank,GO_Biological_Process_2021__regulation of calcium ion transmembrane transport (GO:1903169),0.4400249574634557,0.7647259254542184,0.7926829268292683,1.0,1.0,2/12,8.38%,ANK2;CAV3
prerank,GO_Biological_Process_2021__negative regulation of potassium ion transmembrane transport (GO:1901380),0.47995901748743386,0.7641105145479004,0.8382352941176471,1.0,1.0,1/7,8.38%,CAV3
prerank,GO_Biological_Process_2021__regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),0.37195081611902425,0.7640339495583023,0.8709677419354839,1.0,1.0,8/68,14.72%,THBS1;ASPN;VASN;SPRY1;RPS27A;NREP;PEG10;SDCBP
prerank,GO_Biological_Process_2021__negative regulation of MAP kinase activity (GO:0043407),0.382843565501148,0.763935786905873,0.8352941176470589,1.0,1.0,13/34,22.90%,AGT;RGS2;PAQR3;SPRY1;CAV3;CD300A;DUSP10;AIDA;GSTP1;UCHL1;IRAK3;PDCD4;MAPK8IP1
prerank,GO_Biological_Process_2021__homotypic cell-cell adhesion (GO:0034109),0.3724443829720168,0.7639106757230367,0.8444444444444444,1.0,1.0,4/32,11.25%,PLPP3;MEGF11;FN1;TYRO3
prerank,GO_Biological_Process_2021__regulation of cell differentiation (GO:0045595),0.3600779371198832,0.7638963502909806,0.8947368421052632,1.0,1.0,27/99,20.85%,KLF4;BMPR1B;ALOX15B;MBOAT2;EPHA3;PPP1R13L;NLGN1;TRPS1;MAFB;ID2;ALK;SMYD5;CLASP2;NREP;APC2;OCIAD1;CEBPD;ST7;ROCK1;BCL6;FES;SUZ12;CDK9;CDK5R1;TNF;NR1D1;FGFR2
prerank,"GO_Biological_Process_2021__protein localization to chromosome, centromeric region (GO:0071459)",-0.40023850656487225,-0.7638441105051118,0.7391304347826086,1.0,1.0,3/11,20.41%,BUB3;CTCF;ZW10
prerank,GO_Biological_Process_2021__RNA phosphodiester bond hydrolysis (GO:0090501),0.42942540046715527,0.7632458410497741,0.8333333333333334,1.0,1.0,3/21,14.47%,NUDT16;NHP2;ZC3H12B
prerank,GO_Biological_Process_2021__Golgi organization (GO:0007030),0.34176996088138134,0.7629278898933254,0.8947368421052632,1.0,1.0,17/98,25.40%,ATP8B1;CLASP2;VCPIP1;GOLGA8B;VMP1;SPTBN5;TMED10;FAM174B;UBXN2B;VPS51;SURF4;LRRK2;RAB30;DYNC2H1;HACE1;VRK1;GOLGB1
prerank,GO_Biological_Process_2021__negative regulation of MAPK cascade (GO:0043409),0.37169581192263007,0.7629087874485299,0.8522727272727273,1.0,1.0,18/60,21.35%,AGT;RGS2;SEMA6A;CAMK2N1;PAQR3;SPRY1;CAV3;LMO3;PEBP1;CD300A;DUSP10;TIMP3;GSTP1;PRDM15;DUSP6;UCHL1;IRAK3;TNIP1
prerank,GO_Biological_Process_2021__negative regulation of cellular carbohydrate metabolic process (GO:0010677),0.4628078724363026,0.762770929468308,0.8533333333333334,1.0,1.0,3/11,19.04%,CLK2;FBP1;PPARA
prerank,GO_Biological_Process_2021__respiratory electron transport chain (GO:0022904),0.47420707973504067,0.76274675106032,0.8333333333333334,1.0,1.0,4/12,25.32%,ETFB;UQCRFS1;GPD2;PPARGC1A
prerank,GO_Biological_Process_2021__glycoprotein biosynthetic process (GO:0009101),0.3719392787702075,0.7624285268885238,0.8095238095238095,1.0,1.0,7/48,15.93%,ALG10B;BMPR1B;MGAT1;B4GALT5;SERP1;ST8SIA3;GCNT1
prerank,GO_Biological_Process_2021__aorta morphogenesis (GO:0035909),0.4609865747777042,0.7624038561838424,0.7704918032786885,1.0,1.0,5/7,33.13%,RBPJ;MYLK;PROX1;LRP1;BMPR1A
prerank,GO_Biological_Process_2021__regulation of nervous system development (GO:0051960),0.4322427870289019,0.7623291950902927,0.8148148148148148,1.0,1.0,5/22,12.72%,HMGB2;PTPRZ1;BHLHE40;PTN;TNFRSF1B
prerank,GO_Biological_Process_2021__cellular protein complex disassembly (GO:0043624),-0.4569674448437561,-0.7620438462716742,0.7575757575757576,1.0,1.0,2/5,25.48%,VPS4B;APEH
prerank,GO_Biological_Process_2021__regulation of mRNA 3'-end processing (GO:0031440),-0.41836893236073985,-0.7619733089164863,0.7419354838709677,1.0,1.0,1/10,5.87%,LEO1
prerank,GO_Biological_Process_2021__positive regulation of GTPase activity (GO:0043547),0.3543436429157838,0.7618419369726109,0.8958333333333334,1.0,1.0,25/135,22.63%,RAP1GAP;TBC1D8;RGS1;TBC1D13;SIPA1L1;NGEF;RAPGEF3;NTRK3;TBC1D15;GPR65;APC2;PLXNB1;RASGRF1;PICALM;THY1;PKP4;EZH2;ECT2;TBC1D2;CCDC125;CX3CL1;TBC1D14;GNB5;ARHGAP42;GARNL3
prerank,GO_Biological_Process_2021__mRNA transcription by RNA polymerase II (GO:0042789),0.5130458827819486,0.76168429765287,0.8450704225352113,1.0,1.0,1/6,10.42%,C5AR1
prerank,GO_Biological_Process_2021__glucan catabolic process (GO:0009251),-0.39282045500255003,-0.7615490531788189,0.8,1.0,1.0,1/12,1.12%,PGM2
prerank,GO_Biological_Process_2021__negative regulation of neural precursor cell proliferation (GO:2000178),0.5045602418424183,0.7615180582304374,0.7575757575757576,1.0,1.0,2/6,15.06%,PTN;WNT5A
prerank,GO_Biological_Process_2021__positive regulation of type 2 immune response (GO:0002830),0.45349423021529034,0.7613469551427026,0.8055555555555556,1.0,1.0,4/9,30.20%,NOD2;IL18;RSAD2;CD86
prerank,GO_Biological_Process_2021__porphyrin-containing compound catabolic process (GO:0006787),-0.45380735050083165,-0.7611065740260385,0.7096774193548387,1.0,1.0,3/6,12.44%,ABCG2;SLCO2B1;HMOX2
prerank,GO_Biological_Process_2021__heme catabolic process (GO:0042167),-0.45380735050083165,-0.7611065740260385,0.7096774193548387,1.0,1.0,3/6,12.44%,ABCG2;SLCO2B1;HMOX2
prerank,GO_Biological_Process_2021__cellular response to ATP (GO:0071318),0.4568623173305091,0.7610838883173559,0.76,1.0,1.0,2/8,21.46%,RYR3;HSP90B1
prerank,PanglaoDB_Augmented_2021__Hepatoblasts,0.4516595531031618,0.7609034239073931,0.8148148148148148,1.0,1.0,4/14,7.48%,TOM1L1;ADGRG6;BAIAP2L1;PKP2
prerank,GO_Biological_Process_2021__negative regulation of mononuclear cell migration (GO:0071676),0.4356933534425155,0.7607408106985226,0.765625,1.0,1.0,4/8,31.67%,PLCB1;SLAMF8;MIA3;DUSP1
prerank,GO_Biological_Process_2021__ruffle assembly (GO:0097178),0.5064845417972255,0.7600189035679898,0.8245614035087719,1.0,1.0,1/5,3.86%,ARF6
prerank,GO_Biological_Process_2021__negative regulation of mast cell activation involved in immune response (GO:0033007),-0.48299274422946664,-0.7598502300756115,0.7428571428571429,1.0,1.0,1/5,3.60%,LGALS9
prerank,GO_Biological_Process_2021__regulation of interleukin-10 production (GO:0032653),0.4039832912649475,0.7597569375966549,0.8441558441558441,1.0,1.0,6/24,19.50%,FCGR2B;PDCD1LG2;NOD2;PYCARD;HSPD1;TNFRSF21
prerank,GO_Biological_Process_2021__regulation of Cdc42 protein signal transduction (GO:0032489),0.5024575295010435,0.7592508753096315,0.8529411764705882,1.0,1.0,1/6,9.03%,ABCA1
prerank,GO_Biological_Process_2021__positive regulation of immunoglobulin mediated immune response (GO:0002891),0.477028461476492,0.7592277825375268,0.8108108108108109,1.0,1.0,1/11,3.57%,TFRC
prerank,GO_Biological_Process_2021__polyamine metabolic process (GO:0006595),-0.3796092624274953,-0.7591608239539926,0.8387096774193549,1.0,1.0,3/10,14.72%,SMOX;SMS;HDAC10
prerank,GO_Biological_Process_2021__GTP metabolic process (GO:0046039),0.4527588384885841,0.7583528712120475,0.8333333333333334,1.0,1.0,4/12,31.90%,LRRK2;IMPDH1;OPA1;GTPBP1
prerank,GO_Biological_Process_2021__positive regulation of stem cell proliferation (GO:2000648),0.47409475868461476,0.7581759620383253,0.8153846153846154,1.0,1.0,2/9,21.86%,KDM1A;HNRNPU
prerank,GO_Biological_Process_2021__iron ion transmembrane transport (GO:0034755),0.4814901215008143,0.7581530549995035,0.8028169014084507,1.0,1.0,5/8,31.83%,SLC25A28;SLC39A14;SLC11A2;SLC25A37;SLC39A8
prerank,GO_Biological_Process_2021__RNA transport (GO:0050658),-0.26621448400054787,-0.7581325759609241,1.0,1.0,1.0,13/57,16.47%,SIDT1;DHX38;NUP155;CHTOP;THOC5;NUP188;NUP214;DDX39A;RAE1;SLU7;ZFP36;THOC7;POLDIP3
prerank,GO_Biological_Process_2021__anion transmembrane transport (GO:0098656),0.37663614091491643,0.7578746344187639,0.8369565217391305,1.0,1.0,9/42,21.00%,SLC1A2;SLC13A4;SLC13A3;SLC35A1;SFXN3;SLC25A21;SLC25A4;SLC3A2;SLC5A6
prerank,GO_Biological_Process_2021__DNA replication checkpoint signaling (GO:0000076),0.45336537405718114,0.7574692596298112,0.8055555555555556,1.0,1.0,2/10,8.41%,CLSPN;DNA2
prerank,GO_Biological_Process_2021__peptidyl-tyrosine modification (GO:0018212),0.3874240106856894,0.7573985633869259,0.8941176470588236,1.0,1.0,9/39,20.85%,RELN;INSR;EPHA3;FGR;FLT1;EPHA4;TEC;FES;FGFR2
prerank,GO_Biological_Process_2021__histone H3-K4 methylation (GO:0051568),0.4062242152033393,0.757324010443978,0.8148148148148148,1.0,1.0,1/21,2.35%,WDR5
prerank,GO_Biological_Process_2021__organic anion transport (GO:0015711),0.39161096618107516,0.7572038354424387,0.85,1.0,1.0,5/32,11.75%,SLCO1A2;SLC4A10;CA2;SLCO3A1;SLC35A1
prerank,GO_Biological_Process_2021__negative regulation of extracellular matrix organization (GO:1903054),0.498594506482264,0.7568505248091641,0.8484848484848485,1.0,1.0,2/5,17.86%,TNFRSF1B;TNFRSF1A
prerank,GO_Biological_Process_2021__negative regulation of ion transport (GO:0043271),0.4324086366772627,0.7567844305866736,0.8026315789473685,1.0,1.0,3/16,8.90%,GPM6B;CAV3;PXK
prerank,GO_Biological_Process_2021__sensory organ morphogenesis (GO:0090596),-0.4709160254993857,-0.7566432054926798,0.7878787878787878,1.0,1.0,2/6,11.73%,COL5A1;SKI
prerank,GO_Biological_Process_2021__intracellular estrogen receptor signaling pathway (GO:0030520),-0.37697651327604814,-0.7562867809897313,0.64,1.0,1.0,1/13,1.16%,NCOA4
prerank,GO_Biological_Process_2021__phosphatidylglycerol metabolic process (GO:0046471),0.46122084049683265,0.7559935349551933,0.918918918918919,1.0,1.0,8/13,34.16%,PNPLA8;CDS2;LPCAT4;PGS1;LPGAT1;LPCAT1;ABCA3;PLA2G4A
prerank,GO_Biological_Process_2021__endodermal cell differentiation (GO:0035987),0.42032737533724307,0.7558673173810468,0.8157894736842105,1.0,1.0,3/17,8.46%,COL11A1;LAMB1;FN1
prerank,GO_Biological_Process_2021__positive regulation of mitotic cell cycle phase transition (GO:1901992),0.38229779339809244,0.7556728528334513,0.7831325301204819,1.0,1.0,2/41,3.87%,DTL;ANXA1
prerank,GO_Biological_Process_2021__regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902229),0.4482882364180646,0.7554316274965006,0.7777777777777778,1.0,1.0,1/9,3.52%,TMEM161A
prerank,"GO_Biological_Process_2021__regulation of CD8-positive, alpha-beta T cell activation (GO:2001185)",-0.44544306856122906,-0.7551823129093459,0.7586206896551724,1.0,1.0,2/8,9.22%,CD274;HLA-E
prerank,GO_Biological_Process_2021__cellular response to drug (GO:0035690),0.4242550035722154,0.7549669738198403,0.7654320987654321,1.0,1.0,5/17,14.69%,TFRC;PDE4B;FBP1;PPM1E;AIM2
prerank,GO_Biological_Process_2021__positive regulation of immunoglobulin production (GO:0002639),0.41595108450743756,0.7547820211465457,0.8311688311688312,1.0,1.0,4/20,20.15%,TFRC;GPI;DNAJB9;KMT5C
prerank,GO_Biological_Process_2021__mitotic nuclear division (GO:0140014),0.3652932762446858,0.7546580431217886,0.8522727272727273,1.0,1.0,8/50,15.04%,KNSTRN;SMC4;MAP9;CLASP2;SPAST;CENPK;KIF11;TOGARAM1
prerank,GO_Biological_Process_2021__positive regulation of vascular permeability (GO:0043117),0.49717705700813,0.7546094848095202,0.8135593220338984,1.0,1.0,2/6,9.87%,VEGFA;PDE2A
prerank,GO_Biological_Process_2021__negative regulation of cell-cell adhesion (GO:0022408),0.40417628801895666,0.7544510496106199,0.7951807228915663,1.0,1.0,2/23,5.04%,KLF4;VEGFA
prerank,GO_Biological_Process_2021__epithelial cell-cell adhesion (GO:0090136),-0.4557214401263052,-0.7540646476682688,0.7666666666666667,1.0,1.0,1/7,5.54%,ITGB5
prerank,GO_Biological_Process_2021__regulation of cytoplasmic translation (GO:2000765),0.43920307457220387,0.7540394374778684,0.8,1.0,1.0,5/11,32.04%,PKM;CPEB2;CPEB4;YBX3;DHX9
prerank,GO_Biological_Process_2021__depyrimidination (GO:0045008),0.48633244065720954,0.7531935055326978,0.7846153846153846,1.0,1.0,3/6,17.69%,TDG;NEIL1;NEIL2
prerank,GO_Biological_Process_2021__protein autoprocessing (GO:0016540),0.4545011275213544,0.7529224937208243,0.8289473684210527,1.0,1.0,1/10,3.42%,MYRF
prerank,GO_Biological_Process_2021__regulation of leukocyte degranulation (GO:0043300),0.5100687485032787,0.7528719138936106,0.8507462686567164,1.0,1.0,2/7,18.43%,STXBP2;FES
prerank,GO_Biological_Process_2021__nucleotide-excision repair (GO:0006289),0.3588064784535832,0.752799728691703,0.8645833333333334,1.0,1.0,21/88,23.73%,BRIP1;ERCC2;RPA2;COPS5;RPS27A;RBX1;FAN1;RFC4;GTF2H3;POLR2D;POLL;ERCC6;UVSSA;UBA52;UBB;RFC1;DDB1;POLR2G;RPA3;GPS1;SLX4
prerank,GO_Biological_Process_2021__actomyosin structure organization (GO:0031032),0.3931190526223116,0.752340971436819,0.8777777777777778,1.0,1.0,17/46,27.32%,CIT;FRMD5;SORBS1;FAM171A1;PHACTR1;EPB41L4B;ROCK1;EPB41L5;CSRP1;FHOD3;CDC42BPA;TJP1;EPB41L3;TNFAIP1;KCTD13;TTN;FRMD3
prerank,GO_Biological_Process_2021__nuclear RNA surveillance (GO:0071027),-0.4760923425458995,-0.7522084900073224,0.717948717948718,1.0,1.0,4/6,26.07%,EXOSC10;EXOSC9;EXOSC8;XRN1
prerank,GO_Biological_Process_2021__tail-anchored membrane protein insertion into ER membrane (GO:0071816),0.4503842649242015,0.7517433284996718,0.8607594936708861,1.0,1.0,6/11,31.16%,EMC7;CAMLG;EMC10;BAG6;EMC8;EMC3
prerank,GO_Biological_Process_2021__negative regulation of vascular endothelial growth factor signaling pathway (GO:1900747),0.5079676633684933,0.7517370450703014,0.7910447761194029,1.0,1.0,1/5,6.68%,SEMA6A
prerank,GO_Biological_Process_2021__regulation of cilium assembly (GO:1902017),0.36599948173566993,0.7516912698608339,0.8588235294117647,1.0,1.0,12/50,25.80%,TBC1D8;TBC1D13;DYNC2LI1;TCHP;TBC1D15;ODF2L;TBC1D2;ATG5;TBC1D14;CDK10;LIMK2;CCP110
prerank,GO_Biological_Process_2021__regulation of establishment of cell polarity (GO:2000114),0.43416351661693436,0.751488341502664,0.8472222222222222,1.0,1.0,4/14,25.86%,KANK1;ROCK1;RUFY3;PTK2B
prerank,GO_Biological_Process_2021__proton-transporting ATP synthase complex assembly (GO:0043461),-0.5106278547599716,-0.7509475362657863,0.8333333333333334,1.0,1.0,1/5,4.55%,ATPAF2
prerank,GO_Biological_Process_2021__protein heterooligomerization (GO:0051291),0.4299263128933777,0.7508981595452803,0.8148148148148148,1.0,1.0,4/15,14.52%,MAT2A;TMEM120B;PKD1;GRIN2B
prerank,GO_Biological_Process_2021__negative regulation of potassium ion transport (GO:0043267),0.46906911632123693,0.7506185374935603,0.8309859154929577,1.0,1.0,1/7,8.38%,CAV3
prerank,GO_Biological_Process_2021__regulation of protein localization to plasma membrane (GO:1903076),0.3631173875180478,0.7503668919852008,0.9010989010989011,1.0,1.0,5/57,6.80%,PRKCE;CLIP3;ARF6;PPP2R5A;EPHA3
prerank,GO_Biological_Process_2021__positive regulation of interleukin-2 production (GO:0032743),0.3983883285266439,0.7503651758869575,0.8181818181818182,1.0,1.0,3/22,10.68%,ANXA1;TRAF2;PDE4B
prerank,GO_Biological_Process_2021__regulation of centriole replication (GO:0046599),0.4546290568624458,0.7498550989949818,0.75,1.0,1.0,3/13,20.61%,PLK2;BRCA1;C10ORF90
prerank,GO_Biological_Process_2021__neuron maturation (GO:0042551),0.4357931807596698,0.749655332908726,0.8421052631578947,1.0,1.0,6/14,25.11%,B4GALT5;APP;CX3CL1;MTCH1;ADGRB3;B4GALT6
prerank,GO_Biological_Process_2021__negative regulation of nitrogen compound metabolic process (GO:0051172),0.508205867457498,0.7495414304179138,0.8157894736842105,1.0,1.0,3/7,26.32%,ABCA2;LILRB2;HSP90AB1
prerank,GO_Biological_Process_2021__positive regulation of response to DNA damage stimulus (GO:2001022),0.3919323535846426,0.7488139170647898,0.8674698795180723,1.0,1.0,8/36,24.63%,TMEM161A;EYA2;BRCA1;NSMCE1;ERCC6;NPAS2;NACC2;BCLAF1
prerank,GO_Biological_Process_2021__regulation of clathrin-dependent endocytosis (GO:2000369),-0.32272315287053366,-0.747940477092102,0.8857142857142857,1.0,1.0,4/13,17.60%,SCYL2;UBQLN2;DAB2;DGKD
prerank,GO_Biological_Process_2021__positive regulation of actin cytoskeleton reorganization (GO:2000251),0.4391085259646148,0.7478534092052534,0.881578947368421,1.0,1.0,4/12,18.43%,BAIAP2L1;NTRK3;HCLS1;FES
prerank,GO_Biological_Process_2021__dicarboxylic acid transport (GO:0006835),0.43109079752920465,0.7475686447359252,0.8214285714285714,1.0,1.0,2/14,6.67%,SLC1A2;SLC13A3
prerank,GO_Biological_Process_2021__pentose-phosphate shunt (GO:0006098),-0.3897295537981841,-0.7474828859682376,0.8709677419354839,1.0,1.0,2/10,4.41%,PGM2;RPIA
prerank,GO_Biological_Process_2021__regulation of cell projection organization (GO:0031344),0.4237544790239982,0.7474344170127294,0.7424242424242424,1.0,1.0,3/10,18.70%,ERMN;MFSD2A;NTNG1
prerank,GO_Biological_Process_2021__epithelial cell migration (GO:0010631),0.4120288780679548,0.7472514877332155,0.7837837837837838,1.0,1.0,5/22,21.83%,ANLN;KANK1;ROCK1;STARD13;STAT1
prerank,GO_Biological_Process_2021__negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),0.35746386588520973,0.7470781447074901,0.8888888888888888,1.0,1.0,9/56,17.54%,THBS1;TRAF2;EYA2;FAIM2;MCL1;BRCA1;ITGAV;HSPA1B;GSTP1
prerank,GO_Biological_Process_2021__positive regulation of gene silencing by miRNA (GO:2000637),-0.32051822341299696,-0.7468946802835461,0.9629629629629629,1.0,1.0,6/21,19.65%,TP53;TGFB1;EGFR;ZFP36;DDX5;FMR1
prerank,GO_Biological_Process_2021__cellular response to interleukin-18 (GO:0071351),-0.4558445082988183,-0.7465335019642771,0.7555555555555555,1.0,1.0,3/5,14.21%,ALOX5;IL18R1;AKT1
prerank,GO_Biological_Process_2021__interleukin-18-mediated signaling pathway (GO:0035655),-0.4558445082988183,-0.7465335019642771,0.7555555555555555,1.0,1.0,3/5,14.21%,ALOX5;IL18R1;AKT1
prerank,GO_Biological_Process_2021__response to angiotensin (GO:1990776),0.49308005610065175,0.7462909394135738,0.8611111111111112,1.0,1.0,1/6,17.16%,ROCK1
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)",0.41181965372696094,0.7462430778760819,0.9101123595505618,1.0,1.0,11/28,23.25%,ERCC2;RPA2;RPS27A;RBX1;RFC4;GTF2H3;UBA52;UBB;RFC1;DDB1;RPA3
prerank,GO_Biological_Process_2021__extracellular matrix disassembly (GO:0022617),0.3865274590057545,0.7459973328316866,0.8372093023255814,1.0,1.0,2/27,4.57%,SH3PXD2B;ADAM15
prerank,GO_Biological_Process_2021__cellular response to transforming growth factor beta stimulus (GO:0071560),0.3554550747375464,0.7454185714183944,0.8295454545454546,1.0,1.0,13/71,19.68%,TGFB2;PTPRK;OVOL2;RPS27A;PDE2A;SOX6;PARD3;WNT5A;SMAD1;UBA52;UBB;FOS;SMAD5
prerank,GO_Biological_Process_2021__membrane fusion involved in viral entry into host cell (GO:0039663),-0.4270032930845225,-0.7451710585627801,0.8157894736842105,1.0,1.0,6/6,57.33%,CD4;NECTIN2;GAS6;PPIA;CXCR4;CTSL
prerank,GO_Biological_Process_2021__fusion of virus membrane with host plasma membrane (GO:0019064),-0.4270032930845225,-0.7451710585627801,0.8157894736842105,1.0,1.0,6/6,57.33%,CD4;NECTIN2;GAS6;PPIA;CXCR4;CTSL
prerank,GO_Biological_Process_2021__Fc-gamma receptor signaling pathway (GO:0038094),0.36870288092536124,0.744853927322494,0.8631578947368421,1.0,1.0,5/65,9.71%,PRKCE;DOCK1;FCGR2B;MYO10;FGR
prerank,GO_Biological_Process_2021__cellular hypotonic response (GO:0071476),-0.4711137694086377,-0.7443147929486361,0.7777777777777778,1.0,1.0,4/5,25.89%,TRPV4;CAB39;SLC12A6;STK39
prerank,GO_Biological_Process_2021__positive regulation of cellular catabolic process (GO:0031331),0.35061848540397605,0.7442313551643377,0.9381443298969072,1.0,1.0,22/98,21.38%,INSR;DAPK1;HIF1A;VPS11;TRIM5;IRS2;PLK2;SH3D19;PFKFB4;TNFRSF1B;BNIP3;ROCK1;NPRL2;APP;PRKAA2;ZC3HAV1;PPARA;TRIM65;TNF;LRRK2;TRIM14;RDX
prerank,GO_Biological_Process_2021__positive regulation of interleukin-6 production (GO:0032755),-0.28316613748645963,-0.7436381373273445,1.0,1.0,1.0,16/47,15.45%,IL1B;IL1A;LGALS9;SCIMP;TMEM106A;MAPK13;TLR3;IL17RA;LPL;TLR7;TYROBP;SYK;BCL10;IL6R;LILRA2;TIRAP
prerank,GO_Biological_Process_2021__negative regulation of response to DNA damage stimulus (GO:2001021),0.43453508318922873,0.7435833350730146,0.8552631578947368,1.0,1.0,2/18,9.50%,TMEM161A;KDM1A
prerank,GO_Biological_Process_2021__positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081),-0.3793914028037577,-0.7434776999587093,0.8095238095238095,1.0,1.0,1/13,0.93%,TICAM1
prerank,GO_Biological_Process_2021__positive regulation of embryonic development (GO:0040019),0.44866693898838284,0.7432259840439538,0.75,1.0,1.0,4/7,16.96%,B4GALT5;CFL1;NR2C2;PLCB1
prerank,GO_Biological_Process_2021__regulation of JNK cascade (GO:0046328),0.358550763820655,0.7431924068732497,0.845360824742268,1.0,1.0,18/74,19.42%,SEMA3A;GADD45B;PHLPP1;TRAF2;FCGR2B;COPS5;IGF1R;PER1;NOD2;PINK1;PYCARD;SDCBP;DUSP10;AIDA;PLCB1;APP;ANKRD6;MAPK8IP2
prerank,GO_Biological_Process_2021__Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),0.36925658525593213,0.7423884250578807,0.8723404255319149,1.0,1.0,5/64,9.71%,PRKCE;DOCK1;FCGR2B;MYO10;FGR
prerank,GO_Biological_Process_2021__organic cation transport (GO:0015695),0.4322648289098996,0.7423273424374885,0.8225806451612904,1.0,1.0,3/9,26.90%,SLC44A1;SLC25A26;SEC14L1
prerank,GO_Biological_Process_2021__negative regulation of phagocytosis (GO:0050765),-0.35375296531012357,-0.7421862563682176,0.6923076923076923,1.0,1.0,2/14,6.41%,CD300LF;SIRPA
prerank,GO_Biological_Process_2021__negative regulation of organelle assembly (GO:1902116),0.3780011034718305,0.7421722716733277,0.7727272727272727,1.0,1.0,11/29,25.80%,CAV3;TCHP;TMEM39A;BRCA1;PINK1;ODF2L;LRRK2;CDK10;LIMK2;MTM1;CCP110
prerank,GO_Biological_Process_2021__post-transcriptional gene silencing by RNA (GO:0035194),0.4062911799907504,0.742120694522988,0.8513513513513513,1.0,1.0,5/17,30.08%,LIMD1;CNOT6;CNOT7;AGO4;CNOT8
prerank,GO_Biological_Process_2021__negative regulation of cellular senescence (GO:2000773),-0.43243567904434527,-0.7420836135848666,0.7333333333333333,1.0,1.0,3/9,21.37%,ZKSCAN3;TERF2;SLC30A10
prerank,GO_Biological_Process_2021__positive regulation of ERAD pathway (GO:1904294),0.43737577022648394,0.7419198590988426,0.855072463768116,1.0,1.0,3/11,26.55%,HERPUD1;RNFT1;BAG6
prerank,GO_Biological_Process_2021__mitochondrial genome maintenance (GO:0000002),0.4436554818694384,0.7410366231178882,0.8441558441558441,1.0,1.0,5/12,29.56%,SLC25A4;OPA1;TOP3A;TYMP;SLC25A36
prerank,GO_Biological_Process_2021__negative regulation of interleukin-1 production (GO:0032692),0.40262079127589323,0.7407513445199537,0.8157894736842105,1.0,1.0,1/17,1.30%,NLRP12
prerank,GO_Biological_Process_2021__transcription-coupled nucleotide-excision repair (GO:0006283),0.3699047341339814,0.7406010889029794,0.8494623655913979,1.0,1.0,17/61,23.67%,ERCC2;RPA2;COPS5;RPS27A;RBX1;RFC4;GTF2H3;POLR2D;ERCC6;UVSSA;UBA52;UBB;RFC1;DDB1;POLR2G;RPA3;GPS1
prerank,GO_Biological_Process_2021__negative regulation of macroautophagy (GO:0016242),0.38174881923937454,0.7404202466174057,0.7804878048780488,1.0,1.0,9/23,33.36%,TMEM39A;PINK1;NRBP2;LRRK2;MTM1;UBQLN4;PIK3CA;FEZ1;CHMP4B
prerank,"GO_Biological_Process_2021__positive regulation of transcription, DNA-templated (GO:0045893)",0.33713612860287895,0.7402282310873813,1.0,1.0,1.0,114/739,20.58%,KLF4;NAMPT;NFIL3;MACC1;FGF1;ST18;EGR1;HMGB2;PLAC8;PFKM;NFIX;ZBTB16;CREB5;MYRF;NR4A2;AGT;NFIB;NR4A1;MEIS2;SLC11A1;ACVR2A;BMPR1B;ASXL3;RORB;VEGFA;SOX4;IER5;RXRB;EIF2AK3;COPS5;HIF1A;KDM3A;HSF2;HCFC1;CSRNP3;ARNT2;RUVBL2;PAX8;FOSL2;MAFB;ID2;SS18L1;ATAD2;RBPJ;RRP1B;RPS27A;KDM1A;POU5F1;PTOV1;PER1;CRTC3;NR2F1;NOD2;ING1;GABPB1;DCAF6;DEAF1;HCLS1;ETS2;HINFP;CCNC;CSRNP2;RIPK2;NR4A3;BRCA1;DRAP1;TRIM16;YAF2;ZNF143;PKD1;E2F7;DPF3;PICALM;WNT5A;SMARCD3;ESR1;AKIRIN1;DHX33;IL18;NR2C2;LDB2;TBL1XR1;EPAS1;LITAF;TXK;CXXC1;PLCB1;SMAD1;PCBD2;TFAM;APP;KLF7;RGCC;ERCC6;ZBTB18;TNFRSF1A;UBA52;ESRRG;SMARCC1;UBB;CDK9;PPARA;TAF7;FOS;PRDM15;SMAD5;PRPF6;KDM6B;PCGF5;BEX1;TNF;NR1D1;NPAS2;TCF4
prerank,GO_Biological_Process_2021__mast cell mediated immunity (GO:0002448),-0.42138914374502606,-0.7401138313785754,0.8387096774193549,1.0,1.0,2/6,8.88%,MILR1;SERPINB9
prerank,GO_Biological_Process_2021__regulation of skeletal muscle tissue development (GO:0048641),-0.4510323578854366,-0.7398666443980881,0.6944444444444444,1.0,1.0,1/5,7.51%,TGFB1
prerank,GO_Biological_Process_2021__regulation of neutrophil migration (GO:1902622),-0.3910078048293715,-0.7395149542749853,0.75,1.0,1.0,2/8,9.42%,RHOG;NCKAP1L
prerank,GO_Biological_Process_2021__positive regulation of acute inflammatory response (GO:0002675),0.4976324518428929,0.7392866203971403,0.7605633802816901,1.0,1.0,1/5,3.65%,OSMR
prerank,GO_Biological_Process_2021__endoplasmic reticulum calcium ion homeostasis (GO:0032469),0.39395417643333475,0.7384806462220138,0.8,1.0,1.0,2/17,15.68%,HERPUD1;ATP2A2
prerank,GO_Biological_Process_2021__macroautophagy (GO:0016236),-0.25062695301335086,-0.7384786896268947,1.0,1.0,1.0,18/97,16.04%,ZFYVE1;STAM2;RUBCNL;MTMR14;PIP4K2B;PLEKHM1;VTA1;SRC;VPS37B;WIPI1;CHMP2B;ILRUN;ATG12;TECPR1;VDAC1;HDAC10;VTI1B;BECN1
prerank,GO_Biological_Process_2021__regulation of histamine secretion by mast cell (GO:1903593),0.501864926201152,0.738222347623028,0.8461538461538461,1.0,1.0,4/5,48.22%,VAMP7;VAMP3;SNX4;VAMP8
prerank,GO_Biological_Process_2021__recombinational repair (GO:0000725),0.36677602033843487,0.7377992380062346,0.8791208791208791,1.0,1.0,17/56,25.89%,RPA2;POLQ;BRCA1;XRCC3;NSMCE1;FAN1;POLL;SWI5;RBBP8;RNF138;SFPQ;RPA3;SLX4;PSMD14;RAD54B;SPIDR;REV3L
prerank,GO_Biological_Process_2021__regulation of protein catabolic process (GO:0042176),0.3603186263425168,0.7377468005682575,0.9368421052631579,1.0,1.0,16/75,22.36%,DTL;EEF1A2;GFAP;FMN2;PLK2;NSF;APC2;WNT5A;HECW2;TNF;CDKN1B;IRAK3;DDB1;EEF1A1;HACE1;BARD1
prerank,GO_Biological_Process_2021__negative regulation of protein modification by small protein conjugation or removal (GO:1903321),0.383061671102223,0.7373407807575061,0.8888888888888888,1.0,1.0,7/39,21.98%,SOX4;CAMLG;COPS9;RPL11;HSPA1B;GTPBP4;CHP1
prerank,GO_Biological_Process_2021__protein localization to plasma membrane (GO:0072659),0.3455484912830914,0.7372359787642341,0.9042553191489362,1.0,1.0,22/101,21.58%,CACNB2;SCN3B;RAB3C;ANK3;ANK2;PKP2;FCHO2;RAB15;CAV3;CLASP2;MAP7;ATP1B3;KCNIP4;SPTBN1;ROCK1;DPP6;KCNB2;TNFRSF1A;SPTBN4;TNF;RDX;FLOT2
prerank,GO_Biological_Process_2021__chromatin organization (GO:0006325),0.3450969657208064,0.7369237302073993,0.8913043478260869,1.0,1.0,21/98,27.78%,HMGB2;SUV39H2;HCFC1;RUVBL2;TCF7L1;FAM50A;KDM4B;SMARCD3;ESR1;SMARCC1;EZH2;KDM5B;KDM6B;BRWD1;SMARCD2;SATB2;SMARCA5;JARID2;TAF6L;SETDB2;KDM6A
prerank,GO_Biological_Process_2021__positive regulation of calcium ion transport (GO:0051928),0.39511535232371353,0.7362813182537133,0.8571428571428571,1.0,1.0,2/22,6.41%,CACNB2;ANK2
prerank,GO_Biological_Process_2021__positive regulation of lyase activity (GO:0051349),-0.4295901273906546,-0.7362540626036722,0.84375,1.0,1.0,2/7,15.01%,STIM1;CACNA1D
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle cell proliferation (GO:1904705),0.38258118193633683,0.7357413487355962,0.7625,1.0,1.0,11/25,33.13%,NR4A3;SOD2;CDKN1B;MFN2;PDCD4;JUN;PTEN;PRKG1;MEF2D;GJA1;BMPR1A
prerank,GO_Biological_Process_2021__positive regulation of epithelial to mesenchymal transition (GO:0010718),0.39293446187038195,0.7356322084261215,0.8414634146341463,1.0,1.0,2/27,3.45%,TGFB2;GLIPR2
prerank,GO_Biological_Process_2021__negative regulation of protein binding (GO:0032091),0.35085217863570617,0.7351593243101371,0.8876404494382022,1.0,1.0,12/56,22.43%,TTBK2;ADAM15;MAP2;KDM1A;TFIP11;DNAJB2;IFIT2;ATP2A2;ROCK1;LRRK2;CTNNBIP1;HFE
prerank,GO_Biological_Process_2021__positive regulation of proteolysis (GO:0045862),0.398855678478521,0.7351250121206749,0.9176470588235294,1.0,1.0,7/30,21.55%,SH3D19;TNFRSF1B;PINK1;ASPH;TNF;TNIP1;ATP5IF1
prerank,GO_Biological_Process_2021__regulation of transferase activity (GO:0051338),-0.3516617557085149,-0.7351104087352084,0.8888888888888888,1.0,1.0,5/13,16.02%,PPP1R3F;BAG5;SMG6;FEM1A;EMP2
prerank,GO_Biological_Process_2021__negative regulation of cation transmembrane transport (GO:1904063),0.4447648861017992,0.7351080702433781,0.863013698630137,1.0,1.0,3/11,20.66%,CAV3;HAMP;ATP1A2
prerank,GO_Biological_Process_2021__protein localization to cell periphery (GO:1990778),0.340052886850579,0.7349622195948851,0.875,1.0,1.0,22/103,21.58%,CACNB2;SCN3B;RAB3C;ANK3;ANK2;PKP2;FCHO2;RAB15;CAV3;CLASP2;MAP7;ATP1B3;KCNIP4;SPTBN1;ROCK1;DPP6;KCNB2;TNFRSF1A;SPTBN4;TNF;RDX;FLOT2
prerank,GO_Biological_Process_2021__heart process (GO:0003015),0.4706146286549041,0.7349300251711619,0.7910447761194029,1.0,1.0,3/6,18.25%,SGCZ;SGCD;SOD1
prerank,GO_Biological_Process_2021__regulation of G protein-coupled receptor signaling pathway (GO:0008277),0.3725985196492167,0.7347484247920187,0.9080459770114943,1.0,1.0,11/51,17.63%,RGS20;KCTD8;RGS2;SYP;TULP3;RGS11;RASGRP4;PLCB1;GRK4;ROCK1;SLC39A14
prerank,GO_Biological_Process_2021__Golgi disassembly (GO:0090166),-0.4290726798310807,-0.7347386010544592,0.7647058823529411,1.0,1.0,2/5,15.67%,PLK3;STX5
prerank,GO_Biological_Process_2021__regulation of cytokine production involved in immune response (GO:0002718),0.44295456677636896,0.7346913159181934,0.8243243243243243,1.0,1.0,4/12,20.20%,NOD2;TNFRSF1B;WNT5A;TNF
prerank,GO_Biological_Process_2021__positive regulation of protein catabolic process (GO:0045732),0.37558600795026775,0.7346028441256819,0.875,1.0,1.0,15/61,22.36%,DTL;VPS11;PLK2;SH3D19;TNFRSF1B;NSF;APC2;WNT5A;HECW2;TNF;CDKN1B;DDB1;RDX;HACE1;BARD1
prerank,GO_Biological_Process_2021__regulation of protein export from nucleus (GO:0046825),-0.33398726660100597,-0.7345234674597649,0.85,1.0,1.0,2/21,6.50%,IL1B;TP53
prerank,GO_Biological_Process_2021__nucleoside phosphate catabolic process (GO:1901292),-0.41275921688015604,-0.7339646443341951,0.7096774193548387,1.0,1.0,4/8,12.62%,ITPA;ENPP1;ENTPD4;ENTPD1
prerank,GO_Biological_Process_2021__snRNA transcription by RNA polymerase III (GO:0042796),0.4498388438934152,0.7338087464551815,0.8260869565217391,1.0,1.0,6/8,42.20%,SNAPC3;ICE2;SNAPC4;ELL;SNAPC1;ICE1
prerank,GO_Biological_Process_2021__spinal cord development (GO:0021510),0.48156268098574767,0.7337182088630759,0.8888888888888888,1.0,1.0,3/7,13.96%,RELN;SOX4;PKD1
prerank,GO_Biological_Process_2021__peptidyl-lysine deacetylation (GO:0034983),0.47366066093952486,0.7336527203790162,0.7945205479452054,1.0,1.0,4/8,34.00%,SIRT3;SIRT4;HDAC9;HDAC4
prerank,"GO_Biological_Process_2021__maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)",0.3873806709679009,0.733558368014114,0.8518518518518519,1.0,1.0,2/24,10.58%,NGDN;RRP36
prerank,GO_Biological_Process_2021__negative regulation of RNA catabolic process (GO:1902369),-0.39333899917802356,-0.7329633713329999,0.7741935483870968,1.0,1.0,1/7,4.31%,PHAX
prerank,GO_Biological_Process_2021__negative regulation of intracellular estrogen receptor signaling pathway (GO:0033147),0.5003459195799091,0.7329402596026023,0.8571428571428571,1.0,1.0,2/7,12.87%,VPS11;BRCA1
prerank,GO_Biological_Process_2021__regulation of transposition (GO:0010528),-0.3994588346431338,-0.7328256930488415,0.8214285714285714,1.0,1.0,2/7,8.54%,APOBEC3G;MYBL1
prerank,GO_Biological_Process_2021__nucleus organization (GO:0006997),0.3766787370639507,0.7326376987594021,0.8928571428571429,1.0,1.0,8/36,24.91%,NUP133;REEP3;SEH1L;SUN2;CHMP5;NDC1;PDCD6IP;CHMP7
prerank,GO_Biological_Process_2021__regulation of proteolysis involved in cellular protein catabolic process (GO:1903050),0.3745659041901037,0.732537804171373,0.8148148148148148,1.0,1.0,7/20,25.86%,EPHA4;PINK1;PKD1;UBB;ATP5IF1;PSMD14;PTK2B
prerank,GO_Biological_Process_2021__regulation of vasculature development (GO:1901342),0.3979950973901082,0.732262707132626,0.8260869565217391,1.0,1.0,1/14,5.36%,GPNMB
prerank,GO_Biological_Process_2021__positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737),0.43606817399918746,0.7319814079338802,0.8552631578947368,1.0,1.0,4/15,17.58%,SPDYA;PKD1;CCND3;RGCC
prerank,GO_Biological_Process_2021__snRNA transcription by RNA polymerase II (GO:0042795),-0.25842438376165977,-0.7316210930250083,1.0,1.0,1.0,17/61,20.22%,GTF2F1;RPRD1B;PHAX;SRRT;TAF13;INTS9;RPAP2;POLR2C;RPRD1A;TAF8;GTF2E2;INTS4;GTF2B;POU2F2;TBP;INTS7;SNAPC5
prerank,GO_Biological_Process_2021__regulation of necroptotic process (GO:0060544),0.40406854805612225,0.7316190083632718,0.85,1.0,1.0,6/18,23.39%,CDC37;SDCBP;PELI1;SLC25A4;FLOT2;PDCD6IP
prerank,GO_Biological_Process_2021__regulation of mast cell degranulation (GO:0043304),0.4362894614016995,0.731273433507884,0.8289473684210527,1.0,1.0,4/13,18.43%,FGR;CD300A;STXBP2;FES
prerank,GO_Biological_Process_2021__positive regulation by symbiont of host autophagy (GO:0075044),-0.4550225314982884,-0.7311370694574915,0.7428571428571429,1.0,1.0,2/6,12.49%,PHB2;EIF2AK4
prerank,GO_Biological_Process_2021__leucine metabolic process (GO:0006551),-0.44824592339596847,-0.7310113806570545,0.8275862068965517,1.0,1.0,3/7,22.13%,IVD;MCCC1;BCAT2
prerank,GO_Biological_Process_2021__nucleotide biosynthetic process (GO:0009165),0.4184283254488835,0.7308591219021385,0.7466666666666667,1.0,1.0,8/15,33.92%,PRPS1;HPRT1;NMNAT2;MTHFD1;ME1;PNP;PPAT;GART
prerank,"GO_Biological_Process_2021__regulation of synaptic transmission, GABAergic (GO:0032228)",-0.42520422788257656,-0.7306558288306317,0.8620689655172413,1.0,1.0,1/8,2.69%,ZDHHC3
prerank,GO_Biological_Process_2021__DNA ligation involved in DNA repair (GO:0051103),-0.43280786951752453,-0.7305670251528175,0.7428571428571429,1.0,1.0,1/5,13.75%,POLB
prerank,GO_Biological_Process_2021__cellular response to nitrogen levels (GO:0043562),0.47100479368321135,0.7305055329121695,0.875,1.0,1.0,4/8,33.99%,NPRL2;ATG5;MAP1LC3A;MAP1LC3B
prerank,GO_Biological_Process_2021__cellular response to nitrogen starvation (GO:0006995),0.47100479368321135,0.7305055329121695,0.875,1.0,1.0,4/8,33.99%,NPRL2;ATG5;MAP1LC3A;MAP1LC3B
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle cell apoptotic process (GO:1905459),0.4552420507692845,0.7304478855030783,0.8382352941176471,1.0,1.0,3/7,22.38%,SOD2;MFN2;PDCD4
prerank,GO_Biological_Process_2021__late endosome to vacuole transport via multivesicular body sorting pathway (GO:0032511),0.4213963800320757,0.7303990109060994,0.7777777777777778,1.0,1.0,6/12,36.26%,TMEM50A;CHMP5;CHMP7;CHMP4B;STAM;SNF8
prerank,GO_Biological_Process_2021__negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),0.35234467177702883,0.7303122603323846,0.8620689655172413,1.0,1.0,12/50,24.06%,FBXL7;FHL1;PSMB4;RBX1;INTS3;PSMC2;PSMA3;PSMB2;PSMD5;PSMD7;PSMD14;PSMA5
prerank,GO_Biological_Process_2021__protein ubiquitination (GO:0016567),0.3236926869010529,0.730257625963176,0.98,1.0,1.0,70/390,24.06%,DTL;MKRN3;H2BC11;FBXL7;UBE2QL1;ENC1;RNF144B;TRAF2;FBXL2;HIF1A;VPS11;TRIM5;RPS27A;TRIM25;ARIH2;RNF144A;PSMB4;RBX1;GAN;HIF3A;RNF126;SASH1;VCPIP1;BRCA1;FBXO27;BLMH;PINK1;RNF139;RLIM;TRIM26;UHRF2;PELI1;DTX3;KLHL8;SYVN1;KLHL2;RNF13;EPAS1;NEURL1;UBE2J2;HECW2;FANCL;UVSSA;FBXL13;UBA52;UBB;PSMC2;FBXL5;LONRF1;ZNRF1;PSMA3;FBXO7;PSMB2;C10ORF90;TRIM14;RNF138;DDB1;PSMD5;TRIM24;PSMD7;HACE1;BARD1;MAGEF1;USP5;UHRF1;UBE2D2;RNFT1;PSMD14;DTX2;PSMA5
prerank,GO_Biological_Process_2021__regulation of biosynthetic process (GO:0009889),0.447777357041948,0.7301134222266126,0.8082191780821918,1.0,1.0,2/7,17.54%,MID1IP1;GSTP1
prerank,GO_Biological_Process_2021__positive regulation of isotype switching (GO:0045830),0.4597113182187098,0.7300154839401204,0.8840579710144928,1.0,1.0,1/11,3.57%,TFRC
prerank,GO_Biological_Process_2021__calcineurin-mediated signaling (GO:0097720),0.4604833333260855,0.729864489064885,0.8493150684931506,1.0,1.0,1/8,8.94%,ADGRB2
prerank,GO_Biological_Process_2021__calcineurin-NFAT signaling cascade (GO:0033173),0.4604833333260855,0.729864489064885,0.8493150684931506,1.0,1.0,1/8,8.94%,ADGRB2
prerank,GO_Biological_Process_2021__negative regulation of lipid kinase activity (GO:0090219),0.4615798828692781,0.7295729038111017,0.8235294117647058,1.0,1.0,2/8,11.92%,PPP2R5A;PIK3IP1
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA incision, 3'-to lesion (GO:0006295)",0.4161679254289343,0.7293141565407354,0.8181818181818182,1.0,1.0,4/18,14.88%,ERCC2;RPA2;RBX1;GTF2H3
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, preincision complex stabilization (GO:0006293)",0.4161679254289343,0.7293141565407354,0.8181818181818182,1.0,1.0,4/18,14.88%,ERCC2;RPA2;RBX1;GTF2H3
prerank,GO_Biological_Process_2021__mRNA destabilization (GO:0061157),-0.3028869124483553,-0.7292312894933035,0.875,1.0,1.0,2/32,4.87%,PDE12;KHSRP
prerank,GO_Biological_Process_2021__cytokine-mediated signaling pathway (GO:0019221),0.3307132618401226,0.7288880857564185,0.98989898989899,1.0,1.0,90/368,24.31%,SOCS3;ST18;PRLR;VIM;IFIT5;EGR1;IL15;TALDO1;OSMR;ANXA1;LIFR;MAP3K8;F13A1;VEGFA;TRAF2;IL7;PTPRZ1;HIF1A;GRB10;TRIM5;FN1;IRS2;TNFRSF11B;RPS27A;MCL1;GHR;TRIM25;IFITM3;LMNB1;NOD2;PSMB4;RBX1;CAMK2B;IFNLR1;RIPK2;CRLF1;TNFRSF1B;IFIT2;SOD2;TRIM26;PYCARD;AIM2;PELI1;CASP3;CFL1;UGCG;IL18;CEBPD;IL11RA;TCP1;GBP2;TEC;PLCB1;BCL6;TNFRSF1A;SOD1;UBA52;UBB;PSMC2;PSMA3;FOS;NCAM1;TNF;PSMB2;IL7R;CDKN1B;LEPR;IRAK3;CX3CL1;P4HB;PSMD5;HSP90B1;BRWD1;STAT1;APPL1;PSMD7;MAP3K3;PDCD4;RHOU;STAT6;STAT2;RORA;FPR1;CASP1;TRADD;PSMD14;PSMA5;FOXO3;TRAF3IP2;IL21R
prerank,GO_Biological_Process_2021__protein localization to chromatin (GO:0071168),0.4035580603271267,0.7288118428468556,0.8783783783783784,1.0,1.0,7/15,30.41%,RUVBL2;ESR1;CHMP7;MACROH2A2;WAPL;MACROH2A1;RAD21
prerank,GO_Biological_Process_2021__cellular macromolecule catabolic process (GO:0044265),0.35502774623300365,0.7286183992235907,0.8791208791208791,1.0,1.0,5/36,16.76%,RNASEH2C;OGA;STT3B;FBXO27;SND1
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059),-0.3068765867017882,-0.728377152352029,0.8333333333333334,1.0,1.0,7/23,16.39%,DAB2IP;TRIB3;MAP3K5;QRICH1;ATP2A3;BCL2;DNAJC10
prerank,GO_Biological_Process_2021__antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844),0.4448870103581983,0.7281518394986113,0.8636363636363636,1.0,1.0,1/11,2.98%,H2BC11
prerank,GO_Biological_Process_2021__regulation of Rab protein signal transduction (GO:0032483),-0.3924681246305835,-0.7280587042558752,0.7948717948717948,1.0,1.0,6/6,60.78%,DENND4C;DENND1A;DENND4A;DENND3;DENND4B;MADD
prerank,GO_Biological_Process_2021__positive regulation of Wnt signaling pathway (GO:0030177),0.33931218597894247,0.7277220028448101,0.9042553191489362,1.0,1.0,25/109,24.95%,DKK2;GPC5;DAAM2;SOX4;KANK1;PTK7;GSKIP;SEMA5A;GPRC5B;PSMB4;SULF2;TBL1XR1;PSMC2;PSMA3;PRDM15;PSMB2;LRRK2;FGFR2;PSMD5;PSMD7;PSMD14;PSMA5;RNF220;DDX3X;GPC3
prerank,GO_Biological_Process_2021__release of cytochrome c from mitochondria (GO:0001836),-0.38460415993532404,-0.7276440734850061,0.7692307692307693,1.0,1.0,4/10,15.49%,BCL2L1;BID;BCL2;FIS1
prerank,GO_Biological_Process_2021__regulation of establishment of protein localization (GO:0070201),-0.3548751824744698,-0.7275440363022406,0.8620689655172413,1.0,1.0,3/11,18.20%,TREM2;SCFD1;CEP290
prerank,GO_Biological_Process_2021__regulation of ERBB signaling pathway (GO:1901184),0.444229406692212,0.7274912097571544,0.8676470588235294,1.0,1.0,1/11,9.26%,RBPJ
prerank,GO_Biological_Process_2021__negative regulation of IRE1-mediated unfolded protein response (GO:1903895),0.5072584680644382,0.7274353521725471,0.8771929824561403,1.0,1.0,2/5,14.62%,HSPA5;DNAJB9
prerank,GO_Biological_Process_2021__establishment of protein localization to organelle (GO:0072594),0.35109543302815427,0.727414799970044,0.8791208791208791,1.0,1.0,9/58,14.53%,ZDHHC15;NUP133;RYR2;PRICKLE1;HEATR3;FAM53C;PINK1;TNPO2;RANBP17
prerank,GO_Biological_Process_2021__mitochondrial translation (GO:0032543),-0.2635391670787125,-0.7272036849357751,1.0,1.0,1.0,11/75,13.60%,MRPL57;MRPS9;MRPL50;MRPL35;TUFM;MRPS11;AURKAIP1;LARS2;FASTKD2;MRPS10;MRPL1
prerank,GO_Biological_Process_2021__spindle assembly (GO:0051225),0.35601083487949897,0.7268932568942912,0.8804347826086957,1.0,1.0,7/55,15.04%,HAUS6;RCC1;MAP9;CLASP2;GOLGA8B;KIF11;TOGARAM1
prerank,GO_Biological_Process_2021__actin cytoskeleton reorganization (GO:0031532),0.36000695463188426,0.7268929453140164,0.8409090909090909,1.0,1.0,9/46,15.66%,ANXA1;SIPA1L1;PTK7;MICALL2;THSD7A;GPR65;THSD7B;GAB1;PHACTR1
prerank,GO_Biological_Process_2021__defense response to bacterium (GO:0042742),0.3521431304632261,0.7267594428659884,0.9318181818181818,1.0,1.0,9/54,17.08%,HMGB2;H2BC11;SLC11A1;GSDMD;FGR;NOD2;PYCARD;GBP2;HAMP
prerank,GO_Biological_Process_2021__regulation of amyloid-beta clearance (GO:1900221),0.4186146921818373,0.7266968056527142,0.8225806451612904,1.0,1.0,4/11,29.50%,ROCK1;TNF;LRPAP1;LRP1
prerank,GO_Biological_Process_2021__regulation of proton transport (GO:0010155),-0.4265257957314464,-0.725715942268106,0.7222222222222222,1.0,1.0,2/6,8.31%,SLC30A5;PHB2
prerank,GO_Biological_Process_2021__apoptotic mitochondrial changes (GO:0008637),0.40656665482601917,0.7256704471132298,0.8518518518518519,1.0,1.0,5/22,18.46%,BOK;IFIT2;SOD2;BNIP3;HSPD1
prerank,GO_Biological_Process_2021__regulation of osteoclast differentiation (GO:0045670),-0.3345951895644952,-0.7256652566222086,0.8421052631578947,1.0,1.0,4/19,12.04%,ZNF675;LILRB4;TLR3;UBASH3B
prerank,GO_Biological_Process_2021__sphingosine-1-phosphate receptor signaling pathway (GO:0003376),-0.4509908130576735,-0.7253764328966272,0.8787878787878788,1.0,1.0,1/5,14.21%,AKT1
prerank,GO_Biological_Process_2021__positive regulation of cellular extravasation (GO:0002693),-0.4122816021945589,-0.7253117943974988,0.8,1.0,1.0,3/7,13.01%,ICAM1;RIPOR2;PLVAP
prerank,MSigDB_Hallmark_2020__Wnt-beta Catenin Signaling,0.39098213089853767,0.7253031057924699,0.8876404494382022,1.0,1.0,3/26,12.76%,TCF7;RBPJ;GNAI1
prerank,GO_Biological_Process_2021__histone deacetylation (GO:0016575),0.3755699376821006,0.7252212449947733,0.8620689655172413,1.0,1.0,9/39,29.62%,PER1;MTA3;TBL1XR1;MORF4L2;SFPQ;SUDS3;MSL3;SMARCAD1;HDAC9
prerank,GO_Biological_Process_2021__bleb assembly (GO:0032060),0.4697593432188024,0.724822743837434,0.8142857142857143,1.0,1.0,3/6,33.42%,PMP22;MYLK;EMP3
prerank,GO_Biological_Process_2021__mitotic spindle assembly (GO:0090307),0.3693592463790255,0.7246725321197952,0.8333333333333334,1.0,1.0,5/29,15.04%,RACGAP1;MAP9;CLASP2;KIF11;TOGARAM1
prerank,GO_Biological_Process_2021__snRNA transcription (GO:0009301),-0.2533793252135721,-0.7245044832109973,1.0,1.0,1.0,6/62,6.35%,GTF2F1;RPRD1B;PHAX;SRRT;TAF13;INTS9
prerank,GO_Biological_Process_2021__mitophagy (GO:0000423),-0.39271828341655685,-0.7241229071762245,0.88,1.0,1.0,3/8,22.47%,PHB2;BECN1;PRKN
prerank,GO_Biological_Process_2021__regulation of natural killer cell mediated cytotoxicity (GO:0042269),0.4268843498993005,0.7240586754922452,0.8311688311688312,1.0,1.0,1/14,2.51%,CADM1
prerank,GO_Biological_Process_2021__ectoderm development (GO:0007398),0.4445518628805807,0.723864142867623,0.8648648648648649,1.0,1.0,1/7,1.74%,AMER2
prerank,GO_Biological_Process_2021__regulation of cyclin-dependent protein kinase activity (GO:1904029),0.3894923175108179,0.7237219234023905,0.8414634146341463,1.0,1.0,8/27,22.30%,CAMK2N1;CCNB3;CDC37;CCND3;GTPBP4;CDK5R1;CDKN1B;CNPPD1
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte proliferation (GO:0050671),0.3749601378023202,0.7236222411002661,0.9069767441860465,1.0,1.0,8/43,15.83%,IL15;TFRC;ANXA1;IL7;IRS2;PDCD1LG2;GPR183;IL18
prerank,"GO_Biological_Process_2021__DNA catabolic process, endonucleolytic (GO:0000737)",0.4140161286623811,0.7236203045763591,0.891566265060241,1.0,1.0,1/18,2.26%,HMGB2
prerank,GO_Biological_Process_2021__regulation of myeloid leukocyte mediated immunity (GO:0002886),0.4753202972795433,0.7230776431006913,0.9054054054054054,1.0,1.0,3/8,26.41%,STXBP2;FES;DNASE1
prerank,GO_Biological_Process_2021__protein tetramerization (GO:0051262),-0.3197494710071358,-0.7229363392994337,0.8888888888888888,1.0,1.0,7/46,8.14%,KRT10;APPL2;ALDH9A1;FARSA;RYR1;KCNC3;SSBP1
prerank,GO_Biological_Process_2021__regulation of chromatin organization (GO:1902275),0.44601793834476045,0.7227861402950018,0.863013698630137,1.0,1.0,5/12,30.15%,CDK9;METTL4;HNRNPU;TLK1;MLLT3
prerank,GO_Biological_Process_2021__positive regulation of protein acetylation (GO:1901985),0.41790163968524696,0.7226834535520278,0.8767123287671232,1.0,1.0,6/11,34.26%,RAPGEF3;PRKAA2;DDX3X;TERF2IP;TAOK1;DIP2B
prerank,GO_Biological_Process_2021__Fc receptor mediated stimulatory signaling pathway (GO:0002431),0.3576309328834151,0.722487898016975,0.9157894736842105,1.0,1.0,6/66,12.83%,PRKCE;DOCK1;FCGR2B;MYO10;FGR;NR4A3
prerank,GO_Biological_Process_2021__negative regulation of cytokine-mediated signaling pathway (GO:0001960),0.37181466437634036,0.7223696131123083,0.9047619047619048,1.0,1.0,7/33,23.75%,H2BC11;ROBO1;CCDC3;GSTP1;IRAK3;STAT2;GPS2
prerank,GO_Biological_Process_2021__poly(A)+ mRNA export from nucleus (GO:0016973),0.429446582978387,0.7222594452577416,0.8518518518518519,1.0,1.0,2/10,14.44%,NUP133;NXF1
prerank,GO_Biological_Process_2021__mRNA splice site selection (GO:0006376),0.39961171003627277,0.7222210282336954,0.8734177215189873,1.0,1.0,4/23,20.98%,SRSF12;CELF2;PRPF39;SRSF5
prerank,GO_Biological_Process_2021__cellular response to cytokine stimulus (GO:0071345),0.3309967482414921,0.7221736373627452,0.9897959183673469,1.0,1.0,65/277,23.36%,SOCS3;PRLR;NLRP12;VIM;EGR1;OSMR;CHI3L1;IL1RAPL1;ANXA1;LIFR;F13A1;VEGFA;TCF7;IL7;PTPRZ1;DAPK1;AKAP6;HIF1A;GRB10;PTPRT;FN1;RPS27A;MCL1;GHR;PDE2A;HCLS1;IFNLR1;CRLF1;TNFRSF1B;BRCA1;PYCARD;AIM2;WNT5A;CASP3;IL18;CEBPD;IL11RA;GBP2;TEC;BCL6;PTPN9;TNFRSF1A;UBA52;UBB;CDK9;PTPN5;TNFRSF21;FOS;TNF;NR1D1;PTPN20;CDKN1B;LEPR;IRAK3;CX3CL1;HSP90B1;STAT1;HNRNPU;RHOU;STAT6;GSDME;STAT2;RORA;FPR1;CASP1
prerank,GO_Biological_Process_2021__positive regulation of neuron differentiation (GO:0045666),0.38295443256675377,0.7220452048542856,0.8505747126436781,1.0,1.0,6/24,20.58%,BRINP1;GPRC5B;IMPACT;VWC2;ECT2;TCF4
prerank,GO_Biological_Process_2021__positive regulation of membrane potential (GO:0045838),0.4436672385767889,0.7216478430442171,0.7945205479452054,1.0,1.0,1/7,6.39%,ANK3
prerank,GO_Biological_Process_2021__protein K63-linked ubiquitination (GO:0070534),0.37533141788534563,0.7215908115303389,0.9240506329113924,1.0,1.0,5/33,15.01%,TRAF2;TRIM5;ARIH2;RNF126;PELI1
prerank,GO_Biological_Process_2021__histone lysine demethylation (GO:0070076),0.3988160763347029,0.7212799935021564,0.8611111111111112,1.0,1.0,5/20,19.88%,KDM3A;KDM1A;KDM4B;KDM5B;KDM6B
prerank,GO_Biological_Process_2021__dicarboxylic acid metabolic process (GO:0043648),0.3559749921841759,0.7209441232477883,0.9195402298850575,1.0,1.0,1/38,0.72%,MDH1
prerank,GO_Biological_Process_2021__posttranscriptional regulation of gene expression (GO:0010608),0.3767058257871102,0.720802097520495,0.896551724137931,1.0,1.0,8/35,28.25%,RBM3;PER1;RBM4B;APP;FOXO3;GRM5;PARP9;MAPKAPK5
prerank,GO_Biological_Process_2021__negative regulation of receptor internalization (GO:0002091),0.42594623040064283,0.7207966919958785,0.7647058823529411,1.0,1.0,4/9,30.88%,SDCBP;DLG4;LRPAP1;ATXN2
prerank,PanglaoDB_Augmented_2021__Paneth Cells,-0.30020099577127934,-0.7207928918605161,0.8666666666666667,1.0,1.0,3/18,8.28%,MEP1A;LGR4;TNFSF10
prerank,GO_Biological_Process_2021__neutral amino acid transport (GO:0015804),0.4109945712224157,0.7207148271724227,0.8333333333333334,1.0,1.0,1/16,3.24%,SLC6A15
prerank,GO_Biological_Process_2021__protein modification by small protein conjugation (GO:0032446),0.3258900654499201,0.7205939405986288,0.98989898989899,1.0,1.0,59/300,25.82%,MKRN3;H2BC11;FBXL7;ENC1;PIAS4;NUP133;FBXL2;HIF1A;VPS11;TRIM5;RPS27A;ARIH2;RNF144A;RBX1;GAN;HIF3A;VCPIP1;BRCA1;PINK1;RNF139;RLIM;TRIM26;UHRF2;UBE2M;DTX3;KLHL8;SEH1L;SYVN1;KLHL2;EPAS1;KIAA1586;UBE2J2;HECW2;UVSSA;UBA52;UBB;FBXL5;FBXO7;C10ORF90;TRIM14;BCL11A;RNF138;DDB1;TRIM24;HACE1;BARD1;MAGEF1;NDC1;USP5;UHRF1;UBE2D2;DTX2;DDRGK1;RNF220;PEX10;POM121;TRIM52;TRAF7;TNFAIP1
prerank,GO_Biological_Process_2021__negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435),0.38369074098643347,0.7205151974654532,0.8795180722891566,1.0,1.0,9/27,26.55%,CAMLG;SDCBP;RPL11;NOP53;HFE;MAP1A;DDRGK1;HSP90AB1;BAG6
prerank,GO_Biological_Process_2021__dolichol-linked oligosaccharide biosynthetic process (GO:0006488),0.41223063351389844,0.720443010827471,0.8292682926829268,1.0,1.0,2/13,16.84%,MVD;DHDDS
prerank,GO_Biological_Process_2021__N-acetylneuraminate catabolic process (GO:0019262),-0.4336379128364282,-0.719801059472252,0.71875,1.0,1.0,3/6,15.20%,NPL;GNPDA1;NAGK
prerank,GO_Biological_Process_2021__protein mono-ADP-ribosylation (GO:0140289),0.43630400019514193,0.7196948436053895,0.8955223880597015,1.0,1.0,5/11,41.90%,PARP9;TIPARP;PARP11;PARP10;PARP12
prerank,GO_Biological_Process_2021__positive regulation of antigen receptor-mediated signaling pathway (GO:0050857),-0.31884163886110767,-0.7190090581129205,0.9,1.0,1.0,9/17,25.20%,CD226;BCL10;CARD11;RAB29;CD81;PRKD2;SLC39A10;RELA;IKBKG
prerank,GO_Biological_Process_2021__spliceosomal snRNP assembly (GO:0000387),0.3783610372388538,0.7189605434441426,0.9012345679012346,1.0,1.0,5/29,21.40%,GEMIN2;SRSF12;SART3;PRPF6;SNRPD2
prerank,GO_Biological_Process_2021__peptidyl-threonine dephosphorylation (GO:0035970),0.4013337759864553,0.7188191820043288,0.8428571428571429,1.0,1.0,4/15,20.53%,PPM1E;DUSP10;DUSP16;DUSP6
prerank,GO_Biological_Process_2021__positive regulation of chromatin binding (GO:0035563),0.45848616781284646,0.7184671796337647,0.8481012658227848,1.0,1.0,4/7,37.27%,PARP9;GMNN;MED25;HMBOX1
prerank,GO_Biological_Process_2021__negative regulation of nervous system development (GO:0051961),-0.30487988060738713,-0.7183252779058749,0.8888888888888888,1.0,1.0,4/14,12.50%,IL1B;APPL2;REST;SORL1
prerank,GO_Biological_Process_2021__histone lysine methylation (GO:0034968),0.3778406238664881,0.717983572441838,0.8414634146341463,1.0,1.0,2/23,5.25%,WDR5;SUV39H2
prerank,GO_Biological_Process_2021__regulation of gene silencing by miRNA (GO:0060964),-0.2636445245869302,-0.7177505232706413,1.0,1.0,1.0,9/56,12.73%,NUP42;TGFB1;NUP155;AGO1;NUP188;NUP214;RAE1;POLR2C;ELAVL1
prerank,GO_Biological_Process_2021__Golgi ribbon formation (GO:0090161),-0.3692034800236506,-0.7176517873879681,0.8076923076923077,1.0,1.0,10/10,63.12%,OPTN;TRIP11;GCC2;MYO18A;VTI1A;VAMP4;GOLGA2;STX6;GOLPH3;TMED5
prerank,GO_Biological_Process_2021__peptidyl-serine phosphorylation (GO:0018105),0.3286439548272484,0.7173829268255517,0.9489795918367347,1.0,1.0,21/133,24.09%,PRKCE;CLSPN;TTBK2;MASTL;EIF2AK3;RPS6KB2;PLK2;RPS6KA2;PINK1;PKD1;PDK3;ROCK1;MAP3K13;CDK5R1;UHMK1;LRRK2;VRK2;PRKCB;MAST4;VRK1;BRSK1
prerank,GO_Biological_Process_2021__negative regulation of PERK-mediated unfolded protein response (GO:1903898),0.5021270725613192,0.7166892532440522,0.8676470588235294,1.0,1.0,2/5,27.46%,PPP1R15A;PTPN1
prerank,GO_Biological_Process_2021__ERBB2 signaling pathway (GO:0038128),-0.3166455032036543,-0.7166736304563054,0.96,1.0,1.0,1/22,0.32%,MATK
prerank,GO_Biological_Process_2021__peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity (GO:1990264),0.4747741236387998,0.7159515626261344,0.8783783783783784,1.0,1.0,2/6,14.74%,PTPRT;DUSP10
prerank,GO_Biological_Process_2021__regulation of protein exit from endoplasmic reticulum (GO:0070861),0.4276475375178952,0.71587520362892,0.8333333333333334,1.0,1.0,1/10,13.53%,INSIG1
prerank,GO_Biological_Process_2021__mRNA stabilization (GO:0048255),0.3708265358066566,0.715589158908435,0.8536585365853658,1.0,1.0,4/27,12.35%,SLC11A1;NOCT;TENT5A;HNRNPA0
prerank,GO_Biological_Process_2021__peptidyl-serine modification (GO:0018209),0.32908785121668016,0.7155119464320444,0.9587628865979382,1.0,1.0,22/138,24.09%,PRKCE;CLSPN;TTBK2;MASTL;EIF2AK3;RPS6KB2;GALNT13;PLK2;RPS6KA2;PINK1;PKD1;PDK3;ROCK1;MAP3K13;CDK5R1;UHMK1;LRRK2;VRK2;PRKCB;MAST4;VRK1;BRSK1
prerank,GO_Biological_Process_2021__positive regulation of NF-kappaB transcription factor activity (GO:0051092),0.3333114716904785,0.7155021673198768,0.9791666666666666,1.0,1.0,26/117,21.58%,RAB7B;TFRC;AGT;TRAF2;SLCO3A1;TRIM5;RPS27A;TRIM25;ALK;NOD2;RIPK2;PYCARD;AIM2;WNT5A;DHX33;IL18;MAP3K13;HSPA1B;APP;UBA52;UBB;TNF;TRIM14;IRAK3;CX3CL1;FLOT2
prerank,GO_Biological_Process_2021__ESCRT III complex disassembly (GO:1904903),-0.38038451818064334,-0.7154956515373602,0.8064516129032258,1.0,1.0,4/9,21.06%,VTA1;CHMP2B;CHMP2A;VPS4B
prerank,GO_Biological_Process_2021__ESCRT complex disassembly (GO:1904896),-0.38038451818064334,-0.7154956515373602,0.8064516129032258,1.0,1.0,4/9,21.06%,VTA1;CHMP2B;CHMP2A;VPS4B
prerank,GO_Biological_Process_2021__peptidyl-lysine monomethylation (GO:0018026),-0.42605597628553177,-0.7154277963678238,0.9032258064516129,1.0,1.0,1/9,2.37%,SETD6
prerank,GO_Biological_Process_2021__positive regulation of mitotic cell cycle (GO:0045931),-0.34415833594272366,-0.7150330250937511,0.7692307692307693,1.0,1.0,3/20,7.15%,TAL1;DUSP3;EIF4EBP1
prerank,GO_Biological_Process_2021__regulation of type I interferon production (GO:0032479),0.32934545766158135,0.7148043778349324,0.9347826086956522,1.0,1.0,6/71,15.82%,PQBP1;POLR3F;TRIM25;POLR1C;POLR3H;DHX33
prerank,GO_Biological_Process_2021__positive regulation of leukocyte mediated cytotoxicity (GO:0001912),0.400985072013234,0.7147420102383956,0.8461538461538461,1.0,1.0,1/20,2.51%,CADM1
prerank,GO_Biological_Process_2021__negative regulation of cell population proliferation (GO:0008285),0.32749409483586484,0.7146466835010034,0.97,1.0,1.0,37/203,18.63%,KLF4;ST18;OGN;TGFB2;BMPR1B;PTPRK;SOX4;GPNMB;ALOX15B;CAMK2N1;DNAJB2;RPS6KA2;IFNLR1;MAGI2;RBM5;SOD2;CLMN;RNF139;CD300A;PLXNB1;E2F7;DUSP10;WNT5A;NDRG4;THAP12;CTBP1;CHD5;PRKRA;NEURL1;HSPA1B;APP;GSTP1;RGCC;IGFBP7;FTH1;GTPBP4;AQP11
prerank,GO_Biological_Process_2021__positive regulation of lamellipodium organization (GO:1902745),0.36754260649229564,0.7142259264250435,0.9,1.0,1.0,3/25,15.77%,ENPP2;CARMIL1;AKIRIN1
prerank,GO_Biological_Process_2021__aspartate family amino acid biosynthetic process (GO:0009067),0.4887652255609911,0.7141295751525489,0.8769230769230769,1.0,1.0,4/6,40.80%,MTHFD1;GOT1;PLOD2;MTR
prerank,GO_Biological_Process_2021__signal complex assembly (GO:0007172),-0.4489626242386071,-0.7140384767769349,0.8275862068965517,1.0,1.0,2/5,13.13%,SRC;NCK1
prerank,GO_Biological_Process_2021__negative regulation of epithelial to mesenchymal transition (GO:0010719),0.3827541748687049,0.7138111704961245,0.868421052631579,1.0,1.0,3/14,8.27%,VASN;OVOL2;SPRY1
prerank,GO_Biological_Process_2021__response to type I interferon (GO:0034340),0.4683200944135551,0.7135970481550532,0.8571428571428571,1.0,1.0,2/6,30.45%,TRIM56;MX1
prerank,GO_Biological_Process_2021__positive regulation of leukocyte migration (GO:0002687),0.43742177496798135,0.7129777897842806,0.8873239436619719,1.0,1.0,5/13,24.36%,VEGFA;PTN;THY1;TNF;JAM3
prerank,GO_Biological_Process_2021__regulation of focal adhesion disassembly (GO:0120182),0.48645798525930384,0.712740947998017,0.9,1.0,1.0,1/6,3.86%,ARF6
prerank,GO_Biological_Process_2021__positive regulation of focal adhesion disassembly (GO:0120183),0.48645798525930384,0.712740947998017,0.9,1.0,1.0,1/6,3.86%,ARF6
prerank,GO_Biological_Process_2021__regulation of telomere maintenance via telomere lengthening (GO:1904356),-0.3225785110305089,-0.712486725507607,1.0,1.0,1.0,3/14,18.72%,TERF2;SMG6;ERCC4
prerank,"GO_Biological_Process_2021__positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516)",0.4432510059386126,0.7124357078748086,0.8266666666666667,1.0,1.0,1/9,5.63%,CD55
prerank,GO_Biological_Process_2021__regulation of small molecule metabolic process (GO:0062012),-0.3426071114141591,-0.7123960564470383,0.9333333333333333,1.0,1.0,2/19,1.98%,TTC39B;ARV1
prerank,GO_Biological_Process_2021__cellular polysaccharide catabolic process (GO:0044247),-0.37833288439579815,-0.7119155518932826,0.8461538461538461,1.0,1.0,2/13,8.30%,PGM2;AOAH
prerank,GO_Biological_Process_2021__regulation of aerobic respiration (GO:1903715),-0.36270155777026836,-0.7114376949589751,0.8,1.0,1.0,2/9,4.36%,IDE;UQCC2
prerank,GO_Biological_Process_2021__endothelial cell differentiation (GO:0045446),0.4695135262776621,0.7111664594290728,0.8253968253968254,1.0,1.0,2/6,29.10%,KDM6B;PROX1
prerank,GO_Biological_Process_2021__negative regulation of reactive oxygen species biosynthetic process (GO:1903427),-0.42383751584350726,-0.7108373646961359,0.8333333333333334,1.0,1.0,2/6,8.59%,FYN;ABCB7
prerank,GO_Biological_Process_2021__regulation of epidermal cell differentiation (GO:0045604),0.4039058331470948,0.710797418275719,0.8243243243243243,1.0,1.0,3/12,17.51%,ERRFI1;ROCK1;KLF7
prerank,GO_Biological_Process_2021__nitric oxide biosynthetic process (GO:0006809),-0.40113649999300716,-0.7106562609813095,0.8095238095238095,1.0,1.0,3/6,14.21%,CYB5R3;DDAH2;AKT1
prerank,GO_Biological_Process_2021__nitric oxide metabolic process (GO:0046209),-0.40113649999300716,-0.7106562609813095,0.8095238095238095,1.0,1.0,3/6,14.21%,CYB5R3;DDAH2;AKT1
prerank,GO_Biological_Process_2021__histone H3-K4 demethylation (GO:0034720),0.4481393552645606,0.7106525968836316,0.8125,1.0,1.0,2/7,19.67%,KDM1A;KDM5B
prerank,GO_Biological_Process_2021__regulation of phosphorylation (GO:0042325),0.33401282400791593,0.7104064532068411,0.9574468085106383,1.0,1.0,18/90,22.89%,THBS1;NUP133;PGAM1;HIF1A;FN1;PRKAG2;SDCBP;SEH1L;LDB2;ROCK1;HSPB1;APP;NOP53;CDKN1B;SLAMF8;BARD1;STAT2;NDC1
prerank,PanglaoDB_Augmented_2021__Monocytes,0.3375844686273296,0.7101916714415057,0.9587628865979382,1.0,1.0,20/127,16.48%,CLEC12A;CD163;VCAN;RGS1;ADGRE1;FCGR2B;RGS2;SIRPB2;FN1;IFITM3;FGR;C5AR1;FCGR2C;FGL2;NFKBIZ;TNFRSF1B;CD300A;PYCARD;LTA4H;LRRC25
prerank,GO_Biological_Process_2021__cilium organization (GO:0044782),-0.24308707039791957,-0.7101384866547904,1.0,1.0,1.0,24/144,15.81%,EHD4;KIF27;FLNA;RTTN;WDR35;MKKS;KIF3B;INPP5E;BBS9;EXOC7;TMEM67;TCTN3;OCRL;ABCC4;IFT43;GSN;CCDC66;NUDCD3;GALNT11;DISC1;MARK4;RAB3IP;CDC14B;CFAP70
prerank,GO_Biological_Process_2021__positive regulation of mRNA catabolic process (GO:0061014),-0.2782541057747166,-0.7099174192842344,0.9230769230769231,1.0,1.0,4/38,9.94%,BTG2;KHSRP;PRR5L;METTL16
prerank,GO_Biological_Process_2021__regulation of RNA splicing (GO:0043484),0.34136027104603794,0.7097548053208774,0.9354838709677419,1.0,1.0,14/65,24.66%,PQBP1;RRP1B;KHDRBS2;CLK2;FAM50A;AHNAK;HNRNPH1;METTL4;HNRNPH3;MBNL2;SRSF3;CLK1;C9ORF78;AKAP17A
prerank,GO_Biological_Process_2021__ER-associated misfolded protein catabolic process (GO:0071712),0.4241419020399213,0.7096947968639851,0.8904109589041096,1.0,1.0,2/10,26.55%,AUP1;BAG6
prerank,GO_Biological_Process_2021__histone ubiquitination (GO:0016574),-0.32042768371709807,-0.7096343180660314,0.8235294117647058,1.0,1.0,5/18,22.80%,LEO1;RNF8;RNF20;UBE2A;CDC73
prerank,GO_Biological_Process_2021__camera-type eye morphogenesis (GO:0048593),0.4573109328747843,0.7095793827713807,0.8260869565217391,1.0,1.0,1/7,5.04%,VEGFA
prerank,GO_Biological_Process_2021__Rac protein signal transduction (GO:0016601),-0.3285028544850352,-0.7093508467284079,0.92,1.0,1.0,1/19,1.76%,RHOG
prerank,GO_Biological_Process_2021__cation transmembrane transport (GO:0098655),0.3714545631161082,0.7092413433358634,0.8658536585365854,1.0,1.0,6/23,25.81%,SFXN3;ASIC2;TRPM7;SLC3A2;ATP1A2;ABCC8
prerank,GO_Biological_Process_2021__negative regulation of insulin secretion (GO:0046676),0.4474402323891017,0.7087342255908939,0.8507462686567164,1.0,1.0,4/8,24.47%,KLF7;PIM3;KCNB1;SIRT4
prerank,GO_Biological_Process_2021__autophagosome organization (GO:1905037),0.3627890113304412,0.7086249685947807,0.8390804597701149,1.0,1.0,9/40,29.74%,TMEM41B;VMP1;ATP2A2;UBXN2B;ATG5;ATG13;MAP1LC3A;NSFL1C;ATG2B
prerank,GO_Biological_Process_2021__regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902165),0.45740414945482927,0.7081167662069103,0.868421052631579,1.0,1.0,2/8,18.11%,KDM1A;TAF9B
prerank,GO_Biological_Process_2021__negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902166),0.45740414945482927,0.7081167662069103,0.868421052631579,1.0,1.0,2/8,18.11%,KDM1A;TAF9B
prerank,GO_Biological_Process_2021__positive regulation of intracellular protein transport (GO:0090316),-0.27418439960443025,-0.7079880532169729,1.0,1.0,1.0,18/115,12.50%,FLNA;ITGAM;IL1B;HPS4;ZPR1;BAP1;GZMB;TP53;TGFB1;BID;PPP1R13B;FYN;ZDHHC2;PRR5L;ITGB2;PPP3CC;PLK3;SORL1
prerank,GO_Biological_Process_2021__positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),-0.27297919164602324,-0.7079387458540063,0.8666666666666667,1.0,1.0,9/28,16.04%,BCL2L1;TP53;BID;NCK1;EIF5A;BCL2;FIS1;FBH1;BECN1
prerank,PanglaoDB_Augmented_2021__Red Pulp Macrophages,0.3426923188093958,0.707495022187619,0.9473684210526315,1.0,1.0,11/81,11.30%,CLEC12A;CD163;SLC11A1;ADGRE1;FCGR2B;SIRPB2;CASP5;FGR;C5AR1;FCGR2C;FGL2
prerank,GO_Biological_Process_2021__positive regulation of macrophage differentiation (GO:0045651),0.44332845900442497,0.7074752937114008,0.8524590163934426,1.0,1.0,1/6,8.86%,ID2
prerank,GO_Biological_Process_2021__negative regulation of telomere maintenance via telomerase (GO:0032211),-0.3353922663647658,-0.7074163263584063,0.9230769230769231,1.0,1.0,4/14,15.93%,CTC1;SRC;TERF2;EXOSC10
prerank,GO_Biological_Process_2021__establishment of epithelial cell polarity (GO:0090162),-0.37204325159843404,-0.7072648557804053,0.8333333333333334,1.0,1.0,4/14,20.12%,CYTH3;OPHN1;CDC42;RAP2A
prerank,GO_Biological_Process_2021__positive regulation of apoptotic signaling pathway (GO:2001235),0.36062474407761835,0.7072000002339767,0.8651685393258427,1.0,1.0,4/40,8.90%,AGT;TRAF2;SEPTIN4;BOK
prerank,GO_Biological_Process_2021__negative regulation of ERK1 and ERK2 cascade (GO:0070373),0.3696050359578406,0.7070004059189691,0.875,1.0,1.0,9/31,21.35%,SEMA6A;CAMK2N1;SPRY1;LMO3;DUSP10;TIMP3;GSTP1;DUSP6;TNIP1
prerank,GO_Biological_Process_2021__regulation of RNA export from nucleus (GO:0046831),-0.33616498700733677,-0.7069497725441238,0.8620689655172413,1.0,1.0,4/12,22.94%,AKAP8L;NSUN2;NRDE2;SUPT6H
prerank,GO_Biological_Process_2021__regulation of catecholamine secretion (GO:0050433),0.4036050936953339,0.7069337780141844,0.8857142857142857,1.0,1.0,5/15,26.10%,SYT4;SYT1;SYT11;KCNB1;SYT9
prerank,GO_Biological_Process_2021__regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315),-0.34122352389575555,-0.7067293564901503,0.8421052631578947,1.0,1.0,4/15,10.97%,CORO1B;ARFIP1;WASF3;CYFIP1
prerank,GO_Biological_Process_2021__protein acylation (GO:0043543),-0.3041562914216386,-0.7066027149933909,1.0,1.0,1.0,6/31,9.74%,ZDHHC3;ZDHHC5;ZDHHC21;ZDHHC13;ZDHHC2;EP300
prerank,GO_Biological_Process_2021__protein insertion into ER membrane by stop-transfer membrane-anchor sequence (GO:0045050),0.4410503181709313,0.7065164420526863,0.8933333333333333,1.0,1.0,4/8,31.16%,EMC7;EMC10;EMC8;EMC3
prerank,GO_Biological_Process_2021__organophosphate biosynthetic process (GO:0090407),0.3709539842294676,0.7064943259405578,0.875,1.0,1.0,12/28,34.29%,ITPKC;GK;GK5;LPCAT1;TPK1;PIP5K1A;TKT;GNPAT;GPHN;IP6K1;AGPAT3;AGPAT5
prerank,GO_Biological_Process_2021__embryonic digit morphogenesis (GO:0042733),0.4447681135092437,0.7064014274147169,0.8873239436619719,1.0,1.0,2/8,31.76%,WDPCP;ECE1
prerank,GO_Biological_Process_2021__positive regulation of protein polyubiquitination (GO:1902916),0.44987691356921866,0.7062915884428573,0.8840579710144928,1.0,1.0,2/7,24.61%,NOD2;DDX3X
prerank,GO_Biological_Process_2021__translational elongation (GO:0006414),0.3334511506726942,0.7061193858335008,0.9052631578947369,1.0,1.0,12/75,21.88%,EEF1A2;MRPL33;EEF1B2;MRPL43;MRPL20;MRPL14;MRPL55;MRPL27;MRPL19;MRPL3;MRPS14;EEF1A1
prerank,GO_Biological_Process_2021__iron ion homeostasis (GO:0055072),0.3569210249408854,0.7060905606457355,0.9036144578313253,1.0,1.0,13/41,25.52%,TFRC;SLC11A1;FLVCR1;PICALM;HAMP;SOD1;FTH1;FBXL5;HFE;ISCU;NEO1;TF;SLC11A2
prerank,GO_Biological_Process_2021__ribonucleoside monophosphate biosynthetic process (GO:0009156),0.415281339954527,0.706077334103283,0.8382352941176471,1.0,1.0,3/11,23.92%,PAICS;PFAS;IMPDH1
prerank,GO_Biological_Process_2021__inflammatory response (GO:0006954),0.3337548270255589,0.70573155379833,0.9591836734693877,1.0,1.0,12/100,12.35%,THBS1;TACR1;CHI3L1;ANXA1;SLC11A1;FCGR2B;LTB4R;PXK;C5AR1;ADCY8;RIPK2;HNRNPA0
prerank,GO_Biological_Process_2021__tRNA methylation (GO:0030488),0.36204812721304835,0.7056639458734026,0.8354430379746836,1.0,1.0,3/24,11.13%,DALRD3;FTSJ1;METTL2A
prerank,GO_Biological_Process_2021__regulation of brown fat cell differentiation (GO:0090335),0.456790564940173,0.7054036946503796,0.8082191780821918,1.0,1.0,5/9,30.04%,NAPEPLD;HNRNPU;PIM1;ZBTB7B;RREB1
prerank,GO_Biological_Process_2021__positive regulation of nucleic acid-templated transcription (GO:1903508),0.3241906715046315,0.705202681889694,1.0,1.0,1.0,37/316,17.17%,KLF4;NFIL3;EGR1;HMGB2;ZBTB16;CREB5;MYRF;AGT;NFIB;RORB;SOX4;RXRB;HIF1A;KDM3A;HCFC1;ARNT2;PAX8;MAFB;ID2;SS18L1;ATAD2;ING1;DEAF1;ETS2;HINFP;BRCA1;TRIM16;YAF2;PICALM;WNT5A;SMARCD3;ESR1;TBL1XR1;CXXC1;PLCB1;PCBD2;TFAM
prerank,GO_Biological_Process_2021__cellular response to DNA damage stimulus (GO:0006974),0.324750385506644,0.705018394582975,0.98,1.0,1.0,38/274,21.25%,TOP2A;DTL;SLF1;MASTL;SPDYA;CDKN2AIP;FMN2;ENDOV;WDHD1;BOK;MCL1;POLQ;HINFP;INTS3;VCPIP1;TNFRSF1B;BRCA1;XRCC3;BCL2L2;PPP1R15A;FAN1;RFC4;GTF2H3;POLE2;CIDEB;BCL6;FOXP1;FANCL;ADPRS;FANCA;TIMELESS;NOP53;KMT5C;GNL1;CBX5;MACROD1;RBBP8;DDB1
prerank,PanglaoDB_Augmented_2021__Airway Smooth Muscle Cells,0.40165161428079804,0.7049957761208476,0.8717948717948718,1.0,1.0,1/22,0.99%,ADAMTS2
prerank,GO_Biological_Process_2021__positive regulation of interleukin-10 production (GO:0032733),-0.32773331067754474,-0.7048189393153088,0.7931034482758621,1.0,1.0,2/13,5.98%,LGALS9;CD274
prerank,GO_Biological_Process_2021__fatty acid homeostasis (GO:0055089),0.4434357129176603,0.7047712754893872,0.8253968253968254,1.0,1.0,1/6,18.04%,PRKAA2
prerank,GO_Biological_Process_2021__modification-dependent protein catabolic process (GO:0019941),0.3166045057884281,0.7045213072255576,0.9183673469387755,1.0,1.0,26/162,23.84%,DTL;FBXL7;RNF144B;HERPUD1;RPS27A;TRIM25;ARIH2;RNF144A;RBX1;RNF126;PINK1;RLIM;KLHL8;SYVN1;RNF13;RNF149;UBA52;UBB;PSMC2;FBXO7;DDB1;HACE1;FEM1C;UHRF1;UBE2D2;PSMD14
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA duplex unwinding (GO:0000717)",0.4021720117004178,0.7043301006303179,0.8928571428571429,1.0,1.0,7/19,21.25%,ERCC2;RPS27A;RBX1;GTF2H3;UBA52;UBB;DDB1
prerank,GO_Biological_Process_2021__cellular response to pH (GO:0071467),0.4362570526430055,0.7039896221072157,0.92,1.0,1.0,3/7,21.98%,IMPACT;SLC9A1;CHP1
prerank,GO_Biological_Process_2021__nerve growth factor signaling pathway (GO:0038180),0.48814206994848586,0.7039522628556973,0.8636363636363636,1.0,1.0,1/5,11.99%,MAGI2
prerank,GO_Biological_Process_2021__purine ribonucleoside monophosphate catabolic process (GO:0009169),0.4858324869960764,0.7038840940605977,0.859375,1.0,1.0,4/5,31.05%,HPRT1;PRTFDC1;PNP;NT5C2
prerank,GO_Biological_Process_2021__purine-containing compound biosynthetic process (GO:0072522),0.3937379860344037,0.7038555831758301,0.8873239436619719,1.0,1.0,5/18,21.88%,PAICS;PRPS1;DCK;HPRT1;MTHFD1
prerank,GO_Biological_Process_2021__positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742),0.3938686190404585,0.7037655358516662,0.8795180722891566,1.0,1.0,1/18,3.59%,AGT
prerank,GO_Biological_Process_2021__cellular response to topologically incorrect protein (GO:0035967),0.3740174644627086,0.703723490582622,0.8902439024390244,1.0,1.0,9/27,27.66%,HSPA5;BAG3;HSPA1B;HSPA2;HSPA14;HSPA9;HSPA13;PTPN1;HSPA8
prerank,GO_Biological_Process_2021__MyD88-dependent toll-like receptor signaling pathway (GO:0002755),0.3684826777525203,0.7035547147944351,0.891566265060241,1.0,1.0,8/26,26.10%,RPS27A;UBA52;HSPD1;UBB;IRAK3;TNIP1;TLR5;TLR2
prerank,GO_Biological_Process_2021__cellular response to purine-containing compound (GO:0071415),0.48097707096651887,0.7032225883078513,0.8666666666666667,1.0,1.0,2/6,12.36%,RYR2;RYR3
prerank,GO_Biological_Process_2021__negative regulation of mRNA 3'-end processing (GO:0031441),0.42691190779592264,0.703013492435603,0.8732394366197183,1.0,1.0,3/9,29.71%,CDK9;BARD1;CTR9
prerank,GO_Biological_Process_2021__cellular transition metal ion homeostasis (GO:0046916),0.33903386805942715,0.7024178586447616,0.9,1.0,1.0,17/58,25.67%,TFRC;SLC11A1;ATOX1;FLVCR1;SLC31A2;SLC39A12;HAMP;APP;SLC39A14;SOD1;FTH1;FBXL5;HFE;ISCU;TF;SLC11A2;SLC39A6
prerank,GO_Biological_Process_2021__positive regulation of fatty acid oxidation (GO:0046321),0.4597904161461466,0.7022314883174103,0.855072463768116,1.0,1.0,4/7,25.32%,IRS2;NR4A3;PPARA;PPARGC1A
prerank,GO_Biological_Process_2021__clathrin coat assembly (GO:0048268),0.4214846284777909,0.7006803252899988,0.8795180722891566,1.0,1.0,6/14,20.03%,FCHO2;SGIP1;NSG2;CALY;PICALM;HIP1R
prerank,GO_Biological_Process_2021__lysosomal microautophagy (GO:0016237),0.46249712045016256,0.7005955922720167,0.9016393442622951,1.0,1.0,4/7,39.02%,ATG13;ATG2B;ULK1;ATG2A
prerank,GO_Biological_Process_2021__piecemeal microautophagy of the nucleus (GO:0034727),0.46249712045016256,0.7005955922720167,0.9016393442622951,1.0,1.0,4/7,39.02%,ATG13;ATG2B;ULK1;ATG2A
prerank,GO_Biological_Process_2021__regulation of cellular respiration (GO:0043457),0.43949786633629057,0.7005134199548628,0.8382352941176471,1.0,1.0,4/9,23.47%,IFNLR1;PRELID1;NOP53;TRAP1
prerank,GO_Biological_Process_2021__purine-containing compound salvage (GO:0043101),-0.3965436465803023,-0.7003617503644038,0.8620689655172413,1.0,1.0,3/8,12.57%,ADK;DGUOK;AMPD3
prerank,GO_Biological_Process_2021__neutrophil chemotaxis (GO:0030593),0.38574373460955397,0.7000955987523076,0.8292682926829268,1.0,1.0,1/21,1.28%,TGFB2
prerank,GO_Biological_Process_2021__regulation of dendritic cell differentiation (GO:2001198),0.4403370684882418,0.6996573511693259,0.8571428571428571,1.0,1.0,1/9,5.61%,FCGR2B
prerank,GO_Biological_Process_2021__protein polyufmylation (GO:1990564),0.4909088031601746,0.6996522687427666,0.8833333333333333,1.0,1.0,2/5,37.24%,DDRGK1;UBA5
prerank,GO_Biological_Process_2021__protein ufmylation (GO:0071569),0.4909088031601746,0.6996522687427666,0.8833333333333333,1.0,1.0,2/5,37.24%,DDRGK1;UBA5
prerank,GO_Biological_Process_2021__protein K69-linked ufmylation (GO:1990592),0.4909088031601746,0.6996522687427666,0.8833333333333333,1.0,1.0,2/5,37.24%,DDRGK1;UBA5
prerank,GO_Biological_Process_2021__cellular response to epidermal growth factor stimulus (GO:0071364),0.3802646504226626,0.6993791866140897,0.8705882352941177,1.0,1.0,1/22,1.26%,KNSTRN
prerank,GO_Biological_Process_2021__global genome nucleotide-excision repair (GO:0070911),0.3855466390373307,0.6992769065693074,0.8666666666666667,1.0,1.0,7/23,21.25%,ERCC2;RPS27A;RBX1;GTF2H3;UBA52;UBB;DDB1
prerank,GO_Biological_Process_2021__negative regulation of lipid storage (GO:0010888),-0.3228900435605543,-0.6989640130480063,0.7619047619047619,1.0,1.0,5/16,12.05%,TTC39B;NR1H3;TREM2;NFKBIA;PPARD
prerank,GO_Biological_Process_2021__cell chemotaxis (GO:0060326),0.3514850709400842,0.6989544866239845,0.9204545454545454,1.0,1.0,4/27,10.26%,HMGB2;NR4A1;VEGFA;SEMA5A
prerank,GO_Biological_Process_2021__negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244),0.405957792502173,0.6989492490732782,0.8076923076923077,1.0,1.0,3/12,21.86%,NELFB;HEXIM1;HNRNPU
prerank,GO_Biological_Process_2021__regulation of glycogen biosynthetic process (GO:0005979),0.3681491370967334,0.6986992045243482,0.8571428571428571,1.0,1.0,4/16,12.30%,INSR;IRS2;SORBS1;PPP1R3B
prerank,GO_Biological_Process_2021__miRNA metabolic process (GO:0010586),0.4042947701298326,0.6983514240346232,0.8170731707317073,1.0,1.0,3/15,17.00%,TENT4B;SND1;PRKRA
prerank,GO_Biological_Process_2021__glutathione metabolic process (GO:0006749),-0.3087627617012566,-0.6981709904794591,0.9473684210526315,1.0,1.0,6/20,13.42%,GCLC;HPGDS;GSTM4;GGT7;GCLM;GPX1
prerank,GO_Biological_Process_2021__protein polyubiquitination (GO:0000209),0.313937587272696,0.6981623628343466,1.0,1.0,1.0,43/254,24.20%,DTL;MKRN3;FBXL7;UBE2QL1;RNF144B;TRAF2;TRIM5;RPS27A;ARIH2;RNF144A;PSMB4;RBX1;RNF126;SASH1;BRCA1;FBXO27;BLMH;RLIM;PELI1;SYVN1;UBE2J2;HECW2;FBXL13;UBA52;UBB;PSMC2;FBXL5;LONRF1;ZNRF1;PSMA3;FBXO7;PSMB2;C10ORF90;TRIM14;PSMD5;PSMD7;HACE1;BARD1;UBE2D2;PSMD14;TRIM56;PSMA5;TRAF3IP2
prerank,GO_Biological_Process_2021__reticulophagy (GO:0061709),0.42010114099593976,0.6978718322260983,0.8955223880597015,1.0,1.0,1/13,8.50%,RETREG1
prerank,GO_Biological_Process_2021__response to estradiol (GO:0032355),-0.32897567606917927,-0.6976277000149472,0.8571428571428571,1.0,1.0,5/20,12.46%,ZNF703;CYP19A1;TGFB1;EGFR;GGT7
prerank,GO_Biological_Process_2021__positive regulation of RIG-I signaling pathway (GO:1900246),0.46508645237869395,0.6976079072468305,0.8787878787878788,1.0,1.0,3/7,41.99%,ZCCHC3;DHX58;USP15
prerank,GO_Biological_Process_2021__positive regulation of double-strand break repair via nonhomologous end joining (GO:2001034),-0.3426771119372243,-0.697548399425638,0.8518518518518519,1.0,1.0,2/11,9.52%,SHLD1;KMT5B
prerank,GO_Biological_Process_2021__regulation of lymphocyte migration (GO:2000401),-0.3685269523957889,-0.6971752941762299,0.8717948717948718,1.0,1.0,2/7,18.09%,AKT1;STK10
prerank,GO_Biological_Process_2021__regulation of sister chromatid cohesion (GO:0007063),0.4599773329796974,0.6971668373050166,0.8448275862068966,1.0,1.0,3/6,30.41%,WAPL;CTNNB1;RAD21
prerank,GO_Biological_Process_2021__positive regulation of RNA splicing (GO:0033120),0.3595616500655338,0.6969645104758982,0.8470588235294118,1.0,1.0,1/25,5.92%,RBM3
prerank,GO_Biological_Process_2021__negative regulation of androgen receptor signaling pathway (GO:0060766),0.4052265821337926,0.6968548734203449,0.8,1.0,1.0,1/9,17.56%,FOXP1
prerank,GO_Biological_Process_2021__glycogen metabolic process (GO:0005977),0.3666520537105711,0.6962447582971454,0.875,1.0,1.0,7/20,22.96%,PRKAG2;PHKG1;PGM2L1;PGM1;NR1D1;GYS1;GAA
prerank,GO_Biological_Process_2021__positive regulation of mRNA metabolic process (GO:1903313),-0.36376487325745566,-0.6962393372900434,0.9,1.0,1.0,2/12,9.32%,KHSRP;PRR5L
prerank,GO_Biological_Process_2021__protein modification process (GO:0036211),0.36572126899847496,0.6951039300728592,0.9247311827956989,1.0,1.0,9/58,18.74%,ARAF;FBXL2;CHRM3;SLC35A1;SERP1;UBE2M;CPE;UBA52;ERO1A
prerank,GO_Biological_Process_2021__response to lipopolysaccharide (GO:0032496),0.3255652755563543,0.695084942942079,0.9387755102040817,1.0,1.0,14/84,17.56%,VIM;HMGB2;SLC11A1;NOCT;PDE4B;PDCD1LG2;NOD2;HNRNPA0;TNFRSF1B;PYCARD;PELI1;WNT5A;GSTP1;FOXP1
prerank,GO_Biological_Process_2021__regulation of mammary gland epithelial cell proliferation (GO:0033599),-0.39571072365217297,-0.6950465950666409,0.8125,1.0,1.0,1/7,0.95%,ZNF703
prerank,GO_Biological_Process_2021__positive regulation of brown fat cell differentiation (GO:0090336),0.46001625484310227,0.6949842526357093,0.7878787878787878,1.0,1.0,5/7,30.04%,NAPEPLD;HNRNPU;PIM1;ZBTB7B;RREB1
prerank,"GO_Biological_Process_2021__tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388)",0.393483932519145,0.6946914292071891,0.9,1.0,1.0,3/12,18.60%,DDX1;TSEN54;ZBTB8OS
prerank,GO_Biological_Process_2021__regulation of actin cytoskeleton reorganization (GO:2000249),-0.2994076587198944,-0.6946868108835644,0.8888888888888888,1.0,1.0,7/26,10.62%,BAIAP2L2;CSF1R;ABI3;ARHGDIB;DAPK3;HCK;ABL1
prerank,GO_Biological_Process_2021__mast cell activation involved in immune response (GO:0002279),0.4617866691626127,0.6945434081041645,0.8125,1.0,1.0,1/5,12.83%,NR4A3
prerank,GO_Biological_Process_2021__mast cell degranulation (GO:0043303),0.4617866691626127,0.6945434081041645,0.8125,1.0,1.0,1/5,12.83%,NR4A3
prerank,GO_Biological_Process_2021__negative regulation of leukocyte degranulation (GO:0043301),0.4381541167576611,0.6940601666862604,0.8783783783783784,1.0,1.0,2/8,13.83%,FCGR2B;CD300A
prerank,GO_Biological_Process_2021__regulation of RNA biosynthetic process (GO:2001141),-0.37038034441903067,-0.6935360743936414,0.7777777777777778,1.0,1.0,1/7,2.23%,IL1B
prerank,GO_Biological_Process_2021__vascular process in circulatory system (GO:0003018),-0.40434693830715773,-0.6934843528582408,0.76,1.0,1.0,2/7,13.33%,GCLC;GCLM
prerank,GO_Biological_Process_2021__regulation of tube diameter (GO:0035296),-0.40434693830715773,-0.6934843528582408,0.76,1.0,1.0,2/7,13.33%,GCLC;GCLM
prerank,GO_Biological_Process_2021__nuclear mRNA surveillance (GO:0071028),-0.4269528903047037,-0.6931737534450181,0.7714285714285715,1.0,1.0,4/7,26.07%,EXOSC10;EXOSC9;EXOSC8;XRN1
prerank,PanglaoDB_Augmented_2021__Macrophages,0.3212852364350051,0.6931119457385467,0.9896907216494846,1.0,1.0,20/152,12.83%,RAB7B;CLEC12A;CD163;SLC11A1;RGS1;ADGRE1;F13A1;GPNMB;FCGR2B;RAB20;RBPJ;FGR;CPM;C5AR1;FCGR2C;FGL2;NCEH1;PLTP;TNFRSF1B;NR4A3
prerank,GO_Biological_Process_2021__2-oxoglutarate metabolic process (GO:0006103),0.41445924603711204,0.6930285570548793,0.8970588235294118,1.0,1.0,3/9,31.12%,L2HGDH;GPT2;GOT1
prerank,GO_Biological_Process_2021__SMAD protein complex assembly (GO:0007183),-0.4051490425528788,-0.6929606112413955,0.8055555555555556,1.0,1.0,1/5,7.51%,TGFB1
prerank,GO_Biological_Process_2021__actin filament capping (GO:0051693),-0.3414381640916022,-0.6927968095928351,0.8333333333333334,1.0,1.0,6/16,19.24%,FLII;GSN;CAPG;CAPZB;CAPZA1;VILL
prerank,GO_Biological_Process_2021__barbed-end actin filament capping (GO:0051016),-0.3414381640916022,-0.6927968095928351,0.8333333333333334,1.0,1.0,6/16,19.24%,FLII;GSN;CAPG;CAPZB;CAPZA1;VILL
prerank,GO_Biological_Process_2021__acute inflammatory response (GO:0002526),-0.3744138045999483,-0.6923759054425517,0.9230769230769231,1.0,1.0,3/8,18.50%,IL6R;APOL2;SIGIRR
prerank,GO_Biological_Process_2021__negative regulation of response to endoplasmic reticulum stress (GO:1903573),-0.27952956809848106,-0.6921843362849365,1.0,1.0,1.0,4/22,12.08%,BCL2L1;ALOX5;NR1H3;HSPA1A
prerank,GO_Biological_Process_2021__nucleobase-containing small molecule catabolic process (GO:0034656),0.4498712583392427,0.6917057065975074,0.8873239436619719,1.0,1.0,2/9,4.09%,NUDT16;ENTPD3
prerank,GO_Biological_Process_2021__DNA-dependent DNA replication (GO:0006261),0.32106379112233424,0.6914437530380398,0.96875,1.0,1.0,26/99,24.35%,RPA2;WDHD1;DNA2;RPS27A;GINS1;PSMB4;POLG2;MCMDC2;RFC4;POLE2;ORC6;UBA52;DBF4;UBB;PSMC2;PSMA3;RFC1;PSMB2;TEFM;PSMD5;PSMD7;RPA3;ORC3;PSMD14;PSMA5;MCM3
prerank,GO_Biological_Process_2021__positive regulation of T cell activation (GO:0050870),0.34712261369488373,0.6913886208777393,0.9090909090909091,1.0,1.0,10/44,18.90%,IL15;TFRC;ANXA1;IL7;PDCD1LG2;NOD2;PYCARD;THY1;HSPD1;RHOH
prerank,GO_Biological_Process_2021__regulation of keratinocyte differentiation (GO:0045616),0.36849801065745363,0.6913122556276373,0.8846153846153846,1.0,1.0,3/17,17.16%,ERRFI1;TRIM16;ROCK1
prerank,GO_Biological_Process_2021__regulation of interferon-alpha production (GO:0032647),-0.32797654286843797,-0.6912294840404996,0.92,1.0,1.0,5/19,13.95%,CHUK;TLR3;IRF5;TLR7;HAVCR2
prerank,GO_Biological_Process_2021__cellular amide metabolic process (GO:0043603),0.3300115424226135,0.6910597179312326,0.9247311827956989,1.0,1.0,12/64,22.58%,PLPP3;ABCA2;ACOT13;CPM;NIT1;CPE;NAPEPLD;GPAT4;SLC5A6;MTHFD1;BTD;DBI
prerank,GO_Biological_Process_2021__regulation of IRE1-mediated unfolded protein response (GO:1903894),0.4389671097668728,0.6906035341857593,0.9047619047619048,1.0,1.0,3/11,14.62%,HSPA5;COPS5;DNAJB9
prerank,GO_Biological_Process_2021__negative regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902548),0.45313369309917784,0.6902578530965654,0.8840579710144928,1.0,1.0,1/6,6.68%,SEMA6A
prerank,GO_Biological_Process_2021__cellular response to estradiol stimulus (GO:0071392),-0.3928163492458191,-0.6896538101830685,0.875,1.0,1.0,1/11,0.95%,ZNF703
prerank,GO_Biological_Process_2021__regulation of lipid metabolic process (GO:0019216),0.3276967896249296,0.6893974350027298,0.9468085106382979,1.0,1.0,14/69,16.18%,TM7SF2;IDI1;MVD;ID2;MID1IP1;IRS2;CCDC3;PRKAG2;FASN;SCD;FDFT1;HMGCS1;SMARCD3;TBL1XR1
prerank,GO_Biological_Process_2021__inner mitochondrial membrane organization (GO:0007007),0.34858170289229484,0.6890823140731513,0.9101123595505618,1.0,1.0,13/38,26.75%,TIMM13;ATP5ME;ATP5F1A;ATP5F1D;CHCHD3;ATP5MC1;IMMT;ATP5PB;ATP5F1E;TIMM22;GHITM;OPA1;HSPA9
prerank,GO_Biological_Process_2021__actin filament-based transport (GO:0099515),-0.33534021787991686,-0.6890166602033483,0.8484848484848485,1.0,1.0,4/14,18.04%,MYO1F;MYO1D;SYNE2;MYO7A
prerank,GO_Biological_Process_2021__regulation of superoxide anion generation (GO:0032928),-0.3509594403270285,-0.6888933597199656,0.88,1.0,1.0,5/11,13.23%,ITGAM;TGFB1;ITGB2;TYROBP;SYK
prerank,GO_Biological_Process_2021__regulation of cellular response to growth factor stimulus (GO:0090287),0.44743325638400133,0.6886691206227818,0.9365079365079365,1.0,1.0,3/6,34.73%,PCSK6;ZDHHC17;XIAP
prerank,GO_Biological_Process_2021__regulation of metal ion transport (GO:0010959),0.41254468139825584,0.6879492006215833,0.9041095890410958,1.0,1.0,2/14,11.27%,ANK2;CAMK2B
prerank,GO_Biological_Process_2021__protein homotetramerization (GO:0051289),0.36112972524905057,0.6877979797283527,0.8452380952380952,1.0,1.0,7/30,22.49%,ACOT13;RYR3;SOD2;HCN1;HPRT1;ACACB;ALDH1A2
prerank,GO_Biological_Process_2021__regulation of interleukin-6 production (GO:0032675),0.31857307848621674,0.6877867467662497,0.9213483146067416,1.0,1.0,2/69,1.30%,RAB7B;NLRP12
prerank,GO_Biological_Process_2021__smooth muscle tissue development (GO:0048745),-0.4162776307706736,-0.6874026852399681,0.8611111111111112,1.0,1.0,2/5,15.54%,ENG;PTCH1
prerank,GO_Biological_Process_2021__positive regulation of cell killing (GO:0031343),-0.3279257626256866,-0.6872266253375405,0.8461538461538461,1.0,1.0,3/9,15.70%,PRF1;SYK;DVL2
prerank,GO_Biological_Process_2021__cellular iron ion homeostasis (GO:0006879),0.3466188409556832,0.6871841104763666,0.9012345679012346,1.0,1.0,12/39,25.52%,TFRC;SLC11A1;FLVCR1;HAMP;SLC39A14;SOD1;FTH1;FBXL5;HFE;ISCU;TF;SLC11A2
prerank,GO_Biological_Process_2021__negative regulation of stem cell differentiation (GO:2000737),0.4173386562402831,0.6871196001050716,0.8732394366197183,1.0,1.0,2/9,21.86%,NELFB;HNRNPU
prerank,GO_Biological_Process_2021__regulation of T-helper 17 type immune response (GO:2000316),-0.41912741965320044,-0.6868408565211697,0.7560975609756098,1.0,1.0,2/5,22.17%,IL12RB1;SMAD7
prerank,"GO_Biological_Process_2021__RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394)",0.393364964670498,0.6866703859156793,0.9382716049382716,1.0,1.0,3/13,18.60%,DDX1;TSEN54;ZBTB8OS
prerank,GO_Biological_Process_2021__cardiac ventricle development (GO:0003231),0.42202468383508673,0.686604560183866,0.8873239436619719,1.0,1.0,1/7,9.87%,PDE2A
prerank,GO_Biological_Process_2021__regulation of extent of cell growth (GO:0061387),0.43196375981220836,0.6865949700672245,0.8591549295774648,1.0,1.0,2/8,22.12%,OLFM1;CTTN
prerank,GO_Biological_Process_2021__mitochondrial translational elongation (GO:0070125),-0.2509160754409881,-0.6861872588161764,1.0,1.0,1.0,9/61,13.60%,MRPL57;MRPS9;MRPL50;MRPL35;TUFM;MRPS11;AURKAIP1;MRPS10;MRPL1
prerank,GO_Biological_Process_2021__positive regulation of cyclin-dependent protein kinase activity (GO:1904031),0.41161041705858215,0.6860760042761967,0.8961038961038961,1.0,1.0,4/16,17.58%,SPDYA;PKD1;CCND3;RGCC
prerank,GO_Biological_Process_2021__epithelial to mesenchymal transition (GO:0001837),0.34848930375808373,0.6860129132125776,0.8604651162790697,1.0,1.0,6/28,17.71%,TGFB2;HIF1A;RBPJ;WNT5A;ROCK1;OLFM1
prerank,GO_Biological_Process_2021__nucleosome positioning (GO:0016584),0.3819324808097309,0.6859404973189662,0.8484848484848485,1.0,1.0,2/9,26.06%,H1-0;SMARCA5
prerank,GO_Biological_Process_2021__positive regulation of toll-like receptor signaling pathway (GO:0034123),-0.2906755724378516,-0.6857482521977845,0.9583333333333334,1.0,1.0,5/19,17.46%,TLR3;NR1H3;TASL;TIRAP;NINJ1
prerank,GO_Biological_Process_2021__regulation of toll-like receptor signaling pathway (GO:0034121),-0.2941744959718603,-0.6856517305722044,0.9259259259259259,1.0,1.0,5/18,11.56%,APPL2;LGR4;TLR3;TREM2;BIRC2
prerank,GO_Biological_Process_2021__neuron projection fasciculation (GO:0106030),0.43206772117734615,0.685636493282906,0.8873239436619719,1.0,1.0,4/9,22.83%,SEMA5A;EPHA4;CDK5R1;RTN4
prerank,GO_Biological_Process_2021__regulation of ER-associated ubiquitin-dependent protein catabolic process (GO:1903069),0.4256536798206948,0.6856150536576019,0.8676470588235294,1.0,1.0,1/8,7.35%,HERPUD1
prerank,GO_Biological_Process_2021__negative regulation of dephosphorylation (GO:0035305),0.40628051580607627,0.6853633539217645,0.9240506329113924,1.0,1.0,1/15,1.38%,SH2D4A
prerank,GO_Biological_Process_2021__negative regulation of centrosome duplication (GO:0010826),-0.3401424245562344,-0.6853585608665068,0.8928571428571429,1.0,1.0,2/9,9.66%,MDM1;TMEM67
prerank,GO_Biological_Process_2021__regulation of establishment or maintenance of cell polarity (GO:0032878),0.39629597956180307,0.6853522037815437,0.9066666666666666,1.0,1.0,4/14,25.86%,KANK1;ROCK1;RUFY3;PTK2B
prerank,GO_Biological_Process_2021__ribosomal small subunit biogenesis (GO:0042274),0.3475717626757563,0.6852430931165309,0.896551724137931,1.0,1.0,7/36,17.27%,RIOK2;RPS6;RPS25;RPS27;RRP36;RPS24;NOB1
prerank,GO_Biological_Process_2021__positive regulation of TORC1 signaling (GO:1904263),-0.34884546764305885,-0.685122212590172,0.8,1.0,1.0,3/15,12.21%,TELO2;CLEC16A;PIH1D1
prerank,GO_Biological_Process_2021__regulation of JUN kinase activity (GO:0043506),0.3690370332617569,0.6846842290601914,0.8625,1.0,1.0,8/25,22.90%,TRAF2;SASH1;DUSP10;AIDA;GSTP1;TNF;PDCD4;MAPK8IP1
prerank,GO_Biological_Process_2021__regulation of cell junction assembly (GO:1901888),-0.32040531117180504,-0.6845897800161643,0.9090909090909091,1.0,1.0,6/17,22.55%,CBFB;RAP1A;RAPGEF1;PRKACA;MEF2C;RUNX1
prerank,GO_Biological_Process_2021__polyphosphate metabolic process (GO:0006797),-0.39760875099921494,-0.6843070132155609,0.8620689655172413,1.0,1.0,1/5,13.66%,BNIP2
prerank,GO_Biological_Process_2021__pyrimidine ribonucleotide biosynthetic process (GO:0009220),-0.37594779930616584,-0.683681971969732,0.7647058823529411,1.0,1.0,1/7,2.11%,DHODH
prerank,GO_Biological_Process_2021__protein deacetylation (GO:0006476),-0.2682387419601723,-0.6836793031689892,1.0,1.0,1.0,1/38,0.68%,FLNA
prerank,GO_Biological_Process_2021__regulation of cholesterol efflux (GO:0010874),-0.28596449175138733,-0.6836058383708126,0.9583333333333334,1.0,1.0,5/24,11.00%,TTC39B;LAMTOR1;NR1H3;TREM2;NFKBIA
prerank,GO_Biological_Process_2021__regulation of MAPK cascade (GO:0043408),0.3222540947036205,0.6835788650386687,0.9680851063829787,1.0,1.0,21/97,21.44%,PHLPP1;INSR;TRIM5;CAV3;FN1;IGF1R;NTRK3;EPHA7;FLT1;NTRK2;PAK5;PEBP1;DHX33;IQGAP1;ROCK1;GSTP1;PRDM15;FGFR2;VRK2;CX3CL1;PAK3
prerank,PanglaoDB_Augmented_2021__Acinar Cells,0.41622874555100686,0.6835779616689356,0.9384615384615385,1.0,1.0,1/8,1.84%,AMY2B
prerank,GO_Biological_Process_2021__rDNA heterochromatin assembly (GO:0000183),-0.4174617917757325,-0.6833834541435904,0.8571428571428571,1.0,1.0,6/6,58.28%,MBD2;SIRT2;SIRT1;RRP8;H3-3A;BAZ2A
prerank,GO_Biological_Process_2021__positive regulation of cardiac muscle tissue growth (GO:0055023),-0.36131620916404705,-0.6832505536723404,0.9259259259259259,1.0,1.0,2/12,7.34%,TGFBR3;IGF1
prerank,GO_Biological_Process_2021__negative regulation of T cell activation (GO:0050868),0.36568807281622906,0.683109086808696,0.9166666666666666,1.0,1.0,4/26,10.74%,CR1;GPNMB;FCGR2B;PDCD1LG2
prerank,GO_Biological_Process_2021__axonemal dynein complex assembly (GO:0070286),0.3991308251697909,0.6826745580817687,0.8947368421052632,1.0,1.0,5/12,22.26%,CCDC39;DNAH17;DNAH7;DNAAF2;DNAAF5
prerank,GO_Biological_Process_2021__regulation of mitochondrial membrane potential (GO:0051881),0.3570281462659877,0.6821116063859625,0.8941176470588236,1.0,1.0,7/28,21.55%,MAPT;PINK1;PRELID1;SOD1;UBB;LRRK2;ATP5IF1
prerank,GO_Biological_Process_2021__negative regulation of B cell activation (GO:0050869),0.39869117241173024,0.6819587327569494,0.9,1.0,1.0,4/13,19.50%,FCGR2B;ID2;CD300A;TNFRSF21
prerank,GO_Biological_Process_2021__negative regulation of tumor necrosis factor production (GO:0032720),-0.30594346491987584,-0.68192257968821,0.9,1.0,1.0,5/23,13.95%,LGALS9;SIRPA;IGF1;ILRUN;HAVCR2
prerank,GO_Biological_Process_2021__nuclear transport (GO:0051169),0.40572539521655165,0.6819032758234602,0.8493150684931506,1.0,1.0,1/11,8.25%,XPO1
prerank,GO_Biological_Process_2021__regulation of platelet-derived growth factor receptor-beta signaling pathway (GO:2000586),0.4461796564867716,0.6814418016958864,0.8666666666666667,1.0,1.0,3/5,31.54%,HIP1R;LRP1;HIP1
prerank,GO_Biological_Process_2021__anterior/posterior pattern specification (GO:0009952),0.399822540084781,0.6809291896825499,0.9333333333333333,1.0,1.0,2/14,9.89%,BHLHE40;CELSR2
prerank,GO_Biological_Process_2021__pyrimidine ribonucleotide metabolic process (GO:0009218),-0.4381121659508471,-0.6808947711429143,0.9032258064516129,1.0,1.0,2/5,11.95%,DHODH;ENTPD4
prerank,GO_Biological_Process_2021__mRNA pseudouridine synthesis (GO:1990481),-0.41384239406459106,-0.6808134765913461,0.8157894736842105,1.0,1.0,1/5,1.88%,PUS1
prerank,GO_Biological_Process_2021__early endosome to late endosome transport (GO:0045022),-0.3086529116321568,-0.6800869648137347,0.9523809523809523,1.0,1.0,5/19,18.63%,WDR91;EMP2;BECN1;STX8;RAB7A
prerank,GO_Biological_Process_2021__cellular response to thyroid hormone stimulus (GO:0097067),0.41821524187621373,0.6798561023464577,0.8493150684931506,1.0,1.0,2/10,21.38%,KLF9;RDX
prerank,GO_Biological_Process_2021__vesicle organization (GO:0016050),0.3512714021830313,0.6797615184843531,0.9545454545454546,1.0,1.0,5/31,13.85%,SRGN;VPS11;DNM1;SNX10;HOOK3
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway in response to oxidative stress (GO:0008631),0.42761777556839353,0.6797233644796737,0.8181818181818182,1.0,1.0,1/9,8.75%,GSKIP
prerank,GO_Biological_Process_2021__tRNA modification (GO:0006400),0.3282940164724557,0.6796917383305745,0.9390243902439024,1.0,1.0,4/49,11.13%,TRMT9B;FTSJ1;PUS7;METTL2A
prerank,PanglaoDB_Augmented_2021__Basophils,0.3213714273607848,0.6796196209183546,0.9387755102040817,1.0,1.0,17/109,16.93%,NFIL3;CLEC12A;INF2;F13A1;FCGR2B;SIRPB2;FGR;FCGR2C;CD93;FGL2;TULP3;CD300A;GPR183;ST6GALNAC5;PDK3;LRRC25;TEC
prerank,GO_Biological_Process_2021__negative regulation of cell cycle process (GO:0010948),0.34470896149613234,0.6795843057376372,0.8823529411764706,1.0,1.0,15/43,27.34%,TOM1L1;BMI1;BRCA1;YAF2;E2F7;UXT;SUZ12;EZH2;CBX5;RBBP8;NME6;CCP110;MAX;WAPL;PCGF6
prerank,GO_Biological_Process_2021__transcription by RNA polymerase II (GO:0006366),0.3086971011498422,0.6795748006101744,0.98,1.0,1.0,39/238,22.06%,NFE2L3;NFIX;ERCC2;NR4A2;NR4A1;RORB;NOCT;RXRB;INTS12;RBPJ;C5AR1;NR2F1;DEAF1;INTS3;NR4A3;DRAP1;ZNF143;GTF2H3;NELFB;ESR1;CEBPD;NR2C2;KLF13;TBL1XR1;POLR2D;ERCC6;TAF9B;INTS8;ESRRG;ELL2;CDK9;PPARA;TAF7;NOTCH2;NR1D1;POLR2G;TRIM24;EAF1;INTS6
prerank,GO_Biological_Process_2021__defense response to virus (GO:0051607),0.32326168764615854,0.6795701394616257,0.9578947368421052,1.0,1.0,10/82,13.05%,DDIT4;IFIT5;ATAD3A;PQBP1;TRIM5;BNIP3L;IFITM3;IFNLR1;IFIT2;BNIP3
prerank,GO_Biological_Process_2021__endosome transport via multivesicular body sorting pathway (GO:0032509),-0.2568413547538402,-0.6789941675864117,0.896551724137931,1.0,1.0,3/19,9.99%,LAPTM4B;VTA1;CHMP2B
prerank,GO_Biological_Process_2021__ventricular cardiac muscle tissue development (GO:0003229),-0.37625667568582,-0.6787139730651139,0.896551724137931,1.0,1.0,2/10,7.51%,TGFBR3;TGFB1
prerank,PanglaoDB_Augmented_2021__Reticulocytes,0.31942811233768637,0.6776345988113232,0.9574468085106383,1.0,1.0,18/90,27.76%,TBRG4;TFRC;XPO1;STT3B;INCENP;TIMELESS;IMMT;DDB1;NDC1;GANAB;CCT8;MCM3;EIF3A;SLC11A2;EIF3D;DHX37;UBE2O;PPRC1
prerank,GO_Biological_Process_2021__maturation of SSU-rRNA (GO:0030490),0.3483429621733893,0.6770604052573861,0.9024390243902439,1.0,1.0,3/33,10.58%,RIOK2;NGDN;RRP36
prerank,GO_Biological_Process_2021__L-amino acid transport (GO:0015807),0.382845725634535,0.6770094448694216,0.9111111111111111,1.0,1.0,1/16,3.93%,SLC1A2
prerank,GO_Biological_Process_2021__cellular response to misfolded protein (GO:0071218),0.3582515213147731,0.6766559238678164,0.92,1.0,1.0,2/18,13.84%,RNF126;AUP1
prerank,GO_Biological_Process_2021__regulation of lipid catabolic process (GO:0050994),0.43461916219360547,0.6765332231383561,0.9305555555555556,1.0,1.0,3/8,20.20%,ALK;TYSND1;TNF
prerank,GO_Biological_Process_2021__regulation of cytosolic calcium ion concentration (GO:0051480),0.3263586483573023,0.6759183894639571,0.9361702127659575,1.0,1.0,21/61,26.31%,TACR1;CD55;CAV3;RYR2;TRPC4;C5AR1;ADCY8;WNT5A;ESR1;CACNA1A;ACKR4;DLG4;TMEM178A;ATP1A2;PTGER4;TRPC1;FPR1;ATP2B2;CACNA1C;ATP2B4;C5AR2
prerank,GO_Biological_Process_2021__regulation of programmed necrotic cell death (GO:0062098),0.38035207361850304,0.6758450028853051,0.8888888888888888,1.0,1.0,5/16,23.39%,CDC37;SDCBP;PELI1;FLOT2;PDCD6IP
prerank,GO_Biological_Process_2021__negative regulation of protein exit from endoplasmic reticulum (GO:0070862),-0.3387437668126003,-0.6757711578548318,0.8214285714285714,1.0,1.0,3/9,16.48%,SVIP;DERL2;OS9
prerank,GO_Biological_Process_2021__autophagosome assembly (GO:0000045),0.3463667927209048,0.6757598084410708,0.9186046511627907,1.0,1.0,10/42,29.74%,TMEM41B;VMP1;ATP2A2;UBXN2B;ATG5;MFN2;ATG13;MAP1LC3A;NSFL1C;ATG2B
prerank,GO_Biological_Process_2021__glutamate metabolic process (GO:0006536),0.38073960787775574,0.6757060668197,0.9295774647887324,1.0,1.0,2/13,9.72%,GAD1;GLUL
prerank,GO_Biological_Process_2021__positive regulation of superoxide anion generation (GO:0032930),-0.3537574215253998,-0.6756944453616563,0.8888888888888888,1.0,1.0,5/10,13.23%,ITGAM;TGFB1;ITGB2;TYROBP;SYK
prerank,GO_Biological_Process_2021__regulation of response to oxidative stress (GO:1902882),0.4112760628222585,0.6746884639697185,0.9,1.0,1.0,2/8,15.47%,PINK1;MCTP1
prerank,GO_Biological_Process_2021__regulation of early endosome to late endosome transport (GO:2000641),0.3701716427965573,0.6745280105381012,0.8888888888888888,1.0,1.0,3/17,21.38%,VPS11;RAB21;RDX
prerank,GO_Biological_Process_2021__protein auto-ADP-ribosylation (GO:0070213),-0.3171988511572901,-0.6740712461874513,0.8857142857142857,1.0,1.0,11/11,68.32%,PARP2;PARP8;TNKS;PARP16;PARP6;PARP1;PARP12;TNKS2;PARP10;PARP11;TIPARP
prerank,GO_Biological_Process_2021__positive regulation of establishment of protein localization to mitochondrion (GO:1903749),-0.2657545149496082,-0.6739770773614217,0.9230769230769231,1.0,1.0,6/42,7.96%,HPS4;BAP1;GZMB;TP53;BID;PPP1R13B
prerank,GO_Biological_Process_2021__establishment of protein localization to peroxisome (GO:0072663),0.4322587971816651,0.6738340160519873,0.8636363636363636,1.0,1.0,1/6,18.77%,HACL1
prerank,GO_Biological_Process_2021__peroxisomal transport (GO:0043574),0.4322587971816651,0.6738340160519873,0.8636363636363636,1.0,1.0,1/6,18.77%,HACL1
prerank,GO_Biological_Process_2021__regulation of transcription by RNA polymerase II (GO:0006357),0.30406562140412446,0.673795423698135,1.0,1.0,1.0,206/1260,21.86%,BRIP1;KLF4;NAMPT;NFIL3;ZNF382;MACC1;FGF1;ST18;SAP30;ZNF793;NFE2L3;RPL23;EGR1;TGIF1;HMGB2;PLAC8;PFKM;NFIX;ZBTB16;CREB5;ZNF483;NR4A2;NFIB;NR4A1;MEIS2;TSHZ3;ZNF41;SLC11A1;ACVR2A;PIAS4;BMPR1B;RFX2;ASXL3;RORB;ARID5B;VEGFA;SOX4;ZNF93;IER5;SUV39H2;RXRB;TCF7;ZNF654;ZNF814;HDGFL3;OVOL2;OLIG1;ABCA2;COPS5;HIF1A;BMI1;KDM3A;HSF2;HCFC1;CSRNP3;ARNT2;ZKSCAN5;RUVBL2;POU6F1;ZNF235;ZNF540;PAX8;YEATS2;BHLHE40;PPP1R13L;FOSL2;TCF7L1;TRPS1;KCTD1;MAFB;ID2;SS18L1;ATAD2;RBPJ;RRP1B;ZNF518A;RPS27A;KDM1A;POU5F1;MXD1;PDE2A;SRA1;PTOV1;PER1;ZNF34;CRTC3;IMPACT;NR2F1;NOD2;MXI1;GABPB1;DCAF6;ZNF536;DEAF1;ZNF850;PPID;HIF3A;SOX6;HCLS1;ETS2;HINFP;CCNC;CSRNP2;OTUD7B;RIPK2;FBP1;ZNF606;ZNF550;NR4A3;BRCA1;DRAP1;ZNF549;SOD2;ZNF143;PKD1;E2F7;HIVEP2;SDCBP;DPF3;ZNF248;GTF2H3;HIC2;WNT5A;ZNF292;UXT;SMARCD3;ESR1;MTA3;AKIRIN1;IL18;ZNF789;CEBPD;NR2C2;LDB2;TSHZ2;ZNF260;KLF13;TBL1XR1;CTBP1;TBX19;ZBTB47;ZNF717;EPAS1;LITAF;TXK;KLF9;CHD5;SMAD1;HAMP;BCL6;APP;KLF7;FOXP1;RGCC;ZNF665;ZBTB18;TNFRSF1A;TAF9B;ZNF778;UBA52;HSPD1;ESRRG;SMARCC1;EZH2;UBB;CDK9;PPARA;TAF7;ZNF197;NKX6-2;ZNF684;FOS;PRDM15;ZNF213;KDM5B;SMAD5;PRPF6;NOP53;CTDSP1;KDM6B;PCGF5;BEX1;TNF;ENO1;NR1D1;POU6F2;NPAS2;TCF4;ZNF565;BCL11A;FGFR2;CBX5;SLC9A1;ATF3;RBBP8;WIZ;CX3CL1;TNIP1;HEXIM1;SP140L;BRWD1;TFAP2E;ZNF142;MTF1;STAT1;HNRNPU
prerank,GO_Biological_Process_2021__negative regulation of epithelial cell apoptotic process (GO:1904036),0.41231681475809756,0.6736022893124725,0.9242424242424242,1.0,1.0,2/14,19.04%,SEMA5A;PPARA
prerank,"GO_Biological_Process_2021__regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)",0.3887370527426159,0.6735710885921908,0.9012345679012346,1.0,1.0,1/16,9.50%,KDM1A
prerank,GO_Biological_Process_2021__cellular response to molecule of bacterial origin (GO:0071219),0.3252592330140425,0.6731326651414662,0.9583333333333334,1.0,1.0,9/60,15.06%,VIM;HMGB2;FCGR2B;PDE4B;PDCD1LG2;NOD2;TNFRSF1B;PYCARD;WNT5A
prerank,GO_Biological_Process_2021__adenylate cyclase-activating adrenergic receptor signaling pathway (GO:0071880),-0.38956433637284704,-0.6729457802363751,0.8125,1.0,1.0,5/5,61.07%,ADRB2;ADRA1A;AKAP13;RAPGEF2;ADCY9
prerank,GO_Biological_Process_2021__regulation of purine nucleotide metabolic process (GO:1900542),0.35083312316487614,0.6729013358231454,0.8823529411764706,1.0,1.0,5/35,15.76%,NUP133;PGAM1;HIF1A;PRKAG2;SEH1L
prerank,GO_Biological_Process_2021__chromatin assembly or disassembly (GO:0006333),-0.3938652348910645,-0.6728771668346041,0.8823529411764706,1.0,1.0,5/9,14.80%,TP53;CDAN1;SUPT16H;M1AP;RBBP4
prerank,GO_Biological_Process_2021__negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),0.40926485615775465,0.6726519146684283,0.92,1.0,1.0,2/14,9.50%,TMEM161A;KDM1A
prerank,GO_Biological_Process_2021__regulation of ATP metabolic process (GO:1903578),0.34714402137202305,0.6724307870407199,0.896551724137931,1.0,1.0,7/43,15.76%,NUP133;PGAM1;HIF1A;COX7A2;PRKAG2;PINK1;SEH1L
prerank,GO_Biological_Process_2021__contractile actin filament bundle assembly (GO:0030038),0.3754641119296949,0.6721903642874774,0.9358974358974359,1.0,1.0,5/13,26.64%,SORBS1;FAM171A1;PHACTR1;TNFAIP1;KCTD13
prerank,GO_Biological_Process_2021__stress fiber assembly (GO:0043149),0.3754641119296949,0.6721903642874774,0.9358974358974359,1.0,1.0,5/13,26.64%,SORBS1;FAM171A1;PHACTR1;TNFAIP1;KCTD13
prerank,GO_Biological_Process_2021__negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642),0.42314601986751343,0.6720231656479301,0.921875,1.0,1.0,3/8,34.82%,NDRG4;LRP1;HGS
prerank,GO_Biological_Process_2021__inositol phosphate-mediated signaling (GO:0048016),0.40596144319563254,0.6719679731430463,0.8666666666666667,1.0,1.0,1/11,8.94%,ADGRB2
prerank,GO_Biological_Process_2021__negative regulation of cell cycle G2/M phase transition (GO:1902750),0.3287469192909727,0.6718654580960113,0.9047619047619048,1.0,1.0,11/47,24.06%,FBXL7;FHL1;PSMB4;RBX1;PSMC2;PSMA3;PSMB2;PSMD5;PSMD7;PSMD14;PSMA5
prerank,GO_Biological_Process_2021__regulation of centrosome duplication (GO:0010824),0.3651682855574121,0.6718447439525116,0.9259259259259259,1.0,1.0,5/23,23.39%,PLK2;XRCC3;C10ORF90;CHMP5;PDCD6IP
prerank,GO_Biological_Process_2021__negative regulation of type I interferon production (GO:0032480),-0.26481412484184996,-0.6718086373436402,1.0,1.0,1.0,5/34,13.95%,UBA7;SIRPA;ILRUN;UFD1;HAVCR2
prerank,GO_Biological_Process_2021__positive regulation of autophagy of mitochondrion (GO:1903599),0.40212854089940187,0.6716906621793127,0.8243243243243243,1.0,1.0,2/9,20.22%,SLC25A4;FBXO7
prerank,GO_Biological_Process_2021__regulation of oxidative stress-induced neuron death (GO:1903203),0.4240339346772101,0.6711841406816433,0.8307692307692308,1.0,1.0,2/6,20.22%,PINK1;FBXO7
prerank,GO_Biological_Process_2021__positive regulation of T-helper 1 type immune response (GO:0002827),0.4431869962530317,0.6711180242749388,0.8636363636363636,1.0,1.0,2/5,15.83%,SLC11A1;IL18
prerank,GO_Biological_Process_2021__positive regulation of proteasomal protein catabolic process (GO:1901800),0.31650852335845825,0.6708609081465555,0.9651162790697675,1.0,1.0,14/69,24.39%,RNF144B;ARIH2;RNF144A;RBX1;PRICKLE1;DNAJB2;HSPA1B;PSMC2;NOP53;LRRK2;USP5;BBS7;RNFT1;DDRGK1
prerank,GO_Biological_Process_2021__positive regulation of defense response to virus by host (GO:0002230),0.3632527989906694,0.67039852335938,0.9047619047619048,1.0,1.0,5/19,27.83%,PQBP1;AIM2;STAT1;TRAF3IP2;PARP9
prerank,GO_Biological_Process_2021__spermidine metabolic process (GO:0008216),0.44680553689046293,0.6699695555710868,0.9032258064516129,1.0,1.0,3/6,30.84%,SRM;AMD1;SAT2
prerank,GO_Biological_Process_2021__hemopoiesis (GO:0030097),0.3207433169306495,0.66995509426555,0.9361702127659575,1.0,1.0,7/60,11.67%,TGFB2;ZBTB16;KITLG;BMI1;SBDS;ARIH2;FLT1
prerank,GO_Biological_Process_2021__acyl-CoA metabolic process (GO:0006637),-0.28065281896111705,-0.6698038581113097,0.9545454545454546,1.0,1.0,3/21,10.15%,ACSM5;ACSF2;MLYCD
prerank,GO_Biological_Process_2021__positive regulation of nucleobase-containing compound transport (GO:0032241),0.42923611992480926,0.6697950013207504,0.8620689655172413,1.0,1.0,2/5,32.04%,CPSF6;DHX9
prerank,GO_Biological_Process_2021__positive regulation of RNA export from nucleus (GO:0046833),0.42923611992480926,0.6697950013207504,0.8620689655172413,1.0,1.0,2/5,32.04%,CPSF6;DHX9
prerank,GO_Biological_Process_2021__regulation of DNA-dependent DNA replication (GO:0090329),-0.36046286187948373,-0.6692659895947123,0.8666666666666667,1.0,1.0,3/8,14.16%,NBN;WDR18;KAT7
prerank,GO_Biological_Process_2021__negative regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903799),0.4494336908056641,0.6691946262163453,0.890625,1.0,1.0,2/6,20.20%,ESR1;TNF
prerank,GO_Biological_Process_2021__regulation of response to external stimulus (GO:0032101),0.3223196539556628,0.6684498760339209,0.9680851063829787,1.0,1.0,11/72,17.56%,ANXA1;FCGR2B;CD55;TRIM5;CASP5;FGR;NOD2;WNT5A;GRK4;BCL6;FOXP1
prerank,GO_Biological_Process_2021__myoblast fusion (GO:0007520),0.4332977060400387,0.668209876524097,0.8823529411764706,1.0,1.0,1/6,23.42%,ADGRB3
prerank,GO_Biological_Process_2021__regulation of mitotic cell cycle (GO:0007346),0.3112984157566672,0.6678436631650067,0.9787234042553191,1.0,1.0,26/121,24.06%,NEK11;CKS2;ERCC2;BRINP1;MEIS2;RCC1;SRA1;PSMB4;SDCBP;IQGAP1;APP;PSMC2;CDK9;CDC25B;PSMA3;PSMB2;CDKN1B;DDB1;PSMD5;HNRNPU;PSMD7;PIM3;PSMD14;BORA;CDK10;PSMA5
prerank,"GO_Biological_Process_2021__negative regulation of DNA-templated transcription, elongation (GO:0032785)",0.37751338038782456,0.6673559402314296,0.8571428571428571,1.0,1.0,3/13,21.86%,NELFB;HEXIM1;HNRNPU
prerank,GO_Biological_Process_2021__preassembly of GPI anchor in ER membrane (GO:0016254),0.38592889906359495,0.6672525681308645,0.8840579710144928,1.0,1.0,4/12,19.17%,PIGQ;PIGF;PIGL;PIGG
prerank,GO_Biological_Process_2021__ganglioside biosynthetic process (GO:0001574),0.39193684267784434,0.667038784056105,0.8571428571428571,1.0,1.0,3/10,15.35%,B4GALT5;ST6GALNAC5;ST8SIA3
prerank,GO_Biological_Process_2021__regulation of mRNA polyadenylation (GO:1900363),0.365747601285908,0.6663711041418836,0.9012345679012346,1.0,1.0,6/17,36.38%,CDK9;CPSF6;CTR9;HSF1;NCBP1;ZC3H3
prerank,GO_Biological_Process_2021__positive regulation of protein localization to centrosome (GO:1904781),-0.4076016760429566,-0.6663088449707124,0.8333333333333334,1.0,1.0,1/5,15.17%,MARK4
prerank,GO_Biological_Process_2021__regulation of cellular ketone metabolic process (GO:0010565),0.3235742829660114,0.6656515946546281,0.896551724137931,1.0,1.0,12/47,24.06%,PDK4;SIRT5;PSMB4;PRKAG2;PSMC2;PPARA;PSMA3;PSMB2;PSMD5;PSMD7;PSMD14;PSMA5
prerank,GO_Biological_Process_2021__glutamine family amino acid metabolic process (GO:0009064),0.3655308972389335,0.6653409265045069,0.9518072289156626,1.0,1.0,2/20,9.72%,GLYATL1;GLUL
prerank,"GO_Biological_Process_2021__regulation of transcription, DNA-templated (GO:0006355)",0.30034632622135876,0.665125877979286,1.0,1.0,1.0,157/1271,17.75%,BRIP1;KLF4;CENPF;NFIL3;ACVR1B;ZNF382;ST18;SAP30;CDK14;ZNF793;NFE2L3;EGR1;TGIF1;HMGB2;TLE1;NFIX;ZBTB16;CREB5;ZNF483;MYRF;NR4A2;AGT;NFIB;NRG1;NR4A1;PQBP1;MEIS2;TSHZ3;ZNF41;PIAS4;RFX2;RORB;PTPRK;ARID5B;VEGFA;SOX4;ZNF93;SUV39H2;POLR3F;RXRB;TCF7;ZNF654;RUNX1T1;APBB3;ZNF814;HDGFL3;HINT1;INSR;SFMBT1;RBFOX2;OVOL2;OLIG1;ABCA2;HIF1A;KDM3A;GLRX2;HSF2;HCFC1;FOXN2;CSRNP3;ATP8B1;ARNT2;ZKSCAN5;RUVBL2;POU6F1;ZNF235;ZNF540;PAX8;YEATS2;BHLHE40;PPP1R13L;FOSL2;TCF7L1;TRPS1;KCTD1;MAFB;ID2;SS18L1;ATAD2;LIMD1;RBPJ;ZNF518A;KDM1A;POU5F1;MXD1;CELSR2;SRA1;PER1;ZNF34;NR2F1;MXI1;ING1;PRICKLE1;ZNF536;DEAF1;TULP3;ZNF850;HIF3A;SOX6;HCLS1;ETS2;HINFP;CCNC;CSRNP2;ZNF606;ZNF550;NR4A3;BRCA1;DRAP1;ZNF549;SOD2;LANCL2;RLIM;TRIM16;YAF2;ZNF143;E2F7;HIVEP2;DPF3;ZNF248;PICALM;HIC2;WNT5A;ACTR5;ZNF292;MLF2;UXT;SMARCD3;ESR1;MTA3;ZNF789;CEBPD;NR2C2;TSHZ2;ZNF260;KLF13;TBL1XR1;CTBP1;TBX19;ZBTB47;ZNF717;EPAS1;LITAF;CXXC1;KLF9;CHD5;PLCB1;SMAD1;PCBD2;TFAM;BCL6;KLF7;APBB2;FOXP1;ZNF665;ERCC6;ZBTB18
prerank,GO_Biological_Process_2021__protein deneddylation (GO:0000338),-0.3375887555555738,-0.6650943424520703,0.84375,1.0,1.0,5/10,17.04%,COPS7B;COPS8;COPS7A;COPS2;COPS6
prerank,GO_Biological_Process_2021__spliceosomal complex assembly (GO:0000245),0.3469747677404844,0.664765577720185,0.9285714285714286,1.0,1.0,6/36,21.40%,CELF2;DDX1;RBM5;PRPF6;SRSF5;SNRPD2
prerank,GO_Biological_Process_2021__cellular response to interleukin-1 (GO:0071347),0.31682828214082265,0.6643782920823883,0.9791666666666666,1.0,1.0,24/102,22.13%,ST18;EGR1;MAP3K8;HIF1A;RPS27A;NOD2;PSMB4;RBX1;RIPK2;PYCARD;PELI1;GBP2;PLCB1;UBA52;UBB;PSMC2;PSMA3;PSMB2;NR1D1;IRAK3;CX3CL1;PSMD5;PSMD7;MAP3K3
prerank,GO_Biological_Process_2021__regulation of cell adhesion (GO:0030155),0.32194235465613974,0.6640501148410213,0.9777777777777777,1.0,1.0,19/82,21.29%,FRMD5;VEGFA;CELSR2;SEMA5A;EPHA7;EPHA4;PLXNB1;TGFBI;IL18;EPB41L4B;ITGAV;ROCK1;ARHGDIA;PLXNC1;PKP4;FES;ADAM22;TNF;P4HB
prerank,GO_Biological_Process_2021__tRNA 5'-leader removal (GO:0001682),-0.383823032759203,-0.6638056895141817,0.8461538461538461,1.0,1.0,5/5,61.64%,RPP30;RPP38;POP1;POP5;SSB
prerank,GO_Biological_Process_2021__regulation of autophagosome maturation (GO:1901096),0.38773533919332254,0.6637347063921303,0.8918918918918919,1.0,1.0,4/11,27.13%,TMEM39A;CALCOCO2;FYCO1;UBQLN4
prerank,GO_Biological_Process_2021__regulation of peptidyl-lysine acetylation (GO:2000756),-0.3859437043330479,-0.6631606097910511,0.7666666666666667,1.0,1.0,1/7,7.11%,DIP2A
prerank,PanglaoDB_Augmented_2021__Goblet Cells,0.4094203792883058,0.6630813068011985,0.881578947368421,1.0,1.0,4/12,12.65%,MANF;OVOL2;OTOGL;BACE2
prerank,GO_Biological_Process_2021__secondary alcohol metabolic process (GO:1902652),0.35547089467121457,0.6630153909924593,0.9213483146067416,1.0,1.0,4/25,22.91%,ABCA1;ABCA5;OSBPL5;ABCG1
prerank,GO_Biological_Process_2021__regulation of tumor necrosis factor production (GO:0032680),0.3022677915254622,0.6629415613654184,0.9560439560439561,1.0,1.0,9/76,17.56%,THBS1;NOD2;ARG2;PYCARD;WNT5A;HSPB1;APP;GSTP1;FOXP1
prerank,GO_Biological_Process_2021__embryonic heart tube morphogenesis (GO:0003143),0.37303496405439274,0.6627157303926722,0.9333333333333333,1.0,1.0,7/18,29.90%,RYR2;CCDC39;NDRG4;BBS7;SETDB2;MEGF8;MICAL2
prerank,GO_Biological_Process_2021__protein import into nucleus (GO:0006606),0.3228159200103378,0.6623749514707048,0.9333333333333333,1.0,1.0,7/58,14.53%,RPL23;NUP133;PRICKLE1;HEATR3;FAM53C;TNPO2;RANBP17
prerank,GO_Biological_Process_2021__regulation of carbohydrate catabolic process (GO:0043470),0.3469381245392456,0.6615006721678489,0.9302325581395349,1.0,1.0,5/36,15.76%,NUP133;PGAM1;HIF1A;PRKAG2;SEH1L
prerank,GO_Biological_Process_2021__regulation of protein localization (GO:0032880),0.34793561128149497,0.6613356501627078,0.9302325581395349,1.0,1.0,9/44,26.32%,TRIM5;MAP2;KDM1A;TRIM25;PICALM;TRIM14;BORA;ZDHHC7;HSP90AB1
prerank,GO_Biological_Process_2021__lipoprotein localization (GO:0044872),-0.36673399357761327,-0.6610467631317023,0.9166666666666666,1.0,1.0,1/8,2.69%,ZDHHC3
prerank,GO_Biological_Process_2021__serine family amino acid metabolic process (GO:0009069),0.4169406776206717,0.6606534924594988,0.9230769230769231,1.0,1.0,1/7,4.35%,SEPSECS
prerank,GO_Biological_Process_2021__positive regulation of cytokine-mediated signaling pathway (GO:0001961),0.3598981521425198,0.6606452836100972,0.9195402298850575,1.0,1.0,5/26,17.43%,IL7;HIF1A;WNT5A;TXK;HSPA1B
prerank,GO_Biological_Process_2021__nuclear envelope organization (GO:0006998),0.3643875966311604,0.660240608219097,0.9125,1.0,1.0,2/14,19.70%,REEP3;SUN2
prerank,GO_Biological_Process_2021__modulation by symbiont of host apoptotic process (GO:0052150),-0.397606687057371,-0.6599544639400633,0.8,1.0,1.0,2/6,18.53%,SERPINB9;RNF213
prerank,GO_Biological_Process_2021__negative regulation of programmed necrotic cell death (GO:0062099),0.42241057766857953,0.6597560636861802,0.9848484848484849,1.0,1.0,3/7,27.93%,PELI1;SLC25A4;YBX3
prerank,GO_Biological_Process_2021__negative regulation of necroptotic process (GO:0060546),0.42241057766857953,0.6597560636861802,0.9848484848484849,1.0,1.0,3/7,27.93%,PELI1;SLC25A4;YBX3
prerank,GO_Biological_Process_2021__mitotic sister chromatid cohesion (GO:0007064),0.39296671027959107,0.6595107701043036,0.8714285714285714,1.0,1.0,3/10,37.39%,RAD21;PDS5B;NIPBL
prerank,GO_Biological_Process_2021__cellular response to increased oxygen levels (GO:0036295),-0.352689002973571,-0.6594325970320826,0.8518518518518519,1.0,1.0,4/8,29.12%,FAS;ATP6AP1;ATP6V1G1;ATG7
prerank,GO_Biological_Process_2021__negative regulation of interleukin-10 production (GO:0032693),0.4100730249190849,0.6593417526921093,0.8985507246376812,1.0,1.0,3/10,19.50%,FCGR2B;PDCD1LG2;TNFRSF21
prerank,GO_Biological_Process_2021__negative regulation of glucose import (GO:0046325),0.4322746315997579,0.6590165789567443,0.8625,1.0,1.0,1/6,7.25%,GRB10
prerank,GO_Biological_Process_2021__protein homooligomerization (GO:0051260),0.31709143501043213,0.6588556602209337,0.9368421052631579,1.0,1.0,19/77,23.88%,SLC1A2;ACOT13;GSDMD;ADCY8;POLQ;RYR3;SPAST;SOD2;HCN1;PYCARD;DISP1;HPRT1;ALAD;AQP11;ECT2;ACACB;ALDH1A2;PDCD6IP;NACC2
prerank,GO_Biological_Process_2021__regulation of histone H2B ubiquitination (GO:2001166),0.4211097851255455,0.6588377386677763,0.8923076923076924,1.0,1.0,2/5,29.71%,CDK9;CTR9
prerank,GO_Biological_Process_2021__entrainment of circadian clock by photoperiod (GO:0043153),0.3725514158873015,0.6584943370358172,0.9375,1.0,1.0,4/20,12.81%,BHLHE40;ID2;PER1;RBM4B
prerank,GO_Biological_Process_2021__negative regulation of ATPase activity (GO:0032780),0.39831657460509745,0.6583524120745559,0.8918918918918919,1.0,1.0,2/11,21.55%,PXK;ATP5IF1
prerank,GO_Biological_Process_2021__RNA metabolic process (GO:0016070),0.29708025304535013,0.6580011459197646,0.9797979797979798,1.0,1.0,11/111,12.50%,TBRG4;RNASEH2C;WDR74;RBM3;RBFOX2;ADARB2;TFIP11;CELF2;NOVA1;HNRNPA0;RBM5
prerank,GO_Biological_Process_2021__positive regulation of cellular component biogenesis (GO:0044089),0.3208224764114115,0.6570089810455505,0.9680851063829787,1.0,1.0,4/60,5.04%,TFRC;NRG1;SLF1;VEGFA
prerank,PanglaoDB_Augmented_2021__B Cells,-0.249012917527068,-0.6568185409268058,1.0,1.0,1.0,8/106,3.99%,NKG7;CD37;LY86;BIN2;CD2;BANK1;BLNK;CEACAM21
prerank,GO_Biological_Process_2021__proteasomal ubiquitin-independent protein catabolic process (GO:0010499),0.35978535943092266,0.6567109994907785,0.7875,1.0,1.0,5/17,24.06%,ENC1;PSMB4;PSMA3;PSMB2;PSMA5
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA damage recognition (GO:0000715)",0.36591512099817214,0.6563011874660225,0.8888888888888888,1.0,1.0,7/22,23.67%,COPS5;RPS27A;RBX1;UBA52;UBB;DDB1;GPS1
prerank,GO_Biological_Process_2021__positive regulation of lipid transport (GO:0032370),-0.37964756277737,-0.6562264915253337,0.8787878787878788,1.0,1.0,1/8,2.28%,CYP19A1
prerank,GO_Biological_Process_2021__transcription initiation from RNA polymerase I promoter (GO:0006361),0.34147890788794194,0.6557736014676013,0.95,1.0,1.0,3/26,14.88%,ERCC2;POLR1C;GTF2H3
prerank,GO_Biological_Process_2021__proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),0.2876613389076254,0.6555621894507548,0.9696969696969697,1.0,1.0,54/258,27.34%,FBXL7;KCTD2;HSPA5;SEC61B;FBXL2;HERPUD1;RPS27A;TRIM25;RNF175;TRIM9;STT3B;PSMB4;RBX1;DNAJB2;RNF126;FBXO27;AUP1;DNAJB9;PELI1;SYVN1;TBL1XR1;UBXN2B;ERLIN1;UBE2J2;HECW2;FBXL13;UBA52;UBB;PSMC2;FBXL5;ZNRF1;PSMA3;PSMB2;SPSB3;UCHL1;DDB1;PSMD5;HSP90B1;PSMD7;HACE1;FEM1C;FAM8A1;PSMD14;PSMA5;MAN1A1;RHBDD2;TNFAIP1;BAG6;KCTD13;FZR1;UBE2D1;CTNNB1;FEM1B;UBR2
prerank,GO_Biological_Process_2021__autophagosome maturation (GO:0097352),0.34640764748409525,0.6555518316360154,0.9156626506024096,1.0,1.0,3/25,15.68%,SNAP29;VMP1;ATP2A2
prerank,GO_Biological_Process_2021__osteoclast differentiation (GO:0030316),-0.3197321277531525,-0.6553917377770258,0.9130434782608695,1.0,1.0,4/16,12.54%,CSF1R;SRC;TREM2;TYROBP
prerank,GO_Biological_Process_2021__protein K11-linked ubiquitination (GO:0070979),-0.2706906754586187,-0.6550082932436196,0.9333333333333333,1.0,1.0,20/20,72.99%,ANAPC4;UBE2E2;UBE2A;UBE2E3;CDC26;PRKN;UBE2D4;ANAPC11;CDC16;UBE2H;ANAPC1;CDC27;CDC23;RNF4;UBE2D3;UBE2B;UBE2L3;ANAPC7;ANAPC5;FZR1
prerank,GO_Biological_Process_2021__positive regulation of exocytosis (GO:0045921),0.34625583686582395,0.6549183449142324,0.9382716049382716,1.0,1.0,9/30,26.57%,RAB15;CADPS;CLASP2;SDCBP;RAB2B;RAB5A;PDCD6IP;CFTR;RAB27B
prerank,GO_Biological_Process_2021__positive regulation of cellular protein localization (GO:1903829),0.3203588075054853,0.6548921186559924,0.9425287356321839,1.0,1.0,3/48,5.64%,MAPT;TFRC;EIF2AK3
prerank,GO_Biological_Process_2021__steroid hormone mediated signaling pathway (GO:0043401),0.4030821718443641,0.6546151856784517,0.8974358974358975,1.0,1.0,1/8,15.56%,ESR1
prerank,GO_Biological_Process_2021__response to ATP (GO:0033198),0.40751615972276717,0.6545598669189232,0.8783783783783784,1.0,1.0,3/9,29.48%,RYR3;HSP90B1;DGKQ
prerank,GO_Biological_Process_2021__regulation of ER to Golgi vesicle-mediated transport (GO:0060628),0.41613211956264357,0.6538930559584375,0.9027777777777778,1.0,1.0,2/8,20.68%,RNF139;LRRK2
prerank,GO_Biological_Process_2021__ubiquitin-dependent protein catabolic process (GO:0006511),0.290294225436234,0.6538062432632729,0.9795918367346939,1.0,1.0,41/288,24.06%,TOM1L1;DTL;FBXL7;RNF144B;KCTD2;VPS37C;HERPUD1;TRIM25;ARIH2;TRIM9;RNF144A;PSMB4;RBX1;RNF126;OTUD7B;PINK1;RLIM;PELI1;KLHL8;SYVN1;TBL1XR1;RNF13;UBXN2B;HECW2;RNF149;PSMC2;ZNRF1;PSMA3;FBXO7;PSMB2;SPSB3;UCHL1;DDB1;PSMD5;PSMD7;HACE1;FEM1C;UHRF1;UBE2D2;PSMD14;PSMA5
prerank,GO_Biological_Process_2021__endodermal cell fate commitment (GO:0001711),0.43828917665947364,0.6535042458518263,0.890625,1.0,1.0,1/5,9.56%,POU5F1
prerank,GO_Biological_Process_2021__regulation of smooth muscle contraction (GO:0006940),-0.2975891834465778,-0.6531279147148294,0.8709677419354839,1.0,1.0,5/11,19.10%,ZDHHC21;DAPK3;CHRM2;SETD3;ADRB2
prerank,GO_Biological_Process_2021__endothelial cell migration (GO:0043542),0.36041670930293446,0.6528844969258525,0.9178082191780822,1.0,1.0,2/21,5.04%,NR4A1;VEGFA
prerank,GO_Biological_Process_2021__positive regulation of ubiquitin protein ligase activity (GO:1904668),0.39958319110272456,0.6525726604850738,0.8823529411764706,1.0,1.0,4/8,32.52%,PTEN;FZR1;GORASP1;RAB1A
prerank,GO_Biological_Process_2021__regulation of lipid transport (GO:0032368),0.44079166752945426,0.6521866586957921,0.8688524590163934,1.0,1.0,4/6,30.59%,ITGAV;PPARA;LRP1;NR1H2
prerank,GO_Biological_Process_2021__protein poly-ADP-ribosylation (GO:0070212),0.4290926796291683,0.6519616949648235,0.8939393939393939,1.0,1.0,4/9,39.67%,ZC3HAV1;PARP9;PARP10;TNKS2
prerank,GO_Biological_Process_2021__regulation of organ growth (GO:0046620),-0.38694970375447224,-0.6519331281636835,0.8863636363636364,1.0,1.0,1/7,3.56%,LATS2
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial calcium ion concentration (GO:0051561),-0.3716706331678065,-0.65187953840883,0.7931034482758621,1.0,1.0,2/6,23.62%,FIS1;MCU
prerank,GO_Biological_Process_2021__membrane raft assembly (GO:0001765),0.4333591528316976,0.6517827668757772,0.92,1.0,1.0,1/5,21.58%,FLOT2
prerank,GO_Biological_Process_2021__pyrimidine nucleoside biosynthetic process (GO:0046134),0.3996416581224491,0.6516724676507507,0.9078947368421053,1.0,1.0,5/11,23.19%,UCKL1;DCK;UPP2;UCK2;CAD
prerank,GO_Biological_Process_2021__negative regulation of endothelial cell apoptotic process (GO:2000352),0.40811596993365395,0.651616150564454,0.90625,1.0,1.0,1/10,10.26%,SEMA5A
prerank,GO_Biological_Process_2021__photoperiodism (GO:0009648),0.36455025330643076,0.6515951465675056,0.926829268292683,1.0,1.0,4/21,12.81%,BHLHE40;ID2;PER1;RBM4B
prerank,"GO_Biological_Process_2021__regulation of CD4-positive, alpha-beta T cell proliferation (GO:2000561)",0.4299690505235643,0.6514967856074674,0.8412698412698413,1.0,1.0,1/7,5.63%,CD55
prerank,GO_Biological_Process_2021__regulation of T-helper 2 cell cytokine production (GO:2000551),-0.36409311810527245,-0.651311676004495,0.8333333333333334,1.0,1.0,2/5,20.36%,NLRP3;CD81
prerank,GO_Biological_Process_2021__positive regulation of T-helper 2 cell cytokine production (GO:2000553),-0.36409311810527245,-0.651311676004495,0.8333333333333334,1.0,1.0,2/5,20.36%,NLRP3;CD81
prerank,GO_Biological_Process_2021__regulation of cell activation (GO:0050865),0.3933295202066107,0.6512627052677235,0.863013698630137,1.0,1.0,2/6,16.93%,TXK;TEC
prerank,GO_Biological_Process_2021__adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002460),0.37582616963589205,0.6511957703428226,0.9135802469135802,1.0,1.0,4/13,22.22%,CD55;IL18;GNL1;MYO1G
prerank,GO_Biological_Process_2021__positive regulation of transcription of Notch receptor target (GO:0007221),0.3740479541286713,0.6497265557104744,0.9710144927536232,1.0,1.0,2/12,21.83%,RBPJ;STAT1
prerank,GO_Biological_Process_2021__type I interferon signaling pathway (GO:0060337),0.33091095544385357,0.6489695172494411,0.9418604651162791,1.0,1.0,2/41,2.02%,IFIT5;EGR1
prerank,GO_Biological_Process_2021__cellular response to type I interferon (GO:0071357),0.33091095544385357,0.6489695172494411,0.9418604651162791,1.0,1.0,2/41,2.02%,IFIT5;EGR1
prerank,GO_Biological_Process_2021__positive regulation of protein-containing complex assembly (GO:0031334),0.3170438529173773,0.6486920363796205,0.9782608695652174,1.0,1.0,12/86,15.82%,ERCC2;TFRC;NRG1;SLF1;RPA2;VEGFA;ABCA1;RBX1;TPPP;GTF2H3;ESR1;DHX33
prerank,GO_Biological_Process_2021__positive regulation of cellular component movement (GO:0051272),0.3684504499969228,0.6484063594113794,0.8947368421052632,1.0,1.0,1/15,5.04%,VEGFA
prerank,GO_Biological_Process_2021__negative regulation of protein dephosphorylation (GO:0035308),0.3593897569886313,0.648366361086665,0.8795180722891566,1.0,1.0,3/18,13.87%,MASTL;PPP4R4;PPP1R15A
prerank,GO_Biological_Process_2021__regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),0.2924083303697594,0.6483385684699982,0.98,1.0,1.0,39/168,24.20%,HTR2B;NLRP12;IFIT5;TLE1;TFRC;TRAF2;TRIM5;TRIM25;PLK2;GPRC5B;PER1;NOD2;OTUD7B;RIPK2;DDX1;PINK1;PYCARD;PELI1;WNT5A;ESR1;LITAF;HSPB1;GSTP1;TNFRSF1A;RHOH;ECT2;TNF;NR1D1;TRIM14;CX3CL1;TNIP1;STAT1;MAP3K3;PRKCB;RORA;CASP1;TRADD;SLC20A1;TRAF3IP2
prerank,GO_Biological_Process_2021__regulation of muscle cell differentiation (GO:0051147),0.35840064046587145,0.6481976073210848,0.9102564102564102,1.0,1.0,6/23,23.45%,CDH2;ID2;CTNNA2;CDK9;FGFR2;MEGF10
prerank,GO_Biological_Process_2021__DNA strand elongation (GO:0022616),0.37225416282291524,0.6477594992944767,0.8904109589041096,1.0,1.0,3/11,14.36%,GINS1;MCMDC2;RFC4
prerank,GO_Biological_Process_2021__positive regulation of fatty acid biosynthetic process (GO:0045723),0.4388713834467493,0.6475098924831184,0.8589743589743589,1.0,1.0,1/6,9.13%,MID1IP1
prerank,GO_Biological_Process_2021__regulation of mitotic spindle assembly (GO:1901673),-0.2831294040908246,-0.6471259447489487,0.9259259259259259,1.0,1.0,4/15,12.08%,CEP97;CHMP2B;CCSAP;HSPA1A
prerank,GO_Biological_Process_2021__cellular component assembly (GO:0022607),0.2938380426018102,0.646784135331049,0.9696969696969697,1.0,1.0,35/165,26.05%,GPM6B;LRGUK;TRAF2;ANK3;BAIAP2L1;BSN;PKP2;NLGN3;NLGN1;WASF1;DARS1;PPID;VCPIP1;PARD3;VMP1;PICALM;TOGARAM1;WNT5A;SPTBN1;FANCA;RHOH;DLG4;RTN3;NLGN4X;KNTC1;NAPG;RHOU;HFE;RTN4;SYCE2;REPS2;RIMS1;PPARGC1A;PTK2B;PARVB
prerank,GO_Biological_Process_2021__positive regulation of toll-like receptor 2 signaling pathway (GO:0034137),-0.4099286845857945,-0.6467659573730944,0.8275862068965517,1.0,1.0,2/5,25.57%,TIRAP;CYBA
prerank,GO_Biological_Process_2021__negative regulation of cellular component movement (GO:0051271),0.36448900894434677,0.6464567849901716,0.8840579710144928,1.0,1.0,4/11,20.90%,FRMD5;SPOCK3;SPINT2;CCDC125
prerank,GO_Biological_Process_2021__mismatch repair (GO:0006298),0.3710522837646911,0.6463381136849129,0.9625,1.0,1.0,2/19,5.17%,RPA2;TDG
prerank,GO_Biological_Process_2021__regulation of intracellular estrogen receptor signaling pathway (GO:0033146),0.3495038306674856,0.6461926809337205,0.8961038961038961,1.0,1.0,3/23,15.56%,VPS11;BRCA1;ESR1
prerank,GO_Biological_Process_2021__negative regulation of macrophage activation (GO:0043031),0.37664626153522796,0.6461237465340905,0.9078947368421053,1.0,1.0,5/11,22.61%,FCGR2B;LRFN5;NR1D1;CX3CL1;SYT11
prerank,GO_Biological_Process_2021__ERBB signaling pathway (GO:0038127),-0.2464091734431757,-0.6460355832765894,1.0,1.0,1.0,10/47,17.60%,MATK;TGFB1;SRC;EGFR;TGFA;AKT1;PTPN12;CBL;PRKCA;DGKD
prerank,GO_Biological_Process_2021__sequestering of actin monomers (GO:0042989),0.4311836929381382,0.6459988469407748,0.859375,1.0,1.0,2/5,24.50%,TMSB10;TWF1
prerank,GO_Biological_Process_2021__RNA-dependent DNA biosynthetic process (GO:0006278),0.35614779484332826,0.6459936756482177,0.9629629629629629,1.0,1.0,5/20,27.75%,NHP2;SHQ1;RFC1;HSP90AB1;DKC1
prerank,GO_Biological_Process_2021__membrane protein intracellular domain proteolysis (GO:0031293),-0.2955001383784339,-0.6457313858122654,0.9166666666666666,1.0,1.0,3/17,11.53%,TGFB1;APH1A;HM13
prerank,GO_Biological_Process_2021__purine nucleotide catabolic process (GO:0006195),-0.3662995745163718,-0.6451703165402,0.9090909090909091,1.0,1.0,3/7,13.42%,ITPA;NT5C;GPX1
prerank,GO_Biological_Process_2021__regulation of protein secretion (GO:0050708),0.30826444704398903,0.6450968633641947,0.9787234042553191,1.0,1.0,10/73,16.34%,TGFB2;ARF6;STXBP5L;APBB3;SNAP25;RAPGEF3;PPID;DISP1;TMED10;CACNA1A
prerank,GO_Biological_Process_2021__negative regulation of heart contraction (GO:0045822),-0.3444950770569094,-0.6445805851042391,0.9310344827586207,1.0,1.0,3/8,19.39%,GRK2;PDE4D;SRI
prerank,GO_Biological_Process_2021__cellular response to lectin (GO:1990858),0.30531528509499434,0.6445782068412675,0.9782608695652174,1.0,1.0,1/79,0.35%,CLEC4E
prerank,GO_Biological_Process_2021__stimulatory C-type lectin receptor signaling pathway (GO:0002223),0.30531528509499434,0.6445782068412675,0.9782608695652174,1.0,1.0,1/79,0.35%,CLEC4E
prerank,GO_Biological_Process_2021__negative regulation of leukocyte migration (GO:0002686),0.4165940210032242,0.6444401537046744,0.9193548387096774,1.0,1.0,3/6,29.61%,CD300A;SLAMF8;HMOX1
prerank,GO_Biological_Process_2021__positive regulation of catabolic process (GO:0009896),0.3263224879110492,0.6443087848108504,0.9230769230769231,1.0,1.0,11/46,22.36%,DTL;PLK2;NSF;APC2;WNT5A;HECW2;TNF;CDKN1B;DDB1;HACE1;BARD1
prerank,GO_Biological_Process_2021__protein complex oligomerization (GO:0051259),0.3054686129778724,0.6434820416615605,0.9782608695652174,1.0,1.0,18/67,26.67%,MAT2A;BOK;GSDMD;ADCY8;POLQ;SPAST;TMEM120B;PYCARD;ALAD;AQP11;ECT2;SLC9A1;PDCD6IP;NACC2;KCNC2;OPA1;CPSF6;PRMT1
prerank,GO_Biological_Process_2021__cell projection organization (GO:0030030),-0.3056200963751089,-0.6432840808483676,0.9285714285714286,1.0,1.0,6/24,11.55%,RHOG;P2RY12;NCKAP1L;PLEK;CYFIP1;GSN
prerank,GO_Biological_Process_2021__protein deglycosylation (GO:0006517),0.39742611595434113,0.6431184410891116,0.9054054054054054,1.0,1.0,1/8,10.25%,OGA
prerank,GO_Biological_Process_2021__lamellipodium assembly (GO:0030032),0.35090277422555816,0.642956908379117,0.9210526315789473,1.0,1.0,3/20,14.17%,CARMIL1;ARHGEF4;ABLIM3
prerank,GO_Biological_Process_2021__transforming growth factor beta receptor signaling pathway (GO:0007179),0.31021695906245594,0.6428414268159907,0.9176470588235294,1.0,1.0,11/57,22.86%,TGFB2;PTPRK;RPS27A;PARD3;SMAD1;UBA52;UBB;FOS;SMAD5;APPL1;JUN
prerank,GO_Biological_Process_2021__miRNA loading onto RISC involved in gene silencing by miRNA (GO:0035280),-0.3960329671110085,-0.642688146340087,0.8918918918918919,1.0,1.0,1/6,9.60%,AGO1
prerank,GO_Biological_Process_2021__negative regulation of Arp2/3 complex-mediated actin nucleation (GO:0034316),-0.3768282273501974,-0.6426585037516749,0.9117647058823529,1.0,1.0,1/5,3.49%,CORO1B
prerank,GO_Biological_Process_2021__acylglycerol homeostasis (GO:0055090),-0.32249574893087496,-0.6419631698079562,0.9032258064516129,1.0,1.0,4/10,14.93%,MTLN;LPL;NR1H3;MLXIPL
prerank,GO_Biological_Process_2021__hyaluronan metabolic process (GO:0030212),0.374692411256062,0.6418423603756348,0.9090909090909091,1.0,1.0,4/12,21.98%,CEMIP;CEMIP2;SLC9A1;CHP1
prerank,GO_Biological_Process_2021__regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway (GO:0070432),-0.3516582269456094,-0.641511164861007,0.8235294117647058,1.0,1.0,2/6,14.29%,HSPA1A;SLC15A3
prerank,GO_Biological_Process_2021__insulin secretion involved in cellular response to glucose stimulus (GO:0035773),0.44986650127927075,0.6414367925098695,0.9117647058823529,1.0,1.0,2/5,31.12%,PTPRN2;PTPRN
prerank,GO_Biological_Process_2021__carbohydrate derivative transport (GO:1901264),-0.3427831523468058,-0.6413253111653926,0.9310344827586207,1.0,1.0,1/12,1.31%,NPC2
prerank,GO_Biological_Process_2021__regulation of cellular component movement (GO:0051270),0.3052503338642737,0.6411677522327708,0.9347826086956522,1.0,1.0,7/43,18.84%,NRG1;VEGFA;ZSWIM4;NRG4;ROCK1;FES;NRG2
prerank,GO_Biological_Process_2021__regulation of actin filament depolymerization (GO:0030834),-0.32646285574470896,-0.6408240266758296,0.8666666666666667,1.0,1.0,2/8,10.03%,LIMA1;PLEK
prerank,GO_Biological_Process_2021__NLS-bearing protein import into nucleus (GO:0006607),-0.3272792223279768,-0.6407043609877576,0.8928571428571429,1.0,1.0,1/13,11.76%,KPNA6
prerank,GO_Biological_Process_2021__Golgi inheritance (GO:0048313),0.3896645068747977,0.6399586800139722,0.9333333333333333,1.0,1.0,2/9,24.01%,VCPIP1;VRK1
prerank,GO_Biological_Process_2021__neutrophil migration (GO:1990266),0.35332992166457844,0.6397713399623638,0.9113924050632911,1.0,1.0,1/23,1.28%,TGFB2
prerank,GO_Biological_Process_2021__positive regulation of T cell proliferation (GO:0042102),0.32707659237736386,0.6396075185223487,0.9438202247191011,1.0,1.0,3/36,3.87%,IL15;TFRC;ANXA1
prerank,GO_Biological_Process_2021__single strand break repair (GO:0000012),0.39355945094122596,0.6395701265994663,0.9090909090909091,1.0,1.0,1/7,17.68%,ERCC6
prerank,"GO_Biological_Process_2021__Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",0.29512623847308594,0.6378974666619283,0.9789473684210527,1.0,1.0,14/65,24.06%,FZD6;CELSR2;PSMB4;PRICKLE1;MAGI2;WNT5A;PSMC2;PSMA3;AP2A2;PSMB2;PSMD5;PSMD7;PSMD14;PSMA5
prerank,GO_Biological_Process_2021__innate immune response activating cell surface receptor signaling pathway (GO:0002220),0.30252010529488915,0.637476468100607,0.9782608695652174,1.0,1.0,1/80,0.35%,CLEC4E
prerank,GO_Biological_Process_2021__regulation of epidermal growth factor receptor signaling pathway (GO:0042058),0.3200291002108179,0.6372255168134165,0.9655172413793104,1.0,1.0,5/46,12.42%,AGT;SPRY1;ERRFI1;RNF126;SH3GL2
prerank,GO_Biological_Process_2021__serine transport (GO:0032329),0.4483760053454088,0.6370265518749431,0.9491525423728814,1.0,1.0,1/5,14.57%,SFXN3
prerank,GO_Biological_Process_2021__regulation of histone H4 acetylation (GO:0090239),0.39659910932430265,0.6369164607548145,0.9594594594594594,1.0,1.0,2/8,19.08%,CTBP1;TAF7
prerank,GO_Biological_Process_2021__nucleic acid metabolic process (GO:0090304),0.3005930557737581,0.6366805537633903,0.9893617021276596,1.0,1.0,7/57,16.85%,WDR74;RBFOX2;DNA2;HNRNPA0;DDX1;HNRNPH1;POLR2D
prerank,GO_Biological_Process_2021__ATP-dependent chromatin remodeling (GO:0043044),-0.2465454006160243,-0.6366534731680926,1.0,1.0,1.0,9/37,20.53%,ACTB;GATAD2B;RNF8;CECR2;RBBP4;ZNHIT1;ACTR8;CHD4;INO80
prerank,GO_Biological_Process_2021__negative regulation of telomere maintenance via telomere lengthening (GO:1904357),-0.27270688156372475,-0.6366057451448028,0.9523809523809523,1.0,1.0,5/19,18.72%,CTC1;SRC;TERF2;EXOSC10;ERCC4
prerank,GO_Biological_Process_2021__telomere maintenance via telomerase (GO:0007004),0.35622481717320825,0.6360442087279838,0.95,1.0,1.0,5/19,27.75%,NHP2;SHQ1;RFC1;HSP90AB1;DKC1
prerank,GO_Biological_Process_2021__epithelial cell apoptotic process (GO:1904019),-0.3839630515844677,-0.6358805401090231,0.8214285714285714,1.0,1.0,2/6,11.55%,DAB2IP;GSN
prerank,GO_Biological_Process_2021__regulation of actomyosin structure organization (GO:0110020),0.3722322697709702,0.6357479145889378,0.9166666666666666,1.0,1.0,3/12,22.53%,ROCK1;SLC9A1;PTGER4
prerank,GO_Biological_Process_2021__purine ribonucleoside triphosphate metabolic process (GO:0009205),0.3912848330771808,0.6356435193772074,0.9629629629629629,1.0,1.0,3/10,31.90%,LRRK2;OPA1;GTPBP1
prerank,GO_Biological_Process_2021__positive regulation of amyloid-beta clearance (GO:1900223),0.40019480682688957,0.6355901669576799,0.8490566037735849,1.0,1.0,3/6,29.50%,ROCK1;LRPAP1;LRP1
prerank,GO_Biological_Process_2021__positive regulation of cytokine production involved in inflammatory response (GO:1900017),-0.33677648879231736,-0.6354322144837375,0.9310344827586207,1.0,1.0,1/11,0.93%,TICAM1
prerank,GO_Biological_Process_2021__positive regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000343),-0.37540294384817546,-0.6354148110574819,0.9705882352941176,1.0,1.0,3/6,22.54%,LPL;TIRAP;CD74
prerank,GO_Biological_Process_2021__cellular senescence (GO:0090398),0.35122196046293025,0.6353689294947881,0.96,1.0,1.0,1/19,8.86%,ID2
prerank,GO_Biological_Process_2021__tRNA 5'-end processing (GO:0099116),0.383553616173976,0.634938085642937,0.9206349206349206,1.0,1.0,1/6,21.82%,TRMT10C
prerank,GO_Biological_Process_2021__nuclear membrane reassembly (GO:0031468),0.3068821784594007,0.6343667391727287,0.9662921348314607,1.0,1.0,10/46,25.06%,NUP133;RCC1;SPAST;REEP3;SEH1L;UBXN2B;NDC1;VRK1;CHMP7;POM121
prerank,GO_Biological_Process_2021__bone resorption (GO:0045453),0.44087023504720146,0.634351638980785,0.9230769230769231,1.0,1.0,1/6,5.77%,IL7
prerank,PanglaoDB_Augmented_2021__Ciliated Cells,0.3582198696474559,0.633792022162674,0.9135802469135802,1.0,1.0,3/16,9.57%,ANKUB1;ATP5MK;CCDC39
prerank,GO_Biological_Process_2021__regulation of protein dephosphorylation (GO:0035304),0.33014221018101947,0.6336258934478797,0.9545454545454546,1.0,1.0,5/33,16.31%,PPP2R5A;NSMF;CALM3;PPP1R15A;CNEP1R1
prerank,GO_Biological_Process_2021__positive regulation of histone H4 acetylation (GO:0090240),0.4217314015590775,0.6335983070999691,0.9420289855072463,1.0,1.0,1/6,12.87%,BRCA1
prerank,GO_Biological_Process_2021__JNK cascade (GO:0007254),0.33309150824612455,0.6331249416698439,0.9662921348314607,1.0,1.0,10/36,23.75%,RPS27A;NOD2;RIPK2;MAPK10;MAP3K13;UBA52;UBB;PTGER4;GPS1;GPS2
prerank,GO_Biological_Process_2021__leptin-mediated signaling pathway (GO:0033210),-0.3162910823875674,-0.6328345575672538,0.9310344827586207,1.0,1.0,1/9,5.30%,MKKS
prerank,GO_Biological_Process_2021__cellular response to hormone stimulus (GO:0032870),0.324582041749133,0.6325469976317264,0.9666666666666667,1.0,1.0,10/43,21.92%,ROBO2;NSMF;PAX8;GHR;SRA1;NR4A3;KLF9;ATP1A2;RDX;TRIM24
prerank,GO_Biological_Process_2021__regulation of myosin-light-chain-phosphatase activity (GO:0035507),-0.3153802909843147,-0.6324548606085508,0.9090909090909091,1.0,1.0,3/7,16.29%,NCKAP1L;IKBKB;NUAK1
prerank,GO_Biological_Process_2021__protein K48-linked ubiquitination (GO:0070936),0.299763056883793,0.6322308075389506,0.9888888888888889,1.0,1.0,13/47,31.27%,ARIH2;RBX1;RNF126;PELI1;SYVN1;ZNRF1;HACE1;UBE2D2;UBR5;UBE2D1;KBTBD6;RNF6;UBE2R2
prerank,GO_Biological_Process_2021__negative regulation of transferase activity (GO:0051348),0.3271826866675279,0.6319938025844577,0.9135802469135802,1.0,1.0,6/23,24.15%,MAPT;IRS2;NPRL2;CDKN1B;HNRNPU;EIF4A2
prerank,GO_Biological_Process_2021__regulation of toll-like receptor 3 signaling pathway (GO:0034139),0.4035125819430366,0.6315254273427529,0.9298245614035088,1.0,1.0,1/5,21.58%,FLOT2
prerank,GO_Biological_Process_2021__nucleocytoplasmic transport (GO:0006913),0.3312624349112719,0.6313869113007354,0.9879518072289156,1.0,1.0,2/27,8.25%,GEMIN2;XPO1
prerank,GO_Biological_Process_2021__negative regulation of actin filament polymerization (GO:0030837),-0.3078254673154407,-0.6313666922732126,0.9444444444444444,1.0,1.0,3/16,11.55%,PFN1;SSH3;GSN
prerank,GO_Biological_Process_2021__positive regulation of syncytium formation by plasma membrane fusion (GO:0060143),-0.3621835009185922,-0.6311521007589608,0.9090909090909091,1.0,1.0,4/9,13.10%,RIPOR2;TREM2;TYROBP;CD53
prerank,GO_Biological_Process_2021__positive regulation of membrane protein ectodomain proteolysis (GO:0051044),0.39497389846846387,0.6302046165740777,0.9333333333333333,1.0,1.0,3/8,20.20%,SH3D19;TNFRSF1B;TNF
prerank,GO_Biological_Process_2021__calcium ion transmembrane transport (GO:0070588),0.309199201705177,0.6300747154191451,0.9662921348314607,1.0,1.0,13/62,16.36%,SLC24A2;GRIN2A;TRPC4;SLC24A1;NALCN;RYR3;PMPCA;PKD1;GRIN2B;ATP2A2;SLC24A3;CACNA1A;ITGAV
prerank,GO_Biological_Process_2021__negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254),0.3788214406999718,0.6299487241303029,0.9230769230769231,1.0,1.0,2/12,18.11%,KDM1A;TAF9B
prerank,GO_Biological_Process_2021__non-motile cilium assembly (GO:1905515),-0.27738451340500675,-0.6297616922064363,0.9655172413793104,1.0,1.0,3/21,13.87%,BBS10;TBC1D32;DISC1
prerank,GO_Biological_Process_2021__focal adhesion assembly (GO:0048041),0.3516958447457788,0.6295135653150801,0.9102564102564102,1.0,1.0,3/17,15.39%,PTPRK;SORBS1;THY1
prerank,GO_Biological_Process_2021__positive regulation of toll-like receptor 7 signaling pathway (GO:0034157),0.4151139815324999,0.6294388705340443,0.8955223880597015,1.0,1.0,2/5,24.96%,DDX3X;RSAD2
prerank,GO_Biological_Process_2021__regulation of toll-like receptor 7 signaling pathway (GO:0034155),0.4151139815324999,0.6294388705340443,0.8955223880597015,1.0,1.0,2/5,24.96%,DDX3X;RSAD2
prerank,GO_Biological_Process_2021__lipid catabolic process (GO:0016042),0.3945961154102074,0.6291467676726111,0.8902439024390244,1.0,1.0,2/10,20.27%,LIPE;STS
prerank,GO_Biological_Process_2021__negative regulation of neurotransmitter secretion (GO:0046929),0.3835521471642561,0.6289473386337335,0.9090909090909091,1.0,1.0,2/7,22.61%,PNKD;SYT11
prerank,GO_Biological_Process_2021__non-canonical Wnt signaling pathway (GO:0035567),0.2830134297585787,0.6283967607142078,0.96875,1.0,1.0,15/89,24.06%,FZD6;GNAO1;CELSR2;PSMB4;PRICKLE1;WNT5A;PLCB1;PSMC2;PSMA3;AP2A2;PSMB2;PSMD5;PSMD7;PSMD14;PSMA5
prerank,GO_Biological_Process_2021__regulation of cell cycle phase transition (GO:1901987),0.30031396837435126,0.6280870934068032,1.0,1.0,1.0,16/70,27.20%,NEK11;ERCC2;PSMB4;DBF4;PSMC2;PSMA3;PSMB2;CDKN1B;DDB1;PSMD5;PSMD7;PSMD14;PSMA5;ATP2B4;FZR1;UBE2D1
prerank,GO_Biological_Process_2021__gastrulation (GO:0007369),-0.3358234023994607,-0.6280344823288418,0.9285714285714286,1.0,1.0,2/8,11.82%,MKKS;TASOR
prerank,GO_Biological_Process_2021__regulation of histone modification (GO:0031056),-0.3294431696188001,-0.6280180469709428,0.9666666666666667,1.0,1.0,3/9,23.57%,AKAP8L;AKAP8;MTHFR
prerank,GO_Biological_Process_2021__Notch signaling pathway (GO:0007219),0.30753994925918493,0.6279508698560344,0.9431818181818182,1.0,1.0,7/32,25.74%,RBPJ;DTX3;SORBS2;NOTCH2;STAT1;DTX2;TRAF7
prerank,GO_Biological_Process_2021__amino sugar catabolic process (GO:0046348),0.38835640089707424,0.6278280556359839,0.8695652173913043,1.0,1.0,2/7,14.58%,AMDHD2;ALDH1A1
prerank,GO_Biological_Process_2021__regulation of neuron migration (GO:2001222),0.3420110974383394,0.6273210223035616,0.9204545454545454,1.0,1.0,6/25,15.66%,SEMA3A;NSMF;SEMA6A;CAMK2B;CTNNA2;PHACTR1
prerank,GO_Biological_Process_2021__negative regulation of transforming growth factor beta production (GO:0071635),0.43815521253846745,0.6270306541884029,0.9444444444444444,1.0,1.0,1/5,8.46%,FN1
prerank,GO_Biological_Process_2021__negative regulation of actin nucleation (GO:0051126),-0.374040469741298,-0.6270236147998918,1.0,1.0,1.0,1/6,3.49%,CORO1B
prerank,GO_Biological_Process_2021__response to hydroxyurea (GO:0072710),0.3996280903706198,0.6267562225656723,0.9253731343283582,1.0,1.0,3/9,29.84%,TIMELESS;SPIDR;BLM
prerank,GO_Biological_Process_2021__proteolysis involved in cellular protein catabolic process (GO:0051603),-0.23028728722123162,-0.6266919111475904,1.0,1.0,1.0,17/57,22.47%,IDE;GZMB;RSPRY1;CAPN2;SOCS6;NGLY1;HM13;CTSZ;CHFR;CASP8;CTSH;ZRANB1;VPS4B;CTSC;UBC;ATE1;PRKN
prerank,GO_Biological_Process_2021__nucleotide transport (GO:0006862),-0.3725505702959148,-0.6266493212728118,0.9210526315789473,1.0,1.0,1/5,11.69%,SLC25A33
prerank,GO_Biological_Process_2021__positive regulation of neuroblast proliferation (GO:0002052),0.3774372040697614,0.6258595021192471,0.9342105263157895,1.0,1.0,4/9,21.27%,VEGFA;KDM1A;SMARCD3;CX3CL1
prerank,GO_Biological_Process_2021__lipid homeostasis (GO:0055088),0.3170952129105057,0.6255395733148111,0.9560439560439561,1.0,1.0,8/33,24.61%,ABCA2;ABCA1;IRS2;PNPLA8;PRKAA2;ABCB4;ABCG1;DDX3X
prerank,GO_Biological_Process_2021__regulation of oxidative stress-induced cell death (GO:1903201),-0.31766867523382686,-0.6253893735720943,0.9259259259259259,1.0,1.0,3/9,13.44%,FYN;REST;STK26
prerank,GO_Biological_Process_2021__regulation of metallopeptidase activity (GO:1905048),0.3921353240672696,0.625098977736634,0.8970588235294118,1.0,1.0,2/5,29.50%,DDRGK1;LRP1
prerank,GO_Biological_Process_2021__protein localization to centrosome (GO:0071539),0.3488980616765174,0.6250895797672713,0.9315068493150684,1.0,1.0,2/17,13.85%,SNX10;HOOK3
prerank,GO_Biological_Process_2021__positive regulation of Arp2/3 complex-mediated actin nucleation (GO:2000601),0.4051034324005169,0.6248844303470162,0.9436619718309859,1.0,1.0,1/8,9.85%,WASF1
prerank,"GO_Biological_Process_2021__transcription, DNA-templated (GO:0006351)",0.2868928203688118,0.6248328203508114,0.99,1.0,1.0,26/168,21.95%,NFE2L3;NFIX;ERCC2;NR4A2;NOCT;MTERF1;PAX8;POLR1C;DEAF1;DRAP1;POLR3H;GTF2H3;NELFB;CEBPD;KLF13;POLR2D;TFAM;ERCC6;TAF9B;CDK9;TAF7;POLRMT;POLR2G;TEFM;TRIM24;EAF1
prerank,GO_Biological_Process_2021__exit from mitosis (GO:0010458),0.36353173905956226,0.6245596425077442,0.8840579710144928,1.0,1.0,2/10,12.66%,CLASP2;SPAST
prerank,GO_Biological_Process_2021__negative regulation of biomineralization (GO:0110150),-0.37561359794245064,-0.6243164119710142,0.8387096774193549,1.0,1.0,1/5,7.51%,TGFB1
prerank,GO_Biological_Process_2021__androgen receptor signaling pathway (GO:0030521),0.3653601734550202,0.6240259355796552,0.8974358974358975,1.0,1.0,1/10,7.34%,KDM3A
prerank,GO_Biological_Process_2021__regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664),0.3540655115963275,0.6237694526351589,0.9545454545454546,1.0,1.0,3/15,11.93%,CD55;TRIM5;SASH1
prerank,GO_Biological_Process_2021__positive regulation of translation in response to stress (GO:0032056),0.41202474880168277,0.6236416145240399,0.9384615384615385,1.0,1.0,3/5,30.47%,IMPACT;DDX3X;EIF4G1
prerank,GO_Biological_Process_2021__tetrahydrobiopterin metabolic process (GO:0046146),-0.34867421043742614,-0.6230072296532878,0.8571428571428571,1.0,1.0,7/7,65.16%,AKT1;GCH1;HSP90AA1;CALM1;PTS;DHFR;QDPR
prerank,GO_Biological_Process_2021__positive regulation of autophagy (GO:0010508),0.2999255884978594,0.6227043115527652,0.96875,1.0,1.0,14/65,20.74%,DAPK1;TRIM5;BNIP3L;PLK2;BNIP3;PINK1;ROCK1;NPRL2;PRKAA2;SESN1;TRIM65;FBXO7;LRRK2;TRIM14
prerank,GO_Biological_Process_2021__negative regulation of protein-containing complex assembly (GO:0031333),0.30318435343139993,0.6218793978320185,0.963855421686747,1.0,1.0,8/37,24.61%,HSPA5;TFIP11;IMPACT;AIDA;NOP53;PTGER4;JAM3;DDX3X
prerank,GO_Biological_Process_2021__regulation of T cell differentiation in thymus (GO:0033081),0.40411968131880693,0.621773108388888,0.9558823529411765,1.0,1.0,3/7,34.23%,SOD1;TOX;TESPA1
prerank,GO_Biological_Process_2021__amyloid precursor protein catabolic process (GO:0042987),-0.32809086829034706,-0.6211654634824199,0.8888888888888888,1.0,1.0,3/10,21.84%,APH1A;ADAM10;PSEN1
prerank,GO_Biological_Process_2021__SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),0.29726381249352807,0.6209689983572957,0.9666666666666667,1.0,1.0,14/69,24.06%,FBXL7;FBXL2;PSMB4;RBX1;FBXO27;FBXL13;PSMC2;FBXL5;PSMA3;PSMB2;PSMD5;PSMD7;PSMD14;PSMA5
prerank,GO_Biological_Process_2021__regulation of phosphatidylinositol dephosphorylation (GO:0060304),0.4371722805023074,0.620465249653049,0.9666666666666667,1.0,1.0,2/5,27.21%,MTMR9;MTMR4
prerank,GO_Biological_Process_2021__negative regulation of transporter activity (GO:0032410),-0.3597905935995947,-0.6200744249875026,0.9166666666666666,1.0,1.0,6/6,64.05%,WWP2;PPIF;CTTNBP2NL;NDFIP2;SNCA;NDFIP1
prerank,GO_Biological_Process_2021__positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),0.3565483281918189,0.6197874504395295,0.9864864864864865,1.0,1.0,7/20,24.61%,ANXA1;CCND3;PLCB1;RGCC;RDX;CDK10;DDX3X
prerank,GO_Biological_Process_2021__ether lipid biosynthetic process (GO:0008611),-0.349442035422895,-0.6197101877430119,0.9310344827586207,1.0,1.0,1/9,2.58%,PLA2G4C
prerank,GO_Biological_Process_2021__cellular response to mechanical stimulus (GO:0071260),0.31261984700402473,0.6195699983162236,0.9647058823529412,1.0,1.0,9/34,23.49%,CASP5;PDE2A;BNIP3;PIEZO2;TNFRSF1A;SLC9A1;PTGER4;CASP1;TLR5
prerank,GO_Biological_Process_2021__negative regulation of double-strand break repair via homologous recombination (GO:2000042),0.3586466639247825,0.6195058800019592,0.9066666666666666,1.0,1.0,2/14,11.02%,FANCB;POLQ
prerank,GO_Biological_Process_2021__platelet-derived growth factor receptor signaling pathway (GO:0048008),-0.2830306721668321,-0.6191456952588829,1.0,1.0,1.0,2/12,10.62%,PDGFD;ABL1
prerank,GO_Biological_Process_2021__protein localization to condensed chromosome (GO:1903083),-0.3386538299130141,-0.618308229138077,0.8571428571428571,1.0,1.0,8/8,66.17%,BUB3;ZW10;MIS12;IK;KNL1;CHAMP1;MTBP;ZWILCH
prerank,PanglaoDB_Augmented_2021__Alveolar Macrophages,0.2953556940651778,0.6179340113434492,0.9894736842105263,1.0,1.0,13/90,13.83%,CLEC12A;SLC11A1;GPNMB;FCGR2B;SIRPB2;TRIM25;FGR;C5AR1;FCGR2C;FGL2;MPP1;TNFRSF1B;CD300A
prerank,GO_Biological_Process_2021__regulation of histone acetylation (GO:0035065),0.32893832872339634,0.617754406484951,0.9404761904761905,1.0,1.0,5/26,19.08%,RUVBL2;RAPGEF3;BRCA1;CTBP1;TAF7
prerank,GO_Biological_Process_2021__positive regulation of viral release from host cell (GO:1902188),-0.33705523814433636,-0.6173489480704948,0.8333333333333334,1.0,1.0,2/8,9.99%,VPS37B;CHMP2B
prerank,GO_Biological_Process_2021__histone H4-K12 acetylation (GO:0043983),0.3932391249698827,0.6166675239257048,0.9,1.0,1.0,2/6,29.77%,MEAF6;ING4
prerank,GO_Biological_Process_2021__endosome to pigment granule transport (GO:0043485),-0.3590306510174787,-0.6165421722440636,0.925,1.0,1.0,6/6,64.12%,RAB32;AP3D1;AP1M1;AP1G1;RAB38;CD63
prerank,GO_Biological_Process_2021__endosome to melanosome transport (GO:0035646),-0.3590306510174787,-0.6165421722440636,0.925,1.0,1.0,6/6,64.12%,RAB32;AP3D1;AP1M1;AP1G1;RAB38;CD63
prerank,GO_Biological_Process_2021__regulation of non-membrane spanning protein tyrosine kinase activity (GO:1903995),-0.3498769465097648,-0.61595248248473,0.8666666666666667,1.0,1.0,2/5,8.79%,FYN;SRC
prerank,GO_Biological_Process_2021__L-alpha-amino acid transmembrane transport (GO:1902475),0.35278716358419426,0.6158288829067122,0.9404761904761905,1.0,1.0,1/16,3.93%,SLC1A2
prerank,GO_Biological_Process_2021__I-kappaB kinase/NF-kappaB signaling (GO:0007249),0.3060448171483559,0.6156963642252842,0.989247311827957,1.0,1.0,11/52,20.20%,AZI2;TRAF2;RPS27A;RIPK2;NKIRAS1;ROCK1;TNFRSF1A;UBA52;PRDX4;UBB;TNF
prerank,"GO_Biological_Process_2021__regulation of CD8-positive, alpha-beta T cell proliferation (GO:2000564)",-0.3309763589766454,-0.6152216583320045,0.9090909090909091,1.0,1.0,1/7,9.22%,HLA-E
prerank,GO_Biological_Process_2021__triglyceride homeostasis (GO:0070328),-0.3211001596195844,-0.6150595607777049,0.9259259259259259,1.0,1.0,4/12,14.93%,MTLN;LPL;NR1H3;MLXIPL
prerank,GO_Biological_Process_2021__termination of RNA polymerase I transcription (GO:0006363),0.32757350565343063,0.614730877079075,0.9358974358974359,1.0,1.0,3/24,14.88%,ERCC2;POLR1C;GTF2H3
prerank,GO_Biological_Process_2021__regulation of calcium ion import (GO:0090279),0.33290152900156056,0.6140037276862468,0.9104477611940298,1.0,1.0,1/13,8.38%,CAV3
prerank,GO_Biological_Process_2021__transcription by RNA polymerase I (GO:0006360),0.31603291865043165,0.6139970235956574,0.9135802469135802,1.0,1.0,3/28,14.88%,ERCC2;POLR1C;GTF2H3
prerank,GO_Biological_Process_2021__positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),0.2916975730058316,0.6136932559563467,0.978021978021978,1.0,1.0,3/56,7.94%,GPM6A;ANLN;NLGN1
prerank,GO_Biological_Process_2021__regulation of generation of precursor metabolites and energy (GO:0043467),0.31968774923774557,0.6136832143224237,0.9647058823529412,1.0,1.0,5/37,15.76%,NUP133;PGAM1;HIF1A;PRKAG2;SEH1L
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte differentiation (GO:0045621),0.3490919232043349,0.6136152680716614,0.96,1.0,1.0,1/14,5.77%,IL7
prerank,GO_Biological_Process_2021__pigment granule transport (GO:0051904),-0.2982055032948112,-0.613556026429217,1.0,1.0,1.0,1/11,5.30%,MKKS
prerank,GO_Biological_Process_2021__melanosome transport (GO:0032402),-0.2982055032948112,-0.613556026429217,1.0,1.0,1.0,1/11,5.30%,MKKS
prerank,GO_Biological_Process_2021__establishment of melanosome localization (GO:0032401),-0.2982055032948112,-0.613556026429217,1.0,1.0,1.0,1/11,5.30%,MKKS
prerank,GO_Biological_Process_2021__melanosome localization (GO:0032400),-0.2982055032948112,-0.613556026429217,1.0,1.0,1.0,1/11,5.30%,MKKS
prerank,GO_Biological_Process_2021__cellular response to steroid hormone stimulus (GO:0071383),-0.31789009522243084,-0.6135008053644417,0.875,1.0,1.0,3/9,21.07%,SRC;MED1;NR3C1
prerank,GO_Biological_Process_2021__positive regulation of interferon-beta production (GO:0032728),0.3077676718824841,0.6134208770108976,0.9629629629629629,1.0,1.0,7/31,28.80%,POLR3F;RIPK2;TRIM56;DDX3X;TLR2;IRF1;RIOK3
prerank,GO_Biological_Process_2021__regulation of receptor recycling (GO:0001919),0.3459671663565577,0.6132209729415892,0.9305555555555556,1.0,1.0,4/13,31.76%,NSF;AP1AR;KIF16B;ECE1
prerank,GO_Biological_Process_2021__epidermal growth factor receptor signaling pathway (GO:0007173),-0.2479994267304238,-0.6131832529251324,1.0,1.0,1.0,10/31,21.77%,TGFB1;SRC;EGFR;TGFA;AKT1;CBL;DGKD;RPS6KA5;SLC30A10;GAREM1
prerank,GO_Biological_Process_2021__negative regulation of protein polyubiquitination (GO:1902915),0.41651395915843303,0.6128992783152061,0.8387096774193549,1.0,1.0,3/5,36.85%,GPS2;PLAA;PARP10
prerank,GO_Biological_Process_2021__protein targeting to membrane (GO:0006612),0.29672094209007055,0.6128369819918175,0.9782608695652174,1.0,1.0,10/60,21.71%,ZDHHC15;VPS37C;PARD3;ZDHHC9;SDCBP;PEX3;NACA;AQP11;SRPRA;SRP19
prerank,GO_Biological_Process_2021__cellular response to starvation (GO:0009267),0.2929488934400759,0.6127085252006349,0.9897959183673469,1.0,1.0,23/115,24.09%,HSPA5;PDK4;EIF2AK3;NIM1K;MFSD2A;IMPACT;PRKAG2;SEH1L;NUAK2;NPRL2;PIK3R4;PRKAA2;SESN1;PPARA;ATP6V0B;CPEB4;LRRK2;ATG5;ATP6V1B2;ATP6V0E2;ATP6V1D;FOXO3;BRSK1
prerank,GO_Biological_Process_2021__regulation of mitophagy (GO:1901524),0.42050800846476066,0.6124856927749011,0.9705882352941176,1.0,1.0,1/5,17.42%,SLC25A4
prerank,GO_Biological_Process_2021__regulation of cytoplasmic translational elongation (GO:1900247),0.43513884256126933,0.6124343115395313,0.9558823529411765,1.0,1.0,1/5,15.02%,CPEB2
prerank,GO_Biological_Process_2021__positive regulation of fatty acid metabolic process (GO:0045923),0.37403065686341624,0.6123547485247217,0.9634146341463414,1.0,1.0,6/12,30.59%,MID1IP1;NR4A3;PPARA;PPARGC1A;LPGAT1;NR1H2
prerank,GO_Biological_Process_2021__interleukin-27-mediated signaling pathway (GO:0070106),0.35625980264716295,0.6119305421730042,0.8933333333333333,1.0,1.0,2/12,21.83%,CRLF1;STAT1
prerank,GO_Biological_Process_2021__pseudouridine synthesis (GO:0001522),0.3636319769020845,0.6107702569355478,0.9508196721311475,1.0,1.0,2/10,11.74%,PUS7;NHP2
prerank,GO_Biological_Process_2021__regulation of cellular response to oxidative stress (GO:1900407),0.39221675721288113,0.6107189633555691,0.8873239436619719,1.0,1.0,1/6,13.26%,PINK1
prerank,GO_Biological_Process_2021__tricarboxylic acid metabolic process (GO:0072350),-0.3026188658746954,-0.6106931411851161,0.9393939393939394,1.0,1.0,5/11,28.15%,ACO2;IDH3B;IDH3G;IDH3A;IREB2
prerank,GO_Biological_Process_2021__positive regulation of dephosphorylation (GO:0035306),0.34193529768110803,0.6100332836345068,0.987012987012987,1.0,1.0,5/21,17.76%,PPP2R5A;NSMF;CALM3;CNEP1R1;MTMR9
prerank,GO_Biological_Process_2021__fatty acid catabolic process (GO:0009062),0.29948245620017583,0.6095872013347108,0.9666666666666667,1.0,1.0,2/49,7.92%,FAAH;ACAT1
prerank,"GO_Biological_Process_2021__protein localization to chromosome, telomeric region (GO:0070198)",-0.3317847791198581,-0.6094788128202688,0.967741935483871,1.0,1.0,10/10,66.86%,TERF2;TPP1;TNKS;XRCC5;ATRX;POT1;BRCA2;TNKS2;TERF2IP;ATR
prerank,GO_Biological_Process_2021__IMP metabolic process (GO:0046040),0.4168660334395605,0.6089382185212904,0.9538461538461539,1.0,1.0,3/6,31.05%,HPRT1;PNP;NT5C2
prerank,GO_Biological_Process_2021__semaphorin-plexin signaling pathway involved in axon guidance (GO:1902287),0.3674468565187143,0.6084288656614882,0.9066666666666666,1.0,1.0,2/8,17.93%,PLXNB1;PLXNC1
prerank,GO_Biological_Process_2021__regulation of SMAD protein signal transduction (GO:0060390),0.3534248026365292,0.6079449468793532,0.9516129032258065,1.0,1.0,1/12,6.69%,OVOL2
prerank,GO_Biological_Process_2021__negative regulation of toll-like receptor signaling pathway (GO:0034122),0.325142439614569,0.6076835519440328,0.9342105263157895,1.0,1.0,1/23,0.81%,RAB7B
prerank,GO_Biological_Process_2021__positive regulation of DNA-dependent DNA replication (GO:2000105),0.3724039929458751,0.6075987673782541,0.8947368421052632,1.0,1.0,3/9,21.19%,E2F7;DBF4;WIZ
prerank,GO_Biological_Process_2021__regulation of mRNA catabolic process (GO:0061013),0.2813517775822445,0.6070212833927016,1.0,1.0,1.0,18/104,24.06%,VIM;CARHSP1;PCBP4;XPO1;RPS27A;PSMB4;HSPB1;UBA52;UBB;PSMC2;ZC3HAV1;PSMA3;SAMD4A;PSMB2;PSMD5;PSMD7;PSMD14;PSMA5
prerank,GO_Biological_Process_2021__regulation of autophagy of mitochondrion (GO:1903146),0.34562718171720197,0.6069497013688293,0.9761904761904762,1.0,1.0,2/17,20.22%,PINK1;FBXO7
prerank,GO_Biological_Process_2021__signal peptide processing (GO:0006465),-0.3275700124238844,-0.6061183918953613,0.9375,1.0,1.0,3/8,19.02%,HM13;SEC11C;SPCS1
prerank,GO_Biological_Process_2021__N-glycan processing (GO:0006491),-0.26484426959041507,-0.6054070895556013,0.9545454545454546,1.0,1.0,1/17,3.26%,GANC
prerank,GO_Biological_Process_2021__heterochromatin assembly (GO:0031507),-0.2669659107552643,-0.6052496453611328,1.0,1.0,1.0,2/17,10.21%,BAHD1;POLE3
prerank,GO_Biological_Process_2021__nicotinamide nucleotide biosynthetic process (GO:0019359),0.36421445736080393,0.6050378572888552,0.9420289855072463,1.0,1.0,3/7,29.57%,NMNAT2;KYNU;HAAO
prerank,GO_Biological_Process_2021__positive regulation of peptidyl-lysine acetylation (GO:2000758),0.3396655842357378,0.605023831215436,0.9642857142857143,1.0,1.0,4/18,18.04%,SOX4;RUVBL2;BRCA1;PRKAA2
prerank,GO_Biological_Process_2021__regulation of adenylate cyclase activity (GO:0045761),0.36741384685151235,0.6042353651202955,0.9027777777777778,1.0,1.0,1/12,5.76%,GRM3
prerank,GO_Biological_Process_2021__cellular response to lipopolysaccharide (GO:0071222),0.28939547358030393,0.6038475737909099,0.9789473684210527,1.0,1.0,10/65,15.83%,VIM;HMGB2;PRKCE;PDE4B;PDCD1LG2;NOD2;TNFRSF1B;PYCARD;WNT5A;IL18
prerank,GO_Biological_Process_2021__regulation of histone deacetylation (GO:0031063),-0.3122908218590277,-0.6025213031631305,0.9142857142857143,1.0,1.0,4/8,19.87%,AKAP8L;SAP30BP;SPHK2;AKAP8
prerank,GO_Biological_Process_2021__negative regulation of centriole replication (GO:0046600),0.39883282334063896,0.6024851069256066,0.9166666666666666,1.0,1.0,1/6,12.87%,BRCA1
prerank,GO_Biological_Process_2021__DNA strand elongation involved in DNA replication (GO:0006271),0.34941161234526935,0.6023749678735233,0.96,1.0,1.0,3/13,14.36%,GINS1;MCMDC2;RFC4
prerank,GO_Biological_Process_2021__mitotic nuclear membrane organization (GO:0101024),0.29630491265626857,0.6020351196196388,0.9770114942528736,1.0,1.0,9/43,25.06%,NUP133;RCC1;SPAST;REEP3;SEH1L;NDC1;VRK1;CHMP7;POM121
prerank,GO_Biological_Process_2021__mitotic nuclear membrane reassembly (GO:0007084),0.29630491265626857,0.6020351196196388,0.9770114942528736,1.0,1.0,9/43,25.06%,NUP133;RCC1;SPAST;REEP3;SEH1L;NDC1;VRK1;CHMP7;POM121
prerank,GO_Biological_Process_2021__regulation of interferon-beta production (GO:0032648),0.290469448960625,0.6010243617696787,0.9655172413793104,1.0,1.0,10/42,29.17%,POLR3F;RIPK2;PYCARD;PTPRS;TRIM56;DDX3X;TLR2;IRF1;RIOK3;RELB
prerank,GO_Biological_Process_2021__regulation of translational initiation (GO:0006446),0.28565805828774554,0.6008378482295159,0.9772727272727273,1.0,1.0,12/58,21.28%,EIF2AK3;RPS6KB2;IMPACT;EIF3E;DDX1;EIF2B2;POLR2D;HSPB1;MIF4GD;UHMK1;ATF3;POLR2G
prerank,GO_Biological_Process_2021__negative regulation of lipid catabolic process (GO:0050995),0.3667281689209978,0.5997180356365582,0.9130434782608695,1.0,1.0,2/9,10.17%,MFSD2A;ALK
prerank,"GO_Biological_Process_2021__substrate-dependent cell migration, cell extension (GO:0006930)",-0.3536218279761086,-0.5990838797842472,0.8571428571428571,1.0,1.0,2/6,11.64%,P2RY12;OPHN1
prerank,GO_Biological_Process_2021__purinergic nucleotide receptor signaling pathway (GO:0035590),0.33664727175256526,0.5990166248833121,0.9418604651162791,1.0,1.0,5/18,17.45%,TXN;TXNIP;PYCARD;IL18;APP
prerank,GO_Biological_Process_2021__regulation of cell development (GO:0060284),0.33316973264104704,0.5989246381025778,0.9879518072289156,1.0,1.0,2/21,7.92%,HMGB2;BHLHE40
prerank,GO_Biological_Process_2021__cellular response to low-density lipoprotein particle stimulus (GO:0071404),0.34470572841130753,0.5985569430513173,0.975,1.0,1.0,1/13,9.03%,ABCA1
prerank,GO_Biological_Process_2021__positive regulation of ATPase activity (GO:0032781),0.3069413179542314,0.5984764937749095,0.9651162790697675,1.0,1.0,9/31,25.73%,RYR2;DNAJB2;VMP1;ATP1B3;ATP1B2;HNRNPU;UHRF1;DNAJC9;DYNLL1
prerank,GO_Biological_Process_2021__negative regulation of cell aging (GO:0090344),-0.33683866073241187,-0.5984618963192335,0.9393939393939394,1.0,1.0,3/10,21.37%,ZKSCAN3;TERF2;SLC30A10
prerank,GO_Biological_Process_2021__negative regulation of protein metabolic process (GO:0051248),0.31640754632904655,0.5979660601362304,0.9651162790697675,1.0,1.0,13/34,30.18%,VBP1;FMN2;PFDN4;ITGAV;ROCK1;IRAK3;FLOT2;BANP;LILRB2;HSP90AB1;SNX12;PRNP;PFDN2
prerank,GO_Biological_Process_2021__regulation of establishment of planar polarity (GO:0090175),0.27637763212765415,0.59731314489611,1.0,1.0,1.0,13/63,24.06%,FZD6;CELSR2;PSMB4;PRICKLE1;WNT5A;PSMC2;PSMA3;AP2A2;PSMB2;PSMD5;PSMD7;PSMD14;PSMA5
prerank,GO_Biological_Process_2021__positive regulation of histone exchange (GO:1900051),-0.33676743793278163,-0.5972848979595928,0.8928571428571429,1.0,1.0,7/7,66.35%,TERF2;TERF1;ATRX;POT1;H3-3A;DAXX;TERF2IP
prerank,GO_Biological_Process_2021__regulation of histone exchange (GO:1900049),-0.33676743793278163,-0.5972848979595928,0.8928571428571429,1.0,1.0,7/7,66.35%,TERF2;TERF1;ATRX;POT1;H3-3A;DAXX;TERF2IP
prerank,GO_Biological_Process_2021__purine nucleoside bisphosphate metabolic process (GO:0034032),0.33119102894191865,0.5964385166422487,0.9230769230769231,1.0,1.0,2/16,7.92%,ACOT13;ACAT1
prerank,GO_Biological_Process_2021__ribonucleoside bisphosphate metabolic process (GO:0033875),0.33119102894191865,0.5964385166422487,0.9230769230769231,1.0,1.0,2/16,7.92%,ACOT13;ACAT1
prerank,GO_Biological_Process_2021__branched-chain amino acid catabolic process (GO:0009083),0.3335597074004778,0.5963081387282831,0.9722222222222222,1.0,1.0,4/17,25.13%,ACAT1;ALDH6A1;AUH;ECHS1
prerank,GO_Biological_Process_2021__branched-chain amino acid metabolic process (GO:0009081),0.3335597074004778,0.5963081387282831,0.9722222222222222,1.0,1.0,4/17,25.13%,ACAT1;ALDH6A1;AUH;ECHS1
prerank,GO_Biological_Process_2021__negative regulation of Rho protein signal transduction (GO:0035024),0.33520301016417786,0.5962612386885288,0.9342105263157895,1.0,1.0,4/13,26.64%,KANK1;CCDC125;TNFAIP1;KCTD13
prerank,GO_Biological_Process_2021__mitochondrial transport (GO:0006839),0.2977754942563916,0.5960271932961398,0.9659090909090909,1.0,1.0,11/43,26.53%,TIMM13;FLVCR1;TOMM20;BNIP3;TMEM14A;SLC25A4;FBXO7;MFN2;TOMM40;TIMM22;SLC25A24
prerank,GO_Biological_Process_2021__regulation of DNA recombination at telomere (GO:0072695),0.336691816051377,0.5950391875572303,0.9102564102564102,1.0,1.0,6/15,36.79%,POLR2D;POLR2G;POLR2A;TERF2IP;POLR2H;DAXX
prerank,GO_Biological_Process_2021__negative regulation of DNA recombination at telomere (GO:0048239),0.336691816051377,0.5950391875572303,0.9102564102564102,1.0,1.0,6/15,36.79%,POLR2D;POLR2G;POLR2A;TERF2IP;POLR2H;DAXX
prerank,GO_Biological_Process_2021__cytoplasmic translational initiation (GO:0002183),0.32809631367842373,0.5949735138433117,0.9487179487179487,1.0,1.0,5/17,31.44%,EIF4A2;EIF3A;EIF3D;EIF4G1;DHX29
prerank,GO_Biological_Process_2021__positive regulation of mitotic metaphase/anaphase transition (GO:0045842),-0.28701748458484666,-0.5945317647685523,0.9166666666666666,1.0,1.0,10/10,71.33%,ANAPC4;CUL3;NSMCE2;ANAPC11;CDC16;RB1;CDC27;CDC23;ANAPC7;ANAPC5
prerank,GO_Biological_Process_2021__positive regulation of mitotic sister chromatid separation (GO:1901970),-0.28701748458484666,-0.5945317647685523,0.9166666666666666,1.0,1.0,10/10,71.33%,ANAPC4;CUL3;NSMCE2;ANAPC11;CDC16;RB1;CDC27;CDC23;ANAPC7;ANAPC5
prerank,GO_Biological_Process_2021__positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101),-0.28701748458484666,-0.5945317647685523,0.9166666666666666,1.0,1.0,10/10,71.33%,ANAPC4;CUL3;NSMCE2;ANAPC11;CDC16;RB1;CDC27;CDC23;ANAPC7;ANAPC5
prerank,GO_Biological_Process_2021__constitutive secretory pathway (GO:0045054),-0.3449003714961162,-0.5945272638309865,0.8787878787878788,1.0,1.0,5/5,65.53%,TMEM167A;RAB11B;TRAPPC11;TMEM167B;RAB3A
prerank,GO_Biological_Process_2021__negative regulation of ERAD pathway (GO:1904293),-0.3570016564850471,-0.5936401459640054,0.9523809523809523,1.0,1.0,3/6,17.75%,SVIP;SGTA;USP14
prerank,GO_Biological_Process_2021__cGMP metabolic process (GO:0046068),-0.3601378568876669,-0.5929690495713319,0.9714285714285714,1.0,1.0,1/6,1.38%,NPR2
prerank,GO_Biological_Process_2021__regulation of defense response (GO:0031347),0.2948858955481951,0.5928736113732274,1.0,1.0,1.0,8/52,17.56%,ANXA1;FCGR2B;CASP5;FGR;NOD2;WNT5A;BCL6;FOXP1
prerank,GO_Biological_Process_2021__positive regulation of activated T cell proliferation (GO:0042104),0.36796375932382186,0.5922507664872754,0.8939393939393939,1.0,1.0,2/8,15.83%,PYCARD;IL18
prerank,GO_Biological_Process_2021__regulation of catabolic process (GO:0009894),-0.2982124708862739,-0.5918641991786614,0.9354838709677419,1.0,1.0,3/13,21.23%,ZDHHC2;CENATAC;CHEK2
prerank,GO_Biological_Process_2021__peptidyl-serine dephosphorylation (GO:0070262),0.3303149421586943,0.5915133842008432,0.9452054794520548,1.0,1.0,1/13,11.38%,PPP2R2B
prerank,GO_Biological_Process_2021__regulation of transmembrane transporter activity (GO:0022898),-0.36565029885111744,-0.5909471073122665,0.9705882352941176,1.0,1.0,1/6,3.45%,ACTB
prerank,GO_Biological_Process_2021__negative regulation of response to wounding (GO:1903035),0.33141142039123245,0.590817341479242,0.9538461538461539,1.0,1.0,6/13,32.99%,EPHA4;PTPRS;RTN4RL1;GIT1;AJAP1;SERPINE1
prerank,GO_Biological_Process_2021__retinol metabolic process (GO:0042572),-0.37952050513425345,-0.5905051079525835,0.9428571428571428,1.0,1.0,2/5,9.84%,RDH10;DHRS9
prerank,GO_Biological_Process_2021__mitotic nuclear membrane disassembly (GO:0007077),0.38041214995014533,0.5899887910868316,0.9384615384615385,1.0,1.0,4/7,24.19%,CNEP1R1;PRKCB;VRK1;NEK9
prerank,GO_Biological_Process_2021__purine nucleotide metabolic process (GO:0006163),-0.26405641373431654,-0.5895315712134568,1.0,1.0,1.0,1/16,1.62%,ITPA
prerank,GO_Biological_Process_2021__protein localization to phagophore assembly site (GO:0034497),0.3712844657558918,0.5893105962835828,0.9577464788732394,1.0,1.0,2/8,23.17%,MFN2;ATG13
prerank,GO_Biological_Process_2021__negative regulation of smooth muscle cell differentiation (GO:0051151),-0.39751481353672435,-0.5891031390664444,0.925,1.0,1.0,1/5,8.79%,NFATC3
prerank,GO_Biological_Process_2021__negative regulation of vascular associated smooth muscle cell differentiation (GO:1905064),-0.3865723440847217,-0.5888355225124697,1.0,1.0,1.0,1/6,8.79%,NFATC3
prerank,GO_Biological_Process_2021__negative regulation of fat cell differentiation (GO:0045599),0.32088758414500357,0.5888143283085889,0.9506172839506173,1.0,1.0,6/21,23.75%,RUNX1T1;WNT5A;TNF;ANKRD26;RORA;GPS2
prerank,GO_Biological_Process_2021__RNA biosynthetic process (GO:0032774),-0.26265144013046715,-0.5886123912489454,0.9523809523809523,1.0,1.0,8/21,19.70%,TAF13;HELB;TTF1;TTF2;GTF2B;TBP;TCEA2;PRIM1
prerank,GO_Biological_Process_2021__positive regulation of binding (GO:0051099),0.28119015978658196,0.5885452339755536,1.0,1.0,1.0,11/61,22.43%,HMGB2;TXN;NMD3;RIPK2;PKD1;RPL11;APP;CLIC2;HIP1R;LRRK2;HFE
prerank,GO_Biological_Process_2021__lysine metabolic process (GO:0006553),0.35301996563355487,0.5877837842944927,0.9692307692307692,1.0,1.0,2/10,20.57%,SLC25A21;PIPOX
prerank,GO_Biological_Process_2021__lysine catabolic process (GO:0006554),0.35301996563355487,0.5877837842944927,0.9692307692307692,1.0,1.0,2/10,20.57%,SLC25A21;PIPOX
prerank,GO_Biological_Process_2021__actin filament depolymerization (GO:0030042),0.37259951126184,0.587235553752295,0.9571428571428572,1.0,1.0,4/9,34.18%,CFL1;TWF1;MICAL2;DSTN
prerank,GO_Biological_Process_2021__negative regulation by host of viral process (GO:0044793),-0.33772590691436977,-0.5862180871617003,0.90625,1.0,1.0,2/5,22.47%,EIF2AK4;PRKN
prerank,GO_Biological_Process_2021__phosphate ion transmembrane transport (GO:0035435),-0.2599279090877806,-0.5854762331646508,0.9523809523809523,1.0,1.0,2/11,13.39%,SLC37A1;SLC37A4
prerank,GO_Biological_Process_2021__phosphate ion transport (GO:0006817),-0.2599279090877806,-0.5854762331646508,0.9523809523809523,1.0,1.0,2/11,13.39%,SLC37A1;SLC37A4
prerank,GO_Biological_Process_2021__mitochondrion localization (GO:0051646),0.3496263458775498,0.5850228130781832,0.975609756097561,1.0,1.0,5/12,34.31%,LRRK2;MFN2;MTM1;MARK1;ATCAY
prerank,GO_Biological_Process_2021__acetyl-CoA biosynthetic process (GO:0006085),0.36468957273210667,0.5848926606346145,0.9130434782608695,1.0,1.0,2/9,21.03%,ACAT1;PDHB
prerank,GO_Biological_Process_2021__positive regulation of NIK/NF-kappaB signaling (GO:1901224),0.30181825867645523,0.5844037678843754,0.9880952380952381,1.0,1.0,9/38,26.10%,NLRP12;NOD2;SASH1;APP;TNF;PDCD4;TRADD;DDX3X;TLR2
prerank,GO_Biological_Process_2021__positive regulation of chromosome segregation (GO:0051984),-0.3336797031708263,-0.584294360592344,0.896551724137931,1.0,1.0,5/6,31.59%,RCC2;SMC5;NUMA1;SMC6;SIRT2
prerank,GO_Biological_Process_2021__response to UV-C (GO:0010225),0.3797757221740704,0.584075713987541,0.9384615384615385,1.0,1.0,1/7,10.79%,IMPACT
prerank,GO_Biological_Process_2021__mitochondrial protein processing (GO:0034982),0.34566894392158454,0.5829725822260601,0.9583333333333334,1.0,1.0,3/9,31.18%,PMPCA;IMMP2L;PMPCB
prerank,GO_Biological_Process_2021__negative regulation of protein ubiquitination (GO:0031397),0.3022516272770421,0.5825768912731566,0.9767441860465116,1.0,1.0,5/40,21.98%,SOX4;CAMLG;HSPA1B;GTPBP4;CHP1
prerank,GO_Biological_Process_2021__regulation of stem cell population maintenance (GO:2000036),0.329483081362252,0.5823725826484618,0.9333333333333333,1.0,1.0,3/15,26.36%,PTN;ZNF706;TAF6L
prerank,GO_Biological_Process_2021__stress-activated protein kinase signaling cascade (GO:0031098),0.31417255110591813,0.5821455116658825,0.9550561797752809,1.0,1.0,4/27,18.81%,MAP3K8;RPS27A;UBA52;UBB
prerank,GO_Biological_Process_2021__phosphatidylcholine acyl-chain remodeling (GO:0036151),-0.2766655225908284,-0.5820921531548926,1.0,1.0,1.0,4/17,11.43%,PLA2G4C;PLA2G12A;NR1H3;PLB1
prerank,GO_Biological_Process_2021__regulation of transcription by RNA polymerase III (GO:0006359),0.3207710446943367,0.5816803194921056,0.963855421686747,1.0,1.0,2/19,13.86%,POLR3F;ZNF143
prerank,GO_Biological_Process_2021__long-term memory (GO:0007616),0.3531116514109564,0.5806895468546266,0.975609756097561,1.0,1.0,3/10,33.49%,RASGRF1;PRNP;PJA2
prerank,GO_Biological_Process_2021__positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052),0.3150759219103029,0.5803812353639609,0.9506172839506173,1.0,1.0,7/25,24.39%,CAV3;RNF139;PSMC2;ATP5IF1;MAGEF1;PTEN;DDRGK1
prerank,GO_Biological_Process_2021__cell junction maintenance (GO:0034331),-0.3531094302825546,-0.5799076473112474,0.9722222222222222,1.0,1.0,2/6,12.18%,CSF1R;CHCHD10
prerank,GO_Biological_Process_2021__positive regulation of JUN kinase activity (GO:0043507),0.3303105774843815,0.5798551013211657,0.9605263157894737,1.0,1.0,2/16,11.93%,TRAF2;SASH1
prerank,GO_Biological_Process_2021__regulation of calcium ion transport (GO:0051924),0.3052558181272878,0.5794712084088386,0.9772727272727273,1.0,1.0,4/39,11.27%,CACNB2;ANK2;CAV3;CAMK2B
prerank,GO_Biological_Process_2021__protein autoubiquitination (GO:0051865),-0.2176182529239953,-0.5787278835415729,1.0,1.0,1.0,8/53,15.38%,BFAR;RNF187;DDB2;RNF19B;RNF8;SH3RF3;RNF157;RNF11
prerank,GO_Biological_Process_2021__mitochondrial fusion (GO:0008053),-0.2668046117642856,-0.5783625065656258,0.8947368421052632,1.0,1.0,3/15,15.49%,STOML2;MIGA1;FIS1
prerank,GO_Biological_Process_2021__positive regulation of alpha-beta T cell proliferation (GO:0046641),0.33955508907796966,0.5779262293892806,0.9733333333333334,1.0,1.0,2/11,15.83%,CD55;IL18
prerank,GO_Biological_Process_2021__positive regulation of DNA replication (GO:0045740),-0.3068482566315577,-0.5776160970322677,0.9393939393939394,1.0,1.0,4/10,14.16%,CTC1;BCAR3;EGFR;KAT7
prerank,GO_Biological_Process_2021__heart looping (GO:0001947),0.3309716414556317,0.5774339194458042,0.9733333333333334,1.0,1.0,5/15,29.90%,CCDC39;NDRG4;BBS7;SETDB2;MICAL2
prerank,GO_Biological_Process_2021__histone H4 deacetylation (GO:0070933),-0.295777027027027,-0.5767729432402252,1.0,1.0,1.0,9/9,70.45%,REST;HDAC2;SIRT2;RCOR1;HDAC1;HDAC3;HDAC4;HDAC9;SMARCAD1
prerank,GO_Biological_Process_2021__production of small RNA involved in gene silencing by RNA (GO:0070918),0.3181608977527152,0.5752426044967167,0.95,1.0,1.0,3/15,28.85%,PRKRA;AGO4;DICER1
prerank,GO_Biological_Process_2021__late nucleophagy (GO:0044805),0.38131184012088276,0.5748499320201953,0.967741935483871,1.0,1.0,3/5,39.02%,ATG2B;ULK1;ATG2A
prerank,GO_Biological_Process_2021__negative regulation of protein kinase B signaling (GO:0051898),0.2994460768191847,0.5747486173858036,0.963855421686747,1.0,1.0,3/25,11.99%,PPP2R5B;PHLPP1;MAGI2
prerank,GO_Biological_Process_2021__regulation of cellular extravasation (GO:0002691),-0.3575325490568802,-0.574315277575396,0.8666666666666667,1.0,1.0,2/5,13.01%,ICAM1;PLVAP
prerank,GO_Biological_Process_2021__positive regulation of transcription by RNA polymerase I (GO:0045943),0.3193335046611392,0.5741692306305961,0.963855421686747,1.0,1.0,2/19,15.82%,EIF2AK3;DHX33
prerank,GO_Biological_Process_2021__nuclear membrane disassembly (GO:0051081),0.34845092454186155,0.5734253842769192,0.9852941176470589,1.0,1.0,5/9,24.19%,CNEP1R1;DCTN1;PRKCB;VRK1;NEK9
prerank,GO_Biological_Process_2021__peroxisome proliferator activated receptor signaling pathway (GO:0035357),0.3744316138295489,0.5732368889899045,0.9230769230769231,1.0,1.0,1/5,15.59%,PDK3
prerank,GO_Biological_Process_2021__intracellular protein transport (GO:0006886),0.2608739772549082,0.5713619693582277,1.0,1.0,1.0,40/257,22.12%,CLIP3;TBC1D8;NAPA;ARF6;TBC1D13;NUP133;AKAP6;RAB20;NLGN1;XPO1;RANBP3L;TBC1D15;PRICKLE1;HEATR3;FAM53C;NSF;TNPO2;PKD1;CDC37;RANBP17;TMED10;BAG3;RPL11;SNX17;STXBP2;SCG5;RAB21;STX2;TECPR2;SRPRA;SURF4;TBC1D2;STX19;NAPG;TBC1D14;IPO7;APPL1;CHP1;RAB5A;CTTN
prerank,GO_Biological_Process_2021__anaphase-promoting complex-dependent catabolic process (GO:0031145),-0.22604340507170745,-0.5711302529560256,1.0,1.0,1.0,9/59,15.17%,PSMB3;PSME3;PSMC4;PSMD12;PSME4;PSMA1;ANAPC4;BUB3;PSMA7
prerank,GO_Biological_Process_2021__regulation of establishment of endothelial barrier (GO:1903140),0.3477464662840461,0.5710787523316284,0.9767441860465116,1.0,1.0,4/12,20.20%,VEGFA;ROCK1;TNFRSF1A;TNF
prerank,GO_Biological_Process_2021__mRNA processing (GO:0006397),0.2604536606027339,0.5696524716920528,1.0,1.0,1.0,22/248,17.24%,TBRG4;EIF4A3;ERCC2;PQBP1;WBP11;GEMIN2;DBR1;SRSF12;WBP4;TFIP11;ZMAT2;NOVA1;BCAS2;HNRNPA0;RBM5;RBM4B;MFAP1;GTF2H3;WDR83;HNRNPH1;POLR2D;SART3
prerank,GO_Biological_Process_2021__cell proliferation in forebrain (GO:0021846),0.3588308676674049,0.5690280846062594,0.9014084507042254,1.0,1.0,1/7,13.85%,HOOK3
prerank,GO_Biological_Process_2021__bile acid biosynthetic process (GO:0006699),-0.2554230454950731,-0.5687400815053192,1.0,1.0,1.0,2/15,11.79%,CH25H;OSBPL6
prerank,MSigDB_Hallmark_2020__Myc Targets V1,0.26124708300050903,0.5686984679097713,1.0,1.0,1.0,33/171,26.74%,VBP1;COPS5;RUVBL2;XPO1;RPS6;NHP2;EEF1B2;RFC4;RPL14;TCP1;HPRT1;HSPD1;PRDX4;SMARCC1;PGK1;CYC1;CTPS1;PSMB2;SNRPD2;HNRNPU;PSMD7;GNL3;CAD;SRSF3;PSMD14;ILF2;SRM;HNRNPR;AP3S1;EIF3D;SYNCRIP;HSP90AB1;SLC25A3
prerank,GO_Biological_Process_2021__negative regulation of translational initiation (GO:0045947),-0.2960688788114266,-0.5684373490961568,0.9444444444444444,1.0,1.0,4/11,19.65%,EIF4EBP1;EIF2AK4;RBM4;FMR1
prerank,GO_Biological_Process_2021__negative regulation of cAMP-mediated signaling (GO:0043951),-0.32656791297025245,-0.567590547931244,0.8648648648648649,1.0,1.0,4/7,20.15%,PDE3A;RNF157;PDE4D;MGRN1
prerank,GO_Biological_Process_2021__positive regulation of endoplasmic reticulum unfolded protein response (GO:1900103),0.3541072306749351,0.5668536411993773,1.0,1.0,1.0,1/10,8.90%,BOK
prerank,GO_Biological_Process_2021__B cell homeostasis (GO:0001782),-0.32198108944737347,-0.5663677602898611,1.0,1.0,1.0,4/9,22.31%,NCKAP1L;DOCK10;PPP2R3C;MEF2C
prerank,GO_Biological_Process_2021__T cell differentiation in thymus (GO:0033077),-0.3298429319371728,-0.5661149333104754,0.9130434782608695,1.0,1.0,7/7,67.04%,ZFP36L1;MR1;PTPRC;ZFP36L2;RABL3;LIG4;ADAM17
prerank,GO_Biological_Process_2021__regulation of phospholipid metabolic process (GO:1903725),0.3530589482819562,0.5660412669603129,0.9710144927536232,1.0,1.0,2/9,17.76%,MFSD2A;MTMR9
prerank,GO_Biological_Process_2021__regulation of NIK/NF-kappaB signaling (GO:1901222),0.2728767335151347,0.5656859172048473,0.9893617021276596,1.0,1.0,4/54,12.78%,NLRP12;NOD2;SASH1;UACA
prerank,GO_Biological_Process_2021__glycosphingolipid biosynthetic process (GO:0006688),-0.2996345183148509,-0.5654279850632452,0.9032258064516129,1.0,1.0,1/10,2.95%,ST6GALNAC3
prerank,GO_Biological_Process_2021__neuron remodeling (GO:0016322),-0.29066609926446935,-0.5651916778361515,0.9615384615384616,1.0,1.0,2/8,13.71%,C3;SCARF1
prerank,GO_Biological_Process_2021__positive regulation of histone modification (GO:0031058),0.29559807637375063,0.5648909699992968,0.9767441860465116,1.0,1.0,6/26,18.85%,RUVBL2;KDM1A;BRCA1;CTBP1;SART3;CDK9
prerank,GO_Biological_Process_2021__response to manganese ion (GO:0010042),0.3935244915658293,0.564295140668158,0.9538461538461539,1.0,1.0,1/5,20.68%,LRRK2
prerank,GO_Biological_Process_2021__organelle transport along microtubule (GO:0072384),0.2883986968349819,0.5633408679320876,0.9759036144578314,1.0,1.0,4/27,20.29%,MAPT;UXT;UBB;DYNC1I1
prerank,GO_Biological_Process_2021__negative regulation of chemokine-mediated signaling pathway (GO:0070100),0.3853978019539328,0.5631498630710832,0.9558823529411765,1.0,1.0,1/5,8.14%,ROBO1
prerank,GO_Biological_Process_2021__cellular response to arsenic-containing substance (GO:0071243),0.33918521380719496,0.5630834053572005,0.9743589743589743,1.0,1.0,3/12,24.61%,CPEB2;ATF3;DDX3X
prerank,GO_Biological_Process_2021__response to gamma radiation (GO:0010332),0.31249550464170683,0.5629663775105088,0.9583333333333334,1.0,1.0,1/17,9.50%,KDM1A
prerank,GO_Biological_Process_2021__negative regulation of DNA recombination (GO:0045910),0.286397825608656,0.5628261780169227,0.9888888888888889,1.0,1.0,12/39,33.67%,FANCB;POLQ;POLR2D;POLR2G;MAGEF1;H1-0;UBQLN4;BLM;RIF1;POLR2A;ZRANB3;TERF2IP
prerank,GO_Biological_Process_2021__negative regulation of autophagosome maturation (GO:1901097),0.3550013671315019,0.5623073326027102,0.95,1.0,1.0,1/5,12.70%,TMEM39A
prerank,GO_Biological_Process_2021__cellular response to gamma radiation (GO:0071480),0.3277186840093034,0.5618009338804292,0.9565217391304348,1.0,1.0,1/13,9.50%,KDM1A
prerank,GO_Biological_Process_2021__response to glucocorticoid (GO:0051384),0.3112380954241086,0.5604104140853089,0.9868421052631579,1.0,1.0,1/16,3.87%,ANXA1
prerank,GO_Biological_Process_2021__polyamine biosynthetic process (GO:0006596),-0.3287495610087967,-0.5603163549977127,1.0,1.0,1.0,2/6,13.98%,SMOX;SMS
prerank,GO_Biological_Process_2021__negative regulation of p38MAPK cascade (GO:1903753),0.35832018435119795,0.5569384729179597,0.9841269841269841,1.0,1.0,3/7,33.60%,DUSP10;DUSP1;CYLD
prerank,GO_Biological_Process_2021__protein hydroxylation (GO:0018126),0.35990450065709156,0.5569160865033975,0.974025974025974,1.0,1.0,3/10,17.20%,ASPH;PLOD1;EGLN3
prerank,PanglaoDB_Augmented_2021__Merkel Cells,0.32643733912604533,0.5569077338485278,0.963855421686747,1.0,1.0,4/13,15.51%,OVOL2;ID2;GNAI1;PIEZO2
prerank,GO_Biological_Process_2021__pre-replicative complex assembly (GO:0036388),0.26888683571139843,0.5562904324037073,0.9888888888888889,1.0,1.0,14/51,24.35%,RPS27A;PSMB4;ORC6;UBA52;UBB;PSMC2;PSMA3;PSMB2;PSMD5;PSMD7;ORC3;PSMD14;PSMA5;MCM3
prerank,GO_Biological_Process_2021__response to DNA damage checkpoint signaling (GO:0072423),0.36342743681788026,0.5560955730966212,0.9178082191780822,1.0,1.0,1/5,23.73%,SLX4
prerank,"GO_Biological_Process_2021__RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",0.2536341615170637,0.5548244669644665,1.0,1.0,1.0,34/208,26.18%,EIF4A3;PQBP1;WBP11;DBR1;SRSF12;WBP4;TFIP11;ZMAT2;NOVA1;BCAS2;HNRNPA0;RBM5;RBM4B;MFAP1;WDR83;HNRNPH1;POLR2D;SART3;PRPF6;SRSF5;POLR2G;SNRPD2;HNRNPU;SFPQ;PHF5A;HNRNPH3;SRSF3;PRCC;HNRNPR;BUD13;ELAVL2;SYNCRIP;LSM5;SRSF9
prerank,GO_Biological_Process_2021__chromatin remodeling (GO:0006338),0.27111939641807714,0.5542410511586899,1.0,1.0,1.0,20/79,29.96%,SUV39H2;HCFC1;RUVBL2;KDM4B;ACTR5;SMARCD3;ESR1;ERCC6;SMARCC1;KDM5B;KDM6B;SMARCD2;SATB2;SMARCA5;JARID2;TAF6L;KDM6A;SMARCAD1;ACTL6A;KDM5C
prerank,GO_Biological_Process_2021__multivesicular body organization (GO:0036257),-0.23179968723557698,-0.5539296342162301,1.0,1.0,1.0,4/25,9.99%,STAM2;VTA1;VPS37B;CHMP2B
prerank,GO_Biological_Process_2021__actin nucleation (GO:0045010),0.33375077080539783,0.5537875156793152,0.972972972972973,1.0,1.0,1/14,6.84%,SPIRE2
prerank,GO_Biological_Process_2021__carnitine metabolic process (GO:0009437),0.34844741729659534,0.5535399867652675,1.0,1.0,1.0,2/7,22.64%,CPT1A;TMLHE
prerank,GO_Biological_Process_2021__positive regulation of G protein-coupled receptor signaling pathway (GO:0045745),0.3779232781365981,0.5535112834039848,0.9696969696969697,1.0,1.0,2/5,17.63%,ACP3;SLC39A14
prerank,GO_Biological_Process_2021__lipoprotein biosynthetic process (GO:0042158),0.3401165857938321,0.5533338694668177,0.9393939393939394,1.0,1.0,1/8,15.82%,UGCG
prerank,GO_Biological_Process_2021__cortical actin cytoskeleton organization (GO:0030866),0.32553347728626914,0.5531207921738315,0.9770114942528736,1.0,1.0,4/18,21.71%,ARF6;ROCK1;TNF;FHOD3
prerank,GO_Biological_Process_2021__vesicle fusion with endoplasmic reticulum-Golgi intermediate compartment (ERGIC) membrane (GO:1990668),-0.3345153664302601,-0.552659395717055,0.9032258064516129,1.0,1.0,5/5,66.57%,STX4;TAPBP;CALR;SEC22B;TAP1
prerank,GO_Biological_Process_2021__multivesicular body assembly (GO:0036258),-0.23548554948439898,-0.552519400918303,1.0,1.0,1.0,4/24,9.99%,STAM2;VTA1;VPS37B;CHMP2B
prerank,GO_Biological_Process_2021__phosphatidic acid metabolic process (GO:0046473),0.3072446173317672,0.5516356339577686,1.0,1.0,1.0,14/32,34.29%,DGKB;DGKG;DDHD1;PLD1;GPAT4;LPCAT4;DGKE;DGKZ;LPCAT1;DGKQ;GNPAT;AGPAT3;PLA2G4A;AGPAT5
prerank,GO_Biological_Process_2021__protein insertion into ER membrane (GO:0045048),0.282659324798178,0.5515672984455806,0.9886363636363636,1.0,1.0,6/27,17.45%,SEC61B;EMC7;SERP1;CAMLG;UBE2J2;APP
prerank,"GO_Biological_Process_2021__positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900153)",-0.2690715552927262,-0.5511121843219635,1.0,1.0,1.0,12/12,73.13%,ZFP36;ZFP36L1;DHX36;TOB1;ZFP36L2;TNRC6B;AGO2;CNOT1;PABPC1;CPEB3;TNRC6C;CNOT7
prerank,"GO_Biological_Process_2021__regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151)",-0.2690715552927262,-0.5511121843219635,1.0,1.0,1.0,12/12,73.13%,ZFP36;ZFP36L1;DHX36;TOB1;ZFP36L2;TNRC6B;AGO2;CNOT1;PABPC1;CPEB3;TNRC6C;CNOT7
prerank,GO_Biological_Process_2021__regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901836),-0.26060338167108277,-0.5510453198397186,1.0,1.0,1.0,2/14,12.21%,IPPK;PIH1D1
prerank,GO_Biological_Process_2021__phosphatidic acid biosynthetic process (GO:0006654),0.3088228414327909,0.5509649273842321,0.9876543209876543,1.0,1.0,14/31,34.29%,DGKB;DGKG;DDHD1;PLD1;GPAT4;LPCAT4;DGKE;DGKZ;LPCAT1;DGKQ;GNPAT;AGPAT3;PLA2G4A;AGPAT5
prerank,GO_Biological_Process_2021__negative regulation of alpha-beta T cell activation (GO:0046636),0.3567112106703055,0.5508104455117715,0.9714285714285714,1.0,1.0,2/6,22.43%,CD300A;HFE
prerank,GO_Biological_Process_2021__phosphatidylethanolamine acyl-chain remodeling (GO:0036152),0.3333999798320406,0.550703690715382,0.9459459459459459,1.0,1.0,3/11,22.97%,MBOAT2;PNPLA8;LPCAT4
prerank,GO_Biological_Process_2021__calcium ion export (GO:1901660),-0.3329102937716155,-0.5503884208325776,0.9393939393939394,1.0,1.0,1/6,9.90%,SLC35G1
prerank,GO_Biological_Process_2021__amino acid import (GO:0043090),-0.318002828370002,-0.5503588171483894,1.0,1.0,1.0,4/12,16.25%,SLC7A8;SFXN2;SLC7A1;SLC47A1
prerank,GO_Biological_Process_2021__vesicle tethering to Golgi (GO:0099041),-0.33679500168861876,-0.5503074623325261,1.0,1.0,1.0,5/5,66.34%,TRIP11;TBC1D23;WDR11;FAM91A1;C17ORF75
prerank,GO_Biological_Process_2021__U4 snRNA 3'-end processing (GO:0034475),-0.3559101577259287,-0.5501651284475825,0.8857142857142857,1.0,1.0,3/5,25.96%,EXOSC9;EXOSC8;EXOSC2
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5' (GO:0034427)",-0.3559101577259287,-0.5501651284475825,0.8857142857142857,1.0,1.0,3/5,25.96%,EXOSC9;EXOSC8;EXOSC2
prerank,GO_Biological_Process_2021__muscle tissue development (GO:0060537),-0.3149404284688827,-0.550066428280059,1.0,1.0,1.0,2/6,15.54%,ENG;PTCH1
prerank,GO_Biological_Process_2021__protein prenylation (GO:0018342),-0.31982438365417093,-0.5500051958649481,0.9032258064516129,1.0,1.0,5/5,68.04%,PGGT1B;RABGGTB;PTAR1;FNTA;CHM
prerank,GO_Biological_Process_2021__regulation of spindle assembly (GO:0090169),0.30014783806451173,0.5484005494361389,0.9876543209876543,1.0,1.0,6/20,23.39%,DYNC1H1;HSPA1B;GPSM2;HNRNPU;CHMP5;PDCD6IP
prerank,GO_Biological_Process_2021__protein deubiquitination (GO:0016579),0.2486530594112325,0.5467816013747064,1.0,1.0,1.0,39/200,26.04%,CLSPN;TRAF2;MINDY1;COPS5;HIF1A;HCFC1;RPS27A;PSMB4;USP35;OTUD7B;TOMM20;VCPIP1;BRCA1;ACTR5;USP38;ESR1;SMAD1;TAF9B;UBA52;UBB;PSMC2;PSMA3;PSMB2;UCHL1;OTUD1;TNIP1;PSMD5;PSMD7;BARD1;USP48;USP5;PTEN;PSMD14;PSMA5;CFTR;USP11;SUDS3;CCP110;ATXN7L3
prerank,GO_Biological_Process_2021__amino sugar metabolic process (GO:0006040),0.33501770644790535,0.5463438282677889,0.9242424242424242,1.0,1.0,4/6,33.46%,GFPT1;CSGALNACT1;EXTL2;GNE
prerank,GO_Biological_Process_2021__regulation of release of cytochrome c from mitochondria (GO:0090199),0.2999463364804331,0.5460427866775328,0.974025974025974,1.0,1.0,6/28,15.86%,FAM162A;BNIP3;PINK1;PRELID1;PYCARD;CIDEB
prerank,GO_Biological_Process_2021__protein sumoylation (GO:0016925),0.27748341237470353,0.5457721674012821,0.9886363636363636,1.0,1.0,9/47,27.16%,PIAS4;NUP133;SEH1L;KIAA1586;BCL11A;NDC1;POM121;SAE1;NUP58
prerank,GO_Biological_Process_2021__retina homeostasis (GO:0001895),0.31220408386750453,0.5451998419440227,0.9714285714285714,1.0,1.0,4/11,25.12%,HSPB1;SOD1;ATP1B2;TF
prerank,GO_Biological_Process_2021__cellular heat acclimation (GO:0070370),0.3772386488700488,0.5443918490450825,0.9545454545454546,1.0,1.0,2/5,28.60%,HSPA1B;HSBP1L1
prerank,GO_Biological_Process_2021__heat acclimation (GO:0010286),0.3772386488700488,0.5443918490450825,0.9545454545454546,1.0,1.0,2/5,28.60%,HSPA1B;HSBP1L1
prerank,GO_Biological_Process_2021__negative regulation of alcohol biosynthetic process (GO:1902931),0.3452378956046751,0.5434218997907204,0.9444444444444444,1.0,1.0,2/9,18.25%,ERLIN1;SOD1
prerank,GO_Biological_Process_2021__nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289),0.2759082735298121,0.5428045460848214,0.9864864864864865,1.0,1.0,5/19,30.08%,SAMD4A;CNOT6;PAN2;CNOT7;CNOT8
prerank,"GO_Biological_Process_2021__positive regulation of gene expression, epigenetic (GO:0045815)",-0.20964451190035904,-0.5426877611971718,1.0,1.0,1.0,9/45,20.42%,ACTB;SMARCD1;EP300;ZMIZ1;POLR1F;HMGA1;TBP;SPHK2;ATAD2B
prerank,GO_Biological_Process_2021__iron-sulfur cluster assembly (GO:0016226),-0.24481006621955662,-0.5424980202152239,0.9411764705882353,1.0,1.0,5/19,21.29%,HSCB;ABCB7;MMS19;CIAO2B;NFU1
prerank,GO_Biological_Process_2021__regulation of transport (GO:0051049),0.30713602455928335,0.5417197317748604,0.9746835443037974,1.0,1.0,5/22,20.93%,PINK1;ICA1L;FES;LRRK2;LEPR
prerank,GO_Biological_Process_2021__regulation of protein localization to membrane (GO:1905475),0.2939056749103104,0.5409846692086424,0.987012987012987,1.0,1.0,1/20,3.84%,GPC5
prerank,GO_Biological_Process_2021__negative regulation of DNA replication (GO:0008156),-0.25221188976310116,-0.5407260828664764,1.0,1.0,1.0,1/11,6.86%,CDAN1
prerank,GO_Biological_Process_2021__cellular response to osmotic stress (GO:0071470),-0.24117535850839317,-0.5407189249421456,0.9629629629629629,1.0,1.0,6/16,23.50%,SERPINB6;TRPV4;WNK3;LRRC8D;CAB39;ARHGEF2
prerank,GO_Biological_Process_2021__regulation of fibroblast apoptotic process (GO:2000269),-0.32231301628911296,-0.5399522242378098,1.0,1.0,1.0,1/6,13.04%,PRDM11
prerank,GO_Biological_Process_2021__response to axon injury (GO:0048678),0.29867151358453836,0.5396861772179091,0.96,1.0,1.0,3/14,21.81%,NREP;SOD1;RTN4RL1
prerank,GO_Biological_Process_2021__negative regulation of mRNA polyadenylation (GO:1900364),0.33408671470494866,0.539389852128398,0.9682539682539683,1.0,1.0,2/8,29.71%,CDK9;CTR9
prerank,GO_Biological_Process_2021__acetyl-CoA biosynthetic process from pyruvate (GO:0006086),0.34206462389200776,0.5391134066213875,0.9848484848484849,1.0,1.0,1/5,21.03%,PDHB
prerank,GO_Biological_Process_2021__peptidyl-lysine hydroxylation (GO:0017185),-0.34430587594199896,-0.5385822707162481,0.9655172413793104,1.0,1.0,1/5,6.81%,JMJD6
prerank,GO_Biological_Process_2021__regulation of alpha-beta T cell proliferation (GO:0046640),0.3444393006036288,0.5384064570092555,0.9866666666666667,1.0,1.0,2/6,27.62%,MAPK8IP1;IRF1
prerank,GO_Biological_Process_2021__positive regulation of triglyceride metabolic process (GO:0090208),0.32725399078869744,0.5381705619557522,0.971830985915493,1.0,1.0,2/11,16.31%,MFSD2A;CNEP1R1
prerank,GO_Biological_Process_2021__regulation of lipase activity (GO:0060191),0.3580633955781335,0.5380650792459619,0.967741935483871,1.0,1.0,1/7,16.17%,PCSK6
prerank,GO_Biological_Process_2021__RNA polymerase II preinitiation complex assembly (GO:0051123),-0.286734454373194,-0.537784357073309,0.9583333333333334,1.0,1.0,3/8,19.03%,DR1;GTF2B;TBP
prerank,GO_Biological_Process_2021__regulation of androgen receptor signaling pathway (GO:0060765),0.28562859406984076,0.5373208442179797,0.9868421052631579,1.0,1.0,2/23,17.56%,KDM1A;FOXP1
prerank,GO_Biological_Process_2021__protein deacylation (GO:0035601),0.3144995818845163,0.5372682571344058,0.9634146341463414,1.0,1.0,3/20,23.00%,SIRT5;SIRT3;LYPLAL1
prerank,GO_Biological_Process_2021__cell surface receptor signaling pathway involved in heart development (GO:0061311),0.3193046281728975,0.5372661075906948,0.9850746268656716,1.0,1.0,2/8,20.17%,RBPJ;NOTCH2
prerank,GO_Biological_Process_2021__adenine nucleotide transport (GO:0051503),-0.27702535489055,-0.537181043139352,0.9629629629629629,1.0,1.0,4/11,20.48%,ABCC4;SLC19A1;LRRC8D;SLC25A17
prerank,GO_Biological_Process_2021__protein methylation (GO:0006479),0.2815360953878554,0.5369687570480992,1.0,1.0,1.0,3/27,20.44%,CSKMT;EZH2;EEF1AKMT1
prerank,GO_Biological_Process_2021__intraciliary transport involved in cilium assembly (GO:0035735),0.27525927349663093,0.5358552913107618,1.0,1.0,1.0,8/30,25.73%,DYNC2LI1;IFT74;KIF3A;IFT122;DYNC2H1;SSX2IP;IFT81;DYNLL1
prerank,GO_Biological_Process_2021__establishment of Golgi localization (GO:0051683),0.3271122534123887,0.5358354487409153,0.9558823529411765,1.0,1.0,3/7,36.72%,RIPOR1;COPG1;STK25
prerank,GO_Biological_Process_2021__negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902236),0.3038208885151425,0.5339033201572518,0.9705882352941176,1.0,1.0,3/12,20.68%,HERPUD1;SYVN1;LRRK2
prerank,GO_Biological_Process_2021__small RNA loading onto RISC (GO:0070922),-0.3228251421164388,-0.5327738187483398,0.9428571428571428,1.0,1.0,1/7,9.60%,AGO1
prerank,GO_Biological_Process_2021__regulation of osteoclast development (GO:2001204),0.34287865564308107,0.5322040738195242,0.961038961038961,1.0,1.0,2/6,26.85%,NOTCH2;FBN1
prerank,GO_Biological_Process_2021__response to estrogen (GO:0043627),0.29653414366886244,0.5321668998444936,0.9651162790697675,1.0,1.0,6/20,22.04%,TRIM25;SRA1;BRCA1;ESR1;TRIM24;GSTM3
prerank,GO_Biological_Process_2021__regulation of triglyceride biosynthetic process (GO:0010866),0.3332702659037341,0.5321462975319367,0.9875,1.0,1.0,2/10,16.31%,MFSD2A;CNEP1R1
prerank,GO_Biological_Process_2021__positive regulation of cholesterol efflux (GO:0010875),-0.25111786865753244,-0.5318297612561358,1.0,1.0,1.0,5/17,18.82%,NR1H3;TREM2;NFKBIA;PTCH1;PPARG
prerank,GO_Biological_Process_2021__purine ribonucleotide transport (GO:0015868),-0.27738993600522843,-0.5310699537786789,0.9629629629629629,1.0,1.0,4/10,20.48%,ABCC4;SLC19A1;LRRC8D;SLC25A17
prerank,GO_Biological_Process_2021__pre-miRNA processing (GO:0031054),0.323526757630027,0.5305492891954192,0.9863013698630136,1.0,1.0,3/11,28.85%,PRKRA;AGO4;DICER1
prerank,GO_Biological_Process_2021__covalent chromatin modification (GO:0016569),-0.27341061059918287,-0.5303405988955737,1.0,1.0,1.0,2/12,18.63%,HLCS;PARP2
prerank,GO_Biological_Process_2021__protein catabolic process (GO:0030163),0.25593907995221915,0.5303176646317114,1.0,1.0,1.0,9/41,27.66%,OGA;STT3B;FBXO27;NR1D1;DDB1;TRIM24;CLPX;BAG6;HSPA8
prerank,GO_Biological_Process_2021__histone mRNA catabolic process (GO:0071044),0.30172753027021154,0.5298918938624589,0.9577464788732394,1.0,1.0,1/13,11.28%,TENT4B
prerank,GO_Biological_Process_2021__negative regulation of GTPase activity (GO:0034260),0.3138754299982955,0.5296823342990258,0.9726027397260274,1.0,1.0,4/13,21.38%,RRP1B;CPEB2;LRRK2;RDX
prerank,GO_Biological_Process_2021__glycerophospholipid biosynthetic process (GO:0046474),0.24263427560567244,0.5296756813873951,1.0,1.0,1.0,46/132,33.07%,INPP4B;MTMR7;DGKB;MFSD2A;SELENOI;SLC44A5;DGKG;PEMT;ETNPPL;DDHD1;PIK3R4;MTMR9;CHPT1;SLC44A1;PLD1;CDS2;GPAT4;RAB5A;PLEKHA3;CPNE3;LPCAT4;DGKE;PTEN;MBOAT7;DGKZ;MTM1;PCTP;PGS1;MTMR4;LPCAT1;PLEKHA8;PIP5K1A;FIG4;AGK;DGKQ;PLEKHA4;SYNJ2;PIK3CA;GNPAT;SACM1L;PIK3CB;MTMR6;CDIPT;PIP5K1B;AGPAT3;STARD7
prerank,GO_Biological_Process_2021__negative regulation of phosphatidylinositol 3-kinase signaling (GO:0014067),-0.30344087390962904,-0.5291189678010597,0.9696969696969697,1.0,1.0,2/8,10.32%,DAB2IP;TREM2
prerank,GO_Biological_Process_2021__regulation of vascular wound healing (GO:0061043),-0.3145815466734694,-0.5290547357353393,0.9772727272727273,1.0,1.0,1/6,8.65%,ALOX5
prerank,GO_Biological_Process_2021__negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039532),0.329494978291701,0.5284881440018141,0.9850746268656716,1.0,1.0,4/6,37.06%,SEC14L1;RIOK3;C1QBP;DHX58
prerank,GO_Biological_Process_2021__regulation of protein localization to cell periphery (GO:1904375),0.3046288101759712,0.5283067473013063,0.971830985915493,1.0,1.0,4/13,26.13%,ABCA2;SPTBN1;APPL1;ZDHHC7
prerank,GO_Biological_Process_2021__beta-catenin destruction complex disassembly (GO:1904886),-0.2772299793294861,-0.5268793051326104,1.0,1.0,1.0,2/11,20.26%,DVL2;LRP6
prerank,GO_Biological_Process_2021__dicarboxylic acid biosynthetic process (GO:0043650),0.3324416354595208,0.5266704520571203,0.96875,1.0,1.0,4/7,31.12%,MTHFD1;KYNU;HAAO;GOT1
prerank,GO_Biological_Process_2021__regulation of macroautophagy (GO:0016241),0.2557915800708218,0.5263991485556342,1.0,1.0,1.0,17/92,24.72%,BNIP3L;PRKAG2;BNIP3;PINK1;CASP3;NRBP2;PRKAA2;SESN1;CDK5R1;ATP6V0B;UCHL1;LRRK2;ATP6V1B2;ATG13;ATP6V0E2;ATP6V1D;VPS26B
prerank,GO_Biological_Process_2021__regulation of defense response to virus (GO:0050688),0.2883015851583855,0.5248592267109171,1.0,1.0,1.0,4/13,32.37%,IFNLR1;C1QBP;DHX9;TRAF3IP1
prerank,GO_Biological_Process_2021__regulation of adipose tissue development (GO:1904177),0.3555078987364017,0.5220907374190653,0.9672131147540983,1.0,1.0,1/6,17.51%,KLF7
prerank,GO_Biological_Process_2021__protein localization to microtubule (GO:0035372),0.32788394748362676,0.5219783183899614,0.9436619718309859,1.0,1.0,1/7,21.86%,HNRNPU
prerank,GO_Biological_Process_2021__metallo-sulfur cluster assembly (GO:0031163),-0.24568239793762972,-0.5217773370962286,1.0,1.0,1.0,5/18,21.29%,HSCB;ABCB7;MMS19;CIAO2B;NFU1
prerank,GO_Biological_Process_2021__regulation of antigen receptor-mediated signaling pathway (GO:0050854),0.31219263173546896,0.5203332508375348,1.0,1.0,1.0,1/9,13.83%,CD300A
prerank,GO_Biological_Process_2021__regulation of cytoplasmic transport (GO:1903649),-0.2646815505350071,-0.5187825099419479,1.0,1.0,1.0,2/10,16.93%,SRC;DNAJC13
prerank,GO_Biological_Process_2021__cellular biogenic amine metabolic process (GO:0006576),0.34476835124060085,0.5186828795455062,1.0,1.0,1.0,2/6,26.66%,SRM;AMD1
prerank,"GO_Biological_Process_2021__regulation of gene expression, epigenetic (GO:0040029)",0.23969670042659214,0.518015399098333,1.0,1.0,1.0,7/67,18.65%,TDG;BMI1;POLR1C;SMYD5;ERCC6;SUZ12;EZH2
prerank,GO_Biological_Process_2021__proteasomal protein catabolic process (GO:0010498),0.23087257253022028,0.5145553642655882,1.0,1.0,1.0,44/173,32.46%,ENC1;KCTD2;TRIM9;PSMB4;RBX1;RNF126;RNF139;PELI1;SYVN1;TBL1XR1;UBXN2B;HECW2;PSMC2;ZNRF1;PSMA3;PSMB2;NR1D1;SPSB3;UCHL1;DDB1;PSMD5;PSMD7;HACE1;FEM1C;PSMD14;PSMA5;TNFAIP1;BAG6;KCTD13;CTNNB1;FEM1B;NSFL1C;MAEA;KBTBD6;FBXL17;RBCK1;PRPF19;SPOPL;PLAA;UBE3D;PSMB8;PSMD8;PSMA4;CLOCK
prerank,GO_Biological_Process_2021__negative regulation of interferon-beta production (GO:0032688),0.3160775764091759,0.5138173305198964,0.9863013698630136,1.0,1.0,3/8,29.17%,PYCARD;PTPRS;RELB
prerank,GO_Biological_Process_2021__protein kinase A signaling (GO:0010737),0.3189853529993071,0.5123491020856836,0.9726027397260274,1.0,1.0,3/7,27.29%,RDX;PRKACB;TTN
prerank,GO_Biological_Process_2021__regulation of protein transport (GO:0051223),0.28962218736670936,0.5123159412393263,0.9879518072289156,1.0,1.0,7/24,28.03%,STXBP5L;DISP1;TNF;CHP1;PTPN1;HSPA8;SNX12
prerank,GO_Biological_Process_2021__positive regulation of fibroblast apoptotic process (GO:2000271),-0.32241970949891496,-0.5117813494634693,0.96875,1.0,1.0,1/5,13.04%,PRDM11
prerank,GO_Biological_Process_2021__regulation of viral transcription (GO:0046782),0.26545485089583715,0.511033579658566,0.9761904761904762,1.0,1.0,7/32,21.36%,IFITM3;NELFB;POLR2D;CDK9;TRIM14;POLR2G;HEXIM1
prerank,GO_Biological_Process_2021__DNA unwinding involved in DNA replication (GO:0006268),-0.27516814579008253,-0.5106379863199977,1.0,1.0,1.0,3/11,16.60%,SSBP1;RECQL;HMGA1
prerank,GO_Biological_Process_2021__histone H2A acetylation (GO:0043968),0.28660734409907057,0.5100755683267663,0.987012987012987,1.0,1.0,3/16,20.58%,RUVBL2;MORF4L2;MEAF6
prerank,GO_Biological_Process_2021__myotube differentiation (GO:0014902),0.31516302889424114,0.5094728838255567,0.9701492537313433,1.0,1.0,3/9,23.42%,PLD3;SORT1;ADGRB3
prerank,GO_Biological_Process_2021__RNA interference (GO:0016246),0.29693885329122854,0.5086223637926411,1.0,1.0,1.0,4/13,32.04%,PRKRA;AGO4;DICER1;DHX9
prerank,GO_Biological_Process_2021__autophagy of nucleus (GO:0044804),-0.2364128352794324,-0.5078039755675484,1.0,1.0,1.0,2/13,12.98%,WIPI1;ATG12
prerank,GO_Biological_Process_2021__regulation of centrosome cycle (GO:0046605),0.28812084948933103,0.5061879850059586,0.9866666666666667,1.0,1.0,3/16,23.39%,XRCC3;CHMP5;PDCD6IP
prerank,GO_Biological_Process_2021__mitochondrion disassembly (GO:0061726),0.2699370373775094,0.5056179576605915,0.9883720930232558,1.0,1.0,4/29,20.94%,BNIP3;PINK1;FBXO7;ATG5
prerank,GO_Biological_Process_2021__regulation of muscle system process (GO:0090257),0.3309952625054912,0.5024600351005474,0.9714285714285714,1.0,1.0,2/5,27.81%,ATP1A2;ANXA6
prerank,GO_Biological_Process_2021__positive regulation of cell cycle G1/S phase transition (GO:1902808),0.2779545977544532,0.5017404778412292,1.0,1.0,1.0,8/24,24.61%,ANXA1;CCND3;PLCB1;RGCC;EZH2;RDX;DDRGK1;DDX3X
prerank,GO_Biological_Process_2021__protein K63-linked deubiquitination (GO:0070536),0.2608404725023139,0.5015899255211055,1.0,1.0,1.0,8/24,34.11%,OTUD7B;OTUD1;PSMD14;USP25;UIMC1;OTUD7A;CYLD;BABAM2
prerank,GO_Biological_Process_2021__isotype switching (GO:0045190),-0.2559101380826869,-0.49978106270082207,1.0,1.0,1.0,4/8,23.72%,RNF8;RNF168;MSH6;MSH2
prerank,GO_Biological_Process_2021__regulation of RIG-I signaling pathway (GO:0039535),0.28031012267269706,0.49954987095870823,0.9868421052631579,1.0,1.0,4/13,31.06%,NOP53;ZCCHC3;SEC14L1;C1QBP
prerank,GO_Biological_Process_2021__regulation of NLRP3 inflammasome complex assembly (GO:1900225),0.3047091236691558,0.49938938626088086,0.984375,1.0,1.0,2/9,24.61%,DHX33;DDX3X
prerank,GO_Biological_Process_2021__response to dopamine (GO:1903350),-0.26103666454114544,-0.4991414478304207,1.0,1.0,1.0,1/7,10.62%,ABL1
prerank,GO_Biological_Process_2021__cellular response to dopamine (GO:1903351),-0.26103666454114544,-0.4991414478304207,1.0,1.0,1.0,1/7,10.62%,ABL1
prerank,GO_Biological_Process_2021__negative regulation of striated muscle cell differentiation (GO:0051154),0.2965301898860257,0.4990891226013647,1.0,1.0,1.0,1/10,11.78%,SOX6
prerank,"GO_Biological_Process_2021__regulation of retrograde transport, endosome to Golgi (GO:1905279)",-0.3145974591696277,-0.49847550637873517,1.0,1.0,1.0,1/6,7.61%,ARFIP1
prerank,GO_Biological_Process_2021__mitochondrial translational termination (GO:0070126),0.23781646487121166,0.49840662734269714,1.0,1.0,1.0,9/62,20.71%,MRPL33;MRPL43;MRPL20;MRPL14;MRPL55;MRPL27;MRPL19;MRPL3;MRPS14
prerank,GO_Biological_Process_2021__cellular response to amino acid starvation (GO:0034198),0.24549013297271413,0.49809080294001323,1.0,1.0,1.0,9/58,23.88%,EIF2AK3;IMPACT;SEH1L;NPRL2;SESN1;ATP6V0B;ATP6V1B2;ATP6V0E2;ATP6V1D
prerank,GO_Biological_Process_2021__telomeric D-loop disassembly (GO:0061820),0.32576570948217665,0.49757458677160193,1.0,1.0,1.0,2/6,29.84%,SLX4;BLM
prerank,GO_Biological_Process_2021__phosphatidylinositol dephosphorylation (GO:0046856),-0.2386948350518434,-0.4975137692294658,1.0,1.0,1.0,1/21,1.50%,INPP5K
prerank,GO_Biological_Process_2021__response to amino acid starvation (GO:1990928),0.24531086413977818,0.49723064563476466,1.0,1.0,1.0,9/59,23.88%,EIF2AK3;IMPACT;SEH1L;NPRL2;SESN1;ATP6V0B;ATP6V1B2;ATP6V0E2;ATP6V1D
prerank,GO_Biological_Process_2021__regulation of myeloid leukocyte differentiation (GO:0002761),0.33607983583476764,0.496961693771577,0.9852941176470589,1.0,1.0,1/7,17.56%,FOXP1
prerank,"GO_Biological_Process_2021__negative regulation of gene expression, epigenetic (GO:0045814)",0.26453819172344256,0.4965736284771066,1.0,1.0,1.0,4/25,18.65%,BMI1;SMYD5;SUZ12;EZH2
prerank,GO_Biological_Process_2021__protein deglycosylation involved in glycoprotein catabolic process (GO:0035977),0.32219833403400866,0.49631342233356085,0.971830985915493,1.0,1.0,2/5,32.10%,MAN1A1;EDEM3
prerank,GO_Biological_Process_2021__ubiquitin-dependent glycoprotein ERAD pathway (GO:0097466),0.32219833403400866,0.49631342233356085,0.971830985915493,1.0,1.0,2/5,32.10%,MAN1A1;EDEM3
prerank,GO_Biological_Process_2021__mannose trimming involved in glycoprotein ERAD pathway (GO:1904382),0.32219833403400866,0.49631342233356085,0.971830985915493,1.0,1.0,2/5,32.10%,MAN1A1;EDEM3
prerank,GO_Biological_Process_2021__regulation of type B pancreatic cell development (GO:2000074),-0.2973064257367221,-0.495794463130117,0.9354838709677419,1.0,1.0,6/6,70.29%,AKT1;RHEB;GSK3B;RFX3;CLOCK;FOXO1
prerank,GO_Biological_Process_2021__organelle disassembly (GO:1903008),0.26445248819644884,0.4938194252387095,1.0,1.0,1.0,3/29,24.39%,RETREG1;VRK1;DDRGK1
prerank,GO_Biological_Process_2021__histone-threonine phosphorylation (GO:0035405),-0.29433756683204637,-0.49342882913429786,0.9736842105263158,1.0,1.0,2/5,16.68%,PKN1;PRKCA
prerank,GO_Biological_Process_2021__regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902253),-0.2888722466856988,-0.49319517235059424,0.9642857142857143,1.0,1.0,2/7,13.73%,EIF5A;PTTG1IP
prerank,GO_Biological_Process_2021__Golgi localization (GO:0051645),0.28841842151940034,0.4928757276790883,0.9868421052631579,1.0,1.0,2/11,19.91%,HOOK3;TBCCD1
prerank,GO_Biological_Process_2021__negative regulation of fatty acid oxidation (GO:0046322),0.33180143046360194,0.4924743024652755,0.9710144927536232,1.0,1.0,1/5,9.91%,MFSD2A
prerank,"GO_Biological_Process_2021__mRNA splicing, via spliceosome (GO:0000398)",0.223999514652504,0.4922675191264779,1.0,1.0,1.0,36/226,26.18%,EIF4A3;PQBP1;WBP11;GEMIN2;DBR1;SRSF12;WBP4;TFIP11;ZMAT2;NOVA1;BCAS2;HNRNPA0;DDX1;RBM5;RBM4B;MFAP1;WDR83;HNRNPH1;POLR2D;SART3;PRPF6;SRSF5;POLR2G;SNRPD2;HNRNPU;SFPQ;PHF5A;HNRNPH3;SRSF3;PRCC;HNRNPR;BUD13;ELAVL2;SYNCRIP;LSM5;SRSF9
prerank,GO_Biological_Process_2021__protein alkylation (GO:0008213),0.2793014673981254,0.49216767270648365,0.9866666666666667,1.0,1.0,1/16,8.08%,CSKMT
prerank,GO_Biological_Process_2021__left/right pattern formation (GO:0060972),0.3211053974887207,0.4910785186361127,0.9855072463768116,1.0,1.0,2/5,29.76%,SETDB2;MEGF8
prerank,GO_Biological_Process_2021__regulation of DNA-templated transcription in response to stress (GO:0043620),0.32183804639970054,0.4901955192088879,0.9857142857142858,1.0,1.0,2/6,25.69%,BCLAF1;RPS6KA3
prerank,GO_Biological_Process_2021__translational termination (GO:0006415),0.23210668885525032,0.4880467001711596,1.0,1.0,1.0,9/66,20.71%,MRPL33;MRPL43;MRPL20;MRPL14;MRPL55;MRPL27;MRPL19;MRPL3;MRPS14
prerank,GO_Biological_Process_2021__negative regulation of myosin-light-chain-phosphatase activity (GO:0035509),0.34001201291394795,0.48716491346156654,0.9863013698630136,1.0,1.0,2/5,20.20%,ROCK1;TNF
prerank,GO_Biological_Process_2021__regulation of neurotransmitter transport (GO:0051588),0.28712528245842195,0.48708079132310217,1.0,1.0,1.0,2/12,15.47%,CPLX1;MCTP1
prerank,GO_Biological_Process_2021__response to mitochondrial depolarisation (GO:0098780),0.34560279413518336,0.48702375654593677,1.0,1.0,1.0,1/5,23.75%,GPS2
prerank,GO_Biological_Process_2021__RNA secondary structure unwinding (GO:0010501),-0.28047108637830254,-0.48663530954532525,1.0,1.0,1.0,1/7,9.60%,AGO1
prerank,GO_Biological_Process_2021__cellular biogenic amine catabolic process (GO:0042402),0.29502203569460955,0.4844843816383802,0.9841269841269841,1.0,1.0,2/7,19.64%,DMGDH;SLC44A1
prerank,GO_Biological_Process_2021__stabilization of membrane potential (GO:0030322),-0.30091511780648167,-0.48306760098777024,0.9615384615384616,1.0,1.0,2/5,22.43%,CHCHD10;KCNK1
prerank,GO_Biological_Process_2021__midbody abscission (GO:0061952),0.27362255435206895,0.48190495965431024,0.9722222222222222,1.0,1.0,3/11,24.91%,CHMP5;PDCD6IP;CHMP7
prerank,GO_Biological_Process_2021__plus-end-directed vesicle transport along microtubule (GO:0072383),0.3469035088370424,0.4788266809829554,0.9861111111111112,1.0,1.0,3/5,28.59%,KIF3A;FYCO1;KIF13A
prerank,GO_Biological_Process_2021__Golgi to lysosome transport (GO:0090160),0.28529566709126014,0.47778175164268627,0.972972972972973,1.0,1.0,1/9,22.52%,SORT1
prerank,GO_Biological_Process_2021__positive regulation of vascular associated smooth muscle cell proliferation (GO:1904707),0.28068794700487165,0.47757268524314583,1.0,1.0,1.0,6/15,33.13%,NR4A3;MFN2;JUN;MEF2D;GJA1;BMPR1A
prerank,GO_Biological_Process_2021__cytochrome complex assembly (GO:0017004),-0.28453225261735904,-0.47667282203735273,1.0,1.0,1.0,5/5,71.57%,SURF1;COX18;CYBA;COX10;COA6
prerank,GO_Biological_Process_2021__carbohydrate derivative biosynthetic process (GO:1901137),0.2679004301179957,0.4751422459990335,1.0,1.0,1.0,9/19,29.60%,B4GALT5;GK;GCNT1;ALG11;TNIP1;GK5;LARGE1;TKT;SCCPDH
prerank,GO_Biological_Process_2021__positive regulation of protein deacetylation (GO:0090312),-0.24082977810548856,-0.4750466538084761,0.9655172413793104,1.0,1.0,3/8,19.87%,AKAP8L;SAP30BP;AKAP8
prerank,GO_Biological_Process_2021__histone H3-K14 acetylation (GO:0044154),0.3253203774298893,0.4737484606161943,0.9863013698630136,1.0,1.0,1/6,20.58%,MEAF6
prerank,GO_Biological_Process_2021__biotin metabolic process (GO:0006768),-0.2627690306922442,-0.47352779383241744,1.0,1.0,1.0,3/8,19.66%,HLCS;PCCB;MCCC1
prerank,GO_Biological_Process_2021__negative regulation of lipid localization (GO:1905953),0.3230200165408682,0.4733854022186866,1.0,1.0,1.0,2/6,20.20%,ITGAV;TNF
prerank,GO_Biological_Process_2021__response to lipoteichoic acid (GO:0070391),-0.26106045254981425,-0.47272770265813846,1.0,1.0,1.0,5/5,73.91%,TIRAP;RELA;CD14;MAPK14;TLR2
prerank,GO_Biological_Process_2021__cellular response to lipoteichoic acid (GO:0071223),-0.26106045254981425,-0.47272770265813846,1.0,1.0,1.0,5/5,73.91%,TIRAP;RELA;CD14;MAPK14;TLR2
prerank,GO_Biological_Process_2021__positive regulation of tumor necrosis factor-mediated signaling pathway (GO:1903265),0.29805423759246436,0.4727041068086178,1.0,1.0,1.0,2/9,23.36%,HSPA1B;CASP1
prerank,GO_Biological_Process_2021__protein quality control for misfolded or incompletely synthesized proteins (GO:0006515),0.25479911281630063,0.4721026880383573,0.9859154929577465,1.0,1.0,4/21,30.96%,AUP1;BAG6;FBXL17;ZER1
prerank,GO_Biological_Process_2021__protein modification by small protein removal (GO:0070646),0.2143463566428502,0.46909777511533357,1.0,1.0,1.0,35/210,24.25%,CLSPN;TRAF2;COPS5;HIF1A;HCFC1;RPS27A;PSMB4;USP35;OTUD7B;TOMM20;VCPIP1;BRCA1;ACTR5;USP38;ESR1;SMAD1;TAF9B;UBA52;UBB;PSMC2;PSMA3;PSMB2;UCHL1;OTUD1;TNIP1;PSMD5;PSMD7;BARD1;USP48;USP5;GPS1;PTEN;PSMD14;PSMA5;CFTR
prerank,GO_Biological_Process_2021__nucleosome disassembly (GO:0006337),0.28448238867141545,0.46909380319410876,0.9859154929577465,1.0,1.0,5/11,30.16%,SMARCD3;SMARCC1;SMARCD2;ARID2;SET
prerank,GO_Biological_Process_2021__chromatin disassembly (GO:0031498),0.28448238867141545,0.46909380319410876,0.9859154929577465,1.0,1.0,5/11,30.16%,SMARCD3;SMARCC1;SMARCD2;ARID2;SET
prerank,GO_Biological_Process_2021__phosphatidylglycerol acyl-chain remodeling (GO:0036148),-0.2924069592859749,-0.46752195803465296,1.0,1.0,1.0,1/6,7.62%,PLA2G12A
prerank,GO_Biological_Process_2021__positive regulation of cholesterol transport (GO:0032376),0.25561350734525434,0.46746354593226264,1.0,1.0,1.0,7/22,31.30%,PLTP;ABCA5;ABCB4;GPS2;LRP1;NR1H2;ABCA3
prerank,GO_Biological_Process_2021__mRNA transcription (GO:0009299),0.28579299996510166,0.46551790479165733,1.0,1.0,1.0,1/10,10.42%,C5AR1
prerank,GO_Biological_Process_2021__maintenance of epithelial cell apical/basal polarity (GO:0045199),-0.2944993347646782,-0.46523886712641227,1.0,1.0,1.0,2/6,22.85%,ANK1;LIN7B
prerank,GO_Biological_Process_2021__maintenance of apical/basal cell polarity (GO:0035090),-0.2944993347646782,-0.46523886712641227,1.0,1.0,1.0,2/6,22.85%,ANK1;LIN7B
prerank,GO_Biological_Process_2021__positive regulation of myotube differentiation (GO:0010831),-0.28998592009226365,-0.4647503501970484,1.0,1.0,1.0,1/5,12.66%,MAML1
prerank,GO_Biological_Process_2021__regulation of endocytic recycling (GO:2001135),-0.26938017226819794,-0.4641154947441755,1.0,1.0,1.0,7/7,73.09%,SORL1;RAB11B;INPP5F;ARHGAP1;EIPR1;ACTN2;ATP9A
prerank,GO_Biological_Process_2021__hypotonic response (GO:0006971),-0.28841607565011823,-0.4617290762567306,1.0,1.0,1.0,5/5,71.18%,TRPV4;CAB39;STK39;SLC12A5;MYLK
prerank,GO_Biological_Process_2021__telomere maintenance via telomere lengthening (GO:0010833),0.24984882175773337,0.45961860123147985,1.0,1.0,1.0,6/22,29.55%,NHP2;SHQ1;RFC1;HSP90AB1;DKC1;STN1
prerank,GO_Biological_Process_2021__regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143),0.23295298870862086,0.4580982876378575,0.9879518072289156,1.0,1.0,2/28,15.56%,KDM1A;ESR1
prerank,GO_Biological_Process_2021__regulation of protein localization to early endosome (GO:1902965),0.29311767948817796,0.45759394467709935,1.0,1.0,1.0,1/6,21.38%,RDX
prerank,GO_Biological_Process_2021__positive regulation of protein localization to early endosome (GO:1902966),0.29311767948817796,0.45759394467709935,1.0,1.0,1.0,1/6,21.38%,RDX
prerank,GO_Biological_Process_2021__positive regulation of protein localization to endosome (GO:1905668),0.29311767948817796,0.45759394467709935,1.0,1.0,1.0,1/6,21.38%,RDX
prerank,GO_Biological_Process_2021__cellular response to bacterial lipopeptide (GO:0071221),-0.26106045254981425,-0.4566567879072552,1.0,1.0,1.0,5/5,73.91%,TIRAP;CD36;TLR1;CD14;TLR2
prerank,GO_Biological_Process_2021__positive regulation of chromosome organization (GO:2001252),0.25686347552778926,0.4562466583405771,1.0,1.0,1.0,2/11,30.41%,GNL3;RAD21
prerank,GO_Biological_Process_2021__regulation of protein localization to centrosome (GO:1904779),0.2726736027532921,0.456029684436818,1.0,1.0,1.0,3/8,33.08%,UBXN2B;NSFL1C;BICD1
prerank,GO_Biological_Process_2021__regulation of receptor catabolic process (GO:2000644),-0.2746538331644715,-0.45400987096272083,1.0,1.0,1.0,5/5,72.55%,MTMR2;LAPTM5;ITCH;DTX3L;PTPN1
prerank,GO_Biological_Process_2021__autophagy of mitochondrion (GO:0000422),0.24111601962846363,0.45257488545455454,1.0,1.0,1.0,7/32,29.74%,BNIP3;PINK1;FBXO7;ATG5;ATG13;MAP1LC3A;ATG2B
prerank,GO_Biological_Process_2021__peroxisome organization (GO:0007031),-0.20756518036227,-0.450186699835644,1.0,1.0,1.0,4/18,18.69%,PEX16;ABCD3;FIS1;PEX2
prerank,GO_Biological_Process_2021__regulation of histone H3-K27 methylation (GO:0061085),0.3143917654010179,0.44981427152572323,1.0,1.0,1.0,3/5,37.33%,MACROH2A1;MTF2;OGT
prerank,GO_Biological_Process_2021__negative regulation of RIG-I signaling pathway (GO:0039536),-0.2689969604863222,-0.44832088245614987,1.0,1.0,1.0,5/5,73.12%,UFD1;NPLOC4;DHX58;C1QBP;SEC14L1
prerank,GO_Biological_Process_2021__quinone biosynthetic process (GO:1901663),0.2675377804447925,0.4480344345812266,1.0,1.0,1.0,2/10,21.93%,COQ6;COQ2
prerank,GO_Biological_Process_2021__ubiquinone biosynthetic process (GO:0006744),0.2675377804447925,0.4480344345812266,1.0,1.0,1.0,2/10,21.93%,COQ6;COQ2
prerank,GO_Biological_Process_2021__methionine metabolic process (GO:0006555),0.2914615929653939,0.4458870071178624,1.0,1.0,1.0,2/7,24.74%,MTHFD1;ADI1
prerank,GO_Biological_Process_2021__negative regulation of defense response to virus (GO:0050687),0.2754593298910206,0.44572131289529704,0.9841269841269841,1.0,1.0,3/6,32.37%,MICB;C1QBP;TRAF3IP1
prerank,GO_Biological_Process_2021__ubiquinone metabolic process (GO:0006743),0.25983994042445746,0.4389157497261965,1.0,1.0,1.0,2/11,21.93%,COQ6;COQ2
prerank,GO_Biological_Process_2021__autophagy of peroxisome (GO:0030242),-0.219619283451636,-0.43515683638912567,1.0,1.0,1.0,2/12,18.25%,PJVK;ACBD5
prerank,GO_Biological_Process_2021__regulation of lipoprotein lipase activity (GO:0051004),0.2735726161446465,0.4346203110706812,1.0,1.0,1.0,4/10,30.59%,PCSK6;SORT1;HDAC9;NR1H2
prerank,GO_Biological_Process_2021__proteasome assembly (GO:0043248),-0.23175801854246447,-0.43345282974317334,1.0,1.0,1.0,1/9,11.58%,ADRM1
prerank,GO_Biological_Process_2021__response to thyroid hormone (GO:0097066),0.25746410962513955,0.42935064112261195,0.9866666666666667,1.0,1.0,2/11,21.38%,KLF9;RDX
prerank,GO_Biological_Process_2021__transcription by RNA polymerase III (GO:0006383),0.2342358910055421,0.42740638972952544,1.0,1.0,1.0,7/23,32.67%,POLR3H;SNAPC3;ICE2;SNAPC4;CRCP;GTF3C6;ELL
prerank,GO_Biological_Process_2021__regulation of DNA replication (GO:0006275),0.2151670949454886,0.4273739819930215,1.0,1.0,1.0,10/35,33.16%,DNA2;GTPBP4;ORC3;ATAD5;WAPL;STN1;BLM;GMNN;DHX9;ATR
prerank,GO_Biological_Process_2021__regulation of muscle contraction (GO:0006937),0.2527204047449474,0.4271731253819416,1.0,1.0,1.0,4/11,27.81%,KCNB2;ENO1;ATP1A2;ANXA6
prerank,GO_Biological_Process_2021__telomere capping (GO:0016233),0.24572135434555295,0.4244694657420814,1.0,1.0,1.0,1/11,9.71%,TFIP11
prerank,GO_Biological_Process_2021__mitotic cytokinetic process (GO:1902410),0.2294747148347178,0.41851569690988727,0.9863013698630136,1.0,1.0,3/13,24.91%,CHMP5;PDCD6IP;CHMP7
prerank,GO_Biological_Process_2021__detection of virus (GO:0009597),0.28708197867977314,0.4158903683215757,1.0,1.0,1.0,2/5,23.61%,SERINC5;ZCCHC3
prerank,GO_Biological_Process_2021__regulation of centriole elongation (GO:1903722),-0.26123940327551565,-0.4061363965468027,1.0,1.0,1.0,2/5,21.06%,CHMP2A;VPS4B
prerank,GO_Biological_Process_2021__entry into host (GO:0044409),-0.23315241790088848,-0.40540096456592917,1.0,1.0,1.0,2/9,15.95%,SRC;CBL
prerank,GO_Biological_Process_2021__positive regulation of osteoclast differentiation (GO:0045672),0.2747745524775609,0.4031183625663867,0.9857142857142858,1.0,1.0,1/5,20.20%,TNF
prerank,GO_Biological_Process_2021__aminophospholipid transport (GO:0015917),0.27258446282575255,0.400555023150467,1.0,1.0,1.0,3/5,36.07%,ATP8A2;ATP8A1;SCARB2
prerank,GO_Biological_Process_2021__DNA replication-dependent nucleosome assembly (GO:0006335),0.2591264251550535,0.39641384758826415,1.0,1.0,1.0,2/5,33.82%,NASP;CHAF1A
prerank,GO_Biological_Process_2021__DNA replication-dependent nucleosome organization (GO:0034723),0.2591264251550535,0.39641384758826415,1.0,1.0,1.0,2/5,33.82%,NASP;CHAF1A
prerank,GO_Biological_Process_2021__negative regulation of sequestering of triglyceride (GO:0010891),0.251969691454173,0.39565197138285985,1.0,0.9999110093633092,1.0,2/6,27.94%,PPARA;OSBPL8
prerank,GO_Biological_Process_2021__protein localization to kinetochore (GO:0034501),-0.2055916884872033,-0.3903948811908855,1.0,1.0,1.0,10/10,79.47%,BUB3;RCC2;ZW10;MIS12;IK;KNL1;CHAMP1;MTBP;ZWILCH;CENPT
prerank,GO_Biological_Process_2021__cellular response to interleukin-2 (GO:0071352),-0.2616808650057038,-0.3852068288820533,1.0,1.0,1.0,1/6,13.23%,SYK
prerank,GO_Biological_Process_2021__interleukin-2-mediated signaling pathway (GO:0038110),-0.2616808650057038,-0.3852068288820533,1.0,1.0,1.0,1/6,13.23%,SYK
prerank,GO_Biological_Process_2021__transcription preinitiation complex assembly (GO:0070897),0.2285925552727766,0.3834140314555029,1.0,1.0,1.0,3/10,30.22%,TAF7;GTF2A2;TAF1B
prerank,GO_Biological_Process_2021__amyloid precursor protein metabolic process (GO:0042982),0.23333425983036749,0.3827872296692043,1.0,0.9997655393491882,1.0,2/11,22.91%,TMCC2;ABCG1
prerank,GO_Biological_Process_2021__Golgi to endosome transport (GO:0006895),0.2015037332057146,0.3465550876103526,1.0,0.9999439146006319,1.0,6/14,38.06%,AP1AR;SORT1;KIF16B;MON2;VPS13C;RAB14
prerank,GO_Biological_Process_2021__regulation of lysosomal lumen pH (GO:0035751),-0.21290739768944938,-0.3423146084481145,1.0,0.9999911324720008,1.0,2/7,19.63%,TASL;GRN
